data_1klv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1klv _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.533 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.141 0.496 . . . . 0.0 109.962 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 24.2 t -133.65 103.99 12.1 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.933 . . . . 0.0 110.383 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HD2' ' OH ' ' A' ' 95' ' ' TYR . 48.7 Cg_endo -75.97 85.21 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.264 1.665 . . . . 0.0 109.721 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 2.0 m -77.9 150.33 5.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 110.918 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 35.9 mm -106.54 160.66 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.318 -0.864 . . . . 0.0 108.672 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 HG22 ' CD1' ' A' ' 49' ' ' TYR . 2.2 t -134.36 141.23 44.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.903 -1.123 . . . . 0.0 111.336 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.65 174.97 14.67 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.514 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -115.93 159.85 21.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.779 -1.2 . . . . 0.0 110.526 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.553 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -65.01 -174.3 0.14 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.595 -0.691 . . . . 0.0 109.405 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.7 Cg_endo -71.32 110.37 2.83 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.617 1.325 . . . . 0.0 109.92 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.22 42.9 5.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.326 -0.859 . . . . 0.0 110.066 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -57.47 -179.82 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.466 ' CG ' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.06 35.11 0.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.108 -0.995 . . . . 0.0 110.749 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.554 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 2.1 pp -95.09 176.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 0.0 110.274 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -49.09 -177.69 0.01 OUTLIER Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.467 ' O ' HD21 ' A' ' 44' ' ' LEU . 5.6 t70 -79.79 -179.03 6.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -1.149 . . . . 0.0 109.615 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.467 HD21 ' O ' ' A' ' 43' ' ' ASP . 1.8 mm? -135.63 131.94 36.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.433 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 1.6 m-20 -86.8 -28.73 22.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.703 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 45' ' ' ASP . 3.7 mptt -152.68 157.03 40.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.54 -0.725 . . . . 0.0 109.808 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -123.88 43.19 3.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.955 . . . . 0.0 109.958 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 3.6 pttt -159.67 107.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.846 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.593 ' CD2' HD13 ' A' ' 63' ' ' LEU . 22.4 m-85 -103.84 142.2 34.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.75 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.16 95.67 6.48 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 55' ' ' LEU . 15.6 m -118.54 145.26 37.02 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.728 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.478 ' HD2' HD12 ' A' ' 55' ' ' LEU . 43.8 Cg_endo -70.19 147.59 60.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.0 1.526 . . . . 0.0 109.932 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.547 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.85 -16.04 56.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -0.805 . . . . 0.0 111.476 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -83.57 -13.7 53.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.961 -1.087 . . . . 0.0 111.192 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.526 HD21 ' CB ' ' A' ' 59' ' ' GLN . 4.3 mt -62.44 143.62 56.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.867 -1.145 . . . . 0.0 111.527 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 p -91.12 162.84 14.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.616 -0.678 . . . . 0.0 109.717 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 70.2 t -59.9 -23.71 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.99 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.3 -34.0 68.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.526 ' CB ' HD21 ' A' ' 55' ' ' LEU . 22.1 mm-40 -73.41 -46.98 45.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.097 -1.237 . . . . 0.0 109.827 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.65 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 19.8 t80 -60.87 -46.82 89.11 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.565 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.445 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -50.69 -21.73 1.74 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.916 -1.115 . . . . 0.0 109.913 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -80.66 -54.82 5.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.442 -0.786 . . . . 0.0 110.387 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.593 HD13 ' CD2' ' A' ' 49' ' ' TYR . 3.8 pp -60.11 -19.95 55.86 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.984 -1.072 . . . . 0.0 112.355 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.65 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -92.75 -38.88 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 120.094 -1.629 . . . . 0.0 109.165 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 64' ' ' ILE . 13.9 mtt180 -36.98 -61.37 0.56 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.775 -0.578 . . . . 0.0 110.698 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -65.21 -32.32 73.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.0 109.698 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 4.5 mmp_? -68.04 -14.77 63.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.575 HD12 ' CE2' ' A' ' 109' ' ' TYR . 2.0 mm -100.23 10.21 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.176 -0.953 . . . . 0.0 109.676 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.464 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 52.67 32.83 12.59 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.433 -0.792 . . . . 0.0 110.238 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.526 HD22 ' CG2' ' A' ' 68' ' ' ILE . 4.3 pp -116.03 153.97 30.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.444 -0.785 . . . . 0.0 110.221 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 2.7 ptp180 -166.4 -173.56 2.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.265 -0.897 . . . . 0.0 110.919 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 71' ' ' ARG . . . 56.95 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.72 . . . . 0.0 111.065 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 74' ' ' ASP . 5.6 pt-20 -146.01 24.17 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.092 -1.005 . . . . 0.0 111.301 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -49.09 176.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.943 -1.098 . . . . 0.0 109.786 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -111.28 139.58 46.56 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.252 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 31.9 tp -164.76 153.68 12.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.774 . . . . 0.0 110.332 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 95.2 m-85 -157.66 120.75 3.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.57 -0.706 . . . . 0.0 110.032 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 15.7 m-30 -82.82 133.58 35.13 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.171 -0.956 . . . . 0.0 111.748 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.421 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 51.0 m-85 -120.65 119.38 32.66 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.571 HG12 ' CG ' ' A' ' 98' ' ' HIS . 2.5 t -120.67 128.41 76.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.382 -0.824 . . . . 0.0 109.915 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.533 ' CB ' ' ND1' ' A' ' 98' ' ' HIS . 4.4 t30 48.1 36.61 6.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.984 . . . . 0.0 109.921 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 12.8 m-20 66.69 38.65 3.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.468 -0.77 . . . . 0.0 110.438 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -135.66 166.95 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 110.024 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -155.19 67.7 5.18 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.635 -0.666 . . . . 0.0 109.304 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.468 ' HD3' HG12 ' A' ' 83' ' ' VAL . 49.9 Cg_endo -73.48 164.6 34.62 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.962 1.506 . . . . 0.0 110.808 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.64 -178.33 3.34 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.114 1.587 . . . . 0.0 110.387 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.47 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -84.35 21.42 1.44 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.413 -0.804 . . . . 0.0 110.887 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -96.99 43.15 1.07 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.346 -0.847 . . . . 0.0 109.451 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.03 -172.1 3.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.547 -0.72 . . . . 0.0 110.234 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 72.2 p -139.33 145.7 39.38 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.567 -0.708 . . . . 0.0 110.375 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.533 ' CE ' HG11 ' A' ' 31' ' ' VAL . 95.9 mmm -58.88 -45.03 91.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.165 -0.959 . . . . 0.0 109.649 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -48.11 -47.65 26.54 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 90' ' ' THR . 1.0 OUTLIER -64.46 -32.86 74.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.211 -1.17 . . . . 0.0 109.616 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -66.16 -22.23 66.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.905 . . . . 0.0 109.955 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.513 ' O ' ' HB3' ' A' ' 99' ' ' HIS . 1.2 t80 -49.22 -55.06 13.79 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.012 -1.055 . . . . 0.0 109.971 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 5.1 tp60 -69.47 -18.55 63.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.008 -1.058 . . . . 0.0 111.078 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 12.7 mm-40 -87.3 -68.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.007 -1.058 . . . . 0.0 112.363 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.571 ' CG ' HG12 ' A' ' 80' ' ' VAL . 8.8 m-70 -99.44 38.23 1.46 Allowed 'General case' 0 N--CA 1.484 1.257 0 O-C-N 120.833 -1.167 . . . . 0.0 111.947 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.513 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.8 p80 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.033 -1.042 . . . . 0.0 109.237 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.467 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 4.6 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.056 0.455 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.598 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -109.58 165.68 11.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.064 -1.023 . . . . 0.0 109.502 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.502 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 1.9 m-85 -122.85 128.89 50.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.847 -1.158 . . . . 0.0 111.87 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.598 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 6.3 mt -140.02 128.57 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.343 -0.848 . . . . 0.0 110.016 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -123.7 172.83 8.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 109.75 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.2 p90 -149.92 163.07 39.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.822 -1.174 . . . . 0.0 111.35 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.45 179.47 7.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.741 -0.6 . . . . 0.0 110.688 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.544 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . 5.8 t70 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 8.7 mpt_? . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.232 0.539 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' A' ' 31' ' ' VAL . 24.0 t -145.55 105.78 4.32 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 47.7 Cg_endo -75.89 84.06 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.167 1.614 . . . . 0.0 109.818 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.8 m -80.54 149.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 111.114 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.566 HG13 ' CE1' ' A' ' 104' ' ' PHE . 6.8 mm -102.02 164.93 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.516 ' CG1' ' HA ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -136.09 141.81 40.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.779 -1.201 . . . . 0.0 111.545 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 1.8 tt0 -156.52 165.76 35.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.642 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -99.69 162.47 12.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.917 -1.115 . . . . 0.0 110.738 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.565 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.36 -172.66 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.464 -0.772 . . . . 0.0 109.292 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.8 Cg_endo -71.31 107.59 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.476 1.251 . . . . 0.0 110.033 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 mttt 63.52 36.39 11.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.453 -0.78 . . . . 0.0 110.196 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.459 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -58.68 178.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 110.061 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 35.53 0.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 110.58 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.546 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.54 176.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.006 -1.059 . . . . 0.0 110.432 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.546 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -48.73 -177.47 0.01 OUTLIER Glycine 0 N--CA 1.497 2.717 0 O-C-N 121.438 -0.789 . . . . 0.0 111.179 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.3 t0 -77.12 -175.74 3.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -1.091 . . . . 0.0 109.778 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -136.02 135.21 39.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.985 . . . . 0.0 110.738 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -86.89 -36.03 18.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 109.732 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.562 ' HE2' ' CE2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -152.59 155.29 37.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.474 -0.766 . . . . 0.0 109.837 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -120.31 43.23 2.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 0.0 110.226 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 47' ' ' LYS . 14.8 mttp -157.88 107.56 2.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 109.58 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.585 ' CD2' HD13 ' A' ' 63' ' ' LEU . 31.8 m-85 -103.39 143.34 32.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.114 -0.991 . . . . 0.0 110.884 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.61 89.89 3.49 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 20.2 m -111.04 143.45 28.36 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.347 -0.846 . . . . 0.0 111.002 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 55' ' ' LEU . 46.5 Cg_endo -71.45 148.96 55.42 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.164 1.613 . . . . 0.0 109.74 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.534 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.55 -15.58 51.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.898 . . . . 0.0 111.438 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -83.34 -13.81 54.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.09 -1.006 . . . . 0.0 111.169 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.532 HD21 ' CB ' ' A' ' 59' ' ' GLN . 4.0 mt -62.3 143.63 56.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.829 -1.17 . . . . 0.0 111.129 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.471 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 1.6 p -91.3 167.67 12.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.593 -0.692 . . . . 0.0 109.891 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 80.8 t -62.75 -32.25 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 110.059 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.81 -23.38 70.82 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.532 ' CB ' HD21 ' A' ' 55' ' ' LEU . 34.7 mm-40 -80.4 -50.91 9.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.125 -1.221 . . . . 0.0 109.727 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 14.1 t80 -60.12 -34.06 72.99 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.084 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.565 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -54.8 -37.56 66.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.47 -0.769 . . . . 0.0 109.873 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.8 t80 -74.51 -50.69 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.537 -0.727 . . . . 0.0 112.525 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -58.58 -39.88 81.57 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.506 -1.371 . . . . 0.0 112.489 -177.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.631 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -75.1 -38.89 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 119.764 -1.835 . . . . 0.0 108.761 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.535 ' CD ' HD12 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -39.15 -58.39 1.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.551 -0.718 . . . . 0.0 110.42 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -65.32 -34.4 78.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.968 -1.083 . . . . 0.0 109.903 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.527 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 4.5 mmp_? -70.27 -9.22 55.33 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.258 -0.901 . . . . 0.0 109.835 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.577 HD11 ' CD2' ' A' ' 109' ' ' TYR . 67.1 mt -100.28 4.55 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.337 -0.852 . . . . 0.0 109.733 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.466 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 60.63 27.97 17.68 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.393 -0.817 . . . . 0.0 110.324 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.535 HD12 ' CD ' ' A' ' 65' ' ' ARG . 4.3 pp -114.99 156.33 25.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.639 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.06 -166.94 0.97 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 110.998 -179.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.45 -87.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.835 . . . . 0.0 110.986 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' ARG . 9.7 pt-20 -152.06 27.09 0.61 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 111.238 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -53.84 176.37 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.919 -1.113 . . . . 0.0 109.817 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -97.79 141.97 30.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.954 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 16.6 tp -162.19 152.55 16.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 110.997 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.2 m-85 -160.99 120.54 2.64 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.577 ' CZ ' HD22 ' A' ' 76' ' ' LEU . 77.9 m-85 -89.03 116.81 27.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 110.273 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 55.8 m-85 -108.31 125.87 52.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.399 -0.813 . . . . 0.0 109.507 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.62 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 1.9 t -121.34 129.92 75.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.324 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 55.4 t30 51.05 37.84 18.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 110.361 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 58.2 t30 65.06 36.75 7.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 110.385 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.5 t -135.02 167.04 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.228 -0.92 . . . . 0.0 110.031 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.1 mp -155.05 73.07 5.72 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.585 -0.697 . . . . 0.0 109.556 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.55 164.37 35.12 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.994 1.523 . . . . 0.0 110.563 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.86 -178.38 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.138 1.599 . . . . 0.0 110.221 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.486 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -85.01 20.08 1.97 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 110.741 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.67 42.01 1.11 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.485 -0.76 . . . . 0.0 109.672 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.414 ' HB2' ' OE1' ' A' ' 93' ' ' GLN . . . -145.28 -174.85 4.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.503 -0.748 . . . . 0.0 110.144 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 43.6 p -139.68 146.68 39.96 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.501 -0.75 . . . . 0.0 110.386 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.534 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 24.3 mmm -53.56 -42.45 67.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.662 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.52 -46.71 37.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.1 OUTLIER -65.35 -33.05 75.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -1.209 . . . . 0.0 109.827 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.534 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.11 -19.79 64.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.936 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.58 ' O ' ' HB3' ' A' ' 99' ' ' HIS . 0.6 OUTLIER -49.55 -56.42 9.95 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.005 -1.059 . . . . 0.0 109.632 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -70.15 -15.23 62.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.461 -1.4 . . . . 0.0 111.243 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 2.2 mm-40 -87.44 -64.74 1.1 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.969 -1.082 . . . . 0.0 112.925 -178.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.62 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -97.97 39.69 1.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.875 -1.14 . . . . 0.0 111.445 -177.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.58 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 1.6 t60 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.566 ' CE1' HG13 ' A' ' 32' ' ' ILE . 3.1 p90 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.294 0.568 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.591 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.28 168.11 9.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.19 -0.944 . . . . 0.0 109.113 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.506 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 1.1 p90 -124.64 127.28 47.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.785 -1.197 . . . . 0.0 111.854 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.591 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 6.7 mt -136.73 144.56 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.078 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -133.55 175.65 9.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.949 . . . . 0.0 110.018 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.9 OUTLIER -147.42 167.6 23.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.972 . . . . 0.0 110.478 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -158.58 165.21 35.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.723 . . . . 0.0 110.285 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 4.3 p-10 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 110.312 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 3.2 mpt_? . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.3 0.571 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.472 HG13 ' CG1' ' A' ' 31' ' ' VAL . 9.2 t -143.53 104.45 5.01 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 110.295 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.576 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.7 Cg_endo -78.71 87.84 1.51 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.159 1.61 . . . . 0.0 109.928 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.2 m -83.42 144.02 10.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.136 -0.977 . . . . 0.0 110.882 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 31.5 mm -97.5 162.52 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 2.4 t -136.69 139.6 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.912 -1.117 . . . . 0.0 111.221 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 1.3 tm-20 -154.03 163.87 39.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -99.97 158.68 15.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.885 -1.135 . . . . 0.0 110.909 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.558 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.92 -173.55 0.11 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.562 -0.711 . . . . 0.0 109.185 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 44.0 Cg_endo -72.0 109.1 2.61 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.507 1.267 . . . . 0.0 110.112 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 62.15 42.86 9.21 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.367 -0.833 . . . . 0.0 110.293 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -63.99 179.92 0.48 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.517 ' CG ' ' OD1' ' A' ' 111' ' ' ASP . 0.9 OUTLIER -149.84 30.74 0.72 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.163 -0.961 . . . . 0.0 110.821 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.511 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -85.18 -179.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.048 -1.033 . . . . 0.0 109.924 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -59.81 168.03 8.26 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -87.35 171.64 10.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -1.11 . . . . 0.0 110.34 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.531 HD22 ' CD ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -136.51 146.28 46.06 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.351 -0.843 . . . . 0.0 110.105 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.463 ' N ' HD21 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -86.95 -7.49 58.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.854 . . . . 0.0 110.182 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.469 ' O ' HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -154.12 155.66 35.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.004 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -126.44 45.18 2.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.003 . . . . 0.0 109.716 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.62 111.77 2.35 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.467 -0.77 . . . . 0.0 109.879 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.576 ' CD2' HD13 ' A' ' 63' ' ' LEU . 11.6 m-85 -104.91 142.37 34.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -0.979 . . . . 0.0 110.127 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.49 100.62 8.65 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.509 -0.745 . . . . 0.0 109.136 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.493 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 3.5 m -126.94 159.6 63.66 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.142 -0.974 . . . . 0.0 110.763 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.456 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 46.2 Cg_endo -71.43 147.86 53.29 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.194 1.629 . . . . 0.0 110.594 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.536 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -64.77 -14.59 59.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 111.533 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -83.52 -10.92 58.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.883 -1.136 . . . . 0.0 110.764 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.525 HD23 ' CB ' ' A' ' 59' ' ' GLN . 4.5 mt -62.56 143.38 57.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.083 -1.011 . . . . 0.0 111.038 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 p -90.63 158.27 17.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.49 -0.756 . . . . 0.0 109.199 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.515 HG12 ' CG2' ' A' ' 87' ' ' THR . 61.1 t -57.09 -23.01 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.091 -1.005 . . . . 0.0 110.032 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.98 -33.67 59.49 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.525 ' CB ' HD23 ' A' ' 55' ' ' LEU . 24.3 mm-40 -72.27 -50.61 25.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.151 -1.205 . . . . 0.0 109.759 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.666 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 47.2 t80 -60.56 -32.02 71.11 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.273 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.664 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -63.41 -29.28 70.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.033 -1.042 . . . . 0.0 109.498 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.489 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.3 t80 -69.85 -53.36 18.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 110.126 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.584 HD11 ' CE1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -59.87 -33.59 72.01 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.426 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.666 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -75.13 -33.4 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 119.777 -1.827 . . . . 0.0 109.701 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -38.29 -63.89 0.46 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 0.0 110.721 -179.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -30.62 71.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 110.132 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.531 ' CD ' HD22 ' A' ' 44' ' ' LEU . 20.2 mmt180 -66.15 -20.29 66.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.202 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.593 HD12 ' CD2' ' A' ' 109' ' ' TYR . 68.8 mt -104.2 15.7 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.977 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.493 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 49.68 28.37 2.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.411 -0.806 . . . . 0.0 110.241 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.532 HD21 ' CG2' ' A' ' 68' ' ' ILE . 3.8 pp -110.11 160.48 16.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.428 -0.795 . . . . 0.0 109.519 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.4 ptt180 -165.25 -171.9 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.046 -1.034 . . . . 0.0 110.822 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 52.08 -89.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.487 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 72' ' ' ALA . 33.1 mt-10 -157.11 29.29 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.951 . . . . 0.0 110.703 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.39 176.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.117 -0.99 . . . . 0.0 109.846 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.518 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -87.45 137.71 32.1 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 121.382 0.61 . . . . 0.0 110.367 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.594 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 49.3 tp -164.83 152.78 11.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.787 . . . . 0.0 110.426 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.594 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 89.8 m-85 -158.77 118.47 3.13 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.556 -0.715 . . . . 0.0 110.021 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.664 ' CD2' ' CE2' ' A' ' 61' ' ' TYR . 19.3 m-30 -84.96 132.67 34.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.0 -1.062 . . . . 0.0 111.054 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 59.5 m-85 -117.63 119.79 36.04 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.421 -0.799 . . . . 0.0 109.138 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.584 HG11 ' CG ' ' A' ' 98' ' ' HIS . 2.8 t -120.96 123.47 70.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.592 -0.693 . . . . 0.0 110.198 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.461 ' HB2' ' ND1' ' A' ' 98' ' ' HIS . 1.6 m120 49.54 42.04 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 3.7 m120 62.5 35.72 14.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.351 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.588 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -135.2 167.39 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.1 mp -155.0 68.53 5.48 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 109.454 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.411 ' HD3' HG12 ' A' ' 83' ' ' VAL . 46.8 Cg_endo -73.74 163.07 38.13 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.982 1.517 . . . . 0.0 110.891 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.4 -178.26 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.146 1.603 . . . . 0.0 110.419 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.515 ' CG2' HG12 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -84.75 22.18 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.389 -0.819 . . . . 0.0 110.864 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -94.27 41.23 1.09 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 109.65 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.446 ' HB2' ' OE1' ' A' ' 93' ' ' GLN . . . -145.45 -172.48 3.89 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.598 0.713 . . . . 0.0 110.288 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 63.5 p -139.79 140.74 36.73 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.674 -0.641 . . . . 0.0 110.159 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.557 ' HE2' ' CD1' ' A' ' 60' ' ' PHE . 9.3 mmm -49.18 -41.87 38.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.163 -0.961 . . . . 0.0 110.261 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.81 -47.65 52.71 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.2 OUTLIER -64.86 -30.87 71.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -1.097 . . . . 0.0 109.94 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.3 -24.51 64.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 110.031 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.576 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -49.46 -56.13 10.81 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 109.764 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -69.85 -17.8 63.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.003 -1.06 . . . . 0.0 111.124 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.3 mm-40 -87.53 -68.24 0.77 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.973 -1.08 . . . . 0.0 112.363 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.584 ' CG ' HG11 ' A' ' 80' ' ' VAL . 10.6 m-70 -99.38 38.65 1.39 Allowed 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.871 -1.143 . . . . 0.0 111.937 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.536 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.4 p80 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.136 -0.978 . . . . 0.0 109.41 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.0 p90 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.28 0.562 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.534 ' CD1' HG13 ' A' ' 107' ' ' ILE . 0.3 OUTLIER -111.77 169.55 8.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.313 -0.867 . . . . 0.0 109.693 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.521 ' CD1' ' O ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER -126.56 126.19 43.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.731 -1.23 . . . . 0.0 110.986 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.534 HG12 ' CG2' ' A' ' 80' ' ' VAL . 11.7 mt -141.25 147.98 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.306 -0.872 . . . . 0.0 109.64 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 34' ' ' GLU . . . -142.5 -179.92 6.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.111 -0.993 . . . . 0.0 110.286 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.593 ' CD2' HD12 ' A' ' 68' ' ' ILE . 1.6 p90 -150.02 162.71 39.86 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.645 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -159.39 168.44 26.3 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.566 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.517 ' OD1' ' CG ' ' A' ' 40' ' ' ARG . 16.9 p-10 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.074 -1.016 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.336 0.589 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.517 HG13 ' CG1' ' A' ' 31' ' ' VAL . 21.6 t -145.94 110.64 4.42 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 109.963 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.585 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 47.0 Cg_endo -73.44 87.9 1.05 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 124.175 1.619 . . . . 0.0 109.949 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.4 m -88.12 144.1 9.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.33 -0.856 . . . . 0.0 111.411 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 16.2 mm -108.98 135.8 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 0.4 OUTLIER -120.25 140.89 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.737 -1.227 . . . . 0.0 112.142 -178.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 20.6 tp10 -145.6 172.49 13.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.655 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -97.44 161.49 13.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.814 -1.179 . . . . 0.0 110.802 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.562 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -65.09 -173.22 0.1 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.488 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 44.4 Cg_endo -72.55 112.09 3.39 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.547 1.288 . . . . 0.0 109.827 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 59.67 43.04 16.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.888 . . . . 0.0 110.178 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.417 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -66.05 179.36 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.31 -0.869 . . . . 0.0 110.166 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.455 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.3 34.24 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.948 . . . . 0.0 110.785 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.555 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.89 177.51 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.012 -1.055 . . . . 0.0 110.418 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -52.23 -174.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.832 0 O-C-N 121.266 -0.896 . . . . 0.0 111.273 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -81.67 -175.8 5.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -1.078 . . . . 0.0 110.107 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' A' ' 68' ' ' ILE . 1.2 mm? -140.17 135.33 32.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.942 . . . . 0.0 110.775 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 46' ' ' LYS . 2.9 p30 -86.39 -27.35 24.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.497 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.508 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -153.2 155.65 37.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.84 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -124.4 42.98 3.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.021 -1.05 . . . . 0.0 110.042 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -159.46 109.36 1.91 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.446 -0.784 . . . . 0.0 109.78 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.572 ' CD2' HD12 ' A' ' 63' ' ' LEU . 29.9 m-85 -106.44 141.72 37.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.046 -1.033 . . . . 0.0 110.823 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mp -107.06 93.99 4.86 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.484 ' HB ' HD13 ' A' ' 55' ' ' LEU . 35.0 m -113.18 152.45 45.09 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.933 . . . . 0.0 111.314 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HD2' HD13 ' A' ' 55' ' ' LEU . 44.6 Cg_endo -70.49 145.52 53.12 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.317 1.693 . . . . 0.0 109.625 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.538 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 1.7 m -62.9 -11.87 21.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.349 -0.845 . . . . 0.0 111.451 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -85.5 -14.54 45.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 0.0 111.104 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.518 HD21 ' CB ' ' A' ' 59' ' ' GLN . 3.9 mt -62.21 142.43 57.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.028 -1.045 . . . . 0.0 111.372 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.7 p -91.09 162.65 14.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.744 -0.597 . . . . 0.0 109.788 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 91.4 t -58.44 -25.67 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.093 -1.004 . . . . 0.0 109.963 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.93 94.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.518 ' CB ' HD21 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -67.69 -48.0 67.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -1.197 . . . . 0.0 109.877 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CD1' ' CD1' ' A' ' 63' ' ' LEU . 8.0 t80 -60.23 -32.46 71.15 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.068 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.469 ' CD1' ' HE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -55.36 -36.6 66.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 110.085 178.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.72 -49.98 12.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.437 -0.79 . . . . 0.0 112.691 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.633 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.43 -40.33 82.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.51 -1.368 . . . . 0.0 111.975 -177.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.618 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -75.22 -42.53 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 119.907 -1.746 . . . . 0.0 108.278 178.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -39.84 -54.89 2.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.628 -0.67 . . . . 0.0 110.53 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -64.33 -35.89 82.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.138 -0.976 . . . . 0.0 109.937 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.524 ' CG ' ' OH ' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -69.68 -14.39 62.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.187 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.581 HD11 ' CE2' ' A' ' 109' ' ' TYR . 2.3 mm -93.2 4.27 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.494 -0.754 . . . . 0.0 109.721 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.1 t60 53.43 33.71 16.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 110.484 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.504 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -104.96 156.56 17.92 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' A' ' 73' ' ' GLU . 12.9 ptt180 -165.83 -168.2 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.832 -1.168 . . . . 0.0 111.247 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.35 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 110.963 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 74' ' ' ASP . 5.2 pt-20 -152.16 24.01 0.64 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.146 -0.971 . . . . 0.0 111.106 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.29 177.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 109.85 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.1 141.14 37.18 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.112 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.589 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 26.2 tp -154.83 153.11 30.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.469 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 95.4 m-85 -158.43 121.16 3.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.622 -0.674 . . . . 0.0 109.79 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.514 ' CZ ' HD21 ' A' ' 76' ' ' LEU . 72.3 m-85 -92.26 123.01 35.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 110.488 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 52.0 m-85 -115.45 136.76 52.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.594 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.582 HG13 ' CD2' ' A' ' 98' ' ' HIS . 12.6 t -119.87 121.81 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.0 110.456 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.568 ' HB2' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER 49.31 48.58 20.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.418 -0.801 . . . . 0.0 110.656 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.424 ' C ' HG22 ' A' ' 83' ' ' VAL . 2.7 t-20 62.28 29.37 17.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 110.557 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.8 t -126.16 168.59 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.966 . . . . 0.0 109.675 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -154.63 68.19 5.62 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.472 -0.767 . . . . 0.0 109.747 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD3' HG13 ' A' ' 83' ' ' VAL . 47.3 Cg_endo -74.2 168.1 25.6 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.011 1.532 . . . . 0.0 110.341 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.96 -179.78 4.61 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.052 1.554 . . . . 0.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.453 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -86.91 20.59 2.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.335 -0.853 . . . . 0.0 110.534 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -90.99 39.34 0.99 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.437 -0.789 . . . . 0.0 109.402 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.473 ' CB ' ' OE1' ' A' ' 93' ' ' GLN . . . -145.43 -177.29 5.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.571 -0.705 . . . . 0.0 110.088 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 81.2 p -140.07 144.38 36.81 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.465 -0.772 . . . . 0.0 110.395 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.524 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 39.8 mmm -43.88 -39.02 3.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.513 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.538 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -55.71 -48.27 72.71 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.3 OUTLIER -64.26 -30.51 71.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -1.175 . . . . 0.0 109.87 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.26 -27.37 66.28 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.232 -0.917 . . . . 0.0 109.813 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.585 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -50.28 -54.71 19.34 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.981 -1.074 . . . . 0.0 109.566 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -68.15 -20.68 64.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.815 -1.178 . . . . 0.0 110.51 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 10.1 mt-10 -88.22 -73.69 0.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.182 -0.948 . . . . 0.0 112.468 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.582 ' CD2' HG13 ' A' ' 80' ' ' VAL . 22.2 m-70 -100.69 37.2 1.76 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.786 -1.196 . . . . 0.0 112.361 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.526 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.5 2.032 0 O-C-N 121.035 -1.041 . . . . 0.0 109.748 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 30' ' ' PRO . 7.4 m-85 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.542 ' CD2' ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -84.87 159.76 20.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.746 -1.221 . . . . 0.0 109.486 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.64 120.62 39.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.851 -1.155 . . . . 0.0 111.655 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.541 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 15.6 mt -141.44 140.72 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 109.241 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.43 177.61 7.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.137 -0.977 . . . . 0.0 110.136 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.655 ' CE2' ' CD ' ' A' ' 35' ' ' LYS . 1.4 p90 -144.86 165.12 29.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 110.648 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -158.14 178.67 9.94 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.271 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.455 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 27.9 p-10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 110.266 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.294 0.569 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.527 HG12 ' CG1' ' A' ' 31' ' ' VAL . 24.6 t -147.2 108.48 3.92 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 110.512 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.585 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 50.5 Cg_endo -78.87 81.59 2.74 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.363 1.717 . . . . 0.0 110.108 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.543 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.7 m -77.52 141.41 15.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.187 -0.946 . . . . 0.0 111.119 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.547 HG21 ' CE1' ' A' ' 106' ' ' TYR . 46.8 mm -97.44 155.72 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 2.7 t -133.86 141.77 43.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.933 -1.104 . . . . 0.0 111.298 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.64 -179.24 8.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.525 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -115.83 159.77 21.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.857 -1.152 . . . . 0.0 110.295 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.558 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -61.3 -174.94 0.08 OUTLIER Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.54 -0.725 . . . . 0.0 109.248 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.6 Cg_endo -70.86 108.66 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.52 1.274 . . . . 0.0 109.842 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.4 38.55 9.98 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.352 -0.842 . . . . 0.0 110.012 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.525 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -56.22 179.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.26 -0.9 . . . . 0.0 110.125 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.14 32.18 0.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 110.611 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.555 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.93 176.38 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 110.208 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -50.18 -175.19 0.01 OUTLIER Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.315 -0.866 . . . . 0.0 110.997 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.491 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.3 t0 -77.0 -175.53 3.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -1.134 . . . . 0.0 109.889 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 43' ' ' ASP . 1.4 mm? -137.19 135.56 37.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.06 -1.025 . . . . 0.0 110.494 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.444 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -86.28 -34.63 20.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.723 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -153.87 159.85 41.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.752 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -124.0 40.0 3.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.054 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 47' ' ' LYS . 23.9 mttt -158.69 106.17 1.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.546 -0.721 . . . . 0.0 109.66 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.589 ' CD2' HD11 ' A' ' 63' ' ' LEU . 30.3 m-85 -104.86 139.62 39.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.87 -1.144 . . . . 0.0 110.25 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.52 99.35 8.13 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.475 ' HB ' HD13 ' A' ' 55' ' ' LEU . 4.2 m -126.18 163.65 38.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.128 -0.983 . . . . 0.0 111.157 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 45.4 Cg_endo -71.05 144.09 46.29 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.142 1.601 . . . . 0.0 110.389 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.527 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -63.86 -13.43 44.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.41 -0.806 . . . . 0.0 111.375 -179.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -83.59 -10.2 58.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.989 -1.07 . . . . 0.0 110.884 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.475 HD13 ' HB ' ' A' ' 51' ' ' VAL . 4.0 mt -62.3 141.75 58.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.995 -1.066 . . . . 0.0 111.335 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.441 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 1.4 p -91.24 157.95 16.87 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.628 -0.67 . . . . 0.0 109.217 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.515 ' CG1' HG23 ' A' ' 87' ' ' THR . 53.0 t -55.26 -24.05 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.06 -1.025 . . . . 0.0 110.06 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.2 87.72 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.452 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.4 mt-30 -67.73 -44.2 78.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.179 -1.189 . . . . 0.0 110.122 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.644 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 17.4 t80 -60.65 -46.4 90.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.038 -1.039 . . . . 0.0 109.568 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.78 -21.76 1.81 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.948 -1.095 . . . . 0.0 109.902 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.3 -54.57 5.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.394 -0.816 . . . . 0.0 110.597 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.589 HD11 ' CD2' ' A' ' 49' ' ' TYR . 3.8 pp -59.78 -21.85 61.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.945 -1.097 . . . . 0.0 112.169 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.644 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 2.1 mt -92.77 -35.19 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.191 -1.568 . . . . 0.0 109.219 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.472 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 2.8 mtp85 -35.94 -63.71 0.35 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.853 -0.529 . . . . 0.0 110.855 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -31.15 72.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.043 -1.035 . . . . 0.0 109.88 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.462 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 19.7 mmt180 -67.24 -16.32 64.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 110.009 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.612 ' CD1' ' CE2' ' A' ' 109' ' ' TYR . 1.3 mm -101.1 12.86 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.959 . . . . 0.0 109.708 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.455 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 50.42 30.81 4.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.462 -0.774 . . . . 0.0 110.369 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 4.2 pp -110.35 155.59 21.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 0.0 109.695 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.72 -172.42 2.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.116 -0.99 . . . . 0.0 111.014 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.56 -89.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 110.775 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 71' ' ' ARG . 5.6 pt-20 -150.34 35.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 110.872 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -58.38 177.23 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.14 -0.975 . . . . 0.0 109.966 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.522 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -107.1 138.3 43.54 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.378 0.609 . . . . 0.0 110.34 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.59 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 15.2 tp -164.7 152.66 11.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 0.0 110.249 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 83.8 m-85 -157.79 121.83 4.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.644 -0.66 . . . . 0.0 109.972 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.499 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 16.9 m-30 -82.59 122.67 28.39 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.16 -0.962 . . . . 0.0 111.57 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 69.8 m-85 -113.57 120.37 40.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.583 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 2.4 t -121.06 128.38 76.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.4 -0.812 . . . . 0.0 109.998 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.476 ' HB2' ' ND1' ' A' ' 98' ' ' HIS . 3.3 t30 49.75 42.32 23.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 0.0 110.229 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.9 m-20 60.39 36.56 20.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.467 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.582 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -134.87 166.03 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 109.987 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -155.26 72.89 5.61 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 109.542 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.72 163.79 37.44 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.032 1.543 . . . . 0.0 110.792 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.47 -178.57 3.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.08 1.569 . . . . 0.0 110.357 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.515 HG23 ' CG1' ' A' ' 57' ' ' VAL . 1.1 p -85.92 19.52 2.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.857 . . . . 0.0 110.774 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.0 m -96.75 42.43 1.09 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.525 -0.734 . . . . 0.0 109.621 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.34 -172.46 3.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.491 -0.756 . . . . 0.0 110.319 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 77.2 p -139.42 140.64 37.41 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.477 0.656 . . . . 0.0 110.158 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.558 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 59.7 mtm -52.51 -38.72 60.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 109.938 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -50.51 -49.54 39.0 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 90' ' ' THR . 4.0 pt20 -64.68 -28.92 69.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -1.163 . . . . 0.0 109.664 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.558 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.17 -23.63 64.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 110.132 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.585 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -49.05 -54.29 16.53 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.707 -1.246 . . . . 0.0 109.755 -179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.35 -18.96 63.07 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.21 -0.931 . . . . 0.0 111.25 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.7 mt-10 -86.34 -65.03 1.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.91 -1.119 . . . . 0.0 112.288 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.583 ' CD2' ' HB ' ' A' ' 80' ' ' VAL . 16.6 m-70 -98.02 38.06 1.35 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.929 -1.107 . . . . 0.0 111.254 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.494 -0.754 . . . . 0.0 109.437 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.183 0.516 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.603 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -104.91 168.94 8.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.229 -0.919 . . . . 0.0 109.199 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.547 ' CE1' HG21 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -119.23 128.26 54.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.615 -1.303 . . . . 0.0 111.778 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.603 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 6.2 mt -139.2 129.33 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.19 -0.944 . . . . 0.0 110.483 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -128.55 152.3 48.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.154 -0.966 . . . . 0.0 108.778 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.612 ' CE2' ' CD1' ' A' ' 68' ' ' ILE . 2.3 p90 -131.4 167.09 19.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.55 -1.344 . . . . 0.0 111.647 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -153.88 -179.79 8.17 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.101 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.165 -179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.386 0.612 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 HG13 ' A' ' 31' ' ' VAL . 12.3 t -147.76 114.05 4.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.385 -0.822 . . . . 0.0 110.081 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.587 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 51.3 Cg_endo -78.1 87.08 1.56 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 124.166 1.614 . . . . 0.0 110.055 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.6 m -83.17 151.72 3.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.171 -0.955 . . . . 0.0 110.892 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 30.8 mm -105.96 160.41 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 108.714 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.579 HG22 ' CD1' ' A' ' 49' ' ' TYR . 2.5 t -134.2 141.05 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.801 -1.187 . . . . 0.0 111.404 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 7.0 tt0 -156.23 175.38 14.06 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.605 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -103.7 160.39 14.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.931 -1.106 . . . . 0.0 110.528 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.565 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -62.7 -174.47 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.781 . . . . 0.0 109.095 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.7 Cg_endo -70.52 103.7 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.418 1.22 . . . . 0.0 110.025 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 5.7 mttt 63.61 40.16 8.23 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.859 . . . . 0.0 110.076 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.99 179.49 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.201 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HG2' ' OD2' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -150.22 35.45 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.0 110.532 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.469 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -84.74 179.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.991 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 68' ' ' ILE . . . -57.26 -179.75 0.69 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -167.53 0.19 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.382 -1.069 . . . . 0.0 110.271 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -141.35 147.51 38.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 110.729 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.429 ' OD1' ' HE3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -87.32 -42.84 12.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.154 -0.966 . . . . 0.0 110.324 -179.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.584 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -152.15 159.57 43.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.755 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -116.99 39.85 3.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.113 -0.992 . . . . 0.0 110.463 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 9.7 pttt -162.01 107.34 1.25 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.289 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.581 ' CD2' HD12 ' A' ' 63' ' ' LEU . 11.4 m-85 -108.01 142.43 38.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -0.991 . . . . 0.0 110.125 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mp -116.0 103.22 10.37 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 3.0 m -129.78 162.75 51.53 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 111.098 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 43.5 Cg_endo -68.26 146.47 69.61 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.167 1.614 . . . . 0.0 110.451 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.528 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -63.65 -11.1 22.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 111.598 -178.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.68 -7.91 59.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.902 -1.124 . . . . 0.0 110.675 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.537 ' CD1' ' HB ' ' A' ' 51' ' ' VAL . 4.1 mt -62.43 141.39 58.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.127 -0.983 . . . . 0.0 111.157 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -91.17 158.52 16.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.671 -0.643 . . . . 0.0 109.48 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 79.4 t -57.29 -24.27 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.101 -0.999 . . . . 0.0 109.693 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.56 -34.8 67.61 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.524 ' CB ' HD23 ' A' ' 55' ' ' LEU . 17.8 mm-40 -67.89 -50.72 54.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -1.134 . . . . 0.0 109.336 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.652 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 6.2 t80 -60.21 -35.32 75.15 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.153 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.571 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -53.29 -34.8 58.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 110.028 178.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -51.12 9.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.358 -0.839 . . . . 0.0 112.705 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.636 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.37 -39.19 78.94 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.489 -1.382 . . . . 0.0 112.077 -177.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.652 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -77.49 -41.73 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 119.862 -1.774 . . . . 0.0 108.323 178.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.494 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 9.2 mtp180 -43.25 -52.27 5.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.413 -0.805 . . . . 0.0 109.983 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -35.73 81.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.538 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 8.9 mmt85 -70.29 -15.81 62.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.575 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.57 HD11 ' CD2' ' A' ' 109' ' ' TYR . 30.6 mt -89.39 -1.17 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.4 -0.813 . . . . 0.0 109.352 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 69' ' ' HIS . 18.1 t60 56.33 31.11 18.01 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.412 -0.805 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.553 ' CD1' ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -96.9 153.04 18.13 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.983 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.5 ptp180 -166.94 -168.71 1.15 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.015 -1.053 . . . . 0.0 110.872 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 53.74 -87.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.835 . . . . 0.0 110.855 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 71' ' ' ARG . 35.4 mt-10 -153.93 33.25 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.659 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.526 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -61.56 177.1 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.091 -1.006 . . . . 0.0 109.921 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.526 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.42 140.46 38.5 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.167 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.591 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 18.7 tp -149.78 152.81 35.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.179 -0.951 . . . . 0.0 110.474 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.591 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 73.3 m-85 -161.82 120.73 2.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.772 -0.58 . . . . 0.0 109.649 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.571 ' CE2' ' HA ' ' A' ' 61' ' ' TYR . 63.0 m-85 -93.22 123.22 36.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.064 -1.023 . . . . 0.0 110.106 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 66.8 m-85 -113.88 132.04 56.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.993 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.505 HG13 ' CD2' ' A' ' 98' ' ' HIS . 2.6 t -121.04 113.12 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.326 -0.859 . . . . 0.0 110.156 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.576 ' CB ' ' ND1' ' A' ' 98' ' ' HIS . 3.2 t-20 59.19 51.4 6.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 110.283 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 16.9 m-20 56.44 31.21 18.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.318 -0.863 . . . . 0.0 110.487 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.5 t -130.74 167.3 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.202 -0.936 . . . . 0.0 109.904 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -154.98 67.84 5.33 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.557 -0.715 . . . . 0.0 109.478 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.445 ' HD3' HG13 ' A' ' 83' ' ' VAL . 47.1 Cg_endo -73.58 170.18 20.59 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.052 1.554 . . . . 0.0 110.707 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.99 -179.02 3.52 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.078 1.567 . . . . 0.0 110.416 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.498 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -87.34 25.46 1.4 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.36 -0.838 . . . . 0.0 110.701 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.21 41.84 1.11 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.408 -0.807 . . . . 0.0 109.768 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 90' ' ' THR . . . -145.4 -175.53 4.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 110.461 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 62.8 p -139.44 139.65 37.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.631 -0.668 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.562 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 4.5 mmt -49.26 -38.62 27.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.165 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -52.31 -48.99 52.75 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 90' ' ' THR . 3.9 pt20 -64.63 -29.41 70.41 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.634 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.33 -24.86 64.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.587 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -49.63 -56.17 11.03 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.977 -1.077 . . . . 0.0 109.773 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.62 -17.62 63.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.754 -1.216 . . . . 0.0 111.093 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -88.47 -68.42 0.77 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.142 -0.974 . . . . 0.0 113.402 -177.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.576 ' ND1' ' CB ' ' A' ' 81' ' ' ASN . 18.1 m-70 -100.16 40.71 1.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.726 -1.234 . . . . 0.0 112.771 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.563 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.9 p80 . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.051 -1.031 . . . . 0.0 109.657 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 104' ' ' PHE . 4.3 m-85 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.032 0.444 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.602 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -109.16 165.4 11.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.091 -1.006 . . . . 0.0 109.608 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.478 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 57.9 m-85 -122.06 129.49 52.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.823 -1.173 . . . . 0.0 112.173 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.602 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 4.5 mt -141.4 153.36 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.502 -0.749 . . . . 0.0 109.475 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 34' ' ' GLU . . . -150.42 178.45 9.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 110.326 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.605 ' CE2' ' CD ' ' A' ' 35' ' ' LYS . 6.3 p90 -147.14 164.59 32.63 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.256 -0.977 . . . . 0.0 111.075 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -157.7 170.02 23.34 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.761 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 75' ' ' ALA . 11.7 p30 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 110.593 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.479 0.657 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.485 ' CG2' ' OG ' ' A' ' 53' ' ' SER . 33.0 t -142.58 104.05 5.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.454 -0.779 . . . . 0.0 109.892 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 49.5 Cg_endo -76.9 90.75 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.138 1.599 . . . . 0.0 110.295 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.567 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.3 m -88.57 153.19 3.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.229 -0.92 . . . . 0.0 110.721 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 104' ' ' PHE . 1.4 mp -103.04 165.12 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 108.772 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.576 HG22 ' CD1' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -139.4 133.82 39.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.048 -1.032 . . . . 0.0 110.877 -179.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -151.84 163.69 38.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.722 -0.611 . . . . 0.0 109.616 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.561 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -96.8 158.86 15.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 110.627 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.572 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.22 -174.28 0.12 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.722 . . . . 0.0 109.41 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.572 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.2 Cg_endo -70.33 107.5 1.98 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.486 1.256 . . . . 0.0 109.753 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 4.1 mtpt 64.14 42.72 5.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.375 -0.828 . . . . 0.0 109.944 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.464 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -64.39 179.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 110.267 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.497 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.6 OUTLIER -150.32 33.85 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.947 . . . . 0.0 110.425 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.562 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.7 pp -85.33 178.17 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.046 -1.034 . . . . 0.0 110.644 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.562 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -50.46 -172.73 0.01 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -80.34 179.38 7.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.356 -1.085 . . . . 0.0 110.002 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 1.4 pp -135.04 134.14 40.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 110.614 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . 15.4 t0 -86.43 -36.97 18.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.076 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.55 160.27 43.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 109.954 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -118.41 39.91 3.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.114 -0.992 . . . . 0.0 110.215 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.509 ' CG ' ' C ' ' A' ' 47' ' ' LYS . 6.2 mtmm -156.7 109.01 2.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.471 -0.768 . . . . 0.0 109.28 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.584 ' CD2' HD13 ' A' ' 63' ' ' LEU . 22.9 m-85 -103.63 141.89 35.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.902 -1.124 . . . . 0.0 110.808 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tp -105.44 104.81 14.61 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 ' HB ' HD13 ' A' ' 55' ' ' LEU . 16.6 m -131.76 144.23 52.4 Favored Pre-proline 0 C--N 1.3 -1.554 0 O-C-N 121.112 -0.993 . . . . 0.0 110.622 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 41.5 Cg_endo -66.99 143.86 67.69 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.983 1.518 . . . . 0.0 110.053 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.537 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.7 m -61.47 -14.25 27.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.399 -0.813 . . . . 0.0 111.615 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -83.7 -15.31 49.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.082 -1.011 . . . . 0.0 111.053 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.515 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.9 mt -62.21 144.84 54.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.054 -1.028 . . . . 0.0 111.301 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.468 HG21 HG21 ' A' ' 90' ' ' THR . 1.2 p -90.74 165.91 13.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.51 -0.744 . . . . 0.0 109.621 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.475 ' CG1' HG22 ' A' ' 87' ' ' THR . 46.5 t -60.33 -26.42 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 110.153 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.71 -41.33 93.86 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.515 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.6 mt-30 -67.64 -49.7 61.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.076 -1.25 . . . . 0.0 110.203 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.658 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 43.0 t80 -60.59 -33.9 73.41 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.724 -1.191 . . . . 0.0 109.502 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.665 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -63.43 -28.02 69.69 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.923 -1.11 . . . . 0.0 109.738 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -70.26 -53.52 16.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.295 -0.878 . . . . 0.0 110.281 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -59.54 -37.13 77.58 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 118.92 -1.112 . . . . 0.0 112.341 -178.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.658 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -70.45 -35.28 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 119.835 -1.791 . . . . 0.0 109.025 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 64' ' ' ILE . 0.9 OUTLIER -37.38 -63.41 0.45 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.72 -0.613 . . . . 0.0 110.774 -179.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -30.93 71.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.19 -0.944 . . . . 0.0 110.192 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.531 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 8.0 mmp_? -67.72 -17.81 64.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 109.945 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.583 HD12 ' CD2' ' A' ' 109' ' ' TYR . 36.5 mt -103.55 15.32 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.386 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.545 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 46.24 30.66 1.04 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.564 -0.71 . . . . 0.0 110.263 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.519 HD22 ' CG2' ' A' ' 68' ' ' ILE . 4.1 pp -108.83 155.24 21.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.413 -0.805 . . . . 0.0 109.84 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 73' ' ' GLU . 4.9 ptp180 -166.17 -168.73 1.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.657 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 47.99 -92.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.392 -0.817 . . . . 0.0 110.768 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 4.9 pt-20 -146.25 44.43 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.976 -1.078 . . . . 0.0 110.969 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -67.58 176.68 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.955 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -100.88 140.54 35.03 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.008 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 26.1 tp -164.24 152.68 12.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.982 . . . . 0.0 110.755 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 97.4 m-85 -158.52 119.7 3.42 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.706 -0.621 . . . . 0.0 109.666 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.665 ' CD2' ' CE2' ' A' ' 61' ' ' TYR . 18.5 m-30 -85.6 132.49 34.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.075 -1.015 . . . . 0.0 111.8 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 64.6 m-85 -120.29 120.42 35.99 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.594 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 2.1 t -120.97 125.95 74.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.422 -0.799 . . . . 0.0 109.839 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.499 ' HB2' ' ND1' ' A' ' 98' ' ' HIS . 0.3 OUTLIER 47.15 46.49 16.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.207 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 26.8 m120 58.11 37.07 26.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.288 -0.882 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -135.91 167.6 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.154 -0.966 . . . . 0.0 110.15 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.591 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -155.19 70.05 5.58 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.492 -0.755 . . . . 0.0 109.552 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.83 163.58 36.74 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.009 1.531 . . . . 0.0 110.735 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.3 -178.63 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.214 1.639 . . . . 0.0 110.622 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.475 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -86.7 20.48 2.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.309 -0.869 . . . . 0.0 110.681 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.1 m -91.51 39.2 1.0 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.47 -0.769 . . . . 0.0 109.641 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.423 ' CB ' ' OE1' ' A' ' 93' ' ' GLN . . . -145.51 -171.97 3.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.535 -0.728 . . . . 0.0 110.243 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 73.0 p -139.55 143.08 37.21 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.626 -0.671 . . . . 0.0 110.116 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.533 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 51.0 mmm -46.23 -46.35 17.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.806 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -47.97 -48.77 24.63 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.635 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.3 OUTLIER -64.39 -31.81 73.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.108 -1.23 . . . . 0.0 110.155 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.533 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.59 -22.27 64.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.114 -0.991 . . . . 0.0 110.198 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.572 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -49.27 -55.48 12.54 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.938 -1.101 . . . . 0.0 109.874 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -70.43 -16.89 62.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.034 -1.041 . . . . 0.0 111.34 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -87.35 -64.78 1.1 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.106 -0.996 . . . . 0.0 112.924 -177.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.594 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 14.0 m-70 -98.24 37.37 1.45 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.816 -1.178 . . . . 0.0 112.103 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.489 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.396 -0.815 . . . . 0.0 109.694 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.3 166.71 11.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.866 -1.146 . . . . 0.0 109.693 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.581 ' CE1' HG12 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -124.46 131.61 53.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.959 -1.088 . . . . 0.0 111.503 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.587 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 5.6 mt -138.64 143.4 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.195 -0.94 . . . . 0.0 110.119 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.73 176.06 9.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.227 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.0 OUTLIER -149.93 164.23 35.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.798 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.3 t -152.44 -178.1 6.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.693 -0.629 . . . . 0.0 109.941 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.497 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 57.3 p-10 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.885 . . . . 0.0 110.22 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.457 ' O ' HG21 ' A' ' 29' ' ' VAL . 3.5 mpt_? . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.286 0.565 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 15.6 t -146.99 103.82 3.85 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -74.51 106.63 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.382 1.727 . . . . 0.0 109.829 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.53 ' CG2' HD21 ' A' ' 105' ' ' LEU . 38.2 t -105.44 133.59 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.997 . . . . 0.0 110.718 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.598 ' CD1' ' CD1' ' A' ' 104' ' ' PHE . 44.3 mm -91.63 154.54 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.843 . . . . 0.0 109.025 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 2.7 t -132.13 144.46 37.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.939 -1.1 . . . . 0.0 111.498 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 7.4 mp0 -156.85 -179.65 8.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.571 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -110.7 160.79 16.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.729 -1.232 . . . . 0.0 110.581 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.557 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.91 -175.12 0.16 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.438 -0.789 . . . . 0.0 109.307 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.4 Cg_endo -71.44 106.11 1.88 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.532 1.28 . . . . 0.0 109.769 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 61.69 40.74 12.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.352 -0.843 . . . . 0.0 110.117 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.97 -179.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.214 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HG2' ' OD1' ' A' ' 111' ' ' ASP . 6.6 ptm180 -150.39 33.59 0.64 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 110.533 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -85.54 -175.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.04 . . . . 0.0 110.62 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.507 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -55.42 179.73 0.32 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -70.96 -172.92 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -1.147 . . . . 0.0 110.055 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 1.2 pp -135.19 134.15 39.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 110.63 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -40.23 15.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.85 164.76 37.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.299 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.77 38.22 4.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.106 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.59 105.04 1.82 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 0.0 109.952 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.584 ' CD2' HD13 ' A' ' 63' ' ' LEU . 45.3 m-85 -103.92 146.47 28.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 110.64 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.71 95.4 5.22 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.475 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 13.5 m -119.83 152.66 54.09 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.14 -0.975 . . . . 0.0 110.714 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.457 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.1 Cg_endo -71.23 149.48 57.67 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.097 1.577 . . . . 0.0 110.078 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.522 ' HB3' ' CA ' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -63.73 -13.94 47.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.325 -0.859 . . . . 0.0 111.397 -178.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.55 -10.71 53.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.908 -1.12 . . . . 0.0 111.11 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.511 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.6 mt -62.14 141.89 57.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.867 -1.145 . . . . 0.0 111.335 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.428 HG21 HG23 ' A' ' 90' ' ' THR . 2.1 p -91.59 163.14 14.23 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.637 -0.665 . . . . 0.0 109.449 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.51 ' CG1' HG22 ' A' ' 87' ' ' THR . 78.9 t -58.96 -22.56 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.023 -1.048 . . . . 0.0 110.056 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.73 -40.06 65.72 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.511 ' CB ' HD22 ' A' ' 55' ' ' LEU . 5.0 mm100 -67.87 -47.81 67.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.149 -1.206 . . . . 0.0 109.893 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 19.5 t80 -60.38 -46.39 90.13 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.146 -0.971 . . . . 0.0 109.647 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -50.35 -22.68 1.93 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.016 -1.053 . . . . 0.0 110.021 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -80.86 -54.5 5.54 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.566 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 49' ' ' TYR . 3.9 pp -59.84 -19.1 48.98 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.909 -1.12 . . . . 0.0 112.287 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.639 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 2.4 mt -91.57 -42.98 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.113 -1.617 . . . . 0.0 108.863 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.533 ' CG ' HD23 ' A' ' 70' ' ' LEU . 0.7 OUTLIER -36.91 -58.5 0.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.145 0.498 . . . . 0.0 110.696 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.87 -31.91 71.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 110.052 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 2.6 mmp_? -74.75 -7.5 53.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.86 . . . . 0.0 110.546 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.475 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.2 OUTLIER -99.18 -8.74 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 0.0 109.546 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.469 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER 67.74 29.41 6.86 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.484 -0.76 . . . . 0.0 110.087 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.533 HD23 ' CG ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -88.7 160.86 17.14 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.917 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -164.92 -166.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.004 -1.06 . . . . 0.0 110.724 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 42.9 -96.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.804 . . . . 0.0 110.559 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' ASP . 3.9 pt-20 -151.13 28.46 0.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.935 -1.103 . . . . 0.0 110.721 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.524 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -47.79 176.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.203 1.002 . . . . 0.0 110.029 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.524 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -115.0 142.16 47.01 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.595 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 13.6 tp -148.97 151.63 34.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.309 -0.87 . . . . 0.0 110.466 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 90.4 m-85 -158.2 122.88 4.24 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.793 -0.567 . . . . 0.0 109.866 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.593 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 18.0 m-30 -85.17 120.2 26.4 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.155 -0.966 . . . . 0.0 111.785 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.476 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 59.9 m-85 -106.98 122.1 45.76 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.515 -0.74 . . . . 0.0 109.06 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.595 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 2.2 t -121.3 126.29 74.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.421 -0.8 . . . . 0.0 109.934 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 10.6 t-20 51.32 34.29 11.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 0.0 110.038 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 1.3 t-20 69.31 34.95 2.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.433 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -134.97 166.81 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.9 . . . . 0.0 109.892 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.1 mp -154.95 70.67 5.78 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 0.0 109.609 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.96 165.35 33.03 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.048 1.551 . . . . 0.0 110.582 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.92 -178.96 3.83 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.062 1.559 . . . . 0.0 110.376 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.51 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -85.96 19.59 2.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 0.0 110.825 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -91.07 40.46 1.03 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.488 -0.758 . . . . 0.0 109.355 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.61 -172.88 3.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.517 -0.739 . . . . 0.0 110.262 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.428 HG23 HG21 ' A' ' 56' ' ' THR . 59.1 p -139.27 149.8 44.71 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.66 -0.65 . . . . 0.0 110.28 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.56 ' CE ' ' CD2' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -59.23 -40.6 86.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 110.005 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.522 ' CA ' ' HB3' ' A' ' 53' ' ' SER . . . -51.26 -46.49 51.61 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.7 OUTLIER -66.97 -28.85 68.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.238 -1.154 . . . . 0.0 109.715 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.548 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.97 -22.22 64.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.198 -0.939 . . . . 0.0 109.862 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.578 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -48.95 -53.78 18.31 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.884 -1.135 . . . . 0.0 109.505 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -19.16 63.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.049 -1.032 . . . . 0.0 111.455 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.537 ' OE1' ' CE1' ' A' ' 98' ' ' HIS . 0.5 OUTLIER -88.65 -59.12 2.32 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -177.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.595 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.2 m-70 -98.65 40.12 1.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.648 -1.283 . . . . 0.0 113.09 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.505 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 5.9 p80 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.598 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 1.1 m-85 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.928 0.394 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.596 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -107.4 169.96 8.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.959 -1.088 . . . . 0.0 109.248 179.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 80' ' ' VAL . 6.5 p90 -121.75 128.83 52.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.532 -1.355 . . . . 0.0 111.981 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.596 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 5.9 mt -141.07 141.04 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.311 -0.868 . . . . 0.0 110.184 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -136.29 166.72 22.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.966 -1.084 . . . . 0.0 109.773 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.593 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 2.9 p90 -134.26 163.86 28.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.747 -1.221 . . . . 0.0 111.518 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -158.52 177.1 11.6 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.248 0.547 . . . . 0.0 110.02 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.53 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 32.9 p30 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 110.145 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.451 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 10.5 mpt_? . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.184 0.516 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.45 HG11 HG11 ' A' ' 31' ' ' VAL . 16.3 t -144.99 108.99 4.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.947 . . . . 0.0 110.417 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.8 Cg_endo -77.83 91.16 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.186 1.624 . . . . 0.0 110.093 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -86.63 129.87 37.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.235 -0.916 . . . . 0.0 111.041 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 39.7 mm -91.71 136.06 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.09 -1.006 . . . . 0.0 108.502 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 0.5 OUTLIER -119.94 146.44 24.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.864 -1.147 . . . . 0.0 111.304 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 0.1 OUTLIER -156.24 -164.44 1.68 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HD2' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -122.1 158.84 28.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 0.0 110.605 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.573 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -61.49 -173.42 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.515 -0.74 . . . . 0.0 109.031 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.0 Cg_endo -69.62 106.71 1.68 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.372 1.196 . . . . 0.0 109.864 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 3.7 mmtt 64.69 41.43 5.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.426 -0.796 . . . . 0.0 110.274 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -60.07 -177.71 0.07 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.256 -0.902 . . . . 0.0 109.972 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.514 ' CG ' ' OD1' ' A' ' 111' ' ' ASP . 5.6 ptm180 -150.22 31.84 0.67 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 0.0 110.745 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.562 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.8 pp -85.53 177.12 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.083 -1.01 . . . . 0.0 110.351 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.562 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -49.04 -176.76 0.01 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.494 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 7.8 t0 -75.17 -174.69 2.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.245 . . . . 0.0 109.871 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -135.66 135.66 40.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 0.0 110.371 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.67 -41.23 14.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.808 . . . . 0.0 109.988 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.81 154.32 34.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 110.039 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -113.44 44.94 1.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.04 -1.038 . . . . 0.0 110.004 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -161.85 112.84 1.65 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 110.043 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.586 ' CD2' HD11 ' A' ' 63' ' ' LEU . 8.5 m-85 -111.32 137.57 48.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 109.991 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.92 87.12 3.64 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.501 ' HB ' HD13 ' A' ' 55' ' ' LEU . 12.7 m -107.89 148.36 37.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 110.96 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.478 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 47.7 Cg_endo -72.88 147.36 43.93 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.156 1.608 . . . . 0.0 109.688 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.55 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -62.2 -15.8 49.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.925 . . . . 0.0 111.459 -178.699 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -83.69 -14.23 52.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.115 -0.99 . . . . 0.0 111.18 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.501 HD13 ' HB ' ' A' ' 51' ' ' VAL . 3.7 mt -61.87 144.14 55.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.931 -1.106 . . . . 0.0 111.276 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 6.8 p -90.83 164.51 14.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 60.4 t -62.08 -27.34 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.043 -1.035 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.64 -36.66 88.24 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.49 ' CB ' HD22 ' A' ' 55' ' ' LEU . 8.5 mm-40 -70.17 -47.79 60.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.148 -1.207 . . . . 0.0 109.791 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.668 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 37.5 t80 -59.98 -32.75 71.13 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.144 -1.022 . . . . 0.0 108.942 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.447 ' CE2' ' HD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -60.03 -32.21 70.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 109.827 178.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 5.3 t80 -72.8 -51.8 17.51 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.417 -0.802 . . . . 0.0 111.078 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.601 HD12 ' CE1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -59.9 -35.65 75.32 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 118.571 -1.252 . . . . 0.0 112.589 -178.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.668 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -80.47 -29.08 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 119.663 -1.898 . . . . 0.0 109.629 178.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -41.11 -62.11 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.346 -0.846 . . . . 0.0 110.353 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -27.43 68.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.805 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HB2' ' HA ' ' A' ' 64' ' ' ILE . 8.8 mmp_? -70.26 -16.15 63.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.895 . . . . 0.0 109.8 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.589 ' CD1' ' CE2' ' A' ' 109' ' ' TYR . 2.9 mm -100.93 11.49 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.751 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 54.01 30.98 12.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.298 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.5 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 4.2 pp -115.23 156.49 25.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -0.804 . . . . 0.0 109.792 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.73 -169.34 1.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.0 110.945 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.27 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.454 -0.779 . . . . 0.0 110.735 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' ARG . 5.2 pt-20 -151.37 32.52 0.58 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.08 -1.013 . . . . 0.0 111.076 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -55.25 177.0 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.037 -1.039 . . . . 0.0 109.827 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.522 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -98.36 139.49 34.04 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.167 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.573 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 13.2 tp -164.34 153.23 13.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.352 -0.843 . . . . 0.0 110.391 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 89.4 m-85 -157.55 123.89 4.86 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.562 -0.711 . . . . 0.0 109.784 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.578 ' CE1' HD11 ' A' ' 64' ' ' ILE . 11.8 m-85 -89.16 124.45 34.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.357 -0.839 . . . . 0.0 111.033 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 53.3 m-85 -119.91 121.65 39.48 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.625 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 2.4 t -120.78 112.72 37.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.358 -0.839 . . . . 0.0 109.742 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.527 ' CB ' ' ND1' ' A' ' 98' ' ' HIS . 3.1 t-20 63.67 34.57 12.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.824 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 19.9 t-20 69.18 35.03 2.82 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.326 -0.859 . . . . 0.0 110.271 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.3 t -135.04 168.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.209 -0.932 . . . . 0.0 110.127 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.585 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.1 mp -155.0 77.27 5.07 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.7 . . . . 0.0 109.132 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.69 155.87 53.85 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.079 1.568 . . . . 0.0 110.879 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.47 -177.56 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.195 1.629 . . . . 0.0 110.292 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.479 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 1.1 p -82.23 16.46 2.0 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.305 -0.872 . . . . 0.0 110.948 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.43 41.56 1.12 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.534 -0.728 . . . . 0.0 109.519 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.519 ' HB1' ' NE2' ' A' ' 93' ' ' GLN . . . -145.52 -176.53 5.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.523 -0.736 . . . . 0.0 110.165 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 80.6 p -139.75 141.31 36.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 110.335 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.539 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 2.2 mmt -49.99 -42.78 49.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 110.014 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.55 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -48.59 -47.59 29.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.519 ' NE2' ' HB1' ' A' ' 89' ' ' ALA . 2.2 pt20 -64.63 -31.98 73.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -1.147 . . . . 0.0 109.814 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -67.61 -22.47 65.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.15 -0.969 . . . . 0.0 110.096 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.519 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -49.64 -55.76 12.51 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 120.881 -1.137 . . . . 0.0 109.692 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.429 ' O ' ' NE2' ' A' ' 99' ' ' HIS . 7.6 mt-30 -69.47 -17.22 63.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.963 -1.085 . . . . 0.0 111.294 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 1.8 mm-40 -87.44 -65.25 1.03 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.997 -1.065 . . . . 0.0 112.445 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.625 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 18.0 m-70 -98.63 37.94 1.42 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.86 -1.15 . . . . 0.0 111.808 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.546 ' O ' ' CE2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.504 -0.747 . . . . 0.0 109.673 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 104' ' ' PHE . 4.5 m-30 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.323 0.582 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.594 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -108.19 169.53 8.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.283 -0.885 . . . . 0.0 109.272 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.546 ' CE2' ' O ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -114.5 130.75 56.76 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.615 -1.303 . . . . 0.0 111.493 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.594 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 10.1 mt -141.97 122.65 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 110.236 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.75 153.21 44.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.988 -1.07 . . . . 0.0 109.51 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.651 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.6 OUTLIER -130.36 167.51 18.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.648 -1.282 . . . . 0.0 111.116 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -152.44 -178.39 6.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.674 -0.641 . . . . 0.0 110.086 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.514 ' OD1' ' CG ' ' A' ' 40' ' ' ARG . 2.1 m-20 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.26 -0.9 . . . . 0.0 110.249 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.499 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 2.5 mpt_? . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.223 0.535 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 34.9 t -147.46 104.28 3.74 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.568 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 44.2 Cg_endo -72.97 87.41 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.026 1.54 . . . . 0.0 110.259 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.553 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.3 m -84.52 139.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.178 -0.952 . . . . 0.0 111.056 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 45.8 mm -94.57 158.57 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 108.89 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 2.5 t -133.95 134.77 55.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.886 -1.134 . . . . 0.0 111.273 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 1.3 tt0 -148.54 168.79 21.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.295 0.569 . . . . 0.0 109.538 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.63 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -100.51 156.26 17.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.043 -1.036 . . . . 0.0 110.562 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.561 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -65.52 -172.9 0.1 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.519 -0.738 . . . . 0.0 109.244 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.5 Cg_endo -72.63 107.83 2.4 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.441 1.232 . . . . 0.0 109.922 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.89 42.13 8.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 110.251 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.19 -177.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.905 . . . . 0.0 110.016 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.485 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.2 35.74 0.66 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.12 -0.987 . . . . 0.0 110.588 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.52 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -84.64 179.45 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.092 -1.005 . . . . 0.0 110.049 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -62.16 179.55 4.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.454 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.1 t70 -70.73 -176.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -1.073 . . . . 0.0 109.988 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.457 HD11 ' O ' ' A' ' 67' ' ' ARG . 2.0 mm? -135.67 134.09 38.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.159 -0.963 . . . . 0.0 110.588 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -86.27 -27.0 24.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 109.587 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.51 ' CD ' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -158.04 150.08 21.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.517 -0.74 . . . . 0.0 109.679 179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -116.66 45.31 1.85 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.833 -1.167 . . . . 0.0 110.025 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 108.89 1.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 109.53 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.586 ' CD2' HD13 ' A' ' 63' ' ' LEU . 20.0 m-85 -105.47 141.33 37.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 110.718 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.0 98.37 8.09 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 55' ' ' LEU . 11.2 m -121.89 150.88 56.91 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 110.87 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD2' HD13 ' A' ' 55' ' ' LEU . 43.6 Cg_endo -69.28 145.74 60.92 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.047 1.551 . . . . 0.0 110.201 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.543 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.41 -15.6 50.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 0.0 111.379 -178.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -83.15 -14.7 52.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 111.283 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.9 mt -62.47 143.02 57.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.892 -1.13 . . . . 0.0 111.428 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.8 p -91.03 167.22 12.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.663 -0.648 . . . . 0.0 109.869 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.47 ' CG1' HG23 ' A' ' 87' ' ' THR . 58.7 t -62.75 -26.32 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.998 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.06 -31.65 75.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.527 ' CB ' HD22 ' A' ' 55' ' ' LEU . 7.1 mm100 -76.79 -47.07 22.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.113 -1.228 . . . . 0.0 110.04 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 22.7 t80 -60.7 -47.19 87.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.102 -0.998 . . . . 0.0 109.468 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.24 -22.24 1.68 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.883 -1.136 . . . . 0.0 109.855 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -79.91 -54.98 5.3 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 110.513 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.586 HD13 ' CD2' ' A' ' 49' ' ' TYR . 3.8 pp -59.84 -20.35 56.45 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.271 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.639 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 2.2 mt -90.98 -38.27 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 120.193 -1.567 . . . . 0.0 109.051 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.51 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -35.35 -66.03 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.181 0.515 . . . . 0.0 110.83 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -31.47 72.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.893 -1.13 . . . . 0.0 110.072 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.457 ' O ' HD11 ' A' ' 44' ' ' LEU . 35.4 mmt180 -66.76 -16.82 64.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.54 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.586 HD11 ' CD2' ' A' ' 109' ' ' TYR . 40.8 mt -103.38 11.9 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 0.0 109.763 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.536 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 51.9 23.76 2.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -0.797 . . . . 0.0 110.671 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 4.2 pp -91.85 157.44 16.87 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.319 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' GLU . 25.1 ptt180 -165.16 -169.44 1.65 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.929 -1.107 . . . . 0.0 111.152 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.42 -90.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.581 -0.7 . . . . 0.0 110.62 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 74' ' ' ASP . 6.5 pt-20 -158.67 28.07 0.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.2 -0.938 . . . . 0.0 110.883 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.515 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.16 176.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 109.892 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -103.21 140.63 37.12 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.291 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.591 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 21.5 tp -164.36 150.05 10.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 110.465 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.591 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 89.1 m-85 -157.93 121.97 4.14 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.778 -0.576 . . . . 0.0 109.869 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.602 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 18.3 m-30 -79.95 135.84 36.5 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.074 -1.016 . . . . 0.0 111.246 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.568 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 82.6 m-85 -118.33 126.46 52.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.569 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 2.4 t -120.83 124.06 71.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.571 ' HB2' ' CG ' ' A' ' 98' ' ' HIS . 1.1 t-20 47.63 49.12 16.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 29.3 m-80 56.81 36.01 27.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.639 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -135.18 167.0 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.086 -1.009 . . . . 0.0 109.924 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.1 mp -154.88 72.42 5.84 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.547 -0.721 . . . . 0.0 109.632 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 164.07 36.49 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.04 1.547 . . . . 0.0 110.564 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.7 -178.96 3.75 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.121 1.59 . . . . 0.0 110.311 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.47 HG23 ' CG1' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.12 19.16 2.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 110.652 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.43 39.22 1.02 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.512 -0.743 . . . . 0.0 109.567 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.444 ' HB1' ' OE1' ' A' ' 93' ' ' GLN . . . -145.42 -174.11 4.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.536 -0.728 . . . . 0.0 110.18 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 81.5 p -139.71 143.86 37.25 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.626 -0.671 . . . . 0.0 110.203 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.526 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -44.8 -41.78 7.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 109.747 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -50.69 -48.04 44.57 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.3 OUTLIER -64.38 -31.58 72.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -1.179 . . . . 0.0 109.988 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.526 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.06 -23.72 64.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.81 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.599 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -50.59 -56.96 9.4 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.892 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -69.64 -15.92 63.28 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.614 -1.304 . . . . 0.0 110.819 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -88.57 -71.04 0.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.169 -0.957 . . . . 0.0 113.486 -177.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.571 ' CG ' ' HB2' ' A' ' 81' ' ' ASN . 16.6 m-70 -100.81 38.28 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.68 -1.262 . . . . 0.0 113.189 -176.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.599 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 O-C-N 120.99 -1.069 . . . . 0.0 110.252 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.534 ' CB ' ' O ' ' A' ' 30' ' ' PRO . 18.1 m-85 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.54 ' CD1' HG13 ' A' ' 107' ' ' ILE . 0.3 OUTLIER -96.07 165.86 12.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.749 -1.219 . . . . 0.0 108.848 178.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -123.89 124.4 42.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.575 -1.328 . . . . 0.0 111.638 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.54 HG13 ' CD1' ' A' ' 105' ' ' LEU . 13.2 mt -141.56 133.29 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.439 -0.788 . . . . 0.0 109.475 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 78' ' ' PHE . . . -133.38 178.14 7.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.097 -1.002 . . . . 0.0 110.295 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.1 OUTLIER -133.96 153.87 51.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.133 -0.98 . . . . 0.0 110.851 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 36' ' ' ALA . 1.1 t -145.17 173.23 12.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.679 -0.638 . . . . 0.0 110.119 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 2.5 p30 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.975 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 28' ' ' ARG . 1.6 mpt_? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.114 0.483 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.533 HG13 ' CG1' ' A' ' 31' ' ' VAL . 24.3 t -144.12 105.65 4.81 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.173 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.584 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 48.4 Cg_endo -74.69 84.99 1.52 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.321 1.695 . . . . 0.0 110.038 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.561 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.4 m -85.6 148.29 4.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 110.933 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.495 HD11 ' CD1' ' A' ' 104' ' ' PHE . 1.5 mp -113.97 147.53 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.497 HG23 ' CE1' ' A' ' 109' ' ' TYR . 0.4 OUTLIER -124.36 153.26 30.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.8 -1.187 . . . . 0.0 111.187 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.585 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 2.4 tt0 -156.34 -162.04 1.21 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HD2' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -132.25 159.81 37.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.869 -1.144 . . . . 0.0 110.815 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.562 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.55 -173.8 0.11 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.582 -0.699 . . . . 0.0 109.38 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.3 Cg_endo -71.98 108.9 2.56 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.522 1.275 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.86 41.15 5.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.828 . . . . 0.0 110.553 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.434 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -63.22 178.18 0.54 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 109.841 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.523 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 13.8 ptt180 -145.26 28.72 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.573 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.8 pp -85.32 179.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.012 . . . . 0.0 109.726 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -68.74 146.38 45.07 Favored Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.231 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.5 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -87.82 163.87 16.22 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.618 -0.93 . . . . 0.0 110.787 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' HG ' ' CA ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -153.74 142.49 20.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.729 -0.607 . . . . 0.0 109.472 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 1.6 t0 -84.09 42.17 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 110.038 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.511 ' CD ' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -160.29 105.78 1.51 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.019 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -115.55 48.58 1.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.74 -1.225 . . . . 0.0 110.618 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.17 111.51 1.7 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.875 . . . . 0.0 109.532 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.582 ' CD2' HD13 ' A' ' 63' ' ' LEU . 24.0 m-85 -106.98 141.56 37.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.049 -1.032 . . . . 0.0 110.551 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.77 93.83 4.75 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.464 ' HB ' HD11 ' A' ' 55' ' ' LEU . 13.7 m -117.95 153.88 51.2 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.152 -0.968 . . . . 0.0 110.777 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.467 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.9 Cg_endo -71.65 148.22 52.7 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.111 1.585 . . . . 0.0 110.025 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.533 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.5 m -63.81 -15.34 58.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 111.334 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 7.8 t70 -83.58 -11.26 57.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.018 -1.051 . . . . 0.0 110.916 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.467 ' HG ' ' HG2' ' A' ' 52' ' ' PRO . 3.6 mt -62.05 142.02 57.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.941 -1.099 . . . . 0.0 111.122 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 1.2 p -91.01 154.89 19.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.65 -0.656 . . . . 0.0 109.433 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.532 HG13 ' CG2' ' A' ' 87' ' ' THR . 24.6 t -53.82 -20.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.991 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.37 -41.68 58.21 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.463 ' HG3' ' OG1' ' A' ' 56' ' ' THR . 0.0 OUTLIER -67.72 -46.67 71.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.174 -1.192 . . . . 0.0 109.997 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.65 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 22.8 t80 -60.65 -47.1 87.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.097 -1.002 . . . . 0.0 109.695 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.31 -22.25 1.72 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.01 -1.056 . . . . 0.0 109.87 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.16 -54.55 5.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 110.34 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.582 HD13 ' CD2' ' A' ' 49' ' ' TYR . 3.7 pp -59.75 -19.47 50.42 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.069 -1.052 . . . . 0.0 112.354 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.65 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.9 mt -92.16 -40.18 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 120.125 -1.61 . . . . 0.0 109.077 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.468 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -37.28 -61.46 0.58 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.878 -0.514 . . . . 0.0 110.624 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -32.33 73.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.942 -1.099 . . . . 0.0 109.742 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.535 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 15.1 mmt180 -69.39 -13.14 62.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.359 -0.838 . . . . 0.0 109.946 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.569 HD12 ' CE2' ' A' ' 109' ' ' TYR . 2.4 mm -99.61 7.81 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.061 -1.024 . . . . 0.0 109.528 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.528 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 54.1 32.58 16.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.429 -0.794 . . . . 0.0 110.132 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.499 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 4.1 pp -110.53 151.2 27.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.829 . . . . 0.0 109.934 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.9 ptp180 -167.06 -168.94 1.17 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.851 . . . . 0.0 111.058 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.452 ' C ' ' HG3' ' A' ' 73' ' ' GLU . . . 50.71 -91.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.568 -0.707 . . . . 0.0 111.225 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.452 ' HG3' ' C ' ' A' ' 72' ' ' ALA . 14.2 mt-10 -141.98 49.27 1.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.873 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -77.82 176.04 9.43 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.12 0.962 . . . . 0.0 109.991 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.511 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -118.16 143.85 46.16 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.039 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.572 HD23 ' CE1' ' A' ' 78' ' ' PHE . 18.2 tp -164.05 153.66 14.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 110.628 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 68.0 m-85 -157.58 123.06 4.57 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.617 -0.677 . . . . 0.0 109.465 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.572 ' CE1' HD23 ' A' ' 76' ' ' LEU . 18.4 m-30 -84.8 132.34 34.43 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.012 -1.055 . . . . 0.0 111.93 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 41.1 m-85 -120.55 118.39 30.09 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.618 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 2.0 t -120.68 130.82 74.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.535 ' HB3' ' CE1' ' A' ' 98' ' ' HIS . 53.5 t30 51.28 34.48 11.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 3.8 t-20 67.65 35.91 3.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.224 -0.922 . . . . 0.0 110.208 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.5 t -135.77 168.59 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 110.078 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.3 mp -154.68 71.01 5.99 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.73 . . . . 0.0 109.678 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.32 164.37 34.26 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.122 1.59 . . . . 0.0 110.68 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.08 -178.64 3.69 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.071 1.564 . . . . 0.0 110.611 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.532 ' CG2' HG13 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.2 22.95 1.65 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.331 -0.855 . . . . 0.0 110.672 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.37 43.45 1.07 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.369 -0.832 . . . . 0.0 109.551 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' C ' HG22 ' A' ' 90' ' ' THR . . . -145.28 -171.48 3.67 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.708 0.765 . . . . 0.0 110.294 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 75.9 p -139.21 136.36 34.93 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.538 0.685 . . . . 0.0 110.103 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.551 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 32.1 mmm -48.4 -38.69 20.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.9 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.45 -49.01 47.14 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 90' ' ' THR . 3.0 pt20 -64.64 -30.24 71.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -1.113 . . . . 0.0 109.814 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.551 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.52 -23.79 64.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.208 -0.932 . . . . 0.0 110.102 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 99' ' ' HIS . 1.0 OUTLIER -48.86 -53.04 21.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.843 -1.161 . . . . 0.0 109.774 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -69.36 -21.47 63.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.196 -0.94 . . . . 0.0 111.192 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -85.68 -66.86 0.85 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.941 -1.1 . . . . 0.0 112.007 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.618 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -98.77 42.33 1.1 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.912 -1.117 . . . . 0.0 110.771 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 95' ' ' TYR . 1.4 t-80 . . . . . 0 N--CA 1.498 1.935 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.852 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.495 ' CD1' HD11 ' A' ' 32' ' ' ILE . 38.1 p90 . . . . . 0 N--CA 1.511 2.597 0 CA-C-O 121.367 0.604 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.594 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -123.67 160.3 27.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.771 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -124.97 135.88 53.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.029 -1.044 . . . . 0.0 110.996 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.594 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 6.0 mt -141.69 137.54 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.76 147.21 50.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.212 -0.93 . . . . 0.0 108.864 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.6 p90 -130.67 165.79 22.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.478 -1.389 . . . . 0.0 111.629 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -156.07 174.74 14.92 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.257 0.551 . . . . 0.0 110.328 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.523 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 1.8 p30 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.955 . . . . 0.0 110.217 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.435 ' O ' HG22 ' A' ' 29' ' ' VAL . 6.2 mpt_? . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.393 0.616 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.531 HG13 ' CG1' ' A' ' 31' ' ' VAL . 19.9 t -147.5 102.68 3.73 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.855 . . . . 0.0 109.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.493 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 46.1 Cg_endo -73.46 81.11 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.177 1.62 . . . . 0.0 110.208 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.539 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 2.2 m -77.32 152.33 5.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 110.686 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 1.5 mp -108.24 164.1 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.475 ' HB ' ' HA ' ' A' ' 47' ' ' LYS . 2.4 t -136.31 136.51 48.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.835 -1.166 . . . . 0.0 111.093 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.91 -176.16 5.81 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.322 0.582 . . . . 0.0 109.742 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HD2' ' CD1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -114.9 159.08 21.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.985 -1.072 . . . . 0.0 110.786 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.57 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.76 -173.23 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.529 -0.732 . . . . 0.0 109.191 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.7 Cg_endo -71.91 107.25 2.17 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.472 1.249 . . . . 0.0 109.983 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.95 41.75 8.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.353 -0.842 . . . . 0.0 110.206 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.8 178.75 0.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.283 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.68 32.31 1.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.214 -0.929 . . . . 0.0 110.172 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.532 ' CG2' ' HB2' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -85.81 -173.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.324 -0.86 . . . . 0.0 110.579 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.507 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -67.46 172.43 31.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.54 179.61 3.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.165 -1.197 . . . . 0.0 110.595 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 2.1 pp -134.93 133.42 39.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.369 -0.832 . . . . 0.0 110.706 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' OD2' ' HD2' ' A' ' 46' ' ' LYS . 10.7 p-10 -85.83 -20.52 29.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.191 -0.943 . . . . 0.0 110.143 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.507 ' CD ' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -151.84 154.08 35.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 109.683 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -128.28 40.95 3.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.962 -1.086 . . . . 0.0 110.448 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.92 104.88 0.91 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 109.822 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.571 ' CD2' HD11 ' A' ' 63' ' ' LEU . 30.6 m-85 -105.4 145.26 31.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.112 -0.993 . . . . 0.0 111.09 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.03 94.82 5.22 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.496 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 32.8 m -115.92 153.14 48.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.115 -0.991 . . . . 0.0 110.987 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD2' HD13 ' A' ' 55' ' ' LEU . 44.3 Cg_endo -69.81 149.5 66.65 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.08 1.568 . . . . 0.0 110.407 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.527 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -63.78 -16.24 60.71 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 111.34 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -83.12 -10.99 58.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -0.999 . . . . 0.0 111.017 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.53 HD23 ' CB ' ' A' ' 59' ' ' GLN . 3.7 mt -61.84 141.8 57.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.907 -1.121 . . . . 0.0 110.952 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 3.1 p -91.23 162.41 14.65 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.532 -0.73 . . . . 0.0 109.507 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 37.1 t -59.04 -30.16 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.104 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.73 -27.16 74.06 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.53 ' CB ' HD23 ' A' ' 55' ' ' LEU . 15.3 mm-40 -76.3 -51.35 12.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.169 -1.195 . . . . 0.0 110.054 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 12.0 t80 -60.41 -47.25 86.92 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.919 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.503 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -49.29 -23.27 1.33 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.849 -1.157 . . . . 0.0 109.562 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -55.87 4.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.486 -0.759 . . . . 0.0 111.282 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.615 HD12 ' CE1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -59.03 -23.53 62.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.899 -1.126 . . . . 0.0 111.842 -178.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.647 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -91.08 -35.01 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.078 -1.639 . . . . 0.0 108.77 177.518 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.473 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -38.95 -56.19 1.43 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.446 -0.784 . . . . 0.0 110.51 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' HE2' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -64.89 -34.94 79.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.975 -1.078 . . . . 0.0 108.899 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.518 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 5.0 mmt180 -73.08 -10.54 59.9 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.684 -0.635 . . . . 0.0 110.121 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.587 ' CG2' ' CD2' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -88.09 -10.57 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER 74.01 28.07 1.53 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.751 0.786 . . . . 0.0 109.122 -178.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.587 ' CD2' ' CG2' ' A' ' 68' ' ' ILE . 4.0 pp -113.93 158.67 20.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.745 -0.597 . . . . 0.0 109.873 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -165.08 -174.62 3.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 110.772 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.99 -90.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.0 110.788 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 1.9 pt-20 -153.93 42.26 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 111.027 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -67.51 176.48 2.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.071 -1.018 . . . . 0.0 110.076 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.52 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -92.27 142.85 27.01 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.834 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.583 HD23 ' CE1' ' A' ' 78' ' ' PHE . 17.8 tp -164.09 154.37 14.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 110.773 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 85.2 m-85 -156.91 124.16 5.26 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.581 -0.699 . . . . 0.0 110.121 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.583 ' CE1' HD23 ' A' ' 76' ' ' LEU . 3.7 m-30 -94.73 113.89 25.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 91.2 m-85 -108.99 127.48 54.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 110.122 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.575 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 1.8 t -121.5 122.41 67.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.428 -0.795 . . . . 0.0 109.442 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.523 ' ND2' ' HB3' ' A' ' 98' ' ' HIS . 1.9 m-80 57.38 33.48 23.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.073 -1.017 . . . . 0.0 109.922 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.27 31.91 15.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -133.13 171.19 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.391 -0.818 . . . . 0.0 109.681 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.2 mp -154.26 77.73 5.41 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.427 -0.796 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.52 165.8 31.67 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.149 1.605 . . . . 0.0 110.36 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.58 178.66 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.069 1.563 . . . . 0.0 110.444 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.464 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.19 20.49 2.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.319 -0.863 . . . . 0.0 110.624 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.7 p -94.64 37.47 1.13 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.538 -0.726 . . . . 0.0 109.596 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.77 -174.8 4.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.485 -0.759 . . . . 0.0 110.182 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.492 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 34.7 p -139.09 149.9 45.09 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.317 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.548 ' HE1' ' CD2' ' A' ' 60' ' ' PHE . 30.6 mmm -51.56 -38.6 55.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.478 -0.764 . . . . 0.0 110.16 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -54.12 -40.4 66.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.492 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 2.1 mt-30 -68.43 -46.05 70.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.146 -1.208 . . . . 0.0 109.269 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.54 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -56.92 -20.56 24.04 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.131 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.53 ' O ' ' HB3' ' A' ' 99' ' ' HIS . 1.3 t80 -48.75 -53.28 19.63 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.794 -1.191 . . . . 0.0 109.833 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.579 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 10.3 tt0 -69.49 -19.92 63.73 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.778 -1.201 . . . . 0.0 111.337 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.78 -62.98 1.37 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.066 -1.021 . . . . 0.0 113.53 -177.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.575 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.8 m-70 -98.12 35.8 1.68 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.675 -1.266 . . . . 0.0 112.682 -176.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.579 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.035 -1.041 . . . . 0.0 110.066 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.475 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 20.3 p90 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.497 0.665 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.596 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -117.71 167.3 11.48 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 0.0 109.362 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 2.9 p90 -125.82 133.93 51.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.866 -1.146 . . . . 0.0 111.712 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.596 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 5.6 mt -141.19 147.03 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.437 -0.79 . . . . 0.0 109.785 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.0 177.43 7.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.052 . . . . 0.0 110.287 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.618 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.2 p90 -143.47 171.42 14.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.221 -0.924 . . . . 0.0 110.612 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.427 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 1.9 t -159.63 -175.15 5.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.464 -0.772 . . . . 0.0 110.2 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.532 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . 8.8 t70 . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.401 -0.812 . . . . 0.0 110.095 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.421 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.8 mpt_? . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.345 0.593 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.513 HG12 ' CG1' ' A' ' 31' ' ' VAL . 19.6 t -147.45 109.2 3.88 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.31 -0.869 . . . . 0.0 110.171 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.576 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.1 Cg_endo -75.45 84.14 1.77 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.193 1.628 . . . . 0.0 110.101 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.552 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.2 m -82.72 132.03 32.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.131 -0.98 . . . . 0.0 111.045 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 32' ' ' ILE . 41.4 mm -93.86 142.78 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 0.5 OUTLIER -124.65 147.96 29.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.86 -1.15 . . . . 0.0 111.135 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.579 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -156.57 -174.12 4.79 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HE2' ' CZ ' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -121.39 160.65 23.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.9 -1.125 . . . . 0.0 110.53 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.548 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.92 -174.83 0.15 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.412 -0.805 . . . . 0.0 109.296 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.2 Cg_endo -70.54 111.87 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.531 1.28 . . . . 0.0 109.68 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 2.8 mttt 62.21 42.34 9.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.351 -0.843 . . . . 0.0 110.05 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.504 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -56.13 -177.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.306 -0.871 . . . . 0.0 109.995 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -148.39 28.05 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 111.01 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 2.0 pp -91.81 176.46 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.83 -1.169 . . . . 0.0 110.324 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.551 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -52.12 -176.5 0.04 OUTLIER Glycine 0 N--CA 1.498 2.803 0 O-C-N 121.296 -0.878 . . . . 0.0 111.181 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.53 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 10.1 t0 -80.47 -171.33 3.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -1.09 . . . . 0.0 109.993 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -142.25 138.5 31.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 110.667 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -86.07 -32.97 21.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 109.827 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 151.83 30.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.961 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HA ' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -112.53 46.02 1.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 109.769 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -165.92 109.7 0.81 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.552 -0.718 . . . . 0.0 109.48 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.593 ' CD2' HD11 ' A' ' 63' ' ' LEU . 12.7 m-85 -105.83 140.39 38.93 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.117 -0.989 . . . . 0.0 110.326 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.53 92.91 4.67 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.466 ' HB ' HD13 ' A' ' 55' ' ' LEU . 13.6 m -115.64 150.82 45.4 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.53 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.477 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.0 Cg_endo -70.5 148.48 60.34 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.107 1.583 . . . . 0.0 110.036 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.54 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -62.56 -16.19 54.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -0.805 . . . . 0.0 111.399 -178.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.86 -13.2 54.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.036 -1.04 . . . . 0.0 111.209 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.477 ' HG ' ' HG2' ' A' ' 52' ' ' PRO . 3.8 mt -62.06 140.99 58.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.865 -1.147 . . . . 0.0 111.133 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.6 p -90.57 154.59 19.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.619 -0.676 . . . . 0.0 109.45 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.536 ' CG1' HG22 ' A' ' 87' ' ' THR . 58.9 t -52.74 -21.19 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.061 -1.024 . . . . 0.0 110.04 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.67 -41.24 57.31 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.458 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.1 mm-40 -67.74 -47.24 69.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.214 -1.168 . . . . 0.0 109.903 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 31.1 t80 -60.79 -46.51 90.24 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.496 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -51.13 -22.11 2.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.824 -1.173 . . . . 0.0 109.802 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -78.82 -54.22 6.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.946 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.593 HD11 ' CD2' ' A' ' 49' ' ' TYR . 3.6 pp -59.92 -20.44 57.39 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.02 -1.05 . . . . 0.0 112.189 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.647 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.6 mt -90.19 -37.54 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 120.103 -1.623 . . . . 0.0 108.836 177.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.47 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -37.99 -61.36 0.66 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.278 0.561 . . . . 0.0 110.736 -179.511 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -31.0 71.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.913 -1.117 . . . . 0.0 109.822 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.452 ' C ' HD12 ' A' ' 68' ' ' ILE . 21.4 mmt180 -67.7 -16.94 64.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.582 HD11 ' CE2' ' A' ' 109' ' ' TYR . 2.9 mm -99.76 14.11 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.371 -0.83 . . . . 0.0 109.51 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.451 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER 47.87 33.53 3.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.553 -0.717 . . . . 0.0 110.562 179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.504 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 4.1 pp -112.03 155.62 23.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.695 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.65 -172.23 2.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.079 -1.013 . . . . 0.0 111.056 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.27 -89.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.478 -0.764 . . . . 0.0 110.889 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.5 pt-20 -147.21 32.09 0.91 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 111.032 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -52.92 176.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.074 -1.016 . . . . 0.0 109.843 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -117.59 139.17 51.34 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.134 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.552 ' C ' ' CG ' ' A' ' 77' ' ' PHE . 29.8 tp -164.49 155.25 14.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 110.427 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.568 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 20.1 m-85 -153.79 123.3 6.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.45 -0.781 . . . . 0.0 109.754 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.546 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 18.0 m-30 -84.71 132.78 34.41 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.098 -1.001 . . . . 0.0 111.705 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 62.3 m-85 -120.37 119.81 34.16 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.58 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 2.1 t -120.77 127.95 75.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.235 -0.916 . . . . 0.0 110.206 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 28.8 t30 54.77 35.47 24.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.874 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 64.14 32.15 12.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.38 -0.825 . . . . 0.0 110.077 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -135.63 171.05 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.415 -0.803 . . . . 0.0 109.853 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.1 mp -154.55 75.4 5.74 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.544 -0.723 . . . . 0.0 109.47 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.5 163.91 36.37 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.967 1.509 . . . . 0.0 110.651 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.98 177.64 7.49 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.17 1.616 . . . . 0.0 110.276 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.536 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.88 21.96 2.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.263 -0.898 . . . . 0.0 110.603 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.78 36.68 0.86 Allowed 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 109.745 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -147.45 -170.4 3.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.376 -0.827 . . . . 0.0 110.358 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.525 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 58.6 p -138.96 146.94 41.58 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.488 0.661 . . . . 0.0 109.92 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.584 ' HE2' ' CD2' ' A' ' 60' ' ' PHE . 1.2 mmt -47.13 -47.36 23.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.248 -0.907 . . . . 0.0 110.431 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.54 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -42.73 -44.73 5.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.525 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 1.0 OUTLIER -67.81 -39.76 83.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -1.159 . . . . 0.0 109.243 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.554 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -59.53 -24.94 64.09 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.364 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.576 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -49.16 -56.07 10.39 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.517 -1.365 . . . . 0.0 109.411 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.582 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 8.7 tt0 -71.35 -18.18 62.39 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.163 -0.961 . . . . 0.0 111.911 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.563 ' HG2' ' CE1' ' A' ' 98' ' ' HIS . 1.3 tt0 -87.77 -61.23 1.76 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.756 -1.215 . . . . 0.0 112.552 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.58 ' CD2' ' HB ' ' A' ' 80' ' ' VAL . 17.4 m-70 -98.27 38.64 1.31 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.859 -1.15 . . . . 0.0 111.424 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.582 ' CD2' ' O ' ' A' ' 96' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.424 -0.797 . . . . 0.0 109.122 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.482 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 5.6 m-85 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.28 0.562 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.595 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.51 168.54 9.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.205 -0.934 . . . . 0.0 109.291 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.413 ' N ' HD13 ' A' ' 105' ' ' LEU . 1.2 m-85 -121.92 130.68 53.54 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.64 -1.288 . . . . 0.0 111.597 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.595 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 5.8 mt -141.56 127.05 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.33 -0.856 . . . . 0.0 110.354 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.93 163.64 18.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.111 -0.993 . . . . 0.0 108.851 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.669 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.7 OUTLIER -145.75 164.05 33.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.622 -1.299 . . . . 0.0 111.225 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.481 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 1.5 t -159.27 -175.95 5.53 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.508 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.518 ' OD1' ' CB ' ' A' ' 75' ' ' ALA . 65.5 t0 . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.968 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.422 0.63 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.559 HG11 ' CE1' ' A' ' 95' ' ' TYR . 23.4 t -119.35 134.32 23.76 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.413 -0.804 . . . . 0.0 110.866 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 52.3 Cg_endo -81.16 112.48 2.56 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 124.246 1.656 . . . . 0.0 109.477 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.521 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 45.8 t -100.13 125.06 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 110.897 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.631 ' CD1' ' CE2' ' A' ' 104' ' ' PHE . 27.1 mm -91.51 147.15 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 108.819 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 t -130.61 143.93 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 120.855 -1.153 . . . . 0.0 111.556 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.519 ' HA ' ' CE ' ' A' ' 47' ' ' LYS . 3.5 tt0 -156.54 167.25 31.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.552 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.661 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -96.79 163.46 12.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.937 -1.102 . . . . 0.0 110.921 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.561 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -65.89 -174.0 0.14 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 0.0 109.68 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 44.8 Cg_endo -74.03 116.64 4.72 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.576 1.303 . . . . 0.0 109.968 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.29 39.56 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 110.034 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' CB ' ' CG ' ' A' ' 35' ' ' LYS . . . -62.37 174.42 0.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.359 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 31.75 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.56 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.8 pp -85.88 177.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.026 . . . . 0.0 110.611 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -49.1 -176.89 0.01 OUTLIER Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.26 -177.17 5.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.253 -1.145 . . . . 0.0 110.001 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD1' ' OH ' ' A' ' 109' ' ' TYR . 0.2 OUTLIER -148.58 147.55 29.13 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.047 -1.033 . . . . 0.0 110.453 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.459 ' N ' HD23 ' A' ' 44' ' ' LEU . 9.4 m-20 -86.82 -28.42 22.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.375 -0.828 . . . . 0.0 110.626 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.471 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -152.54 156.83 40.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 0.0 110.011 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.519 ' CE ' ' HA ' ' A' ' 34' ' ' GLU . 6.6 mmmm -120.65 43.8 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.054 -1.029 . . . . 0.0 109.781 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 1.5 ptmm? -157.94 109.75 2.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.379 -0.825 . . . . 0.0 109.74 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.479 ' CE2' HD13 ' A' ' 63' ' ' LEU . 28.1 m-85 -104.29 147.44 27.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 110.965 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -120.12 114.17 21.56 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 55' ' ' LEU . 2.8 m -141.0 165.32 30.2 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.714 -1.241 . . . . 0.0 110.889 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 43.7 Cg_endo -69.22 147.93 67.46 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.151 1.606 . . . . 0.0 110.46 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.531 ' HB3' ' CA ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -65.34 -12.72 54.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.461 -0.775 . . . . 0.0 111.336 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -84.08 -5.48 59.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.084 -1.01 . . . . 0.0 110.913 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.531 HD11 ' CG2' ' A' ' 51' ' ' VAL . 3.8 mt -61.96 141.52 57.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.83 -1.169 . . . . 0.0 111.107 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.47 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 0.9 OUTLIER -92.07 159.57 15.63 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.589 -0.694 . . . . 0.0 109.698 178.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 88.3 t -58.44 -26.64 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.76 -31.51 67.44 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.528 ' CB ' HD21 ' A' ' 55' ' ' LEU . 15.7 mm100 -69.34 -51.1 40.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.639 ' CD1' ' CD1' ' A' ' 63' ' ' LEU . 6.9 t80 -59.97 -33.57 72.12 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.436 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.57 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -55.58 -35.14 65.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 109.998 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -79.74 -50.01 11.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.74 . . . . 0.0 112.682 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.639 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.66 -39.85 81.81 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.434 -1.416 . . . . 0.0 111.927 -177.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -76.11 -42.95 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 119.877 -1.764 . . . . 0.0 108.432 178.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.475 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 3.4 mtt180 -35.92 -61.58 0.47 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.825 -0.547 . . . . 0.0 110.863 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.71 -33.07 75.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.029 . . . . 0.0 109.895 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -69.97 -10.3 58.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -0.901 . . . . 0.0 109.624 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.565 HD11 ' CE2' ' A' ' 109' ' ' TYR . 5.5 mm -100.4 7.5 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.442 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.43 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 3.0 m-70 54.84 31.47 15.74 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.415 -0.803 . . . . 0.0 110.416 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.488 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 4.2 pp -110.62 150.6 28.75 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.835 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.2 ptt180 -167.0 -167.19 0.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 111.017 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.428 ' C ' ' CG ' ' A' ' 73' ' ' GLU . . . 56.56 -86.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.562 -0.711 . . . . 0.0 110.96 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 71' ' ' ARG . 35.7 mt-10 -151.38 30.28 0.61 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.914 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -59.72 176.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.076 -1.015 . . . . 0.0 109.637 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -103.69 139.73 38.55 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.135 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.597 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 19.3 tp -160.95 150.7 17.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.915 . . . . 0.0 110.465 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 85.9 m-85 -160.32 120.57 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.865 -0.522 . . . . 0.0 109.641 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CE2' ' HA ' ' A' ' 61' ' ' TYR . 81.4 m-85 -89.94 113.53 25.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.101 -0.999 . . . . 0.0 110.214 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 68.5 m-85 -104.97 136.61 44.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.342 -0.849 . . . . 0.0 109.876 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.58 HG11 ' CD2' ' A' ' 98' ' ' HIS . 4.9 t -120.18 125.92 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.466 ' HB2' ' CG ' ' A' ' 98' ' ' HIS . 0.8 OUTLIER 46.31 39.26 6.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.241 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 2.3 t30 67.53 38.45 3.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.401 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.7 t -135.51 168.51 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 109.864 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.4 mp -154.44 69.5 5.99 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.505 -0.747 . . . . 0.0 109.718 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.28 170.49 19.75 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.068 1.562 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.22 179.55 5.35 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.101 1.579 . . . . 0.0 110.36 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.48 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.69 21.62 2.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.399 -0.813 . . . . 0.0 110.559 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 t -95.73 39.64 1.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.522 -0.736 . . . . 0.0 109.791 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.81 -176.7 5.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 110.338 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 45.3 p -139.61 148.32 42.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.569 -0.707 . . . . 0.0 110.255 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.547 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -52.96 -41.47 64.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 109.946 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 53' ' ' SER . . . -49.56 -50.07 31.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 90' ' ' THR . 2.2 pt20 -64.72 -28.95 69.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -1.146 . . . . 0.0 109.671 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.547 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.31 -23.12 64.7 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.318 -0.864 . . . . 0.0 109.677 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.604 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -50.07 -55.9 12.98 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.094 -1.004 . . . . 0.0 109.909 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -17.51 63.93 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.545 -1.347 . . . . 0.0 110.623 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.5 mt-10 -88.57 -71.75 0.57 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.17 -0.956 . . . . 0.0 113.445 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.58 ' CD2' HG11 ' A' ' 80' ' ' VAL . 16.3 m-70 -100.74 38.35 1.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.653 -1.28 . . . . 0.0 113.112 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.604 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.951 0 O-C-N 120.988 -1.07 . . . . 0.0 111.029 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.531 ' CD1' HG13 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -98.52 154.22 18.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.67 -1.269 . . . . 0.0 110.057 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.513 ' N ' HD12 ' A' ' 105' ' ' LEU . 62.7 m-85 -119.09 122.07 41.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.115 -0.991 . . . . 0.0 111.218 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.531 HG13 ' CD1' ' A' ' 105' ' ' LEU . 25.3 mt -140.26 149.42 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -143.29 178.69 7.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 110.116 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -143.71 164.07 31.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 110.641 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -160.05 176.27 12.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.386 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 75' ' ' ALA . 6.3 p-10 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 110.127 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.228 0.537 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 23.7 t -145.03 107.06 4.54 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -77.33 86.24 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.145 1.603 . . . . 0.0 109.938 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.567 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -81.45 136.1 23.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.305 -0.872 . . . . 0.0 111.113 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 47.1 mm -91.88 139.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 47' ' ' LYS . 3.0 t -126.06 139.97 49.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.889 -1.132 . . . . 0.0 111.332 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 2.2 tt0 -156.51 174.24 15.72 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.635 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -102.46 159.77 15.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.924 -1.11 . . . . 0.0 110.419 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.548 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -65.04 -175.29 0.17 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.478 -0.764 . . . . 0.0 109.436 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.6 Cg_endo -71.98 107.25 2.18 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.564 1.297 . . . . 0.0 109.877 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 63.46 40.05 8.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 110.026 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.78 -174.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.117 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 31.49 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.0 110.797 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.563 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -90.28 176.31 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.96 -1.087 . . . . 0.0 110.493 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -51.42 -173.8 0.02 OUTLIER Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.308 -0.87 . . . . 0.0 111.117 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -71.49 -175.93 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -1.162 . . . . 0.0 109.867 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.59 ' CD1' ' CD ' ' A' ' 47' ' ' LYS . 1.4 pp -134.99 133.13 39.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.146 -0.972 . . . . 0.0 110.651 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.476 ' HB2' ' HD3' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -86.68 -42.32 13.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.219 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -152.79 151.71 30.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 110.279 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.59 ' CD ' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -111.25 49.59 0.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 109.728 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -169.55 111.17 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.519 -0.738 . . . . 0.0 109.659 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.567 ' HB2' ' CG2' ' A' ' 31' ' ' VAL . 10.2 m-85 -108.36 141.05 40.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.075 -1.015 . . . . 0.0 110.37 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.37 92.14 4.2 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.488 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 34.4 m -114.25 147.57 38.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 110.486 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.1 Cg_endo -70.96 150.33 60.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.815 1.429 . . . . 0.0 109.772 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.526 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -65.08 -13.49 58.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.302 -0.874 . . . . 0.0 111.594 -178.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -87.72 -14.23 40.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.888 -1.132 . . . . 0.0 111.189 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.492 ' HG ' ' HG2' ' A' ' 52' ' ' PRO . 4.2 mt -62.14 146.16 51.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.956 -1.09 . . . . 0.0 111.503 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.462 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 3.9 p -91.28 160.05 15.71 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.638 -0.664 . . . . 0.0 109.533 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.513 HG11 ' CG2' ' A' ' 87' ' ' THR . 63.5 t -60.01 -22.04 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.016 . . . . 0.0 110.043 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.83 -39.72 64.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.464 ' CB ' HD23 ' A' ' 55' ' ' LEU . 1.5 mm-40 -67.96 -48.64 65.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -1.173 . . . . 0.0 109.987 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.658 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 47.2 t80 -60.41 -44.21 95.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.569 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.683 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -53.24 -26.53 18.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.934 -1.104 . . . . 0.0 109.706 179.356 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.478 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -73.97 -47.74 35.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.398 -0.814 . . . . 0.0 109.668 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.612 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 3.2 pp -66.43 -17.16 64.63 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.013 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.658 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.1 mt -89.33 -41.07 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 120.046 -1.659 . . . . 0.0 109.398 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' CG ' ' N ' ' A' ' 66' ' ' LYS . 2.2 ptm180 -39.64 -46.28 1.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.547 -0.721 . . . . 0.0 110.616 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.554 ' N ' ' CG ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -72.81 -36.9 67.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.984 -1.073 . . . . 0.0 109.814 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.519 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 5.8 mmp_? -69.41 -10.12 56.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.302 -0.874 . . . . 0.0 109.857 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.589 HG12 ' CE2' ' A' ' 109' ' ' TYR . 45.1 mt -104.03 7.77 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.006 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.522 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 50.07 31.29 4.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.363 -0.835 . . . . 0.0 110.308 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.525 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 2.9 pp -103.56 156.28 17.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.37 -165.15 0.82 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.036 -1.04 . . . . 0.0 110.941 -179.001 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.04 -90.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.782 . . . . 0.0 110.601 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 71' ' ' ARG . 4.6 pt-20 -156.41 26.1 0.35 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 111.037 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.523 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.04 176.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.063 -1.023 . . . . 0.0 110.002 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.523 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -110.98 142.99 42.37 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.137 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.542 ' C ' ' CG ' ' A' ' 77' ' ' PHE . 21.8 tp -156.16 155.49 32.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 110.545 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.571 ' O ' ' CE1' ' A' ' 79' ' ' PHE . 19.4 m-85 -152.83 123.28 7.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.548 -0.72 . . . . 0.0 109.818 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CD2' ' CE2' ' A' ' 61' ' ' TYR . 21.3 m-30 -88.17 135.85 33.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.255 -0.903 . . . . 0.0 111.273 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.571 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 54.0 m-85 -120.33 119.0 31.85 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.58 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 2.0 t -121.25 112.43 35.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 121.357 -0.839 . . . . 0.0 110.304 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.44 ' O ' HG22 ' A' ' 83' ' ' VAL . 13.4 t-20 59.96 42.22 16.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 0.0 110.22 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.92 34.49 14.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.5 t -134.47 168.02 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 109.994 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -155.02 67.5 5.23 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.581 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HD3' HG13 ' A' ' 83' ' ' VAL . 46.7 Cg_endo -72.86 160.04 46.93 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.922 1.485 . . . . 0.0 110.665 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.82 -178.91 3.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.038 1.547 . . . . 0.0 110.65 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.513 ' CG2' HG11 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -85.85 20.53 2.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.459 -0.776 . . . . 0.0 110.618 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 t -95.37 42.76 1.09 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.443 -0.786 . . . . 0.0 109.507 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' C ' HG22 ' A' ' 90' ' ' THR . . . -145.13 -169.69 3.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.663 0.744 . . . . 0.0 110.3 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 45.0 p -139.24 143.1 37.84 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.687 -0.633 . . . . 0.0 109.935 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.527 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 25.4 mmm -50.88 -45.15 59.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 109.545 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.55 -48.54 34.99 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.1 OUTLIER -64.59 -31.76 73.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -1.136 . . . . 0.0 110.106 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.54 HD12 ' CD1' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -68.54 -23.17 64.49 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.115 -0.991 . . . . 0.0 110.133 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.537 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -48.64 -53.45 18.58 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.519 -179.435 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.12 -20.98 63.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.194 -0.941 . . . . 0.0 111.291 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.479 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 14.8 mt-10 -84.27 -63.99 1.24 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.014 -1.054 . . . . 0.0 112.06 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.58 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 7.5 m-70 -97.41 40.62 1.15 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.966 -1.084 . . . . 0.0 110.779 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.28 0.562 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.62 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -103.04 171.09 7.58 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.449 ' N ' HD13 ' A' ' 105' ' ' LEU . 1.2 m-85 -118.14 126.89 53.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.402 -1.436 . . . . 0.0 112.211 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.62 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 4.1 mt -141.58 144.63 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -146.62 163.05 37.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.192 -0.943 . . . . 0.0 109.372 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.635 ' CE2' ' CD ' ' A' ' 35' ' ' LYS . 1.4 p90 -134.09 165.73 24.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.646 -1.284 . . . . 0.0 111.278 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.22 177.25 11.25 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.483 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.438 ' OD2' ' O ' ' A' ' 75' ' ' ALA . 11.9 t0 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.922 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 5.4 mpt_? . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.33 0.586 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG22 ' OG ' ' A' ' 53' ' ' SER . 17.3 t -148.02 116.97 4.15 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 110.203 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 50.3 Cg_endo -79.35 90.96 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 124.257 1.661 . . . . 0.0 110.005 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.554 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -88.55 138.66 18.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.164 -0.96 . . . . 0.0 110.559 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.52 HG13 ' CE1' ' A' ' 104' ' ' PHE . 24.8 mm -95.95 152.82 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 108.901 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.463 HG11 ' HG3' ' A' ' 47' ' ' LYS . 2.6 t -133.6 141.83 43.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.965 -1.084 . . . . 0.0 111.109 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' ' 33' ' ' VAL . 3.7 tt0 -157.27 -166.76 2.13 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HD2' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -124.56 160.77 27.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.885 -1.135 . . . . 0.0 110.508 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.6 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -61.63 -167.81 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.676 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 42.1 Cg_endo -71.72 123.64 9.57 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.189 1.099 . . . . 0.0 109.673 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 40.55 49.54 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.599 0.714 . . . . 0.0 110.549 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.09 -179.11 0.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.603 -0.686 . . . . 0.0 110.126 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.33 36.18 0.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.699 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.546 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.8 pp -85.18 177.87 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.025 -1.047 . . . . 0.0 110.378 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.546 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -47.9 -179.58 0.01 OUTLIER Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.488 -0.863 . . . . 0.0 110.997 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' O ' HD21 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -75.85 -179.28 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -1.171 . . . . 0.0 110.071 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' CG ' ' OH ' ' A' ' 109' ' ' TYR . 1.6 mm? -136.17 134.8 38.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.164 -0.96 . . . . 0.0 110.579 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 29.7 t0 -86.49 -36.96 18.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.436 -0.79 . . . . 0.0 110.099 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.83 154.44 35.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HG3' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -117.69 46.42 1.74 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.12 -0.987 . . . . 0.0 109.818 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -164.51 109.66 0.97 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.423 -0.798 . . . . 0.0 109.965 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.581 ' CD2' HD12 ' A' ' 63' ' ' LEU . 16.3 m-85 -108.14 139.6 42.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.04 -1.038 . . . . 0.0 110.12 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.85 99.63 8.51 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG2' ' HE2' ' A' ' 91' ' ' MET . 5.1 m -126.14 160.03 59.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.046 -1.034 . . . . 0.0 110.861 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 42.3 Cg_endo -67.69 144.98 67.99 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.052 1.553 . . . . 0.0 110.434 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.541 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -63.5 -14.0 46.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.446 -0.784 . . . . 0.0 111.441 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -83.73 -10.36 58.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.96 -1.088 . . . . 0.0 110.945 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.509 HD21 ' CB ' ' A' ' 59' ' ' GLN . 4.1 mt -62.22 141.32 58.27 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.003 -1.06 . . . . 0.0 111.027 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -91.44 169.15 11.02 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.703 -0.623 . . . . 0.0 109.827 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.494 ' CG1' HG23 ' A' ' 87' ' ' THR . 95.3 t -61.93 -26.63 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.307 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.88 -39.61 75.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.509 ' CB ' HD21 ' A' ' 55' ' ' LEU . 5.3 mm-40 -67.67 -48.56 66.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.1 -1.236 . . . . 0.0 110.101 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.651 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 24.0 t80 -60.45 -46.43 90.1 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.469 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -50.51 -23.62 2.62 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.888 -1.132 . . . . 0.0 109.928 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.79 -51.79 9.26 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.588 HD11 ' CD1' ' A' ' 60' ' ' PHE . 4.0 pp -63.54 -17.83 63.22 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.432 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.651 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.6 mt -91.82 -39.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 120.01 -1.681 . . . . 0.0 109.059 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -35.43 -64.66 0.27 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.086 0.47 . . . . 0.0 110.961 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.02 -31.4 72.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.208 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.525 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 28.6 mmt-85 -68.21 -16.79 64.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.066 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.608 ' CD1' ' CE2' ' A' ' 109' ' ' TYR . 1.2 mm -97.44 8.74 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.601 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.453 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER 57.04 30.17 17.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 110.317 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.529 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.3 pp -117.61 154.84 30.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.917 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -166.25 -169.07 1.34 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.235 -0.916 . . . . 0.0 111.046 -179.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 49.74 -92.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.523 -0.736 . . . . 0.0 111.015 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -142.5 45.9 1.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 111.039 -179.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -72.85 176.32 5.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.889 -1.132 . . . . 0.0 109.803 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.518 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.38 140.32 38.67 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.157 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 44.6 tp -164.3 153.27 13.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.591 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 74.4 m-85 -158.01 119.91 3.65 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.703 -0.623 . . . . 0.0 109.621 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.481 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 16.7 m-30 -83.5 134.7 34.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.155 -0.965 . . . . 0.0 111.977 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.17 123.35 42.06 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.573 HG13 ' CG ' ' A' ' 98' ' ' HIS . 2.1 t -120.49 119.85 60.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 O-C-N 121.201 -0.937 . . . . 0.0 110.077 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 26.4 t30 50.91 39.05 21.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.1 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 64.95 35.2 8.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.5 t -135.41 168.41 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.306 -0.871 . . . . 0.0 109.931 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.3 mp -154.37 72.84 6.18 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.554 -0.716 . . . . 0.0 109.533 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.12 165.64 32.18 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.072 1.564 . . . . 0.0 110.662 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.462 ' HG2' ' OG ' ' A' ' 88' ' ' SER . 45.9 Cg_endo -72.85 178.31 6.56 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.044 1.55 . . . . 0.0 110.348 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.494 HG23 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.56 21.59 2.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.462 ' OG ' ' HG2' ' A' ' 86' ' ' PRO . 3.0 p -93.04 39.68 1.05 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 109.61 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.5 -172.91 3.98 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.684 0.754 . . . . 0.0 110.275 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.466 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 64.2 p -138.95 145.8 40.21 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.501 0.667 . . . . 0.0 110.016 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.557 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 4.3 mmm -51.42 -39.76 57.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 110.232 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.83 -49.96 45.81 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -64.6 -26.48 68.42 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.35 -1.088 . . . . 0.0 109.628 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.557 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -69.02 -25.52 64.53 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.302 -0.874 . . . . 0.0 110.044 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.59 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -49.12 -56.0 10.5 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.824 -1.173 . . . . 0.0 109.652 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -70.14 -18.32 63.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.992 -1.067 . . . . 0.0 111.2 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 14.0 mt-10 -87.75 -67.05 0.85 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 112.789 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.573 ' CG ' HG13 ' A' ' 80' ' ' VAL . 12.9 m-70 -98.6 36.96 1.55 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.795 -1.19 . . . . 0.0 112.315 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.505 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.126 -0.984 . . . . 0.0 109.422 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.52 ' CE1' HG13 ' A' ' 32' ' ' ILE . 7.5 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.078 0.466 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.559 ' CD1' ' CD1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.8 168.37 9.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.989 -1.07 . . . . 0.0 110.304 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -122.11 133.76 54.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.926 -1.109 . . . . 0.0 110.727 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.559 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 4.6 mt -138.86 137.16 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.316 -0.865 . . . . 0.0 110.289 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.16 145.01 38.84 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.236 -0.915 . . . . 0.0 108.778 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.608 ' CE2' ' CD1' ' A' ' 68' ' ' ILE . 2.9 p90 -130.2 170.96 13.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.54 -1.35 . . . . 0.0 111.924 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -157.91 179.78 8.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.845 -0.535 . . . . 0.0 110.063 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.518 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 8.8 p-10 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.928 . . . . 0.0 110.268 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.305 0.574 . . . . 0.0 110.307 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 23.2 t -144.51 109.73 4.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 110.188 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 48.6 Cg_endo -76.02 96.14 1.05 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.162 1.611 . . . . 0.0 110.18 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -90.9 145.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.354 -0.841 . . . . 0.0 110.626 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 1.1 mp -100.25 156.03 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 49' ' ' TYR . 2.3 t -133.19 136.36 55.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.034 -1.041 . . . . 0.0 110.972 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 2.1 mt-10 -148.65 177.23 9.68 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.759 -0.588 . . . . 0.0 109.454 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.596 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -112.82 158.15 20.49 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.898 -1.126 . . . . 0.0 110.614 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.591 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -63.9 -169.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.556 -0.715 . . . . 0.0 109.24 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 44.0 Cg_endo -73.54 109.45 2.85 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.31 1.163 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.23 41.49 6.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.365 -0.834 . . . . 0.0 110.433 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.53 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -61.44 174.47 0.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 109.804 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.58 34.56 0.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 111.092 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -87.66 -175.84 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.848 -1.158 . . . . 0.0 110.033 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.505 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -49.07 178.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.954 -1.117 . . . . 0.0 110.328 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -82.5 -176.81 6.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 109.777 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.466 ' HG ' ' OH ' ' A' ' 109' ' ' TYR . 1.5 mm? -137.18 131.8 33.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 110.782 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -86.84 -26.78 23.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -0.825 . . . . 0.0 109.429 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -152.67 154.31 35.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.457 -0.777 . . . . 0.0 109.798 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -120.05 44.73 2.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.032 -1.042 . . . . 0.0 109.945 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 8.9 pttp -159.0 111.2 2.18 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.355 -0.841 . . . . 0.0 109.497 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.575 ' CD2' HD11 ' A' ' 63' ' ' LEU . 12.0 m-85 -103.86 140.09 38.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.992 -1.067 . . . . 0.0 110.335 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.05 92.3 4.71 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.494 ' HB ' HD13 ' A' ' 55' ' ' LEU . 26.9 m -116.02 142.42 29.16 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.178 -0.951 . . . . 0.0 110.898 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.485 ' HD2' HD13 ' A' ' 55' ' ' LEU . 42.2 Cg_endo -67.49 148.87 79.72 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.103 1.58 . . . . 0.0 109.956 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.554 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 2.0 m -63.12 -13.94 42.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 111.614 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -83.37 -14.8 52.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.111 -0.993 . . . . 0.0 110.888 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.505 HD23 ' CB ' ' A' ' 59' ' ' GLN . 4.7 mt -62.65 142.67 57.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.021 -1.05 . . . . 0.0 111.424 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 3.2 p -90.97 163.97 14.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.637 -0.665 . . . . 0.0 109.288 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.475 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 39.2 t -61.52 -24.6 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.957 -1.089 . . . . 0.0 110.086 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.07 -31.98 66.23 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.505 ' CB ' HD23 ' A' ' 55' ' ' LEU . 5.2 mm100 -74.6 -47.82 30.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -1.214 . . . . 0.0 109.886 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 38.9 t80 -60.2 -32.59 71.24 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.287 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' CE2' ' HD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -60.72 -31.92 71.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 109.567 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.464 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 3.7 t80 -71.74 -52.87 15.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.54 -0.725 . . . . 0.0 110.993 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.604 HD12 ' CE1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -59.67 -35.09 73.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.834 -1.167 . . . . 0.0 112.57 -178.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.664 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -77.7 -32.19 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 119.657 -1.902 . . . . 0.0 109.394 178.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.487 ' HG2' ' CD1' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -39.81 -64.08 0.52 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.512 -0.742 . . . . 0.0 110.624 -179.32 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -30.31 71.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 64' ' ' ILE . 5.8 mmp_? -67.7 -17.42 64.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.011 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.582 ' CD1' ' CE2' ' A' ' 109' ' ' TYR . 2.7 mm -104.44 15.86 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.9 . . . . 0.0 109.793 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.436 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 49.99 28.84 3.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.587 -0.695 . . . . 0.0 110.655 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 68' ' ' ILE . 4.2 pp -111.0 155.06 23.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.839 . . . . 0.0 109.783 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.0 -173.41 2.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.923 -179.365 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.11 -91.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.469 -0.77 . . . . 0.0 110.784 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.467 ' O ' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -146.31 36.61 1.0 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.995 . . . . 0.0 111.051 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -60.05 176.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.078 -1.013 . . . . 0.0 109.825 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -94.23 138.25 32.46 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.553 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 20.3 tp -164.78 152.05 11.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.399 -0.813 . . . . 0.0 110.596 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 81.7 m-85 -158.35 119.9 3.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.578 -0.701 . . . . 0.0 109.757 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 10.7 m-85 -90.44 124.08 34.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 110.862 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 68.3 m-85 -115.5 127.29 55.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.562 HG11 ' CG ' ' A' ' 98' ' ' HIS . 2.8 t -121.25 121.93 66.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.503 -0.748 . . . . 0.0 109.959 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.464 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 0.8 OUTLIER 47.7 47.26 18.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 110.119 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 18.8 m120 57.22 36.84 27.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 110.491 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.6 t -135.3 168.0 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.1 mp -155.02 73.74 5.66 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.539 -0.725 . . . . 0.0 109.524 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.55 165.37 31.81 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.095 1.576 . . . . 0.0 110.767 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.51 -178.86 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.046 1.551 . . . . 0.0 110.435 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.475 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.1 20.57 2.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.223 -0.923 . . . . 0.0 110.593 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.7 t -95.85 41.55 1.1 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.504 -0.748 . . . . 0.0 109.527 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.55 -175.1 4.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.496 -0.752 . . . . 0.0 110.287 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.499 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 77.7 p -139.45 138.24 36.29 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.601 0.715 . . . . 0.0 110.229 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.641 ' CE ' ' CD1' ' A' ' 60' ' ' PHE . 2.7 mmm -45.72 -39.24 7.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.966 -1.084 . . . . 0.0 109.842 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.83 -53.03 23.62 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.972 -1.109 . . . . 0.0 110.439 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 2.6 pt20 -64.13 -27.03 68.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.089 -1.242 . . . . 0.0 110.008 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.557 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.36 -25.97 65.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.21 -0.931 . . . . 0.0 109.929 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.583 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -50.03 -55.5 14.52 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.855 -1.153 . . . . 0.0 109.698 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.575 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 2.0 mt-30 -69.41 -18.44 63.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.951 -1.093 . . . . 0.0 110.974 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 10.5 mt-10 -88.38 -68.36 0.77 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.012 -1.055 . . . . 0.0 113.13 -177.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.562 ' CG ' HG11 ' A' ' 80' ' ' VAL . 11.4 m-70 -99.35 38.05 1.48 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.703 -1.248 . . . . 0.0 112.795 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.575 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 O-C-N 120.995 -1.065 . . . . 0.0 109.856 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.407 ' HB3' HD13 ' A' ' 32' ' ' ILE . 8.8 m-85 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.409 0.623 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.544 HD13 ' CD1' ' A' ' 107' ' ' ILE . 0.4 OUTLIER -101.99 165.29 11.25 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.374 -0.829 . . . . 0.0 109.301 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER -122.9 123.82 41.82 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.77 -1.206 . . . . 0.0 111.165 -179.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.544 ' CD1' HD13 ' A' ' 105' ' ' LEU . 10.9 mt -141.97 147.66 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.204 -0.935 . . . . 0.0 109.82 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 34' ' ' GLU . . . -147.18 -179.57 6.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.145 -0.972 . . . . 0.0 110.159 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.666 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.2 OUTLIER -140.97 162.26 35.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.945 -1.097 . . . . 0.0 111.418 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.438 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 6.8 t -148.0 -177.81 5.94 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 110.53 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.453 ' O ' HG22 ' A' ' 29' ' ' VAL . 6.0 mpt_? . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.283 0.564 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.471 HG11 ' CG1' ' A' ' 31' ' ' VAL . 21.8 t -147.24 107.78 3.89 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 110.39 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.497 ' O ' ' HB3' ' A' ' 104' ' ' PHE . 49.3 Cg_endo -77.78 90.85 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.253 1.66 . . . . 0.0 110.029 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -90.85 133.49 32.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 111.215 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 44.0 mm -95.68 133.76 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 0.0 108.438 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -126.85 128.26 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.711 -1.243 . . . . 0.0 111.866 -178.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 3.1 tm-20 -132.62 159.5 39.37 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.635 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -87.55 163.38 16.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.867 -1.146 . . . . 0.0 110.863 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.556 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -65.47 -174.82 0.16 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 109.62 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 44.1 Cg_endo -72.85 116.61 4.78 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.638 1.336 . . . . 0.0 110.046 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 63.88 42.25 6.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.341 -0.849 . . . . 0.0 110.463 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.589 ' CB ' ' CG ' ' A' ' 35' ' ' LYS . . . -65.49 175.09 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.28 33.17 0.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.669 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.536 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -95.35 177.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.023 -1.048 . . . . 0.0 110.247 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -42.41 169.52 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.093 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -78.75 -176.48 4.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -1.195 . . . . 0.0 110.066 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.513 ' CD2' ' O ' ' A' ' 43' ' ' ASP . 1.2 mm? -139.4 135.84 34.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.898 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -86.49 -29.7 22.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.534 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -153.68 150.17 28.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -111.47 47.14 1.04 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.9 -1.125 . . . . 0.0 109.942 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -159.41 111.71 2.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.588 -0.695 . . . . 0.0 109.244 179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.577 ' CD2' ' CD1' ' A' ' 63' ' ' LEU . 19.6 m-85 -103.76 141.12 36.64 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.022 -1.049 . . . . 0.0 110.351 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -108.01 93.09 4.35 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.456 ' HB ' HD12 ' A' ' 55' ' ' LEU . 9.5 m -117.86 154.06 51.1 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.342 -0.849 . . . . 0.0 110.721 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.6 Cg_endo -70.34 147.01 58.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.085 1.571 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.521 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.3 m -62.38 -14.8 44.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 0.0 111.488 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -84.12 -12.4 55.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.025 -1.047 . . . . 0.0 111.331 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.505 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.8 mt -62.12 142.0 57.84 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.898 -1.126 . . . . 0.0 111.257 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.1 p -91.61 164.78 13.64 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.52 ' CG1' HG23 ' A' ' 87' ' ' THR . 93.4 t -60.87 -21.11 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.868 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.33 59.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.505 ' CB ' HD22 ' A' ' 55' ' ' LEU . 4.3 mm-40 -67.64 -47.98 68.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.164 -1.198 . . . . 0.0 109.845 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.665 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 34.8 t80 -60.82 -42.82 98.44 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.196 -1.001 . . . . 0.0 109.492 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -54.36 -22.56 12.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.752 -1.218 . . . . 0.0 109.838 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -79.39 -54.51 5.87 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.473 -0.767 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.577 ' CD1' ' CD2' ' A' ' 49' ' ' TYR . 1.2 pp -59.64 -25.94 65.1 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.833 -1.167 . . . . 0.0 112.102 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.665 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.7 mt -84.13 -42.45 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 119.997 -1.689 . . . . 0.0 108.844 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.473 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 1.8 mtp-105 -36.49 -60.58 0.58 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.017 0.436 . . . . 0.0 110.721 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -66.94 -32.7 74.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.831 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 64' ' ' ILE . 6.0 mmt-85 -69.34 -10.27 57.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.166 -0.959 . . . . 0.0 109.262 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.527 ' CD1' HG23 ' A' ' 64' ' ' ILE . 62.1 mt -103.97 13.21 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.474 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.538 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.6 OUTLIER 44.67 31.97 0.71 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.44 -0.787 . . . . 0.0 110.344 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.512 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 3.8 pp -104.9 153.55 21.24 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.893 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' GLU . 14.3 ptt180 -166.06 -168.45 1.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 111.033 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 49.85 -92.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.507 -0.746 . . . . 0.0 110.858 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 8.4 pt-20 -143.37 40.49 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 110.834 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.519 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -64.69 176.62 1.1 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.083 -1.011 . . . . 0.0 109.799 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -115.1 140.17 49.29 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.268 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.59 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 43.3 tp -157.6 150.7 23.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 80.9 m-85 -158.82 121.36 3.62 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.762 -0.586 . . . . 0.0 109.943 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 18.3 m-30 -88.09 128.16 35.42 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.061 -1.024 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 60.7 m-85 -115.98 128.61 55.87 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 108.984 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.585 HG13 ' CD2' ' A' ' 98' ' ' HIS . 2.3 t -120.4 128.71 76.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.149 -0.97 . . . . 0.0 110.27 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.539 ' OD1' ' CG2' ' A' ' 83' ' ' VAL . 5.6 p30 43.11 35.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 110.151 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 1.4 m-20 73.69 39.45 0.55 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.598 -0.689 . . . . 0.0 111.311 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.8 t -136.33 168.36 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.0 110.047 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.1 mp -154.96 68.71 5.54 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.58 -0.7 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.44 ' HD3' HG11 ' A' ' 83' ' ' VAL . 46.4 Cg_endo -73.05 164.36 35.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.992 1.522 . . . . 0.0 110.753 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.47 ' HG2' ' OG ' ' A' ' 88' ' ' SER . 44.2 Cg_endo -71.92 179.09 5.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.144 1.602 . . . . 0.0 110.583 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.52 HG23 ' CG1' ' A' ' 57' ' ' VAL . 1.1 p -87.03 20.35 2.71 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.322 -0.861 . . . . 0.0 110.842 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.47 ' OG ' ' HG2' ' A' ' 86' ' ' PRO . 2.2 p -90.53 39.9 0.99 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.447 -0.783 . . . . 0.0 109.475 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.38 -174.39 4.37 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.589 0.709 . . . . 0.0 110.006 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 82.2 p -139.59 152.84 47.15 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.462 -0.773 . . . . 0.0 110.318 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.533 ' CA ' HD23 ' A' ' 94' ' ' LEU . 43.8 mmm -56.57 -41.73 77.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.388 -0.82 . . . . 0.0 109.926 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -52.04 -48.16 52.89 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -65.28 -27.13 68.41 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.407 -1.055 . . . . 0.0 109.657 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.533 HD23 ' CA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -69.02 -23.82 64.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.907 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.591 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -49.26 -56.65 8.69 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.851 -1.156 . . . . 0.0 109.434 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.564 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 11.9 tt0 -70.94 -16.09 62.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.836 -1.165 . . . . 0.0 111.373 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -87.97 -63.31 1.32 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.994 -1.066 . . . . 0.0 113.626 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.585 ' CD2' HG13 ' A' ' 80' ' ' VAL . 9.3 m-70 -98.03 35.89 1.66 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.757 -1.214 . . . . 0.0 112.624 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 110.312 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.497 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 5.6 m-85 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.232 0.539 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.541 ' CD1' HG13 ' A' ' 107' ' ' ILE . 0.3 OUTLIER -99.02 166.08 11.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.291 -0.881 . . . . 0.0 109.12 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.515 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.8 OUTLIER -118.72 121.75 40.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.696 -1.253 . . . . 0.0 111.896 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.541 HG13 ' CD1' ' A' ' 105' ' ' LEU . 7.5 mt -141.63 149.79 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.462 -0.774 . . . . 0.0 109.181 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -139.23 177.02 8.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.005 -1.06 . . . . 0.0 109.963 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.9 OUTLIER -155.13 163.73 39.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.011 -1.056 . . . . 0.0 111.251 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.4 t -159.56 -178.31 7.02 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.234 0.54 . . . . 0.0 110.137 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.516 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 8.5 p-10 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.199 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.467 ' O ' HG22 ' A' ' 29' ' ' VAL . 7.1 mpt_? . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.365 0.602 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.533 HG11 ' CG1' ' A' ' 31' ' ' VAL . 20.0 t -147.4 105.11 3.77 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.596 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -76.37 83.41 2.03 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.289 1.678 . . . . 0.0 110.222 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.9 m -81.26 154.27 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.216 -0.928 . . . . 0.0 110.803 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.493 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 31.1 mm -111.33 161.92 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 108.761 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.477 ' N ' HG23 ' A' ' 32' ' ' ILE . 2.8 t -134.9 144.67 33.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.947 -1.095 . . . . 0.0 111.168 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' N ' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -156.36 178.02 10.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.583 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -117.07 157.61 25.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.905 -1.122 . . . . 0.0 110.681 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.565 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.87 -173.74 0.12 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.516 -0.74 . . . . 0.0 109.253 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.1 Cg_endo -71.25 105.62 1.76 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.446 1.235 . . . . 0.0 109.762 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER 63.43 40.74 8.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.41 -0.806 . . . . 0.0 110.326 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.84 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.184 -0.947 . . . . 0.0 109.831 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG2' ' CB ' ' A' ' 111' ' ' ASP . 2.9 ptm180 -144.67 26.63 1.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 0.0 110.994 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.472 HG21 HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -85.48 -177.37 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.938 -1.101 . . . . 0.0 109.378 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' A' ' 69' ' ' HIS . . . -62.4 171.05 11.08 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.479 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.4 t70 -75.15 -177.29 3.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -1.1 . . . . 0.0 109.998 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.482 ' HG ' ' OH ' ' A' ' 109' ' ' TYR . 1.5 mm? -138.6 133.29 32.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.128 -0.982 . . . . 0.0 110.808 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.505 ' CB ' ' HE2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -86.8 -21.9 26.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.814 . . . . 0.0 109.136 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HE2' ' CB ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -151.68 147.66 26.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.571 -0.706 . . . . 0.0 109.105 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -123.61 48.84 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.921 -1.112 . . . . 0.0 110.184 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 11.5 pttm -158.19 108.95 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 110.118 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.588 ' CD2' HD12 ' A' ' 63' ' ' LEU . 23.4 m-85 -103.83 144.17 31.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.134 -0.979 . . . . 0.0 110.412 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.8 103.68 11.2 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 3.3 m -128.8 159.37 68.66 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 110.931 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.465 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.9 Cg_endo -70.65 148.17 58.74 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.193 1.628 . . . . 0.0 110.513 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.528 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -63.02 -17.08 61.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.494 -0.754 . . . . 0.0 111.305 -179.104 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -83.51 -9.65 58.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 0.0 111.322 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.532 ' CD1' ' HB ' ' A' ' 51' ' ' VAL . 3.9 mt -62.08 141.41 58.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.784 -1.198 . . . . 0.0 110.908 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.427 ' HA ' HG23 ' A' ' 90' ' ' THR . 6.0 p -91.21 156.67 17.67 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.504 -0.748 . . . . 0.0 109.575 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.506 ' CG1' HG22 ' A' ' 87' ' ' THR . 95.5 t -54.05 -24.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.068 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.81 -38.37 66.02 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.49 ' CB ' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -68.57 -49.28 60.66 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.142 -1.211 . . . . 0.0 110.017 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.654 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 31.3 t80 -60.49 -47.38 86.38 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.793 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.85 -21.8 1.87 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.68 -1.263 . . . . 0.0 109.776 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -78.68 -54.16 6.4 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.765 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.588 HD12 ' CD2' ' A' ' 49' ' ' TYR . 3.6 pp -60.72 -18.45 54.48 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.27 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -92.3 -41.36 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.115 -1.616 . . . . 0.0 109.145 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.465 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -37.26 -61.2 0.6 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.872 -0.518 . . . . 0.0 110.677 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -65.16 -32.87 74.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.098 -1.001 . . . . 0.0 109.618 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 29.3 mmt-85 -69.94 -12.11 61.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 110.109 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.491 ' O ' ' CG2' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.09 4.48 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.123 -0.985 . . . . 0.0 109.295 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.479 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 55.47 29.25 12.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.459 -0.776 . . . . 0.0 110.018 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.518 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 3.8 pp -101.0 151.81 21.33 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.038 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.82 -161.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.288 -0.883 . . . . 0.0 110.778 -179.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.525 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 49.92 -87.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.0 110.917 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 72' ' ' ALA . 40.7 mt-10 -156.37 36.45 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 110.634 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -62.91 176.59 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.059 -1.026 . . . . 0.0 109.848 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.52 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -119.0 145.06 46.14 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.061 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.537 ' C ' ' CG ' ' A' ' 77' ' ' PHE . 22.2 tp -158.84 153.56 24.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.537 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 56.2 m-85 -154.39 122.35 5.94 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.547 -0.72 . . . . 0.0 109.767 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 16.7 m-30 -84.2 131.15 34.78 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.337 -0.852 . . . . 0.0 111.869 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 64.6 m-85 -120.12 119.04 32.15 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.643 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 1.4 t -121.59 126.26 74.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 8.7 t-20 55.25 35.28 24.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.079 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 2.0 t-20 64.58 32.16 11.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 110.106 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -135.12 168.55 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.577 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.1 mp -154.86 73.43 5.8 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.58 -0.7 . . . . 0.0 109.297 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.19 165.14 33.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.099 1.579 . . . . 0.0 110.867 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.62 178.73 5.92 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.108 1.583 . . . . 0.0 110.339 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.506 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -88.22 21.91 2.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.361 -0.837 . . . . 0.0 110.657 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.7 p -90.5 37.36 0.91 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.46 -0.775 . . . . 0.0 109.795 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.08 -171.96 4.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.463 -0.773 . . . . 0.0 110.142 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.51 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 44.2 p -138.81 150.12 45.7 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.654 0.74 . . . . 0.0 110.267 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.549 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 3.1 mmt -47.53 -47.93 27.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.469 -0.77 . . . . 0.0 110.692 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -42.69 -43.58 5.17 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.51 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 0.7 OUTLIER -67.82 -42.49 81.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.342 -1.093 . . . . 0.0 109.23 179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.549 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -58.84 -23.24 60.35 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.363 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.596 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -48.36 -54.06 15.27 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.675 -1.265 . . . . 0.0 109.716 -179.305 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.71 -22.7 63.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.251 -0.905 . . . . 0.0 111.375 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 2.1 mm-40 -81.54 -63.52 1.38 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.957 -1.089 . . . . 0.0 111.655 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.643 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.8 m-70 -97.63 41.58 1.12 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.002 -1.061 . . . . 0.0 110.141 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 95' ' ' TYR . 6.1 t-80 . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 121.259 0.552 . . . . 0.0 109.691 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 30' ' ' PRO . 1.9 m-85 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.08 0.467 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.588 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -114.87 161.77 17.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.046 -1.034 . . . . 0.0 109.488 179.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.493 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 4.3 p90 -120.49 132.81 55.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.778 -1.201 . . . . 0.0 111.749 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.588 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 7.7 mt -141.25 124.54 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 0.0 109.98 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -122.36 160.3 25.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.993 -1.067 . . . . 0.0 109.671 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.583 ' CE2' ' CD ' ' A' ' 35' ' ' LYS . 1.4 p90 -135.42 162.2 33.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.694 -1.254 . . . . 0.0 111.258 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.33 178.76 8.16 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.135 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 9.6 t0 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.21 -0.931 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.274 0.559 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG12 HG12 ' A' ' 31' ' ' VAL . 16.3 t -147.2 107.25 3.89 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.483 ' HD2' ' OH ' ' A' ' 95' ' ' TYR . 46.3 Cg_endo -75.41 86.48 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.181 1.621 . . . . 0.0 109.855 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.1 m -79.71 136.61 23.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.317 -0.865 . . . . 0.0 110.553 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 14.9 mm -91.86 157.25 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.435 ' HB ' ' C ' ' A' ' 47' ' ' LYS . 2.5 t -134.05 140.41 46.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 120.898 -1.126 . . . . 0.0 111.336 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.23 169.74 23.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.413 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.519 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -109.5 162.62 14.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.857 -1.152 . . . . 0.0 110.522 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.572 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -62.42 -172.17 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.499 -0.751 . . . . 0.0 109.307 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.572 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.9 Cg_endo -71.55 110.41 2.87 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.433 1.228 . . . . 0.0 109.83 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.64 42.58 10.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.26 -0.9 . . . . 0.0 110.025 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.519 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -59.38 179.13 0.11 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.286 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.527 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 6.5 ptm180 -150.04 29.81 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 110.825 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.543 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.41 178.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.064 . . . . 0.0 110.424 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -48.02 -178.4 0.01 OUTLIER Glycine 0 N--CA 1.496 2.666 0 O-C-N 121.332 -0.855 . . . . 0.0 111.055 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.466 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 7.7 t70 -84.95 -178.98 6.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -1.202 . . . . 0.0 109.858 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.468 ' HG ' ' OH ' ' A' ' 109' ' ' TYR . 1.3 mm? -138.41 134.73 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.096 -1.002 . . . . 0.0 110.592 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.95 -24.02 26.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.456 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.08 154.46 29.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.556 -0.715 . . . . 0.0 109.591 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -118.73 43.18 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.945 -1.097 . . . . 0.0 110.017 179.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' LYS . 18.9 mttt -158.23 109.53 2.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.619 -0.676 . . . . 0.0 109.566 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.588 ' CD2' HD12 ' A' ' 63' ' ' LEU . 15.3 m-85 -103.84 141.06 36.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.018 -1.051 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -103.87 94.57 5.49 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.486 ' HB ' HD11 ' A' ' 55' ' ' LEU . 14.7 m -117.57 149.65 45.3 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 110.851 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.458 ' HD2' HD12 ' A' ' 55' ' ' LEU . 47.0 Cg_endo -70.56 149.71 62.18 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.212 1.638 . . . . 0.0 110.074 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.527 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.5 m -62.27 -17.15 57.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.405 -0.809 . . . . 0.0 111.405 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -83.95 -11.57 56.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 111.385 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.486 HD11 ' HB ' ' A' ' 51' ' ' VAL . 3.3 mt -61.61 141.21 57.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.858 -1.151 . . . . 0.0 111.145 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 p -91.17 154.0 19.63 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.285 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 25.6 t -53.97 -20.98 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.057 -1.027 . . . . 0.0 109.785 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.73 -39.63 59.72 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.476 ' HB2' HD22 ' A' ' 55' ' ' LEU . 10.9 mm-40 -67.85 -47.38 69.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.046 -1.267 . . . . 0.0 109.599 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.644 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 21.3 t80 -60.38 -45.97 91.65 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.432 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.64 -22.86 2.23 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.953 -1.092 . . . . 0.0 109.911 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -80.15 -54.54 5.66 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.818 . . . . 0.0 110.357 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.588 HD12 ' CD2' ' A' ' 49' ' ' TYR . 3.6 pp -59.61 -21.64 60.69 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.012 -1.055 . . . . 0.0 112.306 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.644 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -90.45 -38.56 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 120.09 -1.632 . . . . 0.0 108.816 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -36.65 -62.43 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.863 -0.523 . . . . 0.0 110.691 -179.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -30.63 71.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.133 -0.98 . . . . 0.0 109.845 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 20.1 mmt180 -68.01 -13.85 62.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 109.481 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.519 ' CG2' HD23 ' A' ' 70' ' ' LEU . 70.6 mt -103.21 14.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.449 -0.782 . . . . 0.0 109.545 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.541 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 1.4 t60 47.8 28.76 1.41 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.552 -0.718 . . . . 0.0 110.493 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.519 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.0 pp -110.71 155.17 22.84 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.636 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 73' ' ' GLU . 11.5 ptt180 -166.15 -171.67 2.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.114 -0.991 . . . . 0.0 111.054 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.47 -89.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.522 -0.736 . . . . 0.0 110.763 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -148.55 33.24 0.78 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.143 -0.973 . . . . 0.0 110.919 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -56.76 176.81 0.09 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.024 -1.048 . . . . 0.0 109.796 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.29 138.77 40.96 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.128 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.593 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 17.5 tp -164.41 152.85 12.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 110.505 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 94.1 m-85 -158.85 122.08 3.77 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.663 -0.648 . . . . 0.0 109.896 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 16.9 m-30 -85.62 132.33 34.19 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.136 -0.977 . . . . 0.0 111.346 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 58.2 m-85 -119.45 121.46 39.52 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.49 -0.756 . . . . 0.0 109.227 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.578 HG12 ' CG ' ' A' ' 98' ' ' HIS . 2.5 t -120.63 123.48 70.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.358 -0.839 . . . . 0.0 110.074 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 7.6 t30 50.39 34.54 9.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 8.4 t-20 66.98 37.37 3.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.95 . . . . 0.0 110.146 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.7 t -135.47 169.96 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 109.83 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.584 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.6 OUTLIER -154.68 73.67 5.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.478 -0.764 . . . . 0.0 109.207 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.52 155.77 58.99 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.164 1.613 . . . . 0.0 110.925 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.71 -178.67 3.58 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.167 1.614 . . . . 0.0 110.273 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.51 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 1.2 p -86.03 18.46 3.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.906 . . . . 0.0 110.823 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.4 m -90.33 32.49 0.94 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.397 -0.814 . . . . 0.0 109.662 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.31 -174.18 4.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.525 -0.735 . . . . 0.0 110.096 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.498 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 67.3 p -139.4 149.91 44.66 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.561 -0.712 . . . . 0.0 110.19 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.58 ' CE ' ' CD2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -48.74 -43.81 37.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.317 -0.864 . . . . 0.0 110.175 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -46.1 -44.18 14.02 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.498 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 2.4 mt-30 -65.58 -47.0 77.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.385 -1.067 . . . . 0.0 109.434 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -56.91 -23.43 44.94 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.385 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.504 ' O ' ' HB3' ' A' ' 99' ' ' HIS . 1.0 OUTLIER -48.94 -56.18 9.61 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.812 -1.18 . . . . 0.0 109.848 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -16.78 62.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.027 -1.046 . . . . 0.0 111.532 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -87.15 -65.53 1.0 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.892 -1.13 . . . . 0.0 112.473 -178.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.578 ' CG ' HG12 ' A' ' 80' ' ' VAL . 8.7 m-70 -98.78 41.48 1.14 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.953 -1.092 . . . . 0.0 111.388 -177.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.504 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.8 p80 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.492 -0.755 . . . . 0.0 109.758 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.457 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 4.9 p90 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.256 0.55 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.612 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -121.73 171.64 8.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.125 -0.985 . . . . 0.0 109.752 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.483 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 1.3 m-85 -122.64 126.23 47.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.666 -1.271 . . . . 0.0 111.366 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.612 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 9.0 mt -138.75 136.16 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.179 -0.951 . . . . 0.0 110.358 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -130.73 173.11 11.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -1.0 . . . . 0.0 109.731 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.632 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.4 p90 -150.69 165.33 33.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.87 -1.144 . . . . 0.0 111.364 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -150.54 -178.28 6.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.768 -0.583 . . . . 0.0 110.177 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.539 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 8.4 p-10 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -53.67 -39.96 65.51 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.176 -1.191 . . . . 0.0 109.591 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 1.6 tttp -74.15 -34.78 63.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 110.054 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 12.0 mm -65.23 -12.33 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' HD2' ' HA ' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -83.15 -60.65 2.08 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.261 -0.9 . . . . 0.0 110.271 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.39 -39.71 15.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.0 110.138 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 2.6 mtmt -82.43 -45.59 14.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.009 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 28.8 m-85 -113.65 63.68 1.06 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 110.85 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.453 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 46.7 Cg_endo -72.66 -9.59 24.11 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.818 1.431 . . . . 0.0 110.407 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -98.96 -4.98 31.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.91 . . . . 0.0 110.41 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.533 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -88.54 -173.82 4.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 109.962 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 24.2 t -133.65 103.99 12.1 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.933 . . . . 0.0 110.383 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' HD2' ' OH ' ' A' ' 95' ' ' TYR . 48.7 Cg_endo -75.97 85.21 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.264 1.665 . . . . 0.0 109.721 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 2.0 m -77.9 150.33 5.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 110.918 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 35.9 mm -106.54 160.66 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.318 -0.864 . . . . 0.0 108.672 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 HG22 ' CD1' ' A' ' 49' ' ' TYR . 2.2 t -134.36 141.23 44.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.903 -1.123 . . . . 0.0 111.336 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.65 174.97 14.67 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.514 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -115.93 159.85 21.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.779 -1.2 . . . . 0.0 110.526 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.553 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -65.01 -174.3 0.14 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.595 -0.691 . . . . 0.0 109.405 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.7 Cg_endo -71.32 110.37 2.83 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.617 1.325 . . . . 0.0 109.92 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.22 42.9 5.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.326 -0.859 . . . . 0.0 110.066 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -57.47 -179.82 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.466 ' CG ' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.06 35.11 0.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.108 -0.995 . . . . 0.0 110.749 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.554 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 2.1 pp -95.09 176.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 0.0 110.274 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -49.09 -177.69 0.01 OUTLIER Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.467 ' O ' HD21 ' A' ' 44' ' ' LEU . 5.6 t70 -79.79 -179.03 6.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -1.149 . . . . 0.0 109.615 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.467 HD21 ' O ' ' A' ' 43' ' ' ASP . 1.8 mm? -135.63 131.94 36.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.433 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 1.6 m-20 -86.8 -28.73 22.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.703 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 45' ' ' ASP . 3.7 mptt -152.68 157.03 40.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.54 -0.725 . . . . 0.0 109.808 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -123.88 43.19 3.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.955 . . . . 0.0 109.958 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 3.6 pttt -159.67 107.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.846 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.593 ' CD2' HD13 ' A' ' 63' ' ' LEU . 22.4 m-85 -103.84 142.2 34.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.75 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.16 95.67 6.48 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 55' ' ' LEU . 15.6 m -118.54 145.26 37.02 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.728 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.478 ' HD2' HD12 ' A' ' 55' ' ' LEU . 43.8 Cg_endo -70.19 147.59 60.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.0 1.526 . . . . 0.0 109.932 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.547 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.85 -16.04 56.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -0.805 . . . . 0.0 111.476 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -83.57 -13.7 53.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.961 -1.087 . . . . 0.0 111.192 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.526 HD21 ' CB ' ' A' ' 59' ' ' GLN . 4.3 mt -62.44 143.62 56.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.867 -1.145 . . . . 0.0 111.527 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 p -91.12 162.84 14.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.616 -0.678 . . . . 0.0 109.717 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 70.2 t -59.9 -23.71 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.99 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.3 -34.0 68.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.526 ' CB ' HD21 ' A' ' 55' ' ' LEU . 22.1 mm-40 -73.41 -46.98 45.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.097 -1.237 . . . . 0.0 109.827 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.65 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 19.8 t80 -60.87 -46.82 89.11 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.565 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.445 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -50.69 -21.73 1.74 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.916 -1.115 . . . . 0.0 109.913 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -80.66 -54.82 5.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.442 -0.786 . . . . 0.0 110.387 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.593 HD13 ' CD2' ' A' ' 49' ' ' TYR . 3.8 pp -60.11 -19.95 55.86 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.984 -1.072 . . . . 0.0 112.355 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.65 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -92.75 -38.88 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 120.094 -1.629 . . . . 0.0 109.165 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 64' ' ' ILE . 13.9 mtt180 -36.98 -61.37 0.56 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.775 -0.578 . . . . 0.0 110.698 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -65.21 -32.32 73.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.0 109.698 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 63' ' ' LEU . 4.5 mmp_? -68.04 -14.77 63.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.575 HD12 ' CE2' ' A' ' 109' ' ' TYR . 2.0 mm -100.23 10.21 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.176 -0.953 . . . . 0.0 109.676 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.464 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 52.67 32.83 12.59 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.433 -0.792 . . . . 0.0 110.238 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.526 HD22 ' CG2' ' A' ' 68' ' ' ILE . 4.3 pp -116.03 153.97 30.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.444 -0.785 . . . . 0.0 110.221 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 2.7 ptp180 -166.4 -173.56 2.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.265 -0.897 . . . . 0.0 110.919 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 71' ' ' ARG . . . 56.95 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.72 . . . . 0.0 111.065 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 74' ' ' ASP . 5.6 pt-20 -146.01 24.17 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.092 -1.005 . . . . 0.0 111.301 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -49.09 176.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.943 -1.098 . . . . 0.0 109.786 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -111.28 139.58 46.56 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.252 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 31.9 tp -164.76 153.68 12.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.774 . . . . 0.0 110.332 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 95.2 m-85 -157.66 120.75 3.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.57 -0.706 . . . . 0.0 110.032 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 15.7 m-30 -82.82 133.58 35.13 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.171 -0.956 . . . . 0.0 111.748 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.421 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 51.0 m-85 -120.65 119.38 32.66 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.571 HG12 ' CG ' ' A' ' 98' ' ' HIS . 2.5 t -120.67 128.41 76.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.382 -0.824 . . . . 0.0 109.915 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.533 ' CB ' ' ND1' ' A' ' 98' ' ' HIS . 4.4 t30 48.1 36.61 6.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.984 . . . . 0.0 109.921 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 12.8 m-20 66.69 38.65 3.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.468 -0.77 . . . . 0.0 110.438 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -135.66 166.95 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 110.024 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -155.19 67.7 5.18 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.635 -0.666 . . . . 0.0 109.304 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.468 ' HD3' HG12 ' A' ' 83' ' ' VAL . 49.9 Cg_endo -73.48 164.6 34.62 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.962 1.506 . . . . 0.0 110.808 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.64 -178.33 3.34 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.114 1.587 . . . . 0.0 110.387 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.47 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -84.35 21.42 1.44 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.413 -0.804 . . . . 0.0 110.887 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -96.99 43.15 1.07 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.346 -0.847 . . . . 0.0 109.451 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.03 -172.1 3.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.547 -0.72 . . . . 0.0 110.234 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 72.2 p -139.33 145.7 39.38 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.567 -0.708 . . . . 0.0 110.375 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.533 ' CE ' HG11 ' A' ' 31' ' ' VAL . 95.9 mmm -58.88 -45.03 91.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.165 -0.959 . . . . 0.0 109.649 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -48.11 -47.65 26.54 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 90' ' ' THR . 1.0 OUTLIER -64.46 -32.86 74.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.211 -1.17 . . . . 0.0 109.616 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.527 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -66.16 -22.23 66.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.905 . . . . 0.0 109.955 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.513 ' O ' ' HB3' ' A' ' 99' ' ' HIS . 1.2 t80 -49.22 -55.06 13.79 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.012 -1.055 . . . . 0.0 109.971 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.436 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 5.1 tp60 -69.47 -18.55 63.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.008 -1.058 . . . . 0.0 111.078 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 12.7 mm-40 -87.3 -68.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.007 -1.058 . . . . 0.0 112.363 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.571 ' CG ' HG12 ' A' ' 80' ' ' VAL . 8.8 m-70 -99.44 38.23 1.46 Allowed 'General case' 0 N--CA 1.484 1.257 0 O-C-N 120.833 -1.167 . . . . 0.0 111.947 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.513 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.8 p80 -56.61 -22.09 31.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.033 -1.042 . . . . 0.0 109.237 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.525 ' CG ' ' HB2' ' A' ' 106' ' ' TYR . 0.4 OUTLIER 46.46 -92.45 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.862 -0.524 . . . . 0.0 110.513 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.501 ' OE1' ' CE1' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -71.32 163.54 27.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.138 -0.977 . . . . 0.0 110.371 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -85.36 60.73 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 109.932 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.41 ' HD1' ' CE1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -179.38 -57.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.87 . . . . 0.0 109.915 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.467 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 4.6 m-85 -119.24 -178.37 3.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 109.776 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.598 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -109.58 165.68 11.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.064 -1.023 . . . . 0.0 109.502 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.525 ' HB2' ' CG ' ' A' ' 100' ' ' GLU . 1.9 m-85 -122.85 128.89 50.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.847 -1.158 . . . . 0.0 111.87 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.598 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 6.3 mt -140.02 128.57 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.343 -0.848 . . . . 0.0 110.016 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -123.7 172.83 8.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 109.75 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.2 p90 -149.92 163.07 39.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.822 -1.174 . . . . 0.0 111.35 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.45 179.47 7.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.741 -0.6 . . . . 0.0 110.688 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.544 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . 5.8 t70 -121.29 36.62 4.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.378 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -120.92 151.99 39.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.972 -1.08 . . . . 0.0 110.567 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.579 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 34.5 t -158.06 34.82 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.404 -0.81 . . . . 0.0 109.933 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 113' ' ' SER . 9.5 p -43.54 167.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.343 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -103.36 110.19 22.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -52.52 159.05 3.24 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.8 mt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.171 -1.194 . . . . 0.0 110.199 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.06 -48.86 64.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -1.137 . . . . 0.0 110.184 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -29.11 62.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.165 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 15.8 mm -71.89 -20.89 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 110.207 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -31.54 39.55 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.85 -1.156 . . . . 0.0 109.963 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -38.13 55.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.423 -0.798 . . . . 0.0 110.061 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.595 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -85.32 -29.87 24.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.226 -0.921 . . . . 0.0 110.855 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.595 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 46.1 m-85 -114.44 71.38 2.3 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.791 -1.193 . . . . 0.0 110.276 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 46.7 Cg_endo -73.26 -3.59 13.94 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.996 1.524 . . . . 0.0 110.269 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -107.55 -1.83 20.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' ' 28' ' ' ARG . 8.7 mpt_? -94.03 -167.83 1.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 110.149 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.521 ' CG1' HG13 ' A' ' 31' ' ' VAL . 24.0 t -145.55 105.78 4.32 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 47.7 Cg_endo -75.89 84.06 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.167 1.614 . . . . 0.0 109.818 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.8 m -80.54 149.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 111.114 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.566 HG13 ' CE1' ' A' ' 104' ' ' PHE . 6.8 mm -102.02 164.93 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.516 ' CG1' ' HA ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -136.09 141.81 40.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.779 -1.201 . . . . 0.0 111.545 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 1.8 tt0 -156.52 165.76 35.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.642 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -99.69 162.47 12.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.917 -1.115 . . . . 0.0 110.738 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.565 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.36 -172.66 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.464 -0.772 . . . . 0.0 109.292 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.8 Cg_endo -71.31 107.59 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.476 1.251 . . . . 0.0 110.033 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 mttt 63.52 36.39 11.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.453 -0.78 . . . . 0.0 110.196 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -58.68 178.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 110.061 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 35.53 0.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 110.58 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.546 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.54 176.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.006 -1.059 . . . . 0.0 110.432 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.546 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -48.73 -177.47 0.01 OUTLIER Glycine 0 N--CA 1.497 2.717 0 O-C-N 121.438 -0.789 . . . . 0.0 111.179 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.3 t0 -77.12 -175.74 3.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -1.091 . . . . 0.0 109.778 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -136.02 135.21 39.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.985 . . . . 0.0 110.738 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -86.89 -36.03 18.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 109.732 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.562 ' HE2' ' CE2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -152.59 155.29 37.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.474 -0.766 . . . . 0.0 109.837 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -120.31 43.23 2.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 0.0 110.226 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 47' ' ' LYS . 14.8 mttp -157.88 107.56 2.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 109.58 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.585 ' CD2' HD13 ' A' ' 63' ' ' LEU . 31.8 m-85 -103.39 143.34 32.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.114 -0.991 . . . . 0.0 110.884 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.455 HD21 HG22 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -103.61 89.89 3.49 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 20.2 m -111.04 143.45 28.36 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.347 -0.846 . . . . 0.0 111.002 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.485 ' HD2' HD12 ' A' ' 55' ' ' LEU . 46.5 Cg_endo -71.45 148.96 55.42 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.164 1.613 . . . . 0.0 109.74 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.534 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.55 -15.58 51.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.898 . . . . 0.0 111.438 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -83.34 -13.81 54.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.09 -1.006 . . . . 0.0 111.169 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.532 HD21 ' CB ' ' A' ' 59' ' ' GLN . 4.0 mt -62.3 143.63 56.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.829 -1.17 . . . . 0.0 111.129 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.471 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 1.6 p -91.3 167.67 12.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.593 -0.692 . . . . 0.0 109.891 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 80.8 t -62.75 -32.25 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 110.059 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.81 -23.38 70.82 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.532 ' CB ' HD21 ' A' ' 55' ' ' LEU . 34.7 mm-40 -80.4 -50.91 9.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.125 -1.221 . . . . 0.0 109.727 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 14.1 t80 -60.12 -34.06 72.99 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.084 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.565 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -54.8 -37.56 66.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.47 -0.769 . . . . 0.0 109.873 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.8 t80 -74.51 -50.69 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.537 -0.727 . . . . 0.0 112.525 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -58.58 -39.88 81.57 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.506 -1.371 . . . . 0.0 112.489 -177.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.631 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -75.1 -38.89 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 119.764 -1.835 . . . . 0.0 108.761 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.535 ' CD ' HD12 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -39.15 -58.39 1.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.551 -0.718 . . . . 0.0 110.42 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -65.32 -34.4 78.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.968 -1.083 . . . . 0.0 109.903 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.527 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 4.5 mmp_? -70.27 -9.22 55.33 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.258 -0.901 . . . . 0.0 109.835 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.577 HD11 ' CD2' ' A' ' 109' ' ' TYR . 67.1 mt -100.28 4.55 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.337 -0.852 . . . . 0.0 109.733 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.466 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 60.63 27.97 17.68 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.393 -0.817 . . . . 0.0 110.324 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.535 HD12 ' CD ' ' A' ' 65' ' ' ARG . 4.3 pp -114.99 156.33 25.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.639 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.06 -166.94 0.97 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 110.998 -179.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.45 -87.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.835 . . . . 0.0 110.986 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' ARG . 9.7 pt-20 -152.06 27.09 0.61 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 111.238 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -53.84 176.37 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.919 -1.113 . . . . 0.0 109.817 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -97.79 141.97 30.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.954 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.586 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 16.6 tp -162.19 152.55 16.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 110.997 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.2 m-85 -160.99 120.54 2.64 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.577 ' CZ ' HD22 ' A' ' 76' ' ' LEU . 77.9 m-85 -89.03 116.81 27.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 110.273 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 55.8 m-85 -108.31 125.87 52.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.399 -0.813 . . . . 0.0 109.507 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.62 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 1.9 t -121.34 129.92 75.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.324 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 82' ' ' ASN . 55.4 t30 51.05 37.84 18.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 110.361 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 58.2 t30 65.06 36.75 7.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 110.385 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.5 t -135.02 167.04 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.228 -0.92 . . . . 0.0 110.031 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.1 mp -155.05 73.07 5.72 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.585 -0.697 . . . . 0.0 109.556 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.55 164.37 35.12 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.994 1.523 . . . . 0.0 110.563 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.86 -178.38 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.138 1.599 . . . . 0.0 110.221 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.486 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -85.01 20.08 1.97 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 110.741 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.67 42.01 1.11 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.485 -0.76 . . . . 0.0 109.672 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.414 ' HB2' ' OE1' ' A' ' 93' ' ' GLN . . . -145.28 -174.85 4.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.503 -0.748 . . . . 0.0 110.144 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 43.6 p -139.68 146.68 39.96 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.501 -0.75 . . . . 0.0 110.386 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.534 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 24.3 mmm -53.56 -42.45 67.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.662 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.534 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.52 -46.71 37.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.1 OUTLIER -65.35 -33.05 75.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -1.209 . . . . 0.0 109.827 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.534 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.11 -19.79 64.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.936 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.58 ' O ' ' HB3' ' A' ' 99' ' ' HIS . 0.6 OUTLIER -49.55 -56.42 9.95 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.005 -1.059 . . . . 0.0 109.632 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -70.15 -15.23 62.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.461 -1.4 . . . . 0.0 111.243 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 2.2 mm-40 -87.44 -64.74 1.1 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.969 -1.082 . . . . 0.0 112.925 -178.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.62 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -97.97 39.69 1.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.875 -1.14 . . . . 0.0 111.445 -177.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.582 ' CE1' ' O ' ' A' ' 100' ' ' GLU . 1.6 t60 -156.79 173.89 16.3 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.582 ' O ' ' CE1' ' A' ' 99' ' ' HIS . 1.4 pt-20 -164.26 -128.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.033 -1.042 . . . . 0.0 110.549 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 102' ' ' ASP . 12.7 mm-40 -90.76 -18.33 25.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.728 -1.232 . . . . 0.0 110.787 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 103' ' ' PHE . 22.8 m-20 -41.28 -72.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -0.901 . . . . 0.0 110.329 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER 176.21 -52.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.251 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.566 ' CE1' HG13 ' A' ' 32' ' ' ILE . 3.1 p90 -127.14 -173.03 2.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 110.304 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.591 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.28 168.11 9.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.19 -0.944 . . . . 0.0 109.113 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.506 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 1.1 p90 -124.64 127.28 47.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.785 -1.197 . . . . 0.0 111.854 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.591 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 6.7 mt -136.73 144.56 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.078 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -133.55 175.65 9.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.949 . . . . 0.0 110.018 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.9 OUTLIER -147.42 167.6 23.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.972 . . . . 0.0 110.478 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -158.58 165.21 35.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.723 . . . . 0.0 110.285 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 4.3 p-10 -88.96 -8.88 53.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 110.312 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 14.9 pt-20 -178.3 159.06 1.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 0.0 110.486 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.7 t -154.63 31.92 0.41 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.416 -0.803 . . . . 0.0 110.106 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 115' ' ' TYR . 9.9 p -112.14 177.11 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.377 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 114' ' ' VAL . 17.2 t80 -44.29 131.14 6.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.99 -151.74 7.58 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.238 -1.154 . . . . 0.0 110.116 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -59.03 -49.66 77.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.311 -1.111 . . . . 0.0 109.935 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -77.54 -18.67 56.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.67 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -72.2 -24.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.984 -1.073 . . . . 0.0 110.123 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 5.1 mmm180 -93.34 -49.21 6.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.099 -1.001 . . . . 0.0 110.036 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -54.13 -36.98 63.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.063 -1.023 . . . . 0.0 109.111 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 20' ' ' LYS . 4.7 mmtp -86.35 -49.97 7.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.393 -0.817 . . . . 0.0 109.435 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.481 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 13.0 m-85 -114.32 61.57 1.12 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.46 -0.775 . . . . 0.0 110.393 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 42.9 Cg_endo -69.04 -31.16 24.34 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.865 1.455 . . . . 0.0 110.605 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.412 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 1.8 t0 -103.89 21.9 15.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.051 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.514 ' N ' ' HD2' ' A' ' 28' ' ' ARG . 3.2 mpt_? -99.03 -165.52 1.25 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 110.418 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.472 HG13 ' CG1' ' A' ' 31' ' ' VAL . 9.2 t -143.53 104.45 5.01 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 110.295 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.576 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.7 Cg_endo -78.71 87.84 1.51 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.159 1.61 . . . . 0.0 109.928 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.2 m -83.42 144.02 10.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.136 -0.977 . . . . 0.0 110.882 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 31.5 mm -97.5 162.52 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 2.4 t -136.69 139.6 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.912 -1.117 . . . . 0.0 111.221 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 1.3 tm-20 -154.03 163.87 39.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -99.97 158.68 15.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.885 -1.135 . . . . 0.0 110.909 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.558 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.92 -173.55 0.11 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.562 -0.711 . . . . 0.0 109.185 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 44.0 Cg_endo -72.0 109.1 2.61 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.507 1.267 . . . . 0.0 110.112 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 62.15 42.86 9.21 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.367 -0.833 . . . . 0.0 110.293 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -63.99 179.92 0.48 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.517 ' CG ' ' OD1' ' A' ' 111' ' ' ASP . 0.9 OUTLIER -149.84 30.74 0.72 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.163 -0.961 . . . . 0.0 110.821 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.511 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -85.18 -179.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.048 -1.033 . . . . 0.0 109.924 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.493 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -59.81 168.03 8.26 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -87.35 171.64 10.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -1.11 . . . . 0.0 110.34 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.531 HD22 ' CD ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -136.51 146.28 46.06 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.351 -0.843 . . . . 0.0 110.105 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.463 ' N ' HD21 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -86.95 -7.49 58.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.854 . . . . 0.0 110.182 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.469 ' O ' HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -154.12 155.66 35.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.004 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -126.44 45.18 2.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.003 . . . . 0.0 109.716 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.62 111.77 2.35 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.467 -0.77 . . . . 0.0 109.879 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.576 ' CD2' HD13 ' A' ' 63' ' ' LEU . 11.6 m-85 -104.91 142.37 34.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -0.979 . . . . 0.0 110.127 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.49 100.62 8.65 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.509 -0.745 . . . . 0.0 109.136 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.493 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 3.5 m -126.94 159.6 63.66 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.142 -0.974 . . . . 0.0 110.763 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.456 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 46.2 Cg_endo -71.43 147.86 53.29 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.194 1.629 . . . . 0.0 110.594 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.536 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -64.77 -14.59 59.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 111.533 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -83.52 -10.92 58.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.883 -1.136 . . . . 0.0 110.764 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.525 HD23 ' CB ' ' A' ' 59' ' ' GLN . 4.5 mt -62.56 143.38 57.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.083 -1.011 . . . . 0.0 111.038 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 p -90.63 158.27 17.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.49 -0.756 . . . . 0.0 109.199 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.515 HG12 ' CG2' ' A' ' 87' ' ' THR . 61.1 t -57.09 -23.01 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.091 -1.005 . . . . 0.0 110.032 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.98 -33.67 59.49 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.525 ' CB ' HD23 ' A' ' 55' ' ' LEU . 24.3 mm-40 -72.27 -50.61 25.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.151 -1.205 . . . . 0.0 109.759 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.666 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 47.2 t80 -60.56 -32.02 71.11 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.273 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.664 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -63.41 -29.28 70.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.033 -1.042 . . . . 0.0 109.498 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.489 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.3 t80 -69.85 -53.36 18.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 110.126 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.584 HD11 ' CE1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -59.87 -33.59 72.01 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.426 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.666 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -75.13 -33.4 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 119.777 -1.827 . . . . 0.0 109.701 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -38.29 -63.89 0.46 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 0.0 110.721 -179.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -30.62 71.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 110.132 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.531 ' CD ' HD22 ' A' ' 44' ' ' LEU . 20.2 mmt180 -66.15 -20.29 66.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.202 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.593 HD12 ' CD2' ' A' ' 109' ' ' TYR . 68.8 mt -104.2 15.7 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.977 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.493 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 49.68 28.37 2.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.411 -0.806 . . . . 0.0 110.241 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.532 HD21 ' CG2' ' A' ' 68' ' ' ILE . 3.8 pp -110.11 160.48 16.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.428 -0.795 . . . . 0.0 109.519 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.4 ptt180 -165.25 -171.9 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.046 -1.034 . . . . 0.0 110.822 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 52.08 -89.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.487 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 72' ' ' ALA . 33.1 mt-10 -157.11 29.29 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.951 . . . . 0.0 110.703 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.39 176.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.117 -0.99 . . . . 0.0 109.846 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.518 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -87.45 137.71 32.1 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 121.382 0.61 . . . . 0.0 110.367 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.594 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 49.3 tp -164.83 152.78 11.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.787 . . . . 0.0 110.426 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.594 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 89.8 m-85 -158.77 118.47 3.13 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.556 -0.715 . . . . 0.0 110.021 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.664 ' CD2' ' CE2' ' A' ' 61' ' ' TYR . 19.3 m-30 -84.96 132.67 34.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.0 -1.062 . . . . 0.0 111.054 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 59.5 m-85 -117.63 119.79 36.04 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.421 -0.799 . . . . 0.0 109.138 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.584 HG11 ' CG ' ' A' ' 98' ' ' HIS . 2.8 t -120.96 123.47 70.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.592 -0.693 . . . . 0.0 110.198 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.461 ' HB2' ' ND1' ' A' ' 98' ' ' HIS . 1.6 m120 49.54 42.04 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 3.7 m120 62.5 35.72 14.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.351 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.588 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -135.2 167.39 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.1 mp -155.0 68.53 5.48 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 109.454 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.411 ' HD3' HG12 ' A' ' 83' ' ' VAL . 46.8 Cg_endo -73.74 163.07 38.13 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.982 1.517 . . . . 0.0 110.891 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.4 -178.26 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.146 1.603 . . . . 0.0 110.419 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.515 ' CG2' HG12 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -84.75 22.18 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.389 -0.819 . . . . 0.0 110.864 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -94.27 41.23 1.09 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 109.65 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.446 ' HB2' ' OE1' ' A' ' 93' ' ' GLN . . . -145.45 -172.48 3.89 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.598 0.713 . . . . 0.0 110.288 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 63.5 p -139.79 140.74 36.73 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.674 -0.641 . . . . 0.0 110.159 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.557 ' HE2' ' CD1' ' A' ' 60' ' ' PHE . 9.3 mmm -49.18 -41.87 38.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.163 -0.961 . . . . 0.0 110.261 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.81 -47.65 52.71 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.2 OUTLIER -64.86 -30.87 71.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -1.097 . . . . 0.0 109.94 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.3 -24.51 64.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 110.031 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.576 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -49.46 -56.13 10.81 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 109.764 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -69.85 -17.8 63.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.003 -1.06 . . . . 0.0 111.124 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.3 mm-40 -87.53 -68.24 0.77 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.973 -1.08 . . . . 0.0 112.363 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.584 ' CG ' HG11 ' A' ' 80' ' ' VAL . 10.6 m-70 -99.38 38.65 1.39 Allowed 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.871 -1.143 . . . . 0.0 111.937 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.536 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.4 p80 -59.18 -19.85 48.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.136 -0.978 . . . . 0.0 109.41 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.534 ' CG ' ' HB3' ' A' ' 106' ' ' TYR . 1.9 tm-20 72.02 -79.97 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.113 0.482 . . . . 0.0 110.34 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 102' ' ' ASP . 1.1 mt-10 -121.76 -63.95 1.26 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 110.093 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER 172.47 157.65 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.251 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 2.7 t80 78.26 -20.93 0.36 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.715 -0.616 . . . . 0.0 111.439 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.473 ' CD2' ' HB3' ' A' ' 103' ' ' PHE . 7.0 p90 -166.77 171.43 11.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.767 -1.208 . . . . 0.0 110.438 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.534 ' CD1' HG13 ' A' ' 107' ' ' ILE . 0.3 OUTLIER -111.77 169.55 8.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.313 -0.867 . . . . 0.0 109.693 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.534 ' HB3' ' CG ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -126.56 126.19 43.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.731 -1.23 . . . . 0.0 110.986 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.534 HG12 ' CG2' ' A' ' 80' ' ' VAL . 11.7 mt -141.25 147.98 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.306 -0.872 . . . . 0.0 109.64 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 34' ' ' GLU . . . -142.5 -179.92 6.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.111 -0.993 . . . . 0.0 110.286 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.593 ' CD2' HD12 ' A' ' 68' ' ' ILE . 1.6 p90 -150.02 162.71 39.86 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.645 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -159.39 168.44 26.3 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.566 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.517 ' OD1' ' CG ' ' A' ' 40' ' ' ARG . 16.9 p-10 -127.05 28.78 5.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.074 -1.016 . . . . 0.0 110.187 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 111' ' ' ASP . 1.9 mt-10 59.67 145.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.91 . . . . 0.0 110.159 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.6 t -108.71 12.86 25.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 110.062 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.99 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.246 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -159.41 0.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.48 -158.36 39.45 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.264 -1.139 . . . . 0.0 110.213 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -23.04 62.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -1.184 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.511 ' NZ ' ' HG3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -73.94 -28.74 61.65 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.461 ' N ' HD11 ' A' ' 21' ' ' ILE . 1.2 mp -59.84 -19.32 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 109.95 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 13.8 mmt85 -90.13 -48.24 7.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.146 -0.972 . . . . 0.0 110.026 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HG3' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.53 -42.94 45.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.117 -0.989 . . . . 0.0 109.072 179.154 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 18.0 mttp -85.68 -48.92 8.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.791 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 10.8 m-85 -114.73 64.19 1.52 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 44.9 Cg_endo -70.48 -20.91 30.86 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.836 1.44 . . . . 0.0 110.666 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.432 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 38.1 t70 -111.42 22.11 15.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.964 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 3.2 mpt_? -103.6 -168.08 1.46 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.517 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.517 HG13 ' CG1' ' A' ' 31' ' ' VAL . 21.6 t -145.94 110.64 4.42 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 109.963 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.585 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 47.0 Cg_endo -73.44 87.9 1.05 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 124.175 1.619 . . . . 0.0 109.949 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.4 m -88.12 144.1 9.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.33 -0.856 . . . . 0.0 111.411 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 16.2 mm -108.98 135.8 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 0.4 OUTLIER -120.25 140.89 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.737 -1.227 . . . . 0.0 112.142 -178.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 35' ' ' LYS . 20.6 tp10 -145.6 172.49 13.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.655 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -97.44 161.49 13.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.814 -1.179 . . . . 0.0 110.802 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.562 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -65.09 -173.22 0.1 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.488 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 44.4 Cg_endo -72.55 112.09 3.39 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.547 1.288 . . . . 0.0 109.827 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 59.67 43.04 16.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.888 . . . . 0.0 110.178 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.417 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -66.05 179.36 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.31 -0.869 . . . . 0.0 110.166 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.455 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.3 34.24 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.948 . . . . 0.0 110.785 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.555 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.89 177.51 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.012 -1.055 . . . . 0.0 110.418 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -52.23 -174.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.832 0 O-C-N 121.266 -0.896 . . . . 0.0 111.273 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 0.5 OUTLIER -81.67 -175.8 5.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -1.078 . . . . 0.0 110.107 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.521 ' CD2' HD13 ' A' ' 68' ' ' ILE . 1.2 mm? -140.17 135.33 32.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.942 . . . . 0.0 110.775 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 46' ' ' LYS . 2.9 p30 -86.39 -27.35 24.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.497 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.508 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -153.2 155.65 37.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.84 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -124.4 42.98 3.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.021 -1.05 . . . . 0.0 110.042 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -159.46 109.36 1.91 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.446 -0.784 . . . . 0.0 109.78 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.572 ' CD2' HD12 ' A' ' 63' ' ' LEU . 29.9 m-85 -106.44 141.72 37.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.046 -1.033 . . . . 0.0 110.823 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mp -107.06 93.99 4.86 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.484 ' HB ' HD13 ' A' ' 55' ' ' LEU . 35.0 m -113.18 152.45 45.09 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.933 . . . . 0.0 111.314 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HD2' HD13 ' A' ' 55' ' ' LEU . 44.6 Cg_endo -70.49 145.52 53.12 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.317 1.693 . . . . 0.0 109.625 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.538 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 1.7 m -62.9 -11.87 21.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.349 -0.845 . . . . 0.0 111.451 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -85.5 -14.54 45.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 0.0 111.104 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD21 ' CB ' ' A' ' 59' ' ' GLN . 3.9 mt -62.21 142.43 57.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.028 -1.045 . . . . 0.0 111.372 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.7 p -91.09 162.65 14.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.744 -0.597 . . . . 0.0 109.788 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.453 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 91.4 t -58.44 -25.67 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.093 -1.004 . . . . 0.0 109.963 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.93 94.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.518 ' CB ' HD21 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -67.69 -48.0 67.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -1.197 . . . . 0.0 109.877 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CD1' ' CD1' ' A' ' 63' ' ' LEU . 8.0 t80 -60.23 -32.46 71.15 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.068 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.469 ' CD1' ' HE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -55.36 -36.6 66.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 110.085 178.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.72 -49.98 12.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.437 -0.79 . . . . 0.0 112.691 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.633 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.43 -40.33 82.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.51 -1.368 . . . . 0.0 111.975 -177.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.618 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -75.22 -42.53 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 119.907 -1.746 . . . . 0.0 108.278 178.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -39.84 -54.89 2.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.628 -0.67 . . . . 0.0 110.53 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -64.33 -35.89 82.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.138 -0.976 . . . . 0.0 109.937 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.524 ' CG ' ' OH ' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -69.68 -14.39 62.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.187 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.581 HD11 ' CE2' ' A' ' 109' ' ' TYR . 2.3 mm -93.2 4.27 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.494 -0.754 . . . . 0.0 109.721 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.1 t60 53.43 33.71 16.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 110.484 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.504 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -104.96 156.56 17.92 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' A' ' 73' ' ' GLU . 12.9 ptt180 -165.83 -168.2 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.832 -1.168 . . . . 0.0 111.247 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.35 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 110.963 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 74' ' ' ASP . 5.2 pt-20 -152.16 24.01 0.64 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.146 -0.971 . . . . 0.0 111.106 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.29 177.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 109.85 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.1 141.14 37.18 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.112 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.589 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 26.2 tp -154.83 153.11 30.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.469 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 95.4 m-85 -158.43 121.16 3.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.622 -0.674 . . . . 0.0 109.79 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.514 ' CZ ' HD21 ' A' ' 76' ' ' LEU . 72.3 m-85 -92.26 123.01 35.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 110.488 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 52.0 m-85 -115.45 136.76 52.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.594 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.582 HG13 ' CD2' ' A' ' 98' ' ' HIS . 12.6 t -119.87 121.81 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.0 110.456 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.568 ' HB2' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER 49.31 48.58 20.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.418 -0.801 . . . . 0.0 110.656 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.424 ' C ' HG22 ' A' ' 83' ' ' VAL . 2.7 t-20 62.28 29.37 17.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 110.557 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.8 t -126.16 168.59 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.966 . . . . 0.0 109.675 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -154.63 68.19 5.62 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.472 -0.767 . . . . 0.0 109.747 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD3' HG13 ' A' ' 83' ' ' VAL . 47.3 Cg_endo -74.2 168.1 25.6 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.011 1.532 . . . . 0.0 110.341 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.96 -179.78 4.61 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.052 1.554 . . . . 0.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.453 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -86.91 20.59 2.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.335 -0.853 . . . . 0.0 110.534 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -90.99 39.34 0.99 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.437 -0.789 . . . . 0.0 109.402 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.473 ' CB ' ' OE1' ' A' ' 93' ' ' GLN . . . -145.43 -177.29 5.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.571 -0.705 . . . . 0.0 110.088 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.488 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 81.2 p -140.07 144.38 36.81 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.465 -0.772 . . . . 0.0 110.395 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.524 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 39.8 mmm -43.88 -39.02 3.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.513 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.538 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -55.71 -48.27 72.71 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.3 OUTLIER -64.26 -30.51 71.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -1.175 . . . . 0.0 109.87 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.26 -27.37 66.28 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.232 -0.917 . . . . 0.0 109.813 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.585 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -50.28 -54.71 19.34 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.981 -1.074 . . . . 0.0 109.566 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -68.15 -20.68 64.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.815 -1.178 . . . . 0.0 110.51 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 10.1 mt-10 -88.22 -73.69 0.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.182 -0.948 . . . . 0.0 112.468 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.582 ' CD2' HG13 ' A' ' 80' ' ' VAL . 22.2 m-70 -100.69 37.2 1.76 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.786 -1.196 . . . . 0.0 112.361 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.536 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 1.0 OUTLIER -57.14 -23.65 48.81 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.035 -1.041 . . . . 0.0 109.748 179.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' A' ' 99' ' ' HIS . 0.1 OUTLIER 73.63 -1.87 2.93 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.491 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 58.8 73.46 0.48 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 101' ' ' GLU . 2.6 t0 178.75 31.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 0.0 110.203 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.579 ' O ' ' CD1' ' A' ' 103' ' ' PHE . 3.1 t80 55.61 32.51 19.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.882 . . . . 0.0 110.16 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 103' ' ' PHE . 7.4 m-85 -170.34 127.8 0.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 109.78 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.542 ' CD2' ' CG1' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -84.87 159.76 20.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.746 -1.221 . . . . 0.0 109.486 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.532 ' CD1' ' OE2' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -115.64 120.62 39.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.851 -1.155 . . . . 0.0 111.655 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.541 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 15.6 mt -141.44 140.72 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 109.241 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.43 177.61 7.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.137 -0.977 . . . . 0.0 110.136 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.655 ' CE2' ' CD ' ' A' ' 35' ' ' LYS . 1.4 p90 -144.86 165.12 29.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 110.648 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -158.14 178.67 9.94 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.271 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.455 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 27.9 p-10 -126.5 24.91 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 110.266 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 111' ' ' ASP . 0.6 OUTLIER 58.32 155.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.288 -0.883 . . . . 0.0 110.193 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -104.22 -7.66 19.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 110.226 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.417 HG11 ' OE2' ' A' ' 112' ' ' GLU . 9.8 p -105.88 169.81 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -111.72 151.87 28.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.24 176.5 37.79 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.195 -1.179 . . . . 0.0 110.215 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -39.68 88.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -1.15 . . . . 0.0 109.876 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HD3' HD11 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -73.18 -19.73 61.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.382 -0.824 . . . . 0.0 110.065 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 15.8 mm -72.31 -28.24 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.221 -0.924 . . . . 0.0 110.303 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -79.46 -18.72 51.49 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.75 -1.219 . . . . 0.0 109.746 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -34.43 15.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.458 -0.776 . . . . 0.0 109.159 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.606 ' CE ' ' CZ ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -85.54 -27.31 25.65 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.606 ' CZ ' ' CE ' ' A' ' 24' ' ' LYS . 50.1 m-85 -110.85 57.25 0.36 Allowed Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.02 -1.05 . . . . 0.0 110.851 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.451 ' CD ' ' C ' ' A' ' 24' ' ' LYS . 43.9 Cg_endo -68.91 -34.85 16.65 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.486 1.256 . . . . 0.0 110.783 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -96.6 14.12 25.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 110.684 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 1.4 mpt_? -111.9 -173.0 2.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.053 -1.029 . . . . 0.0 110.316 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.527 HG12 ' CG1' ' A' ' 31' ' ' VAL . 24.6 t -147.2 108.48 3.92 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 110.512 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.585 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 50.5 Cg_endo -78.87 81.59 2.74 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.363 1.717 . . . . 0.0 110.108 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.543 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.7 m -77.52 141.41 15.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.187 -0.946 . . . . 0.0 111.119 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.547 HG21 ' CE1' ' A' ' 106' ' ' TYR . 46.8 mm -97.44 155.72 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 47' ' ' LYS . 2.7 t -133.86 141.77 43.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.933 -1.104 . . . . 0.0 111.298 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.64 -179.24 8.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.525 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -115.83 159.77 21.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.857 -1.152 . . . . 0.0 110.295 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.558 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -61.3 -174.94 0.08 OUTLIER Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.54 -0.725 . . . . 0.0 109.248 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.6 Cg_endo -70.86 108.66 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.52 1.274 . . . . 0.0 109.842 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.4 38.55 9.98 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.352 -0.842 . . . . 0.0 110.012 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.525 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -56.22 179.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.26 -0.9 . . . . 0.0 110.125 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.14 32.18 0.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 110.611 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.555 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.93 176.38 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 110.208 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -50.18 -175.19 0.01 OUTLIER Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.315 -0.866 . . . . 0.0 110.997 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.491 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.3 t0 -77.0 -175.53 3.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -1.134 . . . . 0.0 109.889 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 43' ' ' ASP . 1.4 mm? -137.19 135.56 37.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.06 -1.025 . . . . 0.0 110.494 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.444 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -86.28 -34.63 20.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.723 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -153.87 159.85 41.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.752 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -124.0 40.0 3.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.054 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 47' ' ' LYS . 23.9 mttt -158.69 106.17 1.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.546 -0.721 . . . . 0.0 109.66 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.589 ' CD2' HD11 ' A' ' 63' ' ' LEU . 30.3 m-85 -104.86 139.62 39.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.87 -1.144 . . . . 0.0 110.25 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.52 99.35 8.13 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.475 ' HB ' HD13 ' A' ' 55' ' ' LEU . 4.2 m -126.18 163.65 38.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.128 -0.983 . . . . 0.0 111.157 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 45.4 Cg_endo -71.05 144.09 46.29 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.142 1.601 . . . . 0.0 110.389 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.527 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -63.86 -13.43 44.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.41 -0.806 . . . . 0.0 111.375 -179.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -83.59 -10.2 58.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.989 -1.07 . . . . 0.0 110.884 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.475 HD13 ' HB ' ' A' ' 51' ' ' VAL . 4.0 mt -62.3 141.75 58.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.995 -1.066 . . . . 0.0 111.335 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.441 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 1.4 p -91.24 157.95 16.87 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.628 -0.67 . . . . 0.0 109.217 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.515 ' CG1' HG23 ' A' ' 87' ' ' THR . 53.0 t -55.26 -24.05 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.06 -1.025 . . . . 0.0 110.06 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.2 87.72 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.452 ' HB2' HD21 ' A' ' 55' ' ' LEU . 1.4 mt-30 -67.73 -44.2 78.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.179 -1.189 . . . . 0.0 110.122 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.644 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 17.4 t80 -60.65 -46.4 90.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.038 -1.039 . . . . 0.0 109.568 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.78 -21.76 1.81 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.948 -1.095 . . . . 0.0 109.902 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.3 -54.57 5.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.394 -0.816 . . . . 0.0 110.597 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.589 HD11 ' CD2' ' A' ' 49' ' ' TYR . 3.8 pp -59.78 -21.85 61.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.945 -1.097 . . . . 0.0 112.169 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.644 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 2.1 mt -92.77 -35.19 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.191 -1.568 . . . . 0.0 109.219 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.472 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 2.8 mtp85 -35.94 -63.71 0.35 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.853 -0.529 . . . . 0.0 110.855 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -31.15 72.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.043 -1.035 . . . . 0.0 109.88 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.462 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 19.7 mmt180 -67.24 -16.32 64.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 110.009 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.612 ' CD1' ' CE2' ' A' ' 109' ' ' TYR . 1.3 mm -101.1 12.86 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.959 . . . . 0.0 109.708 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.455 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 50.42 30.81 4.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.462 -0.774 . . . . 0.0 110.369 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 4.2 pp -110.35 155.59 21.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 0.0 109.695 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.72 -172.42 2.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.116 -0.99 . . . . 0.0 111.014 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.56 -89.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 110.775 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 71' ' ' ARG . 5.6 pt-20 -150.34 35.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 110.872 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -58.38 177.23 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.14 -0.975 . . . . 0.0 109.966 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.522 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -107.1 138.3 43.54 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.378 0.609 . . . . 0.0 110.34 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.59 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 15.2 tp -164.7 152.66 11.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 0.0 110.249 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 83.8 m-85 -157.79 121.83 4.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.644 -0.66 . . . . 0.0 109.972 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.499 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 16.9 m-30 -82.59 122.67 28.39 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.16 -0.962 . . . . 0.0 111.57 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 69.8 m-85 -113.57 120.37 40.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.583 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 2.4 t -121.06 128.38 76.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.4 -0.812 . . . . 0.0 109.998 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.476 ' HB2' ' ND1' ' A' ' 98' ' ' HIS . 3.3 t30 49.75 42.32 23.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 0.0 110.229 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 2.9 m-20 60.39 36.56 20.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.467 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.582 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -134.87 166.03 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 109.987 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -155.26 72.89 5.61 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 109.542 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.72 163.79 37.44 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.032 1.543 . . . . 0.0 110.792 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.47 -178.57 3.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.08 1.569 . . . . 0.0 110.357 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.515 HG23 ' CG1' ' A' ' 57' ' ' VAL . 1.1 p -85.92 19.52 2.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.857 . . . . 0.0 110.774 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.0 m -96.75 42.43 1.09 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.525 -0.734 . . . . 0.0 109.621 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.34 -172.46 3.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.491 -0.756 . . . . 0.0 110.319 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 77.2 p -139.42 140.64 37.41 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.477 0.656 . . . . 0.0 110.158 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.558 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 59.7 mtm -52.51 -38.72 60.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 109.938 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -50.51 -49.54 39.0 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 90' ' ' THR . 4.0 pt20 -64.68 -28.92 69.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -1.163 . . . . 0.0 109.664 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.558 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.17 -23.63 64.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 110.132 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.585 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -49.05 -54.29 16.53 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.707 -1.246 . . . . 0.0 109.755 -179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.35 -18.96 63.07 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.21 -0.931 . . . . 0.0 111.25 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.45 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.7 mt-10 -86.34 -65.03 1.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.91 -1.119 . . . . 0.0 112.288 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.583 ' CD2' ' HB ' ' A' ' 80' ' ' VAL . 16.6 m-70 -98.02 38.06 1.35 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.929 -1.107 . . . . 0.0 111.254 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -61.28 175.2 0.58 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.494 -0.754 . . . . 0.0 109.437 178.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.526 ' CG ' ' N ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER -136.34 -93.65 0.25 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.569 -1.332 . . . . 0.0 110.427 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.526 ' N ' ' CG ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -106.81 59.33 0.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.982 -1.073 . . . . 0.0 110.418 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER 41.21 65.86 0.76 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.314 -0.866 . . . . 0.0 109.952 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.77 -64.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 110.0 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 4.6 m-85 -126.12 165.61 18.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 110.068 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.603 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -104.91 168.94 8.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.229 -0.919 . . . . 0.0 109.199 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.547 ' CE1' HG21 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -119.23 128.26 54.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.615 -1.303 . . . . 0.0 111.778 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.603 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 6.2 mt -139.2 129.33 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.19 -0.944 . . . . 0.0 110.483 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -128.55 152.3 48.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.154 -0.966 . . . . 0.0 108.778 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.612 ' CE2' ' CD1' ' A' ' 68' ' ' ILE . 2.3 p90 -131.4 167.09 19.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.55 -1.344 . . . . 0.0 111.647 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -153.88 -179.79 8.17 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.101 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 112' ' ' GLU . 7.1 p-10 -111.99 32.1 5.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.165 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 111' ' ' ASP . 8.4 mm-40 -148.82 134.69 18.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 0.0 110.118 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 92.6 p -123.41 21.52 9.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 110.265 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.26 173.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.189 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -128.84 50.91 2.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.349 -0.844 . . . . 0.0 110.148 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -130.62 -151.9 7.24 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.197 -1.178 . . . . 0.0 110.246 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.26 -22.52 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.196 -1.179 . . . . 0.0 109.887 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 2.0 mmtm -77.19 -41.66 40.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.415 -0.803 . . . . 0.0 109.931 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.5 mm -63.84 -16.19 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -0.946 . . . . 0.0 110.06 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.488 ' NH1' ' HG2' ' A' ' 22' ' ' ARG . 3.0 mmt-85 -90.35 -35.76 15.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 110.02 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -36.87 84.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -85.25 -48.41 9.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.483 -0.761 . . . . 0.0 109.501 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 28.3 m-85 -112.56 59.44 0.59 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.278 -0.889 . . . . 0.0 110.526 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 43.8 Cg_endo -68.86 -32.45 22.63 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.797 1.42 . . . . 0.0 110.369 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -102.95 20.56 17.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.34 -0.85 . . . . 0.0 110.088 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 1.9 mpp_? -122.44 -176.14 3.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.106 -0.996 . . . . 0.0 110.492 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 HG13 ' A' ' 31' ' ' VAL . 12.3 t -147.76 114.05 4.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.385 -0.822 . . . . 0.0 110.081 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.587 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 51.3 Cg_endo -78.1 87.08 1.56 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 124.166 1.614 . . . . 0.0 110.055 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.6 m -83.17 151.72 3.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.171 -0.955 . . . . 0.0 110.892 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 30.8 mm -105.96 160.41 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 108.714 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.579 HG22 ' CD1' ' A' ' 49' ' ' TYR . 2.5 t -134.2 141.05 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.801 -1.187 . . . . 0.0 111.404 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.405 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 7.0 tt0 -156.23 175.38 14.06 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.605 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -103.7 160.39 14.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.931 -1.106 . . . . 0.0 110.528 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.565 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -62.7 -174.47 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.781 . . . . 0.0 109.095 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.7 Cg_endo -70.52 103.7 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.418 1.22 . . . . 0.0 110.025 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 5.7 mttt 63.61 40.16 8.23 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.859 . . . . 0.0 110.076 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.99 179.49 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.201 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HG2' ' OD2' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -150.22 35.45 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.0 110.532 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.469 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -84.74 179.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.991 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 68' ' ' ILE . . . -57.26 -179.75 0.69 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -167.53 0.19 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.382 -1.069 . . . . 0.0 110.271 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -141.35 147.51 38.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 110.729 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' OD1' ' HE3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -87.32 -42.84 12.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.154 -0.966 . . . . 0.0 110.324 -179.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -152.15 159.57 43.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.755 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -116.99 39.85 3.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.113 -0.992 . . . . 0.0 110.463 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 9.7 pttt -162.01 107.34 1.25 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.289 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.581 ' CD2' HD12 ' A' ' 63' ' ' LEU . 11.4 m-85 -108.01 142.43 38.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -0.991 . . . . 0.0 110.125 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mp -116.0 103.22 10.37 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 3.0 m -129.78 162.75 51.53 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 111.098 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 43.5 Cg_endo -68.26 146.47 69.61 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.167 1.614 . . . . 0.0 110.451 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.528 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -63.65 -11.1 22.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 111.598 -178.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.68 -7.91 59.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.902 -1.124 . . . . 0.0 110.675 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.537 ' CD1' ' HB ' ' A' ' 51' ' ' VAL . 4.1 mt -62.43 141.39 58.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.127 -0.983 . . . . 0.0 111.157 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -91.17 158.52 16.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.671 -0.643 . . . . 0.0 109.48 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 79.4 t -57.29 -24.27 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.101 -0.999 . . . . 0.0 109.693 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.56 -34.8 67.61 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.524 ' CB ' HD23 ' A' ' 55' ' ' LEU . 17.8 mm-40 -67.89 -50.72 54.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -1.134 . . . . 0.0 109.336 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.652 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 6.2 t80 -60.21 -35.32 75.15 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.153 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.571 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -53.29 -34.8 58.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 110.028 178.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -51.12 9.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.358 -0.839 . . . . 0.0 112.705 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.636 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.37 -39.19 78.94 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.489 -1.382 . . . . 0.0 112.077 -177.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.652 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -77.49 -41.73 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 119.862 -1.774 . . . . 0.0 108.323 178.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.494 ' CG ' ' CD2' ' A' ' 76' ' ' LEU . 9.2 mtp180 -43.25 -52.27 5.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.413 -0.805 . . . . 0.0 109.983 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -35.73 81.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.538 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 8.9 mmt85 -70.29 -15.81 62.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.575 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.57 HD11 ' CD2' ' A' ' 109' ' ' TYR . 30.6 mt -89.39 -1.17 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.4 -0.813 . . . . 0.0 109.352 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 69' ' ' HIS . 18.1 t60 56.33 31.11 18.01 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.412 -0.805 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.553 ' CD1' ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -96.9 153.04 18.13 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.983 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.5 ptp180 -166.94 -168.71 1.15 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.015 -1.053 . . . . 0.0 110.872 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 53.74 -87.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.835 . . . . 0.0 110.855 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 71' ' ' ARG . 35.4 mt-10 -153.93 33.25 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.659 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.526 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -61.56 177.1 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.091 -1.006 . . . . 0.0 109.921 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.526 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.42 140.46 38.5 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.167 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.591 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 18.7 tp -149.78 152.81 35.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.179 -0.951 . . . . 0.0 110.474 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.591 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 73.3 m-85 -161.82 120.73 2.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.772 -0.58 . . . . 0.0 109.649 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.571 ' CE2' ' HA ' ' A' ' 61' ' ' TYR . 63.0 m-85 -93.22 123.22 36.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.064 -1.023 . . . . 0.0 110.106 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 66.8 m-85 -113.88 132.04 56.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.993 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.505 HG13 ' CD2' ' A' ' 98' ' ' HIS . 2.6 t -121.04 113.12 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.326 -0.859 . . . . 0.0 110.156 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.576 ' CB ' ' ND1' ' A' ' 98' ' ' HIS . 3.2 t-20 59.19 51.4 6.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 110.283 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 16.9 m-20 56.44 31.21 18.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.318 -0.863 . . . . 0.0 110.487 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.5 t -130.74 167.3 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.202 -0.936 . . . . 0.0 109.904 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -154.98 67.84 5.33 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.557 -0.715 . . . . 0.0 109.478 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.445 ' HD3' HG13 ' A' ' 83' ' ' VAL . 47.1 Cg_endo -73.58 170.18 20.59 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.052 1.554 . . . . 0.0 110.707 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.99 -179.02 3.52 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.078 1.567 . . . . 0.0 110.416 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.498 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -87.34 25.46 1.4 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.36 -0.838 . . . . 0.0 110.701 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.21 41.84 1.11 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.408 -0.807 . . . . 0.0 109.768 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 90' ' ' THR . . . -145.4 -175.53 4.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 110.461 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 62.8 p -139.44 139.65 37.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.631 -0.668 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.562 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 4.5 mmt -49.26 -38.62 27.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.165 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -52.31 -48.99 52.75 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 90' ' ' THR . 3.9 pt20 -64.63 -29.41 70.41 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.634 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.33 -24.86 64.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.587 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -49.63 -56.17 11.03 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.977 -1.077 . . . . 0.0 109.773 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.62 -17.62 63.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.754 -1.216 . . . . 0.0 111.093 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -88.47 -68.42 0.77 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.142 -0.974 . . . . 0.0 113.402 -177.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.576 ' ND1' ' CB ' ' A' ' 81' ' ' ASN . 18.1 m-70 -100.16 40.71 1.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.726 -1.234 . . . . 0.0 112.771 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.563 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.9 p80 -77.12 -20.09 56.09 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.051 -1.031 . . . . 0.0 109.657 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 99' ' ' HIS . 0.6 OUTLIER 75.36 -76.37 0.06 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.095 0.474 . . . . 0.0 110.344 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.97 -92.2 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 110.332 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.541 ' C ' ' CG ' ' A' ' 103' ' ' PHE . 9.7 t0 -169.98 50.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.235 -0.915 . . . . 0.0 110.267 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.541 ' CG ' ' C ' ' A' ' 102' ' ' ASP . 18.1 m-85 -151.81 -68.49 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 110.078 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 104' ' ' PHE . 4.3 m-85 -120.0 172.46 7.72 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 109.812 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.602 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -109.16 165.4 11.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.091 -1.006 . . . . 0.0 109.608 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.478 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 57.9 m-85 -122.06 129.49 52.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.823 -1.173 . . . . 0.0 112.173 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.602 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 4.5 mt -141.4 153.36 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.502 -0.749 . . . . 0.0 109.475 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 34' ' ' GLU . . . -150.42 178.45 9.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 110.326 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.605 ' CE2' ' CD ' ' A' ' 35' ' ' LYS . 6.3 p90 -147.14 164.59 32.63 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.256 -0.977 . . . . 0.0 111.075 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -157.7 170.02 23.34 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.761 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 75' ' ' ALA . 11.7 p30 -121.06 19.5 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 110.593 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.46 ' OE2' ' HB2' ' A' ' 77' ' ' PHE . 1.1 pm0 -43.11 149.21 0.23 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.17 -0.956 . . . . 0.0 110.03 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 65.6 m -135.8 35.6 2.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.89 161.41 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.0 110.195 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -77.68 175.65 9.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.162 -0.961 . . . . 0.0 110.2 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 51.8 -160.85 2.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.227 -1.161 . . . . 0.0 110.273 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -47.29 -47.96 25.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -1.076 . . . . 0.0 110.189 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -71.61 -27.98 63.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 110.293 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.506 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.3 mp -70.7 -22.41 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 109.982 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.475 ' HD2' ' O ' ' A' ' 22' ' ' ARG . 3.8 tpt180 -83.86 -40.95 18.0 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.92 -1.113 . . . . 0.0 109.277 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -62.34 -42.99 99.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 110.107 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.607 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 18.2 ptmt -85.73 -33.68 21.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 111.092 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.607 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 28.5 m-85 -112.45 69.79 1.04 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.523 -1.36 . . . . 0.0 109.872 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 43.9 Cg_endo -70.31 -0.78 7.88 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.796 1.419 . . . . 0.0 110.845 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.86 21.07 12.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.102 -0.999 . . . . 0.0 110.513 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.502 ' HD2' ' O ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -96.02 175.07 6.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.966 -1.084 . . . . 0.0 110.642 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.485 ' CG2' ' OG ' ' A' ' 53' ' ' SER . 33.0 t -142.58 104.05 5.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.454 -0.779 . . . . 0.0 109.892 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.575 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 49.5 Cg_endo -76.9 90.75 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.138 1.599 . . . . 0.0 110.295 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.567 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.3 m -88.57 153.19 3.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.229 -0.92 . . . . 0.0 110.721 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 104' ' ' PHE . 1.4 mp -103.04 165.12 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 108.772 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.576 HG22 ' CD1' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -139.4 133.82 39.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.048 -1.032 . . . . 0.0 110.877 -179.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -151.84 163.69 38.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.722 -0.611 . . . . 0.0 109.616 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.561 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -96.8 158.86 15.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 110.627 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.572 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.22 -174.28 0.12 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.722 . . . . 0.0 109.41 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.572 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.2 Cg_endo -70.33 107.5 1.98 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.486 1.256 . . . . 0.0 109.753 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 4.1 mtpt 64.14 42.72 5.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.375 -0.828 . . . . 0.0 109.944 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -64.39 179.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 110.267 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.497 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.6 OUTLIER -150.32 33.85 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.947 . . . . 0.0 110.425 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.562 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.7 pp -85.33 178.17 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.046 -1.034 . . . . 0.0 110.644 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.562 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -50.46 -172.73 0.01 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -80.34 179.38 7.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.356 -1.085 . . . . 0.0 110.002 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 1.4 pp -135.04 134.14 40.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 110.614 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . 15.4 t0 -86.43 -36.97 18.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.076 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.55 160.27 43.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 109.954 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.529 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -118.41 39.91 3.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.114 -0.992 . . . . 0.0 110.215 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' CG ' ' C ' ' A' ' 47' ' ' LYS . 6.2 mtmm -156.7 109.01 2.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.471 -0.768 . . . . 0.0 109.28 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.584 ' CD2' HD13 ' A' ' 63' ' ' LEU . 22.9 m-85 -103.63 141.89 35.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.902 -1.124 . . . . 0.0 110.808 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tp -105.44 104.81 14.61 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 ' HB ' HD13 ' A' ' 55' ' ' LEU . 16.6 m -131.76 144.23 52.4 Favored Pre-proline 0 C--N 1.3 -1.554 0 O-C-N 121.112 -0.993 . . . . 0.0 110.622 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 41.5 Cg_endo -66.99 143.86 67.69 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.983 1.518 . . . . 0.0 110.053 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.537 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.7 m -61.47 -14.25 27.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.399 -0.813 . . . . 0.0 111.615 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -83.7 -15.31 49.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.082 -1.011 . . . . 0.0 111.053 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.515 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.9 mt -62.21 144.84 54.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.054 -1.028 . . . . 0.0 111.301 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.468 HG21 HG21 ' A' ' 90' ' ' THR . 1.2 p -90.74 165.91 13.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.51 -0.744 . . . . 0.0 109.621 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.475 ' CG1' HG22 ' A' ' 87' ' ' THR . 46.5 t -60.33 -26.42 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 110.153 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.71 -41.33 93.86 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.515 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.6 mt-30 -67.64 -49.7 61.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.076 -1.25 . . . . 0.0 110.203 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.658 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 43.0 t80 -60.59 -33.9 73.41 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.724 -1.191 . . . . 0.0 109.502 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.665 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -63.43 -28.02 69.69 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.923 -1.11 . . . . 0.0 109.738 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -70.26 -53.52 16.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.295 -0.878 . . . . 0.0 110.281 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 49' ' ' TYR . 0.8 OUTLIER -59.54 -37.13 77.58 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 118.92 -1.112 . . . . 0.0 112.341 -178.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.658 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -70.45 -35.28 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 119.835 -1.791 . . . . 0.0 109.025 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 64' ' ' ILE . 0.9 OUTLIER -37.38 -63.41 0.45 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.72 -0.613 . . . . 0.0 110.774 -179.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -30.93 71.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.19 -0.944 . . . . 0.0 110.192 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.531 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 8.0 mmp_? -67.72 -17.81 64.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 109.945 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.583 HD12 ' CD2' ' A' ' 109' ' ' TYR . 36.5 mt -103.55 15.32 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.386 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.545 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 46.24 30.66 1.04 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.564 -0.71 . . . . 0.0 110.263 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD22 ' CG2' ' A' ' 68' ' ' ILE . 4.1 pp -108.83 155.24 21.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.413 -0.805 . . . . 0.0 109.84 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 73' ' ' GLU . 4.9 ptp180 -166.17 -168.73 1.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.657 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 47.99 -92.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.392 -0.817 . . . . 0.0 110.768 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 4.9 pt-20 -146.25 44.43 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.976 -1.078 . . . . 0.0 110.969 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -67.58 176.68 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.955 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -100.88 140.54 35.03 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.008 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 26.1 tp -164.24 152.68 12.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.982 . . . . 0.0 110.755 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 97.4 m-85 -158.52 119.7 3.42 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.706 -0.621 . . . . 0.0 109.666 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.665 ' CD2' ' CE2' ' A' ' 61' ' ' TYR . 18.5 m-30 -85.6 132.49 34.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.075 -1.015 . . . . 0.0 111.8 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 64.6 m-85 -120.29 120.42 35.99 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.594 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 2.1 t -120.97 125.95 74.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.422 -0.799 . . . . 0.0 109.839 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.499 ' HB2' ' ND1' ' A' ' 98' ' ' HIS . 0.3 OUTLIER 47.15 46.49 16.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.207 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 26.8 m120 58.11 37.07 26.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.288 -0.882 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -135.91 167.6 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.154 -0.966 . . . . 0.0 110.15 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.591 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -155.19 70.05 5.58 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.492 -0.755 . . . . 0.0 109.552 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.83 163.58 36.74 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.009 1.531 . . . . 0.0 110.735 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.3 -178.63 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.214 1.639 . . . . 0.0 110.622 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.475 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -86.7 20.48 2.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.309 -0.869 . . . . 0.0 110.681 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.1 m -91.51 39.2 1.0 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.47 -0.769 . . . . 0.0 109.641 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.423 ' CB ' ' OE1' ' A' ' 93' ' ' GLN . . . -145.51 -171.97 3.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.535 -0.728 . . . . 0.0 110.243 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 73.0 p -139.55 143.08 37.21 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.626 -0.671 . . . . 0.0 110.116 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.533 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 51.0 mmm -46.23 -46.35 17.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.806 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -47.97 -48.77 24.63 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.635 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.3 OUTLIER -64.39 -31.81 73.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.108 -1.23 . . . . 0.0 110.155 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.533 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.59 -22.27 64.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.114 -0.991 . . . . 0.0 110.198 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.572 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -49.27 -55.48 12.54 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.938 -1.101 . . . . 0.0 109.874 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -70.43 -16.89 62.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.034 -1.041 . . . . 0.0 111.34 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -87.35 -64.78 1.1 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.106 -0.996 . . . . 0.0 112.924 -177.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.594 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 14.0 m-70 -98.24 37.37 1.45 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.816 -1.178 . . . . 0.0 112.103 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.489 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -71.98 169.21 16.41 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.396 -0.815 . . . . 0.0 109.694 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.556 ' OE1' ' CD1' ' A' ' 106' ' ' TYR . 0.8 OUTLIER -153.7 34.09 0.45 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.764 -1.21 . . . . 0.0 110.502 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' HG2' ' N ' ' A' ' 102' ' ' ASP . 20.6 tt0 175.28 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.532 ' N ' ' HG2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -155.94 -39.94 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 109.704 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.525 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 3.7 p90 -144.32 44.22 1.42 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.423 -0.798 . . . . 0.0 109.672 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.603 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -153.02 130.43 11.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.461 -0.774 . . . . 0.0 110.022 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.3 166.71 11.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.866 -1.146 . . . . 0.0 109.693 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.581 ' CE1' HG12 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -124.46 131.61 53.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.959 -1.088 . . . . 0.0 111.503 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.587 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 5.6 mt -138.64 143.4 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.195 -0.94 . . . . 0.0 110.119 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.73 176.06 9.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.227 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.0 OUTLIER -149.93 164.23 35.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.798 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.3 t -152.44 -178.1 6.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.693 -0.629 . . . . 0.0 109.941 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 112' ' ' GLU . 57.3 p-10 -95.14 -13.86 24.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.885 . . . . 0.0 110.22 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.501 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -172.85 150.49 2.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 110.257 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 p -103.79 32.25 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -99.1 172.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -120.29 155.84 32.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.344 -0.848 . . . . 0.0 110.281 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.68 -151.31 27.39 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.262 -1.14 . . . . 0.0 110.213 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -63.33 -53.46 52.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -1.163 . . . . 0.0 109.615 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.483 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -75.34 -26.7 58.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 110.086 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.507 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.1 mp -67.62 -14.22 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 109.906 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' C ' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -80.8 -49.47 11.07 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.914 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.16 -43.77 82.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.938 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 2.6 mtmt -76.41 -42.02 45.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.642 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 38.1 m-85 -115.01 63.31 1.54 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.461 -0.775 . . . . 0.0 110.693 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 47.0 Cg_endo -72.64 -3.4 13.43 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.858 1.451 . . . . 0.0 110.343 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -100.83 -6.24 25.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 110.436 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' O ' HG21 ' A' ' 29' ' ' VAL . 3.5 mpt_? -84.37 -161.97 0.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.148 -0.97 . . . . 0.0 110.184 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 15.6 t -146.99 103.82 3.85 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.578 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -74.51 106.63 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.382 1.727 . . . . 0.0 109.829 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.53 ' CG2' HD21 ' A' ' 105' ' ' LEU . 38.2 t -105.44 133.59 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.997 . . . . 0.0 110.718 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.598 ' CD1' ' CD1' ' A' ' 104' ' ' PHE . 44.3 mm -91.63 154.54 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.843 . . . . 0.0 109.025 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 2.7 t -132.13 144.46 37.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.939 -1.1 . . . . 0.0 111.498 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 7.4 mp0 -156.85 -179.65 8.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.571 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -110.7 160.79 16.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.729 -1.232 . . . . 0.0 110.581 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.557 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.91 -175.12 0.16 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.438 -0.789 . . . . 0.0 109.307 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.4 Cg_endo -71.44 106.11 1.88 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.532 1.28 . . . . 0.0 109.769 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 61.69 40.74 12.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.352 -0.843 . . . . 0.0 110.117 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.97 -179.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.214 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HG2' ' OD1' ' A' ' 111' ' ' ASP . 6.6 ptm180 -150.39 33.59 0.64 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 110.533 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -85.54 -175.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.04 . . . . 0.0 110.62 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.507 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -55.42 179.73 0.32 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -70.96 -172.92 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -1.147 . . . . 0.0 110.055 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 1.2 pp -135.19 134.15 39.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 110.63 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -40.23 15.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.85 164.76 37.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.299 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.77 38.22 4.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.106 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.59 105.04 1.82 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 0.0 109.952 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.584 ' CD2' HD13 ' A' ' 63' ' ' LEU . 45.3 m-85 -103.92 146.47 28.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 110.64 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.71 95.4 5.22 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.475 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 13.5 m -119.83 152.66 54.09 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.14 -0.975 . . . . 0.0 110.714 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.457 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.1 Cg_endo -71.23 149.48 57.67 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.097 1.577 . . . . 0.0 110.078 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.522 ' HB3' ' CA ' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -63.73 -13.94 47.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.325 -0.859 . . . . 0.0 111.397 -178.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.55 -10.71 53.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.908 -1.12 . . . . 0.0 111.11 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.511 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.6 mt -62.14 141.89 57.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.867 -1.145 . . . . 0.0 111.335 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.428 HG21 HG23 ' A' ' 90' ' ' THR . 2.1 p -91.59 163.14 14.23 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.637 -0.665 . . . . 0.0 109.449 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.51 ' CG1' HG22 ' A' ' 87' ' ' THR . 78.9 t -58.96 -22.56 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.023 -1.048 . . . . 0.0 110.056 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.73 -40.06 65.72 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.511 ' CB ' HD22 ' A' ' 55' ' ' LEU . 5.0 mm100 -67.87 -47.81 67.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.149 -1.206 . . . . 0.0 109.893 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 19.5 t80 -60.38 -46.39 90.13 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.146 -0.971 . . . . 0.0 109.647 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -50.35 -22.68 1.93 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.016 -1.053 . . . . 0.0 110.021 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -80.86 -54.5 5.54 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.566 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.584 HD13 ' CD2' ' A' ' 49' ' ' TYR . 3.9 pp -59.84 -19.1 48.98 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.909 -1.12 . . . . 0.0 112.287 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.639 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 2.4 mt -91.57 -42.98 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.113 -1.617 . . . . 0.0 108.863 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.533 ' CG ' HD23 ' A' ' 70' ' ' LEU . 0.7 OUTLIER -36.91 -58.5 0.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.145 0.498 . . . . 0.0 110.696 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.87 -31.91 71.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 110.052 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 2.6 mmp_? -74.75 -7.5 53.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.86 . . . . 0.0 110.546 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.475 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.2 OUTLIER -99.18 -8.74 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 0.0 109.546 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.469 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER 67.74 29.41 6.86 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.484 -0.76 . . . . 0.0 110.087 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.533 HD23 ' CG ' ' A' ' 65' ' ' ARG . 0.3 OUTLIER -88.7 160.86 17.14 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.917 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -164.92 -166.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.004 -1.06 . . . . 0.0 110.724 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 42.9 -96.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.804 . . . . 0.0 110.559 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' ASP . 3.9 pt-20 -151.13 28.46 0.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.935 -1.103 . . . . 0.0 110.721 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.524 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -47.79 176.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.203 1.002 . . . . 0.0 110.029 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -115.0 142.16 47.01 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.595 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 13.6 tp -148.97 151.63 34.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.309 -0.87 . . . . 0.0 110.466 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 90.4 m-85 -158.2 122.88 4.24 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.793 -0.567 . . . . 0.0 109.866 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.593 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 18.0 m-30 -85.17 120.2 26.4 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.155 -0.966 . . . . 0.0 111.785 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.476 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 59.9 m-85 -106.98 122.1 45.76 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.515 -0.74 . . . . 0.0 109.06 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.595 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 2.2 t -121.3 126.29 74.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.421 -0.8 . . . . 0.0 109.934 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 10.6 t-20 51.32 34.29 11.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 0.0 110.038 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 1.3 t-20 69.31 34.95 2.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.433 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -134.97 166.81 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.9 . . . . 0.0 109.892 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.1 mp -154.95 70.67 5.78 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 0.0 109.609 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.96 165.35 33.03 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.048 1.551 . . . . 0.0 110.582 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.92 -178.96 3.83 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.062 1.559 . . . . 0.0 110.376 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.51 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -85.96 19.59 2.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 0.0 110.825 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -91.07 40.46 1.03 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.488 -0.758 . . . . 0.0 109.355 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.61 -172.88 3.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.517 -0.739 . . . . 0.0 110.262 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.428 HG23 HG21 ' A' ' 56' ' ' THR . 59.1 p -139.27 149.8 44.71 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.66 -0.65 . . . . 0.0 110.28 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.56 ' CE ' ' CD2' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -59.23 -40.6 86.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 110.005 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.522 ' CA ' ' HB3' ' A' ' 53' ' ' SER . . . -51.26 -46.49 51.61 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.7 OUTLIER -66.97 -28.85 68.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.238 -1.154 . . . . 0.0 109.715 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.548 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.97 -22.22 64.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.198 -0.939 . . . . 0.0 109.862 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.578 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -48.95 -53.78 18.31 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.884 -1.135 . . . . 0.0 109.505 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -19.16 63.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.049 -1.032 . . . . 0.0 111.455 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.537 ' OE1' ' CE1' ' A' ' 98' ' ' HIS . 0.5 OUTLIER -88.65 -59.12 2.32 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -177.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.595 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.2 m-70 -98.65 40.12 1.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.648 -1.283 . . . . 0.0 113.09 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.505 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 5.9 p80 -106.09 178.55 4.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.11 -54.73 0.98 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.771 -1.206 . . . . 0.0 110.336 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -177.88 56.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.073 -1.017 . . . . 0.0 110.23 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.47 ' HB3' ' O ' ' A' ' 101' ' ' GLU . 57.4 p-10 -178.6 -144.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 110.111 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.459 ' O ' ' HG2' ' A' ' 30' ' ' PRO . 4.5 p90 -118.53 48.68 1.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.905 . . . . 0.0 110.015 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.598 ' CD1' ' CD1' ' A' ' 32' ' ' ILE . 1.1 m-85 -156.86 134.7 10.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.289 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.596 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -107.4 169.96 8.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.959 -1.088 . . . . 0.0 109.248 179.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.464 ' O ' HG13 ' A' ' 80' ' ' VAL . 6.5 p90 -121.75 128.83 52.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.532 -1.355 . . . . 0.0 111.981 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.596 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 5.9 mt -141.07 141.04 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.311 -0.868 . . . . 0.0 110.184 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -136.29 166.72 22.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.966 -1.084 . . . . 0.0 109.773 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.593 ' HB3' ' CD1' ' A' ' 78' ' ' PHE . 2.9 p90 -134.26 163.86 28.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.747 -1.221 . . . . 0.0 111.518 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -158.52 177.1 11.6 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.248 0.547 . . . . 0.0 110.02 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.53 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 32.9 p30 -130.88 28.67 4.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 110.145 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER 178.23 137.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 110.377 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 114' ' ' VAL . 47.1 t -136.6 33.88 2.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.465 ' O ' ' O ' ' A' ' 113' ' ' SER . 9.3 p -47.32 175.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -57.27 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.16 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 114' ' ' VAL . . . -101.69 -134.91 8.63 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.254 -1.144 . . . . 0.0 110.256 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.04 -35.38 4.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.244 . . . . 0.0 109.875 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -80.37 -41.05 25.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.855 . . . . 0.0 110.533 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 9.8 mm -59.53 -15.1 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.027 -1.046 . . . . 0.0 110.344 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' NH1' ' OH ' ' A' ' 95' ' ' TYR . 11.8 mmt85 -91.43 -53.55 4.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.884 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -47.99 -39.32 19.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.127 -0.983 . . . . 0.0 108.996 179.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 9.9 mttt -85.89 -48.88 8.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.525 -0.735 . . . . 0.0 110.192 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 37.4 m-85 -115.18 63.33 1.67 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.164 -0.96 . . . . 0.0 110.785 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 47.6 Cg_endo -72.76 -4.59 15.63 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.813 1.428 . . . . 0.0 110.438 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 11.2 t70 -118.01 16.18 14.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 110.273 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.451 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 10.5 mpt_? -109.58 -164.1 0.91 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.942 . . . . 0.0 110.244 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.45 HG11 HG11 ' A' ' 31' ' ' VAL . 16.3 t -144.99 108.99 4.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.947 . . . . 0.0 110.417 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.519 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.8 Cg_endo -77.83 91.16 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.186 1.624 . . . . 0.0 110.093 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -86.63 129.87 37.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.235 -0.916 . . . . 0.0 111.041 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 39.7 mm -91.71 136.06 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.09 -1.006 . . . . 0.0 108.502 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 0.5 OUTLIER -119.94 146.44 24.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.864 -1.147 . . . . 0.0 111.304 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 0.1 OUTLIER -156.24 -164.44 1.68 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HD2' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -122.1 158.84 28.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 0.0 110.605 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.573 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -61.49 -173.42 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.515 -0.74 . . . . 0.0 109.031 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.0 Cg_endo -69.62 106.71 1.68 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.372 1.196 . . . . 0.0 109.864 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 3.7 mmtt 64.69 41.43 5.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.426 -0.796 . . . . 0.0 110.274 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -60.07 -177.71 0.07 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.256 -0.902 . . . . 0.0 109.972 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.514 ' CG ' ' OD1' ' A' ' 111' ' ' ASP . 5.6 ptm180 -150.22 31.84 0.67 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 0.0 110.745 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.562 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.8 pp -85.53 177.12 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.083 -1.01 . . . . 0.0 110.351 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.562 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -49.04 -176.76 0.01 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.494 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 7.8 t0 -75.17 -174.69 2.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.245 . . . . 0.0 109.871 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -135.66 135.66 40.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 0.0 110.371 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.67 -41.23 14.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.808 . . . . 0.0 109.988 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.81 154.32 34.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 110.039 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -113.44 44.94 1.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.04 -1.038 . . . . 0.0 110.004 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -161.85 112.84 1.65 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 110.043 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.586 ' CD2' HD11 ' A' ' 63' ' ' LEU . 8.5 m-85 -111.32 137.57 48.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 109.991 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.92 87.12 3.64 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.501 ' HB ' HD13 ' A' ' 55' ' ' LEU . 12.7 m -107.89 148.36 37.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 110.96 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.478 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 47.7 Cg_endo -72.88 147.36 43.93 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.156 1.608 . . . . 0.0 109.688 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.55 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -62.2 -15.8 49.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.925 . . . . 0.0 111.459 -178.699 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -83.69 -14.23 52.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.115 -0.99 . . . . 0.0 111.18 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.501 HD13 ' HB ' ' A' ' 51' ' ' VAL . 3.7 mt -61.87 144.14 55.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.931 -1.106 . . . . 0.0 111.276 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 6.8 p -90.83 164.51 14.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.479 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 60.4 t -62.08 -27.34 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.043 -1.035 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.64 -36.66 88.24 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.49 ' CB ' HD22 ' A' ' 55' ' ' LEU . 8.5 mm-40 -70.17 -47.79 60.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.148 -1.207 . . . . 0.0 109.791 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.668 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 37.5 t80 -59.98 -32.75 71.13 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.144 -1.022 . . . . 0.0 108.942 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.447 ' CE2' ' HD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -60.03 -32.21 70.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 109.827 178.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 5.3 t80 -72.8 -51.8 17.51 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.417 -0.802 . . . . 0.0 111.078 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.601 HD12 ' CE1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -59.9 -35.65 75.32 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 118.571 -1.252 . . . . 0.0 112.589 -178.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.668 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -80.47 -29.08 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 119.663 -1.898 . . . . 0.0 109.629 178.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -41.11 -62.11 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.346 -0.846 . . . . 0.0 110.353 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -27.43 68.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.805 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HB2' ' HA ' ' A' ' 64' ' ' ILE . 8.8 mmp_? -70.26 -16.15 63.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.895 . . . . 0.0 109.8 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.589 ' CD1' ' CE2' ' A' ' 109' ' ' TYR . 2.9 mm -100.93 11.49 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.751 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 54.01 30.98 12.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.298 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.5 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 4.2 pp -115.23 156.49 25.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -0.804 . . . . 0.0 109.792 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.73 -169.34 1.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.0 110.945 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.27 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.454 -0.779 . . . . 0.0 110.735 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' ARG . 5.2 pt-20 -151.37 32.52 0.58 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.08 -1.013 . . . . 0.0 111.076 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -55.25 177.0 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.037 -1.039 . . . . 0.0 109.827 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.522 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -98.36 139.49 34.04 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.167 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.573 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 13.2 tp -164.34 153.23 13.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.352 -0.843 . . . . 0.0 110.391 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 89.4 m-85 -157.55 123.89 4.86 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.562 -0.711 . . . . 0.0 109.784 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.578 ' CE1' HD11 ' A' ' 64' ' ' ILE . 11.8 m-85 -89.16 124.45 34.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.357 -0.839 . . . . 0.0 111.033 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 53.3 m-85 -119.91 121.65 39.48 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.625 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 2.4 t -120.78 112.72 37.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.358 -0.839 . . . . 0.0 109.742 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.527 ' CB ' ' ND1' ' A' ' 98' ' ' HIS . 3.1 t-20 63.67 34.57 12.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.824 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 19.9 t-20 69.18 35.03 2.82 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.326 -0.859 . . . . 0.0 110.271 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.3 t -135.04 168.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.209 -0.932 . . . . 0.0 110.127 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.585 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.1 mp -155.0 77.27 5.07 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.7 . . . . 0.0 109.132 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.69 155.87 53.85 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.079 1.568 . . . . 0.0 110.879 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.47 -177.56 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.195 1.629 . . . . 0.0 110.292 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.479 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 1.1 p -82.23 16.46 2.0 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.305 -0.872 . . . . 0.0 110.948 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.43 41.56 1.12 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.534 -0.728 . . . . 0.0 109.519 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.519 ' HB1' ' NE2' ' A' ' 93' ' ' GLN . . . -145.52 -176.53 5.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.523 -0.736 . . . . 0.0 110.165 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.487 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 80.6 p -139.75 141.31 36.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 110.335 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.539 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 2.2 mmt -49.99 -42.78 49.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 110.014 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.55 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -48.59 -47.59 29.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.519 ' NE2' ' HB1' ' A' ' 89' ' ' ALA . 2.2 pt20 -64.63 -31.98 73.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -1.147 . . . . 0.0 109.814 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -67.61 -22.47 65.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.15 -0.969 . . . . 0.0 110.096 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.519 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -49.64 -55.76 12.51 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 120.881 -1.137 . . . . 0.0 109.692 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.429 ' O ' ' NE2' ' A' ' 99' ' ' HIS . 7.6 mt-30 -69.47 -17.22 63.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.963 -1.085 . . . . 0.0 111.294 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 1.8 mm-40 -87.44 -65.25 1.03 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.997 -1.065 . . . . 0.0 112.445 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.625 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 18.0 m-70 -98.63 37.94 1.42 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.86 -1.15 . . . . 0.0 111.808 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.546 ' O ' ' CE2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -71.35 171.56 10.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.504 -0.747 . . . . 0.0 109.673 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.571 ' HB2' ' CD2' ' A' ' 106' ' ' TYR . 27.4 tt0 -138.29 147.79 43.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.89 -1.131 . . . . 0.0 109.93 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 100' ' ' GLU . 4.4 tt0 -41.03 -49.72 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 110.414 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.563 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 24.0 m-20 -49.26 -64.21 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.563 ' CG ' ' O ' ' A' ' 102' ' ' ASP . 0.2 OUTLIER 168.24 -71.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 110.174 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 104' ' ' PHE . 4.5 m-30 -53.15 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.336 -0.852 . . . . 0.0 110.372 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.594 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -108.19 169.53 8.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.283 -0.885 . . . . 0.0 109.272 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 100' ' ' GLU . 0.4 OUTLIER -114.5 130.75 56.76 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.615 -1.303 . . . . 0.0 111.493 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.594 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 10.1 mt -141.97 122.65 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 110.236 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.75 153.21 44.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.988 -1.07 . . . . 0.0 109.51 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.651 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.6 OUTLIER -130.36 167.51 18.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.648 -1.282 . . . . 0.0 111.116 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -152.44 -178.39 6.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.674 -0.641 . . . . 0.0 110.086 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.514 ' OD1' ' CG ' ' A' ' 40' ' ' ARG . 2.1 m-20 -81.32 -29.58 34.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.26 -0.9 . . . . 0.0 110.249 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.576 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -178.53 166.75 1.8 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.318 -0.864 . . . . 0.0 110.382 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.26 13.9 7.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.184 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.3 173.07 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.234 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 115' ' ' TYR . 18.1 t80 -64.43 129.4 39.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.2 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -172.84 165.61 38.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.268 -1.137 . . . . 0.0 110.218 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 21' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -58.81 -36.22 74.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -1.112 . . . . 0.0 110.026 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -74.35 -19.72 60.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 1.6 mp -72.06 -19.33 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.953 . . . . 0.0 110.28 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.566 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 3.8 mpt_? -84.83 -20.51 30.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.779 -1.201 . . . . 0.0 110.374 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -80.35 -48.84 12.36 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.177 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.603 ' HG3' ' CE2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -86.32 -27.74 24.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 111.867 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.603 ' CE2' ' HG3' ' A' ' 24' ' ' LYS . 35.0 m-85 -116.18 64.2 2.63 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.308 -1.495 . . . . 0.0 110.524 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 48.8 Cg_endo -73.58 -0.09 8.84 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.806 1.424 . . . . 0.0 110.489 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.49 0.4 20.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -0.976 . . . . 0.0 110.675 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.499 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 2.5 mpt_? -90.93 -173.78 3.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.058 -1.026 . . . . 0.0 110.1 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 34.9 t -147.46 104.28 3.74 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.568 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 44.2 Cg_endo -72.97 87.41 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.026 1.54 . . . . 0.0 110.259 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.553 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.3 m -84.52 139.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.178 -0.952 . . . . 0.0 111.056 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 45.8 mm -94.57 158.57 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 108.89 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 2.5 t -133.95 134.77 55.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.886 -1.134 . . . . 0.0 111.273 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 108' ' ' ALA . 1.3 tt0 -148.54 168.79 21.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.295 0.569 . . . . 0.0 109.538 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.63 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -100.51 156.26 17.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.043 -1.036 . . . . 0.0 110.562 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.561 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -65.52 -172.9 0.1 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.519 -0.738 . . . . 0.0 109.244 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.5 Cg_endo -72.63 107.83 2.4 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.441 1.232 . . . . 0.0 109.922 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.89 42.13 8.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 110.251 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.19 -177.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.905 . . . . 0.0 110.016 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.485 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.2 35.74 0.66 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.12 -0.987 . . . . 0.0 110.588 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.52 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -84.64 179.45 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.092 -1.005 . . . . 0.0 110.049 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -62.16 179.55 4.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.454 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.1 t70 -70.73 -176.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -1.073 . . . . 0.0 109.988 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.457 HD11 ' O ' ' A' ' 67' ' ' ARG . 2.0 mm? -135.67 134.09 38.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.159 -0.963 . . . . 0.0 110.588 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -86.27 -27.0 24.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 109.587 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.51 ' CD ' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -158.04 150.08 21.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.517 -0.74 . . . . 0.0 109.679 179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -116.66 45.31 1.85 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.833 -1.167 . . . . 0.0 110.025 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 108.89 1.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 109.53 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.586 ' CD2' HD13 ' A' ' 63' ' ' LEU . 20.0 m-85 -105.47 141.33 37.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 110.718 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.0 98.37 8.09 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 55' ' ' LEU . 11.2 m -121.89 150.88 56.91 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 110.87 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD2' HD13 ' A' ' 55' ' ' LEU . 43.6 Cg_endo -69.28 145.74 60.92 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.047 1.551 . . . . 0.0 110.201 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.543 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.41 -15.6 50.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 0.0 111.379 -178.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -83.15 -14.7 52.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 111.283 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.527 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.9 mt -62.47 143.02 57.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.892 -1.13 . . . . 0.0 111.428 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.8 p -91.03 167.22 12.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.663 -0.648 . . . . 0.0 109.869 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.47 ' CG1' HG23 ' A' ' 87' ' ' THR . 58.7 t -62.75 -26.32 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.998 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.06 -31.65 75.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.527 ' CB ' HD22 ' A' ' 55' ' ' LEU . 7.1 mm100 -76.79 -47.07 22.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.113 -1.228 . . . . 0.0 110.04 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 22.7 t80 -60.7 -47.19 87.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.102 -0.998 . . . . 0.0 109.468 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.24 -22.24 1.68 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.883 -1.136 . . . . 0.0 109.855 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -79.91 -54.98 5.3 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 110.513 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.586 HD13 ' CD2' ' A' ' 49' ' ' TYR . 3.8 pp -59.84 -20.35 56.45 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.271 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.639 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 2.2 mt -90.98 -38.27 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 120.193 -1.567 . . . . 0.0 109.051 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.51 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.7 OUTLIER -35.35 -66.03 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.181 0.515 . . . . 0.0 110.83 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -31.47 72.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.893 -1.13 . . . . 0.0 110.072 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.457 ' O ' HD11 ' A' ' 44' ' ' LEU . 35.4 mmt180 -66.76 -16.82 64.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.54 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.586 HD11 ' CD2' ' A' ' 109' ' ' TYR . 40.8 mt -103.38 11.9 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 0.0 109.763 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.536 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 51.9 23.76 2.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -0.797 . . . . 0.0 110.671 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 65' ' ' ARG . 4.2 pp -91.85 157.44 16.87 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.319 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' GLU . 25.1 ptt180 -165.16 -169.44 1.65 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.929 -1.107 . . . . 0.0 111.152 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.42 -90.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.581 -0.7 . . . . 0.0 110.62 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 74' ' ' ASP . 6.5 pt-20 -158.67 28.07 0.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.2 -0.938 . . . . 0.0 110.883 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.515 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.16 176.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 109.892 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -103.21 140.63 37.12 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.291 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.591 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 21.5 tp -164.36 150.05 10.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 110.465 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.591 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 89.1 m-85 -157.93 121.97 4.14 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.778 -0.576 . . . . 0.0 109.869 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.602 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 18.3 m-30 -79.95 135.84 36.5 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.074 -1.016 . . . . 0.0 111.246 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.568 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 82.6 m-85 -118.33 126.46 52.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.569 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 2.4 t -120.83 124.06 71.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.571 ' HB2' ' CG ' ' A' ' 98' ' ' HIS . 1.1 t-20 47.63 49.12 16.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 29.3 m-80 56.81 36.01 27.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.639 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -135.18 167.0 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.086 -1.009 . . . . 0.0 109.924 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.1 mp -154.88 72.42 5.84 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.547 -0.721 . . . . 0.0 109.632 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 164.07 36.49 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.04 1.547 . . . . 0.0 110.564 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.7 -178.96 3.75 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.121 1.59 . . . . 0.0 110.311 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.47 HG23 ' CG1' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.12 19.16 2.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 110.652 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.43 39.22 1.02 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.512 -0.743 . . . . 0.0 109.567 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.444 ' HB1' ' OE1' ' A' ' 93' ' ' GLN . . . -145.42 -174.11 4.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.536 -0.728 . . . . 0.0 110.18 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 81.5 p -139.71 143.86 37.25 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.626 -0.671 . . . . 0.0 110.203 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.526 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -44.8 -41.78 7.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 109.747 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.543 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -50.69 -48.04 44.57 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.3 OUTLIER -64.38 -31.58 72.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -1.179 . . . . 0.0 109.988 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.526 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.06 -23.72 64.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.81 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.599 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -50.59 -56.96 9.4 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.892 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -69.64 -15.92 63.28 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.614 -1.304 . . . . 0.0 110.819 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -88.57 -71.04 0.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.169 -0.957 . . . . 0.0 113.486 -177.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.571 ' CG ' ' HB2' ' A' ' 81' ' ' ASN . 16.6 m-70 -100.81 38.28 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.68 -1.262 . . . . 0.0 113.189 -176.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.599 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -93.07 171.53 8.88 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.99 -1.069 . . . . 0.0 110.252 178.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.531 ' HG3' ' ND1' ' A' ' 99' ' ' HIS . 1.4 mt-10 73.18 114.98 0.06 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.983 -1.073 . . . . 0.0 110.442 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 0.4 OUTLIER 173.46 -28.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.611 -0.681 . . . . 0.0 110.022 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.88 -30.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.431 -0.793 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.63 -60.62 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.276 -0.89 . . . . 0.0 109.62 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.534 ' CB ' ' O ' ' A' ' 30' ' ' PRO . 18.1 m-85 -127.36 -126.36 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.357 -0.84 . . . . 0.0 109.409 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.54 ' CD1' HG13 ' A' ' 107' ' ' ILE . 0.3 OUTLIER -96.07 165.86 12.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.749 -1.219 . . . . 0.0 108.848 178.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -123.89 124.4 42.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.575 -1.328 . . . . 0.0 111.638 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.54 HG13 ' CD1' ' A' ' 105' ' ' LEU . 13.2 mt -141.56 133.29 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.439 -0.788 . . . . 0.0 109.475 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 78' ' ' PHE . . . -133.38 178.14 7.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.097 -1.002 . . . . 0.0 110.295 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.1 OUTLIER -133.96 153.87 51.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.133 -0.98 . . . . 0.0 110.851 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 36' ' ' ALA . 1.1 t -145.17 173.23 12.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.679 -0.638 . . . . 0.0 110.119 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 2.5 p30 -123.92 30.37 6.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.975 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -118.7 160.2 22.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 110.066 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 114' ' ' VAL . 0.7 OUTLIER -125.64 32.99 5.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.232 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 116' ' ' GLY . 8.8 p -46.17 169.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.033 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -45.24 97.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.982 . . . . 0.0 110.186 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 114' ' ' VAL . . . -108.04 162.57 13.1 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.183 -1.186 . . . . 0.0 110.233 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 21' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -39.73 73.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -1.136 . . . . 0.0 110.22 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 4.6 mtpt -76.46 -18.32 58.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.599 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.519 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -70.02 -18.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.022 -1.049 . . . . 0.0 109.964 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' LYS . 16.6 mmm-85 -90.31 -49.54 6.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 109.786 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -45.45 -45.59 13.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.942 179.067 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 12.4 mtmt -85.54 -49.39 8.09 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.477 -0.764 . . . . 0.0 109.834 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 9.8 m-85 -110.88 69.56 0.64 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.403 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 45.6 Cg_endo -71.82 -12.22 28.46 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.921 1.485 . . . . 0.0 110.476 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.75 13.07 21.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.144 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 1.6 mpt_? -105.22 -161.47 0.81 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 110.12 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.533 HG13 ' CG1' ' A' ' 31' ' ' VAL . 24.3 t -144.12 105.65 4.81 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.173 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.584 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 48.4 Cg_endo -74.69 84.99 1.52 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.321 1.695 . . . . 0.0 110.038 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.561 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.4 m -85.6 148.29 4.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 110.933 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.495 HD11 ' CD1' ' A' ' 104' ' ' PHE . 1.5 mp -113.97 147.53 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.497 HG23 ' CE1' ' A' ' 109' ' ' TYR . 0.4 OUTLIER -124.36 153.26 30.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.8 -1.187 . . . . 0.0 111.187 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.585 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 2.4 tt0 -156.34 -162.04 1.21 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HD2' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -132.25 159.81 37.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.869 -1.144 . . . . 0.0 110.815 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.562 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.55 -173.8 0.11 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.582 -0.699 . . . . 0.0 109.38 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.3 Cg_endo -71.98 108.9 2.56 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.522 1.275 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.86 41.15 5.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.828 . . . . 0.0 110.553 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.434 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -63.22 178.18 0.54 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 109.841 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.523 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 13.8 ptt180 -145.26 28.72 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.573 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.8 pp -85.32 179.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.012 . . . . 0.0 109.726 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -68.74 146.38 45.07 Favored Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.231 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.5 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -87.82 163.87 16.22 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.618 -0.93 . . . . 0.0 110.787 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' HG ' ' CA ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -153.74 142.49 20.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.729 -0.607 . . . . 0.0 109.472 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 1.6 t0 -84.09 42.17 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 110.038 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.511 ' CD ' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -160.29 105.78 1.51 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.019 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -115.55 48.58 1.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.74 -1.225 . . . . 0.0 110.618 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.17 111.51 1.7 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.875 . . . . 0.0 109.532 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.582 ' CD2' HD13 ' A' ' 63' ' ' LEU . 24.0 m-85 -106.98 141.56 37.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.049 -1.032 . . . . 0.0 110.551 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.77 93.83 4.75 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.464 ' HB ' HD11 ' A' ' 55' ' ' LEU . 13.7 m -117.95 153.88 51.2 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.152 -0.968 . . . . 0.0 110.777 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.467 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.9 Cg_endo -71.65 148.22 52.7 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.111 1.585 . . . . 0.0 110.025 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.533 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.5 m -63.81 -15.34 58.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 111.334 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 7.8 t70 -83.58 -11.26 57.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.018 -1.051 . . . . 0.0 110.916 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.467 ' HG ' ' HG2' ' A' ' 52' ' ' PRO . 3.6 mt -62.05 142.02 57.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.941 -1.099 . . . . 0.0 111.122 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 1.2 p -91.01 154.89 19.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.65 -0.656 . . . . 0.0 109.433 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.532 HG13 ' CG2' ' A' ' 87' ' ' THR . 24.6 t -53.82 -20.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.991 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.37 -41.68 58.21 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.463 ' HG3' ' OG1' ' A' ' 56' ' ' THR . 0.0 OUTLIER -67.72 -46.67 71.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.174 -1.192 . . . . 0.0 109.997 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.65 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 22.8 t80 -60.65 -47.1 87.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.097 -1.002 . . . . 0.0 109.695 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.31 -22.25 1.72 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.01 -1.056 . . . . 0.0 109.87 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.16 -54.55 5.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 110.34 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.582 HD13 ' CD2' ' A' ' 49' ' ' TYR . 3.7 pp -59.75 -19.47 50.42 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.069 -1.052 . . . . 0.0 112.354 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.65 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.9 mt -92.16 -40.18 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 120.125 -1.61 . . . . 0.0 109.077 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.468 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -37.28 -61.46 0.58 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.878 -0.514 . . . . 0.0 110.624 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -32.33 73.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.942 -1.099 . . . . 0.0 109.742 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.535 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 15.1 mmt180 -69.39 -13.14 62.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.359 -0.838 . . . . 0.0 109.946 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.569 HD12 ' CE2' ' A' ' 109' ' ' TYR . 2.4 mm -99.61 7.81 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.061 -1.024 . . . . 0.0 109.528 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.528 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 54.1 32.58 16.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.429 -0.794 . . . . 0.0 110.132 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.499 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 4.1 pp -110.53 151.2 27.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.829 . . . . 0.0 109.934 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.9 ptp180 -167.06 -168.94 1.17 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.851 . . . . 0.0 111.058 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' C ' ' HG3' ' A' ' 73' ' ' GLU . . . 50.71 -91.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.568 -0.707 . . . . 0.0 111.225 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.452 ' HG3' ' C ' ' A' ' 72' ' ' ALA . 14.2 mt-10 -141.98 49.27 1.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.873 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -77.82 176.04 9.43 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.12 0.962 . . . . 0.0 109.991 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.511 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -118.16 143.85 46.16 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.039 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.572 HD23 ' CE1' ' A' ' 78' ' ' PHE . 18.2 tp -164.05 153.66 14.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 110.628 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 68.0 m-85 -157.58 123.06 4.57 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.617 -0.677 . . . . 0.0 109.465 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.572 ' CE1' HD23 ' A' ' 76' ' ' LEU . 18.4 m-30 -84.8 132.34 34.43 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.012 -1.055 . . . . 0.0 111.93 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.566 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 41.1 m-85 -120.55 118.39 30.09 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.618 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 2.0 t -120.68 130.82 74.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.535 ' HB3' ' CE1' ' A' ' 98' ' ' HIS . 53.5 t30 51.28 34.48 11.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 3.8 t-20 67.65 35.91 3.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.224 -0.922 . . . . 0.0 110.208 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.5 t -135.77 168.59 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 110.078 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.3 mp -154.68 71.01 5.99 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.73 . . . . 0.0 109.678 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.32 164.37 34.26 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.122 1.59 . . . . 0.0 110.68 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.08 -178.64 3.69 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.071 1.564 . . . . 0.0 110.611 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.532 ' CG2' HG13 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.2 22.95 1.65 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.331 -0.855 . . . . 0.0 110.672 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.37 43.45 1.07 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.369 -0.832 . . . . 0.0 109.551 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' C ' HG22 ' A' ' 90' ' ' THR . . . -145.28 -171.48 3.67 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.708 0.765 . . . . 0.0 110.294 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 75.9 p -139.21 136.36 34.93 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.538 0.685 . . . . 0.0 110.103 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.551 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 32.1 mmm -48.4 -38.69 20.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.9 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.45 -49.01 47.14 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 90' ' ' THR . 3.0 pt20 -64.64 -30.24 71.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -1.113 . . . . 0.0 109.814 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.551 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.52 -23.79 64.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.208 -0.932 . . . . 0.0 110.102 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 99' ' ' HIS . 1.0 OUTLIER -48.86 -53.04 21.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.843 -1.161 . . . . 0.0 109.774 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -69.36 -21.47 63.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.196 -0.94 . . . . 0.0 111.192 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -85.68 -66.86 0.85 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.941 -1.1 . . . . 0.0 112.007 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.618 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -98.77 42.33 1.1 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.912 -1.117 . . . . 0.0 110.771 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 95' ' ' TYR . 1.4 t-80 -71.25 -9.01 57.4 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.852 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.517 ' CA ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 44.57 70.35 0.34 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.319 -0.863 . . . . 0.0 109.787 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 103' ' ' PHE . 10.2 mt-10 57.52 155.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.458 -0.776 . . . . 0.0 109.903 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.573 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 7.4 p30 -45.77 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.194 -0.941 . . . . 0.0 110.043 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.612 ' O ' ' CG ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER 171.41 86.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 110.149 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.612 ' CG ' ' O ' ' A' ' 103' ' ' PHE . 38.1 p90 37.56 -162.7 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.533 -0.729 . . . . 0.0 110.849 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.594 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -123.67 160.3 27.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.771 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.544 ' C ' ' CD1' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -124.97 135.88 53.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.029 -1.044 . . . . 0.0 110.996 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.594 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 6.0 mt -141.69 137.54 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.76 147.21 50.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.212 -0.93 . . . . 0.0 108.864 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.6 p90 -130.67 165.79 22.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.478 -1.389 . . . . 0.0 111.629 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -156.07 174.74 14.92 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.257 0.551 . . . . 0.0 110.328 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.523 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 1.8 p30 -107.97 41.07 1.6 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.955 . . . . 0.0 110.217 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER 172.07 140.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.162 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -106.45 -6.98 17.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.495 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.403 HG11 ' OE2' ' A' ' 112' ' ' GLU . 9.3 p -129.89 175.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.108 -0.995 . . . . 0.0 110.327 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -49.39 130.96 20.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.264 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -127.44 -172.01 13.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.224 -1.163 . . . . 0.0 110.271 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -39.94 10.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -1.152 . . . . 0.0 110.248 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 9.7 mtpt -75.3 -33.12 61.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.225 -0.922 . . . . 0.0 110.413 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.2 mp -59.58 -17.66 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 109.651 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' CD ' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -85.09 -49.35 8.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -53.92 -41.43 67.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.868 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 8.6 mttt -82.84 -44.27 15.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.0 109.774 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 22.3 m-85 -112.75 61.03 0.66 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 110.576 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.51 ' HA ' ' CD ' ' A' ' 22' ' ' ARG . 43.8 Cg_endo -69.83 -29.43 23.55 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.743 1.391 . . . . 0.0 110.359 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -96.98 7.29 46.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 110.247 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 6.2 mpt_? -83.86 -167.34 1.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.948 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.531 HG13 ' CG1' ' A' ' 31' ' ' VAL . 19.9 t -147.5 102.68 3.73 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.855 . . . . 0.0 109.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.493 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 46.1 Cg_endo -73.46 81.11 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.177 1.62 . . . . 0.0 110.208 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.539 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 2.2 m -77.32 152.33 5.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 110.686 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 1.5 mp -108.24 164.1 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.475 ' HB ' ' HA ' ' A' ' 47' ' ' LYS . 2.4 t -136.31 136.51 48.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.835 -1.166 . . . . 0.0 111.093 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.91 -176.16 5.81 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.322 0.582 . . . . 0.0 109.742 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HD2' ' CD1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -114.9 159.08 21.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.985 -1.072 . . . . 0.0 110.786 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.57 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.76 -173.23 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.529 -0.732 . . . . 0.0 109.191 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.7 Cg_endo -71.91 107.25 2.17 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.472 1.249 . . . . 0.0 109.983 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.95 41.75 8.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.353 -0.842 . . . . 0.0 110.206 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.8 178.75 0.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.283 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.68 32.31 1.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.214 -0.929 . . . . 0.0 110.172 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.532 ' CG2' ' HB2' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -85.81 -173.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.324 -0.86 . . . . 0.0 110.579 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.507 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -67.46 172.43 31.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.54 179.61 3.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.165 -1.197 . . . . 0.0 110.595 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 2.1 pp -134.93 133.42 39.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.369 -0.832 . . . . 0.0 110.706 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' OD2' ' HD2' ' A' ' 46' ' ' LYS . 10.7 p-10 -85.83 -20.52 29.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.191 -0.943 . . . . 0.0 110.143 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.507 ' CD ' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -151.84 154.08 35.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 109.683 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -128.28 40.95 3.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.962 -1.086 . . . . 0.0 110.448 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.92 104.88 0.91 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 109.822 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.571 ' CD2' HD11 ' A' ' 63' ' ' LEU . 30.6 m-85 -105.4 145.26 31.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.112 -0.993 . . . . 0.0 111.09 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.03 94.82 5.22 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.496 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 32.8 m -115.92 153.14 48.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.115 -0.991 . . . . 0.0 110.987 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.451 ' HD2' HD13 ' A' ' 55' ' ' LEU . 44.3 Cg_endo -69.81 149.5 66.65 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.08 1.568 . . . . 0.0 110.407 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.527 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -63.78 -16.24 60.71 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 111.34 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -83.12 -10.99 58.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -0.999 . . . . 0.0 111.017 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.53 HD23 ' CB ' ' A' ' 59' ' ' GLN . 3.7 mt -61.84 141.8 57.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.907 -1.121 . . . . 0.0 110.952 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 3.1 p -91.23 162.41 14.65 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.532 -0.73 . . . . 0.0 109.507 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 37.1 t -59.04 -30.16 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.104 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.73 -27.16 74.06 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.53 ' CB ' HD23 ' A' ' 55' ' ' LEU . 15.3 mm-40 -76.3 -51.35 12.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.169 -1.195 . . . . 0.0 110.054 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 12.0 t80 -60.41 -47.25 86.92 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.919 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.503 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -49.29 -23.27 1.33 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.849 -1.157 . . . . 0.0 109.562 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -55.87 4.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.486 -0.759 . . . . 0.0 111.282 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.615 HD12 ' CE1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -59.03 -23.53 62.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.899 -1.126 . . . . 0.0 111.842 -178.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.647 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -91.08 -35.01 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.078 -1.639 . . . . 0.0 108.77 177.518 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.473 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -38.95 -56.19 1.43 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.446 -0.784 . . . . 0.0 110.51 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' HE2' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -64.89 -34.94 79.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.975 -1.078 . . . . 0.0 108.899 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 5.0 mmt180 -73.08 -10.54 59.9 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.684 -0.635 . . . . 0.0 110.121 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.587 ' CG2' ' CD2' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -88.09 -10.57 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER 74.01 28.07 1.53 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.751 0.786 . . . . 0.0 109.122 -178.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.587 ' CD2' ' CG2' ' A' ' 68' ' ' ILE . 4.0 pp -113.93 158.67 20.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.745 -0.597 . . . . 0.0 109.873 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -165.08 -174.62 3.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 110.772 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.99 -90.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.0 110.788 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 1.9 pt-20 -153.93 42.26 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 111.027 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -67.51 176.48 2.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.071 -1.018 . . . . 0.0 110.076 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.52 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -92.27 142.85 27.01 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.834 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.583 HD23 ' CE1' ' A' ' 78' ' ' PHE . 17.8 tp -164.09 154.37 14.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 110.773 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 85.2 m-85 -156.91 124.16 5.26 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.581 -0.699 . . . . 0.0 110.121 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.583 ' CE1' HD23 ' A' ' 76' ' ' LEU . 3.7 m-30 -94.73 113.89 25.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 91.2 m-85 -108.99 127.48 54.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 110.122 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.575 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 1.8 t -121.5 122.41 67.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.428 -0.795 . . . . 0.0 109.442 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.523 ' ND2' ' HB3' ' A' ' 98' ' ' HIS . 1.9 m-80 57.38 33.48 23.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.073 -1.017 . . . . 0.0 109.922 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.27 31.91 15.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -133.13 171.19 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.391 -0.818 . . . . 0.0 109.681 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.2 mp -154.26 77.73 5.41 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.427 -0.796 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.52 165.8 31.67 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.149 1.605 . . . . 0.0 110.36 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.58 178.66 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.069 1.563 . . . . 0.0 110.444 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.464 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.19 20.49 2.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.319 -0.863 . . . . 0.0 110.624 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.7 p -94.64 37.47 1.13 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.538 -0.726 . . . . 0.0 109.596 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.77 -174.8 4.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.485 -0.759 . . . . 0.0 110.182 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.492 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 34.7 p -139.09 149.9 45.09 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.317 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.548 ' HE1' ' CD2' ' A' ' 60' ' ' PHE . 30.6 mmm -51.56 -38.6 55.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.478 -0.764 . . . . 0.0 110.16 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -54.12 -40.4 66.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.492 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 2.1 mt-30 -68.43 -46.05 70.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.146 -1.208 . . . . 0.0 109.269 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.54 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -56.92 -20.56 24.04 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.131 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.53 ' O ' ' HB3' ' A' ' 99' ' ' HIS . 1.3 t80 -48.75 -53.28 19.63 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.794 -1.191 . . . . 0.0 109.833 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.579 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 10.3 tt0 -69.49 -19.92 63.73 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.778 -1.201 . . . . 0.0 111.337 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.78 -62.98 1.37 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.066 -1.021 . . . . 0.0 113.53 -177.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.575 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.8 m-70 -98.12 35.8 1.68 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.675 -1.266 . . . . 0.0 112.682 -176.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.579 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -92.16 169.56 10.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.035 -1.041 . . . . 0.0 110.066 178.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 101' ' ' GLU . 3.0 tt0 -153.61 102.57 2.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.721 -1.237 . . . . 0.0 110.059 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 100' ' ' GLU . 3.0 mt-10 43.32 -167.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.112 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.495 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 4.8 t0 41.94 -136.32 0.27 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 8.6 p90 -144.93 45.52 1.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.112 -0.993 . . . . 0.0 110.114 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.495 ' CE2' ' HB3' ' A' ' 102' ' ' ASP . 20.3 p90 -144.97 163.39 34.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.637 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.596 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -117.71 167.3 11.48 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 0.0 109.362 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 2.9 p90 -125.82 133.93 51.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.866 -1.146 . . . . 0.0 111.712 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.596 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 5.6 mt -141.19 147.03 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.437 -0.79 . . . . 0.0 109.785 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.0 177.43 7.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.052 . . . . 0.0 110.287 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.618 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.2 p90 -143.47 171.42 14.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.221 -0.924 . . . . 0.0 110.612 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.427 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 1.9 t -159.63 -175.15 5.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.464 -0.772 . . . . 0.0 110.2 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.532 ' HB2' ' CG2' ' A' ' 41' ' ' ILE . 8.8 t70 -128.57 20.34 6.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.401 -0.812 . . . . 0.0 110.095 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 111' ' ' ASP . 7.7 mt-10 61.47 132.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 110.09 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 64.8 p -86.0 -2.17 58.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.317 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.98 168.27 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.242 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -71.34 158.08 36.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.391 -0.818 . . . . 0.0 110.269 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.5 -154.14 5.36 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.143 . . . . 0.0 110.221 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -43.08 10.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -1.214 . . . . 0.0 110.241 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -77.81 -34.98 51.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -0.901 . . . . 0.0 110.554 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.2 mp -65.8 -18.81 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.088 -1.007 . . . . 0.0 110.1 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' CD ' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -86.86 -35.95 18.74 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.024 -1.048 . . . . 0.0 110.18 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HG3' ' HG2' ' A' ' 24' ' ' LYS . 1.3 tptm -64.71 -40.58 95.6 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.173 -0.954 . . . . 0.0 108.984 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 1.7 mtmt -85.23 -41.11 15.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.0 109.702 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 17.1 m-85 -114.41 68.2 1.83 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.295 -0.878 . . . . 0.0 110.499 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HA ' ' CD ' ' A' ' 22' ' ' ARG . 47.6 Cg_endo -73.29 -0.75 9.62 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.954 1.502 . . . . 0.0 110.459 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -116.92 8.93 13.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.227 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.421 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.8 mpt_? -94.18 -171.24 2.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.128 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.513 HG12 ' CG1' ' A' ' 31' ' ' VAL . 19.6 t -147.45 109.2 3.88 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.31 -0.869 . . . . 0.0 110.171 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.576 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.1 Cg_endo -75.45 84.14 1.77 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.193 1.628 . . . . 0.0 110.101 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.552 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.2 m -82.72 132.03 32.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.131 -0.98 . . . . 0.0 111.045 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 32' ' ' ILE . 41.4 mm -93.86 142.78 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 107' ' ' ILE . 0.5 OUTLIER -124.65 147.96 29.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.86 -1.15 . . . . 0.0 111.135 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.579 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -156.57 -174.12 4.79 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HE2' ' CZ ' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -121.39 160.65 23.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.9 -1.125 . . . . 0.0 110.53 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.548 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.92 -174.83 0.15 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.412 -0.805 . . . . 0.0 109.296 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.2 Cg_endo -70.54 111.87 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.531 1.28 . . . . 0.0 109.68 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 2.8 mttt 62.21 42.34 9.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.351 -0.843 . . . . 0.0 110.05 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.504 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -56.13 -177.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.306 -0.871 . . . . 0.0 109.995 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -148.39 28.05 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 111.01 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.551 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 2.0 pp -91.81 176.46 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.83 -1.169 . . . . 0.0 110.324 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.551 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -52.12 -176.5 0.04 OUTLIER Glycine 0 N--CA 1.498 2.803 0 O-C-N 121.296 -0.878 . . . . 0.0 111.181 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.53 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 10.1 t0 -80.47 -171.33 3.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -1.09 . . . . 0.0 109.993 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -142.25 138.5 31.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 110.667 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -86.07 -32.97 21.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 109.827 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 151.83 30.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.961 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HA ' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -112.53 46.02 1.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 109.769 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -165.92 109.7 0.81 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.552 -0.718 . . . . 0.0 109.48 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.593 ' CD2' HD11 ' A' ' 63' ' ' LEU . 12.7 m-85 -105.83 140.39 38.93 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.117 -0.989 . . . . 0.0 110.326 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.53 92.91 4.67 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.466 ' HB ' HD13 ' A' ' 55' ' ' LEU . 13.6 m -115.64 150.82 45.4 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.53 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.477 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.0 Cg_endo -70.5 148.48 60.34 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.107 1.583 . . . . 0.0 110.036 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.54 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -62.56 -16.19 54.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -0.805 . . . . 0.0 111.399 -178.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.86 -13.2 54.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.036 -1.04 . . . . 0.0 111.209 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.477 ' HG ' ' HG2' ' A' ' 52' ' ' PRO . 3.8 mt -62.06 140.99 58.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.865 -1.147 . . . . 0.0 111.133 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.6 p -90.57 154.59 19.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.619 -0.676 . . . . 0.0 109.45 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.536 ' CG1' HG22 ' A' ' 87' ' ' THR . 58.9 t -52.74 -21.19 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.061 -1.024 . . . . 0.0 110.04 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.67 -41.24 57.31 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.458 ' HB2' HD21 ' A' ' 55' ' ' LEU . 2.1 mm-40 -67.74 -47.24 69.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.214 -1.168 . . . . 0.0 109.903 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.647 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 31.1 t80 -60.79 -46.51 90.24 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.496 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -51.13 -22.11 2.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.824 -1.173 . . . . 0.0 109.802 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -78.82 -54.22 6.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.946 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.593 HD11 ' CD2' ' A' ' 49' ' ' TYR . 3.6 pp -59.92 -20.44 57.39 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.02 -1.05 . . . . 0.0 112.189 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.647 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.6 mt -90.19 -37.54 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 120.103 -1.623 . . . . 0.0 108.836 177.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.47 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -37.99 -61.36 0.66 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.278 0.561 . . . . 0.0 110.736 -179.511 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -31.0 71.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.913 -1.117 . . . . 0.0 109.822 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.452 ' C ' HD12 ' A' ' 68' ' ' ILE . 21.4 mmt180 -67.7 -16.94 64.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.582 HD11 ' CE2' ' A' ' 109' ' ' TYR . 2.9 mm -99.76 14.11 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.371 -0.83 . . . . 0.0 109.51 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.451 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER 47.87 33.53 3.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.553 -0.717 . . . . 0.0 110.562 179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.504 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 4.1 pp -112.03 155.62 23.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.695 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.65 -172.23 2.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.079 -1.013 . . . . 0.0 111.056 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 55.27 -89.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.478 -0.764 . . . . 0.0 110.889 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.5 pt-20 -147.21 32.09 0.91 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 111.032 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -52.92 176.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.074 -1.016 . . . . 0.0 109.843 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -117.59 139.17 51.34 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.134 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.552 ' C ' ' CG ' ' A' ' 77' ' ' PHE . 29.8 tp -164.49 155.25 14.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 110.427 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.568 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 20.1 m-85 -153.79 123.3 6.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.45 -0.781 . . . . 0.0 109.754 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.546 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 18.0 m-30 -84.71 132.78 34.41 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.098 -1.001 . . . . 0.0 111.705 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 62.3 m-85 -120.37 119.81 34.16 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.58 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 2.1 t -120.77 127.95 75.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.235 -0.916 . . . . 0.0 110.206 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.43 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 28.8 t30 54.77 35.47 24.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.874 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 64.14 32.15 12.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.38 -0.825 . . . . 0.0 110.077 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -135.63 171.05 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.415 -0.803 . . . . 0.0 109.853 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.1 mp -154.55 75.4 5.74 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.544 -0.723 . . . . 0.0 109.47 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.5 163.91 36.37 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.967 1.509 . . . . 0.0 110.651 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.98 177.64 7.49 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.17 1.616 . . . . 0.0 110.276 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.536 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.88 21.96 2.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.263 -0.898 . . . . 0.0 110.603 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.78 36.68 0.86 Allowed 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 109.745 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -147.45 -170.4 3.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.376 -0.827 . . . . 0.0 110.358 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.525 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 58.6 p -138.96 146.94 41.58 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.488 0.661 . . . . 0.0 109.92 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.584 ' HE2' ' CD2' ' A' ' 60' ' ' PHE . 1.2 mmt -47.13 -47.36 23.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.248 -0.907 . . . . 0.0 110.431 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.54 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -42.73 -44.73 5.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.525 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 1.0 OUTLIER -67.81 -39.76 83.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -1.159 . . . . 0.0 109.243 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.554 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -59.53 -24.94 64.09 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.364 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.576 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -49.16 -56.07 10.39 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.517 -1.365 . . . . 0.0 109.411 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.582 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 8.7 tt0 -71.35 -18.18 62.39 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.163 -0.961 . . . . 0.0 111.911 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.563 ' HG2' ' CE1' ' A' ' 98' ' ' HIS . 1.3 tt0 -87.77 -61.23 1.76 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.756 -1.215 . . . . 0.0 112.552 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.58 ' CD2' ' HB ' ' A' ' 80' ' ' VAL . 17.4 m-70 -98.27 38.64 1.31 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.859 -1.15 . . . . 0.0 111.424 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.582 ' CD2' ' O ' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -71.63 173.02 8.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.424 -0.797 . . . . 0.0 109.122 178.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -148.4 152.22 36.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.63 -1.294 . . . . 0.0 110.673 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 102' ' ' ASP . 48.7 mt-10 -49.76 89.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.407 -0.808 . . . . 0.0 110.21 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER 170.71 -80.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.118 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.661 ' CD2' ' CE1' ' A' ' 104' ' ' PHE . 3.5 t80 -179.84 -54.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.796 . . . . 0.0 110.124 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.661 ' CE1' ' CD2' ' A' ' 103' ' ' PHE . 5.6 m-85 -77.65 -176.44 4.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.33 -0.856 . . . . 0.0 110.229 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.595 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.51 168.54 9.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.205 -0.934 . . . . 0.0 109.291 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.441 ' HB2' ' HG3' ' A' ' 100' ' ' GLU . 1.2 m-85 -121.92 130.68 53.54 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.64 -1.288 . . . . 0.0 111.597 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.595 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 5.8 mt -141.56 127.05 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.33 -0.856 . . . . 0.0 110.354 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.93 163.64 18.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.111 -0.993 . . . . 0.0 108.851 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.669 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.7 OUTLIER -145.75 164.05 33.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.622 -1.299 . . . . 0.0 111.225 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.481 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 1.5 t -159.27 -175.95 5.53 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.508 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.518 ' OD1' ' CB ' ' A' ' 75' ' ' ALA . 65.5 t0 -134.36 27.62 3.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.968 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.438 ' OE2' ' HB3' ' A' ' 110' ' ' SER . 0.5 OUTLIER -69.06 170.01 10.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.175 -0.953 . . . . 0.0 110.107 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 113' ' ' SER . 4.6 t -156.44 33.7 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.148 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.9 171.14 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.912 . . . . 0.0 110.25 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -80.21 78.31 6.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.85 -133.52 6.05 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.268 -1.137 . . . . 0.0 110.23 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -46.33 -32.27 3.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -1.125 . . . . 0.0 109.905 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -77.88 -39.19 44.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.14 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 10.4 mm -59.62 -13.97 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.924 . . . . 0.0 110.136 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -52.6 5.39 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -53.74 -34.55 59.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.528 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.477 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 12.2 mttt -84.63 -47.87 10.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.615 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.534 ' HB3' ' CD ' ' A' ' 28' ' ' ARG . 68.5 m-85 -109.99 56.7 0.31 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 111.413 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.477 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 51.3 Cg_endo -72.35 -10.03 25.03 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.486 1.256 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -100.74 3.2 42.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.14 -0.975 . . . . 0.0 111.065 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.534 ' CD ' ' HB3' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -145.25 -175.99 4.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.88 -1.138 . . . . 0.0 110.751 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.559 HG11 ' CE1' ' A' ' 95' ' ' TYR . 23.4 t -119.35 134.32 23.76 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.413 -0.804 . . . . 0.0 110.866 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 52.3 Cg_endo -81.16 112.48 2.56 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 124.246 1.656 . . . . 0.0 109.477 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.521 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 45.8 t -100.13 125.06 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 110.897 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.631 ' CD1' ' CE2' ' A' ' 104' ' ' PHE . 27.1 mm -91.51 147.15 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 108.819 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 t -130.61 143.93 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 120.855 -1.153 . . . . 0.0 111.556 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.519 ' HA ' ' CE ' ' A' ' 47' ' ' LYS . 3.5 tt0 -156.54 167.25 31.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.552 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.661 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -96.79 163.46 12.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.937 -1.102 . . . . 0.0 110.921 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.561 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -65.89 -174.0 0.14 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 0.0 109.68 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 44.8 Cg_endo -74.03 116.64 4.72 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.576 1.303 . . . . 0.0 109.968 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.29 39.56 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 110.034 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' CB ' ' CG ' ' A' ' 35' ' ' LYS . . . -62.37 174.42 0.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.359 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 31.75 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.56 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.8 pp -85.88 177.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.026 . . . . 0.0 110.611 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -49.1 -176.89 0.01 OUTLIER Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.26 -177.17 5.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.253 -1.145 . . . . 0.0 110.001 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD1' ' OH ' ' A' ' 109' ' ' TYR . 0.2 OUTLIER -148.58 147.55 29.13 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.047 -1.033 . . . . 0.0 110.453 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.459 ' N ' HD23 ' A' ' 44' ' ' LEU . 9.4 m-20 -86.82 -28.42 22.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.375 -0.828 . . . . 0.0 110.626 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.471 ' O ' HD12 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -152.54 156.83 40.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 0.0 110.011 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.519 ' CE ' ' HA ' ' A' ' 34' ' ' GLU . 6.6 mmmm -120.65 43.8 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.054 -1.029 . . . . 0.0 109.781 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 1.5 ptmm? -157.94 109.75 2.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.379 -0.825 . . . . 0.0 109.74 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.479 ' CE2' HD13 ' A' ' 63' ' ' LEU . 28.1 m-85 -104.29 147.44 27.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 110.965 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.472 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -120.12 114.17 21.56 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 55' ' ' LEU . 2.8 m -141.0 165.32 30.2 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.714 -1.241 . . . . 0.0 110.889 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 43.7 Cg_endo -69.22 147.93 67.46 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.151 1.606 . . . . 0.0 110.46 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.531 ' HB3' ' CA ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -65.34 -12.72 54.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.461 -0.775 . . . . 0.0 111.336 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -84.08 -5.48 59.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.084 -1.01 . . . . 0.0 110.913 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.531 HD11 ' CG2' ' A' ' 51' ' ' VAL . 3.8 mt -61.96 141.52 57.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.83 -1.169 . . . . 0.0 111.107 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.47 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 0.9 OUTLIER -92.07 159.57 15.63 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.589 -0.694 . . . . 0.0 109.698 178.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 88.3 t -58.44 -26.64 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.76 -31.51 67.44 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.528 ' CB ' HD21 ' A' ' 55' ' ' LEU . 15.7 mm100 -69.34 -51.1 40.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.639 ' CD1' ' CD1' ' A' ' 63' ' ' LEU . 6.9 t80 -59.97 -33.57 72.12 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.436 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.57 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -55.58 -35.14 65.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 109.998 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -79.74 -50.01 11.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.74 . . . . 0.0 112.682 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.639 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.66 -39.85 81.81 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.434 -1.416 . . . . 0.0 111.927 -177.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -76.11 -42.95 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 119.877 -1.764 . . . . 0.0 108.432 178.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.475 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 3.4 mtt180 -35.92 -61.58 0.47 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.825 -0.547 . . . . 0.0 110.863 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.71 -33.07 75.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.029 . . . . 0.0 109.895 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -69.97 -10.3 58.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -0.901 . . . . 0.0 109.624 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.565 HD11 ' CE2' ' A' ' 109' ' ' TYR . 5.5 mm -100.4 7.5 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.442 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.43 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 3.0 m-70 54.84 31.47 15.74 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.415 -0.803 . . . . 0.0 110.416 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.488 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 4.2 pp -110.62 150.6 28.75 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.835 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.2 ptt180 -167.0 -167.19 0.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 111.017 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.428 ' C ' ' CG ' ' A' ' 73' ' ' GLU . . . 56.56 -86.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.562 -0.711 . . . . 0.0 110.96 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 71' ' ' ARG . 35.7 mt-10 -151.38 30.28 0.61 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.914 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -59.72 176.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.076 -1.015 . . . . 0.0 109.637 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -103.69 139.73 38.55 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.135 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.597 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 19.3 tp -160.95 150.7 17.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.915 . . . . 0.0 110.465 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 85.9 m-85 -160.32 120.57 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.865 -0.522 . . . . 0.0 109.641 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CE2' ' HA ' ' A' ' 61' ' ' TYR . 81.4 m-85 -89.94 113.53 25.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.101 -0.999 . . . . 0.0 110.214 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 68.5 m-85 -104.97 136.61 44.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.342 -0.849 . . . . 0.0 109.876 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.58 HG11 ' CD2' ' A' ' 98' ' ' HIS . 4.9 t -120.18 125.92 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.466 ' HB2' ' CG ' ' A' ' 98' ' ' HIS . 0.8 OUTLIER 46.31 39.26 6.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.241 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 2.3 t30 67.53 38.45 3.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.401 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.7 t -135.51 168.51 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 109.864 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.4 mp -154.44 69.5 5.99 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.505 -0.747 . . . . 0.0 109.718 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.28 170.49 19.75 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.068 1.562 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.22 179.55 5.35 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.101 1.579 . . . . 0.0 110.36 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.48 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.69 21.62 2.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.399 -0.813 . . . . 0.0 110.559 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 t -95.73 39.64 1.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.522 -0.736 . . . . 0.0 109.791 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.81 -176.7 5.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 110.338 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 45.3 p -139.61 148.32 42.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.569 -0.707 . . . . 0.0 110.255 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.547 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -52.96 -41.47 64.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 109.946 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.531 ' CA ' ' HB3' ' A' ' 53' ' ' SER . . . -49.56 -50.07 31.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 90' ' ' THR . 2.2 pt20 -64.72 -28.95 69.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -1.146 . . . . 0.0 109.671 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.547 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.31 -23.12 64.7 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.318 -0.864 . . . . 0.0 109.677 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.604 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -50.07 -55.9 12.98 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.094 -1.004 . . . . 0.0 109.909 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -17.51 63.93 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.545 -1.347 . . . . 0.0 110.623 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.5 mt-10 -88.57 -71.75 0.57 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.17 -0.956 . . . . 0.0 113.445 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.58 ' CD2' HG11 ' A' ' 80' ' ' VAL . 16.3 m-70 -100.74 38.35 1.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.653 -1.28 . . . . 0.0 113.112 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.604 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -89.58 -2.03 58.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.988 -1.07 . . . . 0.0 111.029 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 60.85 43.13 12.27 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 121.739 -0.601 . . . . 0.0 110.089 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 102' ' ' ASP . 12.7 tt0 44.18 76.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.407 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 101' ' ' GLU . 2.9 t0 177.09 -147.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.323 -0.861 . . . . 0.0 110.315 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.583 ' O ' ' CD1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -122.38 71.12 1.0 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.258 -0.901 . . . . 0.0 110.311 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 32' ' ' ILE . 0.1 OUTLIER 168.38 134.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.243 -0.911 . . . . 0.0 109.658 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.531 ' CD1' HG13 ' A' ' 107' ' ' ILE . 0.4 OUTLIER -98.52 154.22 18.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.67 -1.269 . . . . 0.0 110.057 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.513 ' N ' HD12 ' A' ' 105' ' ' LEU . 62.7 m-85 -119.09 122.07 41.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.115 -0.991 . . . . 0.0 111.218 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.531 HG13 ' CD1' ' A' ' 105' ' ' LEU . 25.3 mt -140.26 149.42 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -143.29 178.69 7.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 110.116 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -143.71 164.07 31.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 110.641 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -160.05 176.27 12.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.386 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.46 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 6.3 p-10 -112.53 31.99 5.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 110.127 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 16.8 pt-20 -178.58 142.55 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.378 -0.827 . . . . 0.0 110.112 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.01 -18.96 16.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 110.409 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.43 170.04 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.458 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -119.21 152.03 37.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 110.167 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 51.88 -154.76 4.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.505 ' CG ' ' O ' ' A' ' 117' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.222 -1.163 . . . . 0.0 110.147 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.13 -38.6 39.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.166 -1.196 . . . . 0.0 109.933 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 3.8 tptt -80.87 -37.61 29.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.268 -0.895 . . . . 0.0 110.394 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.498 ' N ' HD13 ' A' ' 21' ' ' ILE . 1.2 mp -63.24 -17.91 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.068 -1.02 . . . . 0.0 109.898 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.451 ' HD3' ' HA ' ' A' ' 26' ' ' PRO . 11.6 tpp180 -85.71 -57.62 2.98 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.227 -0.921 . . . . 0.0 109.64 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -49.25 -37.33 23.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.196 -0.94 . . . . 0.0 109.881 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 5.2 mmtm -84.31 -47.66 10.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.676 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 29.0 m-85 -112.14 65.06 0.72 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 110.867 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 47.0 Cg_endo -72.24 -4.77 15.83 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.857 1.451 . . . . 0.0 110.347 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -94.55 -6.88 42.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.504 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -97.29 -162.15 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 0.0 110.076 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 23.7 t -145.03 107.06 4.54 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -77.33 86.24 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.145 1.603 . . . . 0.0 109.938 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.567 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -81.45 136.1 23.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.305 -0.872 . . . . 0.0 111.113 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 47.1 mm -91.88 139.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 47' ' ' LYS . 3.0 t -126.06 139.97 49.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.889 -1.132 . . . . 0.0 111.332 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 2.2 tt0 -156.51 174.24 15.72 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.635 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -102.46 159.77 15.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.924 -1.11 . . . . 0.0 110.419 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.548 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -65.04 -175.29 0.17 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.478 -0.764 . . . . 0.0 109.436 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.6 Cg_endo -71.98 107.25 2.18 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.564 1.297 . . . . 0.0 109.877 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 63.46 40.05 8.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 110.026 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.78 -174.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.117 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 31.49 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.0 110.797 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.563 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -90.28 176.31 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.96 -1.087 . . . . 0.0 110.493 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -51.42 -173.8 0.02 OUTLIER Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.308 -0.87 . . . . 0.0 111.117 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -71.49 -175.93 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -1.162 . . . . 0.0 109.867 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.59 ' CD1' ' CD ' ' A' ' 47' ' ' LYS . 1.4 pp -134.99 133.13 39.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.146 -0.972 . . . . 0.0 110.651 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.476 ' HB2' ' HD3' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -86.68 -42.32 13.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.219 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.442 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -152.79 151.71 30.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 110.279 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.59 ' CD ' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -111.25 49.59 0.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 109.728 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -169.55 111.17 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.519 -0.738 . . . . 0.0 109.659 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.567 ' HB2' ' CG2' ' A' ' 31' ' ' VAL . 10.2 m-85 -108.36 141.05 40.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.075 -1.015 . . . . 0.0 110.37 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.37 92.14 4.2 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.488 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 34.4 m -114.25 147.57 38.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 110.486 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.1 Cg_endo -70.96 150.33 60.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.815 1.429 . . . . 0.0 109.772 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.526 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -65.08 -13.49 58.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.302 -0.874 . . . . 0.0 111.594 -178.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -87.72 -14.23 40.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.888 -1.132 . . . . 0.0 111.189 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.492 ' HG ' ' HG2' ' A' ' 52' ' ' PRO . 4.2 mt -62.14 146.16 51.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.956 -1.09 . . . . 0.0 111.503 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.462 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 3.9 p -91.28 160.05 15.71 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.638 -0.664 . . . . 0.0 109.533 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.513 HG11 ' CG2' ' A' ' 87' ' ' THR . 63.5 t -60.01 -22.04 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.016 . . . . 0.0 110.043 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.83 -39.72 64.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.464 ' CB ' HD23 ' A' ' 55' ' ' LEU . 1.5 mm-40 -67.96 -48.64 65.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -1.173 . . . . 0.0 109.987 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.658 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 47.2 t80 -60.41 -44.21 95.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.569 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.683 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -53.24 -26.53 18.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.934 -1.104 . . . . 0.0 109.706 179.356 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.478 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -73.97 -47.74 35.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.398 -0.814 . . . . 0.0 109.668 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.612 ' CD1' ' CD1' ' A' ' 60' ' ' PHE . 3.2 pp -66.43 -17.16 64.63 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.013 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.658 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.1 mt -89.33 -41.07 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 120.046 -1.659 . . . . 0.0 109.398 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' CG ' ' N ' ' A' ' 66' ' ' LYS . 2.2 ptm180 -39.64 -46.28 1.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.547 -0.721 . . . . 0.0 110.616 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.554 ' N ' ' CG ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -72.81 -36.9 67.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.984 -1.073 . . . . 0.0 109.814 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.519 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 5.8 mmp_? -69.41 -10.12 56.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.302 -0.874 . . . . 0.0 109.857 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.589 HG12 ' CE2' ' A' ' 109' ' ' TYR . 45.1 mt -104.03 7.77 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.006 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.522 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 50.07 31.29 4.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.363 -0.835 . . . . 0.0 110.308 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.525 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 2.9 pp -103.56 156.28 17.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.37 -165.15 0.82 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.036 -1.04 . . . . 0.0 110.941 -179.001 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.04 -90.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.782 . . . . 0.0 110.601 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 71' ' ' ARG . 4.6 pt-20 -156.41 26.1 0.35 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 111.037 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.523 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.04 176.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.063 -1.023 . . . . 0.0 110.002 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.523 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -110.98 142.99 42.37 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.137 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.542 ' C ' ' CG ' ' A' ' 77' ' ' PHE . 21.8 tp -156.16 155.49 32.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 110.545 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' O ' ' CE1' ' A' ' 79' ' ' PHE . 19.4 m-85 -152.83 123.28 7.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.548 -0.72 . . . . 0.0 109.818 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CD2' ' CE2' ' A' ' 61' ' ' TYR . 21.3 m-30 -88.17 135.85 33.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.255 -0.903 . . . . 0.0 111.273 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.571 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 54.0 m-85 -120.33 119.0 31.85 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.58 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 2.0 t -121.25 112.43 35.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 121.357 -0.839 . . . . 0.0 110.304 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.44 ' O ' HG22 ' A' ' 83' ' ' VAL . 13.4 t-20 59.96 42.22 16.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 0.0 110.22 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.92 34.49 14.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.5 t -134.47 168.02 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 109.994 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.0 OUTLIER -155.02 67.5 5.23 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.581 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.46 ' HD3' HG13 ' A' ' 83' ' ' VAL . 46.7 Cg_endo -72.86 160.04 46.93 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.922 1.485 . . . . 0.0 110.665 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.82 -178.91 3.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.038 1.547 . . . . 0.0 110.65 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.513 ' CG2' HG11 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -85.85 20.53 2.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.459 -0.776 . . . . 0.0 110.618 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 t -95.37 42.76 1.09 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.443 -0.786 . . . . 0.0 109.507 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' C ' HG22 ' A' ' 90' ' ' THR . . . -145.13 -169.69 3.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.663 0.744 . . . . 0.0 110.3 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 45.0 p -139.24 143.1 37.84 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.687 -0.633 . . . . 0.0 109.935 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.527 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 25.4 mmm -50.88 -45.15 59.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 109.545 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.55 -48.54 34.99 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.1 OUTLIER -64.59 -31.76 73.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -1.136 . . . . 0.0 110.106 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.54 HD12 ' CD1' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -68.54 -23.17 64.49 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.115 -0.991 . . . . 0.0 110.133 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.537 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -48.64 -53.45 18.58 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.519 -179.435 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.12 -20.98 63.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.194 -0.941 . . . . 0.0 111.291 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.479 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 14.8 mt-10 -84.27 -63.99 1.24 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.014 -1.054 . . . . 0.0 112.06 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.58 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 7.5 m-70 -97.41 40.62 1.15 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.966 -1.084 . . . . 0.0 110.779 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER -68.24 -174.45 0.51 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.08 -162.16 1.18 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.858 -1.151 . . . . 0.0 110.523 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.43 1.88 12.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.366 -0.834 . . . . 0.0 110.129 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -135.44 146.15 47.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.92 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.448 ' C ' ' O ' ' A' ' 102' ' ' ASP . 15.1 m-85 -39.42 -27.81 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.471 -0.768 . . . . 0.0 110.453 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' ASP . 4.4 m-85 -77.6 155.04 31.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 110.493 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.62 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -103.04 171.09 7.58 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.449 ' N ' HD13 ' A' ' 105' ' ' LEU . 1.2 m-85 -118.14 126.89 53.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.402 -1.436 . . . . 0.0 112.211 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.62 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 4.1 mt -141.58 144.63 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -146.62 163.05 37.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.192 -0.943 . . . . 0.0 109.372 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.635 ' CE2' ' CD ' ' A' ' 35' ' ' LYS . 1.4 p90 -134.09 165.73 24.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.646 -1.284 . . . . 0.0 111.278 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.22 177.25 11.25 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.483 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 112' ' ' GLU . 11.9 t0 -126.66 37.54 4.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.922 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 4.6 mt-10 62.06 132.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.871 . . . . 0.0 110.165 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.34 48.24 2.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 116' ' ' GLY . 9.6 p -47.2 168.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.944 . . . . 0.0 110.206 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -53.46 89.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 114' ' ' VAL . . . -156.4 167.7 33.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.26 -1.141 . . . . 0.0 110.226 -179.989 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.79 -33.22 6.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -1.095 . . . . 0.0 110.08 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.44 -38.44 41.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.229 -0.92 . . . . 0.0 110.086 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.421 HG23 HD13 ' A' ' 21' ' ' ILE . 9.9 mm -60.15 -19.87 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.227 -0.921 . . . . 0.0 110.089 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.494 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -89.22 -44.22 10.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 110.16 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -53.6 -43.86 68.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.961 . . . . 0.0 109.142 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 5.4 mtpt -85.62 -48.83 8.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.565 -0.71 . . . . 0.0 109.975 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.498 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 6.1 m-85 -115.43 62.49 1.75 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.256 -0.903 . . . . 0.0 110.147 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.487 ' CD ' ' O ' ' A' ' 22' ' ' ARG . 44.3 Cg_endo -70.12 -19.86 33.89 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.837 1.44 . . . . 0.0 110.543 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -111.65 24.84 12.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.214 -0.929 . . . . 0.0 110.021 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.498 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 5.4 mpt_? -118.86 179.82 4.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.777 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG22 ' OG ' ' A' ' 53' ' ' SER . 17.3 t -148.02 116.97 4.15 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 110.203 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 50.3 Cg_endo -79.35 90.96 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 124.257 1.661 . . . . 0.0 110.005 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.554 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -88.55 138.66 18.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.164 -0.96 . . . . 0.0 110.559 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.52 HG13 ' CE1' ' A' ' 104' ' ' PHE . 24.8 mm -95.95 152.82 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 108.901 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.463 HG11 ' HG3' ' A' ' 47' ' ' LYS . 2.6 t -133.6 141.83 43.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.965 -1.084 . . . . 0.0 111.109 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.401 ' N ' HG13 ' A' ' 33' ' ' VAL . 3.7 tt0 -157.27 -166.76 2.13 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HD2' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -124.56 160.77 27.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.885 -1.135 . . . . 0.0 110.508 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.6 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -61.63 -167.81 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.676 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 42.1 Cg_endo -71.72 123.64 9.57 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.189 1.099 . . . . 0.0 109.673 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 40.55 49.54 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.599 0.714 . . . . 0.0 110.549 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.09 -179.11 0.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.603 -0.686 . . . . 0.0 110.126 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.33 36.18 0.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.699 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.546 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.8 pp -85.18 177.87 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.025 -1.047 . . . . 0.0 110.378 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.546 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -47.9 -179.58 0.01 OUTLIER Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.488 -0.863 . . . . 0.0 110.997 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' O ' HD21 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -75.85 -179.28 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -1.171 . . . . 0.0 110.071 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' CG ' ' OH ' ' A' ' 109' ' ' TYR . 1.6 mm? -136.17 134.8 38.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.164 -0.96 . . . . 0.0 110.579 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 29.7 t0 -86.49 -36.96 18.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.436 -0.79 . . . . 0.0 110.099 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.83 154.44 35.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HG3' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -117.69 46.42 1.74 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.12 -0.987 . . . . 0.0 109.818 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -164.51 109.66 0.97 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.423 -0.798 . . . . 0.0 109.965 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.581 ' CD2' HD12 ' A' ' 63' ' ' LEU . 16.3 m-85 -108.14 139.6 42.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.04 -1.038 . . . . 0.0 110.12 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.85 99.63 8.51 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.526 ' CG2' ' HE2' ' A' ' 91' ' ' MET . 5.1 m -126.14 160.03 59.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.046 -1.034 . . . . 0.0 110.861 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 42.3 Cg_endo -67.69 144.98 67.99 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.052 1.553 . . . . 0.0 110.434 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.541 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -63.5 -14.0 46.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.446 -0.784 . . . . 0.0 111.441 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -83.73 -10.36 58.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.96 -1.088 . . . . 0.0 110.945 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.509 HD21 ' CB ' ' A' ' 59' ' ' GLN . 4.1 mt -62.22 141.32 58.27 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.003 -1.06 . . . . 0.0 111.027 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -91.44 169.15 11.02 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.703 -0.623 . . . . 0.0 109.827 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.494 ' CG1' HG23 ' A' ' 87' ' ' THR . 95.3 t -61.93 -26.63 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.307 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.88 -39.61 75.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.509 ' CB ' HD21 ' A' ' 55' ' ' LEU . 5.3 mm-40 -67.67 -48.56 66.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.1 -1.236 . . . . 0.0 110.101 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.651 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 24.0 t80 -60.45 -46.43 90.1 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.469 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -50.51 -23.62 2.62 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.888 -1.132 . . . . 0.0 109.928 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.79 -51.79 9.26 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.588 HD11 ' CD1' ' A' ' 60' ' ' PHE . 4.0 pp -63.54 -17.83 63.22 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.432 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.651 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.6 mt -91.82 -39.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 120.01 -1.681 . . . . 0.0 109.059 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -35.43 -64.66 0.27 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.086 0.47 . . . . 0.0 110.961 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.02 -31.4 72.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.208 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.525 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 28.6 mmt-85 -68.21 -16.79 64.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.066 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.608 ' CD1' ' CE2' ' A' ' 109' ' ' TYR . 1.2 mm -97.44 8.74 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.601 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.453 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER 57.04 30.17 17.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 110.317 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.529 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.3 pp -117.61 154.84 30.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.917 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -166.25 -169.07 1.34 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.235 -0.916 . . . . 0.0 111.046 -179.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 49.74 -92.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.523 -0.736 . . . . 0.0 111.015 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -142.5 45.9 1.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 111.039 -179.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -72.85 176.32 5.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.889 -1.132 . . . . 0.0 109.803 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.518 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.38 140.32 38.67 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.157 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 44.6 tp -164.3 153.27 13.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.591 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 74.4 m-85 -158.01 119.91 3.65 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.703 -0.623 . . . . 0.0 109.621 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.481 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 16.7 m-30 -83.5 134.7 34.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.155 -0.965 . . . . 0.0 111.977 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.17 123.35 42.06 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.573 HG13 ' CG ' ' A' ' 98' ' ' HIS . 2.1 t -120.49 119.85 60.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 O-C-N 121.201 -0.937 . . . . 0.0 110.077 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 26.4 t30 50.91 39.05 21.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.1 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 64.95 35.2 8.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.5 t -135.41 168.41 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.306 -0.871 . . . . 0.0 109.931 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.3 mp -154.37 72.84 6.18 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.554 -0.716 . . . . 0.0 109.533 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.12 165.64 32.18 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.072 1.564 . . . . 0.0 110.662 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.462 ' HG2' ' OG ' ' A' ' 88' ' ' SER . 45.9 Cg_endo -72.85 178.31 6.56 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.044 1.55 . . . . 0.0 110.348 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.494 HG23 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.56 21.59 2.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.462 ' OG ' ' HG2' ' A' ' 86' ' ' PRO . 3.0 p -93.04 39.68 1.05 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 109.61 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.5 -172.91 3.98 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.684 0.754 . . . . 0.0 110.275 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.466 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 64.2 p -138.95 145.8 40.21 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.501 0.667 . . . . 0.0 110.016 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.557 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 4.3 mmm -51.42 -39.76 57.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 110.232 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.541 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.83 -49.96 45.81 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -64.6 -26.48 68.42 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.35 -1.088 . . . . 0.0 109.628 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.557 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -69.02 -25.52 64.53 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.302 -0.874 . . . . 0.0 110.044 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.59 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -49.12 -56.0 10.5 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.824 -1.173 . . . . 0.0 109.652 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -70.14 -18.32 63.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.992 -1.067 . . . . 0.0 111.2 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 14.0 mt-10 -87.75 -67.05 0.85 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 112.789 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.573 ' CG ' HG13 ' A' ' 80' ' ' VAL . 12.9 m-70 -98.6 36.96 1.55 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.795 -1.19 . . . . 0.0 112.315 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.518 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -68.89 167.98 14.54 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.126 -0.984 . . . . 0.0 109.422 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 99' ' ' HIS . 0.1 OUTLIER -176.78 164.74 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.754 -1.216 . . . . 0.0 110.792 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER 47.03 -124.94 1.55 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -0.801 . . . . 0.0 110.349 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.525 ' HB2' ' CD2' ' A' ' 104' ' ' PHE . 6.0 m-20 -59.85 -134.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.95 -1.094 . . . . 0.0 110.403 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.48 ' CD1' ' NH1' ' A' ' 22' ' ' ARG . 18.0 p90 -106.59 13.35 28.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.007 -1.058 . . . . 0.0 110.523 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 101' ' ' GLU . 7.5 p90 -98.08 -176.23 3.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.111 -0.993 . . . . 0.0 109.874 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.559 ' CD1' ' CD1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.8 168.37 9.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.989 -1.07 . . . . 0.0 110.304 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.542 ' C ' ' CD1' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -122.11 133.76 54.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.926 -1.109 . . . . 0.0 110.727 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.559 ' CD1' ' CD1' ' A' ' 105' ' ' LEU . 4.6 mt -138.86 137.16 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.316 -0.865 . . . . 0.0 110.289 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.16 145.01 38.84 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.236 -0.915 . . . . 0.0 108.778 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.608 ' CE2' ' CD1' ' A' ' 68' ' ' ILE . 2.9 p90 -130.2 170.96 13.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.54 -1.35 . . . . 0.0 111.924 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 0.4 OUTLIER -157.91 179.78 8.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.845 -0.535 . . . . 0.0 110.063 -179.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.518 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 8.8 p-10 -121.11 36.68 4.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.928 . . . . 0.0 110.268 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.18 154.22 47.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 110.257 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.46 31.97 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.286 -0.884 . . . . 0.0 110.136 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.08 176.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 110.291 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -78.54 135.67 37.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.21 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.58 -155.06 7.73 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.248 -1.149 . . . . 0.0 110.222 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' O ' ' HB ' ' A' ' 21' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -49.66 -39.36 36.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -1.194 . . . . 0.0 110.203 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 6.0 mtpt -76.2 -28.62 57.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.373 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 21' ' ' ILE . 1.2 mp -61.08 -17.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.0 109.813 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -88.4 -51.4 5.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.44 -42.5 43.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.438 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 24.6 mttm -85.44 -47.41 9.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.471 -0.768 . . . . 0.0 109.904 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 9.9 m-85 -113.77 61.8 0.97 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 0.0 110.345 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 43.7 Cg_endo -69.66 -25.33 29.14 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.816 1.43 . . . . 0.0 110.666 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.76 19.78 19.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 110.282 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -107.78 -163.14 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.964 . . . . 0.0 110.307 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 51' ' ' VAL . 23.2 t -144.51 109.73 4.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 110.188 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.583 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 48.6 Cg_endo -76.02 96.14 1.05 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.162 1.611 . . . . 0.0 110.18 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -90.9 145.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.354 -0.841 . . . . 0.0 110.626 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 1.1 mp -100.25 156.03 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 49' ' ' TYR . 2.3 t -133.19 136.36 55.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.034 -1.041 . . . . 0.0 110.972 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 108' ' ' ALA . 2.1 mt-10 -148.65 177.23 9.68 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.759 -0.588 . . . . 0.0 109.454 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.596 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -112.82 158.15 20.49 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.898 -1.126 . . . . 0.0 110.614 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.591 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -63.9 -169.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.556 -0.715 . . . . 0.0 109.24 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 44.0 Cg_endo -73.54 109.45 2.85 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.31 1.163 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.23 41.49 6.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.365 -0.834 . . . . 0.0 110.433 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.53 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -61.44 174.47 0.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 109.804 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.58 34.56 0.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 111.092 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.533 ' HB ' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -87.66 -175.84 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.848 -1.158 . . . . 0.0 110.033 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.505 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -49.07 178.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.954 -1.117 . . . . 0.0 110.328 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -82.5 -176.81 6.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 109.777 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 ' HG ' ' OH ' ' A' ' 109' ' ' TYR . 1.5 mm? -137.18 131.8 33.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 110.782 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -86.84 -26.78 23.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -0.825 . . . . 0.0 109.429 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -152.67 154.31 35.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.457 -0.777 . . . . 0.0 109.798 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -120.05 44.73 2.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.032 -1.042 . . . . 0.0 109.945 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 8.9 pttp -159.0 111.2 2.18 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.355 -0.841 . . . . 0.0 109.497 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.575 ' CD2' HD11 ' A' ' 63' ' ' LEU . 12.0 m-85 -103.86 140.09 38.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.992 -1.067 . . . . 0.0 110.335 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.05 92.3 4.71 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.494 ' HB ' HD13 ' A' ' 55' ' ' LEU . 26.9 m -116.02 142.42 29.16 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.178 -0.951 . . . . 0.0 110.898 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.485 ' HD2' HD13 ' A' ' 55' ' ' LEU . 42.2 Cg_endo -67.49 148.87 79.72 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.103 1.58 . . . . 0.0 109.956 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.554 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 2.0 m -63.12 -13.94 42.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 111.614 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -83.37 -14.8 52.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.111 -0.993 . . . . 0.0 110.888 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD23 ' CB ' ' A' ' 59' ' ' GLN . 4.7 mt -62.65 142.67 57.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.021 -1.05 . . . . 0.0 111.424 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 3.2 p -90.97 163.97 14.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.637 -0.665 . . . . 0.0 109.288 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.475 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 39.2 t -61.52 -24.6 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.957 -1.089 . . . . 0.0 110.086 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.07 -31.98 66.23 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.505 ' CB ' HD23 ' A' ' 55' ' ' LEU . 5.2 mm100 -74.6 -47.82 30.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -1.214 . . . . 0.0 109.886 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.664 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 38.9 t80 -60.2 -32.59 71.24 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.287 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' CE2' ' HD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -60.72 -31.92 71.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 109.567 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.464 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 3.7 t80 -71.74 -52.87 15.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.54 -0.725 . . . . 0.0 110.993 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.604 HD12 ' CE1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -59.67 -35.09 73.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.834 -1.167 . . . . 0.0 112.57 -178.206 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.664 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -77.7 -32.19 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 119.657 -1.902 . . . . 0.0 109.394 178.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.487 ' HG2' ' CD1' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -39.81 -64.08 0.52 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.512 -0.742 . . . . 0.0 110.624 -179.32 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -30.31 71.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HB2' ' HA ' ' A' ' 64' ' ' ILE . 5.8 mmp_? -67.7 -17.42 64.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.011 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.582 ' CD1' ' CE2' ' A' ' 109' ' ' TYR . 2.7 mm -104.44 15.86 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.9 . . . . 0.0 109.793 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.436 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 49.99 28.84 3.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.587 -0.695 . . . . 0.0 110.655 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD21 ' CG2' ' A' ' 68' ' ' ILE . 4.2 pp -111.0 155.06 23.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.839 . . . . 0.0 109.783 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.0 -173.41 2.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.923 -179.365 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.11 -91.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.469 -0.77 . . . . 0.0 110.784 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.467 ' O ' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -146.31 36.61 1.0 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.995 . . . . 0.0 111.051 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -60.05 176.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.078 -1.013 . . . . 0.0 109.825 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -94.23 138.25 32.46 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.553 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 20.3 tp -164.78 152.05 11.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.399 -0.813 . . . . 0.0 110.596 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 81.7 m-85 -158.35 119.9 3.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.578 -0.701 . . . . 0.0 109.757 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 10.7 m-85 -90.44 124.08 34.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 110.862 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 68.3 m-85 -115.5 127.29 55.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.562 HG11 ' CG ' ' A' ' 98' ' ' HIS . 2.8 t -121.25 121.93 66.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.503 -0.748 . . . . 0.0 109.959 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.464 ' O ' ' CG2' ' A' ' 83' ' ' VAL . 0.8 OUTLIER 47.7 47.26 18.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 110.119 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 18.8 m120 57.22 36.84 27.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 110.491 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.6 t -135.3 168.0 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.596 HG13 ' O ' ' A' ' 83' ' ' VAL . 1.1 mp -155.02 73.74 5.66 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.539 -0.725 . . . . 0.0 109.524 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.55 165.37 31.81 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.095 1.576 . . . . 0.0 110.767 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.51 -178.86 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.046 1.551 . . . . 0.0 110.435 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.475 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.1 20.57 2.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.223 -0.923 . . . . 0.0 110.593 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.7 t -95.85 41.55 1.1 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.504 -0.748 . . . . 0.0 109.527 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.55 -175.1 4.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.496 -0.752 . . . . 0.0 110.287 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.499 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 77.7 p -139.45 138.24 36.29 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.601 0.715 . . . . 0.0 110.229 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.641 ' CE ' ' CD1' ' A' ' 60' ' ' PHE . 2.7 mmm -45.72 -39.24 7.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.966 -1.084 . . . . 0.0 109.842 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.83 -53.03 23.62 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.972 -1.109 . . . . 0.0 110.439 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 2.6 pt20 -64.13 -27.03 68.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.089 -1.242 . . . . 0.0 110.008 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.557 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.36 -25.97 65.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.21 -0.931 . . . . 0.0 109.929 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.583 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -50.03 -55.5 14.52 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.855 -1.153 . . . . 0.0 109.698 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.575 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 2.0 mt-30 -69.41 -18.44 63.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.951 -1.093 . . . . 0.0 110.974 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 10.5 mt-10 -88.38 -68.36 0.77 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.012 -1.055 . . . . 0.0 113.13 -177.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.562 ' CG ' HG11 ' A' ' 80' ' ' VAL . 11.4 m-70 -99.35 38.05 1.48 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.703 -1.248 . . . . 0.0 112.795 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.575 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -82.53 165.98 19.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.995 -1.065 . . . . 0.0 109.856 178.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 99' ' ' HIS . 0.3 OUTLIER 169.54 154.02 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.882 -1.136 . . . . 0.0 110.332 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 100' ' ' GLU . 3.9 mt-10 57.98 117.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.526 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 73.3 m-20 56.12 -122.66 1.78 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.264 -0.898 . . . . 0.0 109.948 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -137.86 33.42 2.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.798 -1.189 . . . . 0.0 109.895 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 102' ' ' ASP . 8.8 m-85 -117.36 169.09 9.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.24 -0.912 . . . . 0.0 110.468 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.544 HD13 ' CD1' ' A' ' 107' ' ' ILE . 0.4 OUTLIER -101.99 165.29 11.25 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.374 -0.829 . . . . 0.0 109.301 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.558 ' CD1' ' O ' ' A' ' 106' ' ' TYR . 0.3 OUTLIER -122.9 123.82 41.82 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.77 -1.206 . . . . 0.0 111.165 -179.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.544 ' CD1' HD13 ' A' ' 105' ' ' LEU . 10.9 mt -141.97 147.66 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.204 -0.935 . . . . 0.0 109.82 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 34' ' ' GLU . . . -147.18 -179.57 6.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.145 -0.972 . . . . 0.0 110.159 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.666 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.2 OUTLIER -140.97 162.26 35.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.945 -1.097 . . . . 0.0 111.418 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.438 ' HB2' ' HB1' ' A' ' 36' ' ' ALA . 6.8 t -148.0 -177.81 5.94 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 3.0 p-10 -116.66 29.96 7.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 110.53 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 4.7 pt-20 -178.98 160.4 1.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.323 -0.861 . . . . 0.0 110.519 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.0 t -160.06 34.93 0.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.417 -0.802 . . . . 0.0 110.09 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.0 p -48.34 169.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 110.213 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.439 ' O ' ' CD2' ' A' ' 115' ' ' TYR . 67.9 t80 -56.99 92.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.139 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.2 -151.67 6.31 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.251 -1.146 . . . . 0.0 110.257 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -49.03 -38.39 23.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -1.171 . . . . 0.0 110.135 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -75.48 -34.12 60.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.363 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.492 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.2 mp -59.97 -17.54 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.164 -0.96 . . . . 0.0 109.74 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -50.48 9.41 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.989 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -56.73 -42.9 80.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.31 -0.869 . . . . 0.0 110.032 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 2.0 mtpm? -76.78 -43.3 37.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.274 -0.891 . . . . 0.0 109.716 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 44.9 m-85 -114.07 62.59 1.13 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.728 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 47.3 Cg_endo -72.37 -11.53 26.71 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.811 1.427 . . . . 0.0 110.441 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 1.2 t0 -102.08 9.45 40.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.32 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.453 ' O ' HG22 ' A' ' 29' ' ' VAL . 6.0 mpt_? -106.9 -169.87 1.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.897 . . . . 0.0 110.152 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.471 HG11 ' CG1' ' A' ' 31' ' ' VAL . 21.8 t -147.24 107.78 3.89 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 110.39 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.497 ' O ' ' HB3' ' A' ' 104' ' ' PHE . 49.3 Cg_endo -77.78 90.85 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.253 1.66 . . . . 0.0 110.029 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.0 OUTLIER -90.85 133.49 32.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 111.215 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 44.0 mm -95.68 133.76 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 0.0 108.438 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -126.85 128.26 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.711 -1.243 . . . . 0.0 111.866 -178.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 3.1 tm-20 -132.62 159.5 39.37 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.635 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -87.55 163.38 16.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.867 -1.146 . . . . 0.0 110.863 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.556 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -65.47 -174.82 0.16 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 109.62 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 44.1 Cg_endo -72.85 116.61 4.78 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.638 1.336 . . . . 0.0 110.046 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 63.88 42.25 6.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.341 -0.849 . . . . 0.0 110.463 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.589 ' CB ' ' CG ' ' A' ' 35' ' ' LYS . . . -65.49 175.09 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.28 33.17 0.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.669 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.536 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -95.35 177.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.023 -1.048 . . . . 0.0 110.247 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -42.41 169.52 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.093 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -78.75 -176.48 4.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -1.195 . . . . 0.0 110.066 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.513 ' CD2' ' O ' ' A' ' 43' ' ' ASP . 1.2 mm? -139.4 135.84 34.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.898 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -86.49 -29.7 22.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.534 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -153.68 150.17 28.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -111.47 47.14 1.04 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.9 -1.125 . . . . 0.0 109.942 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -159.41 111.71 2.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.588 -0.695 . . . . 0.0 109.244 179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.577 ' CD2' ' CD1' ' A' ' 63' ' ' LEU . 19.6 m-85 -103.76 141.12 36.64 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.022 -1.049 . . . . 0.0 110.351 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -108.01 93.09 4.35 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' HB ' HD12 ' A' ' 55' ' ' LEU . 9.5 m -117.86 154.06 51.1 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.342 -0.849 . . . . 0.0 110.721 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.6 Cg_endo -70.34 147.01 58.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.085 1.571 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.521 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.3 m -62.38 -14.8 44.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 0.0 111.488 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -84.12 -12.4 55.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.025 -1.047 . . . . 0.0 111.331 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.8 mt -62.12 142.0 57.84 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.898 -1.126 . . . . 0.0 111.257 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.1 p -91.61 164.78 13.64 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.52 ' CG1' HG23 ' A' ' 87' ' ' THR . 93.4 t -60.87 -21.11 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.868 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.33 59.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.505 ' CB ' HD22 ' A' ' 55' ' ' LEU . 4.3 mm-40 -67.64 -47.98 68.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.164 -1.198 . . . . 0.0 109.845 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.665 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 34.8 t80 -60.82 -42.82 98.44 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.196 -1.001 . . . . 0.0 109.492 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.48 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -54.36 -22.56 12.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.752 -1.218 . . . . 0.0 109.838 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -79.39 -54.51 5.87 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.473 -0.767 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.577 ' CD1' ' CD2' ' A' ' 49' ' ' TYR . 1.2 pp -59.64 -25.94 65.1 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.833 -1.167 . . . . 0.0 112.102 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.665 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.7 mt -84.13 -42.45 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 119.997 -1.689 . . . . 0.0 108.844 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.473 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 1.8 mtp-105 -36.49 -60.58 0.58 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.017 0.436 . . . . 0.0 110.721 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -66.94 -32.7 74.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.831 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 64' ' ' ILE . 6.0 mmt-85 -69.34 -10.27 57.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.166 -0.959 . . . . 0.0 109.262 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.527 ' CD1' HG23 ' A' ' 64' ' ' ILE . 62.1 mt -103.97 13.21 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.474 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.538 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.6 OUTLIER 44.67 31.97 0.71 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.44 -0.787 . . . . 0.0 110.344 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.512 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 3.8 pp -104.9 153.55 21.24 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.893 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' GLU . 14.3 ptt180 -166.06 -168.45 1.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 111.033 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 49.85 -92.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.507 -0.746 . . . . 0.0 110.858 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 8.4 pt-20 -143.37 40.49 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 110.834 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.519 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -64.69 176.62 1.1 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.083 -1.011 . . . . 0.0 109.799 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -115.1 140.17 49.29 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.268 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.59 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 43.3 tp -157.6 150.7 23.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 80.9 m-85 -158.82 121.36 3.62 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.762 -0.586 . . . . 0.0 109.943 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 18.3 m-30 -88.09 128.16 35.42 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.061 -1.024 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 60.7 m-85 -115.98 128.61 55.87 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 108.984 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.585 HG13 ' CD2' ' A' ' 98' ' ' HIS . 2.3 t -120.4 128.71 76.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.149 -0.97 . . . . 0.0 110.27 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.539 ' OD1' ' CG2' ' A' ' 83' ' ' VAL . 5.6 p30 43.11 35.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 110.151 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 1.4 m-20 73.69 39.45 0.55 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.598 -0.689 . . . . 0.0 111.311 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.8 t -136.33 168.36 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.0 110.047 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.1 mp -154.96 68.71 5.54 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.58 -0.7 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.44 ' HD3' HG11 ' A' ' 83' ' ' VAL . 46.4 Cg_endo -73.05 164.36 35.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.992 1.522 . . . . 0.0 110.753 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.47 ' HG2' ' OG ' ' A' ' 88' ' ' SER . 44.2 Cg_endo -71.92 179.09 5.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.144 1.602 . . . . 0.0 110.583 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.52 HG23 ' CG1' ' A' ' 57' ' ' VAL . 1.1 p -87.03 20.35 2.71 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.322 -0.861 . . . . 0.0 110.842 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.47 ' OG ' ' HG2' ' A' ' 86' ' ' PRO . 2.2 p -90.53 39.9 0.99 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.447 -0.783 . . . . 0.0 109.475 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.38 -174.39 4.37 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.589 0.709 . . . . 0.0 110.006 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 82.2 p -139.59 152.84 47.15 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.462 -0.773 . . . . 0.0 110.318 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.533 ' CA ' HD23 ' A' ' 94' ' ' LEU . 43.8 mmm -56.57 -41.73 77.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.388 -0.82 . . . . 0.0 109.926 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.521 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -52.04 -48.16 52.89 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -65.28 -27.13 68.41 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.407 -1.055 . . . . 0.0 109.657 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.533 HD23 ' CA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -69.02 -23.82 64.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.907 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.591 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -49.26 -56.65 8.69 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.851 -1.156 . . . . 0.0 109.434 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.564 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 11.9 tt0 -70.94 -16.09 62.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.836 -1.165 . . . . 0.0 111.373 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.471 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -87.97 -63.31 1.32 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.994 -1.066 . . . . 0.0 113.626 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.585 ' CD2' HG13 ' A' ' 80' ' ' VAL . 9.3 m-70 -98.03 35.89 1.66 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.757 -1.214 . . . . 0.0 112.624 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.591 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -107.81 174.88 5.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 110.312 178.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 99' ' ' HIS . 0.1 OUTLIER 175.16 93.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.738 -1.226 . . . . 0.0 110.083 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 103' ' ' PHE . 32.9 mt-10 43.84 -137.29 0.39 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.764 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 103' ' ' PHE . 10.1 t70 51.75 -89.15 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.06 -1.025 . . . . 0.0 110.275 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 101' ' ' GLU . 0.1 OUTLIER 174.29 -64.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.51 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.497 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 5.6 m-85 -92.64 -174.85 3.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.377 -0.827 . . . . 0.0 110.582 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.541 ' CD1' HG13 ' A' ' 107' ' ' ILE . 0.3 OUTLIER -99.02 166.08 11.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.291 -0.881 . . . . 0.0 109.12 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.515 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.8 OUTLIER -118.72 121.75 40.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.696 -1.253 . . . . 0.0 111.896 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.541 HG13 ' CD1' ' A' ' 105' ' ' LEU . 7.5 mt -141.63 149.79 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.462 -0.774 . . . . 0.0 109.181 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -139.23 177.02 8.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.005 -1.06 . . . . 0.0 109.963 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.9 OUTLIER -155.13 163.73 39.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.011 -1.056 . . . . 0.0 111.251 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.4 t -159.56 -178.31 7.02 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.234 0.54 . . . . 0.0 110.137 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.516 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 8.5 p-10 -117.1 29.19 8.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.199 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.47 ' OE1' ' CE2' ' A' ' 77' ' ' PHE . 2.0 mt-10 61.7 166.28 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.212 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.88 36.2 3.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 110.244 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -99.67 175.34 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.235 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -127.32 142.51 51.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 110.189 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.36 159.21 24.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.281 -179.987 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -46.47 -28.14 1.3 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -1.14 . . . . 0.0 110.194 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -76.83 -41.0 45.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.247 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.7 mm -64.11 -14.47 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.206 -0.934 . . . . 0.0 110.248 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.562 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 1.4 mpt_? -88.95 -52.01 5.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.94 . . . . 0.0 110.168 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -49.75 -42.09 45.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.396 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 3.6 mtpp -85.45 -49.49 8.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 110.088 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 21.6 m-85 -117.03 64.85 3.54 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.912 . . . . 0.0 110.455 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 22' ' ' ARG . 46.4 Cg_endo -72.84 -8.22 22.0 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.841 1.443 . . . . 0.0 110.292 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -120.19 19.46 12.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.915 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.474 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 7.1 mpt_? -102.78 -174.07 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 110.457 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.533 HG11 ' CG1' ' A' ' 31' ' ' VAL . 20.0 t -147.4 105.11 3.77 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.596 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -76.37 83.41 2.03 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.289 1.678 . . . . 0.0 110.222 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.9 m -81.26 154.27 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.216 -0.928 . . . . 0.0 110.803 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.493 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 31.1 mm -111.33 161.92 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 108.761 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.477 ' N ' HG23 ' A' ' 32' ' ' ILE . 2.8 t -134.9 144.67 33.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.947 -1.095 . . . . 0.0 111.168 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' N ' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -156.36 178.02 10.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.597 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.583 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -117.07 157.61 25.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.905 -1.122 . . . . 0.0 110.681 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.565 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -64.87 -173.74 0.12 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.516 -0.74 . . . . 0.0 109.253 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 43.1 Cg_endo -71.25 105.62 1.76 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.446 1.235 . . . . 0.0 109.762 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER 63.43 40.74 8.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.41 -0.806 . . . . 0.0 110.326 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.84 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.184 -0.947 . . . . 0.0 109.831 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG2' ' CB ' ' A' ' 111' ' ' ASP . 2.9 ptm180 -144.67 26.63 1.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 0.0 110.994 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.472 HG21 HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -85.48 -177.37 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.938 -1.101 . . . . 0.0 109.378 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' A' ' 69' ' ' HIS . . . -62.4 171.05 11.08 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.479 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.4 t70 -75.15 -177.29 3.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -1.1 . . . . 0.0 109.998 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.482 ' HG ' ' OH ' ' A' ' 109' ' ' TYR . 1.5 mm? -138.6 133.29 32.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.128 -0.982 . . . . 0.0 110.808 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.505 ' CB ' ' HE2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -86.8 -21.9 26.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.814 . . . . 0.0 109.136 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HE2' ' CB ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -151.68 147.66 26.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.571 -0.706 . . . . 0.0 109.105 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -123.61 48.84 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.921 -1.112 . . . . 0.0 110.184 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 11.5 pttm -158.19 108.95 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 110.118 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.588 ' CD2' HD12 ' A' ' 63' ' ' LEU . 23.4 m-85 -103.83 144.17 31.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.134 -0.979 . . . . 0.0 110.412 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.8 103.68 11.2 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 55' ' ' LEU . 3.3 m -128.8 159.37 68.66 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 110.931 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.465 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.9 Cg_endo -70.65 148.17 58.74 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.193 1.628 . . . . 0.0 110.513 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.528 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -63.02 -17.08 61.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.494 -0.754 . . . . 0.0 111.305 -179.104 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -83.51 -9.65 58.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 0.0 111.322 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.532 ' CD1' ' HB ' ' A' ' 51' ' ' VAL . 3.9 mt -62.08 141.41 58.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.784 -1.198 . . . . 0.0 110.908 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.427 ' HA ' HG23 ' A' ' 90' ' ' THR . 6.0 p -91.21 156.67 17.67 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.504 -0.748 . . . . 0.0 109.575 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.506 ' CG1' HG22 ' A' ' 87' ' ' THR . 95.5 t -54.05 -24.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.068 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.81 -38.37 66.02 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.49 ' CB ' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -68.57 -49.28 60.66 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.142 -1.211 . . . . 0.0 110.017 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.654 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 31.3 t80 -60.49 -47.38 86.38 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.793 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.85 -21.8 1.87 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.68 -1.263 . . . . 0.0 109.776 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -78.68 -54.16 6.4 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.765 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.588 HD12 ' CD2' ' A' ' 49' ' ' TYR . 3.6 pp -60.72 -18.45 54.48 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.27 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -92.3 -41.36 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.115 -1.616 . . . . 0.0 109.145 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.465 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -37.26 -61.2 0.6 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.872 -0.518 . . . . 0.0 110.677 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -65.16 -32.87 74.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.098 -1.001 . . . . 0.0 109.618 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 29.3 mmt-85 -69.94 -12.11 61.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 110.109 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.491 ' O ' ' CG2' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -99.09 4.48 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.123 -0.985 . . . . 0.0 109.295 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.479 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 55.47 29.25 12.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.459 -0.776 . . . . 0.0 110.018 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.518 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 3.8 pp -101.0 151.81 21.33 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.038 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.82 -161.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.288 -0.883 . . . . 0.0 110.778 -179.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.525 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 49.92 -87.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.0 110.917 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 72' ' ' ALA . 40.7 mt-10 -156.37 36.45 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 110.634 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -62.91 176.59 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.059 -1.026 . . . . 0.0 109.848 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.52 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -119.0 145.06 46.14 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.061 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.537 ' C ' ' CG ' ' A' ' 77' ' ' PHE . 22.2 tp -158.84 153.56 24.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.537 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 56.2 m-85 -154.39 122.35 5.94 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.547 -0.72 . . . . 0.0 109.767 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.582 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 16.7 m-30 -84.2 131.15 34.78 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.337 -0.852 . . . . 0.0 111.869 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 64.6 m-85 -120.12 119.04 32.15 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.643 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 1.4 t -121.59 126.26 74.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 8.7 t-20 55.25 35.28 24.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.079 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 2.0 t-20 64.58 32.16 11.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 110.106 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.4 t -135.12 168.55 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.577 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 1.1 mp -154.86 73.43 5.8 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.58 -0.7 . . . . 0.0 109.297 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.19 165.14 33.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.099 1.579 . . . . 0.0 110.867 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.62 178.73 5.92 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.108 1.583 . . . . 0.0 110.339 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.506 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -88.22 21.91 2.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.361 -0.837 . . . . 0.0 110.657 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.7 p -90.5 37.36 0.91 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.46 -0.775 . . . . 0.0 109.795 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.08 -171.96 4.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.463 -0.773 . . . . 0.0 110.142 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.51 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 44.2 p -138.81 150.12 45.7 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.654 0.74 . . . . 0.0 110.267 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.549 ' HA ' ' CD2' ' A' ' 94' ' ' LEU . 3.1 mmt -47.53 -47.93 27.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.469 -0.77 . . . . 0.0 110.692 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -42.69 -43.58 5.17 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.51 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 0.7 OUTLIER -67.82 -42.49 81.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.342 -1.093 . . . . 0.0 109.23 179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.549 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -58.84 -23.24 60.35 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.363 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.596 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -48.36 -54.06 15.27 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.675 -1.265 . . . . 0.0 109.716 -179.305 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.71 -22.7 63.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.251 -0.905 . . . . 0.0 111.375 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 2.1 mm-40 -81.54 -63.52 1.38 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.957 -1.089 . . . . 0.0 111.655 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.643 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.8 m-70 -97.63 41.58 1.12 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.002 -1.061 . . . . 0.0 110.141 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 95' ' ' TYR . 6.1 t-80 -74.48 166.09 24.09 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.259 0.552 . . . . 0.0 109.691 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -145.73 68.98 1.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 109.882 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 103' ' ' PHE . 4.5 mt-10 41.31 -164.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.597 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.483 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 8.3 m-20 39.93 -93.0 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.509 -0.744 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.571 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER 179.26 64.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.976 . . . . 0.0 110.164 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 30' ' ' PRO . 1.9 m-85 -161.36 150.51 16.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.386 -0.821 . . . . 0.0 109.979 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.588 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -114.87 161.77 17.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.046 -1.034 . . . . 0.0 109.488 179.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.493 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 4.3 p90 -120.49 132.81 55.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.778 -1.201 . . . . 0.0 111.749 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.588 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 7.7 mt -141.25 124.54 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 0.0 109.98 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -122.36 160.3 25.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.993 -1.067 . . . . 0.0 109.671 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.583 ' CE2' ' CD ' ' A' ' 35' ' ' LYS . 1.4 p90 -135.42 162.2 33.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.694 -1.254 . . . . 0.0 111.258 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.33 178.76 8.16 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.135 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 112' ' ' GLU . 9.6 t0 -105.95 -3.21 21.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.21 -0.931 . . . . 0.0 110.325 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.519 ' HB2' ' CD2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER 47.59 -177.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.424 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 114' ' ' VAL . 9.1 t -118.94 29.76 7.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 109.883 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 113' ' ' SER . 8.2 p -42.55 166.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 110.407 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.36 126.82 15.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.228 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.68 -146.94 0.73 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.272 -1.134 . . . . 0.0 110.241 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.95 -20.23 5.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -1.149 . . . . 0.0 109.819 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 2.0 mttt -76.57 -36.99 57.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.359 -0.838 . . . . 0.0 110.361 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.516 ' N ' HD13 ' A' ' 21' ' ' ILE . 1.2 mp -59.78 -19.42 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 0.0 109.67 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.2 -36.57 16.72 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.178 -0.952 . . . . 0.0 109.808 179.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -65.76 -36.88 84.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.305 -0.872 . . . . 0.0 108.933 179.315 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' HG2' ' HG2' ' A' ' 23' ' ' LYS . 5.1 mttt -85.34 -44.04 13.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.463 -0.773 . . . . 0.0 109.675 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -114.61 61.51 1.21 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 110.77 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HA ' ' HD2' ' A' ' 22' ' ' ARG . 48.0 Cg_endo -72.81 -4.38 15.27 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.813 1.428 . . . . 0.0 110.381 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -116.39 13.57 15.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 110.453 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.62 -175.1 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.298 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG12 HG12 ' A' ' 31' ' ' VAL . 16.3 t -147.2 107.25 3.89 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.483 ' HD2' ' OH ' ' A' ' 95' ' ' TYR . 46.3 Cg_endo -75.41 86.48 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.181 1.621 . . . . 0.0 109.855 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' A' ' 49' ' ' TYR . 1.1 m -79.71 136.61 23.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.317 -0.865 . . . . 0.0 110.553 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 14.9 mm -91.86 157.25 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.435 ' HB ' ' C ' ' A' ' 47' ' ' LYS . 2.5 t -134.05 140.41 46.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 120.898 -1.126 . . . . 0.0 111.336 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.47 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.23 169.74 23.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.413 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.519 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -109.5 162.62 14.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.857 -1.152 . . . . 0.0 110.522 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.572 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . . . -62.42 -172.17 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.499 -0.751 . . . . 0.0 109.307 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.572 ' HD2' ' CB ' ' A' ' 36' ' ' ALA . 42.9 Cg_endo -71.55 110.41 2.87 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.433 1.228 . . . . 0.0 109.83 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.64 42.58 10.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.26 -0.9 . . . . 0.0 110.025 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.519 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -59.38 179.13 0.11 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.286 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.527 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 6.5 ptm180 -150.04 29.81 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 110.825 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.543 ' CD1' ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.41 178.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.064 . . . . 0.0 110.424 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.543 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -48.02 -178.4 0.01 OUTLIER Glycine 0 N--CA 1.496 2.666 0 O-C-N 121.332 -0.855 . . . . 0.0 111.055 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.466 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 7.7 t70 -84.95 -178.98 6.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -1.202 . . . . 0.0 109.858 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.468 ' HG ' ' OH ' ' A' ' 109' ' ' TYR . 1.3 mm? -138.41 134.73 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.096 -1.002 . . . . 0.0 110.592 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.95 -24.02 26.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.456 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.08 154.46 29.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.556 -0.715 . . . . 0.0 109.591 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -118.73 43.18 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.945 -1.097 . . . . 0.0 110.017 179.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 47' ' ' LYS . 18.9 mttt -158.23 109.53 2.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.619 -0.676 . . . . 0.0 109.566 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.588 ' CD2' HD12 ' A' ' 63' ' ' LEU . 15.3 m-85 -103.84 141.06 36.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.018 -1.051 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -103.87 94.57 5.49 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.486 ' HB ' HD11 ' A' ' 55' ' ' LEU . 14.7 m -117.57 149.65 45.3 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 110.851 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.458 ' HD2' HD12 ' A' ' 55' ' ' LEU . 47.0 Cg_endo -70.56 149.71 62.18 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.212 1.638 . . . . 0.0 110.074 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.527 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.5 m -62.27 -17.15 57.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.405 -0.809 . . . . 0.0 111.405 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -83.95 -11.57 56.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 111.385 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.486 HD11 ' HB ' ' A' ' 51' ' ' VAL . 3.3 mt -61.61 141.21 57.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.858 -1.151 . . . . 0.0 111.145 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 p -91.17 154.0 19.63 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.285 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 25.6 t -53.97 -20.98 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.057 -1.027 . . . . 0.0 109.785 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.73 -39.63 59.72 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.476 ' HB2' HD22 ' A' ' 55' ' ' LEU . 10.9 mm-40 -67.85 -47.38 69.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.046 -1.267 . . . . 0.0 109.599 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.644 ' CE2' ' CD1' ' A' ' 64' ' ' ILE . 21.3 t80 -60.38 -45.97 91.65 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.432 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.64 -22.86 2.23 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.953 -1.092 . . . . 0.0 109.911 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -80.15 -54.54 5.66 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.818 . . . . 0.0 110.357 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.588 HD12 ' CD2' ' A' ' 49' ' ' TYR . 3.6 pp -59.61 -21.64 60.69 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.012 -1.055 . . . . 0.0 112.306 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.644 ' CD1' ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -90.45 -38.56 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 120.09 -1.632 . . . . 0.0 108.816 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -36.65 -62.43 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.863 -0.523 . . . . 0.0 110.691 -179.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -30.63 71.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.133 -0.98 . . . . 0.0 109.845 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 20.1 mmt180 -68.01 -13.85 62.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 109.481 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.519 ' CG2' HD23 ' A' ' 70' ' ' LEU . 70.6 mt -103.21 14.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.449 -0.782 . . . . 0.0 109.545 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.541 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 1.4 t60 47.8 28.76 1.41 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.552 -0.718 . . . . 0.0 110.493 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.0 pp -110.71 155.17 22.84 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.636 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 73' ' ' GLU . 11.5 ptt180 -166.15 -171.67 2.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.114 -0.991 . . . . 0.0 111.054 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.47 -89.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.522 -0.736 . . . . 0.0 110.763 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -148.55 33.24 0.78 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.143 -0.973 . . . . 0.0 110.919 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -56.76 176.81 0.09 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.024 -1.048 . . . . 0.0 109.796 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.29 138.77 40.96 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.128 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.593 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 17.5 tp -164.41 152.85 12.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 110.505 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 94.1 m-85 -158.85 122.08 3.77 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.663 -0.648 . . . . 0.0 109.896 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CD1' ' HB3' ' A' ' 109' ' ' TYR . 16.9 m-30 -85.62 132.33 34.19 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.136 -0.977 . . . . 0.0 111.346 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 58.2 m-85 -119.45 121.46 39.52 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.49 -0.756 . . . . 0.0 109.227 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.578 HG12 ' CG ' ' A' ' 98' ' ' HIS . 2.5 t -120.63 123.48 70.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.358 -0.839 . . . . 0.0 110.074 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 7.6 t30 50.39 34.54 9.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 8.4 t-20 66.98 37.37 3.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.95 . . . . 0.0 110.146 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 84' ' ' ILE . 2.7 t -135.47 169.96 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 109.83 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.584 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.6 OUTLIER -154.68 73.67 5.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.478 -0.764 . . . . 0.0 109.207 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.52 155.77 58.99 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.164 1.613 . . . . 0.0 110.925 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.71 -178.67 3.58 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.167 1.614 . . . . 0.0 110.273 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.51 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 1.2 p -86.03 18.46 3.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.906 . . . . 0.0 110.823 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.4 m -90.33 32.49 0.94 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.397 -0.814 . . . . 0.0 109.662 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.31 -174.18 4.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.525 -0.735 . . . . 0.0 110.096 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.498 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 67.3 p -139.4 149.91 44.66 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.561 -0.712 . . . . 0.0 110.19 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.58 ' CE ' ' CD2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -48.74 -43.81 37.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.317 -0.864 . . . . 0.0 110.175 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.527 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -46.1 -44.18 14.02 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.498 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 2.4 mt-30 -65.58 -47.0 77.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.385 -1.067 . . . . 0.0 109.434 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -56.91 -23.43 44.94 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.385 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.504 ' O ' ' HB3' ' A' ' 99' ' ' HIS . 1.0 OUTLIER -48.94 -56.18 9.61 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.812 -1.18 . . . . 0.0 109.848 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -16.78 62.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.027 -1.046 . . . . 0.0 111.532 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -87.15 -65.53 1.0 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.892 -1.13 . . . . 0.0 112.473 -178.043 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.578 ' CG ' HG12 ' A' ' 80' ' ' VAL . 8.7 m-70 -98.78 41.48 1.14 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.953 -1.092 . . . . 0.0 111.388 -177.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 6.8 p80 -68.12 -19.98 64.88 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.492 -0.755 . . . . 0.0 109.758 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER 75.4 -75.95 0.06 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.918 -0.489 . . . . 0.0 110.778 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 102' ' ' ASP . 6.5 tt0 -166.61 45.53 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.089 -1.007 . . . . 0.0 110.096 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 101' ' ' GLU . 3.8 t0 177.58 -142.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.862 . . . . 0.0 110.105 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -94.01 -58.34 2.27 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.187 -0.946 . . . . 0.0 109.881 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.457 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 4.9 p90 -55.29 166.95 0.51 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.105 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.612 ' CD1' ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -121.73 171.64 8.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.125 -0.985 . . . . 0.0 109.752 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.483 ' HA ' ' HB ' ' A' ' 32' ' ' ILE . 1.3 m-85 -122.64 126.23 47.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.666 -1.271 . . . . 0.0 111.366 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.612 ' CG1' ' CD1' ' A' ' 105' ' ' LEU . 9.0 mt -138.75 136.16 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.179 -0.951 . . . . 0.0 110.358 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -130.73 173.11 11.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -1.0 . . . . 0.0 109.731 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.632 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.4 p90 -150.69 165.33 33.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.87 -1.144 . . . . 0.0 111.364 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -150.54 -178.28 6.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.768 -0.583 . . . . 0.0 110.177 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.539 ' HB3' ' CG2' ' A' ' 41' ' ' ILE . 8.4 p-10 -128.5 29.98 5.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -148.53 147.42 29.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.33 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.2 p -132.17 19.34 4.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.2 p -105.21 172.32 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -82.52 177.09 8.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 110.159 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 45.52 -141.13 4.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.305 -1.115 . . . . 0.0 110.16 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.533 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.141 0.496 . . . . 0.0 109.962 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 31' ' ' VAL . 24.2 t -133.65 103.99 12.1 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.933 . . . . 0.0 110.383 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.487 ' HD2' ' OH ' ' A' ' 95' ' ' TYR . 48.7 Cg_endo -75.97 85.21 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.264 1.665 . . . . 0.0 109.721 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 29' ' ' VAL . 2.0 m -77.9 150.33 5.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 110.918 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 35.9 mm -106.54 160.66 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.318 -0.864 . . . . 0.0 108.672 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.723 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.2 t -134.36 141.23 44.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.903 -1.123 . . . . 0.0 111.336 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.65 174.97 14.67 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.538 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -115.93 159.85 21.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.779 -1.2 . . . . 0.0 110.526 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.01 -174.3 0.14 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.595 -0.691 . . . . 0.0 109.405 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.7 Cg_endo -71.32 110.37 2.83 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.617 1.325 . . . . 0.0 109.92 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.22 42.9 5.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.326 -0.859 . . . . 0.0 110.066 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.538 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -57.47 -179.82 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.491 ' CG ' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.06 35.11 0.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.108 -0.995 . . . . 0.0 110.749 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.879 HD12 ' O ' ' A' ' 42' ' ' GLY . 2.1 pp -95.09 176.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 0.0 110.274 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.879 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -49.09 -177.69 0.01 OUTLIER Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.932 ' O ' HD22 ' A' ' 44' ' ' LEU . 5.6 t70 -79.79 -179.03 6.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -1.149 . . . . 0.0 109.615 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.932 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.8 mm? -135.63 131.94 36.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.433 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' C ' ' HD2' ' A' ' 46' ' ' LYS . 1.6 m-20 -86.8 -28.73 22.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.703 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 45' ' ' ASP . 3.7 mptt -152.68 157.03 40.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.54 -0.725 . . . . 0.0 109.808 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -123.88 43.19 3.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.955 . . . . 0.0 109.958 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 3.6 pttt -159.67 107.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.846 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.896 ' CD2' HD13 ' A' ' 63' ' ' LEU . 22.4 m-85 -103.84 142.2 34.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.75 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.16 95.67 6.48 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.509 ' HB ' HD12 ' A' ' 55' ' ' LEU . 15.6 m -118.54 145.26 37.02 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.728 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HD2' HD12 ' A' ' 55' ' ' LEU . 43.8 Cg_endo -70.19 147.59 60.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.0 1.526 . . . . 0.0 109.932 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.568 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.85 -16.04 56.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -0.805 . . . . 0.0 111.476 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -83.57 -13.7 53.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.961 -1.087 . . . . 0.0 111.192 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.866 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.3 mt -62.44 143.62 56.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.867 -1.145 . . . . 0.0 111.527 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 p -91.12 162.84 14.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.616 -0.678 . . . . 0.0 109.717 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.614 HG12 HG22 ' A' ' 87' ' ' THR . 70.2 t -59.9 -23.71 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.99 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.3 -34.0 68.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.866 ' CB ' HD22 ' A' ' 55' ' ' LEU . 22.1 mm-40 -73.41 -46.98 45.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.097 -1.237 . . . . 0.0 109.827 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.16 ' CE2' HD11 ' A' ' 64' ' ' ILE . 19.8 t80 -60.87 -46.82 89.11 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.565 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -50.69 -21.73 1.74 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.916 -1.115 . . . . 0.0 109.913 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -80.66 -54.82 5.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.442 -0.786 . . . . 0.0 110.387 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.993 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.8 pp -60.11 -19.95 55.86 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.984 -1.072 . . . . 0.0 112.355 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.16 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -92.75 -38.88 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 120.094 -1.629 . . . . 0.0 109.165 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.551 ' HG2' HD11 ' A' ' 70' ' ' LEU . 13.9 mtt180 -36.98 -61.37 0.56 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.775 -0.578 . . . . 0.0 110.698 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -65.21 -32.32 73.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.0 109.698 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.515 ' C ' HD13 ' A' ' 68' ' ' ILE . 4.5 mmp_? -68.04 -14.77 63.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.847 ' CG2' HD23 ' A' ' 70' ' ' LEU . 2.0 mm -100.23 10.21 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.176 -0.953 . . . . 0.0 109.676 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.498 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 52.67 32.83 12.59 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.433 -0.792 . . . . 0.0 110.238 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.847 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.3 pp -116.03 153.97 30.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.444 -0.785 . . . . 0.0 110.221 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 2.7 ptp180 -166.4 -173.56 2.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.265 -0.897 . . . . 0.0 110.919 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 56.95 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.72 . . . . 0.0 111.065 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 74' ' ' ASP . 5.6 pt-20 -146.01 24.17 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.092 -1.005 . . . . 0.0 111.301 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -49.09 176.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.943 -1.098 . . . . 0.0 109.786 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.694 ' HB3' ' OD1' ' A' ' 111' ' ' ASP . . . -111.28 139.58 46.56 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.252 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.7 HD21 ' CE1' ' A' ' 78' ' ' PHE . 31.9 tp -164.76 153.68 12.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.774 . . . . 0.0 110.332 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 95.2 m-85 -157.66 120.75 3.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.57 -0.706 . . . . 0.0 110.032 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.7 ' CE1' HD21 ' A' ' 76' ' ' LEU . 15.7 m-30 -82.82 133.58 35.13 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.171 -0.956 . . . . 0.0 111.748 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 51.0 m-85 -120.65 119.38 32.66 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.912 HG22 HG23 ' A' ' 107' ' ' ILE . 2.5 t -120.67 128.41 76.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.382 -0.824 . . . . 0.0 109.915 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.544 ' HB2' ' CG ' ' A' ' 98' ' ' HIS . 4.4 t30 48.1 36.61 6.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.984 . . . . 0.0 109.921 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 12.8 m-20 66.69 38.65 3.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.468 -0.77 . . . . 0.0 110.438 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.696 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -135.66 166.95 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 110.024 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -155.19 67.7 5.18 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.635 -0.666 . . . . 0.0 109.304 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.48 164.6 34.62 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.962 1.506 . . . . 0.0 110.808 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.64 -178.33 3.34 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.114 1.587 . . . . 0.0 110.387 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.614 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -84.35 21.42 1.44 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.413 -0.804 . . . . 0.0 110.887 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -96.99 43.15 1.07 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.346 -0.847 . . . . 0.0 109.451 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.03 -172.1 3.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.547 -0.72 . . . . 0.0 110.234 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 72.2 p -139.33 145.7 39.38 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.567 -0.708 . . . . 0.0 110.375 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.014 ' HA ' HD23 ' A' ' 94' ' ' LEU . 95.9 mmm -58.88 -45.03 91.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.165 -0.959 . . . . 0.0 109.649 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -48.11 -47.65 26.54 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 1.0 OUTLIER -64.46 -32.86 74.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.211 -1.17 . . . . 0.0 109.616 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.014 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -66.16 -22.23 66.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.905 . . . . 0.0 109.955 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.516 ' CD1' HG13 ' A' ' 29' ' ' VAL . 1.2 t80 -49.22 -55.06 13.79 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.012 -1.055 . . . . 0.0 109.971 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 5.1 tp60 -69.47 -18.55 63.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.008 -1.058 . . . . 0.0 111.078 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 12.7 mm-40 -87.3 -68.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.007 -1.058 . . . . 0.0 112.363 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.544 ' CG ' ' HB2' ' A' ' 81' ' ' ASN . 8.8 m-70 -99.44 38.23 1.46 Allowed 'General case' 0 N--CA 1.484 1.257 0 O-C-N 120.833 -1.167 . . . . 0.0 111.947 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.509 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.8 p80 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.033 -1.042 . . . . 0.0 109.237 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 4.6 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.056 0.455 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.075 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -109.58 165.68 11.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.064 -1.023 . . . . 0.0 109.502 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.713 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.9 m-85 -122.85 128.89 50.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.847 -1.158 . . . . 0.0 111.87 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.075 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.3 mt -140.02 128.57 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.343 -0.848 . . . . 0.0 110.016 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -123.7 172.83 8.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 109.75 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.723 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.2 p90 -149.92 163.07 39.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.822 -1.174 . . . . 0.0 111.35 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.493 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -146.45 179.47 7.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.741 -0.6 . . . . 0.0 110.688 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.694 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 5.8 t70 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.439 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 8.7 mpt_? . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.232 0.539 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.744 HG12 HG12 ' A' ' 31' ' ' VAL . 24.0 t -145.55 105.78 4.32 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 47.7 Cg_endo -75.89 84.06 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.167 1.614 . . . . 0.0 109.818 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.831 HG12 ' CD2' ' A' ' 105' ' ' LEU . 1.8 m -80.54 149.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 111.114 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.588 HG13 ' CE1' ' A' ' 104' ' ' PHE . 6.8 mm -102.02 164.93 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.584 HG21 ' CE1' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -136.09 141.81 40.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.779 -1.201 . . . . 0.0 111.545 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 1.8 tt0 -156.52 165.76 35.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.642 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -99.69 162.47 12.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.917 -1.115 . . . . 0.0 110.738 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.031 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.36 -172.66 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.464 -0.772 . . . . 0.0 109.292 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.031 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.8 Cg_endo -71.31 107.59 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.476 1.251 . . . . 0.0 110.033 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 mttt 63.52 36.39 11.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.453 -0.78 . . . . 0.0 110.196 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.481 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -58.68 178.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 110.061 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 35.53 0.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 110.58 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.824 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.54 176.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.006 -1.059 . . . . 0.0 110.432 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.824 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -48.73 -177.47 0.01 OUTLIER Glycine 0 N--CA 1.497 2.717 0 O-C-N 121.438 -0.789 . . . . 0.0 111.179 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.892 ' O ' HD22 ' A' ' 44' ' ' LEU . 4.3 t0 -77.12 -175.74 3.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -1.091 . . . . 0.0 109.778 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.892 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -136.02 135.21 39.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.985 . . . . 0.0 110.738 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -86.89 -36.03 18.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 109.732 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.56 ' HE2' ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -152.59 155.29 37.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.474 -0.766 . . . . 0.0 109.837 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -120.31 43.23 2.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 0.0 110.226 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HG3' ' HG2' ' A' ' 47' ' ' LYS . 14.8 mttp -157.88 107.56 2.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 109.58 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.596 ' CD2' HD13 ' A' ' 63' ' ' LEU . 31.8 m-85 -103.39 143.34 32.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.114 -0.991 . . . . 0.0 110.884 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.61 89.89 3.49 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.528 ' HB ' HD12 ' A' ' 55' ' ' LEU . 20.2 m -111.04 143.45 28.36 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.347 -0.846 . . . . 0.0 111.002 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.437 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 46.5 Cg_endo -71.45 148.96 55.42 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.164 1.613 . . . . 0.0 109.74 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.554 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.55 -15.58 51.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.898 . . . . 0.0 111.438 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -83.34 -13.81 54.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.09 -1.006 . . . . 0.0 111.169 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.846 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.0 mt -62.3 143.63 56.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.829 -1.17 . . . . 0.0 111.129 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 1.6 p -91.3 167.67 12.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.593 -0.692 . . . . 0.0 109.891 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 80.8 t -62.75 -32.25 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 110.059 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.81 -23.38 70.82 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.846 ' CB ' HD22 ' A' ' 55' ' ' LEU . 34.7 mm-40 -80.4 -50.91 9.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.125 -1.221 . . . . 0.0 109.727 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.184 ' CE2' HD11 ' A' ' 64' ' ' ILE . 14.1 t80 -60.12 -34.06 72.99 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.084 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.586 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -54.8 -37.56 66.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.47 -0.769 . . . . 0.0 109.873 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.8 t80 -74.51 -50.69 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.537 -0.727 . . . . 0.0 112.525 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.129 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -58.58 -39.88 81.57 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.506 -1.371 . . . . 0.0 112.489 -177.488 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.184 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -75.1 -38.89 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 119.764 -1.835 . . . . 0.0 108.761 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.835 ' HD2' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -39.15 -58.39 1.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.551 -0.718 . . . . 0.0 110.42 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -65.32 -34.4 78.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.968 -1.083 . . . . 0.0 109.903 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.527 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 4.5 mmp_? -70.27 -9.22 55.33 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.258 -0.901 . . . . 0.0 109.835 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.016 HG21 HD23 ' A' ' 70' ' ' LEU . 67.1 mt -100.28 4.55 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.337 -0.852 . . . . 0.0 109.733 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.493 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 60.63 27.97 17.68 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.393 -0.817 . . . . 0.0 110.324 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.016 HD23 HG21 ' A' ' 68' ' ' ILE . 4.3 pp -114.99 156.33 25.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.639 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.06 -166.94 0.97 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 110.998 -179.074 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 55.45 -87.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.835 . . . . 0.0 110.986 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' ARG . 9.7 pt-20 -152.06 27.09 0.61 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 111.238 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -53.84 176.37 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.919 -1.113 . . . . 0.0 109.817 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 111' ' ' ASP . . . -97.79 141.97 30.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.954 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.764 HD21 ' CZ ' ' A' ' 78' ' ' PHE . 16.6 tp -162.19 152.55 16.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 110.997 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.2 m-85 -160.99 120.54 2.64 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.839 ' CE1' HD12 ' A' ' 64' ' ' ILE . 77.9 m-85 -89.03 116.81 27.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 110.273 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 55.8 m-85 -108.31 125.87 52.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.399 -0.813 . . . . 0.0 109.507 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.998 HG22 HG23 ' A' ' 107' ' ' ILE . 1.9 t -121.34 129.92 75.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.324 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 83' ' ' VAL . 55.4 t30 51.05 37.84 18.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 110.361 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 58.2 t30 65.06 36.75 7.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 110.385 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.684 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -135.02 167.04 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.228 -0.92 . . . . 0.0 110.031 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.05 73.07 5.72 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.585 -0.697 . . . . 0.0 109.556 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.55 164.37 35.12 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.994 1.523 . . . . 0.0 110.563 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.86 -178.38 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.138 1.599 . . . . 0.0 110.221 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.528 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -85.01 20.08 1.97 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 110.741 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.67 42.01 1.11 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.485 -0.76 . . . . 0.0 109.672 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.28 -174.85 4.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.503 -0.748 . . . . 0.0 110.144 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 43.6 p -139.68 146.68 39.96 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.501 -0.75 . . . . 0.0 110.386 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.092 ' HA ' HD23 ' A' ' 94' ' ' LEU . 24.3 mmm -53.56 -42.45 67.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.662 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.52 -46.71 37.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.1 OUTLIER -65.35 -33.05 75.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -1.209 . . . . 0.0 109.827 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.092 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.11 -19.79 64.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.936 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.651 ' CD1' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -49.55 -56.42 9.95 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.005 -1.059 . . . . 0.0 109.632 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -70.15 -15.23 62.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.461 -1.4 . . . . 0.0 111.243 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 2.2 mm-40 -87.44 -64.74 1.1 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.969 -1.082 . . . . 0.0 112.925 -178.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.62 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -97.97 39.69 1.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.875 -1.14 . . . . 0.0 111.445 -177.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.588 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.588 ' CE1' HG13 ' A' ' 32' ' ' ILE . 3.1 p90 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.294 0.568 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.038 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.28 168.11 9.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.19 -0.944 . . . . 0.0 109.113 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.669 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.1 p90 -124.64 127.28 47.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.785 -1.197 . . . . 0.0 111.854 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.038 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.7 mt -136.73 144.56 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.078 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -133.55 175.65 9.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.949 . . . . 0.0 110.018 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.9 OUTLIER -147.42 167.6 23.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.972 . . . . 0.0 110.478 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -158.58 165.21 35.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.723 . . . . 0.0 110.285 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.536 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 4.3 p-10 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 110.312 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 3.2 mpt_? . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.3 0.571 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.688 HG12 HG12 ' A' ' 31' ' ' VAL . 9.2 t -143.53 104.45 5.01 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 110.295 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.7 Cg_endo -78.71 87.84 1.51 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.159 1.61 . . . . 0.0 109.928 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.688 HG12 HG12 ' A' ' 29' ' ' VAL . 1.2 m -83.42 144.02 10.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.136 -0.977 . . . . 0.0 110.882 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 31.5 mm -97.5 162.52 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.837 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.4 t -136.69 139.6 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.912 -1.117 . . . . 0.0 111.221 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.576 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.3 tm-20 -154.03 163.87 39.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' HD2' HD11 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -99.97 158.68 15.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.885 -1.135 . . . . 0.0 110.909 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.016 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.92 -173.55 0.11 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.562 -0.711 . . . . 0.0 109.185 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.016 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.0 Cg_endo -72.0 109.1 2.61 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.507 1.267 . . . . 0.0 110.112 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 62.15 42.86 9.21 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.367 -0.833 . . . . 0.0 110.293 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.426 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -63.99 179.92 0.48 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.517 ' CG ' ' OD1' ' A' ' 111' ' ' ASP . 0.9 OUTLIER -149.84 30.74 0.72 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.163 -0.961 . . . . 0.0 110.821 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.544 HD11 ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -85.18 -179.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.048 -1.033 . . . . 0.0 109.924 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.515 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -59.81 168.03 8.26 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -87.35 171.64 10.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -1.11 . . . . 0.0 110.34 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.905 HD13 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -136.51 146.28 46.06 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.351 -0.843 . . . . 0.0 110.105 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.441 ' C ' ' HD3' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -86.95 -7.49 58.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.854 . . . . 0.0 110.182 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.905 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -154.12 155.66 35.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.004 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -126.44 45.18 2.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.003 . . . . 0.0 109.716 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -158.62 111.77 2.35 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.467 -0.77 . . . . 0.0 109.879 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.848 ' OH ' HD11 ' A' ' 44' ' ' LEU . 11.6 m-85 -104.91 142.37 34.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -0.979 . . . . 0.0 110.127 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.49 100.62 8.65 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.509 -0.745 . . . . 0.0 109.136 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.98 ' HB ' HD12 ' A' ' 55' ' ' LEU . 3.5 m -126.94 159.6 63.66 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.142 -0.974 . . . . 0.0 110.763 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 46.2 Cg_endo -71.43 147.86 53.29 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.194 1.629 . . . . 0.0 110.594 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.564 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -64.77 -14.59 59.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 111.533 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -83.52 -10.92 58.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.883 -1.136 . . . . 0.0 110.764 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.98 HD12 ' HB ' ' A' ' 51' ' ' VAL . 4.5 mt -62.56 143.38 57.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.083 -1.011 . . . . 0.0 111.038 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 p -90.63 158.27 17.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.49 -0.756 . . . . 0.0 109.199 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.606 HG12 HG22 ' A' ' 87' ' ' THR . 61.1 t -57.09 -23.01 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.091 -1.005 . . . . 0.0 110.032 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.98 -33.67 59.49 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.899 ' CB ' HD22 ' A' ' 55' ' ' LEU . 24.3 mm-40 -72.27 -50.61 25.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.151 -1.205 . . . . 0.0 109.759 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.101 ' CE2' HD11 ' A' ' 64' ' ' ILE . 47.2 t80 -60.56 -32.02 71.11 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.273 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.664 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -63.41 -29.28 70.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.033 -1.042 . . . . 0.0 109.498 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.3 t80 -69.85 -53.36 18.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 110.126 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.075 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -59.87 -33.59 72.01 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.426 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.101 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -75.13 -33.4 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 119.777 -1.827 . . . . 0.0 109.701 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -38.29 -63.89 0.46 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 0.0 110.721 -179.164 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -30.62 71.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 110.132 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.644 ' CD ' HD21 ' A' ' 44' ' ' LEU . 20.2 mmt180 -66.15 -20.29 66.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.202 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.873 ' CG2' HD23 ' A' ' 70' ' ' LEU . 68.8 mt -104.2 15.7 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.977 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.515 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 49.68 28.37 2.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.411 -0.806 . . . . 0.0 110.241 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.873 HD23 ' CG2' ' A' ' 68' ' ' ILE . 3.8 pp -110.11 160.48 16.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.428 -0.795 . . . . 0.0 109.519 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.4 ptt180 -165.25 -171.9 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.046 -1.034 . . . . 0.0 110.822 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 52.08 -89.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.487 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 72' ' ' ALA . 33.1 mt-10 -157.11 29.29 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.951 . . . . 0.0 110.703 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.39 176.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.117 -0.99 . . . . 0.0 109.846 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.518 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -87.45 137.71 32.1 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 121.382 0.61 . . . . 0.0 110.367 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.749 HD21 ' CE1' ' A' ' 78' ' ' PHE . 49.3 tp -164.83 152.78 11.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.787 . . . . 0.0 110.426 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.594 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 89.8 m-85 -158.77 118.47 3.13 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.556 -0.715 . . . . 0.0 110.021 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.749 ' CE1' HD21 ' A' ' 76' ' ' LEU . 19.3 m-30 -84.96 132.67 34.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.0 -1.062 . . . . 0.0 111.054 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 59.5 m-85 -117.63 119.79 36.04 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.421 -0.799 . . . . 0.0 109.138 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.679 HG13 ' CG1' ' A' ' 107' ' ' ILE . 2.8 t -120.96 123.47 70.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.592 -0.693 . . . . 0.0 110.198 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.63 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.9 OUTLIER 49.54 42.04 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 3.7 m120 62.5 35.72 14.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.351 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -135.2 167.39 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.0 68.53 5.48 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 109.454 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.74 163.07 38.13 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.982 1.517 . . . . 0.0 110.891 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.4 -178.26 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.146 1.603 . . . . 0.0 110.419 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.606 HG22 HG12 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -84.75 22.18 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.389 -0.819 . . . . 0.0 110.864 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -94.27 41.23 1.09 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 109.65 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.45 -172.48 3.89 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.598 0.713 . . . . 0.0 110.288 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 63.5 p -139.79 140.74 36.73 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.674 -0.641 . . . . 0.0 110.159 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.038 ' HA ' HD23 ' A' ' 94' ' ' LEU . 9.3 mmm -49.18 -41.87 38.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.163 -0.961 . . . . 0.0 110.261 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.564 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.81 -47.65 52.71 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.2 OUTLIER -64.86 -30.87 71.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -1.097 . . . . 0.0 109.94 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.038 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.3 -24.51 64.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 110.031 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.586 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -49.46 -56.13 10.81 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 109.764 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -69.85 -17.8 63.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.003 -1.06 . . . . 0.0 111.124 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.3 mm-40 -87.53 -68.24 0.77 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.973 -1.08 . . . . 0.0 112.363 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.513 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 10.6 m-70 -99.38 38.65 1.39 Allowed 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.871 -1.143 . . . . 0.0 111.937 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.543 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.4 p80 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.136 -0.978 . . . . 0.0 109.41 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.0 p90 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.28 0.562 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.931 HD13 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -111.77 169.55 8.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.313 -0.867 . . . . 0.0 109.693 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.716 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -126.56 126.19 43.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.731 -1.23 . . . . 0.0 110.986 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.679 ' CG1' HG13 ' A' ' 80' ' ' VAL . 11.7 mt -141.25 147.98 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.306 -0.872 . . . . 0.0 109.64 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -142.5 -179.92 6.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.111 -0.993 . . . . 0.0 110.286 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.837 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.6 p90 -150.02 162.71 39.86 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.645 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.768 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -159.39 168.44 26.3 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.566 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.517 ' OD1' ' CG ' ' A' ' 40' ' ' ARG . 16.9 p-10 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.074 -1.016 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 3.2 mpt_? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.336 0.589 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.807 HG12 HG12 ' A' ' 31' ' ' VAL . 21.6 t -145.94 110.64 4.42 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 109.963 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.597 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 47.0 Cg_endo -73.44 87.9 1.05 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 124.175 1.619 . . . . 0.0 109.949 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 49' ' ' TYR . 1.4 m -88.12 144.1 9.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.33 -0.856 . . . . 0.0 111.411 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 16.2 mm -108.98 135.8 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -120.25 140.89 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.737 -1.227 . . . . 0.0 112.142 -178.324 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -145.6 172.49 13.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.655 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -97.44 161.49 13.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.814 -1.179 . . . . 0.0 110.802 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.026 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.09 -173.22 0.1 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.488 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.026 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.4 Cg_endo -72.55 112.09 3.39 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.547 1.288 . . . . 0.0 109.827 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 59.67 43.04 16.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.888 . . . . 0.0 110.178 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -66.05 179.36 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.31 -0.869 . . . . 0.0 110.166 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.455 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.3 34.24 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.948 . . . . 0.0 110.785 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.88 HD13 HG23 ' A' ' 68' ' ' ILE . 1.9 pp -85.89 177.51 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.012 -1.055 . . . . 0.0 110.418 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.814 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -52.23 -174.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.832 0 O-C-N 121.266 -0.896 . . . . 0.0 111.273 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 1.002 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -81.67 -175.8 5.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -1.078 . . . . 0.0 110.107 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.002 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.2 mm? -140.17 135.33 32.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.942 . . . . 0.0 110.775 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 46' ' ' LYS . 2.9 p30 -86.39 -27.35 24.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.497 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.508 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -153.2 155.65 37.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.84 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.711 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -124.4 42.98 3.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.021 -1.05 . . . . 0.0 110.042 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -159.46 109.36 1.91 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.446 -0.784 . . . . 0.0 109.78 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.874 ' O ' HG22 ' A' ' 31' ' ' VAL . 29.9 m-85 -106.44 141.72 37.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.046 -1.033 . . . . 0.0 110.823 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mp -107.06 93.99 4.86 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.61 ' HB ' HD12 ' A' ' 55' ' ' LEU . 35.0 m -113.18 152.45 45.09 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.933 . . . . 0.0 111.314 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.442 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.6 Cg_endo -70.49 145.52 53.12 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.317 1.693 . . . . 0.0 109.625 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.554 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 1.7 m -62.9 -11.87 21.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.349 -0.845 . . . . 0.0 111.451 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -85.5 -14.54 45.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 0.0 111.104 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.873 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.9 mt -62.21 142.43 57.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.028 -1.045 . . . . 0.0 111.372 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.7 p -91.09 162.65 14.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.744 -0.597 . . . . 0.0 109.788 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.475 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 91.4 t -58.44 -25.67 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.093 -1.004 . . . . 0.0 109.963 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.93 94.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.873 ' CB ' HD22 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -67.69 -48.0 67.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -1.197 . . . . 0.0 109.877 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.177 ' CE2' HD11 ' A' ' 64' ' ' ILE . 8.0 t80 -60.23 -32.46 71.15 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.068 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.476 ' CD1' ' HE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -55.36 -36.6 66.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 110.085 178.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.72 -49.98 12.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.437 -0.79 . . . . 0.0 112.691 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.163 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.43 -40.33 82.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.51 -1.368 . . . . 0.0 111.975 -177.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.177 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -75.22 -42.53 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 119.907 -1.746 . . . . 0.0 108.278 178.157 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.429 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -39.84 -54.89 2.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.628 -0.67 . . . . 0.0 110.53 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -64.33 -35.89 82.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.138 -0.976 . . . . 0.0 109.937 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.524 ' CG ' ' OH ' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -69.68 -14.39 62.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.187 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.97 HD12 HD21 ' A' ' 44' ' ' LEU . 2.3 mm -93.2 4.27 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.494 -0.754 . . . . 0.0 109.721 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.1 t60 53.43 33.71 16.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 110.484 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.96 HD12 ' O ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -104.96 156.56 17.92 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.105 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' A' ' 73' ' ' GLU . 12.9 ptt180 -165.83 -168.2 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.832 -1.168 . . . . 0.0 111.247 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.35 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 110.963 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 74' ' ' ASP . 5.2 pt-20 -152.16 24.01 0.64 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.146 -0.971 . . . . 0.0 111.106 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.29 177.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 109.85 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.1 141.14 37.18 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.112 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.76 HD21 ' CE2' ' A' ' 78' ' ' PHE . 26.2 tp -154.83 153.11 30.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.469 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 95.4 m-85 -158.43 121.16 3.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.622 -0.674 . . . . 0.0 109.79 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.76 ' CE2' HD21 ' A' ' 76' ' ' LEU . 72.3 m-85 -92.26 123.01 35.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 110.488 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 52.0 m-85 -115.45 136.76 52.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.594 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.827 HG22 HG12 ' A' ' 107' ' ' ILE . 12.6 t -119.87 121.81 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.0 110.456 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.633 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.1 OUTLIER 49.31 48.58 20.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.418 -0.801 . . . . 0.0 110.656 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 62.28 29.37 17.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 110.557 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.651 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.8 t -126.16 168.59 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.966 . . . . 0.0 109.675 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -154.63 68.19 5.62 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.472 -0.767 . . . . 0.0 109.747 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.2 168.1 25.6 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.011 1.532 . . . . 0.0 110.341 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.96 -179.78 4.61 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.052 1.554 . . . . 0.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.475 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -86.91 20.59 2.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.335 -0.853 . . . . 0.0 110.534 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -90.99 39.34 0.99 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.437 -0.789 . . . . 0.0 109.402 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.761 ' HB1' ' CD ' ' A' ' 93' ' ' GLN . . . -145.43 -177.29 5.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.571 -0.705 . . . . 0.0 110.088 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 81.2 p -140.07 144.38 36.81 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.465 -0.772 . . . . 0.0 110.395 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.054 ' HA ' HD23 ' A' ' 94' ' ' LEU . 39.8 mmm -43.88 -39.02 3.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.513 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -55.71 -48.27 72.71 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.761 ' CD ' ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -64.26 -30.51 71.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -1.175 . . . . 0.0 109.87 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.054 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.26 -27.37 66.28 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.232 -0.917 . . . . 0.0 109.813 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.585 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -50.28 -54.71 19.34 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.981 -1.074 . . . . 0.0 109.566 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -68.15 -20.68 64.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.815 -1.178 . . . . 0.0 110.51 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 10.1 mt-10 -88.22 -73.69 0.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.182 -0.948 . . . . 0.0 112.468 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.583 ' CG ' ' HB2' ' A' ' 81' ' ' ASN . 22.2 m-70 -100.69 37.2 1.76 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.786 -1.196 . . . . 0.0 112.361 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.518 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.032 0 O-C-N 121.035 -1.041 . . . . 0.0 109.748 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 30' ' ' PRO . 7.4 m-85 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.969 HD11 HD12 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -84.87 159.76 20.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.746 -1.221 . . . . 0.0 109.486 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.477 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -115.64 120.62 39.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.851 -1.155 . . . . 0.0 111.655 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.969 HD12 HD11 ' A' ' 105' ' ' LEU . 15.6 mt -141.44 140.72 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 109.241 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.43 177.61 7.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.137 -0.977 . . . . 0.0 110.136 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.655 ' CE2' ' CD ' ' A' ' 35' ' ' LYS . 1.4 p90 -144.86 165.12 29.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 110.648 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -158.14 178.67 9.94 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.271 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.674 ' HB3' HG22 ' A' ' 41' ' ' ILE . 27.9 p-10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 110.266 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.294 0.569 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.694 HG12 HG12 ' A' ' 31' ' ' VAL . 24.6 t -147.2 108.48 3.92 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 110.512 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.592 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 50.5 Cg_endo -78.87 81.59 2.74 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.363 1.717 . . . . 0.0 110.108 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.694 HG12 HG12 ' A' ' 29' ' ' VAL . 1.7 m -77.52 141.41 15.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.187 -0.946 . . . . 0.0 111.119 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 106' ' ' TYR . 46.8 mm -97.44 155.72 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.832 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.7 t -133.86 141.77 43.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.933 -1.104 . . . . 0.0 111.298 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.64 -179.24 8.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.547 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -115.83 159.77 21.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.857 -1.152 . . . . 0.0 110.295 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -61.3 -174.94 0.08 OUTLIER Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.54 -0.725 . . . . 0.0 109.248 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.6 Cg_endo -70.86 108.66 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.52 1.274 . . . . 0.0 109.842 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.4 38.55 9.98 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.352 -0.842 . . . . 0.0 110.012 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.547 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -56.22 179.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.26 -0.9 . . . . 0.0 110.125 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.14 32.18 0.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 110.611 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.829 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.93 176.38 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 110.208 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.829 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -50.18 -175.19 0.01 OUTLIER Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.315 -0.866 . . . . 0.0 110.997 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.965 ' O ' HD22 ' A' ' 44' ' ' LEU . 3.3 t0 -77.0 -175.53 3.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -1.134 . . . . 0.0 109.889 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.965 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.4 mm? -137.19 135.56 37.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.06 -1.025 . . . . 0.0 110.494 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -86.28 -34.63 20.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.723 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -153.87 159.85 41.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.752 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.561 ' HG2' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -124.0 40.0 3.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.054 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.561 ' HG3' ' HG2' ' A' ' 47' ' ' LYS . 23.9 mttt -158.69 106.17 1.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.546 -0.721 . . . . 0.0 109.66 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.881 ' CD2' HD13 ' A' ' 63' ' ' LEU . 30.3 m-85 -104.86 139.62 39.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.87 -1.144 . . . . 0.0 110.25 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.52 99.35 8.13 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.79 ' HB ' HD12 ' A' ' 55' ' ' LEU . 4.2 m -126.18 163.65 38.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.128 -0.983 . . . . 0.0 111.157 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 45.4 Cg_endo -71.05 144.09 46.29 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.142 1.601 . . . . 0.0 110.389 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.556 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -63.86 -13.43 44.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.41 -0.806 . . . . 0.0 111.375 -179.064 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -83.59 -10.2 58.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.989 -1.07 . . . . 0.0 110.884 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.833 HD22 ' HB2' ' A' ' 59' ' ' GLN . 4.0 mt -62.3 141.75 58.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.995 -1.066 . . . . 0.0 111.335 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 1.4 p -91.24 157.95 16.87 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.628 -0.67 . . . . 0.0 109.217 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.657 HG12 HG22 ' A' ' 87' ' ' THR . 53.0 t -55.26 -24.05 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.06 -1.025 . . . . 0.0 110.06 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.2 87.72 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.833 ' HB2' HD22 ' A' ' 55' ' ' LEU . 1.4 mt-30 -67.73 -44.2 78.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.179 -1.189 . . . . 0.0 110.122 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.154 ' CE2' HD11 ' A' ' 64' ' ' ILE . 17.4 t80 -60.65 -46.4 90.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.038 -1.039 . . . . 0.0 109.568 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.465 ' HE1' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -50.78 -21.76 1.81 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.948 -1.095 . . . . 0.0 109.902 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.3 -54.57 5.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.394 -0.816 . . . . 0.0 110.597 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.994 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.8 pp -59.78 -21.85 61.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.945 -1.097 . . . . 0.0 112.169 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.154 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.1 mt -92.77 -35.19 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.191 -1.568 . . . . 0.0 109.219 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.777 ' HG2' HD11 ' A' ' 70' ' ' LEU . 2.8 mtp85 -35.94 -63.71 0.35 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.853 -0.529 . . . . 0.0 110.855 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -31.15 72.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.043 -1.035 . . . . 0.0 109.88 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.502 ' C ' HD13 ' A' ' 68' ' ' ILE . 19.7 mmt180 -67.24 -16.32 64.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 110.009 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.766 ' CG2' HD23 ' A' ' 70' ' ' LEU . 1.3 mm -101.1 12.86 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.959 . . . . 0.0 109.708 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.5 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 50.42 30.81 4.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.462 -0.774 . . . . 0.0 110.369 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.779 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.2 pp -110.35 155.59 21.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 0.0 109.695 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.72 -172.42 2.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.116 -0.99 . . . . 0.0 111.014 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.56 -89.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 110.775 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 71' ' ' ARG . 5.6 pt-20 -150.34 35.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 110.872 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -58.38 177.23 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.14 -0.975 . . . . 0.0 109.966 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.522 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -107.1 138.3 43.54 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.378 0.609 . . . . 0.0 110.34 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.755 HD21 ' CE1' ' A' ' 78' ' ' PHE . 15.2 tp -164.7 152.66 11.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 0.0 110.249 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 83.8 m-85 -157.79 121.83 4.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.644 -0.66 . . . . 0.0 109.972 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 64' ' ' ILE . 16.9 m-30 -82.59 122.67 28.39 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.16 -0.962 . . . . 0.0 111.57 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 69.8 m-85 -113.57 120.37 40.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.837 HG22 HG23 ' A' ' 107' ' ' ILE . 2.4 t -121.06 128.38 76.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.4 -0.812 . . . . 0.0 109.998 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.3 t30 49.75 42.32 23.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 0.0 110.229 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.9 m-20 60.39 36.56 20.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.467 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.697 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -134.87 166.03 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 109.987 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.812 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -155.26 72.89 5.61 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 109.542 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.72 163.79 37.44 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.032 1.543 . . . . 0.0 110.792 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.47 -178.57 3.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.08 1.569 . . . . 0.0 110.357 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.657 HG22 HG12 ' A' ' 57' ' ' VAL . 1.1 p -85.92 19.52 2.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.857 . . . . 0.0 110.774 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.0 m -96.75 42.43 1.09 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.525 -0.734 . . . . 0.0 109.621 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.34 -172.46 3.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.491 -0.756 . . . . 0.0 110.319 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 77.2 p -139.42 140.64 37.41 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.477 0.656 . . . . 0.0 110.158 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.052 ' HA ' HD23 ' A' ' 94' ' ' LEU . 59.7 mtm -52.51 -38.72 60.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 109.938 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -50.51 -49.54 39.0 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 90' ' ' THR . 4.0 pt20 -64.68 -28.92 69.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -1.163 . . . . 0.0 109.664 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.052 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.17 -23.63 64.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 110.132 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.592 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -49.05 -54.29 16.53 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.707 -1.246 . . . . 0.0 109.755 -179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.35 -18.96 63.07 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.21 -0.931 . . . . 0.0 111.25 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.7 mt-10 -86.34 -65.03 1.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.91 -1.119 . . . . 0.0 112.288 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.581 ' CD2' ' HB ' ' A' ' 80' ' ' VAL . 16.6 m-70 -98.02 38.06 1.35 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.929 -1.107 . . . . 0.0 111.254 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.454 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.494 -0.754 . . . . 0.0 109.437 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.183 0.516 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.068 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -104.91 168.94 8.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.229 -0.919 . . . . 0.0 109.199 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.708 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -119.23 128.26 54.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.615 -1.303 . . . . 0.0 111.778 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.068 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.2 mt -139.2 129.33 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.19 -0.944 . . . . 0.0 110.483 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -128.55 152.3 48.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.154 -0.966 . . . . 0.0 108.778 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.832 ' HE1' HG13 ' A' ' 33' ' ' VAL . 2.3 p90 -131.4 167.09 19.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.55 -1.344 . . . . 0.0 111.647 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -153.88 -179.79 8.17 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.101 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.646 ' HB3' HG22 ' A' ' 41' ' ' ILE . 7.1 p-10 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.165 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.386 0.612 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.68 HG12 HG12 ' A' ' 31' ' ' VAL . 12.3 t -147.76 114.05 4.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.385 -0.822 . . . . 0.0 110.081 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 51.3 Cg_endo -78.1 87.08 1.56 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 124.166 1.614 . . . . 0.0 110.055 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.728 HG12 ' CD2' ' A' ' 105' ' ' LEU . 1.6 m -83.17 151.72 3.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.171 -0.955 . . . . 0.0 110.892 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 30.8 mm -105.96 160.41 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 108.714 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.708 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.5 t -134.2 141.05 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.801 -1.187 . . . . 0.0 111.404 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 7.0 tt0 -156.23 175.38 14.06 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.605 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -103.7 160.39 14.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.931 -1.106 . . . . 0.0 110.528 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.978 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -62.7 -174.47 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.781 . . . . 0.0 109.095 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.978 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.7 Cg_endo -70.52 103.7 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.418 1.22 . . . . 0.0 110.025 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 5.7 mttt 63.61 40.16 8.23 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.859 . . . . 0.0 110.076 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . . . -61.99 179.49 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.201 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.485 ' HG2' ' OD2' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -150.22 35.45 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.0 110.532 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.503 HG12 HG23 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -84.74 179.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.991 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 68' ' ' ILE . . . -57.26 -179.75 0.69 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -167.53 0.19 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.382 -1.069 . . . . 0.0 110.271 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.056 HD13 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.35 147.51 38.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 110.729 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.797 ' N ' HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -87.32 -42.84 12.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.154 -0.966 . . . . 0.0 110.324 -179.421 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.584 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -152.15 159.57 43.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.755 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -116.99 39.85 3.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.113 -0.992 . . . . 0.0 110.463 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 9.7 pttt -162.01 107.34 1.25 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.289 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.717 ' CD2' HD13 ' A' ' 63' ' ' LEU . 11.4 m-85 -108.01 142.43 38.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -0.991 . . . . 0.0 110.125 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mp -116.0 103.22 10.37 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.822 ' HB ' HD12 ' A' ' 55' ' ' LEU . 3.0 m -129.78 162.75 51.53 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 111.098 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 43.5 Cg_endo -68.26 146.47 69.61 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.167 1.614 . . . . 0.0 110.451 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.556 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -63.65 -11.1 22.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 111.598 -178.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.68 -7.91 59.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.902 -1.124 . . . . 0.0 110.675 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.919 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.1 mt -62.43 141.39 58.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.127 -0.983 . . . . 0.0 111.157 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -91.17 158.52 16.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.671 -0.643 . . . . 0.0 109.48 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 79.4 t -57.29 -24.27 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.101 -0.999 . . . . 0.0 109.693 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.56 -34.8 67.61 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.919 ' CB ' HD22 ' A' ' 55' ' ' LEU . 17.8 mm-40 -67.89 -50.72 54.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -1.134 . . . . 0.0 109.336 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.192 ' CE2' HD11 ' A' ' 64' ' ' ILE . 6.2 t80 -60.21 -35.32 75.15 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.153 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.597 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -53.29 -34.8 58.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 110.028 178.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -51.12 9.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.358 -0.839 . . . . 0.0 112.705 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.159 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.37 -39.19 78.94 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.489 -1.382 . . . . 0.0 112.077 -177.646 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.192 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -77.49 -41.73 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 119.862 -1.774 . . . . 0.0 108.323 178.214 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.659 ' HG2' HD22 ' A' ' 76' ' ' LEU . 9.2 mtp180 -43.25 -52.27 5.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.413 -0.805 . . . . 0.0 109.983 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -35.73 81.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.538 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 8.9 mmt85 -70.29 -15.81 62.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.575 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.607 HD11 ' CD2' ' A' ' 109' ' ' TYR . 30.6 mt -89.39 -1.17 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.4 -0.813 . . . . 0.0 109.352 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 69' ' ' HIS . 18.1 t60 56.33 31.11 18.01 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.412 -0.805 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.942 HD12 ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -96.9 153.04 18.13 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.983 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.5 ptp180 -166.94 -168.71 1.15 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.015 -1.053 . . . . 0.0 110.872 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 53.74 -87.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.835 . . . . 0.0 110.855 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 71' ' ' ARG . 35.4 mt-10 -153.93 33.25 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.659 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.526 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -61.56 177.1 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.091 -1.006 . . . . 0.0 109.921 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 111' ' ' ASP . . . -105.42 140.46 38.5 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.167 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.711 HD21 ' CE2' ' A' ' 78' ' ' PHE . 18.7 tp -149.78 152.81 35.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.179 -0.951 . . . . 0.0 110.474 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 73.3 m-85 -161.82 120.73 2.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.772 -0.58 . . . . 0.0 109.649 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' HD21 ' A' ' 76' ' ' LEU . 63.0 m-85 -93.22 123.22 36.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.064 -1.023 . . . . 0.0 110.106 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 66.8 m-85 -113.88 132.04 56.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.993 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.689 HG22 HG23 ' A' ' 107' ' ' ILE . 2.6 t -121.04 113.12 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.326 -0.859 . . . . 0.0 110.156 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.887 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.2 t-20 59.19 51.4 6.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 110.283 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 16.9 m-20 56.44 31.21 18.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.318 -0.863 . . . . 0.0 110.487 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.5 t -130.74 167.3 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.202 -0.936 . . . . 0.0 109.904 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -154.98 67.84 5.33 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.557 -0.715 . . . . 0.0 109.478 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.58 170.18 20.59 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.052 1.554 . . . . 0.0 110.707 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.99 -179.02 3.52 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.078 1.567 . . . . 0.0 110.416 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.524 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -87.34 25.46 1.4 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.36 -0.838 . . . . 0.0 110.701 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.21 41.84 1.11 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.408 -0.807 . . . . 0.0 109.768 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.4 -175.53 4.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 110.461 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 62.8 p -139.44 139.65 37.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.631 -0.668 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.063 ' HA ' HD23 ' A' ' 94' ' ' LEU . 4.5 mmt -49.26 -38.62 27.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.165 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -52.31 -48.99 52.75 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 3.9 pt20 -64.63 -29.41 70.41 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.634 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.063 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.33 -24.86 64.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.59 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -49.63 -56.17 11.03 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.977 -1.077 . . . . 0.0 109.773 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.62 -17.62 63.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.754 -1.216 . . . . 0.0 111.093 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -88.47 -68.42 0.77 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.142 -0.974 . . . . 0.0 113.402 -177.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 81' ' ' ASN . 18.1 m-70 -100.16 40.71 1.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.726 -1.234 . . . . 0.0 112.771 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.568 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.9 p80 . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.051 -1.031 . . . . 0.0 109.657 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 104' ' ' PHE . 4.3 m-85 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.032 0.444 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.075 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -109.16 165.4 11.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.091 -1.006 . . . . 0.0 109.608 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.768 ' N ' HD12 ' A' ' 105' ' ' LEU . 57.9 m-85 -122.06 129.49 52.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.823 -1.173 . . . . 0.0 112.173 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.075 ' CG1' HD11 ' A' ' 105' ' ' LEU . 4.5 mt -141.4 153.36 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.502 -0.749 . . . . 0.0 109.475 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -150.42 178.45 9.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 110.326 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.708 ' HE1' HG13 ' A' ' 33' ' ' VAL . 6.3 p90 -147.14 164.59 32.63 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.256 -0.977 . . . . 0.0 111.075 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.622 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -157.7 170.02 23.34 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.761 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' ALA . 11.7 p30 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 110.593 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.479 0.657 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.648 HG12 HG12 ' A' ' 31' ' ' VAL . 33.0 t -142.58 104.05 5.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.454 -0.779 . . . . 0.0 109.892 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.587 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 49.5 Cg_endo -76.9 90.75 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.138 1.599 . . . . 0.0 110.295 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.722 HG12 ' CD2' ' A' ' 105' ' ' LEU . 1.3 m -88.57 153.19 3.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.229 -0.92 . . . . 0.0 110.721 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.607 HD11 ' CD1' ' A' ' 104' ' ' PHE . 1.4 mp -103.04 165.12 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 108.772 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.803 HG21 ' CE1' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -139.4 133.82 39.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.048 -1.032 . . . . 0.0 110.877 -179.25 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -151.84 163.69 38.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.722 -0.611 . . . . 0.0 109.616 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.561 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -96.8 158.86 15.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 110.627 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.024 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.22 -174.28 0.12 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.722 . . . . 0.0 109.41 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.024 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.2 Cg_endo -70.33 107.5 1.98 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.486 1.256 . . . . 0.0 109.753 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 4.1 mtpt 64.14 42.72 5.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.375 -0.828 . . . . 0.0 109.944 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.485 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -64.39 179.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 110.267 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.497 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.6 OUTLIER -150.32 33.85 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.947 . . . . 0.0 110.425 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.781 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.7 pp -85.33 178.17 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.046 -1.034 . . . . 0.0 110.644 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.781 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -50.46 -172.73 0.01 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -80.34 179.38 7.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.356 -1.085 . . . . 0.0 110.002 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' C ' HD12 ' A' ' 44' ' ' LEU . 1.4 pp -135.04 134.14 40.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 110.614 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . 15.4 t0 -86.43 -36.97 18.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.076 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.55 160.27 43.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 109.954 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -118.41 39.91 3.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.114 -0.992 . . . . 0.0 110.215 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.509 ' CG ' ' C ' ' A' ' 47' ' ' LYS . 6.2 mtmm -156.7 109.01 2.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.471 -0.768 . . . . 0.0 109.28 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.803 ' CE1' HG21 ' A' ' 33' ' ' VAL . 22.9 m-85 -103.63 141.89 35.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.902 -1.124 . . . . 0.0 110.808 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tp -105.44 104.81 14.61 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.472 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 16.6 m -131.76 144.23 52.4 Favored Pre-proline 0 C--N 1.3 -1.554 0 O-C-N 121.112 -0.993 . . . . 0.0 110.622 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 55' ' ' LEU . 41.5 Cg_endo -66.99 143.86 67.69 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.983 1.518 . . . . 0.0 110.053 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.566 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.7 m -61.47 -14.25 27.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.399 -0.813 . . . . 0.0 111.615 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -83.7 -15.31 49.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.082 -1.011 . . . . 0.0 111.053 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.867 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.9 mt -62.21 144.84 54.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.054 -1.028 . . . . 0.0 111.301 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.2 p -90.74 165.91 13.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.51 -0.744 . . . . 0.0 109.621 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.972 HG12 HG22 ' A' ' 87' ' ' THR . 46.5 t -60.33 -26.42 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 110.153 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.71 -41.33 93.86 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.867 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.6 mt-30 -67.64 -49.7 61.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.076 -1.25 . . . . 0.0 110.203 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.139 ' CE2' HD11 ' A' ' 64' ' ' ILE . 43.0 t80 -60.59 -33.9 73.41 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.724 -1.191 . . . . 0.0 109.502 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.665 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -63.43 -28.02 69.69 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.923 -1.11 . . . . 0.0 109.738 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -70.26 -53.52 16.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.295 -0.878 . . . . 0.0 110.281 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.992 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -59.54 -37.13 77.58 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 118.92 -1.112 . . . . 0.0 112.341 -178.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.139 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -70.45 -35.28 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 119.835 -1.791 . . . . 0.0 109.025 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.865 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -37.38 -63.41 0.45 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.72 -0.613 . . . . 0.0 110.774 -179.632 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -30.93 71.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.19 -0.944 . . . . 0.0 110.192 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.531 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 8.0 mmp_? -67.72 -17.81 64.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 109.945 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.89 ' CG2' HD23 ' A' ' 70' ' ' LEU . 36.5 mt -103.55 15.32 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.386 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.563 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 46.24 30.66 1.04 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.564 -0.71 . . . . 0.0 110.263 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.89 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.1 pp -108.83 155.24 21.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.413 -0.805 . . . . 0.0 109.84 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 73' ' ' GLU . 4.9 ptp180 -166.17 -168.73 1.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.657 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 47.99 -92.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.392 -0.817 . . . . 0.0 110.768 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 4.9 pt-20 -146.25 44.43 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.976 -1.078 . . . . 0.0 110.969 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -67.58 176.68 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.955 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -100.88 140.54 35.03 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.008 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.928 HD21 ' CE1' ' A' ' 78' ' ' PHE . 26.1 tp -164.24 152.68 12.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.982 . . . . 0.0 110.755 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 97.4 m-85 -158.52 119.7 3.42 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.706 -0.621 . . . . 0.0 109.666 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.928 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.5 m-30 -85.6 132.49 34.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.075 -1.015 . . . . 0.0 111.8 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 64.6 m-85 -120.29 120.42 35.99 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.771 HG22 HG23 ' A' ' 107' ' ' ILE . 2.1 t -120.97 125.95 74.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.422 -0.799 . . . . 0.0 109.839 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.769 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.3 OUTLIER 47.15 46.49 16.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.207 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 26.8 m120 58.11 37.07 26.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.288 -0.882 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -135.91 167.6 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.154 -0.966 . . . . 0.0 110.15 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.83 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -155.19 70.05 5.58 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.492 -0.755 . . . . 0.0 109.552 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.83 163.58 36.74 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.009 1.531 . . . . 0.0 110.735 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.3 -178.63 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.214 1.639 . . . . 0.0 110.622 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.972 HG22 HG12 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -86.7 20.48 2.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.309 -0.869 . . . . 0.0 110.681 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.1 m -91.51 39.2 1.0 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.47 -0.769 . . . . 0.0 109.641 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.697 ' HB1' ' OE1' ' A' ' 93' ' ' GLN . . . -145.51 -171.97 3.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.535 -0.728 . . . . 0.0 110.243 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 73.0 p -139.55 143.08 37.21 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.626 -0.671 . . . . 0.0 110.116 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.053 ' HA ' HD23 ' A' ' 94' ' ' LEU . 51.0 mmm -46.23 -46.35 17.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.806 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.566 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -47.97 -48.77 24.63 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.635 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.697 ' OE1' ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -64.39 -31.81 73.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.108 -1.23 . . . . 0.0 110.155 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.053 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.59 -22.27 64.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.114 -0.991 . . . . 0.0 110.198 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.579 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -49.27 -55.48 12.54 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.938 -1.101 . . . . 0.0 109.874 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -70.43 -16.89 62.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.034 -1.041 . . . . 0.0 111.34 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -87.35 -64.78 1.1 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.106 -0.996 . . . . 0.0 112.924 -177.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.72 ' CD2' ' HB2' ' A' ' 81' ' ' ASN . 30.8 m170 -98.24 37.37 1.45 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.816 -1.178 . . . . 0.0 112.103 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.396 -0.815 . . . . 0.0 109.694 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.607 ' CD1' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.058 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.3 166.71 11.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.866 -1.146 . . . . 0.0 109.693 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.726 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -124.46 131.61 53.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.959 -1.088 . . . . 0.0 111.503 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.058 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.6 mt -138.64 143.4 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.195 -0.94 . . . . 0.0 110.119 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.73 176.06 9.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.227 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.0 OUTLIER -149.93 164.23 35.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.798 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.3 t -152.44 -178.1 6.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.693 -0.629 . . . . 0.0 109.941 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.497 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 57.3 p-10 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.885 . . . . 0.0 110.22 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.286 0.565 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.517 HG21 ' HA2' ' A' ' 92' ' ' GLY . 15.6 t -146.99 103.82 3.85 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 49.5 Cg_endo -74.51 106.63 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.382 1.727 . . . . 0.0 109.829 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.792 HG13 HD21 ' A' ' 105' ' ' LEU . 38.2 t -105.44 133.59 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.997 . . . . 0.0 110.718 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.858 HD11 ' CD1' ' A' ' 104' ' ' PHE . 44.3 mm -91.63 154.54 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.843 . . . . 0.0 109.025 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.704 HG21 ' CE1' ' A' ' 49' ' ' TYR . 2.7 t -132.13 144.46 37.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.939 -1.1 . . . . 0.0 111.498 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 7.4 mp0 -156.85 -179.65 8.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -110.7 160.79 16.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.729 -1.232 . . . . 0.0 110.581 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.012 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.91 -175.12 0.16 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.438 -0.789 . . . . 0.0 109.307 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.012 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.4 Cg_endo -71.44 106.11 1.88 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.532 1.28 . . . . 0.0 109.769 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 61.69 40.74 12.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.352 -0.843 . . . . 0.0 110.117 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . . . -60.97 -179.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.477 ' HG2' ' OD1' ' A' ' 111' ' ' ASP . 6.6 ptm180 -150.39 33.59 0.64 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 110.533 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.632 HG22 ' HB3' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -85.54 -175.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.04 . . . . 0.0 110.62 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -55.42 179.73 0.32 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -70.96 -172.92 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -1.147 . . . . 0.0 110.055 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' C ' HD12 ' A' ' 44' ' ' LEU . 1.2 pp -135.19 134.15 39.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 110.63 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -40.23 15.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HD3' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -152.85 164.76 37.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.299 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.77 38.22 4.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.106 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.59 105.04 1.82 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 0.0 109.952 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.901 ' CD2' HD13 ' A' ' 63' ' ' LEU . 45.3 m-85 -103.92 146.47 28.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 110.64 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.71 95.4 5.22 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.961 ' HB ' HD12 ' A' ' 55' ' ' LEU . 13.5 m -119.83 152.66 54.09 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.14 -0.975 . . . . 0.0 110.714 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.474 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.1 Cg_endo -71.23 149.48 57.67 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.097 1.577 . . . . 0.0 110.078 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.519 ' HB3' ' HA3' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -63.73 -13.94 47.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.325 -0.859 . . . . 0.0 111.397 -178.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.55 -10.71 53.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.908 -1.12 . . . . 0.0 111.11 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.961 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.6 mt -62.14 141.89 57.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.867 -1.145 . . . . 0.0 111.335 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 p -91.59 163.14 14.23 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.637 -0.665 . . . . 0.0 109.449 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.992 HG12 HG22 ' A' ' 87' ' ' THR . 78.9 t -58.96 -22.56 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.023 -1.048 . . . . 0.0 110.056 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.73 -40.06 65.72 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.898 ' CB ' HD22 ' A' ' 55' ' ' LEU . 5.0 mm100 -67.87 -47.81 67.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.149 -1.206 . . . . 0.0 109.893 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.149 ' CE2' HD11 ' A' ' 64' ' ' ILE . 19.5 t80 -60.38 -46.39 90.13 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.146 -0.971 . . . . 0.0 109.647 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -50.35 -22.68 1.93 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.016 -1.053 . . . . 0.0 110.021 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -80.86 -54.5 5.54 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.566 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.03 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.9 pp -59.84 -19.1 48.98 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.909 -1.12 . . . . 0.0 112.287 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.149 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.4 mt -91.57 -42.98 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.113 -1.617 . . . . 0.0 108.863 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.586 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.7 OUTLIER -36.91 -58.5 0.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.145 0.498 . . . . 0.0 110.696 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.87 -31.91 71.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 110.052 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 2.6 mmp_? -74.75 -7.5 53.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.86 . . . . 0.0 110.546 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.579 ' CD1' HG22 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -99.18 -8.74 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 0.0 109.546 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.469 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER 67.74 29.41 6.86 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.484 -0.76 . . . . 0.0 110.087 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -88.7 160.86 17.14 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.917 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -164.92 -166.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.004 -1.06 . . . . 0.0 110.724 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 42.9 -96.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.804 . . . . 0.0 110.559 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' ASP . 3.9 pt-20 -151.13 28.46 0.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.935 -1.103 . . . . 0.0 110.721 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.524 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -47.79 176.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.203 1.002 . . . . 0.0 110.029 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.524 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -115.0 142.16 47.01 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.778 HD21 ' CE1' ' A' ' 78' ' ' PHE . 13.6 tp -148.97 151.63 34.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.309 -0.87 . . . . 0.0 110.466 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 90.4 m-85 -158.2 122.88 4.24 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.793 -0.567 . . . . 0.0 109.866 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.821 ' CE2' HD12 ' A' ' 64' ' ' ILE . 18.0 m-30 -85.17 120.2 26.4 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.155 -0.966 . . . . 0.0 111.785 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.476 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 59.9 m-85 -106.98 122.1 45.76 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.515 -0.74 . . . . 0.0 109.06 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.939 HG22 HG23 ' A' ' 107' ' ' ILE . 2.2 t -121.3 126.29 74.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.421 -0.8 . . . . 0.0 109.934 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 57.9 t30 51.32 34.29 11.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 0.0 110.038 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 1.3 t-20 69.31 34.95 2.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.433 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.689 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -134.97 166.81 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.9 . . . . 0.0 109.892 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.822 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.95 70.67 5.78 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 0.0 109.609 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.96 165.35 33.03 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.048 1.551 . . . . 0.0 110.582 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.92 -178.96 3.83 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.062 1.559 . . . . 0.0 110.376 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.992 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -85.96 19.59 2.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 0.0 110.825 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -91.07 40.46 1.03 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.488 -0.758 . . . . 0.0 109.355 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.61 -172.88 3.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.517 -0.739 . . . . 0.0 110.262 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 59.1 p -139.27 149.8 44.71 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.66 -0.65 . . . . 0.0 110.28 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.045 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -59.23 -40.6 86.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 110.005 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.519 ' HA3' ' HB3' ' A' ' 53' ' ' SER . . . -51.26 -46.49 51.61 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.7 OUTLIER -66.97 -28.85 68.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.238 -1.154 . . . . 0.0 109.715 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.045 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.97 -22.22 64.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.198 -0.939 . . . . 0.0 109.862 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.576 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -48.95 -53.78 18.31 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.884 -1.135 . . . . 0.0 109.505 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -19.16 63.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.049 -1.032 . . . . 0.0 111.455 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.65 -59.12 2.32 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -177.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.54 ' ND1' HG11 ' A' ' 80' ' ' VAL . 16.7 m170 -98.65 40.12 1.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.648 -1.283 . . . . 0.0 113.09 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.639 ' C ' ' CD2' ' A' ' 99' ' ' HIS . 3.5 p-80 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.858 ' CD1' HD11 ' A' ' 32' ' ' ILE . 1.1 m-85 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.928 0.394 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.065 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -107.4 169.96 8.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.959 -1.088 . . . . 0.0 109.248 179.523 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.697 ' N ' HD12 ' A' ' 105' ' ' LEU . 6.5 p90 -121.75 128.83 52.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.532 -1.355 . . . . 0.0 111.981 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.065 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.9 mt -141.07 141.04 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.311 -0.868 . . . . 0.0 110.184 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -136.29 166.72 22.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.966 -1.084 . . . . 0.0 109.773 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.722 ' HB2' HD11 ' A' ' 76' ' ' LEU . 2.9 p90 -134.26 163.86 28.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.747 -1.221 . . . . 0.0 111.518 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -158.52 177.1 11.6 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.248 0.547 . . . . 0.0 110.02 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.632 ' HB3' HG22 ' A' ' 41' ' ' ILE . 32.9 p30 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 110.145 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.451 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 10.5 mpt_? . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.184 0.516 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.716 HG12 HG12 ' A' ' 31' ' ' VAL . 16.3 t -144.99 108.99 4.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.947 . . . . 0.0 110.417 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.524 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.8 Cg_endo -77.83 91.16 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.186 1.624 . . . . 0.0 110.093 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.716 HG12 HG12 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -86.63 129.87 37.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.235 -0.916 . . . . 0.0 111.041 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 39.7 mm -91.71 136.06 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.09 -1.006 . . . . 0.0 108.502 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.757 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -119.94 146.44 24.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.864 -1.147 . . . . 0.0 111.304 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 0.1 OUTLIER -156.24 -164.44 1.68 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -122.1 158.84 28.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 0.0 110.605 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.974 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -61.49 -173.42 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.515 -0.74 . . . . 0.0 109.031 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.974 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.0 Cg_endo -69.62 106.71 1.68 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.372 1.196 . . . . 0.0 109.864 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 3.7 mmtt 64.69 41.43 5.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.426 -0.796 . . . . 0.0 110.274 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.535 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -60.07 -177.71 0.07 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.256 -0.902 . . . . 0.0 109.972 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.514 ' CG ' ' OD1' ' A' ' 111' ' ' ASP . 5.6 ptm180 -150.22 31.84 0.67 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 0.0 110.745 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.83 HD13 HG23 ' A' ' 68' ' ' ILE . 1.8 pp -85.53 177.12 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.083 -1.01 . . . . 0.0 110.351 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.83 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -49.04 -176.76 0.01 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.902 ' O ' HD22 ' A' ' 44' ' ' LEU . 7.8 t0 -75.17 -174.69 2.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.245 . . . . 0.0 109.871 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.902 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -135.66 135.66 40.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 0.0 110.371 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -86.67 -41.23 14.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.808 . . . . 0.0 109.988 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.81 154.32 34.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 110.039 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.757 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -113.44 44.94 1.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.04 -1.038 . . . . 0.0 110.004 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -161.85 112.84 1.65 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 110.043 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.737 ' HD2' HD13 ' A' ' 63' ' ' LEU . 8.5 m-85 -111.32 137.57 48.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 109.991 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.92 87.12 3.64 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.609 ' HB ' HD12 ' A' ' 55' ' ' LEU . 12.7 m -107.89 148.36 37.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 110.96 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HD2' HD12 ' A' ' 55' ' ' LEU . 47.7 Cg_endo -72.88 147.36 43.93 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.156 1.608 . . . . 0.0 109.688 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.562 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -62.2 -15.8 49.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.925 . . . . 0.0 111.459 -178.699 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -83.69 -14.23 52.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.115 -0.99 . . . . 0.0 111.18 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.793 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.7 mt -61.87 144.14 55.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.931 -1.106 . . . . 0.0 111.276 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 6.8 p -90.83 164.51 14.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 60.4 t -62.08 -27.34 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.043 -1.035 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.64 -36.66 88.24 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.793 ' CB ' HD22 ' A' ' 55' ' ' LEU . 8.5 mm-40 -70.17 -47.79 60.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.148 -1.207 . . . . 0.0 109.791 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.025 ' CE2' HD11 ' A' ' 64' ' ' ILE . 37.5 t80 -59.98 -32.75 71.13 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.144 -1.022 . . . . 0.0 108.942 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.557 ' HE1' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.03 -32.21 70.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 109.827 178.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 5.3 t80 -72.8 -51.8 17.51 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.417 -0.802 . . . . 0.0 111.078 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.985 HD11 ' CD1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -59.9 -35.65 75.32 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 118.571 -1.252 . . . . 0.0 112.589 -178.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.025 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -80.47 -29.08 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 119.663 -1.898 . . . . 0.0 109.629 178.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -41.11 -62.11 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.346 -0.846 . . . . 0.0 110.353 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -27.43 68.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.805 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.527 ' C ' HD13 ' A' ' 68' ' ' ILE . 8.8 mmp_? -70.26 -16.15 63.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.895 . . . . 0.0 109.8 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.83 HG23 HD13 ' A' ' 41' ' ' ILE . 2.9 mm -100.93 11.49 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.751 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.503 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 54.01 30.98 12.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.298 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.776 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.2 pp -115.23 156.49 25.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -0.804 . . . . 0.0 109.792 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.73 -169.34 1.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.0 110.945 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.27 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.454 -0.779 . . . . 0.0 110.735 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' ARG . 5.2 pt-20 -151.37 32.52 0.58 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.08 -1.013 . . . . 0.0 111.076 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -55.25 177.0 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.037 -1.039 . . . . 0.0 109.827 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.522 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -98.36 139.49 34.04 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.167 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.573 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 13.2 tp -164.34 153.23 13.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.352 -0.843 . . . . 0.0 110.391 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 89.4 m-85 -157.55 123.89 4.86 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.562 -0.711 . . . . 0.0 109.784 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.938 ' CZ ' HD12 ' A' ' 64' ' ' ILE . 11.8 m-85 -89.16 124.45 34.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.357 -0.839 . . . . 0.0 111.033 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 53.3 m-85 -119.91 121.65 39.48 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.731 HG22 HG23 ' A' ' 107' ' ' ILE . 2.4 t -120.78 112.72 37.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.358 -0.839 . . . . 0.0 109.742 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.727 ' CB ' ' CD2' ' A' ' 98' ' ' HIS . 3.1 t-20 63.67 34.57 12.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.824 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 19.9 t-20 69.18 35.03 2.82 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.326 -0.859 . . . . 0.0 110.271 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.674 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.3 t -135.04 168.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.209 -0.932 . . . . 0.0 110.127 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.808 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.0 77.27 5.07 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.7 . . . . 0.0 109.132 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.69 155.87 53.85 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.079 1.568 . . . . 0.0 110.879 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.47 -177.56 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.195 1.629 . . . . 0.0 110.292 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.53 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 1.1 p -82.23 16.46 2.0 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.305 -0.872 . . . . 0.0 110.948 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.43 41.56 1.12 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.534 -0.728 . . . . 0.0 109.519 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.52 -176.53 5.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.523 -0.736 . . . . 0.0 110.165 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 80.6 p -139.75 141.31 36.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 110.335 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.047 ' HA ' HD23 ' A' ' 94' ' ' LEU . 2.2 mmt -49.99 -42.78 49.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 110.014 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -48.59 -47.59 29.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 90' ' ' THR . 2.2 pt20 -64.63 -31.98 73.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -1.147 . . . . 0.0 109.814 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.118 HD11 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -67.61 -22.47 65.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.15 -0.969 . . . . 0.0 110.096 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.524 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -49.64 -55.76 12.51 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 120.881 -1.137 . . . . 0.0 109.692 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.429 ' O ' ' NE2' ' A' ' 99' ' ' HIS . 7.6 mt-30 -69.47 -17.22 63.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.963 -1.085 . . . . 0.0 111.294 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 1.8 mm-40 -87.44 -65.25 1.03 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.997 -1.065 . . . . 0.0 112.445 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.727 ' CD2' ' CB ' ' A' ' 81' ' ' ASN . 30.9 m170 -98.63 37.94 1.42 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.86 -1.15 . . . . 0.0 111.808 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.546 ' O ' ' CE2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.504 -0.747 . . . . 0.0 109.673 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 104' ' ' PHE . 4.5 m-30 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.323 0.582 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.118 HD22 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -108.19 169.53 8.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.283 -0.885 . . . . 0.0 109.272 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.683 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -114.5 130.75 56.76 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.615 -1.303 . . . . 0.0 111.493 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.05 ' CG1' HD11 ' A' ' 105' ' ' LEU . 10.1 mt -141.97 122.65 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 110.236 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.75 153.21 44.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.988 -1.07 . . . . 0.0 109.51 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.684 ' OH ' HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -130.36 167.51 18.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.648 -1.282 . . . . 0.0 111.116 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -152.44 -178.39 6.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.674 -0.641 . . . . 0.0 110.086 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.514 ' OD1' ' CG ' ' A' ' 40' ' ' ARG . 2.1 m-20 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.26 -0.9 . . . . 0.0 110.249 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 28' ' ' ARG . 2.5 mpt_? . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.223 0.535 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 HG12 ' A' ' 31' ' ' VAL . 34.9 t -147.46 104.28 3.74 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 44.2 Cg_endo -72.97 87.41 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.026 1.54 . . . . 0.0 110.259 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.74 HG12 HG12 ' A' ' 29' ' ' VAL . 1.3 m -84.52 139.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.178 -0.952 . . . . 0.0 111.056 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 45.8 mm -94.57 158.57 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 108.89 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.801 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.5 t -133.95 134.77 55.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.886 -1.134 . . . . 0.0 111.273 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.3 tt0 -148.54 168.79 21.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.295 0.569 . . . . 0.0 109.538 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.63 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -100.51 156.26 17.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.043 -1.036 . . . . 0.0 110.562 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.034 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.52 -172.9 0.1 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.519 -0.738 . . . . 0.0 109.244 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.034 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.5 Cg_endo -72.63 107.83 2.4 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.441 1.232 . . . . 0.0 109.922 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.89 42.13 8.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 110.251 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.19 -177.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.905 . . . . 0.0 110.016 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.485 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.2 35.74 0.66 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.12 -0.987 . . . . 0.0 110.588 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -84.64 179.45 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.092 -1.005 . . . . 0.0 110.049 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -62.16 179.55 4.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.953 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.1 t70 -70.73 -176.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -1.073 . . . . 0.0 109.988 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.953 HD22 ' O ' ' A' ' 43' ' ' ASP . 2.0 mm? -135.67 134.09 38.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.159 -0.963 . . . . 0.0 110.588 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -86.27 -27.0 24.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 109.587 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.51 ' CD ' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -158.04 150.08 21.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.517 -0.74 . . . . 0.0 109.679 179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -116.66 45.31 1.85 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.833 -1.167 . . . . 0.0 110.025 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 108.89 1.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 109.53 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.865 ' CD2' HD13 ' A' ' 63' ' ' LEU . 20.0 m-85 -105.47 141.33 37.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 110.718 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.0 98.37 8.09 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.609 HG21 ' SD ' ' A' ' 91' ' ' MET . 11.2 m -121.89 150.88 56.91 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 110.87 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 43.6 Cg_endo -69.28 145.74 60.92 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.047 1.551 . . . . 0.0 110.201 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.561 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.41 -15.6 50.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 0.0 111.379 -178.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -83.15 -14.7 52.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 111.283 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.83 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.9 mt -62.47 143.02 57.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.892 -1.13 . . . . 0.0 111.428 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -91.03 167.22 12.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.663 -0.648 . . . . 0.0 109.869 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.821 HG12 HG22 ' A' ' 87' ' ' THR . 58.7 t -62.75 -26.32 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.998 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.06 -31.65 75.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.83 ' CB ' HD22 ' A' ' 55' ' ' LEU . 7.1 mm100 -76.79 -47.07 22.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.113 -1.228 . . . . 0.0 110.04 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.141 ' CE2' HD11 ' A' ' 64' ' ' ILE . 22.7 t80 -60.7 -47.19 87.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.102 -0.998 . . . . 0.0 109.468 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.24 -22.24 1.68 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.883 -1.136 . . . . 0.0 109.855 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -79.91 -54.98 5.3 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 110.513 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.009 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.8 pp -59.84 -20.35 56.45 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.271 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.141 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.2 mt -90.98 -38.27 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 120.193 -1.567 . . . . 0.0 109.051 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.636 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.7 OUTLIER -35.35 -66.03 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.181 0.515 . . . . 0.0 110.83 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -31.47 72.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.893 -1.13 . . . . 0.0 110.072 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.537 ' O ' HD13 ' A' ' 44' ' ' LEU . 35.4 mmt180 -66.76 -16.82 64.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.54 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 68' ' ' ILE . 40.8 mt -103.38 11.9 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 0.0 109.763 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.552 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 51.9 23.76 2.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -0.797 . . . . 0.0 110.671 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.792 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.2 pp -91.85 157.44 16.87 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.319 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' GLU . 25.1 ptt180 -165.16 -169.44 1.65 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.929 -1.107 . . . . 0.0 111.152 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.42 -90.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.581 -0.7 . . . . 0.0 110.62 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 74' ' ' ASP . 6.5 pt-20 -158.67 28.07 0.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.2 -0.938 . . . . 0.0 110.883 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.515 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.16 176.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 109.892 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -103.21 140.63 37.12 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.291 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.89 HD11 ' HB2' ' A' ' 109' ' ' TYR . 21.5 tp -164.36 150.05 10.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 110.465 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.591 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 89.1 m-85 -157.93 121.97 4.14 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.778 -0.576 . . . . 0.0 109.869 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.896 ' CE2' HD12 ' A' ' 64' ' ' ILE . 18.3 m-30 -79.95 135.84 36.5 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.074 -1.016 . . . . 0.0 111.246 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.568 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 82.6 m-85 -118.33 126.46 52.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.739 HG22 HG12 ' A' ' 107' ' ' ILE . 2.4 t -120.83 124.06 71.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.808 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.1 t-20 47.63 49.12 16.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 29.3 m-80 56.81 36.01 27.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.639 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -135.18 167.0 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.086 -1.009 . . . . 0.0 109.924 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.88 72.42 5.84 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.547 -0.721 . . . . 0.0 109.632 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 164.07 36.49 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.04 1.547 . . . . 0.0 110.564 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.7 -178.96 3.75 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.121 1.59 . . . . 0.0 110.311 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.821 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.12 19.16 2.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 110.652 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.43 39.22 1.02 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.512 -0.743 . . . . 0.0 109.567 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.801 ' HB1' ' CD ' ' A' ' 93' ' ' GLN . . . -145.42 -174.11 4.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.536 -0.728 . . . . 0.0 110.18 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 81.5 p -139.71 143.86 37.25 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.626 -0.671 . . . . 0.0 110.203 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.068 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -44.8 -41.78 7.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 109.747 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -50.69 -48.04 44.57 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.801 ' CD ' ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -64.38 -31.58 72.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -1.179 . . . . 0.0 109.988 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.068 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.06 -23.72 64.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.81 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.599 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -50.59 -56.96 9.4 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.892 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -69.64 -15.92 63.28 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.614 -1.304 . . . . 0.0 110.819 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -88.57 -71.04 0.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.169 -0.957 . . . . 0.0 113.486 -177.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.765 ' CD2' ' CB ' ' A' ' 81' ' ' ASN . 33.8 m170 -100.81 38.28 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.68 -1.262 . . . . 0.0 113.189 -176.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.599 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 O-C-N 120.99 -1.069 . . . . 0.0 110.252 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.534 ' CB ' ' O ' ' A' ' 30' ' ' PRO . 18.1 m-85 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.933 HD13 ' CD1' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -96.07 165.86 12.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.749 -1.219 . . . . 0.0 108.848 178.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.743 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -123.89 124.4 42.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.575 -1.328 . . . . 0.0 111.638 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.739 HG12 HG22 ' A' ' 80' ' ' VAL . 13.2 mt -141.56 133.29 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.439 -0.788 . . . . 0.0 109.475 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -133.38 178.14 7.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.097 -1.002 . . . . 0.0 110.295 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.89 ' HB2' HD11 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -133.96 153.87 51.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.133 -0.98 . . . . 0.0 110.851 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 1.1 t -145.17 173.23 12.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.679 -0.638 . . . . 0.0 110.119 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 2.5 p30 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.975 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HD3' ' N ' ' A' ' 28' ' ' ARG . 1.6 mpt_? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.114 0.483 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.792 HG12 HG12 ' A' ' 31' ' ' VAL . 24.3 t -144.12 105.65 4.81 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.173 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 48.4 Cg_endo -74.69 84.99 1.52 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.321 1.695 . . . . 0.0 110.038 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.997 HG11 ' HE3' ' A' ' 91' ' ' MET . 1.4 m -85.6 148.29 4.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 110.933 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.6 HD13 ' CD1' ' A' ' 104' ' ' PHE . 1.5 mp -113.97 147.53 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.551 HG22 ' CE1' ' A' ' 109' ' ' TYR . 0.4 OUTLIER -124.36 153.26 30.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.8 -1.187 . . . . 0.0 111.187 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.585 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 2.4 tt0 -156.34 -162.04 1.21 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.539 ' HD2' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -132.25 159.81 37.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.869 -1.144 . . . . 0.0 110.815 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.55 -173.8 0.11 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.582 -0.699 . . . . 0.0 109.38 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.3 Cg_endo -71.98 108.9 2.56 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.522 1.275 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.86 41.15 5.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.828 . . . . 0.0 110.553 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.455 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -63.22 178.18 0.54 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 109.841 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.523 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 13.8 ptt180 -145.26 28.72 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.802 ' C ' HD12 ' A' ' 41' ' ' ILE . 1.8 pp -85.32 179.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.012 . . . . 0.0 109.726 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -68.74 146.38 45.07 Favored Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.231 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.82 163.87 16.22 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.618 -0.93 . . . . 0.0 110.787 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.532 ' HG ' ' CA ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -153.74 142.49 20.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.729 -0.607 . . . . 0.0 109.472 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 1.6 t0 -84.09 42.17 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 110.038 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.511 ' CD ' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -160.29 105.78 1.51 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.019 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -115.55 48.58 1.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.74 -1.225 . . . . 0.0 110.618 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.17 111.51 1.7 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.875 . . . . 0.0 109.532 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.938 ' CD2' HD13 ' A' ' 63' ' ' LEU . 24.0 m-85 -106.98 141.56 37.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.049 -1.032 . . . . 0.0 110.551 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.77 93.83 4.75 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.991 ' HB ' HD12 ' A' ' 55' ' ' LEU . 13.7 m -117.95 153.88 51.2 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.152 -0.968 . . . . 0.0 110.777 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.9 Cg_endo -71.65 148.22 52.7 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.111 1.585 . . . . 0.0 110.025 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.563 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.5 m -63.81 -15.34 58.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 111.334 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 7.8 t70 -83.58 -11.26 57.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.018 -1.051 . . . . 0.0 110.916 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.991 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.6 mt -62.05 142.02 57.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.941 -1.099 . . . . 0.0 111.122 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 1.2 p -91.01 154.89 19.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.65 -0.656 . . . . 0.0 109.433 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 1.033 HG12 HG22 ' A' ' 87' ' ' THR . 24.6 t -53.82 -20.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.991 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.37 -41.68 58.21 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.823 ' HB2' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -67.72 -46.67 71.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.174 -1.192 . . . . 0.0 109.997 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.17 ' CE2' HD11 ' A' ' 64' ' ' ILE . 22.8 t80 -60.65 -47.1 87.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.097 -1.002 . . . . 0.0 109.695 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.31 -22.25 1.72 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.01 -1.056 . . . . 0.0 109.87 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.16 -54.55 5.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 110.34 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.988 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.7 pp -59.75 -19.47 50.42 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.069 -1.052 . . . . 0.0 112.354 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.17 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.9 mt -92.16 -40.18 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 120.125 -1.61 . . . . 0.0 109.077 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -37.28 -61.46 0.58 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.878 -0.514 . . . . 0.0 110.624 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -32.33 73.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.942 -1.099 . . . . 0.0 109.742 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.535 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 15.1 mmt180 -69.39 -13.14 62.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.359 -0.838 . . . . 0.0 109.946 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.739 HG23 HD13 ' A' ' 41' ' ' ILE . 2.4 mm -99.61 7.81 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.061 -1.024 . . . . 0.0 109.528 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.541 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 54.1 32.58 16.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.429 -0.794 . . . . 0.0 110.132 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 70' ' ' LEU . 4.1 pp -110.53 151.2 27.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.829 . . . . 0.0 109.934 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.9 ptp180 -167.06 -168.94 1.17 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.851 . . . . 0.0 111.058 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.453 ' C ' ' HG3' ' A' ' 73' ' ' GLU . . . 50.71 -91.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.568 -0.707 . . . . 0.0 111.225 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HG3' ' C ' ' A' ' 72' ' ' ALA . 14.2 mt-10 -141.98 49.27 1.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.873 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -77.82 176.04 9.43 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.12 0.962 . . . . 0.0 109.991 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.511 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -118.16 143.85 46.16 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.039 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.813 HD21 ' CE1' ' A' ' 78' ' ' PHE . 18.2 tp -164.05 153.66 14.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 110.628 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 68.0 m-85 -157.58 123.06 4.57 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.617 -0.677 . . . . 0.0 109.465 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.813 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.4 m-30 -84.8 132.34 34.43 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.012 -1.055 . . . . 0.0 111.93 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 41.1 m-85 -120.55 118.39 30.09 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.021 HG22 HG23 ' A' ' 107' ' ' ILE . 2.0 t -120.68 130.82 74.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.556 ' HB3' ' CE1' ' A' ' 98' ' ' HIS . 53.5 t30 51.28 34.48 11.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 3.8 t-20 67.65 35.91 3.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.224 -0.922 . . . . 0.0 110.208 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -135.77 168.59 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 110.078 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.3 mp -154.68 71.01 5.99 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.73 . . . . 0.0 109.678 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.32 164.37 34.26 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.122 1.59 . . . . 0.0 110.68 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.08 -178.64 3.69 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.071 1.564 . . . . 0.0 110.611 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 1.033 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.2 22.95 1.65 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.331 -0.855 . . . . 0.0 110.672 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.37 43.45 1.07 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.369 -0.832 . . . . 0.0 109.551 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.28 -171.48 3.67 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.708 0.765 . . . . 0.0 110.294 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 75.9 p -139.21 136.36 34.93 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.538 0.685 . . . . 0.0 110.103 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.008 ' HA ' HD23 ' A' ' 94' ' ' LEU . 32.1 mmm -48.4 -38.69 20.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.9 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.45 -49.01 47.14 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 90' ' ' THR . 3.0 pt20 -64.64 -30.24 71.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -1.113 . . . . 0.0 109.814 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.008 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.52 -23.79 64.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.208 -0.932 . . . . 0.0 110.102 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 99' ' ' HIS . 1.0 OUTLIER -48.86 -53.04 21.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.843 -1.161 . . . . 0.0 109.774 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -69.36 -21.47 63.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.196 -0.94 . . . . 0.0 111.192 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 8.4 mm-40 -85.68 -66.86 0.85 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.941 -1.1 . . . . 0.0 112.007 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.618 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -98.77 42.33 1.1 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.912 -1.117 . . . . 0.0 110.771 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 95' ' ' TYR . 1.4 t-80 . . . . . 0 N--CA 1.498 1.935 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.852 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.6 ' CD1' HD13 ' A' ' 32' ' ' ILE . 38.1 p90 . . . . . 0 N--CA 1.511 2.597 0 CA-C-O 121.367 0.604 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.032 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -123.67 160.3 27.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.771 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.786 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -124.97 135.88 53.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.029 -1.044 . . . . 0.0 110.996 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.032 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.0 mt -141.69 137.54 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.76 147.21 50.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.212 -0.93 . . . . 0.0 108.864 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.6 p90 -130.67 165.79 22.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.478 -1.389 . . . . 0.0 111.629 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -156.07 174.74 14.92 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.257 0.551 . . . . 0.0 110.328 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.523 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 1.8 p30 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.955 . . . . 0.0 110.217 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.393 0.616 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 31' ' ' VAL . 19.9 t -147.5 102.68 3.73 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.855 . . . . 0.0 109.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.498 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 46.1 Cg_endo -73.46 81.11 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.177 1.62 . . . . 0.0 110.208 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 29' ' ' VAL . 2.2 m -77.32 152.33 5.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 110.686 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 1.5 mp -108.24 164.1 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.686 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.4 t -136.31 136.51 48.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.835 -1.166 . . . . 0.0 111.093 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.91 -176.16 5.81 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.322 0.582 . . . . 0.0 109.742 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HD2' HD11 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -114.9 159.08 21.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.985 -1.072 . . . . 0.0 110.786 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.021 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.76 -173.23 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.529 -0.732 . . . . 0.0 109.191 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.021 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.7 Cg_endo -71.91 107.25 2.17 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.472 1.249 . . . . 0.0 109.983 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.95 41.75 8.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.353 -0.842 . . . . 0.0 110.206 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.8 178.75 0.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.283 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.424 ' HG3' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.68 32.31 1.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.214 -0.929 . . . . 0.0 110.172 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.587 HD11 ' HD2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -85.81 -173.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.324 -0.86 . . . . 0.0 110.579 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.578 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -67.46 172.43 31.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.54 179.61 3.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.165 -1.197 . . . . 0.0 110.595 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 2.1 pp -134.93 133.42 39.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.369 -0.832 . . . . 0.0 110.706 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.454 ' OD2' ' HD2' ' A' ' 46' ' ' LYS . 10.7 p-10 -85.83 -20.52 29.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.191 -0.943 . . . . 0.0 110.143 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.512 ' HD2' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -151.84 154.08 35.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 109.683 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.547 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -128.28 40.95 3.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.962 -1.086 . . . . 0.0 110.448 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.92 104.88 0.91 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 109.822 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.638 ' O ' HG22 ' A' ' 31' ' ' VAL . 30.6 m-85 -105.4 145.26 31.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.112 -0.993 . . . . 0.0 111.09 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.03 94.82 5.22 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.016 ' HB ' HD12 ' A' ' 55' ' ' LEU . 32.8 m -115.92 153.14 48.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.115 -0.991 . . . . 0.0 110.987 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.458 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.3 Cg_endo -69.81 149.5 66.65 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.08 1.568 . . . . 0.0 110.407 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.556 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -63.78 -16.24 60.71 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 111.34 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -83.12 -10.99 58.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -0.999 . . . . 0.0 111.017 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.016 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.7 mt -61.84 141.8 57.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.907 -1.121 . . . . 0.0 110.952 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.499 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 3.1 p -91.23 162.41 14.65 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.532 -0.73 . . . . 0.0 109.507 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 37.1 t -59.04 -30.16 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.104 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.73 -27.16 74.06 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.87 ' CB ' HD22 ' A' ' 55' ' ' LEU . 14.7 mm100 -76.3 -51.35 12.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.169 -1.195 . . . . 0.0 110.054 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.151 ' CE2' HD11 ' A' ' 64' ' ' ILE . 12.0 t80 -60.41 -47.25 86.92 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.919 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.51 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -49.29 -23.27 1.33 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.849 -1.157 . . . . 0.0 109.562 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -55.87 4.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.486 -0.759 . . . . 0.0 111.282 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.127 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -59.03 -23.53 62.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.899 -1.126 . . . . 0.0 111.842 -178.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.151 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -91.08 -35.01 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.078 -1.639 . . . . 0.0 108.77 177.518 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.673 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -38.95 -56.19 1.43 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.446 -0.784 . . . . 0.0 110.51 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HE2' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -64.89 -34.94 79.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.975 -1.078 . . . . 0.0 108.899 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.518 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 5.0 mmt180 -73.08 -10.54 59.9 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.684 -0.635 . . . . 0.0 110.121 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.032 ' CG2' HD23 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -88.09 -10.57 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER 74.01 28.07 1.53 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.751 0.786 . . . . 0.0 109.122 -178.704 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.032 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.0 pp -113.93 158.67 20.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.745 -0.597 . . . . 0.0 109.873 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -165.08 -174.62 3.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 110.772 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.99 -90.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.0 110.788 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 1.9 pt-20 -153.93 42.26 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 111.027 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -67.51 176.48 2.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.071 -1.018 . . . . 0.0 110.076 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.718 ' HB3' ' CG ' ' A' ' 111' ' ' ASP . . . -92.27 142.85 27.01 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.834 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.791 HD21 ' CE1' ' A' ' 78' ' ' PHE . 17.8 tp -164.09 154.37 14.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 110.773 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 85.2 m-85 -156.91 124.16 5.26 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.581 -0.699 . . . . 0.0 110.121 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.791 ' CE1' HD21 ' A' ' 76' ' ' LEU . 3.7 m-30 -94.73 113.89 25.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 91.2 m-85 -108.99 127.48 54.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 110.122 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.959 HG22 HG23 ' A' ' 107' ' ' ILE . 1.8 t -121.5 122.41 67.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.428 -0.795 . . . . 0.0 109.442 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.689 ' O ' HG23 ' A' ' 83' ' ' VAL . 2.6 m120 57.38 33.48 23.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.073 -1.017 . . . . 0.0 109.922 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.27 31.91 15.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -133.13 171.19 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.391 -0.818 . . . . 0.0 109.681 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.807 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.2 mp -154.26 77.73 5.41 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.427 -0.796 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.52 165.8 31.67 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.149 1.605 . . . . 0.0 110.36 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.58 178.66 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.069 1.563 . . . . 0.0 110.444 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.499 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.19 20.49 2.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.319 -0.863 . . . . 0.0 110.624 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.7 p -94.64 37.47 1.13 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.538 -0.726 . . . . 0.0 109.596 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.77 -174.8 4.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.485 -0.759 . . . . 0.0 110.182 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.523 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 34.7 p -139.09 149.9 45.09 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.317 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.116 ' HA ' HD23 ' A' ' 94' ' ' LEU . 30.6 mmm -51.56 -38.6 55.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.478 -0.764 . . . . 0.0 110.16 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -54.12 -40.4 66.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.523 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 2.1 mt-30 -68.43 -46.05 70.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.146 -1.208 . . . . 0.0 109.269 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.116 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -56.92 -20.56 24.04 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.131 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.53 ' O ' ' HB3' ' A' ' 99' ' ' HIS . 1.3 t80 -48.75 -53.28 19.63 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.794 -1.191 . . . . 0.0 109.833 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.641 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 10.3 tt0 -69.49 -19.92 63.73 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.778 -1.201 . . . . 0.0 111.337 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -87.78 -62.98 1.37 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.066 -1.021 . . . . 0.0 113.53 -177.655 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.575 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.8 m-70 -98.12 35.8 1.68 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.675 -1.266 . . . . 0.0 112.682 -176.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.641 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.035 -1.041 . . . . 0.0 110.066 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.475 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 20.3 p90 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.497 0.665 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.028 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -117.71 167.3 11.48 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 0.0 109.362 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.746 ' N ' HD12 ' A' ' 105' ' ' LEU . 2.9 p90 -125.82 133.93 51.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.866 -1.146 . . . . 0.0 111.712 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.028 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.6 mt -141.19 147.03 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.437 -0.79 . . . . 0.0 109.785 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.0 177.43 7.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.052 . . . . 0.0 110.287 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.686 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.2 p90 -143.47 171.42 14.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.221 -0.924 . . . . 0.0 110.612 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -159.63 -175.15 5.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.464 -0.772 . . . . 0.0 110.2 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.718 ' CG ' ' HB3' ' A' ' 75' ' ' ALA . 8.8 t70 . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.401 -0.812 . . . . 0.0 110.095 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 1.8 mpt_? . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.345 0.593 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.822 HG12 HG12 ' A' ' 31' ' ' VAL . 19.6 t -147.45 109.2 3.88 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.31 -0.869 . . . . 0.0 110.171 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.1 Cg_endo -75.45 84.14 1.77 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.193 1.628 . . . . 0.0 110.101 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.822 HG12 HG12 ' A' ' 29' ' ' VAL . 1.2 m -82.72 132.03 32.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.131 -0.98 . . . . 0.0 111.045 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 41.4 mm -93.86 142.78 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -124.65 147.96 29.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.86 -1.15 . . . . 0.0 111.135 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.579 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -156.57 -174.12 4.79 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -121.39 160.65 23.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.9 -1.125 . . . . 0.0 110.53 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.006 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.92 -174.83 0.15 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.412 -0.805 . . . . 0.0 109.296 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.006 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.2 Cg_endo -70.54 111.87 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.531 1.28 . . . . 0.0 109.68 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 2.8 mttt 62.21 42.34 9.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.351 -0.843 . . . . 0.0 110.05 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.528 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -56.13 -177.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.306 -0.871 . . . . 0.0 109.995 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -148.39 28.05 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 111.01 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.895 HD13 HG23 ' A' ' 68' ' ' ILE . 2.0 pp -91.81 176.46 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.83 -1.169 . . . . 0.0 110.324 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.84 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -52.12 -176.5 0.04 OUTLIER Glycine 0 N--CA 1.498 2.803 0 O-C-N 121.296 -0.878 . . . . 0.0 111.181 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 1.017 ' O ' HD22 ' A' ' 44' ' ' LEU . 10.1 t0 -80.47 -171.33 3.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -1.09 . . . . 0.0 109.993 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.017 HD22 ' O ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -142.25 138.5 31.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 110.667 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -86.07 -32.97 21.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 109.827 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 151.83 30.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.961 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.705 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -112.53 46.02 1.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 109.769 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -165.92 109.7 0.81 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.552 -0.718 . . . . 0.0 109.48 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.902 ' CD2' HD13 ' A' ' 63' ' ' LEU . 12.7 m-85 -105.83 140.39 38.93 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.117 -0.989 . . . . 0.0 110.326 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.53 92.91 4.67 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.83 ' HB ' HD12 ' A' ' 55' ' ' LEU . 13.6 m -115.64 150.82 45.4 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.53 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.0 Cg_endo -70.5 148.48 60.34 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.107 1.583 . . . . 0.0 110.036 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.57 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -62.56 -16.19 54.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -0.805 . . . . 0.0 111.399 -178.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.86 -13.2 54.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.036 -1.04 . . . . 0.0 111.209 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.881 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.8 mt -62.06 140.99 58.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.865 -1.147 . . . . 0.0 111.133 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.6 p -90.57 154.59 19.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.619 -0.676 . . . . 0.0 109.45 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.505 ' CG1' HG22 ' A' ' 87' ' ' THR . 58.9 t -52.74 -21.19 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.061 -1.024 . . . . 0.0 110.04 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.67 -41.24 57.31 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.881 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.1 mm-40 -67.74 -47.24 69.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.214 -1.168 . . . . 0.0 109.903 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.184 ' CE2' HD11 ' A' ' 64' ' ' ILE . 31.1 t80 -60.79 -46.51 90.24 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.496 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -51.13 -22.11 2.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.824 -1.173 . . . . 0.0 109.802 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -78.82 -54.22 6.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.946 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.023 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.6 pp -59.92 -20.44 57.39 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.02 -1.05 . . . . 0.0 112.189 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.184 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.6 mt -90.19 -37.54 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 120.103 -1.623 . . . . 0.0 108.836 177.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -37.99 -61.36 0.66 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.278 0.561 . . . . 0.0 110.736 -179.511 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -31.0 71.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.913 -1.117 . . . . 0.0 109.822 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.576 ' C ' HD13 ' A' ' 68' ' ' ILE . 21.4 mmt180 -67.7 -16.94 64.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.895 HG23 HD13 ' A' ' 41' ' ' ILE . 2.9 mm -99.76 14.11 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.371 -0.83 . . . . 0.0 109.51 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.493 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER 47.87 33.53 3.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.553 -0.717 . . . . 0.0 110.562 179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.795 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.1 pp -112.03 155.62 23.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.695 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.65 -172.23 2.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.079 -1.013 . . . . 0.0 111.056 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 55.27 -89.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.478 -0.764 . . . . 0.0 110.889 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.5 pt-20 -147.21 32.09 0.91 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 111.032 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -52.92 176.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.074 -1.016 . . . . 0.0 109.843 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HB3' ' OD1' ' A' ' 111' ' ' ASP . . . -117.59 139.17 51.34 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.134 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.862 HD21 ' HE1' ' A' ' 78' ' ' PHE . 29.8 tp -164.49 155.25 14.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 110.427 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.568 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 20.1 m-85 -153.79 123.3 6.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.45 -0.781 . . . . 0.0 109.754 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.862 ' HE1' HD21 ' A' ' 76' ' ' LEU . 18.0 m-30 -84.71 132.78 34.41 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.098 -1.001 . . . . 0.0 111.705 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 62.3 m-85 -120.37 119.81 34.16 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.802 HG22 HG23 ' A' ' 107' ' ' ILE . 2.1 t -120.77 127.95 75.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.235 -0.916 . . . . 0.0 110.206 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.69 ' O ' HG23 ' A' ' 83' ' ' VAL . 28.8 t30 54.77 35.47 24.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.874 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 64.14 32.15 12.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.38 -0.825 . . . . 0.0 110.077 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -135.63 171.05 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.415 -0.803 . . . . 0.0 109.853 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.55 75.4 5.74 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.544 -0.723 . . . . 0.0 109.47 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.5 163.91 36.37 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.967 1.509 . . . . 0.0 110.651 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.98 177.64 7.49 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.17 1.616 . . . . 0.0 110.276 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.505 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.88 21.96 2.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.263 -0.898 . . . . 0.0 110.603 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.78 36.68 0.86 Allowed 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 109.745 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -147.45 -170.4 3.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.376 -0.827 . . . . 0.0 110.358 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.559 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 58.6 p -138.96 146.94 41.58 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.488 0.661 . . . . 0.0 109.92 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.058 ' HA ' HD23 ' A' ' 94' ' ' LEU . 1.2 mmt -47.13 -47.36 23.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.248 -0.907 . . . . 0.0 110.431 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.57 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -42.73 -44.73 5.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.559 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 1.0 OUTLIER -67.81 -39.76 83.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -1.159 . . . . 0.0 109.243 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.058 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -59.53 -24.94 64.09 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.364 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.577 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -49.16 -56.07 10.39 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.517 -1.365 . . . . 0.0 109.411 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.582 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 8.7 tt0 -71.35 -18.18 62.39 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.163 -0.961 . . . . 0.0 111.911 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.586 ' HG2' ' CE1' ' A' ' 98' ' ' HIS . 1.3 tt0 -87.77 -61.23 1.76 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.756 -1.215 . . . . 0.0 112.552 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.684 ' HB3' HG12 ' A' ' 80' ' ' VAL . 17.4 m-70 -98.27 38.64 1.31 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.859 -1.15 . . . . 0.0 111.424 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.582 ' CD2' ' O ' ' A' ' 96' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.424 -0.797 . . . . 0.0 109.122 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.487 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 5.6 m-85 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.28 0.562 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.046 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.51 168.54 9.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.205 -0.934 . . . . 0.0 109.291 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.657 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.2 m-85 -121.92 130.68 53.54 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.64 -1.288 . . . . 0.0 111.597 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.046 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.8 mt -141.56 127.05 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.33 -0.856 . . . . 0.0 110.354 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -121.93 163.64 18.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.111 -0.993 . . . . 0.0 108.851 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.669 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.7 OUTLIER -145.75 164.05 33.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.622 -1.299 . . . . 0.0 111.225 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.624 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.5 t -159.27 -175.95 5.53 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.508 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.629 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 65.5 t0 . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.968 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.422 0.63 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.881 HG13 ' CE1' ' A' ' 95' ' ' TYR . 23.4 t -119.35 134.32 23.76 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.413 -0.804 . . . . 0.0 110.866 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.609 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 52.3 Cg_endo -81.16 112.48 2.56 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 124.246 1.656 . . . . 0.0 109.477 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.921 HG22 ' CD2' ' A' ' 105' ' ' LEU . 45.8 t -100.13 125.06 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 110.897 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.075 HD11 ' CE2' ' A' ' 104' ' ' PHE . 27.1 mm -91.51 147.15 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 108.819 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.629 HG21 ' CD1' ' A' ' 49' ' ' TYR . 9.2 t -130.61 143.93 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 120.855 -1.153 . . . . 0.0 111.556 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HA ' ' CE ' ' A' ' 47' ' ' LYS . 3.5 tt0 -156.54 167.25 31.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.552 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.661 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -96.79 163.46 12.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.937 -1.102 . . . . 0.0 110.921 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.023 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.89 -174.0 0.14 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 0.0 109.68 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.023 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.8 Cg_endo -74.03 116.64 4.72 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.576 1.303 . . . . 0.0 109.968 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.29 39.56 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 110.034 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.46 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -62.37 174.42 0.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.359 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 31.75 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.976 HD13 HG23 ' A' ' 68' ' ' ILE . 1.8 pp -85.88 177.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.026 . . . . 0.0 110.611 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.822 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -49.1 -176.89 0.01 OUTLIER Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.26 -177.17 5.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.253 -1.145 . . . . 0.0 110.001 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.936 HD12 ' OH ' ' A' ' 109' ' ' TYR . 0.2 OUTLIER -148.58 147.55 29.13 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.047 -1.033 . . . . 0.0 110.453 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 9.4 m-20 -86.82 -28.42 22.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.375 -0.828 . . . . 0.0 110.626 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -152.54 156.83 40.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 0.0 110.011 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' CE ' ' HA ' ' A' ' 34' ' ' GLU . 6.6 mmmm -120.65 43.8 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.054 -1.029 . . . . 0.0 109.781 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 1.5 ptmm? -157.94 109.75 2.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.379 -0.825 . . . . 0.0 109.74 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.629 ' CD1' HG21 ' A' ' 33' ' ' VAL . 28.1 m-85 -104.29 147.44 27.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 110.965 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -120.12 114.17 21.56 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.424 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.747 ' HB ' HD12 ' A' ' 55' ' ' LEU . 2.8 m -141.0 165.32 30.2 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.714 -1.241 . . . . 0.0 110.889 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 43.7 Cg_endo -69.22 147.93 67.46 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.151 1.606 . . . . 0.0 110.46 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.534 ' HB3' ' CA ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -65.34 -12.72 54.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.461 -0.775 . . . . 0.0 111.336 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -84.08 -5.48 59.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.084 -1.01 . . . . 0.0 110.913 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.851 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.8 mt -61.96 141.52 57.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.83 -1.169 . . . . 0.0 111.107 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 0.9 OUTLIER -92.07 159.57 15.63 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.589 -0.694 . . . . 0.0 109.698 178.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 88.3 t -58.44 -26.64 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.76 -31.51 67.44 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.851 ' CB ' HD22 ' A' ' 55' ' ' LEU . 15.7 mm100 -69.34 -51.1 40.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.162 ' CD1' HD11 ' A' ' 63' ' ' LEU . 6.9 t80 -59.97 -33.57 72.12 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.436 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.583 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -55.58 -35.14 65.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 109.998 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -79.74 -50.01 11.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.74 . . . . 0.0 112.682 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.162 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.66 -39.85 81.81 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.434 -1.416 . . . . 0.0 111.927 -177.489 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.132 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -76.11 -42.95 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 119.877 -1.764 . . . . 0.0 108.432 178.224 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.882 ' HG2' HD11 ' A' ' 70' ' ' LEU . 3.4 mtt180 -35.92 -61.58 0.47 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.825 -0.547 . . . . 0.0 110.863 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.71 -33.07 75.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.029 . . . . 0.0 109.895 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.767 ' HB3' HD21 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -69.97 -10.3 58.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -0.901 . . . . 0.0 109.624 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.976 HG23 HD13 ' A' ' 41' ' ' ILE . 5.5 mm -100.4 7.5 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.442 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.43 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 3.0 m-70 54.84 31.47 15.74 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.415 -0.803 . . . . 0.0 110.416 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.882 HD11 ' HG2' ' A' ' 65' ' ' ARG . 4.2 pp -110.62 150.6 28.75 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.835 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 1.2 ptt180 -167.0 -167.19 0.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 111.017 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 56.56 -86.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.562 -0.711 . . . . 0.0 110.96 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 71' ' ' ARG . 35.7 mt-10 -151.38 30.28 0.61 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.914 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -59.72 176.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.076 -1.015 . . . . 0.0 109.637 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -103.69 139.73 38.55 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.135 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.659 HD21 ' CZ ' ' A' ' 78' ' ' PHE . 19.3 tp -160.95 150.7 17.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.915 . . . . 0.0 110.465 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 85.9 m-85 -160.32 120.57 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.865 -0.522 . . . . 0.0 109.641 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.696 ' CE1' HD12 ' A' ' 64' ' ' ILE . 81.4 m-85 -89.94 113.53 25.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.101 -0.999 . . . . 0.0 110.214 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 68.5 m-85 -104.97 136.61 44.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.342 -0.849 . . . . 0.0 109.876 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 107' ' ' ILE . 4.9 t -120.18 125.92 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.512 ' HB2' ' CD2' ' A' ' 98' ' ' HIS . 0.8 OUTLIER 46.31 39.26 6.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.241 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 2.3 t30 67.53 38.45 3.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.401 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.7 t -135.51 168.51 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 109.864 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.815 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.4 mp -154.44 69.5 5.99 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.505 -0.747 . . . . 0.0 109.718 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.28 170.49 19.75 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.068 1.562 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.22 179.55 5.35 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.101 1.579 . . . . 0.0 110.36 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.69 21.62 2.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.399 -0.813 . . . . 0.0 110.559 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 t -95.73 39.64 1.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.522 -0.736 . . . . 0.0 109.791 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.81 -176.7 5.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 110.338 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 45.3 p -139.61 148.32 42.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.569 -0.707 . . . . 0.0 110.255 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.026 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -52.96 -41.47 64.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 109.946 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.534 ' CA ' ' HB3' ' A' ' 53' ' ' SER . . . -49.56 -50.07 31.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 90' ' ' THR . 2.2 pt20 -64.72 -28.95 69.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -1.146 . . . . 0.0 109.671 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.051 HD21 HD22 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -68.31 -23.12 64.7 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.318 -0.864 . . . . 0.0 109.677 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.881 ' CE1' HG13 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -50.07 -55.9 12.98 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.094 -1.004 . . . . 0.0 109.909 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -17.51 63.93 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.545 -1.347 . . . . 0.0 110.623 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.5 mt-10 -88.57 -71.75 0.57 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.17 -0.956 . . . . 0.0 113.445 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.512 ' CD2' ' HB2' ' A' ' 81' ' ' ASN . 34.1 m170 -100.74 38.35 1.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.653 -1.28 . . . . 0.0 113.112 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.604 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.951 0 O-C-N 120.988 -1.07 . . . . 0.0 111.029 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 1.075 ' CE2' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.051 HD22 HD21 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -98.52 154.22 18.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.67 -1.269 . . . . 0.0 110.057 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.648 ' N ' HD12 ' A' ' 105' ' ' LEU . 62.7 m-85 -119.09 122.07 41.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.115 -0.991 . . . . 0.0 111.218 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.768 HD12 HD11 ' A' ' 105' ' ' LEU . 25.3 mt -140.26 149.42 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -143.29 178.69 7.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 110.116 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.936 ' OH ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -143.71 164.07 31.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 110.641 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -160.05 176.27 12.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.386 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.464 ' HB3' HG22 ' A' ' 41' ' ' ILE . 6.3 p-10 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 110.127 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.228 0.537 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.751 HG12 HG12 ' A' ' 31' ' ' VAL . 23.7 t -145.03 107.06 4.54 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.541 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -77.33 86.24 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.145 1.603 . . . . 0.0 109.938 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.751 HG12 HG12 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -81.45 136.1 23.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.305 -0.872 . . . . 0.0 111.113 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 47.1 mm -91.88 139.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.735 HG13 ' HE1' ' A' ' 109' ' ' TYR . 3.0 t -126.06 139.97 49.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.889 -1.132 . . . . 0.0 111.332 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 2.2 tt0 -156.51 174.24 15.72 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.635 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -102.46 159.77 15.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.924 -1.11 . . . . 0.0 110.419 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.04 -175.29 0.17 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.478 -0.764 . . . . 0.0 109.436 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.6 Cg_endo -71.98 107.25 2.18 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.564 1.297 . . . . 0.0 109.877 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 63.46 40.05 8.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 110.026 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.78 -174.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.117 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 31.49 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.0 110.797 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.826 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -90.28 176.31 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.96 -1.087 . . . . 0.0 110.493 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.826 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -51.42 -173.8 0.02 OUTLIER Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.308 -0.87 . . . . 0.0 111.117 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -71.49 -175.93 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -1.162 . . . . 0.0 109.867 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.921 HD13 ' CD ' ' A' ' 47' ' ' LYS . 1.4 pp -134.99 133.13 39.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.146 -0.972 . . . . 0.0 110.651 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.493 ' HB2' ' HD3' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -86.68 -42.32 13.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.219 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HD3' ' HD2' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -152.79 151.71 30.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 110.279 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.921 ' CD ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -111.25 49.59 0.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 109.728 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -169.55 111.17 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.519 -0.738 . . . . 0.0 109.659 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.87 ' CD2' HD13 ' A' ' 63' ' ' LEU . 10.2 m-85 -108.36 141.05 40.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.075 -1.015 . . . . 0.0 110.37 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.37 92.14 4.2 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.5 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 34.4 m -114.25 147.57 38.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 110.486 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.714 ' HD2' HD12 ' A' ' 55' ' ' LEU . 45.1 Cg_endo -70.96 150.33 60.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.815 1.429 . . . . 0.0 109.772 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.55 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -65.08 -13.49 58.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.302 -0.874 . . . . 0.0 111.594 -178.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -87.72 -14.23 40.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.888 -1.132 . . . . 0.0 111.189 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.2 mt -62.14 146.16 51.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.956 -1.09 . . . . 0.0 111.503 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.49 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 3.9 p -91.28 160.05 15.71 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.638 -0.664 . . . . 0.0 109.533 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.728 HG12 HG22 ' A' ' 87' ' ' THR . 63.5 t -60.01 -22.04 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.016 . . . . 0.0 110.043 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.83 -39.72 64.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.722 ' CB ' HD22 ' A' ' 55' ' ' LEU . 1.5 mm-40 -67.96 -48.64 65.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -1.173 . . . . 0.0 109.987 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.122 ' CE2' HD11 ' A' ' 64' ' ' ILE . 47.2 t80 -60.41 -44.21 95.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.569 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.683 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -53.24 -26.53 18.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.934 -1.104 . . . . 0.0 109.706 179.356 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.473 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -73.97 -47.74 35.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.398 -0.814 . . . . 0.0 109.668 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.088 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.2 pp -66.43 -17.16 64.63 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.013 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.122 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.1 mt -89.33 -41.07 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 120.046 -1.659 . . . . 0.0 109.398 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' CG ' ' N ' ' A' ' 66' ' ' LYS . 2.2 ptm180 -39.64 -46.28 1.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.547 -0.721 . . . . 0.0 110.616 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.554 ' N ' ' CG ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -72.81 -36.9 67.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.984 -1.073 . . . . 0.0 109.814 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.519 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 5.8 mmp_? -69.41 -10.12 56.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.302 -0.874 . . . . 0.0 109.857 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.795 HG21 HD23 ' A' ' 70' ' ' LEU . 45.1 mt -104.03 7.77 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.006 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.534 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 50.07 31.29 4.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.363 -0.835 . . . . 0.0 110.308 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.906 HD12 ' O ' ' A' ' 70' ' ' LEU . 2.9 pp -103.56 156.28 17.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.37 -165.15 0.82 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.036 -1.04 . . . . 0.0 110.941 -179.001 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.04 -90.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.782 . . . . 0.0 110.601 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 71' ' ' ARG . 4.6 pt-20 -156.41 26.1 0.35 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 111.037 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.523 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.04 176.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.063 -1.023 . . . . 0.0 110.002 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.523 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -110.98 142.99 42.37 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.137 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.971 HD21 ' CE1' ' A' ' 78' ' ' PHE . 21.8 tp -156.16 155.49 32.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 110.545 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.571 ' O ' ' CE1' ' A' ' 79' ' ' PHE . 19.4 m-85 -152.83 123.28 7.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.548 -0.72 . . . . 0.0 109.818 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.971 ' CE1' HD21 ' A' ' 76' ' ' LEU . 21.3 m-30 -88.17 135.85 33.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.255 -0.903 . . . . 0.0 111.273 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.571 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 54.0 m-85 -120.33 119.0 31.85 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.852 HG22 HG23 ' A' ' 107' ' ' ILE . 2.0 t -121.25 112.43 35.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 121.357 -0.839 . . . . 0.0 110.304 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.645 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.6 OUTLIER 59.96 42.22 16.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 0.0 110.22 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.92 34.49 14.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.662 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -134.47 168.02 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 109.994 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -155.02 67.5 5.23 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.581 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.86 160.04 46.93 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.922 1.485 . . . . 0.0 110.665 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.82 -178.91 3.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.038 1.547 . . . . 0.0 110.65 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.728 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -85.85 20.53 2.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.459 -0.776 . . . . 0.0 110.618 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 t -95.37 42.76 1.09 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.443 -0.786 . . . . 0.0 109.507 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.13 -169.69 3.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.663 0.744 . . . . 0.0 110.3 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 45.0 p -139.24 143.1 37.84 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.687 -0.633 . . . . 0.0 109.935 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.01 ' HA ' HD23 ' A' ' 94' ' ' LEU . 25.4 mmm -50.88 -45.15 59.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 109.545 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.55 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.55 -48.54 34.99 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.1 OUTLIER -64.59 -31.76 73.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -1.136 . . . . 0.0 110.106 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.018 HD11 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -68.54 -23.17 64.49 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.115 -0.991 . . . . 0.0 110.133 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.541 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -48.64 -53.45 18.58 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.519 -179.435 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.12 -20.98 63.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.194 -0.941 . . . . 0.0 111.291 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 14.8 mt-10 -84.27 -63.99 1.24 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.014 -1.054 . . . . 0.0 112.06 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.491 ' HB3' HG12 ' A' ' 80' ' ' VAL . 14.1 m170 -97.41 40.62 1.15 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.966 -1.084 . . . . 0.0 110.779 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.28 0.562 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.056 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -103.04 171.09 7.58 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.717 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.2 m-85 -118.14 126.89 53.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.402 -1.436 . . . . 0.0 112.211 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.056 ' CG1' HD11 ' A' ' 105' ' ' LEU . 4.1 mt -141.58 144.63 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -146.62 163.05 37.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.192 -0.943 . . . . 0.0 109.372 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.735 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.4 p90 -134.09 165.73 24.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.646 -1.284 . . . . 0.0 111.278 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -159.22 177.25 11.25 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.483 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.473 ' HB2' HG22 ' A' ' 41' ' ' ILE . 11.9 t0 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.922 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 5.4 mpt_? . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.33 0.586 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.754 HG12 HG12 ' A' ' 31' ' ' VAL . 17.3 t -148.02 116.97 4.15 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 110.203 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 50.3 Cg_endo -79.35 90.96 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 124.257 1.661 . . . . 0.0 110.005 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.754 HG12 HG12 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -88.55 138.66 18.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.164 -0.96 . . . . 0.0 110.559 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.543 HG13 ' CE1' ' A' ' 104' ' ' PHE . 24.8 mm -95.95 152.82 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 108.901 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.782 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.6 t -133.6 141.83 43.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.965 -1.084 . . . . 0.0 111.109 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -157.27 -166.76 2.13 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD2' HG12 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -124.56 160.77 27.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.885 -1.135 . . . . 0.0 110.508 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.015 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -61.63 -167.81 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.015 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.1 Cg_endo -71.72 123.64 9.57 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.189 1.099 . . . . 0.0 109.673 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 40.55 49.54 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.599 0.714 . . . . 0.0 110.549 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.09 -179.11 0.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.603 -0.686 . . . . 0.0 110.126 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.33 36.18 0.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.699 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 111' ' ' ASP . 1.8 pp -85.18 177.87 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.025 -1.047 . . . . 0.0 110.378 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.822 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -47.9 -179.58 0.01 OUTLIER Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.488 -0.863 . . . . 0.0 110.997 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.963 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -75.85 -179.28 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -1.171 . . . . 0.0 110.071 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.963 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.6 mm? -136.17 134.8 38.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.164 -0.96 . . . . 0.0 110.579 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 29.7 t0 -86.49 -36.96 18.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.436 -0.79 . . . . 0.0 110.099 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.83 154.44 35.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.665 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -117.69 46.42 1.74 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.12 -0.987 . . . . 0.0 109.818 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -164.51 109.66 0.97 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.423 -0.798 . . . . 0.0 109.965 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.926 ' CD2' HD13 ' A' ' 63' ' ' LEU . 16.3 m-85 -108.14 139.6 42.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.04 -1.038 . . . . 0.0 110.12 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.85 99.63 8.51 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.93 ' HB ' HD12 ' A' ' 55' ' ' LEU . 5.1 m -126.14 160.03 59.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.046 -1.034 . . . . 0.0 110.861 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 42.3 Cg_endo -67.69 144.98 67.99 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.052 1.553 . . . . 0.0 110.434 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.572 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -63.5 -14.0 46.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.446 -0.784 . . . . 0.0 111.441 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -83.73 -10.36 58.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.96 -1.088 . . . . 0.0 110.945 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.93 HD12 ' HB ' ' A' ' 51' ' ' VAL . 4.1 mt -62.22 141.32 58.27 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.003 -1.06 . . . . 0.0 111.027 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 1.4 p -91.44 169.15 11.02 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.703 -0.623 . . . . 0.0 109.827 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.829 ' CG1' HG22 ' A' ' 87' ' ' THR . 95.3 t -61.93 -26.63 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.307 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.88 -39.61 75.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.912 ' CB ' HD22 ' A' ' 55' ' ' LEU . 5.3 mm-40 -67.67 -48.56 66.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.1 -1.236 . . . . 0.0 110.101 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.176 ' CE2' HD11 ' A' ' 64' ' ' ILE . 24.0 t80 -60.45 -46.43 90.1 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.469 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -50.51 -23.62 2.62 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.888 -1.132 . . . . 0.0 109.928 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.79 -51.79 9.26 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.047 HD11 ' CE1' ' A' ' 60' ' ' PHE . 4.0 pp -63.54 -17.83 63.22 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.432 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.176 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.6 mt -91.82 -39.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 120.01 -1.681 . . . . 0.0 109.059 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -35.43 -64.66 0.27 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.086 0.47 . . . . 0.0 110.961 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.02 -31.4 72.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.208 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.695 ' O ' HD13 ' A' ' 44' ' ' LEU . 28.6 mmt-85 -68.21 -16.79 64.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.066 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.909 ' CG2' HD23 ' A' ' 70' ' ' LEU . 1.2 mm -97.44 8.74 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.601 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.491 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER 57.04 30.17 17.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 110.317 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.909 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.3 pp -117.61 154.84 30.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.917 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -166.25 -169.07 1.34 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.235 -0.916 . . . . 0.0 111.046 -179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 49.74 -92.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.523 -0.736 . . . . 0.0 111.015 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -142.5 45.9 1.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 111.039 -179.089 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -72.85 176.32 5.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.889 -1.132 . . . . 0.0 109.803 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.518 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.38 140.32 38.67 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.157 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.742 HD21 ' CE1' ' A' ' 78' ' ' PHE . 44.6 tp -164.3 153.27 13.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.591 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 74.4 m-85 -158.01 119.91 3.65 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.703 -0.623 . . . . 0.0 109.621 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.742 ' CE1' HD21 ' A' ' 76' ' ' LEU . 16.7 m-30 -83.5 134.7 34.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.155 -0.965 . . . . 0.0 111.977 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 50.1 m-85 -121.17 123.35 42.06 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 98' ' ' HIS . 2.1 t -120.49 119.85 60.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 O-C-N 121.201 -0.937 . . . . 0.0 110.077 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' HG23 ' A' ' 83' ' ' VAL . 26.4 t30 50.91 39.05 21.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.1 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 64.95 35.2 8.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.68 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -135.41 168.41 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.306 -0.871 . . . . 0.0 109.931 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.808 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.3 mp -154.37 72.84 6.18 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.554 -0.716 . . . . 0.0 109.533 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.12 165.64 32.18 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.072 1.564 . . . . 0.0 110.662 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.47 ' HG2' ' OG ' ' A' ' 88' ' ' SER . 45.9 Cg_endo -72.85 178.31 6.56 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.044 1.55 . . . . 0.0 110.348 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.829 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.56 21.59 2.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.47 ' OG ' ' HG2' ' A' ' 86' ' ' PRO . 3.0 p -93.04 39.68 1.05 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 109.61 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.5 -172.91 3.98 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.684 0.754 . . . . 0.0 110.275 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 64.2 p -138.95 145.8 40.21 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.501 0.667 . . . . 0.0 110.016 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.017 ' HA ' HD23 ' A' ' 94' ' ' LEU . 4.3 mmm -51.42 -39.76 57.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 110.232 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.572 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.83 -49.96 45.81 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -64.6 -26.48 68.42 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.35 -1.088 . . . . 0.0 109.628 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.017 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -69.02 -25.52 64.53 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.302 -0.874 . . . . 0.0 110.044 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.589 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -49.12 -56.0 10.5 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.824 -1.173 . . . . 0.0 109.652 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -70.14 -18.32 63.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.992 -1.067 . . . . 0.0 111.2 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 14.0 mt-10 -87.75 -67.05 0.85 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 112.789 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.499 ' HB3' HG12 ' A' ' 80' ' ' VAL . 28.4 m170 -98.6 36.96 1.55 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.795 -1.19 . . . . 0.0 112.315 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.504 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.126 -0.984 . . . . 0.0 109.422 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.543 ' CE1' HG13 ' A' ' 32' ' ' ILE . 7.5 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.078 0.466 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.071 HD11 ' CD1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.8 168.37 9.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.989 -1.07 . . . . 0.0 110.304 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.705 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -122.11 133.76 54.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.926 -1.109 . . . . 0.0 110.727 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.071 ' CD1' HD11 ' A' ' 105' ' ' LEU . 4.6 mt -138.86 137.16 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.316 -0.865 . . . . 0.0 110.289 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.16 145.01 38.84 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.236 -0.915 . . . . 0.0 108.778 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.782 ' HE1' HG13 ' A' ' 33' ' ' VAL . 2.9 p90 -130.2 170.96 13.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.54 -1.35 . . . . 0.0 111.924 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.91 179.78 8.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.845 -0.535 . . . . 0.0 110.063 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.93 ' HB3' HG22 ' A' ' 41' ' ' ILE . 8.8 p-10 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.928 . . . . 0.0 110.268 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.305 0.574 . . . . 0.0 110.307 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.657 HG13 ' CD1' ' A' ' 95' ' ' TYR . 23.2 t -144.51 109.73 4.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 110.188 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.585 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 48.6 Cg_endo -76.02 96.14 1.05 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.162 1.611 . . . . 0.0 110.18 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.733 ' HB ' HD21 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -90.9 145.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.354 -0.841 . . . . 0.0 110.626 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 1.1 mp -100.25 156.03 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.812 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.3 t -133.19 136.36 55.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.034 -1.041 . . . . 0.0 110.972 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 2.1 mt-10 -148.65 177.23 9.68 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.759 -0.588 . . . . 0.0 109.454 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.619 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -112.82 158.15 20.49 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.898 -1.126 . . . . 0.0 110.614 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -63.9 -169.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.556 -0.715 . . . . 0.0 109.24 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.0 Cg_endo -73.54 109.45 2.85 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.31 1.163 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.23 41.49 6.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.365 -0.834 . . . . 0.0 110.433 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.554 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -61.44 174.47 0.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 109.804 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.58 34.56 0.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 111.092 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -87.66 -175.84 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.848 -1.158 . . . . 0.0 110.033 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.505 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -49.07 178.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.954 -1.117 . . . . 0.0 110.328 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.971 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -82.5 -176.81 6.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 109.777 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.971 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.5 mm? -137.18 131.8 33.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 110.782 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -86.84 -26.78 23.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -0.825 . . . . 0.0 109.429 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.475 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -152.67 154.31 35.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.457 -0.777 . . . . 0.0 109.798 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -120.05 44.73 2.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.032 -1.042 . . . . 0.0 109.945 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 8.9 pttp -159.0 111.2 2.18 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.355 -0.841 . . . . 0.0 109.497 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.719 ' HD2' HD13 ' A' ' 63' ' ' LEU . 12.0 m-85 -103.86 140.09 38.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.992 -1.067 . . . . 0.0 110.335 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 50' ' ' LEU . 3.6 mm? -102.05 92.3 4.71 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.943 HG21 ' HE3' ' A' ' 91' ' ' MET . 26.9 m -116.02 142.42 29.16 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.178 -0.951 . . . . 0.0 110.898 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 42.2 Cg_endo -67.49 148.87 79.72 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.103 1.58 . . . . 0.0 109.956 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.565 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 2.0 m -63.12 -13.94 42.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 111.614 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -83.37 -14.8 52.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.111 -0.993 . . . . 0.0 110.888 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.864 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.7 mt -62.65 142.67 57.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.021 -1.05 . . . . 0.0 111.424 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 3.2 p -90.97 163.97 14.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.637 -0.665 . . . . 0.0 109.288 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.542 HG12 HG22 ' A' ' 87' ' ' THR . 39.2 t -61.52 -24.6 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.957 -1.089 . . . . 0.0 110.086 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.07 -31.98 66.23 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.864 ' CB ' HD22 ' A' ' 55' ' ' LEU . 30.4 mm-40 -74.6 -47.82 30.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -1.214 . . . . 0.0 109.886 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.057 ' CD1' HD11 ' A' ' 63' ' ' LEU . 38.9 t80 -60.2 -32.59 71.24 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.287 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.545 ' HE1' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.72 -31.92 71.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 109.567 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 3.7 t80 -71.74 -52.87 15.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.54 -0.725 . . . . 0.0 110.993 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.057 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -59.67 -35.09 73.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.834 -1.167 . . . . 0.0 112.57 -178.206 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.026 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -77.7 -32.19 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 119.657 -1.902 . . . . 0.0 109.394 178.717 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.93 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -39.81 -64.08 0.52 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.512 -0.742 . . . . 0.0 110.624 -179.32 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -30.31 71.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.47 ' C ' HD13 ' A' ' 68' ' ' ILE . 5.8 mmp_? -67.7 -17.42 64.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.011 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.806 HD12 HD21 ' A' ' 44' ' ' LEU . 2.7 mm -104.44 15.86 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.9 . . . . 0.0 109.793 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.475 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 49.99 28.84 3.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.587 -0.695 . . . . 0.0 110.655 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.93 HD11 ' HG2' ' A' ' 65' ' ' ARG . 4.2 pp -111.0 155.06 23.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.839 . . . . 0.0 109.783 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.0 -173.41 2.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.923 -179.365 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.11 -91.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.469 -0.77 . . . . 0.0 110.784 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.467 ' O ' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -146.31 36.61 1.0 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.995 . . . . 0.0 111.051 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -60.05 176.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.078 -1.013 . . . . 0.0 109.825 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -94.23 138.25 32.46 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.553 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 20.3 tp -164.78 152.05 11.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.399 -0.813 . . . . 0.0 110.596 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.7 m-85 -158.35 119.9 3.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.578 -0.701 . . . . 0.0 109.757 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.906 ' CZ ' HD12 ' A' ' 64' ' ' ILE . 10.7 m-85 -90.44 124.08 34.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 110.862 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 68.3 m-85 -115.5 127.29 55.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.77 HG22 HG12 ' A' ' 107' ' ' ILE . 2.8 t -121.25 121.93 66.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.503 -0.748 . . . . 0.0 109.959 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.802 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.8 OUTLIER 47.7 47.26 18.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 110.119 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 18.8 m120 57.22 36.84 27.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 110.491 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.6 t -135.3 168.0 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.816 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.02 73.74 5.66 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.539 -0.725 . . . . 0.0 109.524 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.55 165.37 31.81 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.095 1.576 . . . . 0.0 110.767 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.51 -178.86 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.046 1.551 . . . . 0.0 110.435 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.1 20.57 2.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.223 -0.923 . . . . 0.0 110.593 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.7 t -95.85 41.55 1.1 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.504 -0.748 . . . . 0.0 109.527 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.55 -175.1 4.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.496 -0.752 . . . . 0.0 110.287 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 77.7 p -139.45 138.24 36.29 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.601 0.715 . . . . 0.0 110.229 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.05 ' HA ' HD23 ' A' ' 94' ' ' LEU . 2.7 mmm -45.72 -39.24 7.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.966 -1.084 . . . . 0.0 109.842 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -49.83 -53.03 23.62 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.972 -1.109 . . . . 0.0 110.439 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.529 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 2.6 pt20 -64.13 -27.03 68.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.089 -1.242 . . . . 0.0 110.008 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.05 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.36 -25.97 65.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.21 -0.931 . . . . 0.0 109.929 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.657 ' CD1' HG13 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -50.03 -55.5 14.52 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.855 -1.153 . . . . 0.0 109.698 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.632 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 2.0 mt-30 -69.41 -18.44 63.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.951 -1.093 . . . . 0.0 110.974 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 10.5 mt-10 -88.38 -68.36 0.77 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.012 -1.055 . . . . 0.0 113.13 -177.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.464 ' CB ' HG12 ' A' ' 80' ' ' VAL . 26.1 m170 -99.35 38.05 1.48 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.703 -1.248 . . . . 0.0 112.795 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.632 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 O-C-N 120.995 -1.065 . . . . 0.0 109.856 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.409 0.623 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.8 HD13 HD11 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -101.99 165.29 11.25 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.374 -0.829 . . . . 0.0 109.301 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.617 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -122.9 123.82 41.82 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.77 -1.206 . . . . 0.0 111.165 -179.408 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.77 HG12 HG22 ' A' ' 80' ' ' VAL . 10.9 mt -141.97 147.66 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.204 -0.935 . . . . 0.0 109.82 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -147.18 -179.57 6.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.145 -0.972 . . . . 0.0 110.159 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.812 ' HE1' HG13 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -140.97 162.26 35.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.945 -1.097 . . . . 0.0 111.418 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 6.8 t -148.0 -177.81 5.94 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 110.53 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.411 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 6.0 mpt_? . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.283 0.564 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.783 HG12 HG12 ' A' ' 31' ' ' VAL . 21.8 t -147.24 107.78 3.89 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 110.39 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.501 ' O ' ' HB3' ' A' ' 104' ' ' PHE . 49.3 Cg_endo -77.78 90.85 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.253 1.66 . . . . 0.0 110.029 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.783 HG12 HG12 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -90.85 133.49 32.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 111.215 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 44.0 mm -95.68 133.76 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 0.0 108.438 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -126.85 128.26 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.711 -1.243 . . . . 0.0 111.866 -178.616 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 3.1 tm-20 -132.62 159.5 39.37 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.7 ' CE ' HD11 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -87.55 163.38 16.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.867 -1.146 . . . . 0.0 110.863 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.994 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.47 -174.82 0.16 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 109.62 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.994 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.1 Cg_endo -72.85 116.61 4.78 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.638 1.336 . . . . 0.0 110.046 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 63.88 42.25 6.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.341 -0.849 . . . . 0.0 110.463 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.589 ' CB ' ' CG ' ' A' ' 35' ' ' LYS . . . -65.49 175.09 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.28 33.17 0.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.669 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.832 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -95.35 177.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.023 -1.048 . . . . 0.0 110.247 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.832 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -42.41 169.52 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.093 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 1.003 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -78.75 -176.48 4.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -1.195 . . . . 0.0 110.066 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.003 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.2 mm? -139.4 135.84 34.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.898 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -86.49 -29.7 22.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.534 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -153.68 150.17 28.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -111.47 47.14 1.04 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.9 -1.125 . . . . 0.0 109.942 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -159.41 111.71 2.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.588 -0.695 . . . . 0.0 109.244 179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.765 ' CD2' HD13 ' A' ' 63' ' ' LEU . 19.6 m-85 -103.76 141.12 36.64 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.022 -1.049 . . . . 0.0 110.351 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -108.01 93.09 4.35 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.92 ' HB ' HD12 ' A' ' 55' ' ' LEU . 9.5 m -117.86 154.06 51.1 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.342 -0.849 . . . . 0.0 110.721 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.6 Cg_endo -70.34 147.01 58.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.085 1.571 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.552 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.3 m -62.38 -14.8 44.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 0.0 111.488 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -84.12 -12.4 55.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.025 -1.047 . . . . 0.0 111.331 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.92 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.8 mt -62.12 142.0 57.84 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.898 -1.126 . . . . 0.0 111.257 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 90' ' ' THR . 1.1 p -91.61 164.78 13.64 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.726 HG12 HG22 ' A' ' 87' ' ' THR . 93.4 t -60.87 -21.11 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.868 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.33 59.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.907 ' CB ' HD22 ' A' ' 55' ' ' LEU . 4.3 mm-40 -67.64 -47.98 68.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.164 -1.198 . . . . 0.0 109.845 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.191 ' CE2' HD11 ' A' ' 64' ' ' ILE . 34.8 t80 -60.82 -42.82 98.44 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.196 -1.001 . . . . 0.0 109.492 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -54.36 -22.56 12.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.752 -1.218 . . . . 0.0 109.838 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -79.39 -54.51 5.87 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.473 -0.767 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 60' ' ' PHE . 1.2 pp -59.64 -25.94 65.1 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.833 -1.167 . . . . 0.0 112.102 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.191 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.7 mt -84.13 -42.45 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 119.997 -1.689 . . . . 0.0 108.844 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.475 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 1.8 mtp-105 -36.49 -60.58 0.58 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.017 0.436 . . . . 0.0 110.721 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -66.94 -32.7 74.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.831 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 64' ' ' ILE . 6.0 mmt-85 -69.34 -10.27 57.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.166 -0.959 . . . . 0.0 109.262 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.771 HG21 HD23 ' A' ' 70' ' ' LEU . 62.1 mt -103.97 13.21 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.474 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.56 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.6 OUTLIER 44.67 31.97 0.71 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.44 -0.787 . . . . 0.0 110.344 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 70' ' ' LEU . 3.8 pp -104.9 153.55 21.24 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.893 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' GLU . 14.3 ptt180 -166.06 -168.45 1.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 111.033 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 49.85 -92.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.507 -0.746 . . . . 0.0 110.858 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 8.4 pt-20 -143.37 40.49 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 110.834 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.519 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -64.69 176.62 1.1 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.083 -1.011 . . . . 0.0 109.799 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -115.1 140.17 49.29 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.268 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.758 HD21 ' CE1' ' A' ' 78' ' ' PHE . 43.3 tp -157.6 150.7 23.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 80.9 m-85 -158.82 121.36 3.62 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.762 -0.586 . . . . 0.0 109.943 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.758 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.3 m-30 -88.09 128.16 35.42 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.061 -1.024 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 60.7 m-85 -115.98 128.61 55.87 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 108.984 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.869 HG11 ' CD2' ' A' ' 98' ' ' HIS . 2.3 t -120.4 128.71 76.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.149 -0.97 . . . . 0.0 110.27 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.804 HD22 HG21 ' A' ' 83' ' ' VAL . 0.8 OUTLIER 43.11 35.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 110.151 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 1.4 m-20 73.69 39.45 0.55 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.598 -0.689 . . . . 0.0 111.311 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.804 HG21 HD22 ' A' ' 81' ' ' ASN . 2.8 t -136.33 168.36 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.0 110.047 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.814 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.96 68.71 5.54 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.58 -0.7 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.05 164.36 35.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.992 1.522 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.479 ' HG2' ' OG ' ' A' ' 88' ' ' SER . 44.2 Cg_endo -71.92 179.09 5.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.144 1.602 . . . . 0.0 110.583 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.726 HG22 HG12 ' A' ' 57' ' ' VAL . 1.1 p -87.03 20.35 2.71 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.322 -0.861 . . . . 0.0 110.842 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.479 ' OG ' ' HG2' ' A' ' 86' ' ' PRO . 2.2 p -90.53 39.9 0.99 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.447 -0.783 . . . . 0.0 109.475 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.38 -174.39 4.37 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.589 0.709 . . . . 0.0 110.006 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 82.2 p -139.59 152.84 47.15 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.462 -0.773 . . . . 0.0 110.318 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.025 ' HA ' HD23 ' A' ' 94' ' ' LEU . 43.8 mmm -56.57 -41.73 77.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.388 -0.82 . . . . 0.0 109.926 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -52.04 -48.16 52.89 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -65.28 -27.13 68.41 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.407 -1.055 . . . . 0.0 109.657 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.06 HD11 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -69.02 -23.82 64.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.907 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.591 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -49.26 -56.65 8.69 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.851 -1.156 . . . . 0.0 109.434 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.597 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 11.9 tt0 -70.94 -16.09 62.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.836 -1.165 . . . . 0.0 111.373 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -87.97 -63.31 1.32 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.994 -1.066 . . . . 0.0 113.626 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.869 ' CD2' HG11 ' A' ' 80' ' ' VAL . 9.3 m-70 -98.03 35.89 1.66 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.757 -1.214 . . . . 0.0 112.624 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.597 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 110.312 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 5.6 m-85 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.232 0.539 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.06 HD22 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -99.02 166.08 11.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.291 -0.881 . . . . 0.0 109.12 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.797 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -118.72 121.75 40.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.696 -1.253 . . . . 0.0 111.896 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.735 ' CG1' HG13 ' A' ' 80' ' ' VAL . 7.5 mt -141.63 149.79 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.462 -0.774 . . . . 0.0 109.181 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -139.23 177.02 8.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.005 -1.06 . . . . 0.0 109.963 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.9 OUTLIER -155.13 163.73 39.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.011 -1.056 . . . . 0.0 111.251 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.4 t -159.56 -178.31 7.02 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.234 0.54 . . . . 0.0 110.137 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.564 ' HB3' HG22 ' A' ' 41' ' ' ILE . 8.5 p-10 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.199 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.365 0.602 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.704 HG12 ' CG1' ' A' ' 31' ' ' VAL . 20.0 t -147.4 105.11 3.77 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.602 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -76.37 83.41 2.03 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.289 1.678 . . . . 0.0 110.222 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.704 ' CG1' HG12 ' A' ' 29' ' ' VAL . 1.9 m -81.26 154.27 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.216 -0.928 . . . . 0.0 110.803 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 31.1 mm -111.33 161.92 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 108.761 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.856 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.8 t -134.9 144.67 33.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.947 -1.095 . . . . 0.0 111.168 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.36 178.02 10.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.593 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -117.07 157.61 25.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.905 -1.122 . . . . 0.0 110.681 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.87 -173.74 0.12 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.516 -0.74 . . . . 0.0 109.253 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.1 Cg_endo -71.25 105.62 1.76 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.446 1.235 . . . . 0.0 109.762 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER 63.43 40.74 8.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.41 -0.806 . . . . 0.0 110.326 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.413 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -54.84 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.184 -0.947 . . . . 0.0 109.831 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.443 ' HD3' ' HB3' ' A' ' 111' ' ' ASP . 2.9 ptm180 -144.67 26.63 1.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 0.0 110.994 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.416 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -85.48 -177.37 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.938 -1.101 . . . . 0.0 109.378 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 69' ' ' HIS . . . -62.4 171.05 11.08 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 1.0 ' O ' HD22 ' A' ' 44' ' ' LEU . 4.4 t70 -75.15 -177.29 3.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -1.1 . . . . 0.0 109.998 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.0 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.5 mm? -138.6 133.29 32.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.128 -0.982 . . . . 0.0 110.808 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.503 ' CB ' ' HE2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -86.8 -21.9 26.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.814 . . . . 0.0 109.136 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.503 ' HE2' ' CB ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -151.68 147.66 26.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.571 -0.706 . . . . 0.0 109.105 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -123.61 48.84 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.921 -1.112 . . . . 0.0 110.184 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 11.5 pttm -158.19 108.95 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 110.118 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.916 ' CD2' HD13 ' A' ' 63' ' ' LEU . 23.4 m-85 -103.83 144.17 31.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.134 -0.979 . . . . 0.0 110.412 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.8 103.68 11.2 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 55' ' ' LEU . 3.3 m -128.8 159.37 68.66 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 110.931 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.9 Cg_endo -70.65 148.17 58.74 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.193 1.628 . . . . 0.0 110.513 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.558 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -63.02 -17.08 61.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.494 -0.754 . . . . 0.0 111.305 -179.104 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -83.51 -9.65 58.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 0.0 111.322 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.004 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.9 mt -62.08 141.41 58.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.784 -1.198 . . . . 0.0 110.908 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.503 ' HA ' HG22 ' A' ' 90' ' ' THR . 6.0 p -91.21 156.67 17.67 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.504 -0.748 . . . . 0.0 109.575 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.731 ' CG1' HG22 ' A' ' 87' ' ' THR . 95.5 t -54.05 -24.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.068 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.81 -38.37 66.02 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.874 ' CB ' HD22 ' A' ' 55' ' ' LEU . 12.5 mm-40 -68.57 -49.28 60.66 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.142 -1.211 . . . . 0.0 110.017 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.19 ' CE2' HD11 ' A' ' 64' ' ' ILE . 31.3 t80 -60.49 -47.38 86.38 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.793 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.85 -21.8 1.87 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.68 -1.263 . . . . 0.0 109.776 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -78.68 -54.16 6.4 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.765 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.013 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.6 pp -60.72 -18.45 54.48 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.27 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.19 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -92.3 -41.36 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.115 -1.616 . . . . 0.0 109.145 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.935 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -37.26 -61.2 0.6 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.872 -0.518 . . . . 0.0 110.677 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -65.16 -32.87 74.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.098 -1.001 . . . . 0.0 109.618 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 29.3 mmt-85 -69.94 -12.11 61.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 110.109 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.833 HD12 HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -99.09 4.48 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.123 -0.985 . . . . 0.0 109.295 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.527 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 55.47 29.25 12.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.459 -0.776 . . . . 0.0 110.018 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.935 HD11 ' HG2' ' A' ' 65' ' ' ARG . 3.8 pp -101.0 151.81 21.33 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.038 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.82 -161.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.288 -0.883 . . . . 0.0 110.778 -179.404 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.525 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 49.92 -87.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.0 110.917 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 72' ' ' ALA . 40.7 mt-10 -156.37 36.45 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 110.634 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -62.91 176.59 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.059 -1.026 . . . . 0.0 109.848 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB3' ' OD1' ' A' ' 111' ' ' ASP . . . -119.0 145.06 46.14 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.061 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.837 HD21 ' CE1' ' A' ' 78' ' ' PHE . 22.2 tp -158.84 153.56 24.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.537 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 56.2 m-85 -154.39 122.35 5.94 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.547 -0.72 . . . . 0.0 109.767 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.837 ' CE1' HD21 ' A' ' 76' ' ' LEU . 16.7 m-30 -84.2 131.15 34.78 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.337 -0.852 . . . . 0.0 111.869 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 64.6 m-85 -120.12 119.04 32.15 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.783 HG22 HG23 ' A' ' 107' ' ' ILE . 1.4 t -121.59 126.26 74.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.654 ' O ' HG23 ' A' ' 83' ' ' VAL . 61.0 t30 55.25 35.28 24.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.079 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 2.0 t-20 64.58 32.16 11.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 110.106 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -135.12 168.55 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.822 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.86 73.43 5.8 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.58 -0.7 . . . . 0.0 109.297 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.19 165.14 33.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.099 1.579 . . . . 0.0 110.867 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.62 178.73 5.92 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.108 1.583 . . . . 0.0 110.339 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.731 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -88.22 21.91 2.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.361 -0.837 . . . . 0.0 110.657 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.7 p -90.5 37.36 0.91 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.46 -0.775 . . . . 0.0 109.795 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.08 -171.96 4.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.463 -0.773 . . . . 0.0 110.142 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.539 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 44.2 p -138.81 150.12 45.7 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.654 0.74 . . . . 0.0 110.267 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.1 ' HA ' HD23 ' A' ' 94' ' ' LEU . 3.1 mmt -47.53 -47.93 27.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.469 -0.77 . . . . 0.0 110.692 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.558 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -42.69 -43.58 5.17 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.539 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 0.7 OUTLIER -67.82 -42.49 81.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.342 -1.093 . . . . 0.0 109.23 179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.1 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -58.84 -23.24 60.35 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.363 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.602 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -48.36 -54.06 15.27 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.675 -1.265 . . . . 0.0 109.716 -179.305 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.71 -22.7 63.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.251 -0.905 . . . . 0.0 111.375 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 2.1 mm-40 -81.54 -63.52 1.38 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.957 -1.089 . . . . 0.0 111.655 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.643 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.8 m-70 -97.63 41.58 1.12 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.002 -1.061 . . . . 0.0 110.141 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 95' ' ' TYR . 1.3 t60 . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 121.259 0.552 . . . . 0.0 109.691 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.595 ' CE1' ' HB2' ' A' ' 30' ' ' PRO . 1.9 m-85 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.08 0.467 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.066 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -114.87 161.77 17.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.046 -1.034 . . . . 0.0 109.488 179.541 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.75 ' N ' HD12 ' A' ' 105' ' ' LEU . 4.3 p90 -120.49 132.81 55.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.778 -1.201 . . . . 0.0 111.749 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.066 ' CG1' HD11 ' A' ' 105' ' ' LEU . 7.7 mt -141.25 124.54 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 0.0 109.98 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -122.36 160.3 25.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.993 -1.067 . . . . 0.0 109.671 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.856 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.4 p90 -135.42 162.2 33.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.694 -1.254 . . . . 0.0 111.258 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -147.33 178.76 8.16 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.135 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.552 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 9.6 t0 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.21 -0.931 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.274 0.559 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.743 HG12 HG12 ' A' ' 31' ' ' VAL . 16.3 t -147.2 107.25 3.89 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.504 ' HD2' ' OH ' ' A' ' 95' ' ' TYR . 46.3 Cg_endo -75.41 86.48 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.181 1.621 . . . . 0.0 109.855 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.743 HG12 HG12 ' A' ' 29' ' ' VAL . 1.1 m -79.71 136.61 23.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.317 -0.865 . . . . 0.0 110.553 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 14.9 mm -91.86 157.25 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.791 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.5 t -134.05 140.41 46.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 120.898 -1.126 . . . . 0.0 111.336 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.23 169.74 23.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.413 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -109.5 162.62 14.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.857 -1.152 . . . . 0.0 110.522 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -62.42 -172.17 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.499 -0.751 . . . . 0.0 109.307 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.9 Cg_endo -71.55 110.41 2.87 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.433 1.228 . . . . 0.0 109.83 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.64 42.58 10.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.26 -0.9 . . . . 0.0 110.025 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.541 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -59.38 179.13 0.11 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.286 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.527 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 6.5 ptm180 -150.04 29.81 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 110.825 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.843 HG22 ' HB3' ' A' ' 111' ' ' ASP . 1.9 pp -85.41 178.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.064 . . . . 0.0 110.424 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.82 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -48.02 -178.4 0.01 OUTLIER Glycine 0 N--CA 1.496 2.666 0 O-C-N 121.332 -0.855 . . . . 0.0 111.055 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.99 ' O ' HD22 ' A' ' 44' ' ' LEU . 7.7 t70 -84.95 -178.98 6.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -1.202 . . . . 0.0 109.858 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.99 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -138.41 134.73 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.096 -1.002 . . . . 0.0 110.592 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.95 -24.02 26.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.456 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.08 154.46 29.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.556 -0.715 . . . . 0.0 109.591 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HG2' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -118.73 43.18 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.945 -1.097 . . . . 0.0 110.017 179.805 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.523 ' HG3' ' HG2' ' A' ' 47' ' ' LYS . 18.9 mttt -158.23 109.53 2.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.619 -0.676 . . . . 0.0 109.566 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.905 ' CD2' HD13 ' A' ' 63' ' ' LEU . 15.3 m-85 -103.84 141.06 36.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.018 -1.051 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -103.87 94.57 5.49 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.952 ' HB ' HD12 ' A' ' 55' ' ' LEU . 14.7 m -117.57 149.65 45.3 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 110.851 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.457 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 47.0 Cg_endo -70.56 149.71 62.18 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.212 1.638 . . . . 0.0 110.074 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.557 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.5 m -62.27 -17.15 57.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.405 -0.809 . . . . 0.0 111.405 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -83.95 -11.57 56.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 111.385 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.952 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.3 mt -61.61 141.21 57.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.858 -1.151 . . . . 0.0 111.145 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 p -91.17 154.0 19.63 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.285 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 25.6 t -53.97 -20.98 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.057 -1.027 . . . . 0.0 109.785 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.73 -39.63 59.72 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.822 ' CB ' HD22 ' A' ' 55' ' ' LEU . 10.9 mm-40 -67.85 -47.38 69.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.046 -1.267 . . . . 0.0 109.599 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.172 ' CE2' HD11 ' A' ' 64' ' ' ILE . 21.3 t80 -60.38 -45.97 91.65 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.432 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.64 -22.86 2.23 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.953 -1.092 . . . . 0.0 109.911 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -80.15 -54.54 5.66 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.818 . . . . 0.0 110.357 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.043 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.6 pp -59.61 -21.64 60.69 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.012 -1.055 . . . . 0.0 112.306 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.172 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -90.45 -38.56 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 120.09 -1.632 . . . . 0.0 108.816 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.839 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -36.65 -62.43 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.863 -0.523 . . . . 0.0 110.691 -179.528 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -30.63 71.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.133 -0.98 . . . . 0.0 109.845 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 20.1 mmt180 -68.01 -13.85 62.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 109.481 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.013 ' CG2' HD23 ' A' ' 70' ' ' LEU . 70.6 mt -103.21 14.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.449 -0.782 . . . . 0.0 109.545 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.564 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 1.4 t60 47.8 28.76 1.41 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.552 -0.718 . . . . 0.0 110.493 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.013 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.0 pp -110.71 155.17 22.84 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.636 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 73' ' ' GLU . 11.5 ptt180 -166.15 -171.67 2.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.114 -0.991 . . . . 0.0 111.054 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.47 -89.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.522 -0.736 . . . . 0.0 110.763 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -148.55 33.24 0.78 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.143 -0.973 . . . . 0.0 110.919 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -56.76 176.81 0.09 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.024 -1.048 . . . . 0.0 109.796 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.29 138.77 40.96 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.128 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.745 HD21 ' CE1' ' A' ' 78' ' ' PHE . 17.5 tp -164.41 152.85 12.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 110.505 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 94.1 m-85 -158.85 122.08 3.77 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.663 -0.648 . . . . 0.0 109.896 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.745 ' CE1' HD21 ' A' ' 76' ' ' LEU . 16.9 m-30 -85.62 132.33 34.19 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.136 -0.977 . . . . 0.0 111.346 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 58.2 m-85 -119.45 121.46 39.52 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.49 -0.756 . . . . 0.0 109.227 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.827 HG22 HG23 ' A' ' 107' ' ' ILE . 2.5 t -120.63 123.48 70.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.358 -0.839 . . . . 0.0 110.074 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.6 t30 50.39 34.54 9.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 8.4 t-20 66.98 37.37 3.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.95 . . . . 0.0 110.146 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.612 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.7 t -135.47 169.96 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 109.83 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.814 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.6 OUTLIER -154.68 73.67 5.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.478 -0.764 . . . . 0.0 109.207 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.52 155.77 58.99 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.164 1.613 . . . . 0.0 110.925 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.71 -178.67 3.58 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.167 1.614 . . . . 0.0 110.273 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.538 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 1.2 p -86.03 18.46 3.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.906 . . . . 0.0 110.823 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.4 m -90.33 32.49 0.94 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.397 -0.814 . . . . 0.0 109.662 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.31 -174.18 4.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.525 -0.735 . . . . 0.0 110.096 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.53 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 67.3 p -139.4 149.91 44.66 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.561 -0.712 . . . . 0.0 110.19 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.019 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -48.74 -43.81 37.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.317 -0.864 . . . . 0.0 110.175 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -46.1 -44.18 14.02 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.53 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 2.4 mt-30 -65.58 -47.0 77.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.385 -1.067 . . . . 0.0 109.434 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.019 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -56.91 -23.43 44.94 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.385 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.53 ' CD1' HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -48.94 -56.18 9.61 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.812 -1.18 . . . . 0.0 109.848 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -16.78 62.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.027 -1.046 . . . . 0.0 111.532 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -87.15 -65.53 1.0 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.892 -1.13 . . . . 0.0 112.473 -178.043 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.429 ' CG ' HG12 ' A' ' 80' ' ' VAL . 17.5 m170 -98.78 41.48 1.14 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.953 -1.092 . . . . 0.0 111.388 -177.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.513 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.8 p80 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.492 -0.755 . . . . 0.0 109.758 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.429 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 4.9 p90 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.256 0.55 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.076 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -121.73 171.64 8.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.125 -0.985 . . . . 0.0 109.752 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.568 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.3 m-85 -122.64 126.23 47.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.666 -1.271 . . . . 0.0 111.366 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 1.076 ' CG1' HD11 ' A' ' 105' ' ' LEU . 9.0 mt -138.75 136.16 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.179 -0.951 . . . . 0.0 110.358 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -130.73 173.11 11.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -1.0 . . . . 0.0 109.731 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.791 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.4 p90 -150.69 165.33 33.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.87 -1.144 . . . . 0.0 111.364 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -150.54 -178.28 6.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.768 -0.583 . . . . 0.0 110.177 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.843 ' HB3' HG22 ' A' ' 41' ' ' ILE . 8.4 p-10 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -53.67 -39.96 65.51 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.176 -1.191 . . . . 0.0 109.591 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 1.6 tttp -74.15 -34.78 63.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 110.054 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.542 HG21 HD11 ' A' ' 50' ' ' LEU . 12.0 mm -65.23 -12.33 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -83.15 -60.65 2.08 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.261 -0.9 . . . . 0.0 110.271 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.39 -39.71 15.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.0 110.138 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 2.6 mtmt -82.43 -45.59 14.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.009 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 28.8 m-85 -113.65 63.68 1.06 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 110.85 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 46.7 Cg_endo -72.66 -9.59 24.11 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.818 1.431 . . . . 0.0 110.407 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -98.96 -4.98 31.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.91 . . . . 0.0 110.41 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.533 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -88.54 -173.82 4.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 109.962 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 31' ' ' VAL . 24.2 t -133.65 103.99 12.1 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.933 . . . . 0.0 110.383 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.487 ' HD2' ' OH ' ' A' ' 95' ' ' TYR . 48.7 Cg_endo -75.97 85.21 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.264 1.665 . . . . 0.0 109.721 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 29' ' ' VAL . 2.0 m -77.9 150.33 5.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 110.918 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 35.9 mm -106.54 160.66 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.318 -0.864 . . . . 0.0 108.672 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.723 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.2 t -134.36 141.23 44.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.903 -1.123 . . . . 0.0 111.336 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.65 174.97 14.67 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.538 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -115.93 159.85 21.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.779 -1.2 . . . . 0.0 110.526 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.01 -174.3 0.14 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.595 -0.691 . . . . 0.0 109.405 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.7 Cg_endo -71.32 110.37 2.83 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.617 1.325 . . . . 0.0 109.92 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.22 42.9 5.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.326 -0.859 . . . . 0.0 110.066 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.538 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -57.47 -179.82 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.491 ' CG ' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.06 35.11 0.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.108 -0.995 . . . . 0.0 110.749 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.879 HD12 ' O ' ' A' ' 42' ' ' GLY . 2.1 pp -95.09 176.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 0.0 110.274 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.879 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -49.09 -177.69 0.01 OUTLIER Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.932 ' O ' HD22 ' A' ' 44' ' ' LEU . 5.6 t70 -79.79 -179.03 6.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -1.149 . . . . 0.0 109.615 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.932 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.8 mm? -135.63 131.94 36.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.433 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' C ' ' HD2' ' A' ' 46' ' ' LYS . 1.6 m-20 -86.8 -28.73 22.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.703 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 45' ' ' ASP . 3.7 mptt -152.68 157.03 40.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.54 -0.725 . . . . 0.0 109.808 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -123.88 43.19 3.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.955 . . . . 0.0 109.958 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 3.6 pttt -159.67 107.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.846 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.896 ' CD2' HD13 ' A' ' 63' ' ' LEU . 22.4 m-85 -103.84 142.2 34.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.75 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.542 HD11 HG21 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -102.16 95.67 6.48 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.509 ' HB ' HD12 ' A' ' 55' ' ' LEU . 15.6 m -118.54 145.26 37.02 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.728 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HD2' HD12 ' A' ' 55' ' ' LEU . 43.8 Cg_endo -70.19 147.59 60.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.0 1.526 . . . . 0.0 109.932 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.568 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.85 -16.04 56.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -0.805 . . . . 0.0 111.476 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -83.57 -13.7 53.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.961 -1.087 . . . . 0.0 111.192 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.866 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.3 mt -62.44 143.62 56.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.867 -1.145 . . . . 0.0 111.527 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 p -91.12 162.84 14.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.616 -0.678 . . . . 0.0 109.717 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.614 HG12 HG22 ' A' ' 87' ' ' THR . 70.2 t -59.9 -23.71 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.99 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.3 -34.0 68.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.866 ' CB ' HD22 ' A' ' 55' ' ' LEU . 22.1 mm-40 -73.41 -46.98 45.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.097 -1.237 . . . . 0.0 109.827 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.16 ' CE2' HD11 ' A' ' 64' ' ' ILE . 19.8 t80 -60.87 -46.82 89.11 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.565 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -50.69 -21.73 1.74 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.916 -1.115 . . . . 0.0 109.913 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -80.66 -54.82 5.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.442 -0.786 . . . . 0.0 110.387 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.993 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.8 pp -60.11 -19.95 55.86 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.984 -1.072 . . . . 0.0 112.355 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.16 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -92.75 -38.88 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 120.094 -1.629 . . . . 0.0 109.165 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.551 ' HG2' HD11 ' A' ' 70' ' ' LEU . 13.9 mtt180 -36.98 -61.37 0.56 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.775 -0.578 . . . . 0.0 110.698 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -65.21 -32.32 73.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.0 109.698 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' C ' HD13 ' A' ' 68' ' ' ILE . 4.5 mmp_? -68.04 -14.77 63.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.847 ' CG2' HD23 ' A' ' 70' ' ' LEU . 2.0 mm -100.23 10.21 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.176 -0.953 . . . . 0.0 109.676 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.498 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 52.67 32.83 12.59 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.433 -0.792 . . . . 0.0 110.238 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.847 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.3 pp -116.03 153.97 30.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.444 -0.785 . . . . 0.0 110.221 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 2.7 ptp180 -166.4 -173.56 2.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.265 -0.897 . . . . 0.0 110.919 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 56.95 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.72 . . . . 0.0 111.065 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 74' ' ' ASP . 5.6 pt-20 -146.01 24.17 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.092 -1.005 . . . . 0.0 111.301 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -49.09 176.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.943 -1.098 . . . . 0.0 109.786 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.694 ' HB3' ' OD1' ' A' ' 111' ' ' ASP . . . -111.28 139.58 46.56 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.252 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.7 HD21 ' CE1' ' A' ' 78' ' ' PHE . 31.9 tp -164.76 153.68 12.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.774 . . . . 0.0 110.332 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.595 ' CE2' ' HB2' ' A' ' 113' ' ' SER . 95.2 m-85 -157.66 120.75 3.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.57 -0.706 . . . . 0.0 110.032 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.7 ' CE1' HD21 ' A' ' 76' ' ' LEU . 15.7 m-30 -82.82 133.58 35.13 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.171 -0.956 . . . . 0.0 111.748 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 51.0 m-85 -120.65 119.38 32.66 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.912 HG22 HG23 ' A' ' 107' ' ' ILE . 2.5 t -120.67 128.41 76.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.382 -0.824 . . . . 0.0 109.915 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.544 ' HB2' ' CG ' ' A' ' 98' ' ' HIS . 4.4 t30 48.1 36.61 6.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.984 . . . . 0.0 109.921 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 12.8 m-20 66.69 38.65 3.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.468 -0.77 . . . . 0.0 110.438 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.696 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -135.66 166.95 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 110.024 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -155.19 67.7 5.18 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.635 -0.666 . . . . 0.0 109.304 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.48 164.6 34.62 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.962 1.506 . . . . 0.0 110.808 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.64 -178.33 3.34 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.114 1.587 . . . . 0.0 110.387 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.614 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -84.35 21.42 1.44 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.413 -0.804 . . . . 0.0 110.887 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -96.99 43.15 1.07 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.346 -0.847 . . . . 0.0 109.451 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.03 -172.1 3.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.547 -0.72 . . . . 0.0 110.234 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 72.2 p -139.33 145.7 39.38 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.567 -0.708 . . . . 0.0 110.375 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.014 ' HA ' HD23 ' A' ' 94' ' ' LEU . 95.9 mmm -58.88 -45.03 91.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.165 -0.959 . . . . 0.0 109.649 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -48.11 -47.65 26.54 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 1.0 OUTLIER -64.46 -32.86 74.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.211 -1.17 . . . . 0.0 109.616 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.014 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -66.16 -22.23 66.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.905 . . . . 0.0 109.955 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.516 ' CD1' HG13 ' A' ' 29' ' ' VAL . 1.2 t80 -49.22 -55.06 13.79 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.012 -1.055 . . . . 0.0 109.971 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 5.1 tp60 -69.47 -18.55 63.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.008 -1.058 . . . . 0.0 111.078 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 12.7 mm-40 -87.3 -68.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.007 -1.058 . . . . 0.0 112.363 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.544 ' CG ' ' HB2' ' A' ' 81' ' ' ASN . 8.8 m-70 -99.44 38.23 1.46 Allowed 'General case' 0 N--CA 1.484 1.257 0 O-C-N 120.833 -1.167 . . . . 0.0 111.947 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.509 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.8 p80 -56.61 -22.09 31.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.033 -1.042 . . . . 0.0 109.237 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' CG ' ' HB2' ' A' ' 106' ' ' TYR . 0.4 OUTLIER 46.46 -92.45 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.862 -0.524 . . . . 0.0 110.513 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.501 ' OE1' ' CE1' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -71.32 163.54 27.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.138 -0.977 . . . . 0.0 110.371 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -85.36 60.73 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 109.932 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.408 ' HD1' ' CE1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -179.38 -57.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.87 . . . . 0.0 109.915 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 4.6 m-85 -119.24 -178.37 3.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 109.776 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.075 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -109.58 165.68 11.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.064 -1.023 . . . . 0.0 109.502 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.713 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.9 m-85 -122.85 128.89 50.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.847 -1.158 . . . . 0.0 111.87 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.075 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.3 mt -140.02 128.57 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.343 -0.848 . . . . 0.0 110.016 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -123.7 172.83 8.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 109.75 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.723 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.2 p90 -149.92 163.07 39.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.822 -1.174 . . . . 0.0 111.35 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.493 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -146.45 179.47 7.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.741 -0.6 . . . . 0.0 110.688 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.694 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 5.8 t70 -121.29 36.62 4.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.378 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -120.92 151.99 39.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.972 -1.08 . . . . 0.0 110.567 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.595 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 34.5 t -158.06 34.82 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.404 -0.81 . . . . 0.0 109.933 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 113' ' ' SER . 9.5 p -43.54 167.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.343 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -103.36 110.19 22.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -52.52 159.05 3.24 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.8 mt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.171 -1.194 . . . . 0.0 110.199 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.06 -48.86 64.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -1.137 . . . . 0.0 110.184 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -29.11 62.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.165 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.922 ' CG2' HD21 ' A' ' 50' ' ' LEU . 15.8 mm -71.89 -20.89 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 110.207 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -31.54 39.55 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.85 -1.156 . . . . 0.0 109.963 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -38.13 55.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.423 -0.798 . . . . 0.0 110.061 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.619 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -85.32 -29.87 24.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.226 -0.921 . . . . 0.0 110.855 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.619 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 46.1 m-85 -114.44 71.38 2.3 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.791 -1.193 . . . . 0.0 110.276 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 46.7 Cg_endo -73.26 -3.59 13.94 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.996 1.524 . . . . 0.0 110.269 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -107.55 -1.83 20.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 28' ' ' ARG . 8.7 mpt_? -94.03 -167.83 1.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 110.149 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.744 HG12 HG12 ' A' ' 31' ' ' VAL . 24.0 t -145.55 105.78 4.32 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 47.7 Cg_endo -75.89 84.06 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.167 1.614 . . . . 0.0 109.818 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.831 HG12 ' CD2' ' A' ' 105' ' ' LEU . 1.8 m -80.54 149.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 111.114 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.588 HG13 ' CE1' ' A' ' 104' ' ' PHE . 6.8 mm -102.02 164.93 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.584 HG21 ' CE1' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -136.09 141.81 40.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.779 -1.201 . . . . 0.0 111.545 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 1.8 tt0 -156.52 165.76 35.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.642 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -99.69 162.47 12.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.917 -1.115 . . . . 0.0 110.738 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.031 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.36 -172.66 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.464 -0.772 . . . . 0.0 109.292 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.031 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.8 Cg_endo -71.31 107.59 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.476 1.251 . . . . 0.0 110.033 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 mttt 63.52 36.39 11.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.453 -0.78 . . . . 0.0 110.196 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -58.68 178.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 110.061 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 35.53 0.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 110.58 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.824 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.54 176.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.006 -1.059 . . . . 0.0 110.432 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.824 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -48.73 -177.47 0.01 OUTLIER Glycine 0 N--CA 1.497 2.717 0 O-C-N 121.438 -0.789 . . . . 0.0 111.179 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.892 ' O ' HD22 ' A' ' 44' ' ' LEU . 4.3 t0 -77.12 -175.74 3.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -1.091 . . . . 0.0 109.778 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.892 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -136.02 135.21 39.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.985 . . . . 0.0 110.738 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -86.89 -36.03 18.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 109.732 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.56 ' HE2' ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -152.59 155.29 37.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.474 -0.766 . . . . 0.0 109.837 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -120.31 43.23 2.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 0.0 110.226 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HG3' ' HG2' ' A' ' 47' ' ' LYS . 14.8 mttp -157.88 107.56 2.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 109.58 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.596 ' CD2' HD13 ' A' ' 63' ' ' LEU . 31.8 m-85 -103.39 143.34 32.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.114 -0.991 . . . . 0.0 110.884 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.922 HD21 ' CG2' ' A' ' 21' ' ' ILE . 0.7 OUTLIER -103.61 89.89 3.49 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.528 ' HB ' HD12 ' A' ' 55' ' ' LEU . 20.2 m -111.04 143.45 28.36 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.347 -0.846 . . . . 0.0 111.002 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.437 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 46.5 Cg_endo -71.45 148.96 55.42 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.164 1.613 . . . . 0.0 109.74 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.554 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.55 -15.58 51.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.898 . . . . 0.0 111.438 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -83.34 -13.81 54.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.09 -1.006 . . . . 0.0 111.169 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.846 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.0 mt -62.3 143.63 56.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.829 -1.17 . . . . 0.0 111.129 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 1.6 p -91.3 167.67 12.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.593 -0.692 . . . . 0.0 109.891 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 80.8 t -62.75 -32.25 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 110.059 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.81 -23.38 70.82 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.846 ' CB ' HD22 ' A' ' 55' ' ' LEU . 34.7 mm-40 -80.4 -50.91 9.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.125 -1.221 . . . . 0.0 109.727 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.184 ' CE2' HD11 ' A' ' 64' ' ' ILE . 14.1 t80 -60.12 -34.06 72.99 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.084 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.586 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -54.8 -37.56 66.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.47 -0.769 . . . . 0.0 109.873 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.8 t80 -74.51 -50.69 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.537 -0.727 . . . . 0.0 112.525 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.129 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -58.58 -39.88 81.57 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.506 -1.371 . . . . 0.0 112.489 -177.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.184 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -75.1 -38.89 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 119.764 -1.835 . . . . 0.0 108.761 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.835 ' HD2' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -39.15 -58.39 1.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.551 -0.718 . . . . 0.0 110.42 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -65.32 -34.4 78.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.968 -1.083 . . . . 0.0 109.903 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.527 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 4.5 mmp_? -70.27 -9.22 55.33 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.258 -0.901 . . . . 0.0 109.835 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.016 HG21 HD23 ' A' ' 70' ' ' LEU . 67.1 mt -100.28 4.55 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.337 -0.852 . . . . 0.0 109.733 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.493 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 60.63 27.97 17.68 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.393 -0.817 . . . . 0.0 110.324 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.016 HD23 HG21 ' A' ' 68' ' ' ILE . 4.3 pp -114.99 156.33 25.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.639 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.06 -166.94 0.97 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 110.998 -179.074 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 55.45 -87.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.835 . . . . 0.0 110.986 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' ARG . 9.7 pt-20 -152.06 27.09 0.61 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 111.238 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -53.84 176.37 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.919 -1.113 . . . . 0.0 109.817 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 111' ' ' ASP . . . -97.79 141.97 30.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.954 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.764 HD21 ' CZ ' ' A' ' 78' ' ' PHE . 16.6 tp -162.19 152.55 16.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 110.997 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.2 m-85 -160.99 120.54 2.64 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.839 ' CE1' HD12 ' A' ' 64' ' ' ILE . 77.9 m-85 -89.03 116.81 27.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 110.273 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 55.8 m-85 -108.31 125.87 52.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.399 -0.813 . . . . 0.0 109.507 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.998 HG22 HG23 ' A' ' 107' ' ' ILE . 1.9 t -121.34 129.92 75.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.324 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 83' ' ' VAL . 55.4 t30 51.05 37.84 18.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 110.361 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 58.2 t30 65.06 36.75 7.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 110.385 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.684 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -135.02 167.04 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.228 -0.92 . . . . 0.0 110.031 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.05 73.07 5.72 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.585 -0.697 . . . . 0.0 109.556 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.55 164.37 35.12 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.994 1.523 . . . . 0.0 110.563 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.86 -178.38 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.138 1.599 . . . . 0.0 110.221 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.528 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -85.01 20.08 1.97 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 110.741 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.67 42.01 1.11 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.485 -0.76 . . . . 0.0 109.672 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.28 -174.85 4.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.503 -0.748 . . . . 0.0 110.144 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 43.6 p -139.68 146.68 39.96 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.501 -0.75 . . . . 0.0 110.386 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.092 ' HA ' HD23 ' A' ' 94' ' ' LEU . 24.3 mmm -53.56 -42.45 67.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.662 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.52 -46.71 37.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.1 OUTLIER -65.35 -33.05 75.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -1.209 . . . . 0.0 109.827 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.092 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.11 -19.79 64.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.936 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.651 ' CD1' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -49.55 -56.42 9.95 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.005 -1.059 . . . . 0.0 109.632 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -70.15 -15.23 62.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.461 -1.4 . . . . 0.0 111.243 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 2.2 mm-40 -87.44 -64.74 1.1 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.969 -1.082 . . . . 0.0 112.925 -178.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.62 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -97.97 39.69 1.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.875 -1.14 . . . . 0.0 111.445 -177.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.588 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER -156.79 173.89 16.3 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.555 ' N ' ' CG ' ' A' ' 99' ' ' HIS . 1.4 pt-20 -164.26 -128.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.033 -1.042 . . . . 0.0 110.549 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 102' ' ' ASP . 12.7 mm-40 -90.76 -18.33 25.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.728 -1.232 . . . . 0.0 110.787 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.464 ' OD2' ' OE2' ' A' ' 100' ' ' GLU . 22.8 m-20 -41.28 -72.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -0.901 . . . . 0.0 110.329 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER 176.21 -52.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.251 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.588 ' CE1' HG13 ' A' ' 32' ' ' ILE . 3.1 p90 -127.14 -173.03 2.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 110.304 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.038 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.28 168.11 9.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.19 -0.944 . . . . 0.0 109.113 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.669 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.1 p90 -124.64 127.28 47.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.785 -1.197 . . . . 0.0 111.854 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.038 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.7 mt -136.73 144.56 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.078 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -133.55 175.65 9.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.949 . . . . 0.0 110.018 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.9 OUTLIER -147.42 167.6 23.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.972 . . . . 0.0 110.478 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -158.58 165.21 35.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.723 . . . . 0.0 110.285 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.536 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 4.3 p-10 -88.96 -8.88 53.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 110.312 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 14.9 pt-20 -178.3 159.06 1.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 0.0 110.486 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.7 t -154.63 31.92 0.41 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.416 -0.803 . . . . 0.0 110.106 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.573 HG22 ' H ' ' A' ' 115' ' ' TYR . 9.9 p -112.14 177.11 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.377 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.573 ' H ' HG22 ' A' ' 114' ' ' VAL . 17.2 t80 -44.29 131.14 6.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.99 -151.74 7.58 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.238 -1.154 . . . . 0.0 110.116 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -59.03 -49.66 77.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.311 -1.111 . . . . 0.0 109.935 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -77.54 -18.67 56.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.67 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -72.2 -24.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.984 -1.073 . . . . 0.0 110.123 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 18' ' ' GLY . 5.1 mmm180 -93.34 -49.21 6.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.099 -1.001 . . . . 0.0 110.036 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -54.13 -36.98 63.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.063 -1.023 . . . . 0.0 109.111 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 20' ' ' LYS . 4.7 mmtp -86.35 -49.97 7.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.393 -0.817 . . . . 0.0 109.435 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.514 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 13.0 m-85 -114.32 61.57 1.12 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.46 -0.775 . . . . 0.0 110.393 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 42.9 Cg_endo -69.04 -31.16 24.34 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.865 1.455 . . . . 0.0 110.605 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 1.8 t0 -103.89 21.9 15.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.051 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 28' ' ' ARG . 3.2 mpt_? -99.03 -165.52 1.25 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 110.418 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.688 HG12 HG12 ' A' ' 31' ' ' VAL . 9.2 t -143.53 104.45 5.01 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 110.295 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.7 Cg_endo -78.71 87.84 1.51 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.159 1.61 . . . . 0.0 109.928 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.688 HG12 HG12 ' A' ' 29' ' ' VAL . 1.2 m -83.42 144.02 10.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.136 -0.977 . . . . 0.0 110.882 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 31.5 mm -97.5 162.52 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.837 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.4 t -136.69 139.6 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.912 -1.117 . . . . 0.0 111.221 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.576 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.3 tm-20 -154.03 163.87 39.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' HD2' HD11 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -99.97 158.68 15.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.885 -1.135 . . . . 0.0 110.909 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.016 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.92 -173.55 0.11 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.562 -0.711 . . . . 0.0 109.185 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.016 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.0 Cg_endo -72.0 109.1 2.61 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.507 1.267 . . . . 0.0 110.112 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 62.15 42.86 9.21 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.367 -0.833 . . . . 0.0 110.293 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.426 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -63.99 179.92 0.48 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.517 ' CG ' ' OD1' ' A' ' 111' ' ' ASP . 0.9 OUTLIER -149.84 30.74 0.72 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.163 -0.961 . . . . 0.0 110.821 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.544 HD11 ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -85.18 -179.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.048 -1.033 . . . . 0.0 109.924 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.515 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -59.81 168.03 8.26 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -87.35 171.64 10.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -1.11 . . . . 0.0 110.34 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.905 HD13 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -136.51 146.28 46.06 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.351 -0.843 . . . . 0.0 110.105 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.441 ' C ' ' HD3' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -86.95 -7.49 58.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.854 . . . . 0.0 110.182 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.905 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -154.12 155.66 35.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.004 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -126.44 45.18 2.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.003 . . . . 0.0 109.716 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -158.62 111.77 2.35 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.467 -0.77 . . . . 0.0 109.879 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.848 ' OH ' HD11 ' A' ' 44' ' ' LEU . 11.6 m-85 -104.91 142.37 34.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -0.979 . . . . 0.0 110.127 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.49 100.62 8.65 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.509 -0.745 . . . . 0.0 109.136 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.98 ' HB ' HD12 ' A' ' 55' ' ' LEU . 3.5 m -126.94 159.6 63.66 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.142 -0.974 . . . . 0.0 110.763 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 46.2 Cg_endo -71.43 147.86 53.29 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.194 1.629 . . . . 0.0 110.594 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.564 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -64.77 -14.59 59.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 111.533 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -83.52 -10.92 58.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.883 -1.136 . . . . 0.0 110.764 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.98 HD12 ' HB ' ' A' ' 51' ' ' VAL . 4.5 mt -62.56 143.38 57.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.083 -1.011 . . . . 0.0 111.038 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 p -90.63 158.27 17.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.49 -0.756 . . . . 0.0 109.199 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.606 HG12 HG22 ' A' ' 87' ' ' THR . 61.1 t -57.09 -23.01 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.091 -1.005 . . . . 0.0 110.032 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.98 -33.67 59.49 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.899 ' CB ' HD22 ' A' ' 55' ' ' LEU . 24.3 mm-40 -72.27 -50.61 25.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.151 -1.205 . . . . 0.0 109.759 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.101 ' CE2' HD11 ' A' ' 64' ' ' ILE . 47.2 t80 -60.56 -32.02 71.11 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.273 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.664 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -63.41 -29.28 70.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.033 -1.042 . . . . 0.0 109.498 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.3 t80 -69.85 -53.36 18.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 110.126 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.075 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -59.87 -33.59 72.01 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.426 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.101 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -75.13 -33.4 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 119.777 -1.827 . . . . 0.0 109.701 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -38.29 -63.89 0.46 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 0.0 110.721 -179.164 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -30.62 71.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 110.132 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.644 ' CD ' HD21 ' A' ' 44' ' ' LEU . 20.2 mmt180 -66.15 -20.29 66.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.202 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.873 ' CG2' HD23 ' A' ' 70' ' ' LEU . 68.8 mt -104.2 15.7 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.977 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.515 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 49.68 28.37 2.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.411 -0.806 . . . . 0.0 110.241 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.873 HD23 ' CG2' ' A' ' 68' ' ' ILE . 3.8 pp -110.11 160.48 16.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.428 -0.795 . . . . 0.0 109.519 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.4 ptt180 -165.25 -171.9 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.046 -1.034 . . . . 0.0 110.822 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 52.08 -89.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.487 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 72' ' ' ALA . 33.1 mt-10 -157.11 29.29 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.951 . . . . 0.0 110.703 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.39 176.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.117 -0.99 . . . . 0.0 109.846 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.518 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -87.45 137.71 32.1 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 121.382 0.61 . . . . 0.0 110.367 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.749 HD21 ' CE1' ' A' ' 78' ' ' PHE . 49.3 tp -164.83 152.78 11.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.787 . . . . 0.0 110.426 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.594 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 89.8 m-85 -158.77 118.47 3.13 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.556 -0.715 . . . . 0.0 110.021 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.749 ' CE1' HD21 ' A' ' 76' ' ' LEU . 19.3 m-30 -84.96 132.67 34.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.0 -1.062 . . . . 0.0 111.054 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 59.5 m-85 -117.63 119.79 36.04 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.421 -0.799 . . . . 0.0 109.138 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.679 HG13 ' CG1' ' A' ' 107' ' ' ILE . 2.8 t -120.96 123.47 70.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.592 -0.693 . . . . 0.0 110.198 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.63 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.9 OUTLIER 49.54 42.04 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 3.7 m120 62.5 35.72 14.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.351 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -135.2 167.39 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.0 68.53 5.48 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 109.454 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.74 163.07 38.13 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.982 1.517 . . . . 0.0 110.891 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.4 -178.26 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.146 1.603 . . . . 0.0 110.419 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.606 HG22 HG12 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -84.75 22.18 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.389 -0.819 . . . . 0.0 110.864 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -94.27 41.23 1.09 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 109.65 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.45 -172.48 3.89 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.598 0.713 . . . . 0.0 110.288 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 63.5 p -139.79 140.74 36.73 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.674 -0.641 . . . . 0.0 110.159 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.038 ' HA ' HD23 ' A' ' 94' ' ' LEU . 9.3 mmm -49.18 -41.87 38.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.163 -0.961 . . . . 0.0 110.261 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.564 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.81 -47.65 52.71 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.2 OUTLIER -64.86 -30.87 71.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -1.097 . . . . 0.0 109.94 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.038 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.3 -24.51 64.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 110.031 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.586 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -49.46 -56.13 10.81 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 109.764 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -69.85 -17.8 63.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.003 -1.06 . . . . 0.0 111.124 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.3 mm-40 -87.53 -68.24 0.77 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.973 -1.08 . . . . 0.0 112.363 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.513 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 10.6 m-70 -99.38 38.65 1.39 Allowed 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.871 -1.143 . . . . 0.0 111.937 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.543 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.4 p80 -59.18 -19.85 48.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.136 -0.978 . . . . 0.0 109.41 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 106' ' ' TYR . 1.9 tm-20 72.02 -79.97 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.113 0.482 . . . . 0.0 110.34 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 102' ' ' ASP . 1.1 mt-10 -121.76 -63.95 1.26 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 110.093 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER 172.47 157.65 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.251 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 2.7 t80 78.26 -20.93 0.36 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.715 -0.616 . . . . 0.0 111.439 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.47 ' CD2' ' HB3' ' A' ' 103' ' ' PHE . 7.0 p90 -166.77 171.43 11.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.767 -1.208 . . . . 0.0 110.438 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.931 HD13 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -111.77 169.55 8.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.313 -0.867 . . . . 0.0 109.693 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.716 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -126.56 126.19 43.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.731 -1.23 . . . . 0.0 110.986 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.679 ' CG1' HG13 ' A' ' 80' ' ' VAL . 11.7 mt -141.25 147.98 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.306 -0.872 . . . . 0.0 109.64 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -142.5 -179.92 6.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.111 -0.993 . . . . 0.0 110.286 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.837 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.6 p90 -150.02 162.71 39.86 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.645 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.768 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -159.39 168.44 26.3 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.566 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.517 ' OD1' ' CG ' ' A' ' 40' ' ' ARG . 16.9 p-10 -127.05 28.78 5.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.074 -1.016 . . . . 0.0 110.187 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 111' ' ' ASP . 1.9 mt-10 59.67 145.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.91 . . . . 0.0 110.159 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.6 t -108.71 12.86 25.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 110.062 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.99 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.246 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -159.41 0.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.48 -158.36 39.45 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.264 -1.139 . . . . 0.0 110.213 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -23.04 62.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -1.184 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' NZ ' ' HG3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -73.94 -28.74 61.65 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -59.84 -19.32 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 109.95 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 13.8 mmt85 -90.13 -48.24 7.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.146 -0.972 . . . . 0.0 110.026 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HG3' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.53 -42.94 45.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.117 -0.989 . . . . 0.0 109.072 179.154 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 18.0 mttp -85.68 -48.92 8.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.791 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.513 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 10.8 m-85 -114.73 64.19 1.52 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.462 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 44.9 Cg_endo -70.48 -20.91 30.86 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.836 1.44 . . . . 0.0 110.666 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 38.1 t70 -111.42 22.11 15.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.964 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 3.2 mpt_? -103.6 -168.08 1.46 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.517 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.807 HG12 HG12 ' A' ' 31' ' ' VAL . 21.6 t -145.94 110.64 4.42 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 109.963 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.597 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 47.0 Cg_endo -73.44 87.9 1.05 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 124.175 1.619 . . . . 0.0 109.949 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 49' ' ' TYR . 1.4 m -88.12 144.1 9.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.33 -0.856 . . . . 0.0 111.411 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 16.2 mm -108.98 135.8 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -120.25 140.89 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.737 -1.227 . . . . 0.0 112.142 -178.324 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -145.6 172.49 13.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.655 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -97.44 161.49 13.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.814 -1.179 . . . . 0.0 110.802 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.026 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.09 -173.22 0.1 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.488 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.026 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.4 Cg_endo -72.55 112.09 3.39 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.547 1.288 . . . . 0.0 109.827 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 59.67 43.04 16.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.888 . . . . 0.0 110.178 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -66.05 179.36 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.31 -0.869 . . . . 0.0 110.166 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.455 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.3 34.24 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.948 . . . . 0.0 110.785 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.88 HD13 HG23 ' A' ' 68' ' ' ILE . 1.9 pp -85.89 177.51 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.012 -1.055 . . . . 0.0 110.418 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.814 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -52.23 -174.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.832 0 O-C-N 121.266 -0.896 . . . . 0.0 111.273 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 1.002 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -81.67 -175.8 5.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -1.078 . . . . 0.0 110.107 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.002 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.2 mm? -140.17 135.33 32.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.942 . . . . 0.0 110.775 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 46' ' ' LYS . 2.9 p30 -86.39 -27.35 24.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.497 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.508 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -153.2 155.65 37.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.84 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.711 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -124.4 42.98 3.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.021 -1.05 . . . . 0.0 110.042 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -159.46 109.36 1.91 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.446 -0.784 . . . . 0.0 109.78 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.874 ' O ' HG22 ' A' ' 31' ' ' VAL . 29.9 m-85 -106.44 141.72 37.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.046 -1.033 . . . . 0.0 110.823 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mp -107.06 93.99 4.86 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.61 ' HB ' HD12 ' A' ' 55' ' ' LEU . 35.0 m -113.18 152.45 45.09 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.933 . . . . 0.0 111.314 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.442 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.6 Cg_endo -70.49 145.52 53.12 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.317 1.693 . . . . 0.0 109.625 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.554 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 1.7 m -62.9 -11.87 21.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.349 -0.845 . . . . 0.0 111.451 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -85.5 -14.54 45.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 0.0 111.104 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.873 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.9 mt -62.21 142.43 57.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.028 -1.045 . . . . 0.0 111.372 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.7 p -91.09 162.65 14.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.744 -0.597 . . . . 0.0 109.788 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.475 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 91.4 t -58.44 -25.67 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.093 -1.004 . . . . 0.0 109.963 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.93 94.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.873 ' CB ' HD22 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -67.69 -48.0 67.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -1.197 . . . . 0.0 109.877 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.177 ' CE2' HD11 ' A' ' 64' ' ' ILE . 8.0 t80 -60.23 -32.46 71.15 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.068 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.476 ' CD1' ' HE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -55.36 -36.6 66.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 110.085 178.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.72 -49.98 12.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.437 -0.79 . . . . 0.0 112.691 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.163 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.43 -40.33 82.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.51 -1.368 . . . . 0.0 111.975 -177.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.177 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -75.22 -42.53 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 119.907 -1.746 . . . . 0.0 108.278 178.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -39.84 -54.89 2.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.628 -0.67 . . . . 0.0 110.53 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -64.33 -35.89 82.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.138 -0.976 . . . . 0.0 109.937 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.524 ' CG ' ' OH ' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -69.68 -14.39 62.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.187 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.97 HD12 HD21 ' A' ' 44' ' ' LEU . 2.3 mm -93.2 4.27 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.494 -0.754 . . . . 0.0 109.721 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.1 t60 53.43 33.71 16.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 110.484 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.96 ' O ' HD12 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -104.96 156.56 17.92 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.105 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' A' ' 73' ' ' GLU . 12.9 ptt180 -165.83 -168.2 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.832 -1.168 . . . . 0.0 111.247 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.35 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 110.963 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 74' ' ' ASP . 5.2 pt-20 -152.16 24.01 0.64 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.146 -0.971 . . . . 0.0 111.106 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.29 177.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 109.85 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.1 141.14 37.18 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.112 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.76 HD21 ' CE2' ' A' ' 78' ' ' PHE . 26.2 tp -154.83 153.11 30.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.469 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 95.4 m-85 -158.43 121.16 3.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.622 -0.674 . . . . 0.0 109.79 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.76 ' CE2' HD21 ' A' ' 76' ' ' LEU . 72.3 m-85 -92.26 123.01 35.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 110.488 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 52.0 m-85 -115.45 136.76 52.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.594 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.827 HG22 HG12 ' A' ' 107' ' ' ILE . 12.6 t -119.87 121.81 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.0 110.456 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.633 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.1 OUTLIER 49.31 48.58 20.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.418 -0.801 . . . . 0.0 110.656 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 62.28 29.37 17.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 110.557 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.651 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.8 t -126.16 168.59 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.966 . . . . 0.0 109.675 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -154.63 68.19 5.62 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.472 -0.767 . . . . 0.0 109.747 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.2 168.1 25.6 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.011 1.532 . . . . 0.0 110.341 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.96 -179.78 4.61 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.052 1.554 . . . . 0.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.475 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -86.91 20.59 2.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.335 -0.853 . . . . 0.0 110.534 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -90.99 39.34 0.99 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.437 -0.789 . . . . 0.0 109.402 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.761 ' HB1' ' CD ' ' A' ' 93' ' ' GLN . . . -145.43 -177.29 5.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.571 -0.705 . . . . 0.0 110.088 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 81.2 p -140.07 144.38 36.81 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.465 -0.772 . . . . 0.0 110.395 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.054 ' HA ' HD23 ' A' ' 94' ' ' LEU . 39.8 mmm -43.88 -39.02 3.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.513 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -55.71 -48.27 72.71 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.761 ' CD ' ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -64.26 -30.51 71.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -1.175 . . . . 0.0 109.87 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.054 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.26 -27.37 66.28 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.232 -0.917 . . . . 0.0 109.813 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.585 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -50.28 -54.71 19.34 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.981 -1.074 . . . . 0.0 109.566 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -68.15 -20.68 64.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.815 -1.178 . . . . 0.0 110.51 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 10.1 mt-10 -88.22 -73.69 0.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.182 -0.948 . . . . 0.0 112.468 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.583 ' CG ' ' HB2' ' A' ' 81' ' ' ASN . 22.2 m-70 -100.69 37.2 1.76 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.786 -1.196 . . . . 0.0 112.361 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.536 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 1.0 OUTLIER -57.14 -23.65 48.81 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.035 -1.041 . . . . 0.0 109.748 179.062 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' A' ' 99' ' ' HIS . 0.1 OUTLIER 73.63 -1.87 2.93 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.491 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 58.8 73.46 0.48 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 2.6 t0 178.75 31.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 0.0 110.203 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.579 ' O ' ' CD1' ' A' ' 103' ' ' PHE . 3.1 t80 55.61 32.51 19.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.882 . . . . 0.0 110.16 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 30' ' ' PRO . 7.4 m-85 -170.34 127.8 0.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 109.78 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.969 HD11 HD12 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -84.87 159.76 20.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.746 -1.221 . . . . 0.0 109.486 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.532 ' CD1' ' OE2' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -115.64 120.62 39.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.851 -1.155 . . . . 0.0 111.655 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.969 HD12 HD11 ' A' ' 105' ' ' LEU . 15.6 mt -141.44 140.72 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 109.241 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.43 177.61 7.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.137 -0.977 . . . . 0.0 110.136 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.655 ' CE2' ' CD ' ' A' ' 35' ' ' LYS . 1.4 p90 -144.86 165.12 29.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 110.648 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -158.14 178.67 9.94 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.271 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.674 ' HB3' HG22 ' A' ' 41' ' ' ILE . 27.9 p-10 -126.5 24.91 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 110.266 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.632 ' OE2' HG12 ' A' ' 114' ' ' VAL . 0.6 OUTLIER 58.32 155.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.288 -0.883 . . . . 0.0 110.193 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -104.22 -7.66 19.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 110.226 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.632 HG12 ' OE2' ' A' ' 112' ' ' GLU . 9.8 p -105.88 169.81 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.417 ' N ' HG22 ' A' ' 114' ' ' VAL . 46.8 t80 -111.72 151.87 28.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.24 176.5 37.79 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.195 -1.179 . . . . 0.0 110.215 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -39.68 88.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -1.15 . . . . 0.0 109.876 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.408 ' HD3' ' C ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -73.18 -19.73 61.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.382 -0.824 . . . . 0.0 110.065 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 15.8 mm -72.31 -28.24 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.221 -0.924 . . . . 0.0 110.303 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' O ' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -79.46 -18.72 51.49 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.75 -1.219 . . . . 0.0 109.746 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -34.43 15.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.458 -0.776 . . . . 0.0 109.159 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.606 ' CE ' ' CZ ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -85.54 -27.31 25.65 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.606 ' CZ ' ' CE ' ' A' ' 24' ' ' LYS . 50.1 m-85 -110.85 57.25 0.36 Allowed Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.02 -1.05 . . . . 0.0 110.851 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.488 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 43.9 Cg_endo -68.91 -34.85 16.65 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.486 1.256 . . . . 0.0 110.783 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -96.6 14.12 25.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 110.684 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 1.4 mpt_? -111.9 -173.0 2.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.053 -1.029 . . . . 0.0 110.316 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.694 HG12 HG12 ' A' ' 31' ' ' VAL . 24.6 t -147.2 108.48 3.92 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 110.512 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.592 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 50.5 Cg_endo -78.87 81.59 2.74 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.363 1.717 . . . . 0.0 110.108 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.694 HG12 HG12 ' A' ' 29' ' ' VAL . 1.7 m -77.52 141.41 15.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.187 -0.946 . . . . 0.0 111.119 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 106' ' ' TYR . 46.8 mm -97.44 155.72 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.832 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.7 t -133.86 141.77 43.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.933 -1.104 . . . . 0.0 111.298 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.64 -179.24 8.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.547 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -115.83 159.77 21.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.857 -1.152 . . . . 0.0 110.295 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -61.3 -174.94 0.08 OUTLIER Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.54 -0.725 . . . . 0.0 109.248 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.6 Cg_endo -70.86 108.66 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.52 1.274 . . . . 0.0 109.842 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.4 38.55 9.98 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.352 -0.842 . . . . 0.0 110.012 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.547 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -56.22 179.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.26 -0.9 . . . . 0.0 110.125 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.14 32.18 0.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 110.611 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.829 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.93 176.38 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 110.208 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.829 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -50.18 -175.19 0.01 OUTLIER Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.315 -0.866 . . . . 0.0 110.997 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.965 ' O ' HD22 ' A' ' 44' ' ' LEU . 3.3 t0 -77.0 -175.53 3.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -1.134 . . . . 0.0 109.889 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.965 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.4 mm? -137.19 135.56 37.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.06 -1.025 . . . . 0.0 110.494 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -86.28 -34.63 20.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.723 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -153.87 159.85 41.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.752 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.561 ' HG2' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -124.0 40.0 3.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.054 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.561 ' HG3' ' HG2' ' A' ' 47' ' ' LYS . 23.9 mttt -158.69 106.17 1.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.546 -0.721 . . . . 0.0 109.66 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.881 ' CD2' HD13 ' A' ' 63' ' ' LEU . 30.3 m-85 -104.86 139.62 39.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.87 -1.144 . . . . 0.0 110.25 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.52 99.35 8.13 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.79 ' HB ' HD12 ' A' ' 55' ' ' LEU . 4.2 m -126.18 163.65 38.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.128 -0.983 . . . . 0.0 111.157 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 45.4 Cg_endo -71.05 144.09 46.29 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.142 1.601 . . . . 0.0 110.389 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.556 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -63.86 -13.43 44.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.41 -0.806 . . . . 0.0 111.375 -179.064 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -83.59 -10.2 58.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.989 -1.07 . . . . 0.0 110.884 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.833 HD22 ' HB2' ' A' ' 59' ' ' GLN . 4.0 mt -62.3 141.75 58.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.995 -1.066 . . . . 0.0 111.335 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 1.4 p -91.24 157.95 16.87 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.628 -0.67 . . . . 0.0 109.217 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.657 HG12 HG22 ' A' ' 87' ' ' THR . 53.0 t -55.26 -24.05 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.06 -1.025 . . . . 0.0 110.06 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.2 87.72 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.833 ' HB2' HD22 ' A' ' 55' ' ' LEU . 1.4 mt-30 -67.73 -44.2 78.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.179 -1.189 . . . . 0.0 110.122 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.154 ' CE2' HD11 ' A' ' 64' ' ' ILE . 17.4 t80 -60.65 -46.4 90.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.038 -1.039 . . . . 0.0 109.568 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.465 ' HE1' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -50.78 -21.76 1.81 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.948 -1.095 . . . . 0.0 109.902 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.3 -54.57 5.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.394 -0.816 . . . . 0.0 110.597 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.994 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.8 pp -59.78 -21.85 61.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.945 -1.097 . . . . 0.0 112.169 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.154 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.1 mt -92.77 -35.19 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.191 -1.568 . . . . 0.0 109.219 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.777 ' HG2' HD11 ' A' ' 70' ' ' LEU . 2.8 mtp85 -35.94 -63.71 0.35 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.853 -0.529 . . . . 0.0 110.855 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -31.15 72.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.043 -1.035 . . . . 0.0 109.88 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.502 ' C ' HD13 ' A' ' 68' ' ' ILE . 19.7 mmt180 -67.24 -16.32 64.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 110.009 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.766 ' CG2' HD23 ' A' ' 70' ' ' LEU . 1.3 mm -101.1 12.86 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.959 . . . . 0.0 109.708 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.5 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 50.42 30.81 4.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.462 -0.774 . . . . 0.0 110.369 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.779 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.2 pp -110.35 155.59 21.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 0.0 109.695 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.72 -172.42 2.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.116 -0.99 . . . . 0.0 111.014 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.56 -89.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 110.775 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 71' ' ' ARG . 5.6 pt-20 -150.34 35.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 110.872 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -58.38 177.23 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.14 -0.975 . . . . 0.0 109.966 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.522 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -107.1 138.3 43.54 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.378 0.609 . . . . 0.0 110.34 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.755 HD21 ' CE1' ' A' ' 78' ' ' PHE . 15.2 tp -164.7 152.66 11.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 0.0 110.249 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 83.8 m-85 -157.79 121.83 4.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.644 -0.66 . . . . 0.0 109.972 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 64' ' ' ILE . 16.9 m-30 -82.59 122.67 28.39 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.16 -0.962 . . . . 0.0 111.57 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 69.8 m-85 -113.57 120.37 40.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.837 HG22 HG23 ' A' ' 107' ' ' ILE . 2.4 t -121.06 128.38 76.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.4 -0.812 . . . . 0.0 109.998 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.3 t30 49.75 42.32 23.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 0.0 110.229 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 2.9 m-20 60.39 36.56 20.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.467 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.697 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -134.87 166.03 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 109.987 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.812 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -155.26 72.89 5.61 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 109.542 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.72 163.79 37.44 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.032 1.543 . . . . 0.0 110.792 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.47 -178.57 3.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.08 1.569 . . . . 0.0 110.357 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.657 HG22 HG12 ' A' ' 57' ' ' VAL . 1.1 p -85.92 19.52 2.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.857 . . . . 0.0 110.774 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.0 m -96.75 42.43 1.09 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.525 -0.734 . . . . 0.0 109.621 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.34 -172.46 3.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.491 -0.756 . . . . 0.0 110.319 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 77.2 p -139.42 140.64 37.41 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.477 0.656 . . . . 0.0 110.158 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.052 ' HA ' HD23 ' A' ' 94' ' ' LEU . 59.7 mtm -52.51 -38.72 60.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 109.938 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -50.51 -49.54 39.0 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 90' ' ' THR . 4.0 pt20 -64.68 -28.92 69.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -1.163 . . . . 0.0 109.664 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.052 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.17 -23.63 64.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 110.132 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.592 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -49.05 -54.29 16.53 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.707 -1.246 . . . . 0.0 109.755 -179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.35 -18.96 63.07 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.21 -0.931 . . . . 0.0 111.25 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.7 mt-10 -86.34 -65.03 1.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.91 -1.119 . . . . 0.0 112.288 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.581 ' CD2' ' HB ' ' A' ' 80' ' ' VAL . 16.6 m-70 -98.02 38.06 1.35 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.929 -1.107 . . . . 0.0 111.254 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.454 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -61.28 175.2 0.58 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.494 -0.754 . . . . 0.0 109.437 178.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.526 ' CG ' ' N ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER -136.34 -93.65 0.25 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.569 -1.332 . . . . 0.0 110.427 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.526 ' N ' ' CG ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -106.81 59.33 0.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.982 -1.073 . . . . 0.0 110.418 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER 41.21 65.86 0.76 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.314 -0.866 . . . . 0.0 109.952 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.77 -64.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 110.0 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 4.6 m-85 -126.12 165.61 18.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 110.068 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.068 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -104.91 168.94 8.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.229 -0.919 . . . . 0.0 109.199 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.708 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -119.23 128.26 54.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.615 -1.303 . . . . 0.0 111.778 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.068 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.2 mt -139.2 129.33 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.19 -0.944 . . . . 0.0 110.483 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -128.55 152.3 48.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.154 -0.966 . . . . 0.0 108.778 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.832 ' HE1' HG13 ' A' ' 33' ' ' VAL . 2.3 p90 -131.4 167.09 19.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.55 -1.344 . . . . 0.0 111.647 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -153.88 -179.79 8.17 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.101 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.646 ' HB3' HG22 ' A' ' 41' ' ' ILE . 7.1 p-10 -111.99 32.1 5.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.165 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 111' ' ' ASP . 8.4 mm-40 -148.82 134.69 18.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 0.0 110.118 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 92.6 p -123.41 21.52 9.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 110.265 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.495 HG22 ' N ' ' A' ' 115' ' ' TYR . 7.5 p -61.26 173.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.189 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.495 ' N ' HG22 ' A' ' 114' ' ' VAL . 4.6 t80 -128.84 50.91 2.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.349 -0.844 . . . . 0.0 110.148 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -130.62 -151.9 7.24 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.197 -1.178 . . . . 0.0 110.246 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.26 -22.52 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.196 -1.179 . . . . 0.0 109.887 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 2.0 mmtm -77.19 -41.66 40.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.415 -0.803 . . . . 0.0 109.931 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 21' ' ' ILE . 11.5 mm -63.84 -16.19 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -0.946 . . . . 0.0 110.06 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.505 ' NH1' ' HG2' ' A' ' 22' ' ' ARG . 3.0 mmt-85 -90.35 -35.76 15.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 110.02 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -36.87 84.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -85.25 -48.41 9.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.483 -0.761 . . . . 0.0 109.501 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 28.3 m-85 -112.56 59.44 0.59 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.278 -0.889 . . . . 0.0 110.526 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.478 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 43.8 Cg_endo -68.86 -32.45 22.63 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.797 1.42 . . . . 0.0 110.369 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -102.95 20.56 17.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.34 -0.85 . . . . 0.0 110.088 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.479 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 1.9 mpp_? -122.44 -176.14 3.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.106 -0.996 . . . . 0.0 110.492 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.68 HG12 HG12 ' A' ' 31' ' ' VAL . 12.3 t -147.76 114.05 4.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.385 -0.822 . . . . 0.0 110.081 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 51.3 Cg_endo -78.1 87.08 1.56 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 124.166 1.614 . . . . 0.0 110.055 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.728 HG12 ' CD2' ' A' ' 105' ' ' LEU . 1.6 m -83.17 151.72 3.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.171 -0.955 . . . . 0.0 110.892 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 30.8 mm -105.96 160.41 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 108.714 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.708 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.5 t -134.2 141.05 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.801 -1.187 . . . . 0.0 111.404 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 7.0 tt0 -156.23 175.38 14.06 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.605 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -103.7 160.39 14.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.931 -1.106 . . . . 0.0 110.528 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.978 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -62.7 -174.47 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.781 . . . . 0.0 109.095 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.978 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.7 Cg_endo -70.52 103.7 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.418 1.22 . . . . 0.0 110.025 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 5.7 mttt 63.61 40.16 8.23 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.859 . . . . 0.0 110.076 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . . . -61.99 179.49 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.201 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.485 ' HG2' ' OD2' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -150.22 35.45 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.0 110.532 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.503 HG12 HG23 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -84.74 179.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.991 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 68' ' ' ILE . . . -57.26 -179.75 0.69 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -167.53 0.19 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.382 -1.069 . . . . 0.0 110.271 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.056 HD13 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.35 147.51 38.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 110.729 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.797 ' N ' HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -87.32 -42.84 12.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.154 -0.966 . . . . 0.0 110.324 -179.421 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -152.15 159.57 43.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.755 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -116.99 39.85 3.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.113 -0.992 . . . . 0.0 110.463 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 9.7 pttt -162.01 107.34 1.25 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.289 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.717 ' CD2' HD13 ' A' ' 63' ' ' LEU . 11.4 m-85 -108.01 142.43 38.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -0.991 . . . . 0.0 110.125 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mp -116.0 103.22 10.37 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.822 ' HB ' HD12 ' A' ' 55' ' ' LEU . 3.0 m -129.78 162.75 51.53 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 111.098 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 43.5 Cg_endo -68.26 146.47 69.61 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.167 1.614 . . . . 0.0 110.451 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.556 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -63.65 -11.1 22.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 111.598 -178.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.68 -7.91 59.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.902 -1.124 . . . . 0.0 110.675 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.919 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.1 mt -62.43 141.39 58.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.127 -0.983 . . . . 0.0 111.157 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -91.17 158.52 16.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.671 -0.643 . . . . 0.0 109.48 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 79.4 t -57.29 -24.27 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.101 -0.999 . . . . 0.0 109.693 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.56 -34.8 67.61 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.919 ' CB ' HD22 ' A' ' 55' ' ' LEU . 17.8 mm-40 -67.89 -50.72 54.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -1.134 . . . . 0.0 109.336 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.192 ' CE2' HD11 ' A' ' 64' ' ' ILE . 6.2 t80 -60.21 -35.32 75.15 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.153 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.597 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -53.29 -34.8 58.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 110.028 178.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -51.12 9.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.358 -0.839 . . . . 0.0 112.705 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.159 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.37 -39.19 78.94 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.489 -1.382 . . . . 0.0 112.077 -177.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.192 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -77.49 -41.73 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 119.862 -1.774 . . . . 0.0 108.323 178.214 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.659 ' HG2' HD22 ' A' ' 76' ' ' LEU . 9.2 mtp180 -43.25 -52.27 5.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.413 -0.805 . . . . 0.0 109.983 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -35.73 81.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.538 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 8.9 mmt85 -70.29 -15.81 62.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.575 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.607 HD11 ' CD2' ' A' ' 109' ' ' TYR . 30.6 mt -89.39 -1.17 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.4 -0.813 . . . . 0.0 109.352 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 69' ' ' HIS . 18.1 t60 56.33 31.11 18.01 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.412 -0.805 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.942 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -96.9 153.04 18.13 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.983 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.5 ptp180 -166.94 -168.71 1.15 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.015 -1.053 . . . . 0.0 110.872 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 53.74 -87.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.835 . . . . 0.0 110.855 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 71' ' ' ARG . 35.4 mt-10 -153.93 33.25 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.659 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.526 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -61.56 177.1 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.091 -1.006 . . . . 0.0 109.921 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 111' ' ' ASP . . . -105.42 140.46 38.5 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.167 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.711 HD21 ' CE2' ' A' ' 78' ' ' PHE . 18.7 tp -149.78 152.81 35.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.179 -0.951 . . . . 0.0 110.474 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 73.3 m-85 -161.82 120.73 2.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.772 -0.58 . . . . 0.0 109.649 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' HD21 ' A' ' 76' ' ' LEU . 63.0 m-85 -93.22 123.22 36.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.064 -1.023 . . . . 0.0 110.106 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 66.8 m-85 -113.88 132.04 56.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.993 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.689 HG22 HG23 ' A' ' 107' ' ' ILE . 2.6 t -121.04 113.12 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.326 -0.859 . . . . 0.0 110.156 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.887 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.2 t-20 59.19 51.4 6.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 110.283 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 16.9 m-20 56.44 31.21 18.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.318 -0.863 . . . . 0.0 110.487 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.5 t -130.74 167.3 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.202 -0.936 . . . . 0.0 109.904 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -154.98 67.84 5.33 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.557 -0.715 . . . . 0.0 109.478 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.58 170.18 20.59 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.052 1.554 . . . . 0.0 110.707 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.99 -179.02 3.52 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.078 1.567 . . . . 0.0 110.416 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.524 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -87.34 25.46 1.4 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.36 -0.838 . . . . 0.0 110.701 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.21 41.84 1.11 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.408 -0.807 . . . . 0.0 109.768 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.4 -175.53 4.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 110.461 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 62.8 p -139.44 139.65 37.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.631 -0.668 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.063 ' HA ' HD23 ' A' ' 94' ' ' LEU . 4.5 mmt -49.26 -38.62 27.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.165 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -52.31 -48.99 52.75 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 3.9 pt20 -64.63 -29.41 70.41 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.634 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.063 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.33 -24.86 64.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.59 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -49.63 -56.17 11.03 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.977 -1.077 . . . . 0.0 109.773 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.62 -17.62 63.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.754 -1.216 . . . . 0.0 111.093 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -88.47 -68.42 0.77 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.142 -0.974 . . . . 0.0 113.402 -177.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 81' ' ' ASN . 18.1 m-70 -100.16 40.71 1.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.726 -1.234 . . . . 0.0 112.771 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.568 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.9 p80 -77.12 -20.09 56.09 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.051 -1.031 . . . . 0.0 109.657 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 99' ' ' HIS . 0.6 OUTLIER 75.36 -76.37 0.06 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.095 0.474 . . . . 0.0 110.344 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.97 -92.2 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 110.332 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.541 ' C ' ' CG ' ' A' ' 103' ' ' PHE . 9.7 t0 -169.98 50.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.235 -0.915 . . . . 0.0 110.267 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.549 ' HB2' ' CD1' ' A' ' 104' ' ' PHE . 18.1 m-85 -151.81 -68.49 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 110.078 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 104' ' ' PHE . 4.3 m-85 -120.0 172.46 7.72 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 109.812 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.075 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -109.16 165.4 11.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.091 -1.006 . . . . 0.0 109.608 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.768 ' N ' HD12 ' A' ' 105' ' ' LEU . 57.9 m-85 -122.06 129.49 52.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.823 -1.173 . . . . 0.0 112.173 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.075 ' CG1' HD11 ' A' ' 105' ' ' LEU . 4.5 mt -141.4 153.36 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.502 -0.749 . . . . 0.0 109.475 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -150.42 178.45 9.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 110.326 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.708 ' HE1' HG13 ' A' ' 33' ' ' VAL . 6.3 p90 -147.14 164.59 32.63 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.256 -0.977 . . . . 0.0 111.075 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.622 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -157.7 170.02 23.34 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.761 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' ALA . 11.7 p30 -121.06 19.5 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 110.593 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.466 ' OE2' ' HB2' ' A' ' 77' ' ' PHE . 1.1 pm0 -43.11 149.21 0.23 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.17 -0.956 . . . . 0.0 110.03 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 65.6 m -135.8 35.6 2.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.89 161.41 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.0 110.195 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -77.68 175.65 9.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.162 -0.961 . . . . 0.0 110.2 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 51.8 -160.85 2.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.227 -1.161 . . . . 0.0 110.273 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -47.29 -47.96 25.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -1.076 . . . . 0.0 110.189 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -71.61 -27.98 63.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 110.293 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.506 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.3 mp -70.7 -22.41 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 109.982 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 22' ' ' ARG . 3.8 tpt180 -83.86 -40.95 18.0 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.92 -1.113 . . . . 0.0 109.277 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -62.34 -42.99 99.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 110.107 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.63 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 18.2 ptmt -85.73 -33.68 21.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 111.092 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.63 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 28.5 m-85 -112.45 69.79 1.04 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.523 -1.36 . . . . 0.0 109.872 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 43.9 Cg_endo -70.31 -0.78 7.88 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.796 1.419 . . . . 0.0 110.845 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.86 21.07 12.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.102 -0.999 . . . . 0.0 110.513 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -96.02 175.07 6.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.966 -1.084 . . . . 0.0 110.642 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.648 HG12 HG12 ' A' ' 31' ' ' VAL . 33.0 t -142.58 104.05 5.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.454 -0.779 . . . . 0.0 109.892 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.587 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 49.5 Cg_endo -76.9 90.75 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.138 1.599 . . . . 0.0 110.295 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.722 HG12 ' CD2' ' A' ' 105' ' ' LEU . 1.3 m -88.57 153.19 3.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.229 -0.92 . . . . 0.0 110.721 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.607 HD11 ' CD1' ' A' ' 104' ' ' PHE . 1.4 mp -103.04 165.12 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 108.772 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.803 HG21 ' CE1' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -139.4 133.82 39.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.048 -1.032 . . . . 0.0 110.877 -179.25 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -151.84 163.69 38.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.722 -0.611 . . . . 0.0 109.616 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.561 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -96.8 158.86 15.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 110.627 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.024 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.22 -174.28 0.12 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.722 . . . . 0.0 109.41 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.024 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.2 Cg_endo -70.33 107.5 1.98 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.486 1.256 . . . . 0.0 109.753 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 4.1 mtpt 64.14 42.72 5.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.375 -0.828 . . . . 0.0 109.944 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.485 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -64.39 179.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 110.267 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.497 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.6 OUTLIER -150.32 33.85 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.947 . . . . 0.0 110.425 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.781 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.7 pp -85.33 178.17 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.046 -1.034 . . . . 0.0 110.644 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.781 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -50.46 -172.73 0.01 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -80.34 179.38 7.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.356 -1.085 . . . . 0.0 110.002 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.4 pp -135.04 134.14 40.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 110.614 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . 15.4 t0 -86.43 -36.97 18.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.076 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.55 160.27 43.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 109.954 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -118.41 39.91 3.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.114 -0.992 . . . . 0.0 110.215 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' CG ' ' C ' ' A' ' 47' ' ' LYS . 6.2 mtmm -156.7 109.01 2.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.471 -0.768 . . . . 0.0 109.28 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.803 ' CE1' HG21 ' A' ' 33' ' ' VAL . 22.9 m-85 -103.63 141.89 35.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.902 -1.124 . . . . 0.0 110.808 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tp -105.44 104.81 14.61 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.472 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 16.6 m -131.76 144.23 52.4 Favored Pre-proline 0 C--N 1.3 -1.554 0 O-C-N 121.112 -0.993 . . . . 0.0 110.622 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 55' ' ' LEU . 41.5 Cg_endo -66.99 143.86 67.69 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.983 1.518 . . . . 0.0 110.053 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.566 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.7 m -61.47 -14.25 27.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.399 -0.813 . . . . 0.0 111.615 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -83.7 -15.31 49.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.082 -1.011 . . . . 0.0 111.053 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.867 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.9 mt -62.21 144.84 54.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.054 -1.028 . . . . 0.0 111.301 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.2 p -90.74 165.91 13.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.51 -0.744 . . . . 0.0 109.621 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.972 HG12 HG22 ' A' ' 87' ' ' THR . 46.5 t -60.33 -26.42 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 110.153 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.71 -41.33 93.86 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.867 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.6 mt-30 -67.64 -49.7 61.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.076 -1.25 . . . . 0.0 110.203 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.139 ' CE2' HD11 ' A' ' 64' ' ' ILE . 43.0 t80 -60.59 -33.9 73.41 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.724 -1.191 . . . . 0.0 109.502 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.665 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -63.43 -28.02 69.69 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.923 -1.11 . . . . 0.0 109.738 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -70.26 -53.52 16.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.295 -0.878 . . . . 0.0 110.281 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.992 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -59.54 -37.13 77.58 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 118.92 -1.112 . . . . 0.0 112.341 -178.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.139 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -70.45 -35.28 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 119.835 -1.791 . . . . 0.0 109.025 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.865 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -37.38 -63.41 0.45 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.72 -0.613 . . . . 0.0 110.774 -179.632 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -30.93 71.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.19 -0.944 . . . . 0.0 110.192 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.531 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 8.0 mmp_? -67.72 -17.81 64.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 109.945 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.89 ' CG2' HD23 ' A' ' 70' ' ' LEU . 36.5 mt -103.55 15.32 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.386 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.563 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 46.24 30.66 1.04 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.564 -0.71 . . . . 0.0 110.263 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.89 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.1 pp -108.83 155.24 21.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.413 -0.805 . . . . 0.0 109.84 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 73' ' ' GLU . 4.9 ptp180 -166.17 -168.73 1.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.657 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 47.99 -92.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.392 -0.817 . . . . 0.0 110.768 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 4.9 pt-20 -146.25 44.43 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.976 -1.078 . . . . 0.0 110.969 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -67.58 176.68 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.955 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -100.88 140.54 35.03 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.008 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.928 HD21 ' CE1' ' A' ' 78' ' ' PHE . 26.1 tp -164.24 152.68 12.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.982 . . . . 0.0 110.755 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 97.4 m-85 -158.52 119.7 3.42 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.706 -0.621 . . . . 0.0 109.666 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.928 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.5 m-30 -85.6 132.49 34.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.075 -1.015 . . . . 0.0 111.8 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 64.6 m-85 -120.29 120.42 35.99 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.771 HG22 HG23 ' A' ' 107' ' ' ILE . 2.1 t -120.97 125.95 74.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.422 -0.799 . . . . 0.0 109.839 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.769 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.3 OUTLIER 47.15 46.49 16.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.207 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 26.8 m120 58.11 37.07 26.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.288 -0.882 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -135.91 167.6 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.154 -0.966 . . . . 0.0 110.15 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.83 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -155.19 70.05 5.58 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.492 -0.755 . . . . 0.0 109.552 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.83 163.58 36.74 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.009 1.531 . . . . 0.0 110.735 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.3 -178.63 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.214 1.639 . . . . 0.0 110.622 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.972 HG22 HG12 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -86.7 20.48 2.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.309 -0.869 . . . . 0.0 110.681 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.1 m -91.51 39.2 1.0 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.47 -0.769 . . . . 0.0 109.641 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.697 ' HB1' ' OE1' ' A' ' 93' ' ' GLN . . . -145.51 -171.97 3.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.535 -0.728 . . . . 0.0 110.243 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 73.0 p -139.55 143.08 37.21 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.626 -0.671 . . . . 0.0 110.116 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.053 ' HA ' HD23 ' A' ' 94' ' ' LEU . 51.0 mmm -46.23 -46.35 17.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.806 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.566 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -47.97 -48.77 24.63 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.635 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.697 ' OE1' ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -64.39 -31.81 73.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.108 -1.23 . . . . 0.0 110.155 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.053 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.59 -22.27 64.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.114 -0.991 . . . . 0.0 110.198 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.579 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -49.27 -55.48 12.54 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.938 -1.101 . . . . 0.0 109.874 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -70.43 -16.89 62.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.034 -1.041 . . . . 0.0 111.34 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -87.35 -64.78 1.1 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.106 -0.996 . . . . 0.0 112.924 -177.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.72 ' CD2' ' HB2' ' A' ' 81' ' ' ASN . 30.8 m170 -98.24 37.37 1.45 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.816 -1.178 . . . . 0.0 112.103 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -71.98 169.21 16.41 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.396 -0.815 . . . . 0.0 109.694 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.556 ' OE1' ' CD1' ' A' ' 106' ' ' TYR . 0.8 OUTLIER -153.7 34.09 0.45 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.764 -1.21 . . . . 0.0 110.502 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.534 ' HG2' ' N ' ' A' ' 102' ' ' ASP . 20.6 tt0 175.28 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.534 ' N ' ' HG2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -155.94 -39.94 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 109.704 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.525 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 3.7 p90 -144.32 44.22 1.42 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.423 -0.798 . . . . 0.0 109.672 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.607 ' CD1' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -153.02 130.43 11.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.461 -0.774 . . . . 0.0 110.022 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.058 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.3 166.71 11.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.866 -1.146 . . . . 0.0 109.693 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.726 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -124.46 131.61 53.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.959 -1.088 . . . . 0.0 111.503 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.058 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.6 mt -138.64 143.4 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.195 -0.94 . . . . 0.0 110.119 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.73 176.06 9.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.227 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.0 OUTLIER -149.93 164.23 35.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.798 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.3 t -152.44 -178.1 6.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.693 -0.629 . . . . 0.0 109.941 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 112' ' ' GLU . 57.3 p-10 -95.14 -13.86 24.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.885 . . . . 0.0 110.22 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.501 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -172.85 150.49 2.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 110.257 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 p -103.79 32.25 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.449 HG22 ' N ' ' A' ' 115' ' ' TYR . 9.8 p -99.1 172.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.449 ' N ' HG22 ' A' ' 114' ' ' VAL . 14.2 t80 -120.29 155.84 32.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.344 -0.848 . . . . 0.0 110.281 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.68 -151.31 27.39 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.262 -1.14 . . . . 0.0 110.213 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -63.33 -53.46 52.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -1.163 . . . . 0.0 109.615 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -75.34 -26.7 58.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 110.086 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.507 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.1 mp -67.62 -14.22 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 109.906 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.429 ' C ' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -80.8 -49.47 11.07 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.914 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.16 -43.77 82.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.938 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 2.6 mtmt -76.41 -42.02 45.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.642 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 38.1 m-85 -115.01 63.31 1.54 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.461 -0.775 . . . . 0.0 110.693 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 47.0 Cg_endo -72.64 -3.4 13.43 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.858 1.451 . . . . 0.0 110.343 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -100.83 -6.24 25.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 110.436 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -84.37 -161.97 0.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.148 -0.97 . . . . 0.0 110.184 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.517 HG21 ' HA2' ' A' ' 92' ' ' GLY . 15.6 t -146.99 103.82 3.85 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 49.5 Cg_endo -74.51 106.63 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.382 1.727 . . . . 0.0 109.829 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.792 HG13 HD21 ' A' ' 105' ' ' LEU . 38.2 t -105.44 133.59 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.997 . . . . 0.0 110.718 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.858 HD11 ' CD1' ' A' ' 104' ' ' PHE . 44.3 mm -91.63 154.54 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.843 . . . . 0.0 109.025 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.704 HG21 ' CE1' ' A' ' 49' ' ' TYR . 2.7 t -132.13 144.46 37.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.939 -1.1 . . . . 0.0 111.498 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 7.4 mp0 -156.85 -179.65 8.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -110.7 160.79 16.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.729 -1.232 . . . . 0.0 110.581 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.012 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.91 -175.12 0.16 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.438 -0.789 . . . . 0.0 109.307 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.012 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.4 Cg_endo -71.44 106.11 1.88 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.532 1.28 . . . . 0.0 109.769 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 61.69 40.74 12.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.352 -0.843 . . . . 0.0 110.117 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . . . -60.97 -179.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.477 ' HG2' ' OD1' ' A' ' 111' ' ' ASP . 6.6 ptm180 -150.39 33.59 0.64 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 110.533 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.632 HG22 ' HB3' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -85.54 -175.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.04 . . . . 0.0 110.62 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -55.42 179.73 0.32 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -70.96 -172.92 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -1.147 . . . . 0.0 110.055 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' C ' HD12 ' A' ' 44' ' ' LEU . 1.2 pp -135.19 134.15 39.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 110.63 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -40.23 15.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HD3' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -152.85 164.76 37.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.299 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.77 38.22 4.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.106 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.59 105.04 1.82 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 0.0 109.952 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.901 ' CD2' HD13 ' A' ' 63' ' ' LEU . 45.3 m-85 -103.92 146.47 28.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 110.64 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.474 HD21 HG21 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -114.71 95.4 5.22 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.961 ' HB ' HD12 ' A' ' 55' ' ' LEU . 13.5 m -119.83 152.66 54.09 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.14 -0.975 . . . . 0.0 110.714 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.474 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.1 Cg_endo -71.23 149.48 57.67 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.097 1.577 . . . . 0.0 110.078 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.519 ' HB3' ' HA3' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -63.73 -13.94 47.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.325 -0.859 . . . . 0.0 111.397 -178.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.55 -10.71 53.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.908 -1.12 . . . . 0.0 111.11 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.961 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.6 mt -62.14 141.89 57.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.867 -1.145 . . . . 0.0 111.335 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 p -91.59 163.14 14.23 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.637 -0.665 . . . . 0.0 109.449 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.992 HG12 HG22 ' A' ' 87' ' ' THR . 78.9 t -58.96 -22.56 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.023 -1.048 . . . . 0.0 110.056 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.73 -40.06 65.72 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.898 ' CB ' HD22 ' A' ' 55' ' ' LEU . 5.0 mm100 -67.87 -47.81 67.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.149 -1.206 . . . . 0.0 109.893 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.149 ' CE2' HD11 ' A' ' 64' ' ' ILE . 19.5 t80 -60.38 -46.39 90.13 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.146 -0.971 . . . . 0.0 109.647 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -50.35 -22.68 1.93 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.016 -1.053 . . . . 0.0 110.021 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -80.86 -54.5 5.54 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.566 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.03 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.9 pp -59.84 -19.1 48.98 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.909 -1.12 . . . . 0.0 112.287 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.149 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.4 mt -91.57 -42.98 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.113 -1.617 . . . . 0.0 108.863 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.586 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.7 OUTLIER -36.91 -58.5 0.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.145 0.498 . . . . 0.0 110.696 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.87 -31.91 71.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 110.052 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 2.6 mmp_? -74.75 -7.5 53.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.86 . . . . 0.0 110.546 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.579 ' CD1' HG22 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -99.18 -8.74 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 0.0 109.546 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.469 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER 67.74 29.41 6.86 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.484 -0.76 . . . . 0.0 110.087 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -88.7 160.86 17.14 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.917 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -164.92 -166.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.004 -1.06 . . . . 0.0 110.724 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 42.9 -96.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.804 . . . . 0.0 110.559 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' ASP . 3.9 pt-20 -151.13 28.46 0.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.935 -1.103 . . . . 0.0 110.721 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.524 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -47.79 176.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.203 1.002 . . . . 0.0 110.029 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -115.0 142.16 47.01 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.778 HD21 ' CE1' ' A' ' 78' ' ' PHE . 13.6 tp -148.97 151.63 34.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.309 -0.87 . . . . 0.0 110.466 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 90.4 m-85 -158.2 122.88 4.24 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.793 -0.567 . . . . 0.0 109.866 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.821 ' CE2' HD12 ' A' ' 64' ' ' ILE . 18.0 m-30 -85.17 120.2 26.4 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.155 -0.966 . . . . 0.0 111.785 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.476 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 59.9 m-85 -106.98 122.1 45.76 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.515 -0.74 . . . . 0.0 109.06 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.939 HG22 HG23 ' A' ' 107' ' ' ILE . 2.2 t -121.3 126.29 74.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.421 -0.8 . . . . 0.0 109.934 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 57.9 t30 51.32 34.29 11.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 0.0 110.038 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 1.3 t-20 69.31 34.95 2.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.433 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.689 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -134.97 166.81 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.9 . . . . 0.0 109.892 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.822 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.95 70.67 5.78 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 0.0 109.609 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.96 165.35 33.03 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.048 1.551 . . . . 0.0 110.582 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.92 -178.96 3.83 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.062 1.559 . . . . 0.0 110.376 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.992 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -85.96 19.59 2.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 0.0 110.825 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -91.07 40.46 1.03 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.488 -0.758 . . . . 0.0 109.355 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.61 -172.88 3.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.517 -0.739 . . . . 0.0 110.262 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 59.1 p -139.27 149.8 44.71 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.66 -0.65 . . . . 0.0 110.28 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.045 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -59.23 -40.6 86.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 110.005 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.519 ' HA3' ' HB3' ' A' ' 53' ' ' SER . . . -51.26 -46.49 51.61 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.7 OUTLIER -66.97 -28.85 68.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.238 -1.154 . . . . 0.0 109.715 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.045 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.97 -22.22 64.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.198 -0.939 . . . . 0.0 109.862 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.576 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -48.95 -53.78 18.31 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.884 -1.135 . . . . 0.0 109.505 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.08 -19.16 63.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.049 -1.032 . . . . 0.0 111.455 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.65 -59.12 2.32 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -177.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.54 ' ND1' HG11 ' A' ' 80' ' ' VAL . 16.7 m170 -98.65 40.12 1.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.648 -1.283 . . . . 0.0 113.09 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.639 ' C ' ' CD2' ' A' ' 99' ' ' HIS . 3.5 p-80 -106.09 178.55 4.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.468 ' N ' ' HD2' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -132.11 -54.73 0.98 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.771 -1.206 . . . . 0.0 110.336 179.407 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -177.88 56.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.073 -1.017 . . . . 0.0 110.23 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 101' ' ' GLU . 57.4 p-10 -178.6 -144.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 110.111 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' O ' ' HG2' ' A' ' 30' ' ' PRO . 4.5 p90 -118.53 48.68 1.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.905 . . . . 0.0 110.015 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.858 ' CD1' HD11 ' A' ' 32' ' ' ILE . 1.1 m-85 -156.86 134.7 10.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.289 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.065 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -107.4 169.96 8.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.959 -1.088 . . . . 0.0 109.248 179.523 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.697 ' N ' HD12 ' A' ' 105' ' ' LEU . 6.5 p90 -121.75 128.83 52.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.532 -1.355 . . . . 0.0 111.981 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.065 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.9 mt -141.07 141.04 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.311 -0.868 . . . . 0.0 110.184 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -136.29 166.72 22.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.966 -1.084 . . . . 0.0 109.773 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.722 ' HB2' HD11 ' A' ' 76' ' ' LEU . 2.9 p90 -134.26 163.86 28.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.747 -1.221 . . . . 0.0 111.518 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -158.52 177.1 11.6 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.248 0.547 . . . . 0.0 110.02 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.632 ' HB3' HG22 ' A' ' 41' ' ' ILE . 32.9 p30 -130.88 28.67 4.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 110.145 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER 178.23 137.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 110.377 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 114' ' ' VAL . 47.1 t -136.6 33.88 2.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 115' ' ' TYR . 9.3 p -47.32 175.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.538 ' H ' HG22 ' A' ' 114' ' ' VAL . 0.9 OUTLIER -57.27 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.16 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 114' ' ' VAL . . . -101.69 -134.91 8.63 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.254 -1.144 . . . . 0.0 110.256 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.04 -35.38 4.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.244 . . . . 0.0 109.875 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -80.37 -41.05 25.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.855 . . . . 0.0 110.533 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 9.8 mm -59.53 -15.1 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.027 -1.046 . . . . 0.0 110.344 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' NH1' ' OH ' ' A' ' 95' ' ' TYR . 11.8 mmt85 -91.43 -53.55 4.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.884 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -47.99 -39.32 19.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.127 -0.983 . . . . 0.0 108.996 179.137 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 9.9 mttt -85.89 -48.88 8.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.525 -0.735 . . . . 0.0 110.192 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 37.4 m-85 -115.18 63.33 1.67 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.164 -0.96 . . . . 0.0 110.785 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 47.6 Cg_endo -72.76 -4.59 15.63 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.813 1.428 . . . . 0.0 110.438 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 11.2 t70 -118.01 16.18 14.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 110.273 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.451 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 10.5 mpt_? -109.58 -164.1 0.91 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.942 . . . . 0.0 110.244 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.716 HG12 HG12 ' A' ' 31' ' ' VAL . 16.3 t -144.99 108.99 4.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.947 . . . . 0.0 110.417 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.524 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.8 Cg_endo -77.83 91.16 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.186 1.624 . . . . 0.0 110.093 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.716 HG12 HG12 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -86.63 129.87 37.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.235 -0.916 . . . . 0.0 111.041 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 39.7 mm -91.71 136.06 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.09 -1.006 . . . . 0.0 108.502 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.757 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -119.94 146.44 24.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.864 -1.147 . . . . 0.0 111.304 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 0.1 OUTLIER -156.24 -164.44 1.68 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -122.1 158.84 28.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 0.0 110.605 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.974 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -61.49 -173.42 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.515 -0.74 . . . . 0.0 109.031 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.974 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.0 Cg_endo -69.62 106.71 1.68 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.372 1.196 . . . . 0.0 109.864 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 3.7 mmtt 64.69 41.43 5.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.426 -0.796 . . . . 0.0 110.274 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.535 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -60.07 -177.71 0.07 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.256 -0.902 . . . . 0.0 109.972 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.514 ' CG ' ' OD1' ' A' ' 111' ' ' ASP . 5.6 ptm180 -150.22 31.84 0.67 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 0.0 110.745 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.83 HD13 HG23 ' A' ' 68' ' ' ILE . 1.8 pp -85.53 177.12 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.083 -1.01 . . . . 0.0 110.351 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.83 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -49.04 -176.76 0.01 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.902 ' O ' HD22 ' A' ' 44' ' ' LEU . 7.8 t0 -75.17 -174.69 2.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.245 . . . . 0.0 109.871 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.902 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -135.66 135.66 40.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 0.0 110.371 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -86.67 -41.23 14.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.808 . . . . 0.0 109.988 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.81 154.32 34.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 110.039 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.757 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -113.44 44.94 1.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.04 -1.038 . . . . 0.0 110.004 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -161.85 112.84 1.65 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 110.043 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.737 ' HD2' HD13 ' A' ' 63' ' ' LEU . 8.5 m-85 -111.32 137.57 48.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 109.991 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.92 87.12 3.64 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.609 ' HB ' HD12 ' A' ' 55' ' ' LEU . 12.7 m -107.89 148.36 37.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 110.96 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HD2' HD12 ' A' ' 55' ' ' LEU . 47.7 Cg_endo -72.88 147.36 43.93 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.156 1.608 . . . . 0.0 109.688 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.562 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -62.2 -15.8 49.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.925 . . . . 0.0 111.459 -178.699 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -83.69 -14.23 52.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.115 -0.99 . . . . 0.0 111.18 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.793 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.7 mt -61.87 144.14 55.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.931 -1.106 . . . . 0.0 111.276 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 6.8 p -90.83 164.51 14.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 60.4 t -62.08 -27.34 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.043 -1.035 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.64 -36.66 88.24 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.793 ' CB ' HD22 ' A' ' 55' ' ' LEU . 8.5 mm-40 -70.17 -47.79 60.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.148 -1.207 . . . . 0.0 109.791 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.025 ' CE2' HD11 ' A' ' 64' ' ' ILE . 37.5 t80 -59.98 -32.75 71.13 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.144 -1.022 . . . . 0.0 108.942 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.557 ' HE1' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.03 -32.21 70.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 109.827 178.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 5.3 t80 -72.8 -51.8 17.51 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.417 -0.802 . . . . 0.0 111.078 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.985 HD11 ' CD1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -59.9 -35.65 75.32 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 118.571 -1.252 . . . . 0.0 112.589 -178.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.025 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -80.47 -29.08 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 119.663 -1.898 . . . . 0.0 109.629 178.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -41.11 -62.11 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.346 -0.846 . . . . 0.0 110.353 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -27.43 68.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.805 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.527 ' C ' HD13 ' A' ' 68' ' ' ILE . 8.8 mmp_? -70.26 -16.15 63.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.895 . . . . 0.0 109.8 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.83 HG23 HD13 ' A' ' 41' ' ' ILE . 2.9 mm -100.93 11.49 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.751 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.503 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 54.01 30.98 12.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.298 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.776 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.2 pp -115.23 156.49 25.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -0.804 . . . . 0.0 109.792 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.73 -169.34 1.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.0 110.945 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.27 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.454 -0.779 . . . . 0.0 110.735 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' ARG . 5.2 pt-20 -151.37 32.52 0.58 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.08 -1.013 . . . . 0.0 111.076 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -55.25 177.0 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.037 -1.039 . . . . 0.0 109.827 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.522 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -98.36 139.49 34.04 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.167 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.573 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 13.2 tp -164.34 153.23 13.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.352 -0.843 . . . . 0.0 110.391 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 89.4 m-85 -157.55 123.89 4.86 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.562 -0.711 . . . . 0.0 109.784 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.938 ' CZ ' HD12 ' A' ' 64' ' ' ILE . 11.8 m-85 -89.16 124.45 34.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.357 -0.839 . . . . 0.0 111.033 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 53.3 m-85 -119.91 121.65 39.48 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.731 HG22 HG23 ' A' ' 107' ' ' ILE . 2.4 t -120.78 112.72 37.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.358 -0.839 . . . . 0.0 109.742 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.727 ' CB ' ' CD2' ' A' ' 98' ' ' HIS . 3.1 t-20 63.67 34.57 12.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.824 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 19.9 t-20 69.18 35.03 2.82 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.326 -0.859 . . . . 0.0 110.271 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.674 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.3 t -135.04 168.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.209 -0.932 . . . . 0.0 110.127 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.808 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.0 77.27 5.07 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.7 . . . . 0.0 109.132 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.69 155.87 53.85 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.079 1.568 . . . . 0.0 110.879 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.47 -177.56 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.195 1.629 . . . . 0.0 110.292 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.53 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 1.1 p -82.23 16.46 2.0 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.305 -0.872 . . . . 0.0 110.948 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.43 41.56 1.12 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.534 -0.728 . . . . 0.0 109.519 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.52 -176.53 5.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.523 -0.736 . . . . 0.0 110.165 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 80.6 p -139.75 141.31 36.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 110.335 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.047 ' HA ' HD23 ' A' ' 94' ' ' LEU . 2.2 mmt -49.99 -42.78 49.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 110.014 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -48.59 -47.59 29.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 90' ' ' THR . 2.2 pt20 -64.63 -31.98 73.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -1.147 . . . . 0.0 109.814 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.118 HD11 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -67.61 -22.47 65.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.15 -0.969 . . . . 0.0 110.096 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.524 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -49.64 -55.76 12.51 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 120.881 -1.137 . . . . 0.0 109.692 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.429 ' O ' ' NE2' ' A' ' 99' ' ' HIS . 7.6 mt-30 -69.47 -17.22 63.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.963 -1.085 . . . . 0.0 111.294 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 1.8 mm-40 -87.44 -65.25 1.03 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.997 -1.065 . . . . 0.0 112.445 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.727 ' CD2' ' CB ' ' A' ' 81' ' ' ASN . 30.9 m170 -98.63 37.94 1.42 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.86 -1.15 . . . . 0.0 111.808 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.546 ' O ' ' CE2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -71.35 171.56 10.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.504 -0.747 . . . . 0.0 109.673 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.583 ' HB2' ' CD2' ' A' ' 106' ' ' TYR . 27.4 tt0 -138.29 147.79 43.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.89 -1.131 . . . . 0.0 109.93 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 100' ' ' GLU . 4.4 tt0 -41.03 -49.72 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 110.414 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.563 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 24.0 m-20 -49.26 -64.21 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.563 ' CG ' ' O ' ' A' ' 102' ' ' ASP . 0.2 OUTLIER 168.24 -71.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 110.174 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 104' ' ' PHE . 4.5 m-30 -53.15 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.336 -0.852 . . . . 0.0 110.372 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.118 HD22 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -108.19 169.53 8.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.283 -0.885 . . . . 0.0 109.272 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.683 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -114.5 130.75 56.76 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.615 -1.303 . . . . 0.0 111.493 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.05 ' CG1' HD11 ' A' ' 105' ' ' LEU . 10.1 mt -141.97 122.65 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 110.236 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.75 153.21 44.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.988 -1.07 . . . . 0.0 109.51 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.684 ' OH ' HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -130.36 167.51 18.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.648 -1.282 . . . . 0.0 111.116 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -152.44 -178.39 6.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.674 -0.641 . . . . 0.0 110.086 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.514 ' OD1' ' CG ' ' A' ' 40' ' ' ARG . 2.1 m-20 -81.32 -29.58 34.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.26 -0.9 . . . . 0.0 110.249 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.559 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -178.53 166.75 1.8 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.318 -0.864 . . . . 0.0 110.382 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.26 13.9 7.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.184 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 115' ' ' TYR . 9.7 p -115.3 173.07 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.234 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.467 ' N ' HG22 ' A' ' 114' ' ' VAL . 18.1 t80 -64.43 129.4 39.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.2 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -172.84 165.61 38.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.268 -1.137 . . . . 0.0 110.218 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 21' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -58.81 -36.22 74.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -1.112 . . . . 0.0 110.026 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -74.35 -19.72 60.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 1.6 mp -72.06 -19.33 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.953 . . . . 0.0 110.28 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.566 ' CD ' ' N ' ' A' ' 22' ' ' ARG . 3.8 mpt_? -84.83 -20.51 30.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.779 -1.201 . . . . 0.0 110.374 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -80.35 -48.84 12.36 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.177 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.621 ' HG3' ' CE2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -86.32 -27.74 24.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 111.867 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.621 ' CE2' ' HG3' ' A' ' 24' ' ' LYS . 35.0 m-85 -116.18 64.2 2.63 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.308 -1.495 . . . . 0.0 110.524 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 48.8 Cg_endo -73.58 -0.09 8.84 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.806 1.424 . . . . 0.0 110.489 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.49 0.4 20.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -0.976 . . . . 0.0 110.675 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 28' ' ' ARG . 2.5 mpt_? -90.93 -173.78 3.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.058 -1.026 . . . . 0.0 110.1 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 HG12 ' A' ' 31' ' ' VAL . 34.9 t -147.46 104.28 3.74 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 44.2 Cg_endo -72.97 87.41 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.026 1.54 . . . . 0.0 110.259 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.74 HG12 HG12 ' A' ' 29' ' ' VAL . 1.3 m -84.52 139.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.178 -0.952 . . . . 0.0 111.056 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 45.8 mm -94.57 158.57 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 108.89 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.801 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.5 t -133.95 134.77 55.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.886 -1.134 . . . . 0.0 111.273 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.3 tt0 -148.54 168.79 21.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.295 0.569 . . . . 0.0 109.538 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.63 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -100.51 156.26 17.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.043 -1.036 . . . . 0.0 110.562 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.034 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.52 -172.9 0.1 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.519 -0.738 . . . . 0.0 109.244 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.034 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.5 Cg_endo -72.63 107.83 2.4 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.441 1.232 . . . . 0.0 109.922 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.89 42.13 8.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 110.251 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.19 -177.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.905 . . . . 0.0 110.016 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.485 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.2 35.74 0.66 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.12 -0.987 . . . . 0.0 110.588 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -84.64 179.45 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.092 -1.005 . . . . 0.0 110.049 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -62.16 179.55 4.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.953 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.1 t70 -70.73 -176.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -1.073 . . . . 0.0 109.988 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.953 HD22 ' O ' ' A' ' 43' ' ' ASP . 2.0 mm? -135.67 134.09 38.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.159 -0.963 . . . . 0.0 110.588 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -86.27 -27.0 24.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 109.587 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.51 ' CD ' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -158.04 150.08 21.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.517 -0.74 . . . . 0.0 109.679 179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -116.66 45.31 1.85 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.833 -1.167 . . . . 0.0 110.025 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 108.89 1.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 109.53 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.865 ' CD2' HD13 ' A' ' 63' ' ' LEU . 20.0 m-85 -105.47 141.33 37.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 110.718 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.0 98.37 8.09 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.609 HG21 ' SD ' ' A' ' 91' ' ' MET . 11.2 m -121.89 150.88 56.91 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 110.87 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 43.6 Cg_endo -69.28 145.74 60.92 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.047 1.551 . . . . 0.0 110.201 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.561 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.41 -15.6 50.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 0.0 111.379 -178.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -83.15 -14.7 52.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 111.283 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.83 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.9 mt -62.47 143.02 57.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.892 -1.13 . . . . 0.0 111.428 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -91.03 167.22 12.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.663 -0.648 . . . . 0.0 109.869 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.821 HG12 HG22 ' A' ' 87' ' ' THR . 58.7 t -62.75 -26.32 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.998 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.06 -31.65 75.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.83 ' CB ' HD22 ' A' ' 55' ' ' LEU . 7.1 mm100 -76.79 -47.07 22.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.113 -1.228 . . . . 0.0 110.04 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.141 ' CE2' HD11 ' A' ' 64' ' ' ILE . 22.7 t80 -60.7 -47.19 87.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.102 -0.998 . . . . 0.0 109.468 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.24 -22.24 1.68 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.883 -1.136 . . . . 0.0 109.855 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -79.91 -54.98 5.3 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 110.513 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.009 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.8 pp -59.84 -20.35 56.45 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.271 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.141 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.2 mt -90.98 -38.27 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 120.193 -1.567 . . . . 0.0 109.051 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.636 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.7 OUTLIER -35.35 -66.03 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.181 0.515 . . . . 0.0 110.83 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -31.47 72.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.893 -1.13 . . . . 0.0 110.072 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.537 ' O ' HD13 ' A' ' 44' ' ' LEU . 35.4 mmt180 -66.76 -16.82 64.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.54 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 68' ' ' ILE . 40.8 mt -103.38 11.9 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 0.0 109.763 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.552 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 51.9 23.76 2.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -0.797 . . . . 0.0 110.671 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.792 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.2 pp -91.85 157.44 16.87 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.319 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' GLU . 25.1 ptt180 -165.16 -169.44 1.65 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.929 -1.107 . . . . 0.0 111.152 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.42 -90.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.581 -0.7 . . . . 0.0 110.62 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 74' ' ' ASP . 6.5 pt-20 -158.67 28.07 0.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.2 -0.938 . . . . 0.0 110.883 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.515 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.16 176.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 109.892 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -103.21 140.63 37.12 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.291 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.89 HD11 ' HB2' ' A' ' 109' ' ' TYR . 21.5 tp -164.36 150.05 10.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 110.465 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.591 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 89.1 m-85 -157.93 121.97 4.14 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.778 -0.576 . . . . 0.0 109.869 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.896 ' CE2' HD12 ' A' ' 64' ' ' ILE . 18.3 m-30 -79.95 135.84 36.5 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.074 -1.016 . . . . 0.0 111.246 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.568 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 82.6 m-85 -118.33 126.46 52.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.739 HG22 HG12 ' A' ' 107' ' ' ILE . 2.4 t -120.83 124.06 71.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.808 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.1 t-20 47.63 49.12 16.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 29.3 m-80 56.81 36.01 27.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.639 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -135.18 167.0 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.086 -1.009 . . . . 0.0 109.924 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.88 72.42 5.84 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.547 -0.721 . . . . 0.0 109.632 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 164.07 36.49 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.04 1.547 . . . . 0.0 110.564 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.7 -178.96 3.75 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.121 1.59 . . . . 0.0 110.311 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.821 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.12 19.16 2.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 110.652 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.43 39.22 1.02 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.512 -0.743 . . . . 0.0 109.567 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.801 ' HB1' ' CD ' ' A' ' 93' ' ' GLN . . . -145.42 -174.11 4.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.536 -0.728 . . . . 0.0 110.18 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 81.5 p -139.71 143.86 37.25 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.626 -0.671 . . . . 0.0 110.203 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.068 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -44.8 -41.78 7.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 109.747 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -50.69 -48.04 44.57 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.801 ' CD ' ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -64.38 -31.58 72.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -1.179 . . . . 0.0 109.988 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.068 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.06 -23.72 64.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.81 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.599 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -50.59 -56.96 9.4 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.892 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -69.64 -15.92 63.28 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.614 -1.304 . . . . 0.0 110.819 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -88.57 -71.04 0.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.169 -0.957 . . . . 0.0 113.486 -177.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.765 ' CD2' ' CB ' ' A' ' 81' ' ' ASN . 33.8 m170 -100.81 38.28 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.68 -1.262 . . . . 0.0 113.189 -176.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.599 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -93.07 171.53 8.88 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.99 -1.069 . . . . 0.0 110.252 178.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.55 ' HG3' ' ND1' ' A' ' 99' ' ' HIS . 1.4 mt-10 73.18 114.98 0.06 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.983 -1.073 . . . . 0.0 110.442 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 0.4 OUTLIER 173.46 -28.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.611 -0.681 . . . . 0.0 110.022 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.88 -30.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.431 -0.793 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.63 -60.62 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.276 -0.89 . . . . 0.0 109.62 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.534 ' CB ' ' O ' ' A' ' 30' ' ' PRO . 18.1 m-85 -127.36 -126.36 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.357 -0.84 . . . . 0.0 109.409 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.933 HD13 ' CD1' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -96.07 165.86 12.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.749 -1.219 . . . . 0.0 108.848 178.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.743 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -123.89 124.4 42.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.575 -1.328 . . . . 0.0 111.638 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.739 HG12 HG22 ' A' ' 80' ' ' VAL . 13.2 mt -141.56 133.29 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.439 -0.788 . . . . 0.0 109.475 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -133.38 178.14 7.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.097 -1.002 . . . . 0.0 110.295 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.89 ' HB2' HD11 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -133.96 153.87 51.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.133 -0.98 . . . . 0.0 110.851 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 1.1 t -145.17 173.23 12.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.679 -0.638 . . . . 0.0 110.119 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 2.5 p30 -123.92 30.37 6.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.975 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -118.7 160.2 22.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 110.066 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 114' ' ' VAL . 0.7 OUTLIER -125.64 32.99 5.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.232 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 116' ' ' GLY . 8.8 p -46.17 169.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.033 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.434 ' N ' HG22 ' A' ' 114' ' ' VAL . 56.8 t80 -45.24 97.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.982 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 114' ' ' VAL . . . -108.04 162.57 13.1 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.183 -1.186 . . . . 0.0 110.233 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 21' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -39.73 73.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -1.136 . . . . 0.0 110.22 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 4.6 mtpt -76.46 -18.32 58.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.599 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.856 HG21 ' HB3' ' A' ' 30' ' ' PRO . 1.2 mp -70.02 -18.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.022 -1.049 . . . . 0.0 109.964 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' LYS . 16.6 mmm-85 -90.31 -49.54 6.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 109.786 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -45.45 -45.59 13.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.942 179.067 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 12.4 mtmt -85.54 -49.39 8.09 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.477 -0.764 . . . . 0.0 109.834 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 9.8 m-85 -110.88 69.56 0.64 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.403 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 45.6 Cg_endo -71.82 -12.22 28.46 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.921 1.485 . . . . 0.0 110.476 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.75 13.07 21.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.144 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 1.6 mpt_? -105.22 -161.47 0.81 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 110.12 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.792 HG12 HG12 ' A' ' 31' ' ' VAL . 24.3 t -144.12 105.65 4.81 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.173 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.856 ' HB3' HG21 ' A' ' 21' ' ' ILE . 48.4 Cg_endo -74.69 84.99 1.52 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.321 1.695 . . . . 0.0 110.038 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.997 HG11 ' HE3' ' A' ' 91' ' ' MET . 1.4 m -85.6 148.29 4.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 110.933 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.6 HD13 ' CD1' ' A' ' 104' ' ' PHE . 1.5 mp -113.97 147.53 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.551 HG22 ' CE1' ' A' ' 109' ' ' TYR . 0.4 OUTLIER -124.36 153.26 30.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.8 -1.187 . . . . 0.0 111.187 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.585 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 2.4 tt0 -156.34 -162.04 1.21 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.539 ' HD2' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -132.25 159.81 37.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.869 -1.144 . . . . 0.0 110.815 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.55 -173.8 0.11 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.582 -0.699 . . . . 0.0 109.38 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.3 Cg_endo -71.98 108.9 2.56 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.522 1.275 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.86 41.15 5.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.828 . . . . 0.0 110.553 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.455 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -63.22 178.18 0.54 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 109.841 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.523 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 13.8 ptt180 -145.26 28.72 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.802 HD12 ' C ' ' A' ' 41' ' ' ILE . 1.8 pp -85.32 179.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.012 . . . . 0.0 109.726 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -68.74 146.38 45.07 Favored Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.231 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.82 163.87 16.22 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.618 -0.93 . . . . 0.0 110.787 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.532 ' HG ' ' CA ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -153.74 142.49 20.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.729 -0.607 . . . . 0.0 109.472 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 1.6 t0 -84.09 42.17 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 110.038 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.511 ' CD ' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -160.29 105.78 1.51 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.019 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -115.55 48.58 1.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.74 -1.225 . . . . 0.0 110.618 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.17 111.51 1.7 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.875 . . . . 0.0 109.532 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.938 ' CD2' HD13 ' A' ' 63' ' ' LEU . 24.0 m-85 -106.98 141.56 37.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.049 -1.032 . . . . 0.0 110.551 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.589 HD21 HG13 ' A' ' 21' ' ' ILE . 4.2 mp -107.77 93.83 4.75 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.991 ' HB ' HD12 ' A' ' 55' ' ' LEU . 13.7 m -117.95 153.88 51.2 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.152 -0.968 . . . . 0.0 110.777 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.9 Cg_endo -71.65 148.22 52.7 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.111 1.585 . . . . 0.0 110.025 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.563 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.5 m -63.81 -15.34 58.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 111.334 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 7.8 t70 -83.58 -11.26 57.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.018 -1.051 . . . . 0.0 110.916 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.991 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.6 mt -62.05 142.02 57.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.941 -1.099 . . . . 0.0 111.122 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 1.2 p -91.01 154.89 19.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.65 -0.656 . . . . 0.0 109.433 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 1.033 HG12 HG22 ' A' ' 87' ' ' THR . 24.6 t -53.82 -20.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.991 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.37 -41.68 58.21 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.823 ' HB2' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -67.72 -46.67 71.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.174 -1.192 . . . . 0.0 109.997 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.17 ' CE2' HD11 ' A' ' 64' ' ' ILE . 22.8 t80 -60.65 -47.1 87.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.097 -1.002 . . . . 0.0 109.695 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.31 -22.25 1.72 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.01 -1.056 . . . . 0.0 109.87 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.16 -54.55 5.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 110.34 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.988 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.7 pp -59.75 -19.47 50.42 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.069 -1.052 . . . . 0.0 112.354 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.17 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.9 mt -92.16 -40.18 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 120.125 -1.61 . . . . 0.0 109.077 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -37.28 -61.46 0.58 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.878 -0.514 . . . . 0.0 110.624 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -32.33 73.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.942 -1.099 . . . . 0.0 109.742 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.535 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 15.1 mmt180 -69.39 -13.14 62.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.359 -0.838 . . . . 0.0 109.946 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.739 HG23 HD13 ' A' ' 41' ' ' ILE . 2.4 mm -99.61 7.81 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.061 -1.024 . . . . 0.0 109.528 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.541 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 54.1 32.58 16.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.429 -0.794 . . . . 0.0 110.132 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.85 ' O ' HD12 ' A' ' 70' ' ' LEU . 4.1 pp -110.53 151.2 27.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.829 . . . . 0.0 109.934 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.9 ptp180 -167.06 -168.94 1.17 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.851 . . . . 0.0 111.058 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.453 ' C ' ' HG3' ' A' ' 73' ' ' GLU . . . 50.71 -91.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.568 -0.707 . . . . 0.0 111.225 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HG3' ' C ' ' A' ' 72' ' ' ALA . 14.2 mt-10 -141.98 49.27 1.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.873 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -77.82 176.04 9.43 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.12 0.962 . . . . 0.0 109.991 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.511 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -118.16 143.85 46.16 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.039 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.813 HD21 ' CE1' ' A' ' 78' ' ' PHE . 18.2 tp -164.05 153.66 14.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 110.628 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 68.0 m-85 -157.58 123.06 4.57 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.617 -0.677 . . . . 0.0 109.465 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.813 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.4 m-30 -84.8 132.34 34.43 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.012 -1.055 . . . . 0.0 111.93 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 41.1 m-85 -120.55 118.39 30.09 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.021 HG22 HG23 ' A' ' 107' ' ' ILE . 2.0 t -120.68 130.82 74.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.556 ' HB3' ' CE1' ' A' ' 98' ' ' HIS . 53.5 t30 51.28 34.48 11.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 3.8 t-20 67.65 35.91 3.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.224 -0.922 . . . . 0.0 110.208 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -135.77 168.59 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 110.078 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.3 mp -154.68 71.01 5.99 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.73 . . . . 0.0 109.678 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.32 164.37 34.26 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.122 1.59 . . . . 0.0 110.68 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.08 -178.64 3.69 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.071 1.564 . . . . 0.0 110.611 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 1.033 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.2 22.95 1.65 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.331 -0.855 . . . . 0.0 110.672 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.37 43.45 1.07 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.369 -0.832 . . . . 0.0 109.551 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.28 -171.48 3.67 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.708 0.765 . . . . 0.0 110.294 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 75.9 p -139.21 136.36 34.93 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.538 0.685 . . . . 0.0 110.103 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.008 ' HA ' HD23 ' A' ' 94' ' ' LEU . 32.1 mmm -48.4 -38.69 20.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.9 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.45 -49.01 47.14 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 90' ' ' THR . 3.0 pt20 -64.64 -30.24 71.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -1.113 . . . . 0.0 109.814 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.008 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.52 -23.79 64.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.208 -0.932 . . . . 0.0 110.102 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 99' ' ' HIS . 1.0 OUTLIER -48.86 -53.04 21.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.843 -1.161 . . . . 0.0 109.774 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -69.36 -21.47 63.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.196 -0.94 . . . . 0.0 111.192 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 8.4 mm-40 -85.68 -66.86 0.85 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.941 -1.1 . . . . 0.0 112.007 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.618 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -98.77 42.33 1.1 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.912 -1.117 . . . . 0.0 110.771 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 95' ' ' TYR . 1.4 t-80 -71.25 -9.01 57.4 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.852 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.517 ' CA ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 44.57 70.35 0.34 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.319 -0.863 . . . . 0.0 109.787 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 103' ' ' PHE . 10.2 mt-10 57.52 155.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.458 -0.776 . . . . 0.0 109.903 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.573 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 7.4 p30 -45.77 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.194 -0.941 . . . . 0.0 110.043 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.612 ' O ' ' CG ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER 171.41 86.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 110.149 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.612 ' CG ' ' O ' ' A' ' 103' ' ' PHE . 38.1 p90 37.56 -162.7 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.533 -0.729 . . . . 0.0 110.849 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.032 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -123.67 160.3 27.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.771 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.786 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -124.97 135.88 53.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.029 -1.044 . . . . 0.0 110.996 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.032 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.0 mt -141.69 137.54 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.76 147.21 50.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.212 -0.93 . . . . 0.0 108.864 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.6 p90 -130.67 165.79 22.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.478 -1.389 . . . . 0.0 111.629 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -156.07 174.74 14.92 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.257 0.551 . . . . 0.0 110.328 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.523 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 1.8 p30 -107.97 41.07 1.6 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.955 . . . . 0.0 110.217 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER 172.07 140.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.162 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -106.45 -6.98 17.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.495 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 115' ' ' TYR . 9.3 p -129.89 175.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.108 -0.995 . . . . 0.0 110.327 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.536 ' H ' HG22 ' A' ' 114' ' ' VAL . 85.9 t80 -49.39 130.96 20.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.264 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -127.44 -172.01 13.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.224 -1.163 . . . . 0.0 110.271 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -39.94 10.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -1.152 . . . . 0.0 110.248 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 9.7 mtpt -75.3 -33.12 61.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.225 -0.922 . . . . 0.0 110.413 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.446 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -59.58 -17.66 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 109.651 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.503 ' CD ' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -85.09 -49.35 8.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -53.92 -41.43 67.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.868 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 8.6 mttt -82.84 -44.27 15.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.0 109.774 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.484 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 22.3 m-85 -112.75 61.03 0.66 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 110.576 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HA ' ' CD ' ' A' ' 22' ' ' ARG . 43.8 Cg_endo -69.83 -29.43 23.55 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.743 1.391 . . . . 0.0 110.359 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -96.98 7.29 46.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 110.247 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 6.2 mpt_? -83.86 -167.34 1.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.948 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 31' ' ' VAL . 19.9 t -147.5 102.68 3.73 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.855 . . . . 0.0 109.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.498 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 46.1 Cg_endo -73.46 81.11 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.177 1.62 . . . . 0.0 110.208 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 29' ' ' VAL . 2.2 m -77.32 152.33 5.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 110.686 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 1.5 mp -108.24 164.1 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.686 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.4 t -136.31 136.51 48.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.835 -1.166 . . . . 0.0 111.093 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.91 -176.16 5.81 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.322 0.582 . . . . 0.0 109.742 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HD2' HD11 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -114.9 159.08 21.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.985 -1.072 . . . . 0.0 110.786 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.021 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.76 -173.23 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.529 -0.732 . . . . 0.0 109.191 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.021 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.7 Cg_endo -71.91 107.25 2.17 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.472 1.249 . . . . 0.0 109.983 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.95 41.75 8.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.353 -0.842 . . . . 0.0 110.206 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.8 178.75 0.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.283 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.424 ' HG3' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.68 32.31 1.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.214 -0.929 . . . . 0.0 110.172 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.587 HD11 ' HD2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -85.81 -173.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.324 -0.86 . . . . 0.0 110.579 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.578 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -67.46 172.43 31.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.54 179.61 3.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.165 -1.197 . . . . 0.0 110.595 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.486 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 2.1 pp -134.93 133.42 39.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.369 -0.832 . . . . 0.0 110.706 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.454 ' OD2' ' HD2' ' A' ' 46' ' ' LYS . 10.7 p-10 -85.83 -20.52 29.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.191 -0.943 . . . . 0.0 110.143 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.512 ' HD2' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -151.84 154.08 35.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 109.683 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.547 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -128.28 40.95 3.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.962 -1.086 . . . . 0.0 110.448 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.92 104.88 0.91 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 109.822 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.638 ' O ' HG22 ' A' ' 31' ' ' VAL . 30.6 m-85 -105.4 145.26 31.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.112 -0.993 . . . . 0.0 111.09 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.03 94.82 5.22 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.016 ' HB ' HD12 ' A' ' 55' ' ' LEU . 32.8 m -115.92 153.14 48.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.115 -0.991 . . . . 0.0 110.987 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.458 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.3 Cg_endo -69.81 149.5 66.65 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.08 1.568 . . . . 0.0 110.407 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.556 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -63.78 -16.24 60.71 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 111.34 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -83.12 -10.99 58.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -0.999 . . . . 0.0 111.017 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.016 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.7 mt -61.84 141.8 57.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.907 -1.121 . . . . 0.0 110.952 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.499 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 3.1 p -91.23 162.41 14.65 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.532 -0.73 . . . . 0.0 109.507 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 37.1 t -59.04 -30.16 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.104 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.73 -27.16 74.06 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.87 ' CB ' HD22 ' A' ' 55' ' ' LEU . 14.7 mm100 -76.3 -51.35 12.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.169 -1.195 . . . . 0.0 110.054 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.151 ' CE2' HD11 ' A' ' 64' ' ' ILE . 12.0 t80 -60.41 -47.25 86.92 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.919 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.51 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -49.29 -23.27 1.33 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.849 -1.157 . . . . 0.0 109.562 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -55.87 4.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.486 -0.759 . . . . 0.0 111.282 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.127 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -59.03 -23.53 62.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.899 -1.126 . . . . 0.0 111.842 -178.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.151 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -91.08 -35.01 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.078 -1.639 . . . . 0.0 108.77 177.518 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.673 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -38.95 -56.19 1.43 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.446 -0.784 . . . . 0.0 110.51 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.488 ' N ' ' HE2' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -64.89 -34.94 79.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.975 -1.078 . . . . 0.0 108.899 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 5.0 mmt180 -73.08 -10.54 59.9 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.684 -0.635 . . . . 0.0 110.121 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.032 ' CG2' HD23 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -88.09 -10.57 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER 74.01 28.07 1.53 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.751 0.786 . . . . 0.0 109.122 -178.704 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.032 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.0 pp -113.93 158.67 20.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.745 -0.597 . . . . 0.0 109.873 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -165.08 -174.62 3.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 110.772 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.99 -90.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.0 110.788 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 1.9 pt-20 -153.93 42.26 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 111.027 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -67.51 176.48 2.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.071 -1.018 . . . . 0.0 110.076 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.718 ' HB3' ' CG ' ' A' ' 111' ' ' ASP . . . -92.27 142.85 27.01 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.834 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.791 HD21 ' CE1' ' A' ' 78' ' ' PHE . 17.8 tp -164.09 154.37 14.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 110.773 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 85.2 m-85 -156.91 124.16 5.26 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.581 -0.699 . . . . 0.0 110.121 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.791 ' CE1' HD21 ' A' ' 76' ' ' LEU . 3.7 m-30 -94.73 113.89 25.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 91.2 m-85 -108.99 127.48 54.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 110.122 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.959 HG22 HG23 ' A' ' 107' ' ' ILE . 1.8 t -121.5 122.41 67.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.428 -0.795 . . . . 0.0 109.442 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.689 ' O ' HG23 ' A' ' 83' ' ' VAL . 2.6 m120 57.38 33.48 23.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.073 -1.017 . . . . 0.0 109.922 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.27 31.91 15.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -133.13 171.19 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.391 -0.818 . . . . 0.0 109.681 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.807 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.2 mp -154.26 77.73 5.41 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.427 -0.796 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.52 165.8 31.67 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.149 1.605 . . . . 0.0 110.36 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.58 178.66 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.069 1.563 . . . . 0.0 110.444 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.499 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.19 20.49 2.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.319 -0.863 . . . . 0.0 110.624 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.7 p -94.64 37.47 1.13 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.538 -0.726 . . . . 0.0 109.596 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.77 -174.8 4.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.485 -0.759 . . . . 0.0 110.182 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.523 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 34.7 p -139.09 149.9 45.09 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.317 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.116 ' HA ' HD23 ' A' ' 94' ' ' LEU . 30.6 mmm -51.56 -38.6 55.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.478 -0.764 . . . . 0.0 110.16 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -54.12 -40.4 66.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.523 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 2.1 mt-30 -68.43 -46.05 70.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.146 -1.208 . . . . 0.0 109.269 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.116 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -56.92 -20.56 24.04 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.131 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.53 ' O ' ' HB3' ' A' ' 99' ' ' HIS . 1.3 t80 -48.75 -53.28 19.63 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.794 -1.191 . . . . 0.0 109.833 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.641 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 10.3 tt0 -69.49 -19.92 63.73 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.778 -1.201 . . . . 0.0 111.337 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -87.78 -62.98 1.37 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.066 -1.021 . . . . 0.0 113.53 -177.655 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.575 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.8 m-70 -98.12 35.8 1.68 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.675 -1.266 . . . . 0.0 112.682 -176.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.641 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -92.16 169.56 10.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.035 -1.041 . . . . 0.0 110.066 178.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 101' ' ' GLU . 3.0 tt0 -153.61 102.57 2.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.721 -1.237 . . . . 0.0 110.059 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 100' ' ' GLU . 3.0 mt-10 43.32 -167.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.112 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.514 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 4.8 t0 41.94 -136.32 0.27 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.458 ' O ' ' HG2' ' A' ' 30' ' ' PRO . 8.6 p90 -144.93 45.52 1.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.112 -0.993 . . . . 0.0 110.114 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 102' ' ' ASP . 20.3 p90 -144.97 163.39 34.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.637 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.028 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -117.71 167.3 11.48 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 0.0 109.362 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.746 ' N ' HD12 ' A' ' 105' ' ' LEU . 2.9 p90 -125.82 133.93 51.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.866 -1.146 . . . . 0.0 111.712 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.028 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.6 mt -141.19 147.03 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.437 -0.79 . . . . 0.0 109.785 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.0 177.43 7.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.052 . . . . 0.0 110.287 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.686 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.2 p90 -143.47 171.42 14.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.221 -0.924 . . . . 0.0 110.612 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -159.63 -175.15 5.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.464 -0.772 . . . . 0.0 110.2 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.718 ' CG ' ' HB3' ' A' ' 75' ' ' ALA . 8.8 t70 -128.57 20.34 6.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.401 -0.812 . . . . 0.0 110.095 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 7.7 mt-10 61.47 132.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 110.09 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 64.8 p -86.0 -2.17 58.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.317 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.98 168.27 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.242 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -71.34 158.08 36.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.391 -0.818 . . . . 0.0 110.269 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.5 -154.14 5.36 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 117' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.143 . . . . 0.0 110.221 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -43.08 10.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -1.214 . . . . 0.0 110.241 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -77.81 -34.98 51.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -0.901 . . . . 0.0 110.554 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -65.8 -18.81 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.088 -1.007 . . . . 0.0 110.1 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -86.86 -35.95 18.74 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.024 -1.048 . . . . 0.0 110.18 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.495 ' HG3' ' HG2' ' A' ' 24' ' ' LYS . 1.3 tptm -64.71 -40.58 95.6 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.173 -0.954 . . . . 0.0 108.984 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' HG2' ' HG3' ' A' ' 23' ' ' LYS . 1.7 mtmt -85.23 -41.11 15.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.0 109.702 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 17.1 m-85 -114.41 68.2 1.83 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.295 -0.878 . . . . 0.0 110.499 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.497 ' HA ' ' HD3' ' A' ' 22' ' ' ARG . 47.6 Cg_endo -73.29 -0.75 9.62 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.954 1.502 . . . . 0.0 110.459 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -116.92 8.93 13.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.227 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 1.8 mpt_? -94.18 -171.24 2.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.128 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.822 HG12 HG12 ' A' ' 31' ' ' VAL . 19.6 t -147.45 109.2 3.88 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.31 -0.869 . . . . 0.0 110.171 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.1 Cg_endo -75.45 84.14 1.77 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.193 1.628 . . . . 0.0 110.101 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.822 HG12 HG12 ' A' ' 29' ' ' VAL . 1.2 m -82.72 132.03 32.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.131 -0.98 . . . . 0.0 111.045 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 41.4 mm -93.86 142.78 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -124.65 147.96 29.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.86 -1.15 . . . . 0.0 111.135 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.579 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -156.57 -174.12 4.79 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -121.39 160.65 23.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.9 -1.125 . . . . 0.0 110.53 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.006 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.92 -174.83 0.15 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.412 -0.805 . . . . 0.0 109.296 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.006 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.2 Cg_endo -70.54 111.87 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.531 1.28 . . . . 0.0 109.68 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 2.8 mttt 62.21 42.34 9.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.351 -0.843 . . . . 0.0 110.05 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.528 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -56.13 -177.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.306 -0.871 . . . . 0.0 109.995 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -148.39 28.05 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 111.01 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.895 HD13 HG23 ' A' ' 68' ' ' ILE . 2.0 pp -91.81 176.46 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.83 -1.169 . . . . 0.0 110.324 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.84 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -52.12 -176.5 0.04 OUTLIER Glycine 0 N--CA 1.498 2.803 0 O-C-N 121.296 -0.878 . . . . 0.0 111.181 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 1.017 ' O ' HD22 ' A' ' 44' ' ' LEU . 10.1 t0 -80.47 -171.33 3.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -1.09 . . . . 0.0 109.993 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.017 HD22 ' O ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -142.25 138.5 31.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 110.667 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -86.07 -32.97 21.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 109.827 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 151.83 30.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.961 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.705 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -112.53 46.02 1.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 109.769 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -165.92 109.7 0.81 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.552 -0.718 . . . . 0.0 109.48 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.902 ' CD2' HD13 ' A' ' 63' ' ' LEU . 12.7 m-85 -105.83 140.39 38.93 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.117 -0.989 . . . . 0.0 110.326 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.429 HD11 HG21 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -103.53 92.91 4.67 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.83 ' HB ' HD12 ' A' ' 55' ' ' LEU . 13.6 m -115.64 150.82 45.4 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.53 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.0 Cg_endo -70.5 148.48 60.34 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.107 1.583 . . . . 0.0 110.036 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.57 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -62.56 -16.19 54.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -0.805 . . . . 0.0 111.399 -178.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.86 -13.2 54.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.036 -1.04 . . . . 0.0 111.209 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.881 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.8 mt -62.06 140.99 58.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.865 -1.147 . . . . 0.0 111.133 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.6 p -90.57 154.59 19.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.619 -0.676 . . . . 0.0 109.45 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.505 ' CG1' HG22 ' A' ' 87' ' ' THR . 58.9 t -52.74 -21.19 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.061 -1.024 . . . . 0.0 110.04 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.67 -41.24 57.31 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.881 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.1 mm-40 -67.74 -47.24 69.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.214 -1.168 . . . . 0.0 109.903 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.184 ' CE2' HD11 ' A' ' 64' ' ' ILE . 31.1 t80 -60.79 -46.51 90.24 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.496 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -51.13 -22.11 2.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.824 -1.173 . . . . 0.0 109.802 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -78.82 -54.22 6.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.946 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.023 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.6 pp -59.92 -20.44 57.39 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.02 -1.05 . . . . 0.0 112.189 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.184 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.6 mt -90.19 -37.54 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 120.103 -1.623 . . . . 0.0 108.836 177.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -37.99 -61.36 0.66 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.278 0.561 . . . . 0.0 110.736 -179.511 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -31.0 71.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.913 -1.117 . . . . 0.0 109.822 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.576 ' C ' HD13 ' A' ' 68' ' ' ILE . 21.4 mmt180 -67.7 -16.94 64.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.895 HG23 HD13 ' A' ' 41' ' ' ILE . 2.9 mm -99.76 14.11 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.371 -0.83 . . . . 0.0 109.51 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.493 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER 47.87 33.53 3.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.553 -0.717 . . . . 0.0 110.562 179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.795 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.1 pp -112.03 155.62 23.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.695 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.65 -172.23 2.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.079 -1.013 . . . . 0.0 111.056 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 55.27 -89.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.478 -0.764 . . . . 0.0 110.889 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.5 pt-20 -147.21 32.09 0.91 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 111.032 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -52.92 176.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.074 -1.016 . . . . 0.0 109.843 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HB3' ' OD1' ' A' ' 111' ' ' ASP . . . -117.59 139.17 51.34 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.134 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.862 HD21 ' HE1' ' A' ' 78' ' ' PHE . 29.8 tp -164.49 155.25 14.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 110.427 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.568 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 20.1 m-85 -153.79 123.3 6.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.45 -0.781 . . . . 0.0 109.754 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.862 ' HE1' HD21 ' A' ' 76' ' ' LEU . 18.0 m-30 -84.71 132.78 34.41 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.098 -1.001 . . . . 0.0 111.705 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 62.3 m-85 -120.37 119.81 34.16 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.802 HG22 HG23 ' A' ' 107' ' ' ILE . 2.1 t -120.77 127.95 75.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.235 -0.916 . . . . 0.0 110.206 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.69 ' O ' HG23 ' A' ' 83' ' ' VAL . 28.8 t30 54.77 35.47 24.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.874 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 64.14 32.15 12.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.38 -0.825 . . . . 0.0 110.077 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -135.63 171.05 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.415 -0.803 . . . . 0.0 109.853 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.55 75.4 5.74 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.544 -0.723 . . . . 0.0 109.47 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.5 163.91 36.37 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.967 1.509 . . . . 0.0 110.651 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.98 177.64 7.49 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.17 1.616 . . . . 0.0 110.276 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.505 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.88 21.96 2.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.263 -0.898 . . . . 0.0 110.603 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.78 36.68 0.86 Allowed 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 109.745 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -147.45 -170.4 3.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.376 -0.827 . . . . 0.0 110.358 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.559 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 58.6 p -138.96 146.94 41.58 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.488 0.661 . . . . 0.0 109.92 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.058 ' HA ' HD23 ' A' ' 94' ' ' LEU . 1.2 mmt -47.13 -47.36 23.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.248 -0.907 . . . . 0.0 110.431 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.57 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -42.73 -44.73 5.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.559 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 1.0 OUTLIER -67.81 -39.76 83.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -1.159 . . . . 0.0 109.243 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.058 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -59.53 -24.94 64.09 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.364 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.577 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -49.16 -56.07 10.39 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.517 -1.365 . . . . 0.0 109.411 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.582 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 8.7 tt0 -71.35 -18.18 62.39 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.163 -0.961 . . . . 0.0 111.911 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.586 ' HG2' ' CE1' ' A' ' 98' ' ' HIS . 1.3 tt0 -87.77 -61.23 1.76 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.756 -1.215 . . . . 0.0 112.552 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.684 ' HB3' HG12 ' A' ' 80' ' ' VAL . 17.4 m-70 -98.27 38.64 1.31 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.859 -1.15 . . . . 0.0 111.424 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.582 ' CD2' ' O ' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -71.63 173.02 8.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.424 -0.797 . . . . 0.0 109.122 178.72 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -148.4 152.22 36.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.63 -1.294 . . . . 0.0 110.673 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 102' ' ' ASP . 48.7 mt-10 -49.76 89.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.407 -0.808 . . . . 0.0 110.21 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER 170.71 -80.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.118 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.661 ' CD2' ' CE1' ' A' ' 104' ' ' PHE . 3.5 t80 -179.84 -54.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.796 . . . . 0.0 110.124 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.661 ' CE1' ' CD2' ' A' ' 103' ' ' PHE . 5.6 m-85 -77.65 -176.44 4.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.33 -0.856 . . . . 0.0 110.229 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.046 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.51 168.54 9.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.205 -0.934 . . . . 0.0 109.291 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.657 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.2 m-85 -121.92 130.68 53.54 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.64 -1.288 . . . . 0.0 111.597 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.046 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.8 mt -141.56 127.05 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.33 -0.856 . . . . 0.0 110.354 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -121.93 163.64 18.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.111 -0.993 . . . . 0.0 108.851 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.669 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.7 OUTLIER -145.75 164.05 33.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.622 -1.299 . . . . 0.0 111.225 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.624 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.5 t -159.27 -175.95 5.53 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.508 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.629 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 65.5 t0 -134.36 27.62 3.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.968 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.447 ' OE2' ' HB3' ' A' ' 110' ' ' SER . 0.5 OUTLIER -69.06 170.01 10.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.175 -0.953 . . . . 0.0 110.107 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.6 t -156.44 33.7 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.148 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 115' ' ' TYR . 9.8 p -109.9 171.14 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.912 . . . . 0.0 110.25 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.436 ' N ' HG22 ' A' ' 114' ' ' VAL . 12.2 t80 -80.21 78.31 6.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.85 -133.52 6.05 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.268 -1.137 . . . . 0.0 110.23 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -46.33 -32.27 3.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -1.125 . . . . 0.0 109.905 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -77.88 -39.19 44.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.14 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.577 HG21 ' HB3' ' A' ' 30' ' ' PRO . 10.4 mm -59.62 -13.97 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.924 . . . . 0.0 110.136 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -52.6 5.39 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -53.74 -34.55 59.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.528 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.522 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 12.2 mttt -84.63 -47.87 10.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.615 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.529 ' HB3' ' CD ' ' A' ' 28' ' ' ARG . 68.5 m-85 -109.99 56.7 0.31 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 111.413 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.522 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 51.3 Cg_endo -72.35 -10.03 25.03 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.486 1.256 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -100.74 3.2 42.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.14 -0.975 . . . . 0.0 111.065 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' HB3' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -145.25 -175.99 4.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.88 -1.138 . . . . 0.0 110.751 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.881 HG13 ' CE1' ' A' ' 95' ' ' TYR . 23.4 t -119.35 134.32 23.76 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.413 -0.804 . . . . 0.0 110.866 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.609 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 52.3 Cg_endo -81.16 112.48 2.56 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 124.246 1.656 . . . . 0.0 109.477 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.921 HG22 ' CD2' ' A' ' 105' ' ' LEU . 45.8 t -100.13 125.06 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 110.897 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.075 HD11 ' CE2' ' A' ' 104' ' ' PHE . 27.1 mm -91.51 147.15 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 108.819 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.629 HG21 ' CD1' ' A' ' 49' ' ' TYR . 9.2 t -130.61 143.93 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 120.855 -1.153 . . . . 0.0 111.556 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HA ' ' CE ' ' A' ' 47' ' ' LYS . 3.5 tt0 -156.54 167.25 31.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.552 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.661 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -96.79 163.46 12.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.937 -1.102 . . . . 0.0 110.921 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.023 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.89 -174.0 0.14 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 0.0 109.68 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.023 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.8 Cg_endo -74.03 116.64 4.72 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.576 1.303 . . . . 0.0 109.968 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.29 39.56 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 110.034 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.46 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -62.37 174.42 0.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.359 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 31.75 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.976 HD13 HG23 ' A' ' 68' ' ' ILE . 1.8 pp -85.88 177.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.026 . . . . 0.0 110.611 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.822 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -49.1 -176.89 0.01 OUTLIER Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.26 -177.17 5.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.253 -1.145 . . . . 0.0 110.001 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.936 HD12 ' OH ' ' A' ' 109' ' ' TYR . 0.2 OUTLIER -148.58 147.55 29.13 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.047 -1.033 . . . . 0.0 110.453 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 9.4 m-20 -86.82 -28.42 22.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.375 -0.828 . . . . 0.0 110.626 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -152.54 156.83 40.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 0.0 110.011 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' CE ' ' HA ' ' A' ' 34' ' ' GLU . 6.6 mmmm -120.65 43.8 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.054 -1.029 . . . . 0.0 109.781 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 1.5 ptmm? -157.94 109.75 2.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.379 -0.825 . . . . 0.0 109.74 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.629 ' CD1' HG21 ' A' ' 33' ' ' VAL . 28.1 m-85 -104.29 147.44 27.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 110.965 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -120.12 114.17 21.56 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.424 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.747 ' HB ' HD12 ' A' ' 55' ' ' LEU . 2.8 m -141.0 165.32 30.2 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.714 -1.241 . . . . 0.0 110.889 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 43.7 Cg_endo -69.22 147.93 67.46 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.151 1.606 . . . . 0.0 110.46 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.534 ' HB3' ' CA ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -65.34 -12.72 54.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.461 -0.775 . . . . 0.0 111.336 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -84.08 -5.48 59.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.084 -1.01 . . . . 0.0 110.913 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.851 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.8 mt -61.96 141.52 57.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.83 -1.169 . . . . 0.0 111.107 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 0.9 OUTLIER -92.07 159.57 15.63 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.589 -0.694 . . . . 0.0 109.698 178.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 88.3 t -58.44 -26.64 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.76 -31.51 67.44 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.851 ' CB ' HD22 ' A' ' 55' ' ' LEU . 15.7 mm100 -69.34 -51.1 40.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.162 ' CD1' HD11 ' A' ' 63' ' ' LEU . 6.9 t80 -59.97 -33.57 72.12 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.436 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.583 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -55.58 -35.14 65.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 109.998 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -79.74 -50.01 11.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.74 . . . . 0.0 112.682 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.162 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.66 -39.85 81.81 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.434 -1.416 . . . . 0.0 111.927 -177.489 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.132 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -76.11 -42.95 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 119.877 -1.764 . . . . 0.0 108.432 178.224 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.882 ' HG2' HD11 ' A' ' 70' ' ' LEU . 3.4 mtt180 -35.92 -61.58 0.47 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.825 -0.547 . . . . 0.0 110.863 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.71 -33.07 75.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.029 . . . . 0.0 109.895 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.767 ' HB3' HD21 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -69.97 -10.3 58.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -0.901 . . . . 0.0 109.624 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.976 HG23 HD13 ' A' ' 41' ' ' ILE . 5.5 mm -100.4 7.5 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.442 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.43 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 3.0 m-70 54.84 31.47 15.74 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.415 -0.803 . . . . 0.0 110.416 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.882 HD11 ' HG2' ' A' ' 65' ' ' ARG . 4.2 pp -110.62 150.6 28.75 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.835 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 1.2 ptt180 -167.0 -167.19 0.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 111.017 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 56.56 -86.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.562 -0.711 . . . . 0.0 110.96 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 71' ' ' ARG . 35.7 mt-10 -151.38 30.28 0.61 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.914 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -59.72 176.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.076 -1.015 . . . . 0.0 109.637 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -103.69 139.73 38.55 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.135 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.659 HD21 ' CZ ' ' A' ' 78' ' ' PHE . 19.3 tp -160.95 150.7 17.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.915 . . . . 0.0 110.465 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 85.9 m-85 -160.32 120.57 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.865 -0.522 . . . . 0.0 109.641 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.696 ' CE1' HD12 ' A' ' 64' ' ' ILE . 81.4 m-85 -89.94 113.53 25.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.101 -0.999 . . . . 0.0 110.214 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 68.5 m-85 -104.97 136.61 44.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.342 -0.849 . . . . 0.0 109.876 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 107' ' ' ILE . 4.9 t -120.18 125.92 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.512 ' HB2' ' CD2' ' A' ' 98' ' ' HIS . 0.8 OUTLIER 46.31 39.26 6.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.241 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 2.3 t30 67.53 38.45 3.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.401 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.7 t -135.51 168.51 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 109.864 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.815 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.4 mp -154.44 69.5 5.99 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.505 -0.747 . . . . 0.0 109.718 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.28 170.49 19.75 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.068 1.562 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.22 179.55 5.35 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.101 1.579 . . . . 0.0 110.36 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.69 21.62 2.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.399 -0.813 . . . . 0.0 110.559 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 t -95.73 39.64 1.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.522 -0.736 . . . . 0.0 109.791 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.81 -176.7 5.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 110.338 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 45.3 p -139.61 148.32 42.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.569 -0.707 . . . . 0.0 110.255 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.026 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -52.96 -41.47 64.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 109.946 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.534 ' CA ' ' HB3' ' A' ' 53' ' ' SER . . . -49.56 -50.07 31.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 90' ' ' THR . 2.2 pt20 -64.72 -28.95 69.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -1.146 . . . . 0.0 109.671 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.051 HD21 HD22 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -68.31 -23.12 64.7 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.318 -0.864 . . . . 0.0 109.677 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.881 ' CE1' HG13 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -50.07 -55.9 12.98 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.094 -1.004 . . . . 0.0 109.909 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -17.51 63.93 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.545 -1.347 . . . . 0.0 110.623 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.5 mt-10 -88.57 -71.75 0.57 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.17 -0.956 . . . . 0.0 113.445 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.512 ' CD2' ' HB2' ' A' ' 81' ' ' ASN . 34.1 m170 -100.74 38.35 1.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.653 -1.28 . . . . 0.0 113.112 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.604 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -89.58 -2.03 58.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.988 -1.07 . . . . 0.0 111.029 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 60.85 43.13 12.27 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 121.739 -0.601 . . . . 0.0 110.089 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 102' ' ' ASP . 12.7 tt0 44.18 76.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.407 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 101' ' ' GLU . 2.9 t0 177.09 -147.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.323 -0.861 . . . . 0.0 110.315 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.583 ' O ' ' CD1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -122.38 71.12 1.0 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.258 -0.901 . . . . 0.0 110.311 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 1.075 ' CE2' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER 168.38 134.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.243 -0.911 . . . . 0.0 109.658 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.051 HD22 HD21 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -98.52 154.22 18.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.67 -1.269 . . . . 0.0 110.057 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.648 ' N ' HD12 ' A' ' 105' ' ' LEU . 62.7 m-85 -119.09 122.07 41.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.115 -0.991 . . . . 0.0 111.218 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.768 HD12 HD11 ' A' ' 105' ' ' LEU . 25.3 mt -140.26 149.42 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -143.29 178.69 7.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 110.116 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.936 ' OH ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -143.71 164.07 31.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 110.641 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -160.05 176.27 12.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.386 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 6.3 p-10 -112.53 31.99 5.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 110.127 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 16.8 pt-20 -178.58 142.55 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.378 -0.827 . . . . 0.0 110.112 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.01 -18.96 16.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 110.409 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.43 170.04 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.458 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -119.21 152.03 37.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 110.167 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 51.88 -154.76 4.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.505 ' CG ' ' O ' ' A' ' 117' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.222 -1.163 . . . . 0.0 110.147 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.13 -38.6 39.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.166 -1.196 . . . . 0.0 109.933 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 3.8 tptt -80.87 -37.61 29.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.268 -0.895 . . . . 0.0 110.394 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -63.24 -17.91 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.068 -1.02 . . . . 0.0 109.898 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.431 ' C ' ' HD3' ' A' ' 22' ' ' ARG . 11.6 tpp180 -85.71 -57.62 2.98 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.227 -0.921 . . . . 0.0 109.64 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -49.25 -37.33 23.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.196 -0.94 . . . . 0.0 109.881 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 5.2 mmtm -84.31 -47.66 10.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.676 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 29.0 m-85 -112.14 65.06 0.72 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 110.867 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 47.0 Cg_endo -72.24 -4.77 15.83 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.857 1.451 . . . . 0.0 110.347 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -94.55 -6.88 42.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.504 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -97.29 -162.15 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 0.0 110.076 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.751 HG12 HG12 ' A' ' 31' ' ' VAL . 23.7 t -145.03 107.06 4.54 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.541 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -77.33 86.24 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.145 1.603 . . . . 0.0 109.938 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.751 HG12 HG12 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -81.45 136.1 23.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.305 -0.872 . . . . 0.0 111.113 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 47.1 mm -91.88 139.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.735 HG13 ' HE1' ' A' ' 109' ' ' TYR . 3.0 t -126.06 139.97 49.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.889 -1.132 . . . . 0.0 111.332 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 2.2 tt0 -156.51 174.24 15.72 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.635 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -102.46 159.77 15.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.924 -1.11 . . . . 0.0 110.419 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.04 -175.29 0.17 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.478 -0.764 . . . . 0.0 109.436 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.6 Cg_endo -71.98 107.25 2.18 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.564 1.297 . . . . 0.0 109.877 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 63.46 40.05 8.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 110.026 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.78 -174.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.117 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 31.49 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.0 110.797 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.826 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -90.28 176.31 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.96 -1.087 . . . . 0.0 110.493 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.826 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -51.42 -173.8 0.02 OUTLIER Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.308 -0.87 . . . . 0.0 111.117 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -71.49 -175.93 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -1.162 . . . . 0.0 109.867 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.921 HD13 ' CD ' ' A' ' 47' ' ' LYS . 1.4 pp -134.99 133.13 39.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.146 -0.972 . . . . 0.0 110.651 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.493 ' HB2' ' HD3' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -86.68 -42.32 13.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.219 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HD3' ' HD2' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -152.79 151.71 30.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 110.279 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.921 ' CD ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -111.25 49.59 0.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 109.728 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -169.55 111.17 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.519 -0.738 . . . . 0.0 109.659 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.87 ' CD2' HD13 ' A' ' 63' ' ' LEU . 10.2 m-85 -108.36 141.05 40.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.075 -1.015 . . . . 0.0 110.37 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.37 92.14 4.2 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.5 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 34.4 m -114.25 147.57 38.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 110.486 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.714 ' HD2' HD12 ' A' ' 55' ' ' LEU . 45.1 Cg_endo -70.96 150.33 60.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.815 1.429 . . . . 0.0 109.772 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.55 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -65.08 -13.49 58.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.302 -0.874 . . . . 0.0 111.594 -178.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -87.72 -14.23 40.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.888 -1.132 . . . . 0.0 111.189 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.2 mt -62.14 146.16 51.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.956 -1.09 . . . . 0.0 111.503 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.49 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 3.9 p -91.28 160.05 15.71 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.638 -0.664 . . . . 0.0 109.533 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.728 HG12 HG22 ' A' ' 87' ' ' THR . 63.5 t -60.01 -22.04 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.016 . . . . 0.0 110.043 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.83 -39.72 64.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.722 ' CB ' HD22 ' A' ' 55' ' ' LEU . 1.5 mm-40 -67.96 -48.64 65.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -1.173 . . . . 0.0 109.987 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.122 ' CE2' HD11 ' A' ' 64' ' ' ILE . 47.2 t80 -60.41 -44.21 95.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.569 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.683 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -53.24 -26.53 18.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.934 -1.104 . . . . 0.0 109.706 179.356 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -73.97 -47.74 35.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.398 -0.814 . . . . 0.0 109.668 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.088 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.2 pp -66.43 -17.16 64.63 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.013 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.122 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.1 mt -89.33 -41.07 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 120.046 -1.659 . . . . 0.0 109.398 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' CG ' ' N ' ' A' ' 66' ' ' LYS . 2.2 ptm180 -39.64 -46.28 1.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.547 -0.721 . . . . 0.0 110.616 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.554 ' N ' ' CG ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -72.81 -36.9 67.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.984 -1.073 . . . . 0.0 109.814 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.519 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 5.8 mmp_? -69.41 -10.12 56.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.302 -0.874 . . . . 0.0 109.857 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.795 HG21 HD23 ' A' ' 70' ' ' LEU . 45.1 mt -104.03 7.77 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.006 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.534 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 50.07 31.29 4.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.363 -0.835 . . . . 0.0 110.308 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.906 HD12 ' O ' ' A' ' 70' ' ' LEU . 2.9 pp -103.56 156.28 17.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.37 -165.15 0.82 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.036 -1.04 . . . . 0.0 110.941 -179.001 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.04 -90.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.782 . . . . 0.0 110.601 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 71' ' ' ARG . 4.6 pt-20 -156.41 26.1 0.35 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 111.037 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.523 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.04 176.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.063 -1.023 . . . . 0.0 110.002 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.523 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -110.98 142.99 42.37 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.137 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.971 HD21 ' CE1' ' A' ' 78' ' ' PHE . 21.8 tp -156.16 155.49 32.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 110.545 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' O ' ' CE1' ' A' ' 79' ' ' PHE . 19.4 m-85 -152.83 123.28 7.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.548 -0.72 . . . . 0.0 109.818 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.971 ' CE1' HD21 ' A' ' 76' ' ' LEU . 21.3 m-30 -88.17 135.85 33.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.255 -0.903 . . . . 0.0 111.273 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.571 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 54.0 m-85 -120.33 119.0 31.85 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.852 HG22 HG23 ' A' ' 107' ' ' ILE . 2.0 t -121.25 112.43 35.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 121.357 -0.839 . . . . 0.0 110.304 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.645 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.6 OUTLIER 59.96 42.22 16.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 0.0 110.22 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.92 34.49 14.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.662 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -134.47 168.02 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 109.994 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -155.02 67.5 5.23 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.581 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.86 160.04 46.93 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.922 1.485 . . . . 0.0 110.665 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.82 -178.91 3.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.038 1.547 . . . . 0.0 110.65 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.728 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -85.85 20.53 2.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.459 -0.776 . . . . 0.0 110.618 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 t -95.37 42.76 1.09 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.443 -0.786 . . . . 0.0 109.507 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.13 -169.69 3.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.663 0.744 . . . . 0.0 110.3 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 45.0 p -139.24 143.1 37.84 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.687 -0.633 . . . . 0.0 109.935 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.01 ' HA ' HD23 ' A' ' 94' ' ' LEU . 25.4 mmm -50.88 -45.15 59.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 109.545 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.55 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.55 -48.54 34.99 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.1 OUTLIER -64.59 -31.76 73.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -1.136 . . . . 0.0 110.106 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.018 HD11 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -68.54 -23.17 64.49 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.115 -0.991 . . . . 0.0 110.133 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.541 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -48.64 -53.45 18.58 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.519 -179.435 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.12 -20.98 63.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.194 -0.941 . . . . 0.0 111.291 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 14.8 mt-10 -84.27 -63.99 1.24 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.014 -1.054 . . . . 0.0 112.06 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.491 ' HB3' HG12 ' A' ' 80' ' ' VAL . 14.1 m170 -97.41 40.62 1.15 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.966 -1.084 . . . . 0.0 110.779 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER -68.24 -174.45 0.51 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.08 -162.16 1.18 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.858 -1.151 . . . . 0.0 110.523 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.43 1.88 12.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.366 -0.834 . . . . 0.0 110.129 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -135.44 146.15 47.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.92 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.448 ' C ' ' O ' ' A' ' 102' ' ' ASP . 15.1 m-85 -39.42 -27.81 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.471 -0.768 . . . . 0.0 110.453 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' ASP . 4.4 m-85 -77.6 155.04 31.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 110.493 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.056 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -103.04 171.09 7.58 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.717 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.2 m-85 -118.14 126.89 53.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.402 -1.436 . . . . 0.0 112.211 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.056 ' CG1' HD11 ' A' ' 105' ' ' LEU . 4.1 mt -141.58 144.63 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -146.62 163.05 37.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.192 -0.943 . . . . 0.0 109.372 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.735 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.4 p90 -134.09 165.73 24.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.646 -1.284 . . . . 0.0 111.278 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -159.22 177.25 11.25 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.483 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.473 ' HB2' HG22 ' A' ' 41' ' ' ILE . 11.9 t0 -126.66 37.54 4.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.922 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 4.6 mt-10 62.06 132.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.871 . . . . 0.0 110.165 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.34 48.24 2.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 116' ' ' GLY . 9.6 p -47.2 168.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.944 . . . . 0.0 110.206 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -53.46 89.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 114' ' ' VAL . . . -156.4 167.7 33.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.26 -1.141 . . . . 0.0 110.226 -179.989 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.79 -33.22 6.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -1.095 . . . . 0.0 110.08 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -78.44 -38.44 41.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.229 -0.92 . . . . 0.0 110.086 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.466 ' HA ' HD13 ' A' ' 21' ' ' ILE . 9.9 mm -60.15 -19.87 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.227 -0.921 . . . . 0.0 110.089 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HD2' ' N ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -89.22 -44.22 10.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 110.16 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -53.6 -43.86 68.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.961 . . . . 0.0 109.142 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.465 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 5.4 mtpt -85.62 -48.83 8.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.565 -0.71 . . . . 0.0 109.975 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.538 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 6.1 m-85 -115.43 62.49 1.75 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.256 -0.903 . . . . 0.0 110.147 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.487 ' CD ' ' O ' ' A' ' 22' ' ' ARG . 44.3 Cg_endo -70.12 -19.86 33.89 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.837 1.44 . . . . 0.0 110.543 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -111.65 24.84 12.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.214 -0.929 . . . . 0.0 110.021 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.538 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 5.4 mpt_? -118.86 179.82 4.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.777 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.754 HG12 HG12 ' A' ' 31' ' ' VAL . 17.3 t -148.02 116.97 4.15 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 110.203 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 50.3 Cg_endo -79.35 90.96 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 124.257 1.661 . . . . 0.0 110.005 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.754 HG12 HG12 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -88.55 138.66 18.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.164 -0.96 . . . . 0.0 110.559 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.543 HG13 ' CE1' ' A' ' 104' ' ' PHE . 24.8 mm -95.95 152.82 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 108.901 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.782 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.6 t -133.6 141.83 43.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.965 -1.084 . . . . 0.0 111.109 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -157.27 -166.76 2.13 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD2' HG12 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -124.56 160.77 27.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.885 -1.135 . . . . 0.0 110.508 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.015 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -61.63 -167.81 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.015 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.1 Cg_endo -71.72 123.64 9.57 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.189 1.099 . . . . 0.0 109.673 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 40.55 49.54 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.599 0.714 . . . . 0.0 110.549 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.09 -179.11 0.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.603 -0.686 . . . . 0.0 110.126 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.33 36.18 0.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.699 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 111' ' ' ASP . 1.8 pp -85.18 177.87 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.025 -1.047 . . . . 0.0 110.378 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.822 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -47.9 -179.58 0.01 OUTLIER Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.488 -0.863 . . . . 0.0 110.997 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.963 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -75.85 -179.28 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -1.171 . . . . 0.0 110.071 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.963 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.6 mm? -136.17 134.8 38.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.164 -0.96 . . . . 0.0 110.579 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 29.7 t0 -86.49 -36.96 18.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.436 -0.79 . . . . 0.0 110.099 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.83 154.44 35.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.665 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -117.69 46.42 1.74 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.12 -0.987 . . . . 0.0 109.818 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -164.51 109.66 0.97 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.423 -0.798 . . . . 0.0 109.965 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.926 ' CD2' HD13 ' A' ' 63' ' ' LEU . 16.3 m-85 -108.14 139.6 42.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.04 -1.038 . . . . 0.0 110.12 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.85 99.63 8.51 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.93 ' HB ' HD12 ' A' ' 55' ' ' LEU . 5.1 m -126.14 160.03 59.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.046 -1.034 . . . . 0.0 110.861 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 42.3 Cg_endo -67.69 144.98 67.99 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.052 1.553 . . . . 0.0 110.434 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.572 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -63.5 -14.0 46.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.446 -0.784 . . . . 0.0 111.441 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -83.73 -10.36 58.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.96 -1.088 . . . . 0.0 110.945 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.93 HD12 ' HB ' ' A' ' 51' ' ' VAL . 4.1 mt -62.22 141.32 58.27 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.003 -1.06 . . . . 0.0 111.027 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 1.4 p -91.44 169.15 11.02 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.703 -0.623 . . . . 0.0 109.827 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.829 ' CG1' HG22 ' A' ' 87' ' ' THR . 95.3 t -61.93 -26.63 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.307 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.88 -39.61 75.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.912 ' CB ' HD22 ' A' ' 55' ' ' LEU . 5.3 mm-40 -67.67 -48.56 66.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.1 -1.236 . . . . 0.0 110.101 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.176 ' CE2' HD11 ' A' ' 64' ' ' ILE . 24.0 t80 -60.45 -46.43 90.1 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.469 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -50.51 -23.62 2.62 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.888 -1.132 . . . . 0.0 109.928 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.79 -51.79 9.26 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.047 HD11 ' CE1' ' A' ' 60' ' ' PHE . 4.0 pp -63.54 -17.83 63.22 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.432 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.176 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.6 mt -91.82 -39.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 120.01 -1.681 . . . . 0.0 109.059 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -35.43 -64.66 0.27 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.086 0.47 . . . . 0.0 110.961 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.02 -31.4 72.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.208 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.695 ' O ' HD13 ' A' ' 44' ' ' LEU . 28.6 mmt-85 -68.21 -16.79 64.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.066 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.909 ' CG2' HD23 ' A' ' 70' ' ' LEU . 1.2 mm -97.44 8.74 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.601 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.491 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER 57.04 30.17 17.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 110.317 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.909 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.3 pp -117.61 154.84 30.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.917 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -166.25 -169.07 1.34 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.235 -0.916 . . . . 0.0 111.046 -179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 49.74 -92.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.523 -0.736 . . . . 0.0 111.015 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -142.5 45.9 1.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 111.039 -179.089 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -72.85 176.32 5.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.889 -1.132 . . . . 0.0 109.803 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.518 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.38 140.32 38.67 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.157 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.742 HD21 ' CE1' ' A' ' 78' ' ' PHE . 44.6 tp -164.3 153.27 13.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.591 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 74.4 m-85 -158.01 119.91 3.65 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.703 -0.623 . . . . 0.0 109.621 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.742 ' CE1' HD21 ' A' ' 76' ' ' LEU . 16.7 m-30 -83.5 134.7 34.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.155 -0.965 . . . . 0.0 111.977 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 50.1 m-85 -121.17 123.35 42.06 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 98' ' ' HIS . 2.1 t -120.49 119.85 60.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 O-C-N 121.201 -0.937 . . . . 0.0 110.077 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' HG23 ' A' ' 83' ' ' VAL . 26.4 t30 50.91 39.05 21.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.1 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 64.95 35.2 8.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.68 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -135.41 168.41 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.306 -0.871 . . . . 0.0 109.931 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.808 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.3 mp -154.37 72.84 6.18 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.554 -0.716 . . . . 0.0 109.533 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.12 165.64 32.18 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.072 1.564 . . . . 0.0 110.662 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.47 ' HG2' ' OG ' ' A' ' 88' ' ' SER . 45.9 Cg_endo -72.85 178.31 6.56 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.044 1.55 . . . . 0.0 110.348 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.829 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.56 21.59 2.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.47 ' OG ' ' HG2' ' A' ' 86' ' ' PRO . 3.0 p -93.04 39.68 1.05 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 109.61 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.5 -172.91 3.98 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.684 0.754 . . . . 0.0 110.275 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 64.2 p -138.95 145.8 40.21 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.501 0.667 . . . . 0.0 110.016 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.017 ' HA ' HD23 ' A' ' 94' ' ' LEU . 4.3 mmm -51.42 -39.76 57.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 110.232 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.572 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.83 -49.96 45.81 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -64.6 -26.48 68.42 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.35 -1.088 . . . . 0.0 109.628 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.017 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -69.02 -25.52 64.53 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.302 -0.874 . . . . 0.0 110.044 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.589 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -49.12 -56.0 10.5 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.824 -1.173 . . . . 0.0 109.652 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -70.14 -18.32 63.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.992 -1.067 . . . . 0.0 111.2 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 14.0 mt-10 -87.75 -67.05 0.85 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 112.789 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.499 ' HB3' HG12 ' A' ' 80' ' ' VAL . 28.4 m170 -98.6 36.96 1.55 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.795 -1.19 . . . . 0.0 112.315 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.518 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -68.89 167.98 14.54 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.126 -0.984 . . . . 0.0 109.422 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 99' ' ' HIS . 0.1 OUTLIER -176.78 164.74 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.754 -1.216 . . . . 0.0 110.792 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER 47.03 -124.94 1.55 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -0.801 . . . . 0.0 110.349 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.529 ' HB2' ' CD2' ' A' ' 104' ' ' PHE . 6.0 m-20 -59.85 -134.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.95 -1.094 . . . . 0.0 110.403 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.48 ' CD1' ' NH1' ' A' ' 22' ' ' ARG . 18.0 p90 -106.59 13.35 28.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.007 -1.058 . . . . 0.0 110.523 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 101' ' ' GLU . 7.5 p90 -98.08 -176.23 3.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.111 -0.993 . . . . 0.0 109.874 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.071 HD11 ' CD1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.8 168.37 9.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.989 -1.07 . . . . 0.0 110.304 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.705 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -122.11 133.76 54.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.926 -1.109 . . . . 0.0 110.727 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.071 ' CD1' HD11 ' A' ' 105' ' ' LEU . 4.6 mt -138.86 137.16 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.316 -0.865 . . . . 0.0 110.289 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.16 145.01 38.84 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.236 -0.915 . . . . 0.0 108.778 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.782 ' HE1' HG13 ' A' ' 33' ' ' VAL . 2.9 p90 -130.2 170.96 13.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.54 -1.35 . . . . 0.0 111.924 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.91 179.78 8.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.845 -0.535 . . . . 0.0 110.063 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.93 ' HB3' HG22 ' A' ' 41' ' ' ILE . 8.8 p-10 -121.11 36.68 4.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.928 . . . . 0.0 110.268 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.18 154.22 47.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 110.257 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.46 31.97 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.286 -0.884 . . . . 0.0 110.136 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 115' ' ' TYR . 9.9 p -52.08 176.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 110.291 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.568 ' H ' HG22 ' A' ' 114' ' ' VAL . 42.7 t80 -78.54 135.67 37.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.21 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.58 -155.06 7.73 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.248 -1.149 . . . . 0.0 110.222 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.439 ' O ' ' HB ' ' A' ' 21' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -49.66 -39.36 36.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -1.194 . . . . 0.0 110.203 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 6.0 mtpt -76.2 -28.62 57.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.373 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 1.2 mp -61.08 -17.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.0 109.813 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -88.4 -51.4 5.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.44 -42.5 43.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.438 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 24.6 mttm -85.44 -47.41 9.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.471 -0.768 . . . . 0.0 109.904 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.498 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 9.9 m-85 -113.77 61.8 0.97 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 0.0 110.345 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.477 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 43.7 Cg_endo -69.66 -25.33 29.14 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.816 1.43 . . . . 0.0 110.666 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.76 19.78 19.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 110.282 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.498 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -107.78 -163.14 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.964 . . . . 0.0 110.307 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.657 HG13 ' CD1' ' A' ' 95' ' ' TYR . 23.2 t -144.51 109.73 4.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 110.188 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.585 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 48.6 Cg_endo -76.02 96.14 1.05 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.162 1.611 . . . . 0.0 110.18 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.733 ' HB ' HD21 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -90.9 145.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.354 -0.841 . . . . 0.0 110.626 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 1.1 mp -100.25 156.03 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.812 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.3 t -133.19 136.36 55.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.034 -1.041 . . . . 0.0 110.972 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 2.1 mt-10 -148.65 177.23 9.68 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.759 -0.588 . . . . 0.0 109.454 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.619 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -112.82 158.15 20.49 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.898 -1.126 . . . . 0.0 110.614 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -63.9 -169.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.556 -0.715 . . . . 0.0 109.24 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.0 Cg_endo -73.54 109.45 2.85 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.31 1.163 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.23 41.49 6.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.365 -0.834 . . . . 0.0 110.433 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.554 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -61.44 174.47 0.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 109.804 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.58 34.56 0.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 111.092 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -87.66 -175.84 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.848 -1.158 . . . . 0.0 110.033 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.505 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -49.07 178.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.954 -1.117 . . . . 0.0 110.328 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.971 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -82.5 -176.81 6.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 109.777 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.971 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.5 mm? -137.18 131.8 33.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 110.782 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -86.84 -26.78 23.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -0.825 . . . . 0.0 109.429 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -152.67 154.31 35.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.457 -0.777 . . . . 0.0 109.798 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -120.05 44.73 2.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.032 -1.042 . . . . 0.0 109.945 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 8.9 pttp -159.0 111.2 2.18 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.355 -0.841 . . . . 0.0 109.497 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.719 ' HD2' HD13 ' A' ' 63' ' ' LEU . 12.0 m-85 -103.86 140.09 38.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.992 -1.067 . . . . 0.0 110.335 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 50' ' ' LEU . 3.6 mm? -102.05 92.3 4.71 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.943 HG21 ' HE3' ' A' ' 91' ' ' MET . 26.9 m -116.02 142.42 29.16 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.178 -0.951 . . . . 0.0 110.898 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 42.2 Cg_endo -67.49 148.87 79.72 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.103 1.58 . . . . 0.0 109.956 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.565 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 2.0 m -63.12 -13.94 42.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 111.614 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -83.37 -14.8 52.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.111 -0.993 . . . . 0.0 110.888 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.864 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.7 mt -62.65 142.67 57.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.021 -1.05 . . . . 0.0 111.424 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 3.2 p -90.97 163.97 14.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.637 -0.665 . . . . 0.0 109.288 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.542 HG12 HG22 ' A' ' 87' ' ' THR . 39.2 t -61.52 -24.6 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.957 -1.089 . . . . 0.0 110.086 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.07 -31.98 66.23 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.864 ' CB ' HD22 ' A' ' 55' ' ' LEU . 30.4 mm-40 -74.6 -47.82 30.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -1.214 . . . . 0.0 109.886 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.057 ' CD1' HD11 ' A' ' 63' ' ' LEU . 38.9 t80 -60.2 -32.59 71.24 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.287 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.545 ' HE1' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.72 -31.92 71.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 109.567 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 3.7 t80 -71.74 -52.87 15.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.54 -0.725 . . . . 0.0 110.993 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.057 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -59.67 -35.09 73.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.834 -1.167 . . . . 0.0 112.57 -178.206 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.026 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -77.7 -32.19 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 119.657 -1.902 . . . . 0.0 109.394 178.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.93 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -39.81 -64.08 0.52 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.512 -0.742 . . . . 0.0 110.624 -179.32 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -30.31 71.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.47 ' C ' HD13 ' A' ' 68' ' ' ILE . 5.8 mmp_? -67.7 -17.42 64.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.011 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.806 HD12 HD21 ' A' ' 44' ' ' LEU . 2.7 mm -104.44 15.86 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.9 . . . . 0.0 109.793 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.475 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 49.99 28.84 3.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.587 -0.695 . . . . 0.0 110.655 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.93 HD11 ' HG2' ' A' ' 65' ' ' ARG . 4.2 pp -111.0 155.06 23.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.839 . . . . 0.0 109.783 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.0 -173.41 2.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.923 -179.365 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.11 -91.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.469 -0.77 . . . . 0.0 110.784 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -146.31 36.61 1.0 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.995 . . . . 0.0 111.051 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -60.05 176.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.078 -1.013 . . . . 0.0 109.825 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -94.23 138.25 32.46 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.553 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 20.3 tp -164.78 152.05 11.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.399 -0.813 . . . . 0.0 110.596 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.7 m-85 -158.35 119.9 3.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.578 -0.701 . . . . 0.0 109.757 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.906 ' CZ ' HD12 ' A' ' 64' ' ' ILE . 10.7 m-85 -90.44 124.08 34.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 110.862 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 68.3 m-85 -115.5 127.29 55.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.77 HG22 HG12 ' A' ' 107' ' ' ILE . 2.8 t -121.25 121.93 66.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.503 -0.748 . . . . 0.0 109.959 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.802 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.8 OUTLIER 47.7 47.26 18.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 110.119 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 18.8 m120 57.22 36.84 27.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 110.491 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.6 t -135.3 168.0 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.816 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.02 73.74 5.66 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.539 -0.725 . . . . 0.0 109.524 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.55 165.37 31.81 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.095 1.576 . . . . 0.0 110.767 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.51 -178.86 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.046 1.551 . . . . 0.0 110.435 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.1 20.57 2.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.223 -0.923 . . . . 0.0 110.593 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.7 t -95.85 41.55 1.1 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.504 -0.748 . . . . 0.0 109.527 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.55 -175.1 4.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.496 -0.752 . . . . 0.0 110.287 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 77.7 p -139.45 138.24 36.29 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.601 0.715 . . . . 0.0 110.229 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.05 ' HA ' HD23 ' A' ' 94' ' ' LEU . 2.7 mmm -45.72 -39.24 7.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.966 -1.084 . . . . 0.0 109.842 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -49.83 -53.03 23.62 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.972 -1.109 . . . . 0.0 110.439 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.529 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 2.6 pt20 -64.13 -27.03 68.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.089 -1.242 . . . . 0.0 110.008 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.05 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.36 -25.97 65.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.21 -0.931 . . . . 0.0 109.929 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.657 ' CD1' HG13 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -50.03 -55.5 14.52 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.855 -1.153 . . . . 0.0 109.698 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.632 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 2.0 mt-30 -69.41 -18.44 63.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.951 -1.093 . . . . 0.0 110.974 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 10.5 mt-10 -88.38 -68.36 0.77 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.012 -1.055 . . . . 0.0 113.13 -177.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.464 ' CB ' HG12 ' A' ' 80' ' ' VAL . 26.1 m170 -99.35 38.05 1.48 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.703 -1.248 . . . . 0.0 112.795 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.632 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -82.53 165.98 19.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.995 -1.065 . . . . 0.0 109.856 178.528 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 99' ' ' HIS . 0.3 OUTLIER 169.54 154.02 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.882 -1.136 . . . . 0.0 110.332 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 100' ' ' GLU . 3.9 mt-10 57.98 117.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.551 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 73.3 m-20 56.12 -122.66 1.78 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.264 -0.898 . . . . 0.0 109.948 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -137.86 33.42 2.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.798 -1.189 . . . . 0.0 109.895 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 102' ' ' ASP . 8.8 m-85 -117.36 169.09 9.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.24 -0.912 . . . . 0.0 110.468 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.8 HD13 HD11 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -101.99 165.29 11.25 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.374 -0.829 . . . . 0.0 109.301 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.617 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -122.9 123.82 41.82 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.77 -1.206 . . . . 0.0 111.165 -179.408 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.77 HG12 HG22 ' A' ' 80' ' ' VAL . 10.9 mt -141.97 147.66 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.204 -0.935 . . . . 0.0 109.82 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -147.18 -179.57 6.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.145 -0.972 . . . . 0.0 110.159 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.812 ' HE1' HG13 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -140.97 162.26 35.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.945 -1.097 . . . . 0.0 111.418 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 6.8 t -148.0 -177.81 5.94 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 3.0 p-10 -116.66 29.96 7.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 110.53 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 4.7 pt-20 -178.98 160.4 1.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.323 -0.861 . . . . 0.0 110.519 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.0 t -160.06 34.93 0.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.417 -0.802 . . . . 0.0 110.09 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.424 HG22 ' N ' ' A' ' 115' ' ' TYR . 10.0 p -48.34 169.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 110.213 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.439 ' CD2' ' O ' ' A' ' 115' ' ' TYR . 67.9 t80 -56.99 92.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.139 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.2 -151.67 6.31 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.251 -1.146 . . . . 0.0 110.257 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -49.03 -38.39 23.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -1.171 . . . . 0.0 110.135 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -75.48 -34.12 60.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.363 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -59.97 -17.54 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.164 -0.96 . . . . 0.0 109.74 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -50.48 9.41 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.989 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -56.73 -42.9 80.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.31 -0.869 . . . . 0.0 110.032 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 2.0 mtpm? -76.78 -43.3 37.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.274 -0.891 . . . . 0.0 109.716 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 44.9 m-85 -114.07 62.59 1.13 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.728 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.487 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 47.3 Cg_endo -72.37 -11.53 26.71 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.811 1.427 . . . . 0.0 110.441 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 1.2 t0 -102.08 9.45 40.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.32 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' HD2' ' C ' ' A' ' 27' ' ' ASP . 6.0 mpt_? -106.9 -169.87 1.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.897 . . . . 0.0 110.152 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.783 HG12 HG12 ' A' ' 31' ' ' VAL . 21.8 t -147.24 107.78 3.89 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 110.39 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.501 ' O ' ' HB3' ' A' ' 104' ' ' PHE . 49.3 Cg_endo -77.78 90.85 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.253 1.66 . . . . 0.0 110.029 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.783 HG12 HG12 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -90.85 133.49 32.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 111.215 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 44.0 mm -95.68 133.76 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 0.0 108.438 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -126.85 128.26 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.711 -1.243 . . . . 0.0 111.866 -178.616 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 3.1 tm-20 -132.62 159.5 39.37 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.7 ' CE ' HD11 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -87.55 163.38 16.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.867 -1.146 . . . . 0.0 110.863 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.994 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.47 -174.82 0.16 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 109.62 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.994 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.1 Cg_endo -72.85 116.61 4.78 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.638 1.336 . . . . 0.0 110.046 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 63.88 42.25 6.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.341 -0.849 . . . . 0.0 110.463 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.589 ' CB ' ' CG ' ' A' ' 35' ' ' LYS . . . -65.49 175.09 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.28 33.17 0.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.669 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.832 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -95.35 177.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.023 -1.048 . . . . 0.0 110.247 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.832 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -42.41 169.52 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.093 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 1.003 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -78.75 -176.48 4.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -1.195 . . . . 0.0 110.066 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.003 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.2 mm? -139.4 135.84 34.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.898 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -86.49 -29.7 22.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.534 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -153.68 150.17 28.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -111.47 47.14 1.04 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.9 -1.125 . . . . 0.0 109.942 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -159.41 111.71 2.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.588 -0.695 . . . . 0.0 109.244 179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.765 ' CD2' HD13 ' A' ' 63' ' ' LEU . 19.6 m-85 -103.76 141.12 36.64 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.022 -1.049 . . . . 0.0 110.351 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -108.01 93.09 4.35 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.92 ' HB ' HD12 ' A' ' 55' ' ' LEU . 9.5 m -117.86 154.06 51.1 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.342 -0.849 . . . . 0.0 110.721 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.6 Cg_endo -70.34 147.01 58.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.085 1.571 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.552 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.3 m -62.38 -14.8 44.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 0.0 111.488 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -84.12 -12.4 55.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.025 -1.047 . . . . 0.0 111.331 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.92 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.8 mt -62.12 142.0 57.84 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.898 -1.126 . . . . 0.0 111.257 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 90' ' ' THR . 1.1 p -91.61 164.78 13.64 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.726 HG12 HG22 ' A' ' 87' ' ' THR . 93.4 t -60.87 -21.11 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.868 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.33 59.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.907 ' CB ' HD22 ' A' ' 55' ' ' LEU . 4.3 mm-40 -67.64 -47.98 68.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.164 -1.198 . . . . 0.0 109.845 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.191 ' CE2' HD11 ' A' ' 64' ' ' ILE . 34.8 t80 -60.82 -42.82 98.44 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.196 -1.001 . . . . 0.0 109.492 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -54.36 -22.56 12.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.752 -1.218 . . . . 0.0 109.838 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -79.39 -54.51 5.87 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.473 -0.767 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 60' ' ' PHE . 1.2 pp -59.64 -25.94 65.1 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.833 -1.167 . . . . 0.0 112.102 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.191 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.7 mt -84.13 -42.45 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 119.997 -1.689 . . . . 0.0 108.844 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.475 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 1.8 mtp-105 -36.49 -60.58 0.58 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.017 0.436 . . . . 0.0 110.721 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -66.94 -32.7 74.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.831 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 64' ' ' ILE . 6.0 mmt-85 -69.34 -10.27 57.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.166 -0.959 . . . . 0.0 109.262 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.771 HG21 HD23 ' A' ' 70' ' ' LEU . 62.1 mt -103.97 13.21 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.474 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.56 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.6 OUTLIER 44.67 31.97 0.71 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.44 -0.787 . . . . 0.0 110.344 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.848 ' O ' HD12 ' A' ' 70' ' ' LEU . 3.8 pp -104.9 153.55 21.24 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.893 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' GLU . 14.3 ptt180 -166.06 -168.45 1.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 111.033 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 49.85 -92.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.507 -0.746 . . . . 0.0 110.858 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 8.4 pt-20 -143.37 40.49 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 110.834 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.519 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -64.69 176.62 1.1 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.083 -1.011 . . . . 0.0 109.799 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -115.1 140.17 49.29 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.268 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.758 HD21 ' CE1' ' A' ' 78' ' ' PHE . 43.3 tp -157.6 150.7 23.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 80.9 m-85 -158.82 121.36 3.62 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.762 -0.586 . . . . 0.0 109.943 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.758 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.3 m-30 -88.09 128.16 35.42 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.061 -1.024 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 60.7 m-85 -115.98 128.61 55.87 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 108.984 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.869 HG11 ' CD2' ' A' ' 98' ' ' HIS . 2.3 t -120.4 128.71 76.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.149 -0.97 . . . . 0.0 110.27 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.804 HD22 HG21 ' A' ' 83' ' ' VAL . 0.8 OUTLIER 43.11 35.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 110.151 -179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 1.4 m-20 73.69 39.45 0.55 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.598 -0.689 . . . . 0.0 111.311 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.804 HG21 HD22 ' A' ' 81' ' ' ASN . 2.8 t -136.33 168.36 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.0 110.047 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.814 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.96 68.71 5.54 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.58 -0.7 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.05 164.36 35.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.992 1.522 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.479 ' HG2' ' OG ' ' A' ' 88' ' ' SER . 44.2 Cg_endo -71.92 179.09 5.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.144 1.602 . . . . 0.0 110.583 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.726 HG22 HG12 ' A' ' 57' ' ' VAL . 1.1 p -87.03 20.35 2.71 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.322 -0.861 . . . . 0.0 110.842 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.479 ' OG ' ' HG2' ' A' ' 86' ' ' PRO . 2.2 p -90.53 39.9 0.99 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.447 -0.783 . . . . 0.0 109.475 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.38 -174.39 4.37 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.589 0.709 . . . . 0.0 110.006 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 82.2 p -139.59 152.84 47.15 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.462 -0.773 . . . . 0.0 110.318 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.025 ' HA ' HD23 ' A' ' 94' ' ' LEU . 43.8 mmm -56.57 -41.73 77.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.388 -0.82 . . . . 0.0 109.926 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -52.04 -48.16 52.89 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -65.28 -27.13 68.41 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.407 -1.055 . . . . 0.0 109.657 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.06 HD11 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -69.02 -23.82 64.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.907 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.591 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -49.26 -56.65 8.69 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.851 -1.156 . . . . 0.0 109.434 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.597 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 11.9 tt0 -70.94 -16.09 62.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.836 -1.165 . . . . 0.0 111.373 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -87.97 -63.31 1.32 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.994 -1.066 . . . . 0.0 113.626 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.869 ' CD2' HG11 ' A' ' 80' ' ' VAL . 9.3 m-70 -98.03 35.89 1.66 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.757 -1.214 . . . . 0.0 112.624 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.597 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -107.81 174.88 5.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 110.312 178.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 99' ' ' HIS . 0.1 OUTLIER 175.16 93.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.738 -1.226 . . . . 0.0 110.083 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 103' ' ' PHE . 32.9 mt-10 43.84 -137.29 0.39 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.764 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 103' ' ' PHE . 10.1 t70 51.75 -89.15 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.06 -1.025 . . . . 0.0 110.275 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 101' ' ' GLU . 0.1 OUTLIER 174.29 -64.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.51 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 5.6 m-85 -92.64 -174.85 3.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.377 -0.827 . . . . 0.0 110.582 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.06 HD22 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -99.02 166.08 11.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.291 -0.881 . . . . 0.0 109.12 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.797 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -118.72 121.75 40.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.696 -1.253 . . . . 0.0 111.896 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.735 ' CG1' HG13 ' A' ' 80' ' ' VAL . 7.5 mt -141.63 149.79 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.462 -0.774 . . . . 0.0 109.181 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -139.23 177.02 8.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.005 -1.06 . . . . 0.0 109.963 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.9 OUTLIER -155.13 163.73 39.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.011 -1.056 . . . . 0.0 111.251 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.4 t -159.56 -178.31 7.02 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.234 0.54 . . . . 0.0 110.137 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.564 ' HB3' HG22 ' A' ' 41' ' ' ILE . 8.5 p-10 -117.1 29.19 8.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.199 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.47 ' OE1' ' CE2' ' A' ' 77' ' ' PHE . 2.0 mt-10 61.7 166.28 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.212 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.88 36.2 3.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 110.244 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.516 HG22 ' H ' ' A' ' 115' ' ' TYR . 9.9 p -99.67 175.34 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.235 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.516 ' H ' HG22 ' A' ' 114' ' ' VAL . 12.9 t80 -127.32 142.51 51.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.36 159.21 24.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.281 -179.987 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -46.47 -28.14 1.3 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -1.14 . . . . 0.0 110.194 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -76.83 -41.0 45.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.247 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 21' ' ' ILE . 11.7 mm -64.11 -14.47 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.206 -0.934 . . . . 0.0 110.248 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.562 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 1.4 mpt_? -88.95 -52.01 5.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.94 . . . . 0.0 110.168 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -49.75 -42.09 45.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.396 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 3.6 mtpp -85.45 -49.49 8.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 110.088 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.503 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 21.6 m-85 -117.03 64.85 3.54 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.912 . . . . 0.0 110.455 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 46.4 Cg_endo -72.84 -8.22 22.0 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.841 1.443 . . . . 0.0 110.292 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -120.19 19.46 12.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.915 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 7.1 mpt_? -102.78 -174.07 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 110.457 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.704 HG12 ' CG1' ' A' ' 31' ' ' VAL . 20.0 t -147.4 105.11 3.77 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.602 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -76.37 83.41 2.03 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.289 1.678 . . . . 0.0 110.222 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.704 ' CG1' HG12 ' A' ' 29' ' ' VAL . 1.9 m -81.26 154.27 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.216 -0.928 . . . . 0.0 110.803 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 31.1 mm -111.33 161.92 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 108.761 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.856 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.8 t -134.9 144.67 33.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.947 -1.095 . . . . 0.0 111.168 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.36 178.02 10.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.593 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -117.07 157.61 25.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.905 -1.122 . . . . 0.0 110.681 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.87 -173.74 0.12 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.516 -0.74 . . . . 0.0 109.253 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.1 Cg_endo -71.25 105.62 1.76 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.446 1.235 . . . . 0.0 109.762 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER 63.43 40.74 8.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.41 -0.806 . . . . 0.0 110.326 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -54.84 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.184 -0.947 . . . . 0.0 109.831 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.443 ' HD3' ' HB3' ' A' ' 111' ' ' ASP . 2.9 ptm180 -144.67 26.63 1.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 0.0 110.994 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.416 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -85.48 -177.37 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.938 -1.101 . . . . 0.0 109.378 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 69' ' ' HIS . . . -62.4 171.05 11.08 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 1.0 ' O ' HD22 ' A' ' 44' ' ' LEU . 4.4 t70 -75.15 -177.29 3.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -1.1 . . . . 0.0 109.998 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.0 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.5 mm? -138.6 133.29 32.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.128 -0.982 . . . . 0.0 110.808 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.503 ' CB ' ' HE2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -86.8 -21.9 26.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.814 . . . . 0.0 109.136 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.503 ' HE2' ' CB ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -151.68 147.66 26.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.571 -0.706 . . . . 0.0 109.105 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -123.61 48.84 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.921 -1.112 . . . . 0.0 110.184 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 11.5 pttm -158.19 108.95 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 110.118 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.916 ' CD2' HD13 ' A' ' 63' ' ' LEU . 23.4 m-85 -103.83 144.17 31.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.134 -0.979 . . . . 0.0 110.412 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.8 103.68 11.2 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 55' ' ' LEU . 3.3 m -128.8 159.37 68.66 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 110.931 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.9 Cg_endo -70.65 148.17 58.74 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.193 1.628 . . . . 0.0 110.513 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.558 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -63.02 -17.08 61.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.494 -0.754 . . . . 0.0 111.305 -179.104 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -83.51 -9.65 58.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 0.0 111.322 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.004 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.9 mt -62.08 141.41 58.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.784 -1.198 . . . . 0.0 110.908 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.503 ' HA ' HG22 ' A' ' 90' ' ' THR . 6.0 p -91.21 156.67 17.67 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.504 -0.748 . . . . 0.0 109.575 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.731 ' CG1' HG22 ' A' ' 87' ' ' THR . 95.5 t -54.05 -24.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.068 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.81 -38.37 66.02 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.874 ' CB ' HD22 ' A' ' 55' ' ' LEU . 12.5 mm-40 -68.57 -49.28 60.66 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.142 -1.211 . . . . 0.0 110.017 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.19 ' CE2' HD11 ' A' ' 64' ' ' ILE . 31.3 t80 -60.49 -47.38 86.38 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.793 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.85 -21.8 1.87 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.68 -1.263 . . . . 0.0 109.776 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -78.68 -54.16 6.4 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.765 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.013 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.6 pp -60.72 -18.45 54.48 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.27 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.19 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -92.3 -41.36 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.115 -1.616 . . . . 0.0 109.145 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.935 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -37.26 -61.2 0.6 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.872 -0.518 . . . . 0.0 110.677 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -65.16 -32.87 74.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.098 -1.001 . . . . 0.0 109.618 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 29.3 mmt-85 -69.94 -12.11 61.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 110.109 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.833 HD12 HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -99.09 4.48 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.123 -0.985 . . . . 0.0 109.295 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.527 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 55.47 29.25 12.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.459 -0.776 . . . . 0.0 110.018 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.935 HD11 ' HG2' ' A' ' 65' ' ' ARG . 3.8 pp -101.0 151.81 21.33 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.038 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.82 -161.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.288 -0.883 . . . . 0.0 110.778 -179.404 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.525 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 49.92 -87.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.0 110.917 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 72' ' ' ALA . 40.7 mt-10 -156.37 36.45 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 110.634 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -62.91 176.59 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.059 -1.026 . . . . 0.0 109.848 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB3' ' OD1' ' A' ' 111' ' ' ASP . . . -119.0 145.06 46.14 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.061 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.837 HD21 ' CE1' ' A' ' 78' ' ' PHE . 22.2 tp -158.84 153.56 24.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.537 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 56.2 m-85 -154.39 122.35 5.94 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.547 -0.72 . . . . 0.0 109.767 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.837 ' CE1' HD21 ' A' ' 76' ' ' LEU . 16.7 m-30 -84.2 131.15 34.78 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.337 -0.852 . . . . 0.0 111.869 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 64.6 m-85 -120.12 119.04 32.15 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.783 HG22 HG23 ' A' ' 107' ' ' ILE . 1.4 t -121.59 126.26 74.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.654 ' O ' HG23 ' A' ' 83' ' ' VAL . 61.0 t30 55.25 35.28 24.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.079 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 2.0 t-20 64.58 32.16 11.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 110.106 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -135.12 168.55 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.822 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.86 73.43 5.8 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.58 -0.7 . . . . 0.0 109.297 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.19 165.14 33.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.099 1.579 . . . . 0.0 110.867 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.62 178.73 5.92 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.108 1.583 . . . . 0.0 110.339 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.731 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -88.22 21.91 2.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.361 -0.837 . . . . 0.0 110.657 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.7 p -90.5 37.36 0.91 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.46 -0.775 . . . . 0.0 109.795 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.08 -171.96 4.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.463 -0.773 . . . . 0.0 110.142 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.539 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 44.2 p -138.81 150.12 45.7 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.654 0.74 . . . . 0.0 110.267 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.1 ' HA ' HD23 ' A' ' 94' ' ' LEU . 3.1 mmt -47.53 -47.93 27.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.469 -0.77 . . . . 0.0 110.692 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.558 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -42.69 -43.58 5.17 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.539 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 0.7 OUTLIER -67.82 -42.49 81.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.342 -1.093 . . . . 0.0 109.23 179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.1 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -58.84 -23.24 60.35 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.363 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.602 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -48.36 -54.06 15.27 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.675 -1.265 . . . . 0.0 109.716 -179.305 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.71 -22.7 63.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.251 -0.905 . . . . 0.0 111.375 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 2.1 mm-40 -81.54 -63.52 1.38 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.957 -1.089 . . . . 0.0 111.655 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.643 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.8 m-70 -97.63 41.58 1.12 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.002 -1.061 . . . . 0.0 110.141 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 95' ' ' TYR . 6.1 t-80 -74.48 166.09 24.09 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.259 0.552 . . . . 0.0 109.691 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -145.73 68.98 1.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 109.882 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 103' ' ' PHE . 4.5 mt-10 41.31 -164.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.597 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.483 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 8.3 m-20 39.93 -93.0 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.509 -0.744 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.571 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER 179.26 64.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.976 . . . . 0.0 110.164 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.595 ' CE1' ' HB2' ' A' ' 30' ' ' PRO . 1.9 m-85 -161.36 150.51 16.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.386 -0.821 . . . . 0.0 109.979 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.066 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -114.87 161.77 17.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.046 -1.034 . . . . 0.0 109.488 179.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.75 ' N ' HD12 ' A' ' 105' ' ' LEU . 4.3 p90 -120.49 132.81 55.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.778 -1.201 . . . . 0.0 111.749 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.066 ' CG1' HD11 ' A' ' 105' ' ' LEU . 7.7 mt -141.25 124.54 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 0.0 109.98 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -122.36 160.3 25.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.993 -1.067 . . . . 0.0 109.671 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.856 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.4 p90 -135.42 162.2 33.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.694 -1.254 . . . . 0.0 111.258 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -147.33 178.76 8.16 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.135 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.552 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 9.6 t0 -105.95 -3.21 21.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.21 -0.931 . . . . 0.0 110.325 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.533 ' HB2' ' CD2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER 47.59 -177.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.424 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 114' ' ' VAL . 9.1 t -118.94 29.76 7.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 109.883 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 113' ' ' SER . 8.2 p -42.55 166.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 110.407 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.36 126.82 15.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.228 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.68 -146.94 0.73 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 117' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.272 -1.134 . . . . 0.0 110.241 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.95 -20.23 5.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -1.149 . . . . 0.0 109.819 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 2.0 mttt -76.57 -36.99 57.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.359 -0.838 . . . . 0.0 110.361 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.443 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -59.78 -19.42 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 0.0 109.67 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' CD ' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.2 -36.57 16.72 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.178 -0.952 . . . . 0.0 109.808 179.405 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HG2' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -65.76 -36.88 84.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.305 -0.872 . . . . 0.0 108.933 179.315 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.477 ' HG2' ' HG2' ' A' ' 23' ' ' LYS . 5.1 mttt -85.34 -44.04 13.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.463 -0.773 . . . . 0.0 109.675 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -114.61 61.51 1.21 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 110.77 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.47 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 48.0 Cg_endo -72.81 -4.38 15.27 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.813 1.428 . . . . 0.0 110.381 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -116.39 13.57 15.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 110.453 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.62 -175.1 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.298 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.743 HG12 HG12 ' A' ' 31' ' ' VAL . 16.3 t -147.2 107.25 3.89 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.504 ' HD2' ' OH ' ' A' ' 95' ' ' TYR . 46.3 Cg_endo -75.41 86.48 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.181 1.621 . . . . 0.0 109.855 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.743 HG12 HG12 ' A' ' 29' ' ' VAL . 1.1 m -79.71 136.61 23.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.317 -0.865 . . . . 0.0 110.553 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 14.9 mm -91.86 157.25 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.791 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.5 t -134.05 140.41 46.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 120.898 -1.126 . . . . 0.0 111.336 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.23 169.74 23.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.413 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -109.5 162.62 14.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.857 -1.152 . . . . 0.0 110.522 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -62.42 -172.17 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.499 -0.751 . . . . 0.0 109.307 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.9 Cg_endo -71.55 110.41 2.87 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.433 1.228 . . . . 0.0 109.83 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.64 42.58 10.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.26 -0.9 . . . . 0.0 110.025 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.541 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -59.38 179.13 0.11 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.286 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.527 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 6.5 ptm180 -150.04 29.81 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 110.825 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.843 HG22 ' HB3' ' A' ' 111' ' ' ASP . 1.9 pp -85.41 178.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.064 . . . . 0.0 110.424 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.82 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -48.02 -178.4 0.01 OUTLIER Glycine 0 N--CA 1.496 2.666 0 O-C-N 121.332 -0.855 . . . . 0.0 111.055 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.99 ' O ' HD22 ' A' ' 44' ' ' LEU . 7.7 t70 -84.95 -178.98 6.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -1.202 . . . . 0.0 109.858 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.99 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -138.41 134.73 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.096 -1.002 . . . . 0.0 110.592 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.95 -24.02 26.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.456 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.08 154.46 29.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.556 -0.715 . . . . 0.0 109.591 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HG2' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -118.73 43.18 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.945 -1.097 . . . . 0.0 110.017 179.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.523 ' HG3' ' HG2' ' A' ' 47' ' ' LYS . 18.9 mttt -158.23 109.53 2.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.619 -0.676 . . . . 0.0 109.566 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.905 ' CD2' HD13 ' A' ' 63' ' ' LEU . 15.3 m-85 -103.84 141.06 36.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.018 -1.051 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -103.87 94.57 5.49 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.952 ' HB ' HD12 ' A' ' 55' ' ' LEU . 14.7 m -117.57 149.65 45.3 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 110.851 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.457 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 47.0 Cg_endo -70.56 149.71 62.18 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.212 1.638 . . . . 0.0 110.074 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.557 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.5 m -62.27 -17.15 57.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.405 -0.809 . . . . 0.0 111.405 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -83.95 -11.57 56.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 111.385 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.952 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.3 mt -61.61 141.21 57.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.858 -1.151 . . . . 0.0 111.145 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 p -91.17 154.0 19.63 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.285 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 25.6 t -53.97 -20.98 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.057 -1.027 . . . . 0.0 109.785 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.73 -39.63 59.72 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.822 ' CB ' HD22 ' A' ' 55' ' ' LEU . 10.9 mm-40 -67.85 -47.38 69.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.046 -1.267 . . . . 0.0 109.599 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.172 ' CE2' HD11 ' A' ' 64' ' ' ILE . 21.3 t80 -60.38 -45.97 91.65 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.432 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.64 -22.86 2.23 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.953 -1.092 . . . . 0.0 109.911 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -80.15 -54.54 5.66 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.818 . . . . 0.0 110.357 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.043 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.6 pp -59.61 -21.64 60.69 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.012 -1.055 . . . . 0.0 112.306 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.172 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -90.45 -38.56 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 120.09 -1.632 . . . . 0.0 108.816 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.839 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -36.65 -62.43 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.863 -0.523 . . . . 0.0 110.691 -179.528 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -30.63 71.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.133 -0.98 . . . . 0.0 109.845 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 20.1 mmt180 -68.01 -13.85 62.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 109.481 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.013 ' CG2' HD23 ' A' ' 70' ' ' LEU . 70.6 mt -103.21 14.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.449 -0.782 . . . . 0.0 109.545 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.564 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 1.4 t60 47.8 28.76 1.41 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.552 -0.718 . . . . 0.0 110.493 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.013 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.0 pp -110.71 155.17 22.84 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.636 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 73' ' ' GLU . 11.5 ptt180 -166.15 -171.67 2.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.114 -0.991 . . . . 0.0 111.054 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.47 -89.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.522 -0.736 . . . . 0.0 110.763 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -148.55 33.24 0.78 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.143 -0.973 . . . . 0.0 110.919 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -56.76 176.81 0.09 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.024 -1.048 . . . . 0.0 109.796 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.29 138.77 40.96 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.128 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.745 HD21 ' CE1' ' A' ' 78' ' ' PHE . 17.5 tp -164.41 152.85 12.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 110.505 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 94.1 m-85 -158.85 122.08 3.77 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.663 -0.648 . . . . 0.0 109.896 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.745 ' CE1' HD21 ' A' ' 76' ' ' LEU . 16.9 m-30 -85.62 132.33 34.19 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.136 -0.977 . . . . 0.0 111.346 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 58.2 m-85 -119.45 121.46 39.52 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.49 -0.756 . . . . 0.0 109.227 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.827 HG22 HG23 ' A' ' 107' ' ' ILE . 2.5 t -120.63 123.48 70.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.358 -0.839 . . . . 0.0 110.074 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.6 t30 50.39 34.54 9.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 8.4 t-20 66.98 37.37 3.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.95 . . . . 0.0 110.146 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.612 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.7 t -135.47 169.96 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 109.83 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.814 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.6 OUTLIER -154.68 73.67 5.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.478 -0.764 . . . . 0.0 109.207 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.52 155.77 58.99 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.164 1.613 . . . . 0.0 110.925 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.71 -178.67 3.58 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.167 1.614 . . . . 0.0 110.273 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.538 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 1.2 p -86.03 18.46 3.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.906 . . . . 0.0 110.823 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.4 m -90.33 32.49 0.94 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.397 -0.814 . . . . 0.0 109.662 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.31 -174.18 4.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.525 -0.735 . . . . 0.0 110.096 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.53 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 67.3 p -139.4 149.91 44.66 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.561 -0.712 . . . . 0.0 110.19 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.019 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -48.74 -43.81 37.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.317 -0.864 . . . . 0.0 110.175 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -46.1 -44.18 14.02 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.53 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 2.4 mt-30 -65.58 -47.0 77.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.385 -1.067 . . . . 0.0 109.434 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.019 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -56.91 -23.43 44.94 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.385 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.53 ' CD1' HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -48.94 -56.18 9.61 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.812 -1.18 . . . . 0.0 109.848 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -16.78 62.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.027 -1.046 . . . . 0.0 111.532 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -87.15 -65.53 1.0 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.892 -1.13 . . . . 0.0 112.473 -178.043 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.429 ' CG ' HG12 ' A' ' 80' ' ' VAL . 17.5 m170 -98.78 41.48 1.14 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.953 -1.092 . . . . 0.0 111.388 -177.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 6.8 p80 -68.12 -19.98 64.88 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.492 -0.755 . . . . 0.0 109.758 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER 75.4 -75.95 0.06 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.918 -0.489 . . . . 0.0 110.778 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 102' ' ' ASP . 6.5 tt0 -166.61 45.53 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.089 -1.007 . . . . 0.0 110.096 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 101' ' ' GLU . 3.8 t0 177.58 -142.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.862 . . . . 0.0 110.105 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -94.01 -58.34 2.27 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.187 -0.946 . . . . 0.0 109.881 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.429 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 4.9 p90 -55.29 166.95 0.51 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.105 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.076 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -121.73 171.64 8.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.125 -0.985 . . . . 0.0 109.752 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.568 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.3 m-85 -122.64 126.23 47.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.666 -1.271 . . . . 0.0 111.366 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 1.076 ' CG1' HD11 ' A' ' 105' ' ' LEU . 9.0 mt -138.75 136.16 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.179 -0.951 . . . . 0.0 110.358 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -130.73 173.11 11.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -1.0 . . . . 0.0 109.731 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.791 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.4 p90 -150.69 165.33 33.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.87 -1.144 . . . . 0.0 111.364 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -150.54 -178.28 6.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.768 -0.583 . . . . 0.0 110.177 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.843 ' HB3' HG22 ' A' ' 41' ' ' ILE . 8.4 p-10 -128.5 29.98 5.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -148.53 147.42 29.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.33 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.2 p -132.17 19.34 4.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.443 HG22 ' N ' ' A' ' 115' ' ' TYR . 9.2 p -105.21 172.32 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.443 ' N ' HG22 ' A' ' 114' ' ' VAL . 2.0 t80 -82.52 177.09 8.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 110.159 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 45.52 -141.13 4.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.305 -1.115 . . . . 0.0 110.16 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.533 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.141 0.496 . . . . 0.0 109.962 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 31' ' ' VAL . 24.2 t -133.65 103.99 12.1 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.933 . . . . 0.0 110.383 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.487 ' HD2' ' OH ' ' A' ' 95' ' ' TYR . 48.7 Cg_endo -75.97 85.21 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.264 1.665 . . . . 0.0 109.721 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 29' ' ' VAL . 2.0 m -77.9 150.33 5.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 110.918 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 35.9 mm -106.54 160.66 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.318 -0.864 . . . . 0.0 108.672 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.723 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.2 t -134.36 141.23 44.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.903 -1.123 . . . . 0.0 111.336 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.65 174.97 14.67 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.538 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -115.93 159.85 21.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.779 -1.2 . . . . 0.0 110.526 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.01 -174.3 0.14 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.595 -0.691 . . . . 0.0 109.405 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.7 Cg_endo -71.32 110.37 2.83 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.617 1.325 . . . . 0.0 109.92 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.22 42.9 5.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.326 -0.859 . . . . 0.0 110.066 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.538 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -57.47 -179.82 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.491 ' CG ' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.06 35.11 0.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.108 -0.995 . . . . 0.0 110.749 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.879 HD12 ' O ' ' A' ' 42' ' ' GLY . 2.1 pp -95.09 176.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 0.0 110.274 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.879 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -49.09 -177.69 0.01 OUTLIER Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.932 ' O ' HD22 ' A' ' 44' ' ' LEU . 5.6 t70 -79.79 -179.03 6.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -1.149 . . . . 0.0 109.615 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.932 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.8 mm? -135.63 131.94 36.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.433 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' C ' ' HD2' ' A' ' 46' ' ' LYS . 1.6 m-20 -86.8 -28.73 22.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.703 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 45' ' ' ASP . 3.7 mptt -152.68 157.03 40.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.54 -0.725 . . . . 0.0 109.808 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -123.88 43.19 3.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.955 . . . . 0.0 109.958 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 3.6 pttt -159.67 107.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.846 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.896 ' CD2' HD13 ' A' ' 63' ' ' LEU . 22.4 m-85 -103.84 142.2 34.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.75 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.16 95.67 6.48 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.509 ' HB ' HD12 ' A' ' 55' ' ' LEU . 15.6 m -118.54 145.26 37.02 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.728 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HD2' HD12 ' A' ' 55' ' ' LEU . 43.8 Cg_endo -70.19 147.59 60.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.0 1.526 . . . . 0.0 109.932 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.568 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.85 -16.04 56.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -0.805 . . . . 0.0 111.476 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -83.57 -13.7 53.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.961 -1.087 . . . . 0.0 111.192 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.866 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.3 mt -62.44 143.62 56.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.867 -1.145 . . . . 0.0 111.527 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 p -91.12 162.84 14.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.616 -0.678 . . . . 0.0 109.717 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.614 HG12 HG22 ' A' ' 87' ' ' THR . 70.2 t -59.9 -23.71 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.99 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.3 -34.0 68.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.866 ' CB ' HD22 ' A' ' 55' ' ' LEU . 22.1 mm-40 -73.41 -46.98 45.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.097 -1.237 . . . . 0.0 109.827 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.16 ' CE2' HD11 ' A' ' 64' ' ' ILE . 19.8 t80 -60.87 -46.82 89.11 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.565 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -50.69 -21.73 1.74 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.916 -1.115 . . . . 0.0 109.913 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -80.66 -54.82 5.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.442 -0.786 . . . . 0.0 110.387 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.993 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.8 pp -60.11 -19.95 55.86 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.984 -1.072 . . . . 0.0 112.355 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.16 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -92.75 -38.88 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 120.094 -1.629 . . . . 0.0 109.165 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.551 ' HG2' HD11 ' A' ' 70' ' ' LEU . 13.9 mtt180 -36.98 -61.37 0.56 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.775 -0.578 . . . . 0.0 110.698 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -65.21 -32.32 73.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.0 109.698 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.515 ' C ' HD13 ' A' ' 68' ' ' ILE . 4.5 mmp_? -68.04 -14.77 63.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.847 ' CG2' HD23 ' A' ' 70' ' ' LEU . 2.0 mm -100.23 10.21 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.176 -0.953 . . . . 0.0 109.676 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.498 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 52.67 32.83 12.59 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.433 -0.792 . . . . 0.0 110.238 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.847 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.3 pp -116.03 153.97 30.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.444 -0.785 . . . . 0.0 110.221 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 2.7 ptp180 -166.4 -173.56 2.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.265 -0.897 . . . . 0.0 110.919 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 56.95 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.72 . . . . 0.0 111.065 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 74' ' ' ASP . 5.6 pt-20 -146.01 24.17 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.092 -1.005 . . . . 0.0 111.301 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -49.09 176.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.943 -1.098 . . . . 0.0 109.786 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.694 ' HB3' ' OD1' ' A' ' 111' ' ' ASP . . . -111.28 139.58 46.56 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.252 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.7 HD21 ' CE1' ' A' ' 78' ' ' PHE . 31.9 tp -164.76 153.68 12.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.774 . . . . 0.0 110.332 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.586 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 95.2 m-85 -157.66 120.75 3.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.57 -0.706 . . . . 0.0 110.032 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.7 ' CE1' HD21 ' A' ' 76' ' ' LEU . 15.7 m-30 -82.82 133.58 35.13 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.171 -0.956 . . . . 0.0 111.748 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 51.0 m-85 -120.65 119.38 32.66 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.912 HG22 HG23 ' A' ' 107' ' ' ILE . 2.5 t -120.67 128.41 76.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.382 -0.824 . . . . 0.0 109.915 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.544 ' HB2' ' CG ' ' A' ' 98' ' ' HIS . 4.4 t30 48.1 36.61 6.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.984 . . . . 0.0 109.921 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 12.8 m-20 66.69 38.65 3.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.468 -0.77 . . . . 0.0 110.438 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.696 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -135.66 166.95 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 110.024 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -155.19 67.7 5.18 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.635 -0.666 . . . . 0.0 109.304 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.48 164.6 34.62 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.962 1.506 . . . . 0.0 110.808 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.64 -178.33 3.34 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.114 1.587 . . . . 0.0 110.387 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.614 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -84.35 21.42 1.44 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.413 -0.804 . . . . 0.0 110.887 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -96.99 43.15 1.07 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.346 -0.847 . . . . 0.0 109.451 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.03 -172.1 3.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.547 -0.72 . . . . 0.0 110.234 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 72.2 p -139.33 145.7 39.38 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.567 -0.708 . . . . 0.0 110.375 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.014 ' HA ' HD23 ' A' ' 94' ' ' LEU . 95.9 mmm -58.88 -45.03 91.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.165 -0.959 . . . . 0.0 109.649 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -48.11 -47.65 26.54 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 1.0 OUTLIER -64.46 -32.86 74.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.211 -1.17 . . . . 0.0 109.616 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.014 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -66.16 -22.23 66.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.905 . . . . 0.0 109.955 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.516 ' CD1' HG13 ' A' ' 29' ' ' VAL . 1.2 t80 -49.22 -55.06 13.79 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.012 -1.055 . . . . 0.0 109.971 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 5.1 tp60 -69.47 -18.55 63.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.008 -1.058 . . . . 0.0 111.078 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 12.7 mm-40 -87.3 -68.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.007 -1.058 . . . . 0.0 112.363 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.544 ' CG ' ' HB2' ' A' ' 81' ' ' ASN . 8.8 m-70 -99.44 38.23 1.46 Allowed 'General case' 0 N--CA 1.484 1.257 0 O-C-N 120.833 -1.167 . . . . 0.0 111.947 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.509 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.8 p80 . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.033 -1.042 . . . . 0.0 109.237 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 4.6 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.056 0.455 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.075 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -109.58 165.68 11.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.064 -1.023 . . . . 0.0 109.502 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.713 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.9 m-85 -122.85 128.89 50.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.847 -1.158 . . . . 0.0 111.87 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.075 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.3 mt -140.02 128.57 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.343 -0.848 . . . . 0.0 110.016 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -123.7 172.83 8.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 109.75 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.723 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.2 p90 -149.92 163.07 39.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.822 -1.174 . . . . 0.0 111.35 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.493 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -146.45 179.47 7.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.741 -0.6 . . . . 0.0 110.688 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.694 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 5.8 t70 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.378 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.439 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 8.7 mpt_? . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.232 0.539 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.744 HG12 HG12 ' A' ' 31' ' ' VAL . 24.0 t -145.55 105.78 4.32 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 47.7 Cg_endo -75.89 84.06 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.167 1.614 . . . . 0.0 109.818 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.831 HG12 ' CD2' ' A' ' 105' ' ' LEU . 1.8 m -80.54 149.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 111.114 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.588 HG13 ' CE1' ' A' ' 104' ' ' PHE . 6.8 mm -102.02 164.93 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.584 HG21 ' CE1' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -136.09 141.81 40.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.779 -1.201 . . . . 0.0 111.545 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 1.8 tt0 -156.52 165.76 35.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.642 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -99.69 162.47 12.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.917 -1.115 . . . . 0.0 110.738 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.031 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.36 -172.66 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.464 -0.772 . . . . 0.0 109.292 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.031 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.8 Cg_endo -71.31 107.59 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.476 1.251 . . . . 0.0 110.033 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 mttt 63.52 36.39 11.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.453 -0.78 . . . . 0.0 110.196 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.481 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -58.68 178.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 110.061 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 35.53 0.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 110.58 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.824 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.54 176.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.006 -1.059 . . . . 0.0 110.432 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.824 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -48.73 -177.47 0.01 OUTLIER Glycine 0 N--CA 1.497 2.717 0 O-C-N 121.438 -0.789 . . . . 0.0 111.179 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.892 ' O ' HD22 ' A' ' 44' ' ' LEU . 4.3 t0 -77.12 -175.74 3.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -1.091 . . . . 0.0 109.778 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.892 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -136.02 135.21 39.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.985 . . . . 0.0 110.738 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -86.89 -36.03 18.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 109.732 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.56 ' HE2' ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -152.59 155.29 37.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.474 -0.766 . . . . 0.0 109.837 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -120.31 43.23 2.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 0.0 110.226 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HG3' ' HG2' ' A' ' 47' ' ' LYS . 14.8 mttp -157.88 107.56 2.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 109.58 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.596 ' CD2' HD13 ' A' ' 63' ' ' LEU . 31.8 m-85 -103.39 143.34 32.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.114 -0.991 . . . . 0.0 110.884 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.61 89.89 3.49 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.528 ' HB ' HD12 ' A' ' 55' ' ' LEU . 20.2 m -111.04 143.45 28.36 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.347 -0.846 . . . . 0.0 111.002 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.437 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 46.5 Cg_endo -71.45 148.96 55.42 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.164 1.613 . . . . 0.0 109.74 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.554 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.55 -15.58 51.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.898 . . . . 0.0 111.438 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -83.34 -13.81 54.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.09 -1.006 . . . . 0.0 111.169 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.846 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.0 mt -62.3 143.63 56.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.829 -1.17 . . . . 0.0 111.129 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 1.6 p -91.3 167.67 12.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.593 -0.692 . . . . 0.0 109.891 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 80.8 t -62.75 -32.25 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 110.059 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.81 -23.38 70.82 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.846 ' CB ' HD22 ' A' ' 55' ' ' LEU . 34.7 mm-40 -80.4 -50.91 9.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.125 -1.221 . . . . 0.0 109.727 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.184 ' CE2' HD11 ' A' ' 64' ' ' ILE . 14.1 t80 -60.12 -34.06 72.99 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.084 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.586 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -54.8 -37.56 66.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.47 -0.769 . . . . 0.0 109.873 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.8 t80 -74.51 -50.69 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.537 -0.727 . . . . 0.0 112.525 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.129 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -58.58 -39.88 81.57 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.506 -1.371 . . . . 0.0 112.489 -177.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.184 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -75.1 -38.89 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 119.764 -1.835 . . . . 0.0 108.761 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.835 ' HD2' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -39.15 -58.39 1.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.551 -0.718 . . . . 0.0 110.42 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -65.32 -34.4 78.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.968 -1.083 . . . . 0.0 109.903 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.527 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 4.5 mmp_? -70.27 -9.22 55.33 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.258 -0.901 . . . . 0.0 109.835 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.016 HG21 HD23 ' A' ' 70' ' ' LEU . 67.1 mt -100.28 4.55 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.337 -0.852 . . . . 0.0 109.733 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.493 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 60.63 27.97 17.68 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.393 -0.817 . . . . 0.0 110.324 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.016 HD23 HG21 ' A' ' 68' ' ' ILE . 4.3 pp -114.99 156.33 25.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.639 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.06 -166.94 0.97 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 110.998 -179.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 55.45 -87.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.835 . . . . 0.0 110.986 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' ARG . 9.7 pt-20 -152.06 27.09 0.61 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 111.238 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -53.84 176.37 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.919 -1.113 . . . . 0.0 109.817 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 111' ' ' ASP . . . -97.79 141.97 30.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.954 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.764 HD21 ' CZ ' ' A' ' 78' ' ' PHE . 16.6 tp -162.19 152.55 16.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 110.997 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.2 m-85 -160.99 120.54 2.64 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.839 ' CE1' HD12 ' A' ' 64' ' ' ILE . 77.9 m-85 -89.03 116.81 27.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 110.273 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 55.8 m-85 -108.31 125.87 52.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.399 -0.813 . . . . 0.0 109.507 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.998 HG22 HG23 ' A' ' 107' ' ' ILE . 1.9 t -121.34 129.92 75.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.324 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 83' ' ' VAL . 55.4 t30 51.05 37.84 18.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 110.361 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 58.2 t30 65.06 36.75 7.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 110.385 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.684 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -135.02 167.04 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.228 -0.92 . . . . 0.0 110.031 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.05 73.07 5.72 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.585 -0.697 . . . . 0.0 109.556 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.55 164.37 35.12 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.994 1.523 . . . . 0.0 110.563 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.86 -178.38 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.138 1.599 . . . . 0.0 110.221 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.528 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -85.01 20.08 1.97 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 110.741 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.67 42.01 1.11 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.485 -0.76 . . . . 0.0 109.672 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.28 -174.85 4.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.503 -0.748 . . . . 0.0 110.144 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 43.6 p -139.68 146.68 39.96 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.501 -0.75 . . . . 0.0 110.386 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.092 ' HA ' HD23 ' A' ' 94' ' ' LEU . 24.3 mmm -53.56 -42.45 67.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.662 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.52 -46.71 37.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.1 OUTLIER -65.35 -33.05 75.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -1.209 . . . . 0.0 109.827 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.092 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.11 -19.79 64.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.936 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.651 ' CD1' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -49.55 -56.42 9.95 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.005 -1.059 . . . . 0.0 109.632 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -70.15 -15.23 62.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.461 -1.4 . . . . 0.0 111.243 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 2.2 mm-40 -87.44 -64.74 1.1 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.969 -1.082 . . . . 0.0 112.925 -178.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.62 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -97.97 39.69 1.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.875 -1.14 . . . . 0.0 111.445 -177.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.588 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 1.6 t60 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.588 ' CE1' HG13 ' A' ' 32' ' ' ILE . 3.1 p90 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.294 0.568 . . . . 0.0 110.304 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.038 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.28 168.11 9.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.19 -0.944 . . . . 0.0 109.113 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.669 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.1 p90 -124.64 127.28 47.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.785 -1.197 . . . . 0.0 111.854 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.038 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.7 mt -136.73 144.56 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.078 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -133.55 175.65 9.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.949 . . . . 0.0 110.018 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.9 OUTLIER -147.42 167.6 23.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.972 . . . . 0.0 110.478 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -158.58 165.21 35.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.723 . . . . 0.0 110.285 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.536 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 4.3 p-10 . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 110.312 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HD2' ' N ' ' A' ' 28' ' ' ARG . 3.2 mpt_? . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.3 0.571 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.688 HG12 HG12 ' A' ' 31' ' ' VAL . 9.2 t -143.53 104.45 5.01 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 110.295 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.7 Cg_endo -78.71 87.84 1.51 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.159 1.61 . . . . 0.0 109.928 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.688 HG12 HG12 ' A' ' 29' ' ' VAL . 1.2 m -83.42 144.02 10.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.136 -0.977 . . . . 0.0 110.882 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 31.5 mm -97.5 162.52 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.837 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.4 t -136.69 139.6 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.912 -1.117 . . . . 0.0 111.221 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.576 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.3 tm-20 -154.03 163.87 39.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' HD2' HD11 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -99.97 158.68 15.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.885 -1.135 . . . . 0.0 110.909 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.016 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.92 -173.55 0.11 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.562 -0.711 . . . . 0.0 109.185 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.016 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.0 Cg_endo -72.0 109.1 2.61 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.507 1.267 . . . . 0.0 110.112 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 62.15 42.86 9.21 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.367 -0.833 . . . . 0.0 110.293 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.426 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -63.99 179.92 0.48 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.517 ' CG ' ' OD1' ' A' ' 111' ' ' ASP . 0.9 OUTLIER -149.84 30.74 0.72 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.163 -0.961 . . . . 0.0 110.821 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.544 HD11 ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -85.18 -179.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.048 -1.033 . . . . 0.0 109.924 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.515 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -59.81 168.03 8.26 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -87.35 171.64 10.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -1.11 . . . . 0.0 110.34 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.905 HD13 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -136.51 146.28 46.06 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.351 -0.843 . . . . 0.0 110.105 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.441 ' C ' ' HD3' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -86.95 -7.49 58.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.854 . . . . 0.0 110.182 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.905 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -154.12 155.66 35.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.004 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -126.44 45.18 2.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.003 . . . . 0.0 109.716 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -158.62 111.77 2.35 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.467 -0.77 . . . . 0.0 109.879 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.848 ' OH ' HD11 ' A' ' 44' ' ' LEU . 11.6 m-85 -104.91 142.37 34.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -0.979 . . . . 0.0 110.127 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.49 100.62 8.65 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.509 -0.745 . . . . 0.0 109.136 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.98 ' HB ' HD12 ' A' ' 55' ' ' LEU . 3.5 m -126.94 159.6 63.66 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.142 -0.974 . . . . 0.0 110.763 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 46.2 Cg_endo -71.43 147.86 53.29 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.194 1.629 . . . . 0.0 110.594 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.564 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -64.77 -14.59 59.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 111.533 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -83.52 -10.92 58.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.883 -1.136 . . . . 0.0 110.764 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.98 HD12 ' HB ' ' A' ' 51' ' ' VAL . 4.5 mt -62.56 143.38 57.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.083 -1.011 . . . . 0.0 111.038 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 p -90.63 158.27 17.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.49 -0.756 . . . . 0.0 109.199 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.606 HG12 HG22 ' A' ' 87' ' ' THR . 61.1 t -57.09 -23.01 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.091 -1.005 . . . . 0.0 110.032 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.98 -33.67 59.49 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.899 ' CB ' HD22 ' A' ' 55' ' ' LEU . 24.3 mm-40 -72.27 -50.61 25.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.151 -1.205 . . . . 0.0 109.759 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.101 ' CE2' HD11 ' A' ' 64' ' ' ILE . 47.2 t80 -60.56 -32.02 71.11 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.273 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.664 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -63.41 -29.28 70.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.033 -1.042 . . . . 0.0 109.498 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.3 t80 -69.85 -53.36 18.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 110.126 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.075 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -59.87 -33.59 72.01 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.426 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.101 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -75.13 -33.4 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 119.777 -1.827 . . . . 0.0 109.701 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -38.29 -63.89 0.46 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 0.0 110.721 -179.164 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -30.62 71.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 110.132 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.644 ' CD ' HD21 ' A' ' 44' ' ' LEU . 20.2 mmt180 -66.15 -20.29 66.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.202 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.873 ' CG2' HD23 ' A' ' 70' ' ' LEU . 68.8 mt -104.2 15.7 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.977 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.515 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 49.68 28.37 2.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.411 -0.806 . . . . 0.0 110.241 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.873 HD23 ' CG2' ' A' ' 68' ' ' ILE . 3.8 pp -110.11 160.48 16.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.428 -0.795 . . . . 0.0 109.519 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.4 ptt180 -165.25 -171.9 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.046 -1.034 . . . . 0.0 110.822 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 52.08 -89.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.487 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 72' ' ' ALA . 33.1 mt-10 -157.11 29.29 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.951 . . . . 0.0 110.703 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.39 176.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.117 -0.99 . . . . 0.0 109.846 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.518 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -87.45 137.71 32.1 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 121.382 0.61 . . . . 0.0 110.367 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.749 HD21 ' CE1' ' A' ' 78' ' ' PHE . 49.3 tp -164.83 152.78 11.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.787 . . . . 0.0 110.426 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.594 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 89.8 m-85 -158.77 118.47 3.13 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.556 -0.715 . . . . 0.0 110.021 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.749 ' CE1' HD21 ' A' ' 76' ' ' LEU . 19.3 m-30 -84.96 132.67 34.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.0 -1.062 . . . . 0.0 111.054 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 59.5 m-85 -117.63 119.79 36.04 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.421 -0.799 . . . . 0.0 109.138 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.679 HG13 ' CG1' ' A' ' 107' ' ' ILE . 2.8 t -120.96 123.47 70.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.592 -0.693 . . . . 0.0 110.198 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.63 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.6 m120 49.54 42.04 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 3.7 m120 62.5 35.72 14.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.351 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -135.2 167.39 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.0 68.53 5.48 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 109.454 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.74 163.07 38.13 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.982 1.517 . . . . 0.0 110.891 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.4 -178.26 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.146 1.603 . . . . 0.0 110.419 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.606 HG22 HG12 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -84.75 22.18 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.389 -0.819 . . . . 0.0 110.864 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -94.27 41.23 1.09 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 109.65 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.45 -172.48 3.89 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.598 0.713 . . . . 0.0 110.288 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 63.5 p -139.79 140.74 36.73 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.674 -0.641 . . . . 0.0 110.159 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.038 ' HA ' HD23 ' A' ' 94' ' ' LEU . 9.3 mmm -49.18 -41.87 38.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.163 -0.961 . . . . 0.0 110.261 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.564 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.81 -47.65 52.71 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.2 OUTLIER -64.86 -30.87 71.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -1.097 . . . . 0.0 109.94 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.038 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.3 -24.51 64.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 110.031 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.586 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -49.46 -56.13 10.81 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 109.764 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -69.85 -17.8 63.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.003 -1.06 . . . . 0.0 111.124 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.3 mm-40 -87.53 -68.24 0.77 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.973 -1.08 . . . . 0.0 112.363 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.513 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 10.6 m-70 -99.38 38.65 1.39 Allowed 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.871 -1.143 . . . . 0.0 111.937 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.543 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.4 p80 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.136 -0.978 . . . . 0.0 109.41 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.0 p90 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.28 0.562 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.931 HD13 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -111.77 169.55 8.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.313 -0.867 . . . . 0.0 109.693 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.716 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -126.56 126.19 43.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.731 -1.23 . . . . 0.0 110.986 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.679 ' CG1' HG13 ' A' ' 80' ' ' VAL . 11.7 mt -141.25 147.98 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.306 -0.872 . . . . 0.0 109.64 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -142.5 -179.92 6.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.111 -0.993 . . . . 0.0 110.286 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.837 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.6 p90 -150.02 162.71 39.86 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.645 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.768 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -159.39 168.44 26.3 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.566 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.517 ' OD1' ' CG ' ' A' ' 40' ' ' ARG . 16.9 p-10 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.074 -1.016 . . . . 0.0 110.187 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 3.2 mpt_? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.336 0.589 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.807 HG12 HG12 ' A' ' 31' ' ' VAL . 21.6 t -145.94 110.64 4.42 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 109.963 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.597 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 47.0 Cg_endo -73.44 87.9 1.05 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 124.175 1.619 . . . . 0.0 109.949 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 49' ' ' TYR . 1.4 m -88.12 144.1 9.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.33 -0.856 . . . . 0.0 111.411 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 16.2 mm -108.98 135.8 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -120.25 140.89 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.737 -1.227 . . . . 0.0 112.142 -178.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -145.6 172.49 13.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.655 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -97.44 161.49 13.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.814 -1.179 . . . . 0.0 110.802 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.026 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.09 -173.22 0.1 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.488 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.026 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.4 Cg_endo -72.55 112.09 3.39 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.547 1.288 . . . . 0.0 109.827 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 59.67 43.04 16.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.888 . . . . 0.0 110.178 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -66.05 179.36 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.31 -0.869 . . . . 0.0 110.166 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.455 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.3 34.24 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.948 . . . . 0.0 110.785 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.88 HD13 HG23 ' A' ' 68' ' ' ILE . 1.9 pp -85.89 177.51 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.012 -1.055 . . . . 0.0 110.418 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.814 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -52.23 -174.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.832 0 O-C-N 121.266 -0.896 . . . . 0.0 111.273 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 1.002 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -81.67 -175.8 5.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -1.078 . . . . 0.0 110.107 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.002 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.2 mm? -140.17 135.33 32.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.942 . . . . 0.0 110.775 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 46' ' ' LYS . 2.9 p30 -86.39 -27.35 24.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.497 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.508 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -153.2 155.65 37.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.84 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.711 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -124.4 42.98 3.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.021 -1.05 . . . . 0.0 110.042 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -159.46 109.36 1.91 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.446 -0.784 . . . . 0.0 109.78 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.874 ' O ' HG22 ' A' ' 31' ' ' VAL . 29.9 m-85 -106.44 141.72 37.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.046 -1.033 . . . . 0.0 110.823 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mp -107.06 93.99 4.86 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.61 ' HB ' HD12 ' A' ' 55' ' ' LEU . 35.0 m -113.18 152.45 45.09 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.933 . . . . 0.0 111.314 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.442 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.6 Cg_endo -70.49 145.52 53.12 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.317 1.693 . . . . 0.0 109.625 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.554 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 1.7 m -62.9 -11.87 21.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.349 -0.845 . . . . 0.0 111.451 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -85.5 -14.54 45.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 0.0 111.104 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.873 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.9 mt -62.21 142.43 57.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.028 -1.045 . . . . 0.0 111.372 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.7 p -91.09 162.65 14.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.744 -0.597 . . . . 0.0 109.788 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.475 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 91.4 t -58.44 -25.67 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.093 -1.004 . . . . 0.0 109.963 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.93 94.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.873 ' CB ' HD22 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -67.69 -48.0 67.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -1.197 . . . . 0.0 109.877 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.177 ' CE2' HD11 ' A' ' 64' ' ' ILE . 8.0 t80 -60.23 -32.46 71.15 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.068 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.476 ' CD1' ' HE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -55.36 -36.6 66.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 110.085 178.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.72 -49.98 12.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.437 -0.79 . . . . 0.0 112.691 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.163 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.43 -40.33 82.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.51 -1.368 . . . . 0.0 111.975 -177.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.177 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -75.22 -42.53 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 119.907 -1.746 . . . . 0.0 108.278 178.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.429 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -39.84 -54.89 2.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.628 -0.67 . . . . 0.0 110.53 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -64.33 -35.89 82.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.138 -0.976 . . . . 0.0 109.937 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.524 ' CG ' ' OH ' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -69.68 -14.39 62.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.187 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.97 HD12 HD21 ' A' ' 44' ' ' LEU . 2.3 mm -93.2 4.27 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.494 -0.754 . . . . 0.0 109.721 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.1 t60 53.43 33.71 16.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 110.484 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.96 HD12 ' O ' ' A' ' 70' ' ' LEU . 1.0 OUTLIER -104.96 156.56 17.92 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' A' ' 73' ' ' GLU . 12.9 ptt180 -165.83 -168.2 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.832 -1.168 . . . . 0.0 111.247 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.35 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 110.963 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 74' ' ' ASP . 5.2 pt-20 -152.16 24.01 0.64 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.146 -0.971 . . . . 0.0 111.106 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.29 177.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 109.85 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.1 141.14 37.18 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.112 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.76 HD21 ' CE2' ' A' ' 78' ' ' PHE . 26.2 tp -154.83 153.11 30.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.469 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 95.4 m-85 -158.43 121.16 3.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.622 -0.674 . . . . 0.0 109.79 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.76 ' CE2' HD21 ' A' ' 76' ' ' LEU . 72.3 m-85 -92.26 123.01 35.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 110.488 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 52.0 m-85 -115.45 136.76 52.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.594 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.827 HG22 HG12 ' A' ' 107' ' ' ILE . 12.6 t -119.87 121.81 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.0 110.456 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.633 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.1 OUTLIER 49.31 48.58 20.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.418 -0.801 . . . . 0.0 110.656 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 62.28 29.37 17.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 110.557 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.651 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.8 t -126.16 168.59 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.966 . . . . 0.0 109.675 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -154.63 68.19 5.62 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.472 -0.767 . . . . 0.0 109.747 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.2 168.1 25.6 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.011 1.532 . . . . 0.0 110.341 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.96 -179.78 4.61 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.052 1.554 . . . . 0.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.475 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -86.91 20.59 2.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.335 -0.853 . . . . 0.0 110.534 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -90.99 39.34 0.99 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.437 -0.789 . . . . 0.0 109.402 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.761 ' HB1' ' CD ' ' A' ' 93' ' ' GLN . . . -145.43 -177.29 5.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.571 -0.705 . . . . 0.0 110.088 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 81.2 p -140.07 144.38 36.81 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.465 -0.772 . . . . 0.0 110.395 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.054 ' HA ' HD23 ' A' ' 94' ' ' LEU . 39.8 mmm -43.88 -39.02 3.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.513 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -55.71 -48.27 72.71 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.761 ' CD ' ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -64.26 -30.51 71.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -1.175 . . . . 0.0 109.87 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.054 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.26 -27.37 66.28 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.232 -0.917 . . . . 0.0 109.813 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.585 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -50.28 -54.71 19.34 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.981 -1.074 . . . . 0.0 109.566 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -68.15 -20.68 64.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.815 -1.178 . . . . 0.0 110.51 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 10.1 mt-10 -88.22 -73.69 0.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.182 -0.948 . . . . 0.0 112.468 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.583 ' CG ' ' HB2' ' A' ' 81' ' ' ASN . 22.2 m-70 -100.69 37.2 1.76 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.786 -1.196 . . . . 0.0 112.361 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.518 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.5 2.032 0 O-C-N 121.035 -1.041 . . . . 0.0 109.748 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 30' ' ' PRO . 7.4 m-85 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.969 HD11 HD12 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -84.87 159.76 20.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.746 -1.221 . . . . 0.0 109.486 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.477 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -115.64 120.62 39.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.851 -1.155 . . . . 0.0 111.655 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.969 HD12 HD11 ' A' ' 105' ' ' LEU . 15.6 mt -141.44 140.72 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 109.241 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.43 177.61 7.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.137 -0.977 . . . . 0.0 110.136 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.655 ' CE2' ' CD ' ' A' ' 35' ' ' LYS . 1.4 p90 -144.86 165.12 29.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 110.648 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -158.14 178.67 9.94 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.271 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.674 ' HB3' HG22 ' A' ' 41' ' ' ILE . 27.9 p-10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 110.266 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.294 0.569 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.694 HG12 HG12 ' A' ' 31' ' ' VAL . 24.6 t -147.2 108.48 3.92 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 110.512 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.592 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 50.5 Cg_endo -78.87 81.59 2.74 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.363 1.717 . . . . 0.0 110.108 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.694 HG12 HG12 ' A' ' 29' ' ' VAL . 1.7 m -77.52 141.41 15.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.187 -0.946 . . . . 0.0 111.119 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 106' ' ' TYR . 46.8 mm -97.44 155.72 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.832 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.7 t -133.86 141.77 43.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.933 -1.104 . . . . 0.0 111.298 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.64 -179.24 8.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.547 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -115.83 159.77 21.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.857 -1.152 . . . . 0.0 110.295 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -61.3 -174.94 0.08 OUTLIER Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.54 -0.725 . . . . 0.0 109.248 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.6 Cg_endo -70.86 108.66 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.52 1.274 . . . . 0.0 109.842 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.4 38.55 9.98 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.352 -0.842 . . . . 0.0 110.012 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.547 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -56.22 179.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.26 -0.9 . . . . 0.0 110.125 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.14 32.18 0.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 110.611 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.829 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.93 176.38 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 110.208 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.829 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -50.18 -175.19 0.01 OUTLIER Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.315 -0.866 . . . . 0.0 110.997 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.965 ' O ' HD22 ' A' ' 44' ' ' LEU . 3.3 t0 -77.0 -175.53 3.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -1.134 . . . . 0.0 109.889 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.965 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.4 mm? -137.19 135.56 37.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.06 -1.025 . . . . 0.0 110.494 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -86.28 -34.63 20.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.723 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -153.87 159.85 41.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.752 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.561 ' HG2' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -124.0 40.0 3.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.054 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.561 ' HG3' ' HG2' ' A' ' 47' ' ' LYS . 23.9 mttt -158.69 106.17 1.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.546 -0.721 . . . . 0.0 109.66 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.881 ' CD2' HD13 ' A' ' 63' ' ' LEU . 30.3 m-85 -104.86 139.62 39.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.87 -1.144 . . . . 0.0 110.25 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.52 99.35 8.13 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.79 ' HB ' HD12 ' A' ' 55' ' ' LEU . 4.2 m -126.18 163.65 38.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.128 -0.983 . . . . 0.0 111.157 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 45.4 Cg_endo -71.05 144.09 46.29 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.142 1.601 . . . . 0.0 110.389 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.556 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -63.86 -13.43 44.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.41 -0.806 . . . . 0.0 111.375 -179.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -83.59 -10.2 58.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.989 -1.07 . . . . 0.0 110.884 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.833 HD22 ' HB2' ' A' ' 59' ' ' GLN . 4.0 mt -62.3 141.75 58.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.995 -1.066 . . . . 0.0 111.335 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 1.4 p -91.24 157.95 16.87 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.628 -0.67 . . . . 0.0 109.217 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.657 HG12 HG22 ' A' ' 87' ' ' THR . 53.0 t -55.26 -24.05 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.06 -1.025 . . . . 0.0 110.06 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.2 87.72 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.833 ' HB2' HD22 ' A' ' 55' ' ' LEU . 1.4 mt-30 -67.73 -44.2 78.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.179 -1.189 . . . . 0.0 110.122 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.154 ' CE2' HD11 ' A' ' 64' ' ' ILE . 17.4 t80 -60.65 -46.4 90.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.038 -1.039 . . . . 0.0 109.568 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.465 ' HE1' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -50.78 -21.76 1.81 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.948 -1.095 . . . . 0.0 109.902 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.3 -54.57 5.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.394 -0.816 . . . . 0.0 110.597 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.994 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.8 pp -59.78 -21.85 61.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.945 -1.097 . . . . 0.0 112.169 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.154 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.1 mt -92.77 -35.19 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.191 -1.568 . . . . 0.0 109.219 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.777 ' HG2' HD11 ' A' ' 70' ' ' LEU . 2.8 mtp85 -35.94 -63.71 0.35 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.853 -0.529 . . . . 0.0 110.855 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -31.15 72.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.043 -1.035 . . . . 0.0 109.88 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.502 ' C ' HD13 ' A' ' 68' ' ' ILE . 19.7 mmt180 -67.24 -16.32 64.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 110.009 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.766 ' CG2' HD23 ' A' ' 70' ' ' LEU . 1.3 mm -101.1 12.86 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.959 . . . . 0.0 109.708 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.5 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 50.42 30.81 4.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.462 -0.774 . . . . 0.0 110.369 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.779 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.2 pp -110.35 155.59 21.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 0.0 109.695 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.72 -172.42 2.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.116 -0.99 . . . . 0.0 111.014 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.56 -89.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 110.775 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 71' ' ' ARG . 5.6 pt-20 -150.34 35.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 110.872 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -58.38 177.23 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.14 -0.975 . . . . 0.0 109.966 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.522 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -107.1 138.3 43.54 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.378 0.609 . . . . 0.0 110.34 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.755 HD21 ' CE1' ' A' ' 78' ' ' PHE . 15.2 tp -164.7 152.66 11.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 0.0 110.249 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 83.8 m-85 -157.79 121.83 4.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.644 -0.66 . . . . 0.0 109.972 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 64' ' ' ILE . 16.9 m-30 -82.59 122.67 28.39 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.16 -0.962 . . . . 0.0 111.57 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 69.8 m-85 -113.57 120.37 40.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.837 HG22 HG23 ' A' ' 107' ' ' ILE . 2.4 t -121.06 128.38 76.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.4 -0.812 . . . . 0.0 109.998 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.3 t30 49.75 42.32 23.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 0.0 110.229 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 2.9 m-20 60.39 36.56 20.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.467 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.697 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -134.87 166.03 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 109.987 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.812 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -155.26 72.89 5.61 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 109.542 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.72 163.79 37.44 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.032 1.543 . . . . 0.0 110.792 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.47 -178.57 3.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.08 1.569 . . . . 0.0 110.357 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.657 HG22 HG12 ' A' ' 57' ' ' VAL . 1.1 p -85.92 19.52 2.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.857 . . . . 0.0 110.774 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.0 m -96.75 42.43 1.09 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.525 -0.734 . . . . 0.0 109.621 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.34 -172.46 3.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.491 -0.756 . . . . 0.0 110.319 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 77.2 p -139.42 140.64 37.41 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.477 0.656 . . . . 0.0 110.158 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.052 ' HA ' HD23 ' A' ' 94' ' ' LEU . 59.7 mtm -52.51 -38.72 60.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 109.938 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -50.51 -49.54 39.0 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 90' ' ' THR . 4.0 pt20 -64.68 -28.92 69.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -1.163 . . . . 0.0 109.664 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.052 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.17 -23.63 64.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 110.132 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.592 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -49.05 -54.29 16.53 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.707 -1.246 . . . . 0.0 109.755 -179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.35 -18.96 63.07 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.21 -0.931 . . . . 0.0 111.25 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.7 mt-10 -86.34 -65.03 1.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.91 -1.119 . . . . 0.0 112.288 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.581 ' CD2' ' HB ' ' A' ' 80' ' ' VAL . 16.6 m-70 -98.02 38.06 1.35 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.929 -1.107 . . . . 0.0 111.254 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.454 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.494 -0.754 . . . . 0.0 109.437 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.183 0.516 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.068 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -104.91 168.94 8.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.229 -0.919 . . . . 0.0 109.199 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.708 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -119.23 128.26 54.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.615 -1.303 . . . . 0.0 111.778 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.068 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.2 mt -139.2 129.33 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.19 -0.944 . . . . 0.0 110.483 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -128.55 152.3 48.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.154 -0.966 . . . . 0.0 108.778 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.832 ' HE1' HG13 ' A' ' 33' ' ' VAL . 2.3 p90 -131.4 167.09 19.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.55 -1.344 . . . . 0.0 111.647 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -153.88 -179.79 8.17 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.101 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.646 ' HB3' HG22 ' A' ' 41' ' ' ILE . 7.1 p-10 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.165 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.386 0.612 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.68 HG12 HG12 ' A' ' 31' ' ' VAL . 12.3 t -147.76 114.05 4.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.385 -0.822 . . . . 0.0 110.081 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 51.3 Cg_endo -78.1 87.08 1.56 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 124.166 1.614 . . . . 0.0 110.055 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.728 HG12 ' CD2' ' A' ' 105' ' ' LEU . 1.6 m -83.17 151.72 3.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.171 -0.955 . . . . 0.0 110.892 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 30.8 mm -105.96 160.41 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 108.714 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.708 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.5 t -134.2 141.05 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.801 -1.187 . . . . 0.0 111.404 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 7.0 tt0 -156.23 175.38 14.06 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.605 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -103.7 160.39 14.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.931 -1.106 . . . . 0.0 110.528 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.978 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -62.7 -174.47 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.781 . . . . 0.0 109.095 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.978 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.7 Cg_endo -70.52 103.7 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.418 1.22 . . . . 0.0 110.025 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 5.7 mttt 63.61 40.16 8.23 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.859 . . . . 0.0 110.076 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . . . -61.99 179.49 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.201 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.485 ' HG2' ' OD2' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -150.22 35.45 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.0 110.532 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.503 HG12 HG23 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -84.74 179.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.991 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 68' ' ' ILE . . . -57.26 -179.75 0.69 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -167.53 0.19 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.382 -1.069 . . . . 0.0 110.271 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.056 HD13 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.35 147.51 38.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 110.729 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.797 ' N ' HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -87.32 -42.84 12.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.154 -0.966 . . . . 0.0 110.324 -179.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.584 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -152.15 159.57 43.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.755 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -116.99 39.85 3.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.113 -0.992 . . . . 0.0 110.463 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 9.7 pttt -162.01 107.34 1.25 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.289 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.717 ' CD2' HD13 ' A' ' 63' ' ' LEU . 11.4 m-85 -108.01 142.43 38.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -0.991 . . . . 0.0 110.125 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mp -116.0 103.22 10.37 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.822 ' HB ' HD12 ' A' ' 55' ' ' LEU . 3.0 m -129.78 162.75 51.53 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 111.098 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 43.5 Cg_endo -68.26 146.47 69.61 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.167 1.614 . . . . 0.0 110.451 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.556 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -63.65 -11.1 22.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 111.598 -178.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.68 -7.91 59.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.902 -1.124 . . . . 0.0 110.675 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.919 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.1 mt -62.43 141.39 58.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.127 -0.983 . . . . 0.0 111.157 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -91.17 158.52 16.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.671 -0.643 . . . . 0.0 109.48 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 79.4 t -57.29 -24.27 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.101 -0.999 . . . . 0.0 109.693 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.56 -34.8 67.61 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.919 ' CB ' HD22 ' A' ' 55' ' ' LEU . 17.8 mm-40 -67.89 -50.72 54.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -1.134 . . . . 0.0 109.336 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.192 ' CE2' HD11 ' A' ' 64' ' ' ILE . 6.2 t80 -60.21 -35.32 75.15 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.153 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.597 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -53.29 -34.8 58.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 110.028 178.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -51.12 9.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.358 -0.839 . . . . 0.0 112.705 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.159 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.37 -39.19 78.94 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.489 -1.382 . . . . 0.0 112.077 -177.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.192 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -77.49 -41.73 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 119.862 -1.774 . . . . 0.0 108.323 178.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.659 ' HG2' HD22 ' A' ' 76' ' ' LEU . 9.2 mtp180 -43.25 -52.27 5.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.413 -0.805 . . . . 0.0 109.983 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -35.73 81.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.538 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 8.9 mmt85 -70.29 -15.81 62.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.575 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.607 HD11 ' CD2' ' A' ' 109' ' ' TYR . 30.6 mt -89.39 -1.17 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.4 -0.813 . . . . 0.0 109.352 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 69' ' ' HIS . 18.1 t60 56.33 31.11 18.01 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.412 -0.805 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.942 HD12 ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -96.9 153.04 18.13 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.983 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.5 ptp180 -166.94 -168.71 1.15 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.015 -1.053 . . . . 0.0 110.872 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 53.74 -87.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.835 . . . . 0.0 110.855 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 71' ' ' ARG . 35.4 mt-10 -153.93 33.25 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.659 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.526 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -61.56 177.1 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.091 -1.006 . . . . 0.0 109.921 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 111' ' ' ASP . . . -105.42 140.46 38.5 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.167 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.711 HD21 ' CE2' ' A' ' 78' ' ' PHE . 18.7 tp -149.78 152.81 35.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.179 -0.951 . . . . 0.0 110.474 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 73.3 m-85 -161.82 120.73 2.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.772 -0.58 . . . . 0.0 109.649 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' HD21 ' A' ' 76' ' ' LEU . 63.0 m-85 -93.22 123.22 36.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.064 -1.023 . . . . 0.0 110.106 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 66.8 m-85 -113.88 132.04 56.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.993 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.689 HG22 HG23 ' A' ' 107' ' ' ILE . 2.6 t -121.04 113.12 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.326 -0.859 . . . . 0.0 110.156 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.887 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.2 t-20 59.19 51.4 6.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 110.283 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 16.9 m-20 56.44 31.21 18.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.318 -0.863 . . . . 0.0 110.487 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.5 t -130.74 167.3 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.202 -0.936 . . . . 0.0 109.904 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -154.98 67.84 5.33 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.557 -0.715 . . . . 0.0 109.478 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.58 170.18 20.59 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.052 1.554 . . . . 0.0 110.707 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.99 -179.02 3.52 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.078 1.567 . . . . 0.0 110.416 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.524 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -87.34 25.46 1.4 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.36 -0.838 . . . . 0.0 110.701 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.21 41.84 1.11 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.408 -0.807 . . . . 0.0 109.768 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.4 -175.53 4.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 110.461 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 62.8 p -139.44 139.65 37.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.631 -0.668 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.063 ' HA ' HD23 ' A' ' 94' ' ' LEU . 4.5 mmt -49.26 -38.62 27.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.165 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -52.31 -48.99 52.75 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 3.9 pt20 -64.63 -29.41 70.41 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.634 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.063 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.33 -24.86 64.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.59 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -49.63 -56.17 11.03 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.977 -1.077 . . . . 0.0 109.773 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.62 -17.62 63.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.754 -1.216 . . . . 0.0 111.093 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -88.47 -68.42 0.77 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.142 -0.974 . . . . 0.0 113.402 -177.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 81' ' ' ASN . 18.1 m-70 -100.16 40.71 1.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.726 -1.234 . . . . 0.0 112.771 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.568 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.9 p80 . . . . . 0 N--CA 1.497 1.915 0 O-C-N 121.051 -1.031 . . . . 0.0 109.657 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 104' ' ' PHE . 4.3 m-85 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.032 0.444 . . . . 0.0 109.812 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.075 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -109.16 165.4 11.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.091 -1.006 . . . . 0.0 109.608 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.768 ' N ' HD12 ' A' ' 105' ' ' LEU . 57.9 m-85 -122.06 129.49 52.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.823 -1.173 . . . . 0.0 112.173 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.075 ' CG1' HD11 ' A' ' 105' ' ' LEU . 4.5 mt -141.4 153.36 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.502 -0.749 . . . . 0.0 109.475 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -150.42 178.45 9.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 110.326 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.708 ' HE1' HG13 ' A' ' 33' ' ' VAL . 6.3 p90 -147.14 164.59 32.63 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.256 -0.977 . . . . 0.0 111.075 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.622 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -157.7 170.02 23.34 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.761 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' ALA . 11.7 p30 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 110.593 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.479 0.657 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.648 HG12 HG12 ' A' ' 31' ' ' VAL . 33.0 t -142.58 104.05 5.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.454 -0.779 . . . . 0.0 109.892 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.587 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 49.5 Cg_endo -76.9 90.75 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.138 1.599 . . . . 0.0 110.295 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.722 HG12 ' CD2' ' A' ' 105' ' ' LEU . 1.3 m -88.57 153.19 3.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.229 -0.92 . . . . 0.0 110.721 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.607 HD11 ' CD1' ' A' ' 104' ' ' PHE . 1.4 mp -103.04 165.12 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 108.772 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.803 HG21 ' CE1' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -139.4 133.82 39.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.048 -1.032 . . . . 0.0 110.877 -179.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -151.84 163.69 38.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.722 -0.611 . . . . 0.0 109.616 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.561 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -96.8 158.86 15.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 110.627 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.024 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.22 -174.28 0.12 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.722 . . . . 0.0 109.41 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.024 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.2 Cg_endo -70.33 107.5 1.98 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.486 1.256 . . . . 0.0 109.753 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 4.1 mtpt 64.14 42.72 5.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.375 -0.828 . . . . 0.0 109.944 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.485 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -64.39 179.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 110.267 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.497 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.6 OUTLIER -150.32 33.85 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.947 . . . . 0.0 110.425 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.781 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.7 pp -85.33 178.17 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.046 -1.034 . . . . 0.0 110.644 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.781 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -50.46 -172.73 0.01 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -80.34 179.38 7.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.356 -1.085 . . . . 0.0 110.002 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.4 pp -135.04 134.14 40.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 110.614 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . 15.4 t0 -86.43 -36.97 18.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.076 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.55 160.27 43.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 109.954 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -118.41 39.91 3.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.114 -0.992 . . . . 0.0 110.215 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.509 ' CG ' ' C ' ' A' ' 47' ' ' LYS . 6.2 mtmm -156.7 109.01 2.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.471 -0.768 . . . . 0.0 109.28 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.803 ' CE1' HG21 ' A' ' 33' ' ' VAL . 22.9 m-85 -103.63 141.89 35.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.902 -1.124 . . . . 0.0 110.808 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tp -105.44 104.81 14.61 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.472 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 16.6 m -131.76 144.23 52.4 Favored Pre-proline 0 C--N 1.3 -1.554 0 O-C-N 121.112 -0.993 . . . . 0.0 110.622 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 55' ' ' LEU . 41.5 Cg_endo -66.99 143.86 67.69 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.983 1.518 . . . . 0.0 110.053 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.566 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.7 m -61.47 -14.25 27.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.399 -0.813 . . . . 0.0 111.615 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -83.7 -15.31 49.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.082 -1.011 . . . . 0.0 111.053 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.867 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.9 mt -62.21 144.84 54.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.054 -1.028 . . . . 0.0 111.301 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.2 p -90.74 165.91 13.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.51 -0.744 . . . . 0.0 109.621 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.972 HG12 HG22 ' A' ' 87' ' ' THR . 46.5 t -60.33 -26.42 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 110.153 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.71 -41.33 93.86 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.867 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.6 mt-30 -67.64 -49.7 61.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.076 -1.25 . . . . 0.0 110.203 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.139 ' CE2' HD11 ' A' ' 64' ' ' ILE . 43.0 t80 -60.59 -33.9 73.41 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.724 -1.191 . . . . 0.0 109.502 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.665 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -63.43 -28.02 69.69 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.923 -1.11 . . . . 0.0 109.738 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -70.26 -53.52 16.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.295 -0.878 . . . . 0.0 110.281 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.992 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -59.54 -37.13 77.58 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 118.92 -1.112 . . . . 0.0 112.341 -178.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.139 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -70.45 -35.28 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 119.835 -1.791 . . . . 0.0 109.025 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.865 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -37.38 -63.41 0.45 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.72 -0.613 . . . . 0.0 110.774 -179.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -30.93 71.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.19 -0.944 . . . . 0.0 110.192 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.531 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 8.0 mmp_? -67.72 -17.81 64.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 109.945 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.89 ' CG2' HD23 ' A' ' 70' ' ' LEU . 36.5 mt -103.55 15.32 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.386 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.563 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 46.24 30.66 1.04 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.564 -0.71 . . . . 0.0 110.263 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.89 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.1 pp -108.83 155.24 21.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.413 -0.805 . . . . 0.0 109.84 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 73' ' ' GLU . 4.9 ptp180 -166.17 -168.73 1.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.657 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 47.99 -92.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.392 -0.817 . . . . 0.0 110.768 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 4.9 pt-20 -146.25 44.43 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.976 -1.078 . . . . 0.0 110.969 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -67.58 176.68 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.955 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -100.88 140.54 35.03 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.008 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.928 HD21 ' CE1' ' A' ' 78' ' ' PHE . 26.1 tp -164.24 152.68 12.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.982 . . . . 0.0 110.755 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 97.4 m-85 -158.52 119.7 3.42 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.706 -0.621 . . . . 0.0 109.666 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.928 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.5 m-30 -85.6 132.49 34.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.075 -1.015 . . . . 0.0 111.8 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 64.6 m-85 -120.29 120.42 35.99 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.771 HG22 HG23 ' A' ' 107' ' ' ILE . 2.1 t -120.97 125.95 74.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.422 -0.799 . . . . 0.0 109.839 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.769 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.3 OUTLIER 47.15 46.49 16.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.207 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 26.8 m120 58.11 37.07 26.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.288 -0.882 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -135.91 167.6 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.154 -0.966 . . . . 0.0 110.15 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.83 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -155.19 70.05 5.58 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.492 -0.755 . . . . 0.0 109.552 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.83 163.58 36.74 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.009 1.531 . . . . 0.0 110.735 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.3 -178.63 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.214 1.639 . . . . 0.0 110.622 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.972 HG22 HG12 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -86.7 20.48 2.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.309 -0.869 . . . . 0.0 110.681 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.1 m -91.51 39.2 1.0 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.47 -0.769 . . . . 0.0 109.641 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.697 ' HB1' ' OE1' ' A' ' 93' ' ' GLN . . . -145.51 -171.97 3.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.535 -0.728 . . . . 0.0 110.243 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 73.0 p -139.55 143.08 37.21 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.626 -0.671 . . . . 0.0 110.116 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.053 ' HA ' HD23 ' A' ' 94' ' ' LEU . 51.0 mmm -46.23 -46.35 17.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.806 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.566 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -47.97 -48.77 24.63 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.635 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.697 ' OE1' ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -64.39 -31.81 73.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.108 -1.23 . . . . 0.0 110.155 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.053 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.59 -22.27 64.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.114 -0.991 . . . . 0.0 110.198 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.579 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -49.27 -55.48 12.54 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.938 -1.101 . . . . 0.0 109.874 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -70.43 -16.89 62.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.034 -1.041 . . . . 0.0 111.34 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -87.35 -64.78 1.1 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.106 -0.996 . . . . 0.0 112.924 -177.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.594 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 14.0 m-70 -98.24 37.37 1.45 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.816 -1.178 . . . . 0.0 112.103 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.396 -0.815 . . . . 0.0 109.694 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.607 ' CD1' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.058 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.3 166.71 11.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.866 -1.146 . . . . 0.0 109.693 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.726 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -124.46 131.61 53.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.959 -1.088 . . . . 0.0 111.503 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.058 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.6 mt -138.64 143.4 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.195 -0.94 . . . . 0.0 110.119 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.73 176.06 9.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.227 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.0 OUTLIER -149.93 164.23 35.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.798 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.3 t -152.44 -178.1 6.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.693 -0.629 . . . . 0.0 109.941 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.497 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 57.3 p-10 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.885 . . . . 0.0 110.22 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.286 0.565 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.517 HG21 ' HA2' ' A' ' 92' ' ' GLY . 15.6 t -146.99 103.82 3.85 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 49.5 Cg_endo -74.51 106.63 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.382 1.727 . . . . 0.0 109.829 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.792 HG13 HD21 ' A' ' 105' ' ' LEU . 38.2 t -105.44 133.59 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.997 . . . . 0.0 110.718 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.858 HD11 ' CD1' ' A' ' 104' ' ' PHE . 44.3 mm -91.63 154.54 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.843 . . . . 0.0 109.025 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.704 HG21 ' CE1' ' A' ' 49' ' ' TYR . 2.7 t -132.13 144.46 37.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.939 -1.1 . . . . 0.0 111.498 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 7.4 mp0 -156.85 -179.65 8.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -110.7 160.79 16.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.729 -1.232 . . . . 0.0 110.581 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.012 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.91 -175.12 0.16 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.438 -0.789 . . . . 0.0 109.307 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.012 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.4 Cg_endo -71.44 106.11 1.88 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.532 1.28 . . . . 0.0 109.769 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 61.69 40.74 12.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.352 -0.843 . . . . 0.0 110.117 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . . . -60.97 -179.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.477 ' HG2' ' OD1' ' A' ' 111' ' ' ASP . 6.6 ptm180 -150.39 33.59 0.64 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 110.533 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.632 HG22 ' HB3' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -85.54 -175.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.04 . . . . 0.0 110.62 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -55.42 179.73 0.32 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -70.96 -172.92 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -1.147 . . . . 0.0 110.055 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.526 ' C ' HD12 ' A' ' 44' ' ' LEU . 1.2 pp -135.19 134.15 39.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 110.63 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -40.23 15.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HD3' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -152.85 164.76 37.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.299 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.77 38.22 4.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.106 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.59 105.04 1.82 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 0.0 109.952 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.901 ' CD2' HD13 ' A' ' 63' ' ' LEU . 45.3 m-85 -103.92 146.47 28.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 110.64 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.71 95.4 5.22 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.961 ' HB ' HD12 ' A' ' 55' ' ' LEU . 13.5 m -119.83 152.66 54.09 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.14 -0.975 . . . . 0.0 110.714 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.474 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.1 Cg_endo -71.23 149.48 57.67 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.097 1.577 . . . . 0.0 110.078 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.519 ' HB3' ' HA3' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -63.73 -13.94 47.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.325 -0.859 . . . . 0.0 111.397 -178.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.55 -10.71 53.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.908 -1.12 . . . . 0.0 111.11 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.961 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.6 mt -62.14 141.89 57.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.867 -1.145 . . . . 0.0 111.335 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 p -91.59 163.14 14.23 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.637 -0.665 . . . . 0.0 109.449 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.992 HG12 HG22 ' A' ' 87' ' ' THR . 78.9 t -58.96 -22.56 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.023 -1.048 . . . . 0.0 110.056 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.73 -40.06 65.72 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.898 ' CB ' HD22 ' A' ' 55' ' ' LEU . 5.0 mm100 -67.87 -47.81 67.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.149 -1.206 . . . . 0.0 109.893 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.149 ' CE2' HD11 ' A' ' 64' ' ' ILE . 19.5 t80 -60.38 -46.39 90.13 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.146 -0.971 . . . . 0.0 109.647 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -50.35 -22.68 1.93 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.016 -1.053 . . . . 0.0 110.021 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -80.86 -54.5 5.54 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.566 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.03 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.9 pp -59.84 -19.1 48.98 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.909 -1.12 . . . . 0.0 112.287 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.149 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.4 mt -91.57 -42.98 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.113 -1.617 . . . . 0.0 108.863 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.586 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.7 OUTLIER -36.91 -58.5 0.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.145 0.498 . . . . 0.0 110.696 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.87 -31.91 71.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 110.052 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 2.6 mmp_? -74.75 -7.5 53.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.86 . . . . 0.0 110.546 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.579 ' CD1' HG22 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -99.18 -8.74 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 0.0 109.546 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.469 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER 67.74 29.41 6.86 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.484 -0.76 . . . . 0.0 110.087 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -88.7 160.86 17.14 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.917 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -164.92 -166.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.004 -1.06 . . . . 0.0 110.724 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 42.9 -96.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.804 . . . . 0.0 110.559 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' ASP . 3.9 pt-20 -151.13 28.46 0.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.935 -1.103 . . . . 0.0 110.721 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.524 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -47.79 176.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.203 1.002 . . . . 0.0 110.029 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.524 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -115.0 142.16 47.01 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.778 HD21 ' CE1' ' A' ' 78' ' ' PHE . 13.6 tp -148.97 151.63 34.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.309 -0.87 . . . . 0.0 110.466 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 90.4 m-85 -158.2 122.88 4.24 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.793 -0.567 . . . . 0.0 109.866 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.821 ' CE2' HD12 ' A' ' 64' ' ' ILE . 18.0 m-30 -85.17 120.2 26.4 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.155 -0.966 . . . . 0.0 111.785 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.476 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 59.9 m-85 -106.98 122.1 45.76 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.515 -0.74 . . . . 0.0 109.06 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.939 HG22 HG23 ' A' ' 107' ' ' ILE . 2.2 t -121.3 126.29 74.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.421 -0.8 . . . . 0.0 109.934 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 10.6 t-20 51.32 34.29 11.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 0.0 110.038 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 1.3 t-20 69.31 34.95 2.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.433 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.689 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -134.97 166.81 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.9 . . . . 0.0 109.892 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.822 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.95 70.67 5.78 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 0.0 109.609 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.96 165.35 33.03 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.048 1.551 . . . . 0.0 110.582 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.92 -178.96 3.83 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.062 1.559 . . . . 0.0 110.376 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.992 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -85.96 19.59 2.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 0.0 110.825 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -91.07 40.46 1.03 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.488 -0.758 . . . . 0.0 109.355 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.61 -172.88 3.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.517 -0.739 . . . . 0.0 110.262 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 59.1 p -139.27 149.8 44.71 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.66 -0.65 . . . . 0.0 110.28 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.045 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -59.23 -40.6 86.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 110.005 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.519 ' HA3' ' HB3' ' A' ' 53' ' ' SER . . . -51.26 -46.49 51.61 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.7 OUTLIER -66.97 -28.85 68.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.238 -1.154 . . . . 0.0 109.715 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.045 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.97 -22.22 64.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.198 -0.939 . . . . 0.0 109.862 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.576 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -48.95 -53.78 18.31 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.884 -1.135 . . . . 0.0 109.505 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' HA ' ' HD2' ' A' ' 99' ' ' HIS . 0.0 OUTLIER -70.08 -19.16 63.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.049 -1.032 . . . . 0.0 111.455 179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.537 ' OE1' ' CE1' ' A' ' 98' ' ' HIS . 0.5 OUTLIER -88.65 -59.12 2.32 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -177.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.752 ' CD2' HG11 ' A' ' 80' ' ' VAL . 8.2 m-70 -98.65 40.12 1.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.648 -1.283 . . . . 0.0 113.09 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 5.9 p80 . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.858 ' CD1' HD11 ' A' ' 32' ' ' ILE . 1.1 m-85 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.928 0.394 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.065 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -107.4 169.96 8.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.959 -1.088 . . . . 0.0 109.248 179.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.697 ' N ' HD12 ' A' ' 105' ' ' LEU . 6.5 p90 -121.75 128.83 52.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.532 -1.355 . . . . 0.0 111.981 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.065 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.9 mt -141.07 141.04 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.311 -0.868 . . . . 0.0 110.184 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -136.29 166.72 22.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.966 -1.084 . . . . 0.0 109.773 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.722 ' HB2' HD11 ' A' ' 76' ' ' LEU . 2.9 p90 -134.26 163.86 28.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.747 -1.221 . . . . 0.0 111.518 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -158.52 177.1 11.6 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.248 0.547 . . . . 0.0 110.02 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.632 ' HB3' HG22 ' A' ' 41' ' ' ILE . 32.9 p30 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 110.145 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.451 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 10.5 mpt_? . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.184 0.516 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.716 HG12 HG12 ' A' ' 31' ' ' VAL . 16.3 t -144.99 108.99 4.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.947 . . . . 0.0 110.417 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.524 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.8 Cg_endo -77.83 91.16 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.186 1.624 . . . . 0.0 110.093 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.716 HG12 HG12 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -86.63 129.87 37.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.235 -0.916 . . . . 0.0 111.041 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 39.7 mm -91.71 136.06 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.09 -1.006 . . . . 0.0 108.502 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.757 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -119.94 146.44 24.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.864 -1.147 . . . . 0.0 111.304 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 0.1 OUTLIER -156.24 -164.44 1.68 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -122.1 158.84 28.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 0.0 110.605 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.974 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -61.49 -173.42 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.515 -0.74 . . . . 0.0 109.031 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.974 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.0 Cg_endo -69.62 106.71 1.68 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.372 1.196 . . . . 0.0 109.864 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 3.7 mmtt 64.69 41.43 5.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.426 -0.796 . . . . 0.0 110.274 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.535 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -60.07 -177.71 0.07 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.256 -0.902 . . . . 0.0 109.972 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.514 ' CG ' ' OD1' ' A' ' 111' ' ' ASP . 5.6 ptm180 -150.22 31.84 0.67 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 0.0 110.745 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.83 HD13 HG23 ' A' ' 68' ' ' ILE . 1.8 pp -85.53 177.12 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.083 -1.01 . . . . 0.0 110.351 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.83 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -49.04 -176.76 0.01 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.902 ' O ' HD22 ' A' ' 44' ' ' LEU . 7.8 t0 -75.17 -174.69 2.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.245 . . . . 0.0 109.871 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.902 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -135.66 135.66 40.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 0.0 110.371 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -86.67 -41.23 14.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.808 . . . . 0.0 109.988 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.81 154.32 34.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 110.039 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.757 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -113.44 44.94 1.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.04 -1.038 . . . . 0.0 110.004 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -161.85 112.84 1.65 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 110.043 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.737 ' HD2' HD13 ' A' ' 63' ' ' LEU . 8.5 m-85 -111.32 137.57 48.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 109.991 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.92 87.12 3.64 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.609 ' HB ' HD12 ' A' ' 55' ' ' LEU . 12.7 m -107.89 148.36 37.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 110.96 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HD2' HD12 ' A' ' 55' ' ' LEU . 47.7 Cg_endo -72.88 147.36 43.93 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.156 1.608 . . . . 0.0 109.688 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.562 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -62.2 -15.8 49.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.925 . . . . 0.0 111.459 -178.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -83.69 -14.23 52.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.115 -0.99 . . . . 0.0 111.18 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.793 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.7 mt -61.87 144.14 55.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.931 -1.106 . . . . 0.0 111.276 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 6.8 p -90.83 164.51 14.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 60.4 t -62.08 -27.34 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.043 -1.035 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.64 -36.66 88.24 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.793 ' CB ' HD22 ' A' ' 55' ' ' LEU . 8.5 mm-40 -70.17 -47.79 60.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.148 -1.207 . . . . 0.0 109.791 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.025 ' CE2' HD11 ' A' ' 64' ' ' ILE . 37.5 t80 -59.98 -32.75 71.13 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.144 -1.022 . . . . 0.0 108.942 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.557 ' HE1' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.03 -32.21 70.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 109.827 178.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 5.3 t80 -72.8 -51.8 17.51 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.417 -0.802 . . . . 0.0 111.078 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.985 HD11 ' CD1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -59.9 -35.65 75.32 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 118.571 -1.252 . . . . 0.0 112.589 -178.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.025 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -80.47 -29.08 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 119.663 -1.898 . . . . 0.0 109.629 178.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -41.11 -62.11 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.346 -0.846 . . . . 0.0 110.353 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -27.43 68.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.805 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.527 ' C ' HD13 ' A' ' 68' ' ' ILE . 8.8 mmp_? -70.26 -16.15 63.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.895 . . . . 0.0 109.8 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.83 HG23 HD13 ' A' ' 41' ' ' ILE . 2.9 mm -100.93 11.49 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.751 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.503 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 54.01 30.98 12.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.298 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.776 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.2 pp -115.23 156.49 25.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -0.804 . . . . 0.0 109.792 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.73 -169.34 1.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.0 110.945 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.27 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.454 -0.779 . . . . 0.0 110.735 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' ARG . 5.2 pt-20 -151.37 32.52 0.58 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.08 -1.013 . . . . 0.0 111.076 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -55.25 177.0 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.037 -1.039 . . . . 0.0 109.827 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.522 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -98.36 139.49 34.04 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.167 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.573 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 13.2 tp -164.34 153.23 13.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.352 -0.843 . . . . 0.0 110.391 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 89.4 m-85 -157.55 123.89 4.86 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.562 -0.711 . . . . 0.0 109.784 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.938 ' CZ ' HD12 ' A' ' 64' ' ' ILE . 11.8 m-85 -89.16 124.45 34.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.357 -0.839 . . . . 0.0 111.033 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 53.3 m-85 -119.91 121.65 39.48 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.731 HG22 HG23 ' A' ' 107' ' ' ILE . 2.4 t -120.78 112.72 37.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.358 -0.839 . . . . 0.0 109.742 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.527 ' CB ' ' ND1' ' A' ' 98' ' ' HIS . 3.1 t-20 63.67 34.57 12.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.824 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 19.9 t-20 69.18 35.03 2.82 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.326 -0.859 . . . . 0.0 110.271 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.674 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.3 t -135.04 168.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.209 -0.932 . . . . 0.0 110.127 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.808 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.0 77.27 5.07 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.7 . . . . 0.0 109.132 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.69 155.87 53.85 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.079 1.568 . . . . 0.0 110.879 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.47 -177.56 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.195 1.629 . . . . 0.0 110.292 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.53 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 1.1 p -82.23 16.46 2.0 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.305 -0.872 . . . . 0.0 110.948 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.43 41.56 1.12 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.534 -0.728 . . . . 0.0 109.519 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.52 -176.53 5.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.523 -0.736 . . . . 0.0 110.165 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 80.6 p -139.75 141.31 36.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 110.335 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.047 ' HA ' HD23 ' A' ' 94' ' ' LEU . 2.2 mmt -49.99 -42.78 49.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 110.014 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -48.59 -47.59 29.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 90' ' ' THR . 2.2 pt20 -64.63 -31.98 73.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -1.147 . . . . 0.0 109.814 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.118 HD11 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -67.61 -22.47 65.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.15 -0.969 . . . . 0.0 110.096 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.524 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -49.64 -55.76 12.51 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 120.881 -1.137 . . . . 0.0 109.692 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.429 ' O ' ' NE2' ' A' ' 99' ' ' HIS . 7.6 mt-30 -69.47 -17.22 63.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.963 -1.085 . . . . 0.0 111.294 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 1.8 mm-40 -87.44 -65.25 1.03 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.997 -1.065 . . . . 0.0 112.445 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.625 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 18.0 m-70 -98.63 37.94 1.42 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.86 -1.15 . . . . 0.0 111.808 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.546 ' O ' ' CE2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.001 0 O-C-N 121.504 -0.747 . . . . 0.0 109.673 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 104' ' ' PHE . 4.5 m-30 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.323 0.582 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.118 HD22 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -108.19 169.53 8.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.283 -0.885 . . . . 0.0 109.272 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.683 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -114.5 130.75 56.76 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.615 -1.303 . . . . 0.0 111.493 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.05 ' CG1' HD11 ' A' ' 105' ' ' LEU . 10.1 mt -141.97 122.65 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 110.236 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.75 153.21 44.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.988 -1.07 . . . . 0.0 109.51 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.684 ' OH ' HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -130.36 167.51 18.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.648 -1.282 . . . . 0.0 111.116 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -152.44 -178.39 6.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.674 -0.641 . . . . 0.0 110.086 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.514 ' OD1' ' CG ' ' A' ' 40' ' ' ARG . 2.1 m-20 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.26 -0.9 . . . . 0.0 110.249 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 28' ' ' ARG . 2.5 mpt_? . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.223 0.535 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 HG12 ' A' ' 31' ' ' VAL . 34.9 t -147.46 104.28 3.74 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 44.2 Cg_endo -72.97 87.41 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.026 1.54 . . . . 0.0 110.259 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.74 HG12 HG12 ' A' ' 29' ' ' VAL . 1.3 m -84.52 139.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.178 -0.952 . . . . 0.0 111.056 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 45.8 mm -94.57 158.57 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 108.89 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.801 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.5 t -133.95 134.77 55.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.886 -1.134 . . . . 0.0 111.273 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.3 tt0 -148.54 168.79 21.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.295 0.569 . . . . 0.0 109.538 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.63 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -100.51 156.26 17.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.043 -1.036 . . . . 0.0 110.562 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.034 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.52 -172.9 0.1 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.519 -0.738 . . . . 0.0 109.244 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.034 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.5 Cg_endo -72.63 107.83 2.4 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.441 1.232 . . . . 0.0 109.922 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.89 42.13 8.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 110.251 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.19 -177.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.905 . . . . 0.0 110.016 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.485 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.2 35.74 0.66 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.12 -0.987 . . . . 0.0 110.588 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -84.64 179.45 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.092 -1.005 . . . . 0.0 110.049 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -62.16 179.55 4.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.953 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.1 t70 -70.73 -176.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -1.073 . . . . 0.0 109.988 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.953 HD22 ' O ' ' A' ' 43' ' ' ASP . 2.0 mm? -135.67 134.09 38.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.159 -0.963 . . . . 0.0 110.588 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -86.27 -27.0 24.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 109.587 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.51 ' CD ' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -158.04 150.08 21.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.517 -0.74 . . . . 0.0 109.679 179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -116.66 45.31 1.85 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.833 -1.167 . . . . 0.0 110.025 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 108.89 1.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 109.53 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.865 ' CD2' HD13 ' A' ' 63' ' ' LEU . 20.0 m-85 -105.47 141.33 37.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 110.718 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.0 98.37 8.09 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.609 HG21 ' SD ' ' A' ' 91' ' ' MET . 11.2 m -121.89 150.88 56.91 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 110.87 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 43.6 Cg_endo -69.28 145.74 60.92 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.047 1.551 . . . . 0.0 110.201 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.561 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.41 -15.6 50.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 0.0 111.379 -178.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -83.15 -14.7 52.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 111.283 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.83 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.9 mt -62.47 143.02 57.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.892 -1.13 . . . . 0.0 111.428 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -91.03 167.22 12.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.663 -0.648 . . . . 0.0 109.869 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.821 HG12 HG22 ' A' ' 87' ' ' THR . 58.7 t -62.75 -26.32 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.998 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.06 -31.65 75.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.83 ' CB ' HD22 ' A' ' 55' ' ' LEU . 7.1 mm100 -76.79 -47.07 22.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.113 -1.228 . . . . 0.0 110.04 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.141 ' CE2' HD11 ' A' ' 64' ' ' ILE . 22.7 t80 -60.7 -47.19 87.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.102 -0.998 . . . . 0.0 109.468 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.24 -22.24 1.68 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.883 -1.136 . . . . 0.0 109.855 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -79.91 -54.98 5.3 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 110.513 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.009 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.8 pp -59.84 -20.35 56.45 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.271 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.141 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.2 mt -90.98 -38.27 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 120.193 -1.567 . . . . 0.0 109.051 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.636 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.7 OUTLIER -35.35 -66.03 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.181 0.515 . . . . 0.0 110.83 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -31.47 72.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.893 -1.13 . . . . 0.0 110.072 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.537 ' O ' HD13 ' A' ' 44' ' ' LEU . 35.4 mmt180 -66.76 -16.82 64.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.54 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 68' ' ' ILE . 40.8 mt -103.38 11.9 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 0.0 109.763 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.552 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 51.9 23.76 2.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -0.797 . . . . 0.0 110.671 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.792 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.2 pp -91.85 157.44 16.87 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.319 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' GLU . 25.1 ptt180 -165.16 -169.44 1.65 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.929 -1.107 . . . . 0.0 111.152 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.42 -90.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.581 -0.7 . . . . 0.0 110.62 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 74' ' ' ASP . 6.5 pt-20 -158.67 28.07 0.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.2 -0.938 . . . . 0.0 110.883 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.515 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.16 176.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 109.892 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -103.21 140.63 37.12 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.291 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.89 HD11 ' HB2' ' A' ' 109' ' ' TYR . 21.5 tp -164.36 150.05 10.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 110.465 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.591 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 89.1 m-85 -157.93 121.97 4.14 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.778 -0.576 . . . . 0.0 109.869 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.896 ' CE2' HD12 ' A' ' 64' ' ' ILE . 18.3 m-30 -79.95 135.84 36.5 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.074 -1.016 . . . . 0.0 111.246 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.568 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 82.6 m-85 -118.33 126.46 52.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.739 HG22 HG12 ' A' ' 107' ' ' ILE . 2.4 t -120.83 124.06 71.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.808 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.1 t-20 47.63 49.12 16.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 29.3 m-80 56.81 36.01 27.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.639 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -135.18 167.0 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.086 -1.009 . . . . 0.0 109.924 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.88 72.42 5.84 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.547 -0.721 . . . . 0.0 109.632 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 164.07 36.49 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.04 1.547 . . . . 0.0 110.564 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.7 -178.96 3.75 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.121 1.59 . . . . 0.0 110.311 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.821 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.12 19.16 2.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 110.652 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.43 39.22 1.02 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.512 -0.743 . . . . 0.0 109.567 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.801 ' HB1' ' CD ' ' A' ' 93' ' ' GLN . . . -145.42 -174.11 4.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.536 -0.728 . . . . 0.0 110.18 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 81.5 p -139.71 143.86 37.25 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.626 -0.671 . . . . 0.0 110.203 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.068 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -44.8 -41.78 7.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 109.747 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -50.69 -48.04 44.57 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.801 ' CD ' ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -64.38 -31.58 72.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -1.179 . . . . 0.0 109.988 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.068 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.06 -23.72 64.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.81 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.599 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -50.59 -56.96 9.4 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.892 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -69.64 -15.92 63.28 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.614 -1.304 . . . . 0.0 110.819 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -88.57 -71.04 0.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.169 -0.957 . . . . 0.0 113.486 -177.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.686 ' CE1' HG21 ' A' ' 83' ' ' VAL . 16.6 m-70 -100.81 38.28 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.68 -1.262 . . . . 0.0 113.189 -176.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.599 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.85 0 O-C-N 120.99 -1.069 . . . . 0.0 110.252 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.534 ' CB ' ' O ' ' A' ' 30' ' ' PRO . 18.1 m-85 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.933 HD13 ' CD1' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -96.07 165.86 12.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.749 -1.219 . . . . 0.0 108.848 178.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.743 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -123.89 124.4 42.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.575 -1.328 . . . . 0.0 111.638 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.739 HG12 HG22 ' A' ' 80' ' ' VAL . 13.2 mt -141.56 133.29 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.439 -0.788 . . . . 0.0 109.475 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -133.38 178.14 7.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.097 -1.002 . . . . 0.0 110.295 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.89 ' HB2' HD11 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -133.96 153.87 51.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.133 -0.98 . . . . 0.0 110.851 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 1.1 t -145.17 173.23 12.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.679 -0.638 . . . . 0.0 110.119 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 2.5 p30 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.975 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HD3' ' N ' ' A' ' 28' ' ' ARG . 1.6 mpt_? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.114 0.483 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.792 HG12 HG12 ' A' ' 31' ' ' VAL . 24.3 t -144.12 105.65 4.81 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.173 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 48.4 Cg_endo -74.69 84.99 1.52 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.321 1.695 . . . . 0.0 110.038 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.997 HG11 ' HE3' ' A' ' 91' ' ' MET . 1.4 m -85.6 148.29 4.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 110.933 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.6 HD13 ' CD1' ' A' ' 104' ' ' PHE . 1.5 mp -113.97 147.53 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.551 HG22 ' CE1' ' A' ' 109' ' ' TYR . 0.4 OUTLIER -124.36 153.26 30.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.8 -1.187 . . . . 0.0 111.187 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.585 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 2.4 tt0 -156.34 -162.04 1.21 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.539 ' HD2' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -132.25 159.81 37.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.869 -1.144 . . . . 0.0 110.815 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.55 -173.8 0.11 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.582 -0.699 . . . . 0.0 109.38 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.3 Cg_endo -71.98 108.9 2.56 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.522 1.275 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.86 41.15 5.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.828 . . . . 0.0 110.553 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.455 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -63.22 178.18 0.54 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 109.841 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.523 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 13.8 ptt180 -145.26 28.72 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.802 ' C ' HD12 ' A' ' 41' ' ' ILE . 1.8 pp -85.32 179.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.012 . . . . 0.0 109.726 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -68.74 146.38 45.07 Favored Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.231 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.82 163.87 16.22 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.618 -0.93 . . . . 0.0 110.787 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.532 ' HG ' ' CA ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -153.74 142.49 20.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.729 -0.607 . . . . 0.0 109.472 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 1.6 t0 -84.09 42.17 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 110.038 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.511 ' CD ' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -160.29 105.78 1.51 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.019 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -115.55 48.58 1.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.74 -1.225 . . . . 0.0 110.618 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.17 111.51 1.7 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.875 . . . . 0.0 109.532 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.938 ' CD2' HD13 ' A' ' 63' ' ' LEU . 24.0 m-85 -106.98 141.56 37.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.049 -1.032 . . . . 0.0 110.551 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.77 93.83 4.75 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.991 ' HB ' HD12 ' A' ' 55' ' ' LEU . 13.7 m -117.95 153.88 51.2 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.152 -0.968 . . . . 0.0 110.777 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.9 Cg_endo -71.65 148.22 52.7 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.111 1.585 . . . . 0.0 110.025 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.563 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.5 m -63.81 -15.34 58.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 111.334 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 7.8 t70 -83.58 -11.26 57.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.018 -1.051 . . . . 0.0 110.916 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.991 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.6 mt -62.05 142.02 57.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.941 -1.099 . . . . 0.0 111.122 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 1.2 p -91.01 154.89 19.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.65 -0.656 . . . . 0.0 109.433 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 1.033 HG12 HG22 ' A' ' 87' ' ' THR . 24.6 t -53.82 -20.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.991 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.37 -41.68 58.21 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.823 ' HB2' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -67.72 -46.67 71.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.174 -1.192 . . . . 0.0 109.997 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.17 ' CE2' HD11 ' A' ' 64' ' ' ILE . 22.8 t80 -60.65 -47.1 87.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.097 -1.002 . . . . 0.0 109.695 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.31 -22.25 1.72 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.01 -1.056 . . . . 0.0 109.87 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.16 -54.55 5.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 110.34 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.988 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.7 pp -59.75 -19.47 50.42 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.069 -1.052 . . . . 0.0 112.354 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.17 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.9 mt -92.16 -40.18 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 120.125 -1.61 . . . . 0.0 109.077 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -37.28 -61.46 0.58 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.878 -0.514 . . . . 0.0 110.624 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -32.33 73.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.942 -1.099 . . . . 0.0 109.742 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.535 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 15.1 mmt180 -69.39 -13.14 62.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.359 -0.838 . . . . 0.0 109.946 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.739 HG23 HD13 ' A' ' 41' ' ' ILE . 2.4 mm -99.61 7.81 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.061 -1.024 . . . . 0.0 109.528 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.541 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 54.1 32.58 16.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.429 -0.794 . . . . 0.0 110.132 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.85 HD12 ' O ' ' A' ' 70' ' ' LEU . 4.1 pp -110.53 151.2 27.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.829 . . . . 0.0 109.934 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.9 ptp180 -167.06 -168.94 1.17 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.851 . . . . 0.0 111.058 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.453 ' C ' ' HG3' ' A' ' 73' ' ' GLU . . . 50.71 -91.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.568 -0.707 . . . . 0.0 111.225 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HG3' ' C ' ' A' ' 72' ' ' ALA . 14.2 mt-10 -141.98 49.27 1.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.873 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -77.82 176.04 9.43 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.12 0.962 . . . . 0.0 109.991 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.511 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -118.16 143.85 46.16 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.039 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.813 HD21 ' CE1' ' A' ' 78' ' ' PHE . 18.2 tp -164.05 153.66 14.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 110.628 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 68.0 m-85 -157.58 123.06 4.57 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.617 -0.677 . . . . 0.0 109.465 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.813 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.4 m-30 -84.8 132.34 34.43 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.012 -1.055 . . . . 0.0 111.93 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 41.1 m-85 -120.55 118.39 30.09 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.021 HG22 HG23 ' A' ' 107' ' ' ILE . 2.0 t -120.68 130.82 74.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.556 ' HB3' ' CE1' ' A' ' 98' ' ' HIS . 53.5 t30 51.28 34.48 11.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 3.8 t-20 67.65 35.91 3.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.224 -0.922 . . . . 0.0 110.208 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -135.77 168.59 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 110.078 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.3 mp -154.68 71.01 5.99 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.73 . . . . 0.0 109.678 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.32 164.37 34.26 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.122 1.59 . . . . 0.0 110.68 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.08 -178.64 3.69 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.071 1.564 . . . . 0.0 110.611 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 1.033 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.2 22.95 1.65 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.331 -0.855 . . . . 0.0 110.672 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.37 43.45 1.07 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.369 -0.832 . . . . 0.0 109.551 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.28 -171.48 3.67 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.708 0.765 . . . . 0.0 110.294 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 75.9 p -139.21 136.36 34.93 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.538 0.685 . . . . 0.0 110.103 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.008 ' HA ' HD23 ' A' ' 94' ' ' LEU . 32.1 mmm -48.4 -38.69 20.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.9 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.45 -49.01 47.14 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 90' ' ' THR . 3.0 pt20 -64.64 -30.24 71.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -1.113 . . . . 0.0 109.814 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.008 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.52 -23.79 64.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.208 -0.932 . . . . 0.0 110.102 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 99' ' ' HIS . 1.0 OUTLIER -48.86 -53.04 21.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.843 -1.161 . . . . 0.0 109.774 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -69.36 -21.47 63.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.196 -0.94 . . . . 0.0 111.192 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 8.4 mm-40 -85.68 -66.86 0.85 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.941 -1.1 . . . . 0.0 112.007 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.618 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -98.77 42.33 1.1 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.912 -1.117 . . . . 0.0 110.771 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 95' ' ' TYR . 1.4 t-80 . . . . . 0 N--CA 1.498 1.935 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.852 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.6 ' CD1' HD13 ' A' ' 32' ' ' ILE . 38.1 p90 . . . . . 0 N--CA 1.511 2.597 0 CA-C-O 121.367 0.604 . . . . 0.0 110.849 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.032 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -123.67 160.3 27.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.771 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.786 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -124.97 135.88 53.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.029 -1.044 . . . . 0.0 110.996 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.032 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.0 mt -141.69 137.54 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.76 147.21 50.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.212 -0.93 . . . . 0.0 108.864 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.6 p90 -130.67 165.79 22.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.478 -1.389 . . . . 0.0 111.629 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -156.07 174.74 14.92 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.257 0.551 . . . . 0.0 110.328 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.523 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 1.8 p30 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.955 . . . . 0.0 110.217 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.393 0.616 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 31' ' ' VAL . 19.9 t -147.5 102.68 3.73 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.855 . . . . 0.0 109.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.498 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 46.1 Cg_endo -73.46 81.11 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.177 1.62 . . . . 0.0 110.208 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 29' ' ' VAL . 2.2 m -77.32 152.33 5.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 110.686 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 1.5 mp -108.24 164.1 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.686 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.4 t -136.31 136.51 48.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.835 -1.166 . . . . 0.0 111.093 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.91 -176.16 5.81 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.322 0.582 . . . . 0.0 109.742 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HD2' HD11 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -114.9 159.08 21.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.985 -1.072 . . . . 0.0 110.786 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.021 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.76 -173.23 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.529 -0.732 . . . . 0.0 109.191 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.021 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.7 Cg_endo -71.91 107.25 2.17 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.472 1.249 . . . . 0.0 109.983 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.95 41.75 8.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.353 -0.842 . . . . 0.0 110.206 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.8 178.75 0.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.283 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.424 ' HG3' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.68 32.31 1.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.214 -0.929 . . . . 0.0 110.172 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.587 HD11 ' HD2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -85.81 -173.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.324 -0.86 . . . . 0.0 110.579 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.578 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -67.46 172.43 31.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.54 179.61 3.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.165 -1.197 . . . . 0.0 110.595 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 44' ' ' LEU . 2.1 pp -134.93 133.42 39.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.369 -0.832 . . . . 0.0 110.706 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.454 ' OD2' ' HD2' ' A' ' 46' ' ' LYS . 10.7 p-10 -85.83 -20.52 29.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.191 -0.943 . . . . 0.0 110.143 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.512 ' HD2' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -151.84 154.08 35.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 109.683 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.547 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -128.28 40.95 3.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.962 -1.086 . . . . 0.0 110.448 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.92 104.88 0.91 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 109.822 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.638 ' O ' HG22 ' A' ' 31' ' ' VAL . 30.6 m-85 -105.4 145.26 31.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.112 -0.993 . . . . 0.0 111.09 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.03 94.82 5.22 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.016 ' HB ' HD12 ' A' ' 55' ' ' LEU . 32.8 m -115.92 153.14 48.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.115 -0.991 . . . . 0.0 110.987 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.458 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.3 Cg_endo -69.81 149.5 66.65 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.08 1.568 . . . . 0.0 110.407 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.556 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -63.78 -16.24 60.71 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 111.34 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -83.12 -10.99 58.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -0.999 . . . . 0.0 111.017 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.016 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.7 mt -61.84 141.8 57.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.907 -1.121 . . . . 0.0 110.952 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.499 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 3.1 p -91.23 162.41 14.65 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.532 -0.73 . . . . 0.0 109.507 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 37.1 t -59.04 -30.16 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.104 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.73 -27.16 74.06 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.87 ' CB ' HD22 ' A' ' 55' ' ' LEU . 15.3 mm-40 -76.3 -51.35 12.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.169 -1.195 . . . . 0.0 110.054 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.151 ' CE2' HD11 ' A' ' 64' ' ' ILE . 12.0 t80 -60.41 -47.25 86.92 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.919 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.51 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -49.29 -23.27 1.33 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.849 -1.157 . . . . 0.0 109.562 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -55.87 4.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.486 -0.759 . . . . 0.0 111.282 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.127 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -59.03 -23.53 62.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.899 -1.126 . . . . 0.0 111.842 -178.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.151 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -91.08 -35.01 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.078 -1.639 . . . . 0.0 108.77 177.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.673 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -38.95 -56.19 1.43 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.446 -0.784 . . . . 0.0 110.51 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HE2' ' N ' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -64.89 -34.94 79.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.975 -1.078 . . . . 0.0 108.899 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.518 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 5.0 mmt180 -73.08 -10.54 59.9 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.684 -0.635 . . . . 0.0 110.121 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.032 ' CG2' HD23 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -88.09 -10.57 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER 74.01 28.07 1.53 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.751 0.786 . . . . 0.0 109.122 -178.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.032 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.0 pp -113.93 158.67 20.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.745 -0.597 . . . . 0.0 109.873 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -165.08 -174.62 3.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 110.772 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.99 -90.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.0 110.788 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' CG ' ' O ' ' A' ' 73' ' ' GLU . 1.9 pt-20 -153.93 42.26 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 111.027 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -67.51 176.48 2.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.071 -1.018 . . . . 0.0 110.076 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.718 ' HB3' ' CG ' ' A' ' 111' ' ' ASP . . . -92.27 142.85 27.01 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.834 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.791 HD21 ' CE1' ' A' ' 78' ' ' PHE . 17.8 tp -164.09 154.37 14.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 110.773 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 85.2 m-85 -156.91 124.16 5.26 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.581 -0.699 . . . . 0.0 110.121 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.791 ' CE1' HD21 ' A' ' 76' ' ' LEU . 3.7 m-30 -94.73 113.89 25.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 91.2 m-85 -108.99 127.48 54.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 110.122 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.959 HG22 HG23 ' A' ' 107' ' ' ILE . 1.8 t -121.5 122.41 67.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.428 -0.795 . . . . 0.0 109.442 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.689 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.9 m-80 57.38 33.48 23.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.073 -1.017 . . . . 0.0 109.922 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.27 31.91 15.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -133.13 171.19 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.391 -0.818 . . . . 0.0 109.681 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.807 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.2 mp -154.26 77.73 5.41 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.427 -0.796 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.52 165.8 31.67 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.149 1.605 . . . . 0.0 110.36 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.58 178.66 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.069 1.563 . . . . 0.0 110.444 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.499 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.19 20.49 2.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.319 -0.863 . . . . 0.0 110.624 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.7 p -94.64 37.47 1.13 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.538 -0.726 . . . . 0.0 109.596 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.77 -174.8 4.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.485 -0.759 . . . . 0.0 110.182 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.523 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 34.7 p -139.09 149.9 45.09 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.317 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.116 ' HA ' HD23 ' A' ' 94' ' ' LEU . 30.6 mmm -51.56 -38.6 55.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.478 -0.764 . . . . 0.0 110.16 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -54.12 -40.4 66.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.523 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 2.1 mt-30 -68.43 -46.05 70.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.146 -1.208 . . . . 0.0 109.269 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.116 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -56.92 -20.56 24.04 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.131 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.53 ' O ' ' HB3' ' A' ' 99' ' ' HIS . 1.3 t80 -48.75 -53.28 19.63 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.794 -1.191 . . . . 0.0 109.833 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.641 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 10.3 tt0 -69.49 -19.92 63.73 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.778 -1.201 . . . . 0.0 111.337 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -87.78 -62.98 1.37 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.066 -1.021 . . . . 0.0 113.53 -177.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.575 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.8 m-70 -98.12 35.8 1.68 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.675 -1.266 . . . . 0.0 112.682 -176.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.641 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.035 -1.041 . . . . 0.0 110.066 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.475 ' C ' ' CD1' ' A' ' 104' ' ' PHE . 20.3 p90 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.497 0.665 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.028 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -117.71 167.3 11.48 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 0.0 109.362 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.746 ' N ' HD12 ' A' ' 105' ' ' LEU . 2.9 p90 -125.82 133.93 51.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.866 -1.146 . . . . 0.0 111.712 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.028 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.6 mt -141.19 147.03 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.437 -0.79 . . . . 0.0 109.785 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.0 177.43 7.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.052 . . . . 0.0 110.287 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.686 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.2 p90 -143.47 171.42 14.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.221 -0.924 . . . . 0.0 110.612 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -159.63 -175.15 5.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.464 -0.772 . . . . 0.0 110.2 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.718 ' CG ' ' HB3' ' A' ' 75' ' ' ALA . 8.8 t70 . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.401 -0.812 . . . . 0.0 110.095 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 1.8 mpt_? . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.345 0.593 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.822 HG12 HG12 ' A' ' 31' ' ' VAL . 19.6 t -147.45 109.2 3.88 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.31 -0.869 . . . . 0.0 110.171 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.1 Cg_endo -75.45 84.14 1.77 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.193 1.628 . . . . 0.0 110.101 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.822 HG12 HG12 ' A' ' 29' ' ' VAL . 1.2 m -82.72 132.03 32.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.131 -0.98 . . . . 0.0 111.045 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 41.4 mm -93.86 142.78 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -124.65 147.96 29.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.86 -1.15 . . . . 0.0 111.135 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.579 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -156.57 -174.12 4.79 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -121.39 160.65 23.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.9 -1.125 . . . . 0.0 110.53 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.006 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.92 -174.83 0.15 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.412 -0.805 . . . . 0.0 109.296 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.006 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.2 Cg_endo -70.54 111.87 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.531 1.28 . . . . 0.0 109.68 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 2.8 mttt 62.21 42.34 9.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.351 -0.843 . . . . 0.0 110.05 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.528 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -56.13 -177.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.306 -0.871 . . . . 0.0 109.995 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -148.39 28.05 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 111.01 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.895 HD13 HG23 ' A' ' 68' ' ' ILE . 2.0 pp -91.81 176.46 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.83 -1.169 . . . . 0.0 110.324 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.84 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -52.12 -176.5 0.04 OUTLIER Glycine 0 N--CA 1.498 2.803 0 O-C-N 121.296 -0.878 . . . . 0.0 111.181 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 1.017 ' O ' HD22 ' A' ' 44' ' ' LEU . 10.1 t0 -80.47 -171.33 3.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -1.09 . . . . 0.0 109.993 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.017 HD22 ' O ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -142.25 138.5 31.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 110.667 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -86.07 -32.97 21.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 109.827 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 151.83 30.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.961 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.705 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -112.53 46.02 1.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 109.769 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -165.92 109.7 0.81 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.552 -0.718 . . . . 0.0 109.48 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.902 ' CD2' HD13 ' A' ' 63' ' ' LEU . 12.7 m-85 -105.83 140.39 38.93 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.117 -0.989 . . . . 0.0 110.326 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.53 92.91 4.67 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.83 ' HB ' HD12 ' A' ' 55' ' ' LEU . 13.6 m -115.64 150.82 45.4 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.53 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.0 Cg_endo -70.5 148.48 60.34 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.107 1.583 . . . . 0.0 110.036 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.57 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -62.56 -16.19 54.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -0.805 . . . . 0.0 111.399 -178.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.86 -13.2 54.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.036 -1.04 . . . . 0.0 111.209 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.881 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.8 mt -62.06 140.99 58.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.865 -1.147 . . . . 0.0 111.133 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.6 p -90.57 154.59 19.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.619 -0.676 . . . . 0.0 109.45 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.505 ' CG1' HG22 ' A' ' 87' ' ' THR . 58.9 t -52.74 -21.19 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.061 -1.024 . . . . 0.0 110.04 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.67 -41.24 57.31 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.881 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.1 mm-40 -67.74 -47.24 69.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.214 -1.168 . . . . 0.0 109.903 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.184 ' CE2' HD11 ' A' ' 64' ' ' ILE . 31.1 t80 -60.79 -46.51 90.24 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.496 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -51.13 -22.11 2.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.824 -1.173 . . . . 0.0 109.802 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -78.82 -54.22 6.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.946 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.023 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.6 pp -59.92 -20.44 57.39 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.02 -1.05 . . . . 0.0 112.189 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.184 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.6 mt -90.19 -37.54 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 120.103 -1.623 . . . . 0.0 108.836 177.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -37.99 -61.36 0.66 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.278 0.561 . . . . 0.0 110.736 -179.511 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -31.0 71.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.913 -1.117 . . . . 0.0 109.822 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.576 ' C ' HD13 ' A' ' 68' ' ' ILE . 21.4 mmt180 -67.7 -16.94 64.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.895 HG23 HD13 ' A' ' 41' ' ' ILE . 2.9 mm -99.76 14.11 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.371 -0.83 . . . . 0.0 109.51 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.493 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER 47.87 33.53 3.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.553 -0.717 . . . . 0.0 110.562 179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.795 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.1 pp -112.03 155.62 23.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.695 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.65 -172.23 2.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.079 -1.013 . . . . 0.0 111.056 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 55.27 -89.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.478 -0.764 . . . . 0.0 110.889 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.5 pt-20 -147.21 32.09 0.91 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 111.032 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -52.92 176.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.074 -1.016 . . . . 0.0 109.843 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HB3' ' OD1' ' A' ' 111' ' ' ASP . . . -117.59 139.17 51.34 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.134 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.862 HD21 ' HE1' ' A' ' 78' ' ' PHE . 29.8 tp -164.49 155.25 14.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 110.427 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.568 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 20.1 m-85 -153.79 123.3 6.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.45 -0.781 . . . . 0.0 109.754 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.862 ' HE1' HD21 ' A' ' 76' ' ' LEU . 18.0 m-30 -84.71 132.78 34.41 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.098 -1.001 . . . . 0.0 111.705 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 62.3 m-85 -120.37 119.81 34.16 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.802 HG22 HG23 ' A' ' 107' ' ' ILE . 2.1 t -120.77 127.95 75.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.235 -0.916 . . . . 0.0 110.206 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.69 ' O ' HG23 ' A' ' 83' ' ' VAL . 28.8 t30 54.77 35.47 24.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.874 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 64.14 32.15 12.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.38 -0.825 . . . . 0.0 110.077 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -135.63 171.05 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.415 -0.803 . . . . 0.0 109.853 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.55 75.4 5.74 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.544 -0.723 . . . . 0.0 109.47 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.5 163.91 36.37 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.967 1.509 . . . . 0.0 110.651 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.98 177.64 7.49 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.17 1.616 . . . . 0.0 110.276 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.505 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.88 21.96 2.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.263 -0.898 . . . . 0.0 110.603 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.78 36.68 0.86 Allowed 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 109.745 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -147.45 -170.4 3.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.376 -0.827 . . . . 0.0 110.358 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.559 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 58.6 p -138.96 146.94 41.58 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.488 0.661 . . . . 0.0 109.92 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.058 ' HA ' HD23 ' A' ' 94' ' ' LEU . 1.2 mmt -47.13 -47.36 23.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.248 -0.907 . . . . 0.0 110.431 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.57 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -42.73 -44.73 5.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.559 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 1.0 OUTLIER -67.81 -39.76 83.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -1.159 . . . . 0.0 109.243 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.058 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -59.53 -24.94 64.09 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.364 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.577 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -49.16 -56.07 10.39 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.517 -1.365 . . . . 0.0 109.411 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.582 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 8.7 tt0 -71.35 -18.18 62.39 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.163 -0.961 . . . . 0.0 111.911 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.586 ' HG2' ' CE1' ' A' ' 98' ' ' HIS . 1.3 tt0 -87.77 -61.23 1.76 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.756 -1.215 . . . . 0.0 112.552 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.684 ' HB3' HG12 ' A' ' 80' ' ' VAL . 17.4 m-70 -98.27 38.64 1.31 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.859 -1.15 . . . . 0.0 111.424 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.582 ' CD2' ' O ' ' A' ' 96' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.424 -0.797 . . . . 0.0 109.122 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.487 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 5.6 m-85 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.28 0.562 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.046 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.51 168.54 9.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.205 -0.934 . . . . 0.0 109.291 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.657 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.2 m-85 -121.92 130.68 53.54 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.64 -1.288 . . . . 0.0 111.597 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.046 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.8 mt -141.56 127.05 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.33 -0.856 . . . . 0.0 110.354 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -121.93 163.64 18.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.111 -0.993 . . . . 0.0 108.851 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.669 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.7 OUTLIER -145.75 164.05 33.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.622 -1.299 . . . . 0.0 111.225 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.624 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.5 t -159.27 -175.95 5.53 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.508 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.629 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 65.5 t0 . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.968 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.422 0.63 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.881 HG13 ' CE1' ' A' ' 95' ' ' TYR . 23.4 t -119.35 134.32 23.76 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.413 -0.804 . . . . 0.0 110.866 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.609 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 52.3 Cg_endo -81.16 112.48 2.56 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 124.246 1.656 . . . . 0.0 109.477 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.921 HG22 ' CD2' ' A' ' 105' ' ' LEU . 45.8 t -100.13 125.06 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 110.897 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.075 HD11 ' CE2' ' A' ' 104' ' ' PHE . 27.1 mm -91.51 147.15 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 108.819 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.629 HG21 ' CD1' ' A' ' 49' ' ' TYR . 9.2 t -130.61 143.93 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 120.855 -1.153 . . . . 0.0 111.556 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HA ' ' CE ' ' A' ' 47' ' ' LYS . 3.5 tt0 -156.54 167.25 31.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.552 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.661 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -96.79 163.46 12.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.937 -1.102 . . . . 0.0 110.921 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.023 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.89 -174.0 0.14 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 0.0 109.68 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.023 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.8 Cg_endo -74.03 116.64 4.72 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.576 1.303 . . . . 0.0 109.968 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.29 39.56 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 110.034 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.46 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -62.37 174.42 0.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.359 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 31.75 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.976 HD13 HG23 ' A' ' 68' ' ' ILE . 1.8 pp -85.88 177.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.026 . . . . 0.0 110.611 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.822 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -49.1 -176.89 0.01 OUTLIER Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.26 -177.17 5.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.253 -1.145 . . . . 0.0 110.001 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.936 HD12 ' OH ' ' A' ' 109' ' ' TYR . 0.2 OUTLIER -148.58 147.55 29.13 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.047 -1.033 . . . . 0.0 110.453 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 9.4 m-20 -86.82 -28.42 22.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.375 -0.828 . . . . 0.0 110.626 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -152.54 156.83 40.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 0.0 110.011 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' CE ' ' HA ' ' A' ' 34' ' ' GLU . 6.6 mmmm -120.65 43.8 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.054 -1.029 . . . . 0.0 109.781 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 1.5 ptmm? -157.94 109.75 2.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.379 -0.825 . . . . 0.0 109.74 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.629 ' CD1' HG21 ' A' ' 33' ' ' VAL . 28.1 m-85 -104.29 147.44 27.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 110.965 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -120.12 114.17 21.56 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.747 ' HB ' HD12 ' A' ' 55' ' ' LEU . 2.8 m -141.0 165.32 30.2 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.714 -1.241 . . . . 0.0 110.889 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 43.7 Cg_endo -69.22 147.93 67.46 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.151 1.606 . . . . 0.0 110.46 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.534 ' HB3' ' CA ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -65.34 -12.72 54.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.461 -0.775 . . . . 0.0 111.336 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -84.08 -5.48 59.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.084 -1.01 . . . . 0.0 110.913 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.851 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.8 mt -61.96 141.52 57.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.83 -1.169 . . . . 0.0 111.107 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 0.9 OUTLIER -92.07 159.57 15.63 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.589 -0.694 . . . . 0.0 109.698 178.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 88.3 t -58.44 -26.64 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.76 -31.51 67.44 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.851 ' CB ' HD22 ' A' ' 55' ' ' LEU . 15.7 mm100 -69.34 -51.1 40.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.162 ' CD1' HD11 ' A' ' 63' ' ' LEU . 6.9 t80 -59.97 -33.57 72.12 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.436 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.583 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -55.58 -35.14 65.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 109.998 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -79.74 -50.01 11.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.74 . . . . 0.0 112.682 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.162 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.66 -39.85 81.81 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.434 -1.416 . . . . 0.0 111.927 -177.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.132 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -76.11 -42.95 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 119.877 -1.764 . . . . 0.0 108.432 178.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.882 ' HG2' HD11 ' A' ' 70' ' ' LEU . 3.4 mtt180 -35.92 -61.58 0.47 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.825 -0.547 . . . . 0.0 110.863 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.71 -33.07 75.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.029 . . . . 0.0 109.895 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.767 ' HB3' HD21 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -69.97 -10.3 58.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -0.901 . . . . 0.0 109.624 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.976 HG23 HD13 ' A' ' 41' ' ' ILE . 5.5 mm -100.4 7.5 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.442 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.43 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 3.0 m-70 54.84 31.47 15.74 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.415 -0.803 . . . . 0.0 110.416 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.882 HD11 ' HG2' ' A' ' 65' ' ' ARG . 4.2 pp -110.62 150.6 28.75 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.835 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 1.2 ptt180 -167.0 -167.19 0.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 111.017 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 56.56 -86.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.562 -0.711 . . . . 0.0 110.96 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 71' ' ' ARG . 35.7 mt-10 -151.38 30.28 0.61 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.914 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -59.72 176.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.076 -1.015 . . . . 0.0 109.637 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -103.69 139.73 38.55 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.135 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.659 HD21 ' CZ ' ' A' ' 78' ' ' PHE . 19.3 tp -160.95 150.7 17.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.915 . . . . 0.0 110.465 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 85.9 m-85 -160.32 120.57 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.865 -0.522 . . . . 0.0 109.641 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.696 ' CE1' HD12 ' A' ' 64' ' ' ILE . 81.4 m-85 -89.94 113.53 25.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.101 -0.999 . . . . 0.0 110.214 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 68.5 m-85 -104.97 136.61 44.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.342 -0.849 . . . . 0.0 109.876 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 107' ' ' ILE . 4.9 t -120.18 125.92 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.474 ' HB2' ' CG ' ' A' ' 98' ' ' HIS . 0.8 OUTLIER 46.31 39.26 6.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.241 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 2.3 t30 67.53 38.45 3.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.401 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.7 t -135.51 168.51 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 109.864 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.815 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.4 mp -154.44 69.5 5.99 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.505 -0.747 . . . . 0.0 109.718 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.28 170.49 19.75 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.068 1.562 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.22 179.55 5.35 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.101 1.579 . . . . 0.0 110.36 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.69 21.62 2.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.399 -0.813 . . . . 0.0 110.559 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 t -95.73 39.64 1.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.522 -0.736 . . . . 0.0 109.791 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.81 -176.7 5.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 110.338 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 45.3 p -139.61 148.32 42.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.569 -0.707 . . . . 0.0 110.255 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.026 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -52.96 -41.47 64.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 109.946 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.534 ' CA ' ' HB3' ' A' ' 53' ' ' SER . . . -49.56 -50.07 31.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 90' ' ' THR . 2.2 pt20 -64.72 -28.95 69.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -1.146 . . . . 0.0 109.671 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.051 HD21 HD22 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -68.31 -23.12 64.7 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.318 -0.864 . . . . 0.0 109.677 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.881 ' CE1' HG13 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -50.07 -55.9 12.98 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.094 -1.004 . . . . 0.0 109.909 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -17.51 63.93 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.545 -1.347 . . . . 0.0 110.623 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.5 mt-10 -88.57 -71.75 0.57 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.17 -0.956 . . . . 0.0 113.445 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 81' ' ' ASN . 16.3 m-70 -100.74 38.35 1.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.653 -1.28 . . . . 0.0 113.112 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.604 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.951 0 O-C-N 120.988 -1.07 . . . . 0.0 111.029 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 1.075 ' CE2' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.051 HD22 HD21 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -98.52 154.22 18.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.67 -1.269 . . . . 0.0 110.057 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.648 ' N ' HD12 ' A' ' 105' ' ' LEU . 62.7 m-85 -119.09 122.07 41.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.115 -0.991 . . . . 0.0 111.218 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.768 HD12 HD11 ' A' ' 105' ' ' LEU . 25.3 mt -140.26 149.42 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -143.29 178.69 7.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 110.116 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.936 ' OH ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -143.71 164.07 31.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 110.641 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -160.05 176.27 12.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.386 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.464 ' HB3' HG22 ' A' ' 41' ' ' ILE . 6.3 p-10 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 110.127 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.228 0.537 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.751 HG12 HG12 ' A' ' 31' ' ' VAL . 23.7 t -145.03 107.06 4.54 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.541 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -77.33 86.24 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.145 1.603 . . . . 0.0 109.938 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.751 HG12 HG12 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -81.45 136.1 23.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.305 -0.872 . . . . 0.0 111.113 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 47.1 mm -91.88 139.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.735 HG13 ' HE1' ' A' ' 109' ' ' TYR . 3.0 t -126.06 139.97 49.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.889 -1.132 . . . . 0.0 111.332 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 2.2 tt0 -156.51 174.24 15.72 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.635 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -102.46 159.77 15.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.924 -1.11 . . . . 0.0 110.419 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.04 -175.29 0.17 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.478 -0.764 . . . . 0.0 109.436 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.6 Cg_endo -71.98 107.25 2.18 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.564 1.297 . . . . 0.0 109.877 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 63.46 40.05 8.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 110.026 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.78 -174.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.117 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 31.49 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.0 110.797 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.826 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -90.28 176.31 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.96 -1.087 . . . . 0.0 110.493 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.826 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -51.42 -173.8 0.02 OUTLIER Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.308 -0.87 . . . . 0.0 111.117 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -71.49 -175.93 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -1.162 . . . . 0.0 109.867 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.921 HD13 ' CD ' ' A' ' 47' ' ' LYS . 1.4 pp -134.99 133.13 39.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.146 -0.972 . . . . 0.0 110.651 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.493 ' HB2' ' HD3' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -86.68 -42.32 13.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.219 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HD3' ' HD2' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -152.79 151.71 30.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 110.279 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.921 ' CD ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -111.25 49.59 0.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 109.728 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -169.55 111.17 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.519 -0.738 . . . . 0.0 109.659 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.87 ' CD2' HD13 ' A' ' 63' ' ' LEU . 10.2 m-85 -108.36 141.05 40.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.075 -1.015 . . . . 0.0 110.37 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.37 92.14 4.2 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.5 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 34.4 m -114.25 147.57 38.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 110.486 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.714 ' HD2' HD12 ' A' ' 55' ' ' LEU . 45.1 Cg_endo -70.96 150.33 60.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.815 1.429 . . . . 0.0 109.772 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.55 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -65.08 -13.49 58.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.302 -0.874 . . . . 0.0 111.594 -178.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -87.72 -14.23 40.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.888 -1.132 . . . . 0.0 111.189 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.2 mt -62.14 146.16 51.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.956 -1.09 . . . . 0.0 111.503 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.49 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 3.9 p -91.28 160.05 15.71 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.638 -0.664 . . . . 0.0 109.533 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.728 HG12 HG22 ' A' ' 87' ' ' THR . 63.5 t -60.01 -22.04 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.016 . . . . 0.0 110.043 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.83 -39.72 64.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.722 ' CB ' HD22 ' A' ' 55' ' ' LEU . 1.5 mm-40 -67.96 -48.64 65.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -1.173 . . . . 0.0 109.987 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.122 ' CE2' HD11 ' A' ' 64' ' ' ILE . 47.2 t80 -60.41 -44.21 95.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.569 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.683 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -53.24 -26.53 18.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.934 -1.104 . . . . 0.0 109.706 179.356 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.473 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -73.97 -47.74 35.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.398 -0.814 . . . . 0.0 109.668 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.088 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.2 pp -66.43 -17.16 64.63 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.013 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.122 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.1 mt -89.33 -41.07 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 120.046 -1.659 . . . . 0.0 109.398 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.554 ' CG ' ' N ' ' A' ' 66' ' ' LYS . 2.2 ptm180 -39.64 -46.28 1.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.547 -0.721 . . . . 0.0 110.616 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.554 ' N ' ' CG ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -72.81 -36.9 67.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.984 -1.073 . . . . 0.0 109.814 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.519 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 5.8 mmp_? -69.41 -10.12 56.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.302 -0.874 . . . . 0.0 109.857 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.795 HG21 HD23 ' A' ' 70' ' ' LEU . 45.1 mt -104.03 7.77 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.006 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.534 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 50.07 31.29 4.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.363 -0.835 . . . . 0.0 110.308 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.906 HD12 ' O ' ' A' ' 70' ' ' LEU . 2.9 pp -103.56 156.28 17.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.37 -165.15 0.82 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.036 -1.04 . . . . 0.0 110.941 -179.001 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.04 -90.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.782 . . . . 0.0 110.601 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 71' ' ' ARG . 4.6 pt-20 -156.41 26.1 0.35 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 111.037 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.523 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.04 176.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.063 -1.023 . . . . 0.0 110.002 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.523 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -110.98 142.99 42.37 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.137 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.971 HD21 ' CE1' ' A' ' 78' ' ' PHE . 21.8 tp -156.16 155.49 32.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 110.545 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.571 ' O ' ' CE1' ' A' ' 79' ' ' PHE . 19.4 m-85 -152.83 123.28 7.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.548 -0.72 . . . . 0.0 109.818 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.971 ' CE1' HD21 ' A' ' 76' ' ' LEU . 21.3 m-30 -88.17 135.85 33.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.255 -0.903 . . . . 0.0 111.273 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.571 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 54.0 m-85 -120.33 119.0 31.85 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.852 HG22 HG23 ' A' ' 107' ' ' ILE . 2.0 t -121.25 112.43 35.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 121.357 -0.839 . . . . 0.0 110.304 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.645 ' O ' HG23 ' A' ' 83' ' ' VAL . 13.4 t-20 59.96 42.22 16.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 0.0 110.22 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.92 34.49 14.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.662 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -134.47 168.02 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 109.994 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -155.02 67.5 5.23 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.581 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.86 160.04 46.93 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.922 1.485 . . . . 0.0 110.665 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.82 -178.91 3.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.038 1.547 . . . . 0.0 110.65 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.728 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -85.85 20.53 2.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.459 -0.776 . . . . 0.0 110.618 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 t -95.37 42.76 1.09 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.443 -0.786 . . . . 0.0 109.507 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.13 -169.69 3.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.663 0.744 . . . . 0.0 110.3 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 45.0 p -139.24 143.1 37.84 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.687 -0.633 . . . . 0.0 109.935 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.01 ' HA ' HD23 ' A' ' 94' ' ' LEU . 25.4 mmm -50.88 -45.15 59.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 109.545 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.55 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.55 -48.54 34.99 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.1 OUTLIER -64.59 -31.76 73.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -1.136 . . . . 0.0 110.106 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.018 HD11 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -68.54 -23.17 64.49 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.115 -0.991 . . . . 0.0 110.133 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.541 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -48.64 -53.45 18.58 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.519 -179.435 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.12 -20.98 63.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.194 -0.941 . . . . 0.0 111.291 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 14.8 mt-10 -84.27 -63.99 1.24 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.014 -1.054 . . . . 0.0 112.06 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.58 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 7.5 m-70 -97.41 40.62 1.15 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.966 -1.084 . . . . 0.0 110.779 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.002 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.28 0.562 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.056 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -103.04 171.09 7.58 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.717 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.2 m-85 -118.14 126.89 53.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.402 -1.436 . . . . 0.0 112.211 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.056 ' CG1' HD11 ' A' ' 105' ' ' LEU . 4.1 mt -141.58 144.63 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -146.62 163.05 37.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.192 -0.943 . . . . 0.0 109.372 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.735 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.4 p90 -134.09 165.73 24.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.646 -1.284 . . . . 0.0 111.278 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -159.22 177.25 11.25 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.483 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.473 ' HB2' HG22 ' A' ' 41' ' ' ILE . 11.9 t0 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.922 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 5.4 mpt_? . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.33 0.586 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.754 HG12 HG12 ' A' ' 31' ' ' VAL . 17.3 t -148.02 116.97 4.15 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 110.203 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 50.3 Cg_endo -79.35 90.96 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 124.257 1.661 . . . . 0.0 110.005 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.754 HG12 HG12 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -88.55 138.66 18.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.164 -0.96 . . . . 0.0 110.559 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.543 HG13 ' CE1' ' A' ' 104' ' ' PHE . 24.8 mm -95.95 152.82 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 108.901 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.782 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.6 t -133.6 141.83 43.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.965 -1.084 . . . . 0.0 111.109 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -157.27 -166.76 2.13 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD2' HG12 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -124.56 160.77 27.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.885 -1.135 . . . . 0.0 110.508 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.015 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -61.63 -167.81 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.015 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.1 Cg_endo -71.72 123.64 9.57 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.189 1.099 . . . . 0.0 109.673 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 40.55 49.54 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.599 0.714 . . . . 0.0 110.549 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.09 -179.11 0.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.603 -0.686 . . . . 0.0 110.126 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.33 36.18 0.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.699 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 111' ' ' ASP . 1.8 pp -85.18 177.87 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.025 -1.047 . . . . 0.0 110.378 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.822 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -47.9 -179.58 0.01 OUTLIER Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.488 -0.863 . . . . 0.0 110.997 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.963 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -75.85 -179.28 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -1.171 . . . . 0.0 110.071 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.963 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.6 mm? -136.17 134.8 38.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.164 -0.96 . . . . 0.0 110.579 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 29.7 t0 -86.49 -36.96 18.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.436 -0.79 . . . . 0.0 110.099 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.83 154.44 35.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.665 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -117.69 46.42 1.74 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.12 -0.987 . . . . 0.0 109.818 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -164.51 109.66 0.97 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.423 -0.798 . . . . 0.0 109.965 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.926 ' CD2' HD13 ' A' ' 63' ' ' LEU . 16.3 m-85 -108.14 139.6 42.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.04 -1.038 . . . . 0.0 110.12 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.85 99.63 8.51 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.93 ' HB ' HD12 ' A' ' 55' ' ' LEU . 5.1 m -126.14 160.03 59.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.046 -1.034 . . . . 0.0 110.861 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 42.3 Cg_endo -67.69 144.98 67.99 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.052 1.553 . . . . 0.0 110.434 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.572 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -63.5 -14.0 46.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.446 -0.784 . . . . 0.0 111.441 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -83.73 -10.36 58.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.96 -1.088 . . . . 0.0 110.945 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.93 HD12 ' HB ' ' A' ' 51' ' ' VAL . 4.1 mt -62.22 141.32 58.27 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.003 -1.06 . . . . 0.0 111.027 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 1.4 p -91.44 169.15 11.02 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.703 -0.623 . . . . 0.0 109.827 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.829 ' CG1' HG22 ' A' ' 87' ' ' THR . 95.3 t -61.93 -26.63 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.307 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.88 -39.61 75.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.912 ' CB ' HD22 ' A' ' 55' ' ' LEU . 5.3 mm-40 -67.67 -48.56 66.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.1 -1.236 . . . . 0.0 110.101 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.176 ' CE2' HD11 ' A' ' 64' ' ' ILE . 24.0 t80 -60.45 -46.43 90.1 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.469 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -50.51 -23.62 2.62 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.888 -1.132 . . . . 0.0 109.928 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.79 -51.79 9.26 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.047 HD11 ' CE1' ' A' ' 60' ' ' PHE . 4.0 pp -63.54 -17.83 63.22 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.432 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.176 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.6 mt -91.82 -39.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 120.01 -1.681 . . . . 0.0 109.059 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -35.43 -64.66 0.27 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.086 0.47 . . . . 0.0 110.961 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.02 -31.4 72.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.208 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.695 ' O ' HD13 ' A' ' 44' ' ' LEU . 28.6 mmt-85 -68.21 -16.79 64.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.066 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.909 ' CG2' HD23 ' A' ' 70' ' ' LEU . 1.2 mm -97.44 8.74 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.601 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.491 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER 57.04 30.17 17.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 110.317 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.909 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.3 pp -117.61 154.84 30.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.917 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -166.25 -169.07 1.34 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.235 -0.916 . . . . 0.0 111.046 -179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 49.74 -92.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.523 -0.736 . . . . 0.0 111.015 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -142.5 45.9 1.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 111.039 -179.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -72.85 176.32 5.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.889 -1.132 . . . . 0.0 109.803 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.518 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.38 140.32 38.67 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.157 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.742 HD21 ' CE1' ' A' ' 78' ' ' PHE . 44.6 tp -164.3 153.27 13.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.591 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 74.4 m-85 -158.01 119.91 3.65 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.703 -0.623 . . . . 0.0 109.621 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.742 ' CE1' HD21 ' A' ' 76' ' ' LEU . 16.7 m-30 -83.5 134.7 34.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.155 -0.965 . . . . 0.0 111.977 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 50.1 m-85 -121.17 123.35 42.06 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.551 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 2.1 t -120.49 119.85 60.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 O-C-N 121.201 -0.937 . . . . 0.0 110.077 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' HG23 ' A' ' 83' ' ' VAL . 26.4 t30 50.91 39.05 21.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.1 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 64.95 35.2 8.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.68 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -135.41 168.41 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.306 -0.871 . . . . 0.0 109.931 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.808 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.3 mp -154.37 72.84 6.18 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.554 -0.716 . . . . 0.0 109.533 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.12 165.64 32.18 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.072 1.564 . . . . 0.0 110.662 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.47 ' HG2' ' OG ' ' A' ' 88' ' ' SER . 45.9 Cg_endo -72.85 178.31 6.56 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.044 1.55 . . . . 0.0 110.348 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.829 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.56 21.59 2.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.47 ' OG ' ' HG2' ' A' ' 86' ' ' PRO . 3.0 p -93.04 39.68 1.05 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 109.61 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.5 -172.91 3.98 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.684 0.754 . . . . 0.0 110.275 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 64.2 p -138.95 145.8 40.21 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.501 0.667 . . . . 0.0 110.016 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.017 ' HA ' HD23 ' A' ' 94' ' ' LEU . 4.3 mmm -51.42 -39.76 57.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 110.232 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.572 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.83 -49.96 45.81 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -64.6 -26.48 68.42 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.35 -1.088 . . . . 0.0 109.628 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.017 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -69.02 -25.52 64.53 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.302 -0.874 . . . . 0.0 110.044 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.589 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -49.12 -56.0 10.5 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.824 -1.173 . . . . 0.0 109.652 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -70.14 -18.32 63.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.992 -1.067 . . . . 0.0 111.2 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 14.0 mt-10 -87.75 -67.05 0.85 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 112.789 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.551 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 12.9 m-70 -98.6 36.96 1.55 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.795 -1.19 . . . . 0.0 112.315 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.504 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.126 -0.984 . . . . 0.0 109.422 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.543 ' CE1' HG13 ' A' ' 32' ' ' ILE . 7.5 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.078 0.466 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.071 HD11 ' CD1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.8 168.37 9.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.989 -1.07 . . . . 0.0 110.304 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.705 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -122.11 133.76 54.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.926 -1.109 . . . . 0.0 110.727 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.071 ' CD1' HD11 ' A' ' 105' ' ' LEU . 4.6 mt -138.86 137.16 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.316 -0.865 . . . . 0.0 110.289 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.16 145.01 38.84 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.236 -0.915 . . . . 0.0 108.778 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.782 ' HE1' HG13 ' A' ' 33' ' ' VAL . 2.9 p90 -130.2 170.96 13.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.54 -1.35 . . . . 0.0 111.924 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.91 179.78 8.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.845 -0.535 . . . . 0.0 110.063 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.93 ' HB3' HG22 ' A' ' 41' ' ' ILE . 8.8 p-10 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.928 . . . . 0.0 110.268 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.305 0.574 . . . . 0.0 110.307 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.657 HG13 ' CD1' ' A' ' 95' ' ' TYR . 23.2 t -144.51 109.73 4.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 110.188 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.585 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 48.6 Cg_endo -76.02 96.14 1.05 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.162 1.611 . . . . 0.0 110.18 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.733 ' HB ' HD21 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -90.9 145.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.354 -0.841 . . . . 0.0 110.626 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 1.1 mp -100.25 156.03 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.812 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.3 t -133.19 136.36 55.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.034 -1.041 . . . . 0.0 110.972 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 2.1 mt-10 -148.65 177.23 9.68 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.759 -0.588 . . . . 0.0 109.454 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.619 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -112.82 158.15 20.49 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.898 -1.126 . . . . 0.0 110.614 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -63.9 -169.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.556 -0.715 . . . . 0.0 109.24 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.0 Cg_endo -73.54 109.45 2.85 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.31 1.163 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.23 41.49 6.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.365 -0.834 . . . . 0.0 110.433 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.554 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -61.44 174.47 0.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 109.804 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.58 34.56 0.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 111.092 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -87.66 -175.84 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.848 -1.158 . . . . 0.0 110.033 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.505 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -49.07 178.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.954 -1.117 . . . . 0.0 110.328 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.971 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -82.5 -176.81 6.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 109.777 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.971 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.5 mm? -137.18 131.8 33.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 110.782 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -86.84 -26.78 23.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -0.825 . . . . 0.0 109.429 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.475 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -152.67 154.31 35.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.457 -0.777 . . . . 0.0 109.798 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -120.05 44.73 2.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.032 -1.042 . . . . 0.0 109.945 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 8.9 pttp -159.0 111.2 2.18 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.355 -0.841 . . . . 0.0 109.497 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.719 ' HD2' HD13 ' A' ' 63' ' ' LEU . 12.0 m-85 -103.86 140.09 38.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.992 -1.067 . . . . 0.0 110.335 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 50' ' ' LEU . 3.6 mm? -102.05 92.3 4.71 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.943 HG21 ' HE3' ' A' ' 91' ' ' MET . 26.9 m -116.02 142.42 29.16 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.178 -0.951 . . . . 0.0 110.898 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 42.2 Cg_endo -67.49 148.87 79.72 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.103 1.58 . . . . 0.0 109.956 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.565 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 2.0 m -63.12 -13.94 42.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 111.614 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -83.37 -14.8 52.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.111 -0.993 . . . . 0.0 110.888 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.864 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.7 mt -62.65 142.67 57.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.021 -1.05 . . . . 0.0 111.424 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 3.2 p -90.97 163.97 14.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.637 -0.665 . . . . 0.0 109.288 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.542 HG12 HG22 ' A' ' 87' ' ' THR . 39.2 t -61.52 -24.6 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.957 -1.089 . . . . 0.0 110.086 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.07 -31.98 66.23 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.864 ' CB ' HD22 ' A' ' 55' ' ' LEU . 5.2 mm100 -74.6 -47.82 30.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -1.214 . . . . 0.0 109.886 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.057 ' CD1' HD11 ' A' ' 63' ' ' LEU . 38.9 t80 -60.2 -32.59 71.24 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.287 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.545 ' HE1' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.72 -31.92 71.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 109.567 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 3.7 t80 -71.74 -52.87 15.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.54 -0.725 . . . . 0.0 110.993 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.057 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -59.67 -35.09 73.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.834 -1.167 . . . . 0.0 112.57 -178.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.026 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -77.7 -32.19 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 119.657 -1.902 . . . . 0.0 109.394 178.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.93 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -39.81 -64.08 0.52 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.512 -0.742 . . . . 0.0 110.624 -179.32 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -30.31 71.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.47 ' C ' HD13 ' A' ' 68' ' ' ILE . 5.8 mmp_? -67.7 -17.42 64.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.011 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.806 HD12 HD21 ' A' ' 44' ' ' LEU . 2.7 mm -104.44 15.86 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.9 . . . . 0.0 109.793 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.475 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 49.99 28.84 3.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.587 -0.695 . . . . 0.0 110.655 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.93 HD11 ' HG2' ' A' ' 65' ' ' ARG . 4.2 pp -111.0 155.06 23.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.839 . . . . 0.0 109.783 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.0 -173.41 2.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.923 -179.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.11 -91.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.469 -0.77 . . . . 0.0 110.784 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.467 ' O ' ' OE2' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -146.31 36.61 1.0 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.995 . . . . 0.0 111.051 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -60.05 176.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.078 -1.013 . . . . 0.0 109.825 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -94.23 138.25 32.46 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.553 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 20.3 tp -164.78 152.05 11.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.399 -0.813 . . . . 0.0 110.596 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.7 m-85 -158.35 119.9 3.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.578 -0.701 . . . . 0.0 109.757 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.906 ' CZ ' HD12 ' A' ' 64' ' ' ILE . 10.7 m-85 -90.44 124.08 34.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 110.862 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 68.3 m-85 -115.5 127.29 55.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.77 HG22 HG12 ' A' ' 107' ' ' ILE . 2.8 t -121.25 121.93 66.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.503 -0.748 . . . . 0.0 109.959 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.802 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.8 OUTLIER 47.7 47.26 18.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 110.119 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 18.8 m120 57.22 36.84 27.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 110.491 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.6 t -135.3 168.0 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.816 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.02 73.74 5.66 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.539 -0.725 . . . . 0.0 109.524 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.55 165.37 31.81 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.095 1.576 . . . . 0.0 110.767 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.51 -178.86 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.046 1.551 . . . . 0.0 110.435 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.1 20.57 2.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.223 -0.923 . . . . 0.0 110.593 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.7 t -95.85 41.55 1.1 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.504 -0.748 . . . . 0.0 109.527 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.55 -175.1 4.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.496 -0.752 . . . . 0.0 110.287 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 77.7 p -139.45 138.24 36.29 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.601 0.715 . . . . 0.0 110.229 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.05 ' HA ' HD23 ' A' ' 94' ' ' LEU . 2.7 mmm -45.72 -39.24 7.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.966 -1.084 . . . . 0.0 109.842 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -49.83 -53.03 23.62 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.972 -1.109 . . . . 0.0 110.439 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.529 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 2.6 pt20 -64.13 -27.03 68.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.089 -1.242 . . . . 0.0 110.008 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.05 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.36 -25.97 65.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.21 -0.931 . . . . 0.0 109.929 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.657 ' CD1' HG13 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -50.03 -55.5 14.52 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.855 -1.153 . . . . 0.0 109.698 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.632 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 2.0 mt-30 -69.41 -18.44 63.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.951 -1.093 . . . . 0.0 110.974 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 10.5 mt-10 -88.38 -68.36 0.77 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.012 -1.055 . . . . 0.0 113.13 -177.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.49 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 11.4 m-70 -99.35 38.05 1.48 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.703 -1.248 . . . . 0.0 112.795 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.632 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.899 0 O-C-N 120.995 -1.065 . . . . 0.0 109.856 178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.409 0.623 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.8 HD13 HD11 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -101.99 165.29 11.25 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.374 -0.829 . . . . 0.0 109.301 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.617 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -122.9 123.82 41.82 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.77 -1.206 . . . . 0.0 111.165 -179.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.77 HG12 HG22 ' A' ' 80' ' ' VAL . 10.9 mt -141.97 147.66 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.204 -0.935 . . . . 0.0 109.82 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -147.18 -179.57 6.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.145 -0.972 . . . . 0.0 110.159 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.812 ' HE1' HG13 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -140.97 162.26 35.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.945 -1.097 . . . . 0.0 111.418 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 6.8 t -148.0 -177.81 5.94 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 110.53 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.411 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 6.0 mpt_? . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.283 0.564 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.783 HG12 HG12 ' A' ' 31' ' ' VAL . 21.8 t -147.24 107.78 3.89 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 110.39 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.501 ' O ' ' HB3' ' A' ' 104' ' ' PHE . 49.3 Cg_endo -77.78 90.85 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.253 1.66 . . . . 0.0 110.029 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.783 HG12 HG12 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -90.85 133.49 32.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 111.215 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 44.0 mm -95.68 133.76 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 0.0 108.438 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -126.85 128.26 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.711 -1.243 . . . . 0.0 111.866 -178.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 3.1 tm-20 -132.62 159.5 39.37 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.7 ' CE ' HD11 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -87.55 163.38 16.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.867 -1.146 . . . . 0.0 110.863 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.994 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.47 -174.82 0.16 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 109.62 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.994 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.1 Cg_endo -72.85 116.61 4.78 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.638 1.336 . . . . 0.0 110.046 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 63.88 42.25 6.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.341 -0.849 . . . . 0.0 110.463 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.589 ' CB ' ' CG ' ' A' ' 35' ' ' LYS . . . -65.49 175.09 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.28 33.17 0.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.669 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.832 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -95.35 177.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.023 -1.048 . . . . 0.0 110.247 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.832 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -42.41 169.52 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.093 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 1.003 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -78.75 -176.48 4.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -1.195 . . . . 0.0 110.066 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.003 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.2 mm? -139.4 135.84 34.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.898 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -86.49 -29.7 22.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.534 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -153.68 150.17 28.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -111.47 47.14 1.04 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.9 -1.125 . . . . 0.0 109.942 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -159.41 111.71 2.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.588 -0.695 . . . . 0.0 109.244 179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.765 ' CD2' HD13 ' A' ' 63' ' ' LEU . 19.6 m-85 -103.76 141.12 36.64 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.022 -1.049 . . . . 0.0 110.351 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -108.01 93.09 4.35 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.92 ' HB ' HD12 ' A' ' 55' ' ' LEU . 9.5 m -117.86 154.06 51.1 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.342 -0.849 . . . . 0.0 110.721 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.6 Cg_endo -70.34 147.01 58.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.085 1.571 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.552 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.3 m -62.38 -14.8 44.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 0.0 111.488 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -84.12 -12.4 55.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.025 -1.047 . . . . 0.0 111.331 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.92 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.8 mt -62.12 142.0 57.84 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.898 -1.126 . . . . 0.0 111.257 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 90' ' ' THR . 1.1 p -91.61 164.78 13.64 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.726 HG12 HG22 ' A' ' 87' ' ' THR . 93.4 t -60.87 -21.11 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.868 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.33 59.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.907 ' CB ' HD22 ' A' ' 55' ' ' LEU . 4.3 mm-40 -67.64 -47.98 68.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.164 -1.198 . . . . 0.0 109.845 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.191 ' CE2' HD11 ' A' ' 64' ' ' ILE . 34.8 t80 -60.82 -42.82 98.44 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.196 -1.001 . . . . 0.0 109.492 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -54.36 -22.56 12.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.752 -1.218 . . . . 0.0 109.838 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -79.39 -54.51 5.87 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.473 -0.767 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 60' ' ' PHE . 1.2 pp -59.64 -25.94 65.1 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.833 -1.167 . . . . 0.0 112.102 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.191 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.7 mt -84.13 -42.45 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 119.997 -1.689 . . . . 0.0 108.844 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.475 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 1.8 mtp-105 -36.49 -60.58 0.58 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.017 0.436 . . . . 0.0 110.721 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -66.94 -32.7 74.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.831 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 64' ' ' ILE . 6.0 mmt-85 -69.34 -10.27 57.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.166 -0.959 . . . . 0.0 109.262 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.771 HG21 HD23 ' A' ' 70' ' ' LEU . 62.1 mt -103.97 13.21 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.474 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.56 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.6 OUTLIER 44.67 31.97 0.71 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.44 -0.787 . . . . 0.0 110.344 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 70' ' ' LEU . 3.8 pp -104.9 153.55 21.24 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.893 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' GLU . 14.3 ptt180 -166.06 -168.45 1.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 111.033 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 49.85 -92.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.507 -0.746 . . . . 0.0 110.858 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 8.4 pt-20 -143.37 40.49 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 110.834 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.519 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -64.69 176.62 1.1 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.083 -1.011 . . . . 0.0 109.799 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -115.1 140.17 49.29 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.268 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.758 HD21 ' CE1' ' A' ' 78' ' ' PHE . 43.3 tp -157.6 150.7 23.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 80.9 m-85 -158.82 121.36 3.62 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.762 -0.586 . . . . 0.0 109.943 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.758 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.3 m-30 -88.09 128.16 35.42 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.061 -1.024 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 60.7 m-85 -115.98 128.61 55.87 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 108.984 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.869 HG11 ' CD2' ' A' ' 98' ' ' HIS . 2.3 t -120.4 128.71 76.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.149 -0.97 . . . . 0.0 110.27 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.539 ' OD1' ' CG2' ' A' ' 83' ' ' VAL . 5.6 p30 43.11 35.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 110.151 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 1.4 m-20 73.69 39.45 0.55 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.598 -0.689 . . . . 0.0 111.311 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.688 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.8 t -136.33 168.36 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.0 110.047 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.814 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.96 68.71 5.54 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.58 -0.7 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.05 164.36 35.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.992 1.522 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.479 ' HG2' ' OG ' ' A' ' 88' ' ' SER . 44.2 Cg_endo -71.92 179.09 5.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.144 1.602 . . . . 0.0 110.583 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.726 HG22 HG12 ' A' ' 57' ' ' VAL . 1.1 p -87.03 20.35 2.71 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.322 -0.861 . . . . 0.0 110.842 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.479 ' OG ' ' HG2' ' A' ' 86' ' ' PRO . 2.2 p -90.53 39.9 0.99 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.447 -0.783 . . . . 0.0 109.475 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.38 -174.39 4.37 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.589 0.709 . . . . 0.0 110.006 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 82.2 p -139.59 152.84 47.15 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.462 -0.773 . . . . 0.0 110.318 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.025 ' HA ' HD23 ' A' ' 94' ' ' LEU . 43.8 mmm -56.57 -41.73 77.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.388 -0.82 . . . . 0.0 109.926 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -52.04 -48.16 52.89 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -65.28 -27.13 68.41 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.407 -1.055 . . . . 0.0 109.657 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.06 HD11 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -69.02 -23.82 64.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.907 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.591 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -49.26 -56.65 8.69 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.851 -1.156 . . . . 0.0 109.434 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.597 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 11.9 tt0 -70.94 -16.09 62.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.836 -1.165 . . . . 0.0 111.373 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -87.97 -63.31 1.32 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.994 -1.066 . . . . 0.0 113.626 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.869 ' CD2' HG11 ' A' ' 80' ' ' VAL . 9.3 m-70 -98.03 35.89 1.66 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.757 -1.214 . . . . 0.0 112.624 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.597 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 110.312 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 5.6 m-85 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.232 0.539 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.06 HD22 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -99.02 166.08 11.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.291 -0.881 . . . . 0.0 109.12 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.797 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -118.72 121.75 40.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.696 -1.253 . . . . 0.0 111.896 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.735 ' CG1' HG13 ' A' ' 80' ' ' VAL . 7.5 mt -141.63 149.79 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.462 -0.774 . . . . 0.0 109.181 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -139.23 177.02 8.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.005 -1.06 . . . . 0.0 109.963 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.9 OUTLIER -155.13 163.73 39.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.011 -1.056 . . . . 0.0 111.251 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.4 t -159.56 -178.31 7.02 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.234 0.54 . . . . 0.0 110.137 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.564 ' HB3' HG22 ' A' ' 41' ' ' ILE . 8.5 p-10 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.199 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.365 0.602 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.704 HG12 ' CG1' ' A' ' 31' ' ' VAL . 20.0 t -147.4 105.11 3.77 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.602 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -76.37 83.41 2.03 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.289 1.678 . . . . 0.0 110.222 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.704 ' CG1' HG12 ' A' ' 29' ' ' VAL . 1.9 m -81.26 154.27 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.216 -0.928 . . . . 0.0 110.803 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 31.1 mm -111.33 161.92 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 108.761 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.856 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.8 t -134.9 144.67 33.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.947 -1.095 . . . . 0.0 111.168 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.36 178.02 10.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.593 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -117.07 157.61 25.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.905 -1.122 . . . . 0.0 110.681 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.87 -173.74 0.12 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.516 -0.74 . . . . 0.0 109.253 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.1 Cg_endo -71.25 105.62 1.76 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.446 1.235 . . . . 0.0 109.762 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER 63.43 40.74 8.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.41 -0.806 . . . . 0.0 110.326 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.413 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -54.84 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.184 -0.947 . . . . 0.0 109.831 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.443 ' HD3' ' HB3' ' A' ' 111' ' ' ASP . 2.9 ptm180 -144.67 26.63 1.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 0.0 110.994 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.416 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -85.48 -177.37 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.938 -1.101 . . . . 0.0 109.378 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 69' ' ' HIS . . . -62.4 171.05 11.08 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 1.0 ' O ' HD22 ' A' ' 44' ' ' LEU . 4.4 t70 -75.15 -177.29 3.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -1.1 . . . . 0.0 109.998 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.0 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.5 mm? -138.6 133.29 32.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.128 -0.982 . . . . 0.0 110.808 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.503 ' CB ' ' HE2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -86.8 -21.9 26.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.814 . . . . 0.0 109.136 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.503 ' HE2' ' CB ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -151.68 147.66 26.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.571 -0.706 . . . . 0.0 109.105 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -123.61 48.84 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.921 -1.112 . . . . 0.0 110.184 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 11.5 pttm -158.19 108.95 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 110.118 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.916 ' CD2' HD13 ' A' ' 63' ' ' LEU . 23.4 m-85 -103.83 144.17 31.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.134 -0.979 . . . . 0.0 110.412 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.8 103.68 11.2 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 55' ' ' LEU . 3.3 m -128.8 159.37 68.66 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 110.931 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.9 Cg_endo -70.65 148.17 58.74 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.193 1.628 . . . . 0.0 110.513 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.558 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -63.02 -17.08 61.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.494 -0.754 . . . . 0.0 111.305 -179.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -83.51 -9.65 58.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 0.0 111.322 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.004 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.9 mt -62.08 141.41 58.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.784 -1.198 . . . . 0.0 110.908 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.503 ' HA ' HG22 ' A' ' 90' ' ' THR . 6.0 p -91.21 156.67 17.67 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.504 -0.748 . . . . 0.0 109.575 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.731 ' CG1' HG22 ' A' ' 87' ' ' THR . 95.5 t -54.05 -24.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.068 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.81 -38.37 66.02 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.874 ' CB ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -68.57 -49.28 60.66 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.142 -1.211 . . . . 0.0 110.017 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.19 ' CE2' HD11 ' A' ' 64' ' ' ILE . 31.3 t80 -60.49 -47.38 86.38 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.793 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.85 -21.8 1.87 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.68 -1.263 . . . . 0.0 109.776 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -78.68 -54.16 6.4 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.765 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.013 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.6 pp -60.72 -18.45 54.48 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.27 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.19 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -92.3 -41.36 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.115 -1.616 . . . . 0.0 109.145 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.935 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -37.26 -61.2 0.6 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.872 -0.518 . . . . 0.0 110.677 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -65.16 -32.87 74.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.098 -1.001 . . . . 0.0 109.618 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 29.3 mmt-85 -69.94 -12.11 61.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 110.109 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.833 HD12 HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -99.09 4.48 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.123 -0.985 . . . . 0.0 109.295 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.527 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 55.47 29.25 12.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.459 -0.776 . . . . 0.0 110.018 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.935 HD11 ' HG2' ' A' ' 65' ' ' ARG . 3.8 pp -101.0 151.81 21.33 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.038 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.82 -161.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.288 -0.883 . . . . 0.0 110.778 -179.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.525 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 49.92 -87.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.0 110.917 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 72' ' ' ALA . 40.7 mt-10 -156.37 36.45 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 110.634 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -62.91 176.59 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.059 -1.026 . . . . 0.0 109.848 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB3' ' OD1' ' A' ' 111' ' ' ASP . . . -119.0 145.06 46.14 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.061 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.837 HD21 ' CE1' ' A' ' 78' ' ' PHE . 22.2 tp -158.84 153.56 24.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.537 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 56.2 m-85 -154.39 122.35 5.94 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.547 -0.72 . . . . 0.0 109.767 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.837 ' CE1' HD21 ' A' ' 76' ' ' LEU . 16.7 m-30 -84.2 131.15 34.78 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.337 -0.852 . . . . 0.0 111.869 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 64.6 m-85 -120.12 119.04 32.15 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.783 HG22 HG23 ' A' ' 107' ' ' ILE . 1.4 t -121.59 126.26 74.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.654 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.7 t-20 55.25 35.28 24.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.079 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 2.0 t-20 64.58 32.16 11.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 110.106 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -135.12 168.55 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.822 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.86 73.43 5.8 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.58 -0.7 . . . . 0.0 109.297 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.19 165.14 33.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.099 1.579 . . . . 0.0 110.867 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.62 178.73 5.92 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.108 1.583 . . . . 0.0 110.339 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.731 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -88.22 21.91 2.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.361 -0.837 . . . . 0.0 110.657 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.7 p -90.5 37.36 0.91 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.46 -0.775 . . . . 0.0 109.795 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.08 -171.96 4.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.463 -0.773 . . . . 0.0 110.142 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.539 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 44.2 p -138.81 150.12 45.7 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.654 0.74 . . . . 0.0 110.267 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.1 ' HA ' HD23 ' A' ' 94' ' ' LEU . 3.1 mmt -47.53 -47.93 27.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.469 -0.77 . . . . 0.0 110.692 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.558 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -42.69 -43.58 5.17 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.539 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 0.7 OUTLIER -67.82 -42.49 81.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.342 -1.093 . . . . 0.0 109.23 179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.1 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -58.84 -23.24 60.35 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.363 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.602 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -48.36 -54.06 15.27 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.675 -1.265 . . . . 0.0 109.716 -179.305 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.71 -22.7 63.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.251 -0.905 . . . . 0.0 111.375 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 2.1 mm-40 -81.54 -63.52 1.38 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.957 -1.089 . . . . 0.0 111.655 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.643 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.8 m-70 -97.63 41.58 1.12 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.002 -1.061 . . . . 0.0 110.141 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 95' ' ' TYR . 6.1 t-80 . . . . . 0 N--CA 1.498 1.965 0 CA-C-O 121.259 0.552 . . . . 0.0 109.691 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.595 ' CE1' ' HB2' ' A' ' 30' ' ' PRO . 1.9 m-85 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.08 0.467 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.066 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -114.87 161.77 17.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.046 -1.034 . . . . 0.0 109.488 179.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.75 ' N ' HD12 ' A' ' 105' ' ' LEU . 4.3 p90 -120.49 132.81 55.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.778 -1.201 . . . . 0.0 111.749 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.066 ' CG1' HD11 ' A' ' 105' ' ' LEU . 7.7 mt -141.25 124.54 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 0.0 109.98 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -122.36 160.3 25.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.993 -1.067 . . . . 0.0 109.671 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.856 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.4 p90 -135.42 162.2 33.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.694 -1.254 . . . . 0.0 111.258 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -147.33 178.76 8.16 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.135 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.552 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 9.6 t0 . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.21 -0.931 . . . . 0.0 110.325 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.274 0.559 . . . . 0.0 110.298 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.743 HG12 HG12 ' A' ' 31' ' ' VAL . 16.3 t -147.2 107.25 3.89 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.504 ' HD2' ' OH ' ' A' ' 95' ' ' TYR . 46.3 Cg_endo -75.41 86.48 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.181 1.621 . . . . 0.0 109.855 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.743 HG12 HG12 ' A' ' 29' ' ' VAL . 1.1 m -79.71 136.61 23.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.317 -0.865 . . . . 0.0 110.553 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 14.9 mm -91.86 157.25 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.791 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.5 t -134.05 140.41 46.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 120.898 -1.126 . . . . 0.0 111.336 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.23 169.74 23.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -109.5 162.62 14.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.857 -1.152 . . . . 0.0 110.522 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -62.42 -172.17 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.499 -0.751 . . . . 0.0 109.307 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.9 Cg_endo -71.55 110.41 2.87 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.433 1.228 . . . . 0.0 109.83 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.64 42.58 10.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.26 -0.9 . . . . 0.0 110.025 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.541 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -59.38 179.13 0.11 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.286 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.527 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 6.5 ptm180 -150.04 29.81 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 110.825 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.843 HG22 ' HB3' ' A' ' 111' ' ' ASP . 1.9 pp -85.41 178.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.064 . . . . 0.0 110.424 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.82 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -48.02 -178.4 0.01 OUTLIER Glycine 0 N--CA 1.496 2.666 0 O-C-N 121.332 -0.855 . . . . 0.0 111.055 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.99 ' O ' HD22 ' A' ' 44' ' ' LEU . 7.7 t70 -84.95 -178.98 6.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -1.202 . . . . 0.0 109.858 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.99 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -138.41 134.73 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.096 -1.002 . . . . 0.0 110.592 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.95 -24.02 26.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.456 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.08 154.46 29.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.556 -0.715 . . . . 0.0 109.591 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HG2' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -118.73 43.18 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.945 -1.097 . . . . 0.0 110.017 179.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.523 ' HG3' ' HG2' ' A' ' 47' ' ' LYS . 18.9 mttt -158.23 109.53 2.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.619 -0.676 . . . . 0.0 109.566 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.905 ' CD2' HD13 ' A' ' 63' ' ' LEU . 15.3 m-85 -103.84 141.06 36.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.018 -1.051 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -103.87 94.57 5.49 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.952 ' HB ' HD12 ' A' ' 55' ' ' LEU . 14.7 m -117.57 149.65 45.3 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 110.851 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.457 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 47.0 Cg_endo -70.56 149.71 62.18 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.212 1.638 . . . . 0.0 110.074 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.557 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.5 m -62.27 -17.15 57.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.405 -0.809 . . . . 0.0 111.405 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -83.95 -11.57 56.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 111.385 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.952 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.3 mt -61.61 141.21 57.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.858 -1.151 . . . . 0.0 111.145 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 p -91.17 154.0 19.63 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.285 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 25.6 t -53.97 -20.98 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.057 -1.027 . . . . 0.0 109.785 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.73 -39.63 59.72 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.822 ' CB ' HD22 ' A' ' 55' ' ' LEU . 10.9 mm-40 -67.85 -47.38 69.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.046 -1.267 . . . . 0.0 109.599 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.172 ' CE2' HD11 ' A' ' 64' ' ' ILE . 21.3 t80 -60.38 -45.97 91.65 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.432 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.64 -22.86 2.23 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.953 -1.092 . . . . 0.0 109.911 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -80.15 -54.54 5.66 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.818 . . . . 0.0 110.357 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.043 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.6 pp -59.61 -21.64 60.69 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.012 -1.055 . . . . 0.0 112.306 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.172 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -90.45 -38.56 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 120.09 -1.632 . . . . 0.0 108.816 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.839 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -36.65 -62.43 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.863 -0.523 . . . . 0.0 110.691 -179.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -30.63 71.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.133 -0.98 . . . . 0.0 109.845 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 20.1 mmt180 -68.01 -13.85 62.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 109.481 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.013 ' CG2' HD23 ' A' ' 70' ' ' LEU . 70.6 mt -103.21 14.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.449 -0.782 . . . . 0.0 109.545 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.564 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 1.4 t60 47.8 28.76 1.41 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.552 -0.718 . . . . 0.0 110.493 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.013 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.0 pp -110.71 155.17 22.84 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.636 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 73' ' ' GLU . 11.5 ptt180 -166.15 -171.67 2.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.114 -0.991 . . . . 0.0 111.054 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.47 -89.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.522 -0.736 . . . . 0.0 110.763 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -148.55 33.24 0.78 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.143 -0.973 . . . . 0.0 110.919 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -56.76 176.81 0.09 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.024 -1.048 . . . . 0.0 109.796 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.29 138.77 40.96 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.128 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.745 HD21 ' CE1' ' A' ' 78' ' ' PHE . 17.5 tp -164.41 152.85 12.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 110.505 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 94.1 m-85 -158.85 122.08 3.77 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.663 -0.648 . . . . 0.0 109.896 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.745 ' CE1' HD21 ' A' ' 76' ' ' LEU . 16.9 m-30 -85.62 132.33 34.19 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.136 -0.977 . . . . 0.0 111.346 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 58.2 m-85 -119.45 121.46 39.52 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.49 -0.756 . . . . 0.0 109.227 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.827 HG22 HG23 ' A' ' 107' ' ' ILE . 2.5 t -120.63 123.48 70.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.358 -0.839 . . . . 0.0 110.074 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.6 t30 50.39 34.54 9.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 8.4 t-20 66.98 37.37 3.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.95 . . . . 0.0 110.146 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.612 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.7 t -135.47 169.96 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 109.83 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.814 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.6 OUTLIER -154.68 73.67 5.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.478 -0.764 . . . . 0.0 109.207 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.52 155.77 58.99 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.164 1.613 . . . . 0.0 110.925 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.71 -178.67 3.58 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.167 1.614 . . . . 0.0 110.273 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.538 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 1.2 p -86.03 18.46 3.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.906 . . . . 0.0 110.823 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.4 m -90.33 32.49 0.94 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.397 -0.814 . . . . 0.0 109.662 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.31 -174.18 4.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.525 -0.735 . . . . 0.0 110.096 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.53 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 67.3 p -139.4 149.91 44.66 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.561 -0.712 . . . . 0.0 110.19 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.019 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -48.74 -43.81 37.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.317 -0.864 . . . . 0.0 110.175 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -46.1 -44.18 14.02 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.53 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 2.4 mt-30 -65.58 -47.0 77.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.385 -1.067 . . . . 0.0 109.434 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.019 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -56.91 -23.43 44.94 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.385 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.53 ' CD1' HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -48.94 -56.18 9.61 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.812 -1.18 . . . . 0.0 109.848 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -16.78 62.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.027 -1.046 . . . . 0.0 111.532 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -87.15 -65.53 1.0 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.892 -1.13 . . . . 0.0 112.473 -178.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.555 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -98.78 41.48 1.14 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.953 -1.092 . . . . 0.0 111.388 -177.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.513 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.8 p80 . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.492 -0.755 . . . . 0.0 109.758 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.429 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 4.9 p90 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.256 0.55 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.076 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -121.73 171.64 8.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.125 -0.985 . . . . 0.0 109.752 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.568 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.3 m-85 -122.64 126.23 47.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.666 -1.271 . . . . 0.0 111.366 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 1.076 ' CG1' HD11 ' A' ' 105' ' ' LEU . 9.0 mt -138.75 136.16 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.179 -0.951 . . . . 0.0 110.358 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -130.73 173.11 11.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -1.0 . . . . 0.0 109.731 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.791 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.4 p90 -150.69 165.33 33.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.87 -1.144 . . . . 0.0 111.364 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -150.54 -178.28 6.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.768 -0.583 . . . . 0.0 110.177 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.843 ' HB3' HG22 ' A' ' 41' ' ' ILE . 8.4 p-10 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -53.67 -39.96 65.51 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.176 -1.191 . . . . 0.0 109.591 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 1.6 tttp -74.15 -34.78 63.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 110.054 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.542 HG21 HD11 ' A' ' 50' ' ' LEU . 12.0 mm -65.23 -12.33 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.177 -0.952 . . . . 0.0 110.208 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -83.15 -60.65 2.08 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.261 -0.9 . . . . 0.0 110.271 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.39 -39.71 15.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.0 110.138 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 2.6 mtmt -82.43 -45.59 14.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.178 -0.951 . . . . 0.0 110.009 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 28.8 m-85 -113.65 63.68 1.06 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 110.85 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.483 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 46.7 Cg_endo -72.66 -9.59 24.11 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.818 1.431 . . . . 0.0 110.407 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -98.96 -4.98 31.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.245 -0.91 . . . . 0.0 110.41 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.533 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 0.9 OUTLIER -88.54 -173.82 4.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 109.962 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 31' ' ' VAL . 24.2 t -133.65 103.99 12.1 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.933 . . . . 0.0 110.383 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.487 ' HD2' ' OH ' ' A' ' 95' ' ' TYR . 48.7 Cg_endo -75.97 85.21 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 124.264 1.665 . . . . 0.0 109.721 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 29' ' ' VAL . 2.0 m -77.9 150.33 5.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 110.918 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 35.9 mm -106.54 160.66 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.318 -0.864 . . . . 0.0 108.672 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.723 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.2 t -134.36 141.23 44.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.903 -1.123 . . . . 0.0 111.336 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.65 174.97 14.67 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.538 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -115.93 159.85 21.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.779 -1.2 . . . . 0.0 110.526 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.01 -174.3 0.14 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.595 -0.691 . . . . 0.0 109.405 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.7 Cg_endo -71.32 110.37 2.83 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.617 1.325 . . . . 0.0 109.92 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.22 42.9 5.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.326 -0.859 . . . . 0.0 110.066 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.538 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -57.47 -179.82 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 110.052 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.491 ' CG ' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.06 35.11 0.66 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.108 -0.995 . . . . 0.0 110.749 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.879 HD12 ' O ' ' A' ' 42' ' ' GLY . 2.1 pp -95.09 176.22 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 0.0 110.274 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.879 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -49.09 -177.69 0.01 OUTLIER Glycine 0 N--CA 1.497 2.701 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.932 ' O ' HD22 ' A' ' 44' ' ' LEU . 5.6 t70 -79.79 -179.03 6.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -1.149 . . . . 0.0 109.615 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.932 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.8 mm? -135.63 131.94 36.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.433 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' C ' ' HD2' ' A' ' 46' ' ' LYS . 1.6 m-20 -86.8 -28.73 22.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -0.829 . . . . 0.0 109.703 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 45' ' ' ASP . 3.7 mptt -152.68 157.03 40.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.54 -0.725 . . . . 0.0 109.808 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -123.88 43.19 3.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.955 . . . . 0.0 109.958 179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 3.6 pttt -159.67 107.57 1.73 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.846 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.896 ' CD2' HD13 ' A' ' 63' ' ' LEU . 22.4 m-85 -103.84 142.2 34.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.158 -0.964 . . . . 0.0 110.75 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.542 HD11 HG21 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -102.16 95.67 6.48 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.509 ' HB ' HD12 ' A' ' 55' ' ' LEU . 15.6 m -118.54 145.26 37.02 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.193 -0.942 . . . . 0.0 110.728 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.52 ' HD2' HD12 ' A' ' 55' ' ' LEU . 43.8 Cg_endo -70.19 147.59 60.43 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 124.0 1.526 . . . . 0.0 109.932 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.568 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.85 -16.04 56.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -0.805 . . . . 0.0 111.476 -178.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -83.57 -13.7 53.81 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.961 -1.087 . . . . 0.0 111.192 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.866 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.3 mt -62.44 143.62 56.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.867 -1.145 . . . . 0.0 111.527 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.1 p -91.12 162.84 14.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.616 -0.678 . . . . 0.0 109.717 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.614 HG12 HG22 ' A' ' 87' ' ' THR . 70.2 t -59.9 -23.71 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.99 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.3 -34.0 68.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.866 ' CB ' HD22 ' A' ' 55' ' ' LEU . 22.1 mm-40 -73.41 -46.98 45.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.097 -1.237 . . . . 0.0 109.827 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.16 ' CE2' HD11 ' A' ' 64' ' ' ILE . 19.8 t80 -60.87 -46.82 89.11 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.565 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -50.69 -21.73 1.74 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.916 -1.115 . . . . 0.0 109.913 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -80.66 -54.82 5.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.442 -0.786 . . . . 0.0 110.387 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.993 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.8 pp -60.11 -19.95 55.86 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.984 -1.072 . . . . 0.0 112.355 -178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.16 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -92.75 -38.88 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 O-C-N 120.094 -1.629 . . . . 0.0 109.165 177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.551 ' HG2' HD11 ' A' ' 70' ' ' LEU . 13.9 mtt180 -36.98 -61.37 0.56 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.775 -0.578 . . . . 0.0 110.698 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -65.21 -32.32 73.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.0 109.698 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' C ' HD13 ' A' ' 68' ' ' ILE . 4.5 mmp_? -68.04 -14.77 63.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.251 -0.906 . . . . 0.0 109.987 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.847 ' CG2' HD23 ' A' ' 70' ' ' LEU . 2.0 mm -100.23 10.21 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.176 -0.953 . . . . 0.0 109.676 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.498 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.5 OUTLIER 52.67 32.83 12.59 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.433 -0.792 . . . . 0.0 110.238 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.847 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.3 pp -116.03 153.97 30.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.444 -0.785 . . . . 0.0 110.221 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 2.7 ptp180 -166.4 -173.56 2.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.265 -0.897 . . . . 0.0 110.919 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 56.95 -88.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.548 -0.72 . . . . 0.0 111.065 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.432 ' O ' ' O ' ' A' ' 74' ' ' ASP . 5.6 pt-20 -146.01 24.17 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.092 -1.005 . . . . 0.0 111.301 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -49.09 176.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.943 -1.098 . . . . 0.0 109.786 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.694 ' HB3' ' OD1' ' A' ' 111' ' ' ASP . . . -111.28 139.58 46.56 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.252 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.7 HD21 ' CE1' ' A' ' 78' ' ' PHE . 31.9 tp -164.76 153.68 12.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.774 . . . . 0.0 110.332 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.595 ' CE2' ' HB2' ' A' ' 113' ' ' SER . 95.2 m-85 -157.66 120.75 3.96 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.57 -0.706 . . . . 0.0 110.032 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.7 ' CE1' HD21 ' A' ' 76' ' ' LEU . 15.7 m-30 -82.82 133.58 35.13 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.171 -0.956 . . . . 0.0 111.748 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 51.0 m-85 -120.65 119.38 32.66 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.912 HG22 HG23 ' A' ' 107' ' ' ILE . 2.5 t -120.67 128.41 76.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 O-C-N 121.382 -0.824 . . . . 0.0 109.915 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.544 ' HB2' ' CG ' ' A' ' 98' ' ' HIS . 4.4 t30 48.1 36.61 6.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.984 . . . . 0.0 109.921 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 12.8 m-20 66.69 38.65 3.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.468 -0.77 . . . . 0.0 110.438 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.696 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -135.66 166.95 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 110.024 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -155.19 67.7 5.18 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.635 -0.666 . . . . 0.0 109.304 179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -73.48 164.6 34.62 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.962 1.506 . . . . 0.0 110.808 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.64 -178.33 3.34 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.114 1.587 . . . . 0.0 110.387 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.614 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -84.35 21.42 1.44 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.413 -0.804 . . . . 0.0 110.887 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -96.99 43.15 1.07 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.346 -0.847 . . . . 0.0 109.451 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.03 -172.1 3.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.547 -0.72 . . . . 0.0 110.234 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 72.2 p -139.33 145.7 39.38 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.567 -0.708 . . . . 0.0 110.375 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.014 ' HA ' HD23 ' A' ' 94' ' ' LEU . 95.9 mmm -58.88 -45.03 91.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.165 -0.959 . . . . 0.0 109.649 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.568 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -48.11 -47.65 26.54 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 1.0 OUTLIER -64.46 -32.86 74.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.211 -1.17 . . . . 0.0 109.616 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.014 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -66.16 -22.23 66.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.905 . . . . 0.0 109.955 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.516 ' CD1' HG13 ' A' ' 29' ' ' VAL . 1.2 t80 -49.22 -55.06 13.79 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.012 -1.055 . . . . 0.0 109.971 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 96' ' ' GLN . 5.1 tp60 -69.47 -18.55 63.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.008 -1.058 . . . . 0.0 111.078 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 12.7 mm-40 -87.3 -68.69 0.73 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.007 -1.058 . . . . 0.0 112.363 -178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.544 ' CG ' ' HB2' ' A' ' 81' ' ' ASN . 8.8 m-70 -99.44 38.23 1.46 Allowed 'General case' 0 N--CA 1.484 1.257 0 O-C-N 120.833 -1.167 . . . . 0.0 111.947 -177.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.509 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.8 p80 -56.61 -22.09 31.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.033 -1.042 . . . . 0.0 109.237 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' CG ' ' HB2' ' A' ' 106' ' ' TYR . 0.4 OUTLIER 46.46 -92.45 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.862 -0.524 . . . . 0.0 110.513 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.501 ' OE1' ' CE1' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -71.32 163.54 27.47 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.138 -0.977 . . . . 0.0 110.371 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.6 p30 -85.36 60.73 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.906 . . . . 0.0 109.932 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.408 ' HD1' ' CE1' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -179.38 -57.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.307 -0.87 . . . . 0.0 109.915 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 4.6 m-85 -119.24 -178.37 3.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 109.776 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.075 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -109.58 165.68 11.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.064 -1.023 . . . . 0.0 109.502 179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.713 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.9 m-85 -122.85 128.89 50.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.847 -1.158 . . . . 0.0 111.87 -178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.075 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.3 mt -140.02 128.57 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.343 -0.848 . . . . 0.0 110.016 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -123.7 172.83 8.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 109.75 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.723 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.2 p90 -149.92 163.07 39.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.822 -1.174 . . . . 0.0 111.35 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.493 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -146.45 179.47 7.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.741 -0.6 . . . . 0.0 110.688 -179.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.694 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 5.8 t70 -121.29 36.62 4.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.414 -0.804 . . . . 0.0 110.378 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -120.92 151.99 39.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.972 -1.08 . . . . 0.0 110.567 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.595 ' HB2' ' CE2' ' A' ' 77' ' ' PHE . 34.5 t -158.06 34.82 0.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.404 -0.81 . . . . 0.0 109.933 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 113' ' ' SER . 9.5 p -43.54 167.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.356 -0.84 . . . . 0.0 110.343 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -103.36 110.19 22.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -52.52 159.05 3.24 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.8 mt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.171 -1.194 . . . . 0.0 110.199 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.06 -48.86 64.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -1.137 . . . . 0.0 110.184 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -29.11 62.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.267 -0.896 . . . . 0.0 110.165 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.922 ' CG2' HD21 ' A' ' 50' ' ' LEU . 15.8 mm -71.89 -20.89 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 110.207 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -31.54 39.55 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.85 -1.156 . . . . 0.0 109.963 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.63 -38.13 55.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.423 -0.798 . . . . 0.0 110.061 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.619 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 0.1 OUTLIER -85.32 -29.87 24.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.226 -0.921 . . . . 0.0 110.855 -179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.619 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 46.1 m-85 -114.44 71.38 2.3 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.791 -1.193 . . . . 0.0 110.276 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 46.7 Cg_endo -73.26 -3.59 13.94 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.996 1.524 . . . . 0.0 110.269 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -107.55 -1.83 20.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 28' ' ' ARG . 8.7 mpt_? -94.03 -167.83 1.75 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 110.149 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.744 HG12 HG12 ' A' ' 31' ' ' VAL . 24.0 t -145.55 105.78 4.32 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 110.194 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.496 ' O ' ' HB2' ' A' ' 104' ' ' PHE . 47.7 Cg_endo -75.89 84.06 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.167 1.614 . . . . 0.0 109.818 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.831 HG12 ' CD2' ' A' ' 105' ' ' LEU . 1.8 m -80.54 149.69 5.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 111.114 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.588 HG13 ' CE1' ' A' ' 104' ' ' PHE . 6.8 mm -102.02 164.93 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.584 HG21 ' CE1' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -136.09 141.81 40.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.779 -1.201 . . . . 0.0 111.545 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 1.8 tt0 -156.52 165.76 35.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.642 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -99.69 162.47 12.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.917 -1.115 . . . . 0.0 110.738 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.031 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.36 -172.66 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.464 -0.772 . . . . 0.0 109.292 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.031 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.8 Cg_endo -71.31 107.59 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.476 1.251 . . . . 0.0 110.033 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 mttt 63.52 36.39 11.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.453 -0.78 . . . . 0.0 110.196 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -58.68 178.85 0.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -0.944 . . . . 0.0 110.061 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 35.53 0.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.197 -0.939 . . . . 0.0 110.58 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.824 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.54 176.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.006 -1.059 . . . . 0.0 110.432 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.824 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -48.73 -177.47 0.01 OUTLIER Glycine 0 N--CA 1.497 2.717 0 O-C-N 121.438 -0.789 . . . . 0.0 111.179 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.892 ' O ' HD22 ' A' ' 44' ' ' LEU . 4.3 t0 -77.12 -175.74 3.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -1.091 . . . . 0.0 109.778 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.892 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -136.02 135.21 39.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.985 . . . . 0.0 110.738 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -86.89 -36.03 18.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 109.732 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.56 ' HE2' ' CD2' ' A' ' 49' ' ' TYR . 0.0 OUTLIER -152.59 155.29 37.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.474 -0.766 . . . . 0.0 109.837 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -120.31 43.23 2.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 0.0 110.226 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HG3' ' HG2' ' A' ' 47' ' ' LYS . 14.8 mttp -157.88 107.56 2.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.539 -0.726 . . . . 0.0 109.58 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.596 ' CD2' HD13 ' A' ' 63' ' ' LEU . 31.8 m-85 -103.39 143.34 32.82 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.114 -0.991 . . . . 0.0 110.884 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.922 HD21 ' CG2' ' A' ' 21' ' ' ILE . 0.7 OUTLIER -103.61 89.89 3.49 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.528 ' HB ' HD12 ' A' ' 55' ' ' LEU . 20.2 m -111.04 143.45 28.36 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.347 -0.846 . . . . 0.0 111.002 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.437 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 46.5 Cg_endo -71.45 148.96 55.42 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.164 1.613 . . . . 0.0 109.74 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.554 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.55 -15.58 51.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.264 -0.898 . . . . 0.0 111.438 -178.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -83.34 -13.81 54.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.09 -1.006 . . . . 0.0 111.169 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.846 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.0 mt -62.3 143.63 56.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.829 -1.17 . . . . 0.0 111.129 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.496 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 1.6 p -91.3 167.67 12.13 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.593 -0.692 . . . . 0.0 109.891 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 80.8 t -62.75 -32.25 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 110.059 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.81 -23.38 70.82 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.846 ' CB ' HD22 ' A' ' 55' ' ' LEU . 34.7 mm-40 -80.4 -50.91 9.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.125 -1.221 . . . . 0.0 109.727 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.184 ' CE2' HD11 ' A' ' 64' ' ' ILE . 14.1 t80 -60.12 -34.06 72.99 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.037 -1.065 . . . . 0.0 109.084 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.586 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -54.8 -37.56 66.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.47 -0.769 . . . . 0.0 109.873 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.8 t80 -74.51 -50.69 17.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.537 -0.727 . . . . 0.0 112.525 -178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.129 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -58.58 -39.88 81.57 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.506 -1.371 . . . . 0.0 112.489 -177.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.184 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -75.1 -38.89 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 119.764 -1.835 . . . . 0.0 108.761 178.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.835 ' HD2' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -39.15 -58.39 1.17 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.551 -0.718 . . . . 0.0 110.42 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -65.32 -34.4 78.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.968 -1.083 . . . . 0.0 109.903 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.527 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 4.5 mmp_? -70.27 -9.22 55.33 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.258 -0.901 . . . . 0.0 109.835 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.016 HG21 HD23 ' A' ' 70' ' ' LEU . 67.1 mt -100.28 4.55 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.337 -0.852 . . . . 0.0 109.733 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.493 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 60.63 27.97 17.68 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.393 -0.817 . . . . 0.0 110.324 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.016 HD23 HG21 ' A' ' 68' ' ' ILE . 4.3 pp -114.99 156.33 25.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.639 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.06 -166.94 0.97 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 110.998 -179.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 55.45 -87.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.835 . . . . 0.0 110.986 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' ARG . 9.7 pt-20 -152.06 27.09 0.61 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 111.238 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -53.84 176.37 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.919 -1.113 . . . . 0.0 109.817 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 111' ' ' ASP . . . -97.79 141.97 30.13 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.954 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.764 HD21 ' CZ ' ' A' ' 78' ' ' PHE . 16.6 tp -162.19 152.55 16.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 110.997 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.2 m-85 -160.99 120.54 2.64 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.839 ' CE1' HD12 ' A' ' 64' ' ' ILE . 77.9 m-85 -89.03 116.81 27.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.087 -1.008 . . . . 0.0 110.273 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 55.8 m-85 -108.31 125.87 52.19 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.399 -0.813 . . . . 0.0 109.507 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.998 HG22 HG23 ' A' ' 107' ' ' ILE . 1.9 t -121.34 129.92 75.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.324 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.502 ' O ' HG23 ' A' ' 83' ' ' VAL . 55.4 t30 51.05 37.84 18.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.0 110.361 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 58.2 t30 65.06 36.75 7.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 110.385 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.684 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -135.02 167.04 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.228 -0.92 . . . . 0.0 110.031 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.81 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.05 73.07 5.72 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.585 -0.697 . . . . 0.0 109.556 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.55 164.37 35.12 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.994 1.523 . . . . 0.0 110.563 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.86 -178.38 3.09 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.138 1.599 . . . . 0.0 110.221 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.528 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -85.01 20.08 1.97 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 110.741 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.67 42.01 1.11 Allowed 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.485 -0.76 . . . . 0.0 109.672 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.28 -174.85 4.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.503 -0.748 . . . . 0.0 110.144 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 43.6 p -139.68 146.68 39.96 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.501 -0.75 . . . . 0.0 110.386 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.092 ' HA ' HD23 ' A' ' 94' ' ' LEU . 24.3 mmm -53.56 -42.45 67.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.662 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.52 -46.71 37.21 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.1 OUTLIER -65.35 -33.05 75.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -1.209 . . . . 0.0 109.827 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.092 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.11 -19.79 64.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.936 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.651 ' CD1' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -49.55 -56.42 9.95 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.005 -1.059 . . . . 0.0 109.632 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -70.15 -15.23 62.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.461 -1.4 . . . . 0.0 111.243 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 2.2 mm-40 -87.44 -64.74 1.1 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.969 -1.082 . . . . 0.0 112.925 -178.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.62 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -97.97 39.69 1.21 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.875 -1.14 . . . . 0.0 111.445 -177.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.588 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 1.6 t60 -156.79 173.89 16.3 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.582 ' O ' ' CE1' ' A' ' 99' ' ' HIS . 1.4 pt-20 -164.26 -128.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.033 -1.042 . . . . 0.0 110.549 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 102' ' ' ASP . 12.7 mm-40 -90.76 -18.33 25.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.728 -1.232 . . . . 0.0 110.787 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.464 ' OD2' ' OE2' ' A' ' 100' ' ' GLU . 22.8 m-20 -41.28 -72.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -0.901 . . . . 0.0 110.329 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER 176.21 -52.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.277 -0.889 . . . . 0.0 110.251 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.588 ' CE1' HG13 ' A' ' 32' ' ' ILE . 3.1 p90 -127.14 -173.03 2.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 110.304 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.038 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.28 168.11 9.45 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.19 -0.944 . . . . 0.0 109.113 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.669 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.1 p90 -124.64 127.28 47.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.785 -1.197 . . . . 0.0 111.854 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.038 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.7 mt -136.73 144.56 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.353 -0.842 . . . . 0.0 110.078 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -133.55 175.65 9.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.181 -0.949 . . . . 0.0 110.018 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.656 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.9 OUTLIER -147.42 167.6 23.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.972 . . . . 0.0 110.478 179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -158.58 165.21 35.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.543 -0.723 . . . . 0.0 110.285 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.536 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 4.3 p-10 -88.96 -8.88 53.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.304 -0.873 . . . . 0.0 110.312 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 14.9 pt-20 -178.3 159.06 1.2 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 0.0 110.486 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.7 t -154.63 31.92 0.41 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.416 -0.803 . . . . 0.0 110.106 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.573 HG22 ' H ' ' A' ' 115' ' ' TYR . 9.9 p -112.14 177.11 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.234 -0.916 . . . . 0.0 110.377 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.573 ' H ' HG22 ' A' ' 114' ' ' VAL . 17.2 t80 -44.29 131.14 6.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.99 -151.74 7.58 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.238 -1.154 . . . . 0.0 110.116 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -59.03 -49.66 77.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.311 -1.111 . . . . 0.0 109.935 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -77.54 -18.67 56.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.25 -0.906 . . . . 0.0 110.67 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -72.2 -24.35 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.984 -1.073 . . . . 0.0 110.123 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 18' ' ' GLY . 5.1 mmm180 -93.34 -49.21 6.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.099 -1.001 . . . . 0.0 110.036 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -54.13 -36.98 63.87 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.063 -1.023 . . . . 0.0 109.111 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 20' ' ' LYS . 4.7 mmtp -86.35 -49.97 7.26 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.393 -0.817 . . . . 0.0 109.435 179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.514 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 13.0 m-85 -114.32 61.57 1.12 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.46 -0.775 . . . . 0.0 110.393 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 42.9 Cg_endo -69.04 -31.16 24.34 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.865 1.455 . . . . 0.0 110.605 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 1.8 t0 -103.89 21.9 15.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.051 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' N ' ' HD2' ' A' ' 28' ' ' ARG . 3.2 mpt_? -99.03 -165.52 1.25 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.201 -0.937 . . . . 0.0 110.418 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.688 HG12 HG12 ' A' ' 31' ' ' VAL . 9.2 t -143.53 104.45 5.01 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 110.295 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.7 Cg_endo -78.71 87.84 1.51 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 124.159 1.61 . . . . 0.0 109.928 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.688 HG12 HG12 ' A' ' 29' ' ' VAL . 1.2 m -83.42 144.02 10.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.136 -0.977 . . . . 0.0 110.882 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 31.5 mm -97.5 162.52 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.837 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.4 t -136.69 139.6 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.912 -1.117 . . . . 0.0 111.221 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.576 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.3 tm-20 -154.03 163.87 39.37 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' HD2' HD11 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -99.97 158.68 15.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.885 -1.135 . . . . 0.0 110.909 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.016 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.92 -173.55 0.11 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.562 -0.711 . . . . 0.0 109.185 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.016 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.0 Cg_endo -72.0 109.1 2.61 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.507 1.267 . . . . 0.0 110.112 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 62.15 42.86 9.21 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.367 -0.833 . . . . 0.0 110.293 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.426 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -63.99 179.92 0.48 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.235 -0.916 . . . . 0.0 109.996 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.517 ' CG ' ' OD1' ' A' ' 111' ' ' ASP . 0.9 OUTLIER -149.84 30.74 0.72 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.163 -0.961 . . . . 0.0 110.821 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.544 HD11 ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -85.18 -179.65 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.048 -1.033 . . . . 0.0 109.924 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.515 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -59.81 168.03 8.26 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -87.35 171.64 10.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -1.11 . . . . 0.0 110.34 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.905 HD13 ' O ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -136.51 146.28 46.06 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.351 -0.843 . . . . 0.0 110.105 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.441 ' C ' ' HD3' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -86.95 -7.49 58.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.333 -0.854 . . . . 0.0 110.182 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.905 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -154.12 155.66 35.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.0 110.004 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -126.44 45.18 2.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.096 -1.003 . . . . 0.0 109.716 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -158.62 111.77 2.35 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.467 -0.77 . . . . 0.0 109.879 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.848 ' OH ' HD11 ' A' ' 44' ' ' LEU . 11.6 m-85 -104.91 142.37 34.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.133 -0.979 . . . . 0.0 110.127 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.49 100.62 8.65 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.509 -0.745 . . . . 0.0 109.136 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.98 ' HB ' HD12 ' A' ' 55' ' ' LEU . 3.5 m -126.94 159.6 63.66 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.142 -0.974 . . . . 0.0 110.763 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 46.2 Cg_endo -71.43 147.86 53.29 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 124.194 1.629 . . . . 0.0 110.594 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.564 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.0 OUTLIER -64.77 -14.59 59.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.433 -0.792 . . . . 0.0 111.533 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -83.52 -10.92 58.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.883 -1.136 . . . . 0.0 110.764 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.98 HD12 ' HB ' ' A' ' 51' ' ' VAL . 4.5 mt -62.56 143.38 57.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.083 -1.011 . . . . 0.0 111.038 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.0 p -90.63 158.27 17.03 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.49 -0.756 . . . . 0.0 109.199 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.606 HG12 HG22 ' A' ' 87' ' ' THR . 61.1 t -57.09 -23.01 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.091 -1.005 . . . . 0.0 110.032 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.98 -33.67 59.49 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.899 ' CB ' HD22 ' A' ' 55' ' ' LEU . 24.3 mm-40 -72.27 -50.61 25.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.151 -1.205 . . . . 0.0 109.759 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.101 ' CE2' HD11 ' A' ' 64' ' ' ILE . 47.2 t80 -60.56 -32.02 71.11 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.273 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.664 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -63.41 -29.28 70.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.033 -1.042 . . . . 0.0 109.498 178.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 1.3 t80 -69.85 -53.36 18.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.452 -0.78 . . . . 0.0 110.126 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.075 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -59.87 -33.59 72.01 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 118.756 -1.178 . . . . 0.0 112.426 -178.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.101 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -75.13 -33.4 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 119.777 -1.827 . . . . 0.0 109.701 179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -38.29 -63.89 0.46 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 0.0 110.721 -179.164 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -30.62 71.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 110.132 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.644 ' CD ' HD21 ' A' ' 44' ' ' LEU . 20.2 mmt180 -66.15 -20.29 66.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.202 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.873 ' CG2' HD23 ' A' ' 70' ' ' LEU . 68.8 mt -104.2 15.7 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.977 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.515 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 49.68 28.37 2.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.411 -0.806 . . . . 0.0 110.241 -179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.873 HD23 ' CG2' ' A' ' 68' ' ' ILE . 3.8 pp -110.11 160.48 16.43 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.428 -0.795 . . . . 0.0 109.519 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.4 ptt180 -165.25 -171.9 2.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.046 -1.034 . . . . 0.0 110.822 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 52.08 -89.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.487 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 72' ' ' ALA . 33.1 mt-10 -157.11 29.29 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.179 -0.951 . . . . 0.0 110.703 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.39 176.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.117 -0.99 . . . . 0.0 109.846 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.518 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -87.45 137.71 32.1 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 121.382 0.61 . . . . 0.0 110.367 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.749 HD21 ' CE1' ' A' ' 78' ' ' PHE . 49.3 tp -164.83 152.78 11.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.787 . . . . 0.0 110.426 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.594 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 89.8 m-85 -158.77 118.47 3.13 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.556 -0.715 . . . . 0.0 110.021 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.749 ' CE1' HD21 ' A' ' 76' ' ' LEU . 19.3 m-30 -84.96 132.67 34.32 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.0 -1.062 . . . . 0.0 111.054 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.583 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 59.5 m-85 -117.63 119.79 36.04 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.421 -0.799 . . . . 0.0 109.138 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.679 HG13 ' CG1' ' A' ' 107' ' ' ILE . 2.8 t -120.96 123.47 70.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.592 -0.693 . . . . 0.0 110.198 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.63 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.6 m120 49.54 42.04 22.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 3.7 m120 62.5 35.72 14.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.351 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -135.2 167.39 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.931 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.0 68.53 5.48 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 109.454 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.74 163.07 38.13 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.982 1.517 . . . . 0.0 110.891 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.4 -178.26 3.22 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.146 1.603 . . . . 0.0 110.419 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.606 HG22 HG12 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -84.75 22.18 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.389 -0.819 . . . . 0.0 110.864 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -94.27 41.23 1.09 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 109.65 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.45 -172.48 3.89 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.598 0.713 . . . . 0.0 110.288 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 63.5 p -139.79 140.74 36.73 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.674 -0.641 . . . . 0.0 110.159 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.038 ' HA ' HD23 ' A' ' 94' ' ' LEU . 9.3 mmm -49.18 -41.87 38.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.163 -0.961 . . . . 0.0 110.261 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.564 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.81 -47.65 52.71 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.2 OUTLIER -64.86 -30.87 71.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.335 -1.097 . . . . 0.0 109.94 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.038 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.3 -24.51 64.86 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.225 -0.922 . . . . 0.0 110.031 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.586 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -49.46 -56.13 10.81 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.972 -1.08 . . . . 0.0 109.764 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -69.85 -17.8 63.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.003 -1.06 . . . . 0.0 111.124 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.3 mm-40 -87.53 -68.24 0.77 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.973 -1.08 . . . . 0.0 112.363 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.513 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 10.6 m-70 -99.38 38.65 1.39 Allowed 'General case' 0 N--CA 1.485 1.275 0 O-C-N 120.871 -1.143 . . . . 0.0 111.937 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.543 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.4 p80 -59.18 -19.85 48.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.136 -0.978 . . . . 0.0 109.41 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 106' ' ' TYR . 1.9 tm-20 72.02 -79.97 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.113 0.482 . . . . 0.0 110.34 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 102' ' ' ASP . 1.1 mt-10 -121.76 -63.95 1.26 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 110.093 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 103' ' ' PHE . 0.4 OUTLIER 172.47 157.65 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 110.251 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 2.7 t80 78.26 -20.93 0.36 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.715 -0.616 . . . . 0.0 111.439 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.47 ' CD2' ' HB3' ' A' ' 103' ' ' PHE . 7.0 p90 -166.77 171.43 11.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.767 -1.208 . . . . 0.0 110.438 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.931 HD13 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -111.77 169.55 8.75 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.313 -0.867 . . . . 0.0 109.693 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.716 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -126.56 126.19 43.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.731 -1.23 . . . . 0.0 110.986 -179.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.679 ' CG1' HG13 ' A' ' 80' ' ' VAL . 11.7 mt -141.25 147.98 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.306 -0.872 . . . . 0.0 109.64 179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -142.5 -179.92 6.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.111 -0.993 . . . . 0.0 110.286 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.837 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.6 p90 -150.02 162.71 39.86 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.645 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.768 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -159.39 168.44 26.3 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.566 179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.517 ' OD1' ' CG ' ' A' ' 40' ' ' ARG . 16.9 p-10 -127.05 28.78 5.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.074 -1.016 . . . . 0.0 110.187 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 111' ' ' ASP . 1.9 mt-10 59.67 145.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.91 . . . . 0.0 110.159 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.6 t -108.71 12.86 25.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 110.062 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.99 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.332 -0.855 . . . . 0.0 110.246 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -159.41 0.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.338 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 81.48 -158.36 39.45 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.264 -1.139 . . . . 0.0 110.213 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -23.04 62.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -1.184 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.524 ' NZ ' ' HG3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -73.94 -28.74 61.65 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -59.84 -19.32 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.095 -1.003 . . . . 0.0 109.95 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' O ' ' CD ' ' A' ' 26' ' ' PRO . 13.8 mmt85 -90.13 -48.24 7.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.146 -0.972 . . . . 0.0 110.026 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HG3' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -49.53 -42.94 45.21 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.117 -0.989 . . . . 0.0 109.072 179.154 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 18.0 mttp -85.68 -48.92 8.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.386 -0.821 . . . . 0.0 109.791 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.513 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 10.8 m-85 -114.73 64.19 1.52 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.129 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.462 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 44.9 Cg_endo -70.48 -20.91 30.86 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.836 1.44 . . . . 0.0 110.666 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 38.1 t70 -111.42 22.11 15.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -0.889 . . . . 0.0 109.964 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.513 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 3.2 mpt_? -103.6 -168.08 1.46 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -0.897 . . . . 0.0 110.517 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.807 HG12 HG12 ' A' ' 31' ' ' VAL . 21.6 t -145.94 110.64 4.42 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 109.963 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.597 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 47.0 Cg_endo -73.44 87.9 1.05 Allowed 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 124.175 1.619 . . . . 0.0 109.949 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.874 HG22 ' O ' ' A' ' 49' ' ' TYR . 1.4 m -88.12 144.1 9.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.33 -0.856 . . . . 0.0 111.411 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 16.2 mm -108.98 135.8 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -120.25 140.89 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.737 -1.227 . . . . 0.0 112.142 -178.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -145.6 172.49 13.17 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.655 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -97.44 161.49 13.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.814 -1.179 . . . . 0.0 110.802 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.026 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.09 -173.22 0.1 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.547 -0.72 . . . . 0.0 109.488 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.026 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.4 Cg_endo -72.55 112.09 3.39 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.547 1.288 . . . . 0.0 109.827 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 59.67 43.04 16.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.888 . . . . 0.0 110.178 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -66.05 179.36 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.31 -0.869 . . . . 0.0 110.166 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.455 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.3 34.24 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -0.948 . . . . 0.0 110.785 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.88 HD13 HG23 ' A' ' 68' ' ' ILE . 1.9 pp -85.89 177.51 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.012 -1.055 . . . . 0.0 110.418 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.814 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -52.23 -174.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.832 0 O-C-N 121.266 -0.896 . . . . 0.0 111.273 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 1.002 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -81.67 -175.8 5.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -1.078 . . . . 0.0 110.107 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.002 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.2 mm? -140.17 135.33 32.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.942 . . . . 0.0 110.775 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 46' ' ' LYS . 2.9 p30 -86.39 -27.35 24.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.297 -0.877 . . . . 0.0 109.497 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.508 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -153.2 155.65 37.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.468 -0.77 . . . . 0.0 109.84 179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.711 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -124.4 42.98 3.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.021 -1.05 . . . . 0.0 110.042 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -159.46 109.36 1.91 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.446 -0.784 . . . . 0.0 109.78 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.874 ' O ' HG22 ' A' ' 31' ' ' VAL . 29.9 m-85 -106.44 141.72 37.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.046 -1.033 . . . . 0.0 110.823 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.6 mp -107.06 93.99 4.86 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.61 ' HB ' HD12 ' A' ' 55' ' ' LEU . 35.0 m -113.18 152.45 45.09 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.208 -0.933 . . . . 0.0 111.314 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.442 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.6 Cg_endo -70.49 145.52 53.12 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.317 1.693 . . . . 0.0 109.625 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.554 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 1.7 m -62.9 -11.87 21.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.349 -0.845 . . . . 0.0 111.451 -178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -85.5 -14.54 45.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.043 -1.036 . . . . 0.0 111.104 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.873 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.9 mt -62.21 142.43 57.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.028 -1.045 . . . . 0.0 111.372 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.7 p -91.09 162.65 14.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.744 -0.597 . . . . 0.0 109.788 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.475 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 91.4 t -58.44 -25.67 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.093 -1.004 . . . . 0.0 109.963 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.93 94.23 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.873 ' CB ' HD22 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -67.69 -48.0 67.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -1.197 . . . . 0.0 109.877 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.177 ' CE2' HD11 ' A' ' 64' ' ' ILE . 8.0 t80 -60.23 -32.46 71.15 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.068 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.476 ' CD1' ' HE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -55.36 -36.6 66.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 110.085 178.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.72 -49.98 12.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.437 -0.79 . . . . 0.0 112.691 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.163 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.43 -40.33 82.24 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.51 -1.368 . . . . 0.0 111.975 -177.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.177 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -75.22 -42.53 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 119.907 -1.746 . . . . 0.0 108.278 178.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -39.84 -54.89 2.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.628 -0.67 . . . . 0.0 110.53 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -64.33 -35.89 82.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.138 -0.976 . . . . 0.0 109.937 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.524 ' CG ' ' OH ' ' A' ' 49' ' ' TYR . 0.2 OUTLIER -69.68 -14.39 62.78 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.187 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.97 HD12 HD21 ' A' ' 44' ' ' LEU . 2.3 mm -93.2 4.27 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.494 -0.754 . . . . 0.0 109.721 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.1 t60 53.43 33.71 16.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -0.871 . . . . 0.0 110.484 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.96 ' O ' HD12 ' A' ' 70' ' ' LEU . 1.0 OUTLIER -104.96 156.56 17.92 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.276 -0.89 . . . . 0.0 109.468 179.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' A' ' 73' ' ' GLU . 12.9 ptt180 -165.83 -168.2 1.25 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.832 -1.168 . . . . 0.0 111.247 -178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.35 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.481 -0.762 . . . . 0.0 110.963 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' O ' ' O ' ' A' ' 74' ' ' ASP . 5.2 pt-20 -152.16 24.01 0.64 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.146 -0.971 . . . . 0.0 111.106 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.29 177.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.053 -1.029 . . . . 0.0 109.85 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.1 141.14 37.18 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.112 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.76 HD21 ' CE2' ' A' ' 78' ' ' PHE . 26.2 tp -154.83 153.11 30.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 110.469 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 95.4 m-85 -158.43 121.16 3.74 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.622 -0.674 . . . . 0.0 109.79 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.76 ' CE2' HD21 ' A' ' 76' ' ' LEU . 72.3 m-85 -92.26 123.01 35.28 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 0.0 110.488 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 52.0 m-85 -115.45 136.76 52.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.594 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.827 HG22 HG12 ' A' ' 107' ' ' ILE . 12.6 t -119.87 121.81 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.0 110.456 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.633 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.1 OUTLIER 49.31 48.58 20.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.418 -0.801 . . . . 0.0 110.656 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 62.28 29.37 17.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 110.557 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.651 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.8 t -126.16 168.59 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.155 -0.966 . . . . 0.0 109.675 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -154.63 68.19 5.62 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.472 -0.767 . . . . 0.0 109.747 -179.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.2 168.1 25.6 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.011 1.532 . . . . 0.0 110.341 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.96 -179.78 4.61 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.052 1.554 . . . . 0.0 110.287 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.475 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -86.91 20.59 2.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.335 -0.853 . . . . 0.0 110.534 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.4 t -90.99 39.34 0.99 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.437 -0.789 . . . . 0.0 109.402 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.761 ' HB1' ' CD ' ' A' ' 93' ' ' GLN . . . -145.43 -177.29 5.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.571 -0.705 . . . . 0.0 110.088 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 81.2 p -140.07 144.38 36.81 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.465 -0.772 . . . . 0.0 110.395 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.054 ' HA ' HD23 ' A' ' 94' ' ' LEU . 39.8 mmm -43.88 -39.02 3.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 0.0 109.513 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.554 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -55.71 -48.27 72.71 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.761 ' CD ' ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -64.26 -30.51 71.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -1.175 . . . . 0.0 109.87 -179.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.054 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.26 -27.37 66.28 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.232 -0.917 . . . . 0.0 109.813 179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.585 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -50.28 -54.71 19.34 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.981 -1.074 . . . . 0.0 109.566 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -68.15 -20.68 64.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.815 -1.178 . . . . 0.0 110.51 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 10.1 mt-10 -88.22 -73.69 0.48 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.182 -0.948 . . . . 0.0 112.468 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.583 ' CG ' ' HB2' ' A' ' 81' ' ' ASN . 22.2 m-70 -100.69 37.2 1.76 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.786 -1.196 . . . . 0.0 112.361 -177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.536 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 1.0 OUTLIER -57.14 -23.65 48.81 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.035 -1.041 . . . . 0.0 109.748 179.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' A' ' 99' ' ' HIS . 0.1 OUTLIER 73.63 -1.87 2.93 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.491 -179.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 58.8 73.46 0.48 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 110.382 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 103' ' ' PHE . 2.6 t0 178.75 31.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 0.0 110.203 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.579 ' O ' ' CD1' ' A' ' 103' ' ' PHE . 3.1 t80 55.61 32.51 19.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.882 . . . . 0.0 110.16 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 30' ' ' PRO . 7.4 m-85 -170.34 127.8 0.82 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.313 -0.867 . . . . 0.0 109.78 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.969 HD11 HD12 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -84.87 159.76 20.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.746 -1.221 . . . . 0.0 109.486 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.532 ' CD1' ' OE2' ' A' ' 100' ' ' GLU . 0.3 OUTLIER -115.64 120.62 39.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.851 -1.155 . . . . 0.0 111.655 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.969 HD12 HD11 ' A' ' 105' ' ' LEU . 15.6 mt -141.44 140.72 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.826 . . . . 0.0 109.241 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -135.43 177.61 7.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.137 -0.977 . . . . 0.0 110.136 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.655 ' CE2' ' CD ' ' A' ' 35' ' ' LYS . 1.4 p90 -144.86 165.12 29.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 110.648 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -158.14 178.67 9.94 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.151 -0.62 . . . . 0.0 110.271 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.674 ' HB3' HG22 ' A' ' 41' ' ' ILE . 27.9 p-10 -126.5 24.91 6.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.285 -0.884 . . . . 0.0 110.266 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.632 ' OE2' HG12 ' A' ' 114' ' ' VAL . 0.6 OUTLIER 58.32 155.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.288 -0.883 . . . . 0.0 110.193 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 93.9 p -104.22 -7.66 19.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.885 . . . . 0.0 110.226 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.632 HG12 ' OE2' ' A' ' 112' ' ' GLU . 9.8 p -105.88 169.81 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 110.297 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.417 ' N ' HG22 ' A' ' 114' ' ' VAL . 46.8 t80 -111.72 151.87 28.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.148 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.24 176.5 37.79 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.195 -1.179 . . . . 0.0 110.215 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.4 -39.68 88.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -1.15 . . . . 0.0 109.876 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.408 ' HD3' ' C ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -73.18 -19.73 61.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.382 -0.824 . . . . 0.0 110.065 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 15.8 mm -72.31 -28.24 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.221 -0.924 . . . . 0.0 110.303 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.472 ' O ' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -79.46 -18.72 51.49 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.75 -1.219 . . . . 0.0 109.746 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -34.43 15.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.458 -0.776 . . . . 0.0 109.159 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.606 ' CE ' ' CZ ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -85.54 -27.31 25.65 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.606 ' CZ ' ' CE ' ' A' ' 24' ' ' LYS . 50.1 m-85 -110.85 57.25 0.36 Allowed Pre-proline 0 N--CA 1.498 1.972 0 O-C-N 121.02 -1.05 . . . . 0.0 110.851 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.488 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 43.9 Cg_endo -68.91 -34.85 16.65 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.486 1.256 . . . . 0.0 110.783 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -96.6 14.12 25.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 110.684 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 1.4 mpt_? -111.9 -173.0 2.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.053 -1.029 . . . . 0.0 110.316 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.694 HG12 HG12 ' A' ' 31' ' ' VAL . 24.6 t -147.2 108.48 3.92 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.159 -0.963 . . . . 0.0 110.512 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.592 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 50.5 Cg_endo -78.87 81.59 2.74 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 124.363 1.717 . . . . 0.0 110.108 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.694 HG12 HG12 ' A' ' 29' ' ' VAL . 1.7 m -77.52 141.41 15.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.187 -0.946 . . . . 0.0 111.119 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 106' ' ' TYR . 46.8 mm -97.44 155.72 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.832 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.7 t -133.86 141.77 43.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.933 -1.104 . . . . 0.0 111.298 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.64 -179.24 8.0 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.547 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -115.83 159.77 21.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.857 -1.152 . . . . 0.0 110.295 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.987 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -61.3 -174.94 0.08 OUTLIER Pre-proline 0 C--N 1.3 -1.567 0 O-C-N 121.54 -0.725 . . . . 0.0 109.248 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.987 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.6 Cg_endo -70.86 108.66 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.52 1.274 . . . . 0.0 109.842 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.4 38.55 9.98 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.352 -0.842 . . . . 0.0 110.012 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.547 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -56.22 179.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.26 -0.9 . . . . 0.0 110.125 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.14 32.18 0.67 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.164 -0.96 . . . . 0.0 110.611 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.829 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -85.93 176.38 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 110.208 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.829 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -50.18 -175.19 0.01 OUTLIER Glycine 0 N--CA 1.498 2.799 0 O-C-N 121.315 -0.866 . . . . 0.0 110.997 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.965 ' O ' HD22 ' A' ' 44' ' ' LEU . 3.3 t0 -77.0 -175.53 3.58 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.272 -1.134 . . . . 0.0 109.889 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.965 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.4 mm? -137.19 135.56 37.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.06 -1.025 . . . . 0.0 110.494 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -86.28 -34.63 20.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.723 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.455 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -153.87 159.85 41.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 109.752 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.561 ' HG2' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -124.0 40.0 3.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.072 -1.017 . . . . 0.0 110.054 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.561 ' HG3' ' HG2' ' A' ' 47' ' ' LYS . 23.9 mttt -158.69 106.17 1.86 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.546 -0.721 . . . . 0.0 109.66 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.881 ' CD2' HD13 ' A' ' 63' ' ' LEU . 30.3 m-85 -104.86 139.62 39.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.87 -1.144 . . . . 0.0 110.25 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.52 99.35 8.13 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.79 ' HB ' HD12 ' A' ' 55' ' ' LEU . 4.2 m -126.18 163.65 38.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.128 -0.983 . . . . 0.0 111.157 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 45.4 Cg_endo -71.05 144.09 46.29 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.142 1.601 . . . . 0.0 110.389 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.556 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -63.86 -13.43 44.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.41 -0.806 . . . . 0.0 111.375 -179.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -83.59 -10.2 58.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.989 -1.07 . . . . 0.0 110.884 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.833 HD22 ' HB2' ' A' ' 59' ' ' GLN . 4.0 mt -62.3 141.75 58.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.995 -1.066 . . . . 0.0 111.335 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.463 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 1.4 p -91.24 157.95 16.87 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.628 -0.67 . . . . 0.0 109.217 178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.657 HG12 HG22 ' A' ' 87' ' ' THR . 53.0 t -55.26 -24.05 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.06 -1.025 . . . . 0.0 110.06 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.2 87.72 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.909 -1.277 . . . . 0.0 109.909 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.833 ' HB2' HD22 ' A' ' 55' ' ' LEU . 1.4 mt-30 -67.73 -44.2 78.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.179 -1.189 . . . . 0.0 110.122 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.154 ' CE2' HD11 ' A' ' 64' ' ' ILE . 17.4 t80 -60.65 -46.4 90.47 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.038 -1.039 . . . . 0.0 109.568 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.465 ' HE1' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -50.78 -21.76 1.81 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.948 -1.095 . . . . 0.0 109.902 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -81.3 -54.57 5.37 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.394 -0.816 . . . . 0.0 110.597 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.994 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.8 pp -59.78 -21.85 61.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.945 -1.097 . . . . 0.0 112.169 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.154 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.1 mt -92.77 -35.19 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.275 0 O-C-N 120.191 -1.568 . . . . 0.0 109.219 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.777 ' HG2' HD11 ' A' ' 70' ' ' LEU . 2.8 mtp85 -35.94 -63.71 0.35 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.853 -0.529 . . . . 0.0 110.855 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -31.15 72.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.043 -1.035 . . . . 0.0 109.88 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.502 ' C ' HD13 ' A' ' 68' ' ' ILE . 19.7 mmt180 -67.24 -16.32 64.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 110.009 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.766 ' CG2' HD23 ' A' ' 70' ' ' LEU . 1.3 mm -101.1 12.86 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.959 . . . . 0.0 109.708 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.5 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 50.42 30.81 4.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.462 -0.774 . . . . 0.0 110.369 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.779 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.2 pp -110.35 155.59 21.91 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 0.0 109.695 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.72 -172.42 2.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.116 -0.99 . . . . 0.0 111.014 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.56 -89.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 110.775 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 71' ' ' ARG . 5.6 pt-20 -150.34 35.96 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.902 . . . . 0.0 110.872 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -58.38 177.23 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.14 -0.975 . . . . 0.0 109.966 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.522 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -107.1 138.3 43.54 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.378 0.609 . . . . 0.0 110.34 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.755 HD21 ' CE1' ' A' ' 78' ' ' PHE . 15.2 tp -164.7 152.66 11.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 0.0 110.249 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 83.8 m-85 -157.79 121.83 4.17 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.644 -0.66 . . . . 0.0 109.972 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 64' ' ' ILE . 16.9 m-30 -82.59 122.67 28.39 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.16 -0.962 . . . . 0.0 111.57 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 69.8 m-85 -113.57 120.37 40.72 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.837 HG22 HG23 ' A' ' 107' ' ' ILE . 2.4 t -121.06 128.38 76.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 O-C-N 121.4 -0.812 . . . . 0.0 109.998 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.3 t30 49.75 42.32 23.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.35 -0.844 . . . . 0.0 110.229 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 82' ' ' ASN . 2.9 m-20 60.39 36.56 20.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.467 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.697 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -134.87 166.03 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -0.987 . . . . 0.0 109.987 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.812 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -155.26 72.89 5.61 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.597 -0.689 . . . . 0.0 109.542 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.72 163.79 37.44 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.032 1.543 . . . . 0.0 110.792 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.47 -178.57 3.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.08 1.569 . . . . 0.0 110.357 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.657 HG22 HG12 ' A' ' 57' ' ' VAL . 1.1 p -85.92 19.52 2.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.328 -0.857 . . . . 0.0 110.774 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.0 m -96.75 42.43 1.09 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.525 -0.734 . . . . 0.0 109.621 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.34 -172.46 3.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.491 -0.756 . . . . 0.0 110.319 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 77.2 p -139.42 140.64 37.41 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.477 0.656 . . . . 0.0 110.158 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.052 ' HA ' HD23 ' A' ' 94' ' ' LEU . 59.7 mtm -52.51 -38.72 60.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 0.0 109.938 -179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -50.51 -49.54 39.0 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 90' ' ' THR . 4.0 pt20 -64.68 -28.92 69.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -1.163 . . . . 0.0 109.664 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.052 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.17 -23.63 64.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.263 -0.898 . . . . 0.0 110.132 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.592 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -49.05 -54.29 16.53 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.707 -1.246 . . . . 0.0 109.755 -179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -70.35 -18.96 63.07 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.21 -0.931 . . . . 0.0 111.25 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.514 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.7 mt-10 -86.34 -65.03 1.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.91 -1.119 . . . . 0.0 112.288 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.581 ' CD2' ' HB ' ' A' ' 80' ' ' VAL . 16.6 m-70 -98.02 38.06 1.35 Allowed 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.929 -1.107 . . . . 0.0 111.254 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.454 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.1 OUTLIER -61.28 175.2 0.58 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.494 -0.754 . . . . 0.0 109.437 178.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.526 ' CG ' ' N ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER -136.34 -93.65 0.25 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.569 -1.332 . . . . 0.0 110.427 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.526 ' N ' ' CG ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -106.81 59.33 0.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.982 -1.073 . . . . 0.0 110.418 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.447 ' C ' ' O ' ' A' ' 101' ' ' GLU . 0.7 OUTLIER 41.21 65.86 0.76 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.314 -0.866 . . . . 0.0 109.952 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.77 -64.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 110.0 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 4.6 m-85 -126.12 165.61 18.55 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 110.068 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.068 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -104.91 168.94 8.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.229 -0.919 . . . . 0.0 109.199 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.708 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -119.23 128.26 54.03 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.615 -1.303 . . . . 0.0 111.778 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.068 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.2 mt -139.2 129.33 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.19 -0.944 . . . . 0.0 110.483 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -128.55 152.3 48.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.154 -0.966 . . . . 0.0 108.778 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.832 ' HE1' HG13 ' A' ' 33' ' ' VAL . 2.3 p90 -131.4 167.09 19.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.55 -1.344 . . . . 0.0 111.647 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -153.88 -179.79 8.17 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 120.271 -0.572 . . . . 0.0 110.101 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.646 ' HB3' HG22 ' A' ' 41' ' ' ILE . 7.1 p-10 -111.99 32.1 5.74 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.232 -0.917 . . . . 0.0 110.165 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 111' ' ' ASP . 8.4 mm-40 -148.82 134.69 18.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 0.0 110.118 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 92.6 p -123.41 21.52 9.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 110.265 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.495 HG22 ' N ' ' A' ' 115' ' ' TYR . 7.5 p -61.26 173.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.189 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.495 ' N ' HG22 ' A' ' 114' ' ' VAL . 4.6 t80 -128.84 50.91 2.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.349 -0.844 . . . . 0.0 110.148 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -130.62 -151.9 7.24 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.197 -1.178 . . . . 0.0 110.246 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.26 -22.52 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.196 -1.179 . . . . 0.0 109.887 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 2.0 mmtm -77.19 -41.66 40.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.415 -0.803 . . . . 0.0 109.931 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 21' ' ' ILE . 11.5 mm -63.84 -16.19 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -0.946 . . . . 0.0 110.06 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.505 ' NH1' ' HG2' ' A' ' 22' ' ' ARG . 3.0 mmt-85 -90.35 -35.76 15.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 110.02 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.05 -36.87 84.41 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -85.25 -48.41 9.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.483 -0.761 . . . . 0.0 109.501 179.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 28.3 m-85 -112.56 59.44 0.59 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.278 -0.889 . . . . 0.0 110.526 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.478 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 43.8 Cg_endo -68.86 -32.45 22.63 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.797 1.42 . . . . 0.0 110.369 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -102.95 20.56 17.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.34 -0.85 . . . . 0.0 110.088 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.479 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 1.9 mpp_? -122.44 -176.14 3.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.106 -0.996 . . . . 0.0 110.492 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.68 HG12 HG12 ' A' ' 31' ' ' VAL . 12.3 t -147.76 114.05 4.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.385 -0.822 . . . . 0.0 110.081 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.59 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 51.3 Cg_endo -78.1 87.08 1.56 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 124.166 1.614 . . . . 0.0 110.055 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.728 HG12 ' CD2' ' A' ' 105' ' ' LEU . 1.6 m -83.17 151.72 3.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.171 -0.955 . . . . 0.0 110.892 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.472 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 30.8 mm -105.96 160.41 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 108.714 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.708 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.5 t -134.2 141.05 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.801 -1.187 . . . . 0.0 111.404 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 7.0 tt0 -156.23 175.38 14.06 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.605 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -103.7 160.39 14.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.931 -1.106 . . . . 0.0 110.528 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.978 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -62.7 -174.47 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.451 -0.781 . . . . 0.0 109.095 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.978 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.7 Cg_endo -70.52 103.7 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.418 1.22 . . . . 0.0 110.025 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 5.7 mttt 63.61 40.16 8.23 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.325 -0.859 . . . . 0.0 110.076 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . . . -61.99 179.49 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 0.0 110.201 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.485 ' HG2' ' OD2' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -150.22 35.45 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.0 110.532 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.503 HG12 HG23 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -84.74 179.71 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.991 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 68' ' ' ILE . . . -57.26 -179.75 0.69 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.53 -167.53 0.19 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.382 -1.069 . . . . 0.0 110.271 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.056 HD13 ' O ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.35 147.51 38.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.208 -0.932 . . . . 0.0 110.729 -179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.797 ' N ' HD22 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -87.32 -42.84 12.6 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.154 -0.966 . . . . 0.0 110.324 -179.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' N ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -152.15 159.57 43.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.377 -0.827 . . . . 0.0 109.755 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -116.99 39.85 3.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.113 -0.992 . . . . 0.0 110.463 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.419 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 9.7 pttt -162.01 107.34 1.25 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 110.289 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.717 ' CD2' HD13 ' A' ' 63' ' ' LEU . 11.4 m-85 -108.01 142.43 38.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.114 -0.991 . . . . 0.0 110.125 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mp -116.0 103.22 10.37 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.822 ' HB ' HD12 ' A' ' 55' ' ' LEU . 3.0 m -129.78 162.75 51.53 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 111.098 -178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 43.5 Cg_endo -68.26 146.47 69.61 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.167 1.614 . . . . 0.0 110.451 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.556 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -63.65 -11.1 22.6 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.801 . . . . 0.0 111.598 -178.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.68 -7.91 59.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.902 -1.124 . . . . 0.0 110.675 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.919 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.1 mt -62.43 141.39 58.38 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.127 -0.983 . . . . 0.0 111.157 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -91.17 158.52 16.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.671 -0.643 . . . . 0.0 109.48 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 79.4 t -57.29 -24.27 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.101 -0.999 . . . . 0.0 109.693 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.56 -34.8 67.61 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.919 ' CB ' HD22 ' A' ' 55' ' ' LEU . 17.8 mm-40 -67.89 -50.72 54.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.272 -1.134 . . . . 0.0 109.336 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.192 ' CE2' HD11 ' A' ' 64' ' ' ILE . 6.2 t80 -60.21 -35.32 75.15 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.153 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.597 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -53.29 -34.8 58.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 0.0 110.028 178.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -79.99 -51.12 9.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.358 -0.839 . . . . 0.0 112.705 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.159 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.37 -39.19 78.94 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.489 -1.382 . . . . 0.0 112.077 -177.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.192 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -77.49 -41.73 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 119.862 -1.774 . . . . 0.0 108.323 178.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.659 ' HG2' HD22 ' A' ' 76' ' ' LEU . 9.2 mtp180 -43.25 -52.27 5.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.413 -0.805 . . . . 0.0 109.983 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -35.73 81.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.538 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 8.9 mmt85 -70.29 -15.81 62.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.575 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.607 HD11 ' CD2' ' A' ' 109' ' ' TYR . 30.6 mt -89.39 -1.17 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.4 -0.813 . . . . 0.0 109.352 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.411 ' CG ' ' O ' ' A' ' 69' ' ' HIS . 18.1 t60 56.33 31.11 18.01 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.412 -0.805 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.942 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -96.9 153.04 18.13 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.983 179.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.5 ptp180 -166.94 -168.71 1.15 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.015 -1.053 . . . . 0.0 110.872 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 53.74 -87.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.835 . . . . 0.0 110.855 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 71' ' ' ARG . 35.4 mt-10 -153.93 33.25 0.44 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 110.659 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.526 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -61.56 177.1 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.091 -1.006 . . . . 0.0 109.921 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 111' ' ' ASP . . . -105.42 140.46 38.5 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.167 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.711 HD21 ' CE2' ' A' ' 78' ' ' PHE . 18.7 tp -149.78 152.81 35.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.179 -0.951 . . . . 0.0 110.474 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 73.3 m-85 -161.82 120.73 2.38 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.772 -0.58 . . . . 0.0 109.649 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.711 ' CE2' HD21 ' A' ' 76' ' ' LEU . 63.0 m-85 -93.22 123.22 36.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.064 -1.023 . . . . 0.0 110.106 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 66.8 m-85 -113.88 132.04 56.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.993 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.689 HG22 HG23 ' A' ' 107' ' ' ILE . 2.6 t -121.04 113.12 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.326 -0.859 . . . . 0.0 110.156 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.887 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.2 t-20 59.19 51.4 6.99 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 110.283 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 16.9 m-20 56.44 31.21 18.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.318 -0.863 . . . . 0.0 110.487 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.5 t -130.74 167.3 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.202 -0.936 . . . . 0.0 109.904 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.818 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -154.98 67.84 5.33 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.557 -0.715 . . . . 0.0 109.478 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.58 170.18 20.59 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.052 1.554 . . . . 0.0 110.707 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.99 -179.02 3.52 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.078 1.567 . . . . 0.0 110.416 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.524 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -87.34 25.46 1.4 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.36 -0.838 . . . . 0.0 110.701 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.21 41.84 1.11 Allowed 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.408 -0.807 . . . . 0.0 109.768 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.4 -175.53 4.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 110.461 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 62.8 p -139.44 139.65 37.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.631 -0.668 . . . . 0.0 110.125 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.063 ' HA ' HD23 ' A' ' 94' ' ' LEU . 4.5 mmt -49.26 -38.62 27.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.165 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -52.31 -48.99 52.75 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 90' ' ' THR . 3.9 pt20 -64.63 -29.41 70.41 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.634 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.063 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.33 -24.86 64.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 0.0 109.931 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.59 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -49.63 -56.17 11.03 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.977 -1.077 . . . . 0.0 109.773 -179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.62 -17.62 63.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.754 -1.216 . . . . 0.0 111.093 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -88.47 -68.42 0.77 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.142 -0.974 . . . . 0.0 113.402 -177.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' A' ' 81' ' ' ASN . 18.1 m-70 -100.16 40.71 1.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.726 -1.234 . . . . 0.0 112.771 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.568 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 6.9 p80 -77.12 -20.09 56.09 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.051 -1.031 . . . . 0.0 109.657 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' CB ' ' O ' ' A' ' 99' ' ' HIS . 0.6 OUTLIER 75.36 -76.37 0.06 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.095 0.474 . . . . 0.0 110.344 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -103.97 -92.2 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 110.332 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.541 ' C ' ' CG ' ' A' ' 103' ' ' PHE . 9.7 t0 -169.98 50.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.235 -0.915 . . . . 0.0 110.267 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.549 ' HB2' ' CD1' ' A' ' 104' ' ' PHE . 18.1 m-85 -151.81 -68.49 0.17 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 110.078 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' A' ' 104' ' ' PHE . 4.3 m-85 -120.0 172.46 7.72 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.258 -0.901 . . . . 0.0 109.812 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.075 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -109.16 165.4 11.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.091 -1.006 . . . . 0.0 109.608 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.768 ' N ' HD12 ' A' ' 105' ' ' LEU . 57.9 m-85 -122.06 129.49 52.45 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.823 -1.173 . . . . 0.0 112.173 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.075 ' CG1' HD11 ' A' ' 105' ' ' LEU . 4.5 mt -141.4 153.36 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.502 -0.749 . . . . 0.0 109.475 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -150.42 178.45 9.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.054 -1.029 . . . . 0.0 110.326 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.708 ' HE1' HG13 ' A' ' 33' ' ' VAL . 6.3 p90 -147.14 164.59 32.63 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.256 -0.977 . . . . 0.0 111.075 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.622 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.1 OUTLIER -157.7 170.02 23.34 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.761 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' ALA . 11.7 p30 -121.06 19.5 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 110.593 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.466 ' OE2' ' HB2' ' A' ' 77' ' ' PHE . 1.1 pm0 -43.11 149.21 0.23 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.17 -0.956 . . . . 0.0 110.03 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 65.6 m -135.8 35.6 2.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.9 p -72.89 161.41 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.0 110.195 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -77.68 175.65 9.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.162 -0.961 . . . . 0.0 110.2 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 51.8 -160.85 2.1 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.227 -1.161 . . . . 0.0 110.273 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -47.29 -47.96 25.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -1.076 . . . . 0.0 110.189 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -71.61 -27.98 63.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 110.293 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.506 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.3 mp -70.7 -22.41 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 109.982 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 22' ' ' ARG . 3.8 tpt180 -83.86 -40.95 18.0 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.92 -1.113 . . . . 0.0 109.277 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -62.34 -42.99 99.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 110.107 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.63 ' HG3' ' CD2' ' A' ' 25' ' ' TYR . 18.2 ptmt -85.73 -33.68 21.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 111.092 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.63 ' CD2' ' HG3' ' A' ' 24' ' ' LYS . 28.5 m-85 -112.45 69.79 1.04 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.523 -1.36 . . . . 0.0 109.872 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 43.9 Cg_endo -70.31 -0.78 7.88 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.796 1.419 . . . . 0.0 110.845 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.86 21.07 12.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.102 -0.999 . . . . 0.0 110.513 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.524 ' HD2' ' O ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -96.02 175.07 6.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.966 -1.084 . . . . 0.0 110.642 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.648 HG12 HG12 ' A' ' 31' ' ' VAL . 33.0 t -142.58 104.05 5.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.454 -0.779 . . . . 0.0 109.892 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.587 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 49.5 Cg_endo -76.9 90.75 1.21 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.138 1.599 . . . . 0.0 110.295 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.722 HG12 ' CD2' ' A' ' 105' ' ' LEU . 1.3 m -88.57 153.19 3.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.229 -0.92 . . . . 0.0 110.721 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.607 HD11 ' CD1' ' A' ' 104' ' ' PHE . 1.4 mp -103.04 165.12 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.332 -0.855 . . . . 0.0 108.772 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.803 HG21 ' CE1' ' A' ' 49' ' ' TYR . 0.9 OUTLIER -139.4 133.82 39.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.048 -1.032 . . . . 0.0 110.877 -179.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -151.84 163.69 38.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.722 -0.611 . . . . 0.0 109.616 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.561 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -96.8 158.86 15.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 110.627 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.024 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.22 -174.28 0.12 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.722 . . . . 0.0 109.41 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.024 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.2 Cg_endo -70.33 107.5 1.98 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.486 1.256 . . . . 0.0 109.753 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 4.1 mtpt 64.14 42.72 5.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.375 -0.828 . . . . 0.0 109.944 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.485 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -64.39 179.31 0.6 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 110.267 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.497 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.6 OUTLIER -150.32 33.85 0.64 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.184 -0.947 . . . . 0.0 110.425 -179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.781 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.7 pp -85.33 178.17 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.046 -1.034 . . . . 0.0 110.644 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.781 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -50.46 -172.73 0.01 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -80.34 179.38 7.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.356 -1.085 . . . . 0.0 110.002 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.4 pp -135.04 134.14 40.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.893 . . . . 0.0 110.614 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . 15.4 t0 -86.43 -36.97 18.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 110.076 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.55 160.27 43.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.341 -0.849 . . . . 0.0 109.954 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -118.41 39.91 3.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.114 -0.992 . . . . 0.0 110.215 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' CG ' ' C ' ' A' ' 47' ' ' LYS . 6.2 mtmm -156.7 109.01 2.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.471 -0.768 . . . . 0.0 109.28 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.803 ' CE1' HG21 ' A' ' 33' ' ' VAL . 22.9 m-85 -103.63 141.89 35.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.902 -1.124 . . . . 0.0 110.808 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tp -105.44 104.81 14.61 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.472 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 16.6 m -131.76 144.23 52.4 Favored Pre-proline 0 C--N 1.3 -1.554 0 O-C-N 121.112 -0.993 . . . . 0.0 110.622 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 55' ' ' LEU . 41.5 Cg_endo -66.99 143.86 67.69 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.983 1.518 . . . . 0.0 110.053 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.566 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.7 m -61.47 -14.25 27.29 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.399 -0.813 . . . . 0.0 111.615 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -83.7 -15.31 49.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.082 -1.011 . . . . 0.0 111.053 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.867 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.9 mt -62.21 144.84 54.98 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.054 -1.028 . . . . 0.0 111.301 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.2 p -90.74 165.91 13.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.51 -0.744 . . . . 0.0 109.621 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.972 HG12 HG22 ' A' ' 87' ' ' THR . 46.5 t -60.33 -26.42 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 110.153 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.71 -41.33 93.86 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.867 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.6 mt-30 -67.64 -49.7 61.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.076 -1.25 . . . . 0.0 110.203 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.139 ' CE2' HD11 ' A' ' 64' ' ' ILE . 43.0 t80 -60.59 -33.9 73.41 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.724 -1.191 . . . . 0.0 109.502 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.665 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -63.43 -28.02 69.69 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.923 -1.11 . . . . 0.0 109.738 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -70.26 -53.52 16.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.295 -0.878 . . . . 0.0 110.281 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.992 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -59.54 -37.13 77.58 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 118.92 -1.112 . . . . 0.0 112.341 -178.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.139 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -70.45 -35.28 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 119.835 -1.791 . . . . 0.0 109.025 179.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.865 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -37.38 -63.41 0.45 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.72 -0.613 . . . . 0.0 110.774 -179.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -30.93 71.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.19 -0.944 . . . . 0.0 110.192 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.531 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 8.0 mmp_? -67.72 -17.81 64.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.23 -0.919 . . . . 0.0 109.945 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.89 ' CG2' HD23 ' A' ' 70' ' ' LEU . 36.5 mt -103.55 15.32 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 109.386 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.563 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 46.24 30.66 1.04 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.564 -0.71 . . . . 0.0 110.263 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.89 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.1 pp -108.83 155.24 21.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.413 -0.805 . . . . 0.0 109.84 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.449 ' O ' ' N ' ' A' ' 73' ' ' GLU . 4.9 ptp180 -166.17 -168.73 1.29 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.657 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 47.99 -92.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.392 -0.817 . . . . 0.0 110.768 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 4.9 pt-20 -146.25 44.43 1.23 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.976 -1.078 . . . . 0.0 110.969 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -67.58 176.68 2.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.955 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -100.88 140.54 35.03 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.008 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.928 HD21 ' CE1' ' A' ' 78' ' ' PHE . 26.1 tp -164.24 152.68 12.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.982 . . . . 0.0 110.755 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 97.4 m-85 -158.52 119.7 3.42 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.706 -0.621 . . . . 0.0 109.666 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.928 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.5 m-30 -85.6 132.49 34.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.075 -1.015 . . . . 0.0 111.8 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 64.6 m-85 -120.29 120.42 35.99 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.771 HG22 HG23 ' A' ' 107' ' ' ILE . 2.1 t -120.97 125.95 74.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.422 -0.799 . . . . 0.0 109.839 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.769 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.3 OUTLIER 47.15 46.49 16.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.2 -0.938 . . . . 0.0 110.207 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 26.8 m120 58.11 37.07 26.38 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.288 -0.882 . . . . 0.0 110.521 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -135.91 167.6 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.154 -0.966 . . . . 0.0 110.15 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.83 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -155.19 70.05 5.58 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.492 -0.755 . . . . 0.0 109.552 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.83 163.58 36.74 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.009 1.531 . . . . 0.0 110.735 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.3 -178.63 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.214 1.639 . . . . 0.0 110.622 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.972 HG22 HG12 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -86.7 20.48 2.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.309 -0.869 . . . . 0.0 110.681 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.1 m -91.51 39.2 1.0 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.47 -0.769 . . . . 0.0 109.641 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.697 ' HB1' ' OE1' ' A' ' 93' ' ' GLN . . . -145.51 -171.97 3.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.535 -0.728 . . . . 0.0 110.243 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 73.0 p -139.55 143.08 37.21 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.626 -0.671 . . . . 0.0 110.116 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.053 ' HA ' HD23 ' A' ' 94' ' ' LEU . 51.0 mmm -46.23 -46.35 17.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.806 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.566 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -47.97 -48.77 24.63 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 120.162 -1.018 . . . . 0.0 110.635 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.697 ' OE1' ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -64.39 -31.81 73.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.108 -1.23 . . . . 0.0 110.155 -179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.053 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.59 -22.27 64.47 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.114 -0.991 . . . . 0.0 110.198 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.579 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.8 OUTLIER -49.27 -55.48 12.54 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.938 -1.101 . . . . 0.0 109.874 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -70.43 -16.89 62.99 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.034 -1.041 . . . . 0.0 111.34 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.7 OUTLIER -87.35 -64.78 1.1 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.106 -0.996 . . . . 0.0 112.924 -177.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.594 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 14.0 m-70 -98.24 37.37 1.45 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.816 -1.178 . . . . 0.0 112.103 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -71.98 169.21 16.41 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.396 -0.815 . . . . 0.0 109.694 178.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.556 ' OE1' ' CD1' ' A' ' 106' ' ' TYR . 0.8 OUTLIER -153.7 34.09 0.45 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.764 -1.21 . . . . 0.0 110.502 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.534 ' HG2' ' N ' ' A' ' 102' ' ' ASP . 20.6 tt0 175.28 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.534 ' N ' ' HG2' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -155.94 -39.94 0.08 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 109.704 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.525 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 3.7 p90 -144.32 44.22 1.42 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.423 -0.798 . . . . 0.0 109.672 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.607 ' CD1' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -153.02 130.43 11.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.461 -0.774 . . . . 0.0 110.022 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.058 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.3 166.71 11.03 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.866 -1.146 . . . . 0.0 109.693 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.726 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -124.46 131.61 53.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.959 -1.088 . . . . 0.0 111.503 -179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.058 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.6 mt -138.64 143.4 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.195 -0.94 . . . . 0.0 110.119 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -136.73 176.06 9.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.159 -0.963 . . . . 0.0 110.227 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.0 OUTLIER -149.93 164.23 35.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.124 -0.985 . . . . 0.0 110.798 179.429 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.3 t -152.44 -178.1 6.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.693 -0.629 . . . . 0.0 109.941 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 112' ' ' GLU . 57.3 p-10 -95.14 -13.86 24.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.885 . . . . 0.0 110.22 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.501 ' N ' ' OD1' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -172.85 150.49 2.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.163 -0.961 . . . . 0.0 110.257 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 p -103.79 32.25 4.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 110.218 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.449 HG22 ' N ' ' A' ' 115' ' ' TYR . 9.8 p -99.1 172.28 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.198 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.449 ' N ' HG22 ' A' ' 114' ' ' VAL . 14.2 t80 -120.29 155.84 32.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.344 -0.848 . . . . 0.0 110.281 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.68 -151.31 27.39 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.262 -1.14 . . . . 0.0 110.213 179.993 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -63.33 -53.46 52.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -1.163 . . . . 0.0 109.615 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -75.34 -26.7 58.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 110.086 179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.507 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.1 mp -67.62 -14.22 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 109.906 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.429 ' C ' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -80.8 -49.47 11.07 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.227 -0.921 . . . . 0.0 109.914 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.16 -43.77 82.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.938 . . . . 0.0 109.982 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.506 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 2.6 mtmt -76.41 -42.02 45.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.313 -0.867 . . . . 0.0 109.642 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 38.1 m-85 -115.01 63.31 1.54 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.461 -0.775 . . . . 0.0 110.693 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 47.0 Cg_endo -72.64 -3.4 13.43 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.858 1.451 . . . . 0.0 110.343 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -100.83 -6.24 25.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 110.436 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -84.37 -161.97 0.61 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.148 -0.97 . . . . 0.0 110.184 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.517 HG21 ' HA2' ' A' ' 92' ' ' GLY . 15.6 t -146.99 103.82 3.85 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 49.5 Cg_endo -74.51 106.63 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.382 1.727 . . . . 0.0 109.829 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.792 HG13 HD21 ' A' ' 105' ' ' LEU . 38.2 t -105.44 133.59 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.104 -0.997 . . . . 0.0 110.718 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.858 HD11 ' CD1' ' A' ' 104' ' ' PHE . 44.3 mm -91.63 154.54 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.843 . . . . 0.0 109.025 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.704 HG21 ' CE1' ' A' ' 49' ' ' TYR . 2.7 t -132.13 144.46 37.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 120.939 -1.1 . . . . 0.0 111.498 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 7.4 mp0 -156.85 -179.65 8.41 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -110.7 160.79 16.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.729 -1.232 . . . . 0.0 110.581 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.012 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.91 -175.12 0.16 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.438 -0.789 . . . . 0.0 109.307 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.012 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.4 Cg_endo -71.44 106.11 1.88 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.532 1.28 . . . . 0.0 109.769 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 61.69 40.74 12.87 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.352 -0.843 . . . . 0.0 110.117 -179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 36' ' ' ALA . . . -60.97 -179.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.214 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.477 ' HG2' ' OD1' ' A' ' 111' ' ' ASP . 6.6 ptm180 -150.39 33.59 0.64 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 110.533 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.632 HG22 ' HB3' ' A' ' 111' ' ' ASP . 0.2 OUTLIER -85.54 -175.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.037 -1.04 . . . . 0.0 110.62 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -55.42 179.73 0.32 Allowed Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -70.96 -172.92 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -1.147 . . . . 0.0 110.055 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' C ' HD12 ' A' ' 44' ' ' LEU . 1.2 pp -135.19 134.15 39.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 110.63 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 -40.23 15.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.923 . . . . 0.0 110.142 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HD3' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -152.85 164.76 37.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 110.299 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -124.77 38.22 4.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.106 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.59 105.04 1.82 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 0.0 109.952 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.901 ' CD2' HD13 ' A' ' 63' ' ' LEU . 45.3 m-85 -103.92 146.47 28.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.26 -0.9 . . . . 0.0 110.64 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.474 HD21 HG21 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -114.71 95.4 5.22 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.961 ' HB ' HD12 ' A' ' 55' ' ' LEU . 13.5 m -119.83 152.66 54.09 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.14 -0.975 . . . . 0.0 110.714 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.474 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.1 Cg_endo -71.23 149.48 57.67 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.097 1.577 . . . . 0.0 110.078 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.519 ' HB3' ' HA3' ' A' ' 92' ' ' GLY . 0.8 OUTLIER -63.73 -13.94 47.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.325 -0.859 . . . . 0.0 111.397 -178.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.55 -10.71 53.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.908 -1.12 . . . . 0.0 111.11 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.961 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.6 mt -62.14 141.89 57.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.867 -1.145 . . . . 0.0 111.335 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 p -91.59 163.14 14.23 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.637 -0.665 . . . . 0.0 109.449 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.992 HG12 HG22 ' A' ' 87' ' ' THR . 78.9 t -58.96 -22.56 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.023 -1.048 . . . . 0.0 110.056 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.73 -40.06 65.72 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.898 ' CB ' HD22 ' A' ' 55' ' ' LEU . 5.0 mm100 -67.87 -47.81 67.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.149 -1.206 . . . . 0.0 109.893 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.149 ' CE2' HD11 ' A' ' 64' ' ' ILE . 19.5 t80 -60.38 -46.39 90.13 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.146 -0.971 . . . . 0.0 109.647 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -50.35 -22.68 1.93 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.016 -1.053 . . . . 0.0 110.021 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -80.86 -54.5 5.54 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.819 . . . . 0.0 110.566 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.03 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.9 pp -59.84 -19.1 48.98 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.909 -1.12 . . . . 0.0 112.287 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.149 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.4 mt -91.57 -42.98 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 120.113 -1.617 . . . . 0.0 108.863 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.586 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.7 OUTLIER -36.91 -58.5 0.76 Allowed 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.145 0.498 . . . . 0.0 110.696 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.87 -31.91 71.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 0.0 110.052 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 2.6 mmp_? -74.75 -7.5 53.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.86 . . . . 0.0 110.546 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.579 ' CD1' HG22 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -99.18 -8.74 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 0.0 109.546 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.469 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER 67.74 29.41 6.86 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.484 -0.76 . . . . 0.0 110.087 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -88.7 160.86 17.14 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.917 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -164.92 -166.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.004 -1.06 . . . . 0.0 110.724 -179.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 42.9 -96.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.804 . . . . 0.0 110.559 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' ASP . 3.9 pt-20 -151.13 28.46 0.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.935 -1.103 . . . . 0.0 110.721 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.524 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -47.79 176.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 122.203 1.002 . . . . 0.0 110.029 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -115.0 142.16 47.01 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.778 HD21 ' CE1' ' A' ' 78' ' ' PHE . 13.6 tp -148.97 151.63 34.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.309 -0.87 . . . . 0.0 110.466 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 90.4 m-85 -158.2 122.88 4.24 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.793 -0.567 . . . . 0.0 109.866 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.821 ' CE2' HD12 ' A' ' 64' ' ' ILE . 18.0 m-30 -85.17 120.2 26.4 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.155 -0.966 . . . . 0.0 111.785 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.476 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 59.9 m-85 -106.98 122.1 45.76 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.515 -0.74 . . . . 0.0 109.06 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.939 HG22 HG23 ' A' ' 107' ' ' ILE . 2.2 t -121.3 126.29 74.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.421 -0.8 . . . . 0.0 109.934 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.483 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 10.6 t-20 51.32 34.29 11.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.147 -0.971 . . . . 0.0 110.038 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 1.3 t-20 69.31 34.95 2.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.325 -0.859 . . . . 0.0 110.433 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.689 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -134.97 166.81 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.9 . . . . 0.0 109.892 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.822 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.95 70.67 5.78 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 0.0 109.609 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.96 165.35 33.03 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.048 1.551 . . . . 0.0 110.582 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.92 -178.96 3.83 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.062 1.559 . . . . 0.0 110.376 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.992 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -85.96 19.59 2.53 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 0.0 110.825 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -91.07 40.46 1.03 Allowed 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.488 -0.758 . . . . 0.0 109.355 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.61 -172.88 3.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.517 -0.739 . . . . 0.0 110.262 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.429 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 59.1 p -139.27 149.8 44.71 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.66 -0.65 . . . . 0.0 110.28 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.045 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -59.23 -40.6 86.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 110.005 -179.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.519 ' HA3' ' HB3' ' A' ' 53' ' ' SER . . . -51.26 -46.49 51.61 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.7 OUTLIER -66.97 -28.85 68.6 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.238 -1.154 . . . . 0.0 109.715 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.045 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.97 -22.22 64.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.198 -0.939 . . . . 0.0 109.862 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.576 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -48.95 -53.78 18.31 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.884 -1.135 . . . . 0.0 109.505 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' HA ' ' HD2' ' A' ' 99' ' ' HIS . 0.0 OUTLIER -70.08 -19.16 63.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.049 -1.032 . . . . 0.0 111.455 179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.537 ' OE1' ' CE1' ' A' ' 98' ' ' HIS . 0.5 OUTLIER -88.65 -59.12 2.32 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -177.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.752 ' CD2' HG11 ' A' ' 80' ' ' VAL . 8.2 m-70 -98.65 40.12 1.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.648 -1.283 . . . . 0.0 113.09 -175.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.507 ' HB3' ' O ' ' A' ' 95' ' ' TYR . 5.9 p80 -106.09 178.55 4.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.0 109.434 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.11 -54.73 0.98 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.771 -1.206 . . . . 0.0 110.336 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -177.88 56.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.073 -1.017 . . . . 0.0 110.23 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 101' ' ' GLU . 57.4 p-10 -178.6 -144.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.297 -0.877 . . . . 0.0 110.111 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.485 ' O ' ' HG2' ' A' ' 30' ' ' PRO . 4.5 p90 -118.53 48.68 1.39 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.905 . . . . 0.0 110.015 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.858 ' CD1' HD11 ' A' ' 32' ' ' ILE . 1.1 m-85 -156.86 134.7 10.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.289 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.065 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -107.4 169.96 8.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.959 -1.088 . . . . 0.0 109.248 179.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.697 ' N ' HD12 ' A' ' 105' ' ' LEU . 6.5 p90 -121.75 128.83 52.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.532 -1.355 . . . . 0.0 111.981 -178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.065 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.9 mt -141.07 141.04 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.311 -0.868 . . . . 0.0 110.184 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -136.29 166.72 22.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.966 -1.084 . . . . 0.0 109.773 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.722 ' HB2' HD11 ' A' ' 76' ' ' LEU . 2.9 p90 -134.26 163.86 28.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.747 -1.221 . . . . 0.0 111.518 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -158.52 177.1 11.6 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.248 0.547 . . . . 0.0 110.02 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.632 ' HB3' HG22 ' A' ' 41' ' ' ILE . 32.9 p30 -130.88 28.67 4.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 110.145 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER 178.23 137.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.171 -0.956 . . . . 0.0 110.377 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 114' ' ' VAL . 47.1 t -136.6 33.88 2.71 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 115' ' ' TYR . 9.3 p -47.32 175.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 110.257 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.538 ' H ' HG22 ' A' ' 114' ' ' VAL . 0.9 OUTLIER -57.27 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.16 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 114' ' ' VAL . . . -101.69 -134.91 8.63 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mt . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.254 -1.144 . . . . 0.0 110.256 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.04 -35.38 4.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.085 -1.244 . . . . 0.0 109.875 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -80.37 -41.05 25.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.855 . . . . 0.0 110.533 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 9.8 mm -59.53 -15.1 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.027 -1.046 . . . . 0.0 110.344 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' NH1' ' OH ' ' A' ' 95' ' ' TYR . 11.8 mmt85 -91.43 -53.55 4.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 109.884 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -47.99 -39.32 19.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.127 -0.983 . . . . 0.0 108.996 179.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 9.9 mttt -85.89 -48.88 8.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.525 -0.735 . . . . 0.0 110.192 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 37.4 m-85 -115.18 63.33 1.67 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.164 -0.96 . . . . 0.0 110.785 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 47.6 Cg_endo -72.76 -4.59 15.63 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.813 1.428 . . . . 0.0 110.438 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.436 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 11.2 t70 -118.01 16.18 14.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 110.273 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.451 ' CD ' ' N ' ' A' ' 28' ' ' ARG . 10.5 mpt_? -109.58 -164.1 0.91 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.192 -0.942 . . . . 0.0 110.244 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.716 HG12 HG12 ' A' ' 31' ' ' VAL . 16.3 t -144.99 108.99 4.66 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.186 -0.947 . . . . 0.0 110.417 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.524 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.8 Cg_endo -77.83 91.16 1.2 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 124.186 1.624 . . . . 0.0 110.093 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.716 HG12 HG12 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -86.63 129.87 37.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.235 -0.916 . . . . 0.0 111.041 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 39.7 mm -91.71 136.06 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.09 -1.006 . . . . 0.0 108.502 178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.757 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -119.94 146.44 24.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.864 -1.147 . . . . 0.0 111.304 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 0.1 OUTLIER -156.24 -164.44 1.68 Allowed 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -122.1 158.84 28.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 0.0 110.605 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.974 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -61.49 -173.42 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.515 -0.74 . . . . 0.0 109.031 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.974 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.0 Cg_endo -69.62 106.71 1.68 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.372 1.196 . . . . 0.0 109.864 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 3.7 mmtt 64.69 41.43 5.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.426 -0.796 . . . . 0.0 110.274 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.535 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -60.07 -177.71 0.07 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.256 -0.902 . . . . 0.0 109.972 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.514 ' CG ' ' OD1' ' A' ' 111' ' ' ASP . 5.6 ptm180 -150.22 31.84 0.67 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 0.0 110.745 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.83 HD13 HG23 ' A' ' 68' ' ' ILE . 1.8 pp -85.53 177.12 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.083 -1.01 . . . . 0.0 110.351 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.83 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -49.04 -176.76 0.01 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.902 ' O ' HD22 ' A' ' 44' ' ' LEU . 7.8 t0 -75.17 -174.69 2.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.245 . . . . 0.0 109.871 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.902 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -135.66 135.66 40.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 0.0 110.371 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -86.67 -41.23 14.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.808 . . . . 0.0 109.988 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.81 154.32 34.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 110.039 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.757 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -113.44 44.94 1.48 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.04 -1.038 . . . . 0.0 110.004 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -161.85 112.84 1.65 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.41 -0.806 . . . . 0.0 110.043 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.737 ' HD2' HD13 ' A' ' 63' ' ' LEU . 8.5 m-85 -111.32 137.57 48.91 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 109.991 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.92 87.12 3.64 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.609 ' HB ' HD12 ' A' ' 55' ' ' LEU . 12.7 m -107.89 148.36 37.24 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 110.96 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HD2' HD12 ' A' ' 55' ' ' LEU . 47.7 Cg_endo -72.88 147.36 43.93 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.156 1.608 . . . . 0.0 109.688 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.562 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -62.2 -15.8 49.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.221 -0.925 . . . . 0.0 111.459 -178.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -83.69 -14.23 52.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.115 -0.99 . . . . 0.0 111.18 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.793 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.7 mt -61.87 144.14 55.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.931 -1.106 . . . . 0.0 111.276 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 6.8 p -90.83 164.51 14.04 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 60.4 t -62.08 -27.34 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.043 -1.035 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.64 -36.66 88.24 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.793 ' CB ' HD22 ' A' ' 55' ' ' LEU . 8.5 mm-40 -70.17 -47.79 60.08 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.148 -1.207 . . . . 0.0 109.791 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.025 ' CE2' HD11 ' A' ' 64' ' ' ILE . 37.5 t80 -59.98 -32.75 71.13 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.144 -1.022 . . . . 0.0 108.942 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.557 ' HE1' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.03 -32.21 70.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.323 -0.861 . . . . 0.0 109.827 178.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 5.3 t80 -72.8 -51.8 17.51 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.417 -0.802 . . . . 0.0 111.078 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.985 HD11 ' CD1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -59.9 -35.65 75.32 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 118.571 -1.252 . . . . 0.0 112.589 -178.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.025 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -80.47 -29.08 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 119.663 -1.898 . . . . 0.0 109.629 178.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -41.11 -62.11 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.346 -0.846 . . . . 0.0 110.353 -179.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -27.43 68.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.805 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.527 ' C ' HD13 ' A' ' 68' ' ' ILE . 8.8 mmp_? -70.26 -16.15 63.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.267 -0.895 . . . . 0.0 109.8 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.83 HG23 HD13 ' A' ' 41' ' ' ILE . 2.9 mm -100.93 11.49 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.326 -0.859 . . . . 0.0 109.751 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.503 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 54.01 30.98 12.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.454 -0.779 . . . . 0.0 110.298 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.776 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.2 pp -115.23 156.49 25.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -0.804 . . . . 0.0 109.792 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.73 -169.34 1.51 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.0 110.945 -179.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.27 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.454 -0.779 . . . . 0.0 110.735 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' ARG . 5.2 pt-20 -151.37 32.52 0.58 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.08 -1.013 . . . . 0.0 111.076 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -55.25 177.0 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.037 -1.039 . . . . 0.0 109.827 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.522 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -98.36 139.49 34.04 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.167 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.573 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 13.2 tp -164.34 153.23 13.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.352 -0.843 . . . . 0.0 110.391 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 89.4 m-85 -157.55 123.89 4.86 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.562 -0.711 . . . . 0.0 109.784 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.938 ' CZ ' HD12 ' A' ' 64' ' ' ILE . 11.8 m-85 -89.16 124.45 34.35 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.357 -0.839 . . . . 0.0 111.033 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 53.3 m-85 -119.91 121.65 39.48 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.731 HG22 HG23 ' A' ' 107' ' ' ILE . 2.4 t -120.78 112.72 37.18 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.358 -0.839 . . . . 0.0 109.742 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.527 ' CB ' ' ND1' ' A' ' 98' ' ' HIS . 3.1 t-20 63.67 34.57 12.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.824 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 19.9 t-20 69.18 35.03 2.82 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.326 -0.859 . . . . 0.0 110.271 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.674 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.3 t -135.04 168.19 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.209 -0.932 . . . . 0.0 110.127 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.808 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.0 77.27 5.07 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.7 . . . . 0.0 109.132 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.69 155.87 53.85 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.079 1.568 . . . . 0.0 110.879 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.47 -177.56 2.5 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.195 1.629 . . . . 0.0 110.292 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.53 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 1.1 p -82.23 16.46 2.0 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.305 -0.872 . . . . 0.0 110.948 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.43 41.56 1.12 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.534 -0.728 . . . . 0.0 109.519 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.52 -176.53 5.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.523 -0.736 . . . . 0.0 110.165 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 80.6 p -139.75 141.31 36.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 110.335 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.047 ' HA ' HD23 ' A' ' 94' ' ' LEU . 2.2 mmt -49.99 -42.78 49.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 110.014 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.562 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -48.59 -47.59 29.51 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 90' ' ' THR . 2.2 pt20 -64.63 -31.98 73.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -1.147 . . . . 0.0 109.814 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.118 HD11 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -67.61 -22.47 65.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.15 -0.969 . . . . 0.0 110.096 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.524 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -49.64 -55.76 12.51 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 120.881 -1.137 . . . . 0.0 109.692 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.429 ' O ' ' NE2' ' A' ' 99' ' ' HIS . 7.6 mt-30 -69.47 -17.22 63.6 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.963 -1.085 . . . . 0.0 111.294 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.531 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 1.8 mm-40 -87.44 -65.25 1.03 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.997 -1.065 . . . . 0.0 112.445 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.625 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 18.0 m-70 -98.63 37.94 1.42 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.86 -1.15 . . . . 0.0 111.808 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.546 ' O ' ' CE2' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -71.35 171.56 10.98 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.504 -0.747 . . . . 0.0 109.673 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.583 ' HB2' ' CD2' ' A' ' 106' ' ' TYR . 27.4 tt0 -138.29 147.79 43.98 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.89 -1.131 . . . . 0.0 109.93 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 100' ' ' GLU . 4.4 tt0 -41.03 -49.72 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 110.414 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.563 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 24.0 m-20 -49.26 -64.21 0.88 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.0 110.008 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.563 ' CG ' ' O ' ' A' ' 102' ' ' ASP . 0.2 OUTLIER 168.24 -71.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 110.174 179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 104' ' ' PHE . 4.5 m-30 -53.15 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.336 -0.852 . . . . 0.0 110.372 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.118 HD22 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -108.19 169.53 8.57 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.283 -0.885 . . . . 0.0 109.272 179.506 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.683 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.4 OUTLIER -114.5 130.75 56.76 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.615 -1.303 . . . . 0.0 111.493 -179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.05 ' CG1' HD11 ' A' ' 105' ' ' LEU . 10.1 mt -141.97 122.65 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 110.236 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.75 153.21 44.31 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.988 -1.07 . . . . 0.0 109.51 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.684 ' OH ' HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -130.36 167.51 18.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.648 -1.282 . . . . 0.0 111.116 -179.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -152.44 -178.39 6.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.674 -0.641 . . . . 0.0 110.086 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.514 ' OD1' ' CG ' ' A' ' 40' ' ' ARG . 2.1 m-20 -81.32 -29.58 34.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.26 -0.9 . . . . 0.0 110.249 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.559 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -178.53 166.75 1.8 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.318 -0.864 . . . . 0.0 110.382 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.26 13.9 7.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.184 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 115' ' ' TYR . 9.7 p -115.3 173.07 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.326 -0.859 . . . . 0.0 110.234 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.467 ' N ' HG22 ' A' ' 114' ' ' VAL . 18.1 t80 -64.43 129.4 39.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 110.2 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -172.84 165.61 38.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.268 -1.137 . . . . 0.0 110.218 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' O ' ' HB ' ' A' ' 21' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -58.81 -36.22 74.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.309 -1.112 . . . . 0.0 110.026 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -74.35 -19.72 60.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.218 -0.926 . . . . 0.0 110.135 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.53 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 1.6 mp -72.06 -19.33 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.176 -0.953 . . . . 0.0 110.28 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.566 ' CD ' ' N ' ' A' ' 22' ' ' ARG . 3.8 mpt_? -84.83 -20.51 30.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.779 -1.201 . . . . 0.0 110.374 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -80.35 -48.84 12.36 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.177 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.621 ' HG3' ' CE2' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -86.32 -27.74 24.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.381 -0.824 . . . . 0.0 111.867 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.621 ' CE2' ' HG3' ' A' ' 24' ' ' LYS . 35.0 m-85 -116.18 64.2 2.63 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.308 -1.495 . . . . 0.0 110.524 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 48.8 Cg_endo -73.58 -0.09 8.84 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.806 1.424 . . . . 0.0 110.489 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.49 0.4 20.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.139 -0.976 . . . . 0.0 110.675 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 28' ' ' ARG . 2.5 mpt_? -90.93 -173.78 3.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.058 -1.026 . . . . 0.0 110.1 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 HG12 ' A' ' 31' ' ' VAL . 34.9 t -147.46 104.28 3.74 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 44.2 Cg_endo -72.97 87.41 1.01 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.026 1.54 . . . . 0.0 110.259 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.74 HG12 HG12 ' A' ' 29' ' ' VAL . 1.3 m -84.52 139.22 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.178 -0.952 . . . . 0.0 111.056 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 45.8 mm -94.57 158.57 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 108.89 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.801 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.5 t -133.95 134.77 55.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 120.886 -1.134 . . . . 0.0 111.273 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 1.3 tt0 -148.54 168.79 21.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.295 0.569 . . . . 0.0 109.538 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.63 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -100.51 156.26 17.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.043 -1.036 . . . . 0.0 110.562 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.034 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.52 -172.9 0.1 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.519 -0.738 . . . . 0.0 109.244 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.034 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.5 Cg_endo -72.63 107.83 2.4 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.441 1.232 . . . . 0.0 109.922 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.89 42.13 8.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.824 . . . . 0.0 110.251 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.19 -177.52 0.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.253 -0.905 . . . . 0.0 110.016 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.485 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -150.2 35.74 0.66 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.12 -0.987 . . . . 0.0 110.588 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -84.64 179.45 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.092 -1.005 . . . . 0.0 110.049 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 69' ' ' HIS . . . -62.16 179.55 4.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.953 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.1 t70 -70.73 -176.53 1.33 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -1.073 . . . . 0.0 109.988 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.953 HD22 ' O ' ' A' ' 43' ' ' ASP . 2.0 mm? -135.67 134.09 38.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.159 -0.963 . . . . 0.0 110.588 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -86.27 -27.0 24.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 109.587 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.51 ' CD ' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -158.04 150.08 21.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.517 -0.74 . . . . 0.0 109.679 179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -116.66 45.31 1.85 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.833 -1.167 . . . . 0.0 110.025 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.62 108.89 1.06 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.412 -0.805 . . . . 0.0 109.53 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.865 ' CD2' HD13 ' A' ' 63' ' ' LEU . 20.0 m-85 -105.47 141.33 37.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 110.718 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.0 98.37 8.09 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.609 HG21 ' SD ' ' A' ' 91' ' ' MET . 11.2 m -121.89 150.88 56.91 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.311 -0.868 . . . . 0.0 110.87 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 43.6 Cg_endo -69.28 145.74 60.92 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.047 1.551 . . . . 0.0 110.201 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.561 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -62.41 -15.6 50.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 0.0 111.379 -178.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -83.15 -14.7 52.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.176 -0.952 . . . . 0.0 111.283 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.83 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.9 mt -62.47 143.02 57.61 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.892 -1.13 . . . . 0.0 111.428 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -91.03 167.22 12.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.663 -0.648 . . . . 0.0 109.869 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.821 HG12 HG22 ' A' ' 87' ' ' THR . 58.7 t -62.75 -26.32 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.998 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.06 -31.65 75.43 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.83 ' CB ' HD22 ' A' ' 55' ' ' LEU . 7.1 mm100 -76.79 -47.07 22.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.113 -1.228 . . . . 0.0 110.04 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.141 ' CE2' HD11 ' A' ' 64' ' ' ILE . 22.7 t80 -60.7 -47.19 87.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.102 -0.998 . . . . 0.0 109.468 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.24 -22.24 1.68 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.883 -1.136 . . . . 0.0 109.855 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -79.91 -54.98 5.3 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 110.513 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.009 HD11 ' CE1' ' A' ' 60' ' ' PHE . 3.8 pp -59.84 -20.35 56.45 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 119.078 -1.049 . . . . 0.0 112.271 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.141 HD11 ' CE2' ' A' ' 60' ' ' PHE . 2.2 mt -90.98 -38.27 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 120.193 -1.567 . . . . 0.0 109.051 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.636 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.7 OUTLIER -35.35 -66.03 0.21 Allowed 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.181 0.515 . . . . 0.0 110.83 -179.333 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -31.47 72.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.893 -1.13 . . . . 0.0 110.072 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.537 ' O ' HD13 ' A' ' 44' ' ' LEU . 35.4 mmt180 -66.76 -16.82 64.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 0.0 110.54 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 68' ' ' ILE . 40.8 mt -103.38 11.9 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.07 -1.019 . . . . 0.0 109.763 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.552 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 51.9 23.76 2.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -0.797 . . . . 0.0 110.671 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.792 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.2 pp -91.85 157.44 16.87 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.319 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' GLU . 25.1 ptt180 -165.16 -169.44 1.65 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.929 -1.107 . . . . 0.0 111.152 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.42 -90.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.581 -0.7 . . . . 0.0 110.62 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 74' ' ' ASP . 6.5 pt-20 -158.67 28.07 0.23 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.2 -0.938 . . . . 0.0 110.883 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.515 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.16 176.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 109.892 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -103.21 140.63 37.12 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.291 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.89 HD11 ' HB2' ' A' ' 109' ' ' TYR . 21.5 tp -164.36 150.05 10.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 110.465 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.591 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 89.1 m-85 -157.93 121.97 4.14 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.778 -0.576 . . . . 0.0 109.869 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.896 ' CE2' HD12 ' A' ' 64' ' ' ILE . 18.3 m-30 -79.95 135.84 36.5 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.074 -1.016 . . . . 0.0 111.246 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.568 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 82.6 m-85 -118.33 126.46 52.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.739 HG22 HG12 ' A' ' 107' ' ' ILE . 2.4 t -120.83 124.06 71.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.305 -0.872 . . . . 0.0 110.381 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.808 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.1 t-20 47.63 49.12 16.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 29.3 m-80 56.81 36.01 27.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.639 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -135.18 167.0 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.086 -1.009 . . . . 0.0 109.924 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.88 72.42 5.84 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.547 -0.721 . . . . 0.0 109.632 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.07 164.07 36.49 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.04 1.547 . . . . 0.0 110.564 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.7 -178.96 3.75 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.121 1.59 . . . . 0.0 110.311 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.821 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.12 19.16 2.75 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 110.652 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.43 39.22 1.02 Allowed 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.512 -0.743 . . . . 0.0 109.567 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.801 ' HB1' ' CD ' ' A' ' 93' ' ' GLN . . . -145.42 -174.11 4.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.536 -0.728 . . . . 0.0 110.18 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 81.5 p -139.71 143.86 37.25 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.626 -0.671 . . . . 0.0 110.203 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.068 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -44.8 -41.78 7.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.153 -0.967 . . . . 0.0 109.747 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.561 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -50.69 -48.04 44.57 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.801 ' CD ' ' HB1' ' A' ' 89' ' ' ALA . 0.3 OUTLIER -64.38 -31.58 72.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -1.179 . . . . 0.0 109.988 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.068 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.06 -23.72 64.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.81 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.599 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -50.59 -56.96 9.4 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.201 -0.937 . . . . 0.0 109.892 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -69.64 -15.92 63.28 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.614 -1.304 . . . . 0.0 110.819 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.6 OUTLIER -88.57 -71.04 0.61 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.169 -0.957 . . . . 0.0 113.486 -177.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.686 ' CE1' HG21 ' A' ' 83' ' ' VAL . 16.6 m-70 -100.81 38.28 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.68 -1.262 . . . . 0.0 113.189 -176.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.599 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -93.07 171.53 8.88 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.99 -1.069 . . . . 0.0 110.252 178.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.55 ' HG3' ' ND1' ' A' ' 99' ' ' HIS . 1.4 mt-10 73.18 114.98 0.06 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.983 -1.073 . . . . 0.0 110.442 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 0.4 OUTLIER 173.46 -28.32 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.611 -0.681 . . . . 0.0 110.022 179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.88 -30.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.431 -0.793 . . . . 0.0 110.347 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -164.63 -60.62 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.276 -0.89 . . . . 0.0 109.62 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.534 ' CB ' ' O ' ' A' ' 30' ' ' PRO . 18.1 m-85 -127.36 -126.36 0.23 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.357 -0.84 . . . . 0.0 109.409 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.933 HD13 ' CD1' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -96.07 165.86 12.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.749 -1.219 . . . . 0.0 108.848 178.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.743 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -123.89 124.4 42.55 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.575 -1.328 . . . . 0.0 111.638 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.739 HG12 HG22 ' A' ' 80' ' ' VAL . 13.2 mt -141.56 133.29 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.439 -0.788 . . . . 0.0 109.475 178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.513 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -133.38 178.14 7.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.097 -1.002 . . . . 0.0 110.295 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.89 ' HB2' HD11 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -133.96 153.87 51.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.133 -0.98 . . . . 0.0 110.851 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 1.1 t -145.17 173.23 12.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.679 -0.638 . . . . 0.0 110.119 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 2.5 p30 -123.92 30.37 6.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.378 -0.826 . . . . 0.0 109.975 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -118.7 160.2 22.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.266 -0.897 . . . . 0.0 110.066 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 114' ' ' VAL . 0.7 OUTLIER -125.64 32.99 5.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.232 -179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 116' ' ' GLY . 8.8 p -46.17 169.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -0.903 . . . . 0.0 110.033 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.434 ' N ' HG22 ' A' ' 114' ' ' VAL . 56.8 t80 -45.24 97.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.982 . . . . 0.0 110.186 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 114' ' ' VAL . . . -108.04 162.57 13.1 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.183 -1.186 . . . . 0.0 110.233 180.0 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.451 ' O ' ' HB ' ' A' ' 21' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -39.73 73.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -1.136 . . . . 0.0 110.22 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 4.6 mtpt -76.46 -18.32 58.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 110.599 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.856 HG21 ' HB3' ' A' ' 30' ' ' PRO . 1.2 mp -70.02 -18.78 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.022 -1.049 . . . . 0.0 109.964 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 23' ' ' LYS . 16.6 mmm-85 -90.31 -49.54 6.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.166 -0.959 . . . . 0.0 109.786 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -45.45 -45.59 13.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.2 -0.938 . . . . 0.0 108.942 179.067 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 12.4 mtmt -85.54 -49.39 8.09 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.477 -0.764 . . . . 0.0 109.834 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 9.8 m-85 -110.88 69.56 0.64 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 110.403 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 45.6 Cg_endo -71.82 -12.22 28.46 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.921 1.485 . . . . 0.0 110.476 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.75 13.07 21.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 110.144 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 1.6 mpt_? -105.22 -161.47 0.81 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 110.12 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.792 HG12 HG12 ' A' ' 31' ' ' VAL . 24.3 t -144.12 105.65 4.81 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.173 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.856 ' HB3' HG21 ' A' ' 21' ' ' ILE . 48.4 Cg_endo -74.69 84.99 1.52 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.321 1.695 . . . . 0.0 110.038 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.997 HG11 ' HE3' ' A' ' 91' ' ' MET . 1.4 m -85.6 148.29 4.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 110.933 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.6 HD13 ' CD1' ' A' ' 104' ' ' PHE . 1.5 mp -113.97 147.53 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.551 HG22 ' CE1' ' A' ' 109' ' ' TYR . 0.4 OUTLIER -124.36 153.26 30.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 120.8 -1.187 . . . . 0.0 111.187 -178.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.585 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 2.4 tt0 -156.34 -162.04 1.21 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.539 ' HD2' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -132.25 159.81 37.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.869 -1.144 . . . . 0.0 110.815 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.55 -173.8 0.11 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.582 -0.699 . . . . 0.0 109.38 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.3 Cg_endo -71.98 108.9 2.56 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.522 1.275 . . . . 0.0 110.178 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 64.86 41.15 5.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.376 -0.828 . . . . 0.0 110.553 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.455 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -63.22 178.18 0.54 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 109.841 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.523 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 13.8 ptt180 -145.26 28.72 1.2 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.802 HD12 ' C ' ' A' ' 41' ' ' ILE . 1.8 pp -85.32 179.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.012 . . . . 0.0 109.726 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.573 ' O ' ' CD1' ' A' ' 41' ' ' ILE . . . -68.74 146.38 45.07 Favored Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.231 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.82 163.87 16.22 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.618 -0.93 . . . . 0.0 110.787 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.532 ' HG ' ' CA ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -153.74 142.49 20.99 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.729 -0.607 . . . . 0.0 109.472 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.511 ' O ' ' CD ' ' A' ' 46' ' ' LYS . 1.6 t0 -84.09 42.17 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 110.038 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.511 ' CD ' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -160.29 105.78 1.51 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.0 110.019 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -115.55 48.58 1.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.74 -1.225 . . . . 0.0 110.618 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.17 111.51 1.7 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.299 -0.875 . . . . 0.0 109.532 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.938 ' CD2' HD13 ' A' ' 63' ' ' LEU . 24.0 m-85 -106.98 141.56 37.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.049 -1.032 . . . . 0.0 110.551 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.589 HD21 HG13 ' A' ' 21' ' ' ILE . 4.2 mp -107.77 93.83 4.75 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.991 ' HB ' HD12 ' A' ' 55' ' ' LEU . 13.7 m -117.95 153.88 51.2 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.152 -0.968 . . . . 0.0 110.777 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.484 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.9 Cg_endo -71.65 148.22 52.7 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.111 1.585 . . . . 0.0 110.025 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.563 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.5 m -63.81 -15.34 58.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 111.334 -179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 7.8 t70 -83.58 -11.26 57.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.018 -1.051 . . . . 0.0 110.916 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.991 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.6 mt -62.05 142.02 57.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.941 -1.099 . . . . 0.0 111.122 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.485 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 1.2 p -91.01 154.89 19.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.65 -0.656 . . . . 0.0 109.433 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 1.033 HG12 HG22 ' A' ' 87' ' ' THR . 24.6 t -53.82 -20.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.991 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.37 -41.68 58.21 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.823 ' HB2' HD22 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -67.72 -46.67 71.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.174 -1.192 . . . . 0.0 109.997 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.17 ' CE2' HD11 ' A' ' 64' ' ' ILE . 22.8 t80 -60.65 -47.1 87.77 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.097 -1.002 . . . . 0.0 109.695 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.31 -22.25 1.72 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.01 -1.056 . . . . 0.0 109.87 179.476 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.16 -54.55 5.65 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.335 -0.853 . . . . 0.0 110.34 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.988 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.7 pp -59.75 -19.47 50.42 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.069 -1.052 . . . . 0.0 112.354 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.17 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.9 mt -92.16 -40.18 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 120.125 -1.61 . . . . 0.0 109.077 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.519 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -37.28 -61.46 0.58 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.878 -0.514 . . . . 0.0 110.624 -179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -32.33 73.99 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.942 -1.099 . . . . 0.0 109.742 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.535 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 15.1 mmt180 -69.39 -13.14 62.2 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.359 -0.838 . . . . 0.0 109.946 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.739 HG23 HD13 ' A' ' 41' ' ' ILE . 2.4 mm -99.61 7.81 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.061 -1.024 . . . . 0.0 109.528 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.541 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 54.1 32.58 16.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.429 -0.794 . . . . 0.0 110.132 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.85 ' O ' HD12 ' A' ' 70' ' ' LEU . 4.1 pp -110.53 151.2 27.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.373 -0.829 . . . . 0.0 109.934 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 73' ' ' GLU . 3.9 ptp180 -167.06 -168.94 1.17 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.338 -0.851 . . . . 0.0 111.058 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.453 ' C ' ' HG3' ' A' ' 73' ' ' GLU . . . 50.71 -91.7 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.568 -0.707 . . . . 0.0 111.225 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HG3' ' C ' ' A' ' 72' ' ' ALA . 14.2 mt-10 -141.98 49.27 1.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.136 -0.978 . . . . 0.0 110.873 -179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -77.82 176.04 9.43 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 122.12 0.962 . . . . 0.0 109.991 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.511 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -118.16 143.85 46.16 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.039 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.813 HD21 ' CE1' ' A' ' 78' ' ' PHE . 18.2 tp -164.05 153.66 14.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.913 . . . . 0.0 110.628 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 68.0 m-85 -157.58 123.06 4.57 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.617 -0.677 . . . . 0.0 109.465 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.813 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.4 m-30 -84.8 132.34 34.43 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.012 -1.055 . . . . 0.0 111.93 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 41.1 m-85 -120.55 118.39 30.09 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.021 HG22 HG23 ' A' ' 107' ' ' ILE . 2.0 t -120.68 130.82 74.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.272 -0.892 . . . . 0.0 110.089 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.556 ' HB3' ' CE1' ' A' ' 98' ' ' HIS . 53.5 t30 51.28 34.48 11.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 3.8 t-20 67.65 35.91 3.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.224 -0.922 . . . . 0.0 110.208 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -135.77 168.59 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.292 -0.88 . . . . 0.0 110.078 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.806 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.3 mp -154.68 71.01 5.99 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.73 . . . . 0.0 109.678 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.32 164.37 34.26 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.122 1.59 . . . . 0.0 110.68 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.08 -178.64 3.69 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.071 1.564 . . . . 0.0 110.611 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 1.033 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.2 22.95 1.65 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.331 -0.855 . . . . 0.0 110.672 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.37 43.45 1.07 Allowed 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.369 -0.832 . . . . 0.0 109.551 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.28 -171.48 3.67 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.708 0.765 . . . . 0.0 110.294 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 75.9 p -139.21 136.36 34.93 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.538 0.685 . . . . 0.0 110.103 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.008 ' HA ' HD23 ' A' ' 94' ' ' LEU . 32.1 mmm -48.4 -38.69 20.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 0.0 109.9 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.45 -49.01 47.14 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 90' ' ' THR . 3.0 pt20 -64.64 -30.24 71.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -1.113 . . . . 0.0 109.814 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.008 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -68.52 -23.79 64.58 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.208 -0.932 . . . . 0.0 110.102 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 99' ' ' HIS . 1.0 OUTLIER -48.86 -53.04 21.05 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.843 -1.161 . . . . 0.0 109.774 -179.53 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -69.36 -21.47 63.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.196 -0.94 . . . . 0.0 111.192 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 8.4 mm-40 -85.68 -66.86 0.85 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.941 -1.1 . . . . 0.0 112.007 -178.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.618 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -98.77 42.33 1.1 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 120.912 -1.117 . . . . 0.0 110.771 -178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.621 ' NE2' ' CE2' ' A' ' 95' ' ' TYR . 1.4 t-80 -71.25 -9.01 57.4 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.852 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.517 ' CA ' ' OE1' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 44.57 70.35 0.34 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.319 -0.863 . . . . 0.0 109.787 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 103' ' ' PHE . 10.2 mt-10 57.52 155.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.458 -0.776 . . . . 0.0 109.903 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.573 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 7.4 p30 -45.77 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.194 -0.941 . . . . 0.0 110.043 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.612 ' O ' ' CG ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER 171.41 86.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.277 -0.889 . . . . 0.0 110.149 -179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.612 ' CG ' ' O ' ' A' ' 103' ' ' PHE . 38.1 p90 37.56 -162.7 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.533 -0.729 . . . . 0.0 110.849 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.032 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -123.67 160.3 27.47 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.771 -179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.786 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -124.97 135.88 53.22 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.029 -1.044 . . . . 0.0 110.996 -179.4 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.032 ' CG1' HD11 ' A' ' 105' ' ' LEU . 6.0 mt -141.69 137.54 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.287 -0.883 . . . . 0.0 110.307 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.76 147.21 50.0 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.212 -0.93 . . . . 0.0 108.864 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 1.6 p90 -130.67 165.79 22.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.478 -1.389 . . . . 0.0 111.629 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -156.07 174.74 14.92 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.257 0.551 . . . . 0.0 110.328 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.523 ' OD2' ' CG ' ' A' ' 40' ' ' ARG . 1.8 p30 -107.97 41.07 1.6 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.955 . . . . 0.0 110.217 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 111' ' ' ASP . 0.0 OUTLIER 172.07 140.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.162 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.1 t -106.45 -6.98 17.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 110.495 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 115' ' ' TYR . 9.3 p -129.89 175.4 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.108 -0.995 . . . . 0.0 110.327 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.536 ' H ' HG22 ' A' ' 114' ' ' VAL . 85.9 t80 -49.39 130.96 20.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.0 110.264 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -127.44 -172.01 13.16 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.224 -1.163 . . . . 0.0 110.271 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.27 -39.94 10.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -1.152 . . . . 0.0 110.248 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 9.7 mtpt -75.3 -33.12 61.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.225 -0.922 . . . . 0.0 110.413 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.446 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -59.58 -17.66 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -0.966 . . . . 0.0 109.651 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.503 ' CD ' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -85.09 -49.35 8.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -53.92 -41.43 67.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.868 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 8.6 mttt -82.84 -44.27 15.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.0 109.774 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.484 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 22.3 m-85 -112.75 61.03 0.66 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.29 -0.881 . . . . 0.0 110.576 -179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.503 ' HA ' ' CD ' ' A' ' 22' ' ' ARG . 43.8 Cg_endo -69.83 -29.43 23.55 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.743 1.391 . . . . 0.0 110.359 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -96.98 7.29 46.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 0.0 110.247 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.484 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 6.2 mpt_? -83.86 -167.34 1.7 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.948 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 31' ' ' VAL . 19.9 t -147.5 102.68 3.73 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.855 . . . . 0.0 109.899 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.498 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 46.1 Cg_endo -73.46 81.11 1.85 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.177 1.62 . . . . 0.0 110.208 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.705 HG12 HG12 ' A' ' 29' ' ' VAL . 2.2 m -77.32 152.33 5.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.348 -0.845 . . . . 0.0 110.686 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 1.5 mp -108.24 164.1 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.686 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.4 t -136.31 136.51 48.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 120.835 -1.166 . . . . 0.0 111.093 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.91 -176.16 5.81 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.322 0.582 . . . . 0.0 109.742 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HD2' HD11 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -114.9 159.08 21.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.985 -1.072 . . . . 0.0 110.786 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.021 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.76 -173.23 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.529 -0.732 . . . . 0.0 109.191 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.021 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.7 Cg_endo -71.91 107.25 2.17 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.472 1.249 . . . . 0.0 109.983 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.95 41.75 8.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.353 -0.842 . . . . 0.0 110.206 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.8 178.75 0.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.864 . . . . 0.0 110.283 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.424 ' HG3' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.68 32.31 1.05 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.214 -0.929 . . . . 0.0 110.172 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.587 HD11 ' HD2' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -85.81 -173.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.324 -0.86 . . . . 0.0 110.579 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.578 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -67.46 172.43 31.43 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.54 179.61 3.99 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.165 -1.197 . . . . 0.0 110.595 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.486 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 2.1 pp -134.93 133.42 39.57 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.369 -0.832 . . . . 0.0 110.706 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.454 ' OD2' ' HD2' ' A' ' 46' ' ' LYS . 10.7 p-10 -85.83 -20.52 29.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.191 -0.943 . . . . 0.0 110.143 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.512 ' HD2' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -151.84 154.08 35.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.307 -0.871 . . . . 0.0 109.683 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.547 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -128.28 40.95 3.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.962 -1.086 . . . . 0.0 110.448 -179.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.92 104.88 0.91 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.311 -0.868 . . . . 0.0 109.822 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.638 ' O ' HG22 ' A' ' 31' ' ' VAL . 30.6 m-85 -105.4 145.26 31.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.112 -0.993 . . . . 0.0 111.09 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.03 94.82 5.22 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.016 ' HB ' HD12 ' A' ' 55' ' ' LEU . 32.8 m -115.92 153.14 48.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.115 -0.991 . . . . 0.0 110.987 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.458 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.3 Cg_endo -69.81 149.5 66.65 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.08 1.568 . . . . 0.0 110.407 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.556 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.2 OUTLIER -63.78 -16.24 60.71 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.376 -0.828 . . . . 0.0 111.34 -178.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -83.12 -10.99 58.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.101 -0.999 . . . . 0.0 111.017 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.016 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.7 mt -61.84 141.8 57.72 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.907 -1.121 . . . . 0.0 110.952 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.499 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 3.1 p -91.23 162.41 14.65 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.532 -0.73 . . . . 0.0 109.507 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.499 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 37.1 t -59.04 -30.16 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.104 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.73 -27.16 74.06 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.87 ' CB ' HD22 ' A' ' 55' ' ' LEU . 15.3 mm-40 -76.3 -51.35 12.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.169 -1.195 . . . . 0.0 110.054 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.151 ' CE2' HD11 ' A' ' 64' ' ' ILE . 12.0 t80 -60.41 -47.25 86.92 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.236 -0.986 . . . . 0.0 109.919 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.51 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -49.29 -23.27 1.33 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.849 -1.157 . . . . 0.0 109.562 179.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -55.87 4.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.486 -0.759 . . . . 0.0 111.282 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.127 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -59.03 -23.53 62.04 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.899 -1.126 . . . . 0.0 111.842 -178.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.151 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -91.08 -35.01 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.078 -1.639 . . . . 0.0 108.77 177.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.673 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -38.95 -56.19 1.43 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.446 -0.784 . . . . 0.0 110.51 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.488 ' N ' ' HE2' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -64.89 -34.94 79.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.975 -1.078 . . . . 0.0 108.899 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 5.0 mmt180 -73.08 -10.54 59.9 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.684 -0.635 . . . . 0.0 110.121 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.032 ' CG2' HD23 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -88.09 -10.57 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER 74.01 28.07 1.53 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.751 0.786 . . . . 0.0 109.122 -178.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.032 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.0 pp -113.93 158.67 20.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.745 -0.597 . . . . 0.0 109.873 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -165.08 -174.62 3.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 110.772 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.99 -90.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.433 -0.792 . . . . 0.0 110.788 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 1.9 pt-20 -153.93 42.26 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 111.027 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -67.51 176.48 2.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.071 -1.018 . . . . 0.0 110.076 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.718 ' HB3' ' CG ' ' A' ' 111' ' ' ASP . . . -92.27 142.85 27.01 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.834 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.791 HD21 ' CE1' ' A' ' 78' ' ' PHE . 17.8 tp -164.09 154.37 14.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 110.773 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 85.2 m-85 -156.91 124.16 5.26 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.581 -0.699 . . . . 0.0 110.121 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.791 ' CE1' HD21 ' A' ' 76' ' ' LEU . 3.7 m-30 -94.73 113.89 25.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 91.2 m-85 -108.99 127.48 54.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.195 -0.941 . . . . 0.0 110.122 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.959 HG22 HG23 ' A' ' 107' ' ' ILE . 1.8 t -121.5 122.41 67.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.428 -0.795 . . . . 0.0 109.442 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.689 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.9 m-80 57.38 33.48 23.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.073 -1.017 . . . . 0.0 109.922 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.27 31.91 15.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -133.13 171.19 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.391 -0.818 . . . . 0.0 109.681 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.807 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.2 mp -154.26 77.73 5.41 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.427 -0.796 . . . . 0.0 109.494 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.52 165.8 31.67 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.149 1.605 . . . . 0.0 110.36 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.58 178.66 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.069 1.563 . . . . 0.0 110.444 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.499 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.19 20.49 2.73 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.319 -0.863 . . . . 0.0 110.624 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.7 p -94.64 37.47 1.13 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.538 -0.726 . . . . 0.0 109.596 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.77 -174.8 4.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.485 -0.759 . . . . 0.0 110.182 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.523 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 34.7 p -139.09 149.9 45.09 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.317 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.116 ' HA ' HD23 ' A' ' 94' ' ' LEU . 30.6 mmm -51.56 -38.6 55.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.478 -0.764 . . . . 0.0 110.16 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -54.12 -40.4 66.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.523 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 2.1 mt-30 -68.43 -46.05 70.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.146 -1.208 . . . . 0.0 109.269 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.116 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -56.92 -20.56 24.04 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.131 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.53 ' O ' ' HB3' ' A' ' 99' ' ' HIS . 1.3 t80 -48.75 -53.28 19.63 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.794 -1.191 . . . . 0.0 109.833 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.641 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 10.3 tt0 -69.49 -19.92 63.73 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.778 -1.201 . . . . 0.0 111.337 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -87.78 -62.98 1.37 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.066 -1.021 . . . . 0.0 113.53 -177.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.575 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.8 m-70 -98.12 35.8 1.68 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.675 -1.266 . . . . 0.0 112.682 -176.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.641 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -92.16 169.56 10.52 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.035 -1.041 . . . . 0.0 110.066 178.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 101' ' ' GLU . 3.0 tt0 -153.61 102.57 2.57 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.721 -1.237 . . . . 0.0 110.059 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 100' ' ' GLU . 3.0 mt-10 43.32 -167.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.112 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.514 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 4.8 t0 41.94 -136.32 0.27 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.458 ' O ' ' HG2' ' A' ' 30' ' ' PRO . 8.6 p90 -144.93 45.52 1.35 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.112 -0.993 . . . . 0.0 110.114 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.514 ' CE2' ' HB3' ' A' ' 102' ' ' ASP . 20.3 p90 -144.97 163.39 34.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.637 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.028 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -117.71 167.3 11.48 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 0.0 109.362 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.746 ' N ' HD12 ' A' ' 105' ' ' LEU . 2.9 p90 -125.82 133.93 51.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.866 -1.146 . . . . 0.0 111.712 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.028 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.6 mt -141.19 147.03 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.437 -0.79 . . . . 0.0 109.785 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -140.0 177.43 7.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.017 -1.052 . . . . 0.0 110.287 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.686 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.2 p90 -143.47 171.42 14.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.221 -0.924 . . . . 0.0 110.612 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -159.63 -175.15 5.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.464 -0.772 . . . . 0.0 110.2 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.718 ' CG ' ' HB3' ' A' ' 75' ' ' ALA . 8.8 t70 -128.57 20.34 6.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.401 -0.812 . . . . 0.0 110.095 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 7.7 mt-10 61.47 132.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 110.09 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 64.8 p -86.0 -2.17 58.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -0.889 . . . . 0.0 110.317 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.98 168.27 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 0.0 110.242 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -71.34 158.08 36.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.391 -0.818 . . . . 0.0 110.269 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.5 -154.14 5.36 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 117' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.143 . . . . 0.0 110.221 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -43.08 10.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -1.214 . . . . 0.0 110.241 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -77.81 -34.98 51.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.259 -0.901 . . . . 0.0 110.554 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.488 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -65.8 -18.81 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.088 -1.007 . . . . 0.0 110.1 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HD3' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -86.86 -35.95 18.74 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.024 -1.048 . . . . 0.0 110.18 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.495 ' HG3' ' HG2' ' A' ' 24' ' ' LYS . 1.3 tptm -64.71 -40.58 95.6 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.173 -0.954 . . . . 0.0 108.984 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' HG2' ' HG3' ' A' ' 23' ' ' LYS . 1.7 mtmt -85.23 -41.11 15.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.0 109.702 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 17.1 m-85 -114.41 68.2 1.83 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.295 -0.878 . . . . 0.0 110.499 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.497 ' HA ' ' HD3' ' A' ' 22' ' ' ARG . 47.6 Cg_endo -73.29 -0.75 9.62 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.954 1.502 . . . . 0.0 110.459 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -116.92 8.93 13.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 110.227 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 1.8 mpt_? -94.18 -171.24 2.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.128 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.822 HG12 HG12 ' A' ' 31' ' ' VAL . 19.6 t -147.45 109.2 3.88 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.31 -0.869 . . . . 0.0 110.171 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.1 Cg_endo -75.45 84.14 1.77 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.193 1.628 . . . . 0.0 110.101 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.822 HG12 HG12 ' A' ' 29' ' ' VAL . 1.2 m -82.72 132.03 32.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.131 -0.98 . . . . 0.0 111.045 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.47 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 41.4 mm -93.86 142.78 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.705 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -124.65 147.96 29.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.86 -1.15 . . . . 0.0 111.135 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.579 ' O ' ' CE1' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -156.57 -174.12 4.79 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.528 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -121.39 160.65 23.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.9 -1.125 . . . . 0.0 110.53 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.006 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.92 -174.83 0.15 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.412 -0.805 . . . . 0.0 109.296 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.006 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.2 Cg_endo -70.54 111.87 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.531 1.28 . . . . 0.0 109.68 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 2.8 mttt 62.21 42.34 9.59 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.351 -0.843 . . . . 0.0 110.05 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.528 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -56.13 -177.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.306 -0.871 . . . . 0.0 109.995 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -148.39 28.05 0.9 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 111.01 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.895 HD13 HG23 ' A' ' 68' ' ' ILE . 2.0 pp -91.81 176.46 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.83 -1.169 . . . . 0.0 110.324 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.84 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -52.12 -176.5 0.04 OUTLIER Glycine 0 N--CA 1.498 2.803 0 O-C-N 121.296 -0.878 . . . . 0.0 111.181 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 1.017 ' O ' HD22 ' A' ' 44' ' ' LEU . 10.1 t0 -80.47 -171.33 3.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -1.09 . . . . 0.0 109.993 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.017 HD22 ' O ' ' A' ' 43' ' ' ASP . 0.7 OUTLIER -142.25 138.5 31.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 0.0 110.667 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -86.07 -32.97 21.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.308 -0.87 . . . . 0.0 109.827 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.8 151.83 30.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.277 -0.889 . . . . 0.0 109.961 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.705 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -112.53 46.02 1.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 109.769 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -165.92 109.7 0.81 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.552 -0.718 . . . . 0.0 109.48 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.902 ' CD2' HD13 ' A' ' 63' ' ' LEU . 12.7 m-85 -105.83 140.39 38.93 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.117 -0.989 . . . . 0.0 110.326 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.429 HD11 HG21 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -103.53 92.91 4.67 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.83 ' HB ' HD12 ' A' ' 55' ' ' LEU . 13.6 m -115.64 150.82 45.4 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 110.53 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 45.0 Cg_endo -70.5 148.48 60.34 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.107 1.583 . . . . 0.0 110.036 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.57 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.9 OUTLIER -62.56 -16.19 54.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -0.805 . . . . 0.0 111.399 -178.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.86 -13.2 54.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.036 -1.04 . . . . 0.0 111.209 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.881 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.8 mt -62.06 140.99 58.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.865 -1.147 . . . . 0.0 111.133 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 1.6 p -90.57 154.59 19.49 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.619 -0.676 . . . . 0.0 109.45 178.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.505 ' CG1' HG22 ' A' ' 87' ' ' THR . 58.9 t -52.74 -21.19 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.061 -1.024 . . . . 0.0 110.04 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.67 -41.24 57.31 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.881 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.1 mm-40 -67.74 -47.24 69.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.214 -1.168 . . . . 0.0 109.903 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.184 ' CE2' HD11 ' A' ' 64' ' ' ILE . 31.1 t80 -60.79 -46.51 90.24 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.496 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -51.13 -22.11 2.32 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.824 -1.173 . . . . 0.0 109.802 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -78.82 -54.22 6.29 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.946 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.023 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.6 pp -59.92 -20.44 57.39 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.02 -1.05 . . . . 0.0 112.189 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.184 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.6 mt -90.19 -37.54 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 120.103 -1.623 . . . . 0.0 108.836 177.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -37.99 -61.36 0.66 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.278 0.561 . . . . 0.0 110.736 -179.511 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -31.0 71.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.913 -1.117 . . . . 0.0 109.822 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.576 ' C ' HD13 ' A' ' 68' ' ' ILE . 21.4 mmt180 -67.7 -16.94 64.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.895 HG23 HD13 ' A' ' 41' ' ' ILE . 2.9 mm -99.76 14.11 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.371 -0.83 . . . . 0.0 109.51 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.493 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER 47.87 33.53 3.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.553 -0.717 . . . . 0.0 110.562 179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.795 ' C ' HD12 ' A' ' 70' ' ' LEU . 4.1 pp -112.03 155.62 23.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.695 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.65 -172.23 2.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.079 -1.013 . . . . 0.0 111.056 -179.094 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 55.27 -89.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.478 -0.764 . . . . 0.0 110.889 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.5 pt-20 -147.21 32.09 0.91 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.2 -0.937 . . . . 0.0 111.032 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -52.92 176.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.074 -1.016 . . . . 0.0 109.843 179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.629 ' HB3' ' OD1' ' A' ' 111' ' ' ASP . . . -117.59 139.17 51.34 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.134 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.862 HD21 ' HE1' ' A' ' 78' ' ' PHE . 29.8 tp -164.49 155.25 14.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 0.0 110.427 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.568 ' O ' ' CE2' ' A' ' 79' ' ' PHE . 20.1 m-85 -153.79 123.3 6.65 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.45 -0.781 . . . . 0.0 109.754 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.862 ' HE1' HD21 ' A' ' 76' ' ' LEU . 18.0 m-30 -84.71 132.78 34.41 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.098 -1.001 . . . . 0.0 111.705 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.568 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 62.3 m-85 -120.37 119.81 34.16 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.802 HG22 HG23 ' A' ' 107' ' ' ILE . 2.1 t -120.77 127.95 75.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 O-C-N 121.235 -0.916 . . . . 0.0 110.206 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.69 ' O ' HG23 ' A' ' 83' ' ' VAL . 28.8 t30 54.77 35.47 24.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.874 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 64.14 32.15 12.82 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.38 -0.825 . . . . 0.0 110.077 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.4 t -135.63 171.05 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.415 -0.803 . . . . 0.0 109.853 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.55 75.4 5.74 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.544 -0.723 . . . . 0.0 109.47 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.5 163.91 36.37 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.967 1.509 . . . . 0.0 110.651 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -72.98 177.64 7.49 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.17 1.616 . . . . 0.0 110.276 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.505 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.88 21.96 2.5 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.263 -0.898 . . . . 0.0 110.603 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.78 36.68 0.86 Allowed 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.528 -0.732 . . . . 0.0 109.745 179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -147.45 -170.4 3.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.376 -0.827 . . . . 0.0 110.358 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.559 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 58.6 p -138.96 146.94 41.58 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.488 0.661 . . . . 0.0 109.92 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.058 ' HA ' HD23 ' A' ' 94' ' ' LEU . 1.2 mmt -47.13 -47.36 23.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.248 -0.907 . . . . 0.0 110.431 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.57 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -42.73 -44.73 5.55 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.559 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 1.0 OUTLIER -67.81 -39.76 83.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -1.159 . . . . 0.0 109.243 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.058 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -59.53 -24.94 64.09 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.364 -179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.577 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.7 OUTLIER -49.16 -56.07 10.39 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.517 -1.365 . . . . 0.0 109.411 -179.447 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.582 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 8.7 tt0 -71.35 -18.18 62.39 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.163 -0.961 . . . . 0.0 111.911 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.586 ' HG2' ' CE1' ' A' ' 98' ' ' HIS . 1.3 tt0 -87.77 -61.23 1.76 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.756 -1.215 . . . . 0.0 112.552 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.684 ' HB3' HG12 ' A' ' 80' ' ' VAL . 17.4 m-70 -98.27 38.64 1.31 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.859 -1.15 . . . . 0.0 111.424 -177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.582 ' CD2' ' O ' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -71.63 173.02 8.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.424 -0.797 . . . . 0.0 109.122 178.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 102' ' ' ASP . 0.7 OUTLIER -148.4 152.22 36.62 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.63 -1.294 . . . . 0.0 110.673 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 102' ' ' ASP . 48.7 mt-10 -49.76 89.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.407 -0.808 . . . . 0.0 110.21 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER 170.71 -80.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.118 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.661 ' CD2' ' CE1' ' A' ' 104' ' ' PHE . 3.5 t80 -179.84 -54.43 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.427 -0.796 . . . . 0.0 110.124 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.661 ' CE1' ' CD2' ' A' ' 103' ' ' PHE . 5.6 m-85 -77.65 -176.44 4.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.33 -0.856 . . . . 0.0 110.229 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.046 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.51 168.54 9.17 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.205 -0.934 . . . . 0.0 109.291 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.657 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.2 m-85 -121.92 130.68 53.54 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.64 -1.288 . . . . 0.0 111.597 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.046 ' CG1' HD11 ' A' ' 105' ' ' LEU . 5.8 mt -141.56 127.05 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.33 -0.856 . . . . 0.0 110.354 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -121.93 163.64 18.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.111 -0.993 . . . . 0.0 108.851 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.669 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.7 OUTLIER -145.75 164.05 33.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.622 -1.299 . . . . 0.0 111.225 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.624 ' O ' HD12 ' A' ' 76' ' ' LEU . 1.5 t -159.27 -175.95 5.53 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.508 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.629 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 65.5 t0 -134.36 27.62 3.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.968 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.447 ' OE2' ' HB3' ' A' ' 110' ' ' SER . 0.5 OUTLIER -69.06 170.01 10.75 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.175 -0.953 . . . . 0.0 110.107 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.6 t -156.44 33.7 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.148 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.436 HG22 ' N ' ' A' ' 115' ' ' TYR . 9.8 p -109.9 171.14 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -0.912 . . . . 0.0 110.25 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.436 ' N ' HG22 ' A' ' 114' ' ' VAL . 12.2 t80 -80.21 78.31 6.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.202 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.85 -133.52 6.05 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.268 -1.137 . . . . 0.0 110.23 -179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -46.33 -32.27 3.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.287 -1.125 . . . . 0.0 109.905 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -77.88 -39.19 44.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 110.14 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.577 HG21 ' HB3' ' A' ' 30' ' ' PRO . 10.4 mm -59.62 -13.97 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.924 . . . . 0.0 110.136 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -52.6 5.39 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -53.74 -34.55 59.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.528 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.522 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 12.2 mttt -84.63 -47.87 10.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.615 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.529 ' HB3' ' CD ' ' A' ' 28' ' ' ARG . 68.5 m-85 -109.99 56.7 0.31 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.417 -0.802 . . . . 0.0 111.413 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.522 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 51.3 Cg_endo -72.35 -10.03 25.03 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.486 1.256 . . . . 0.0 110.641 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -100.74 3.2 42.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.14 -0.975 . . . . 0.0 111.065 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.529 ' CD ' ' HB3' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -145.25 -175.99 4.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.88 -1.138 . . . . 0.0 110.751 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.881 HG13 ' CE1' ' A' ' 95' ' ' TYR . 23.4 t -119.35 134.32 23.76 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.413 -0.804 . . . . 0.0 110.866 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.609 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 52.3 Cg_endo -81.16 112.48 2.56 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 124.246 1.656 . . . . 0.0 109.477 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.921 HG22 ' CD2' ' A' ' 105' ' ' LEU . 45.8 t -100.13 125.06 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.317 -0.865 . . . . 0.0 110.897 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.075 HD11 ' CE2' ' A' ' 104' ' ' PHE . 27.1 mm -91.51 147.15 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 108.819 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.629 HG21 ' CD1' ' A' ' 49' ' ' TYR . 9.2 t -130.61 143.93 39.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 120.855 -1.153 . . . . 0.0 111.556 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HA ' ' CE ' ' A' ' 47' ' ' LYS . 3.5 tt0 -156.54 167.25 31.02 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.552 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.661 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -96.79 163.46 12.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.937 -1.102 . . . . 0.0 110.921 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.023 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.89 -174.0 0.14 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 0.0 109.68 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.023 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.8 Cg_endo -74.03 116.64 4.72 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.576 1.303 . . . . 0.0 109.968 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 60.29 39.56 18.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 110.034 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.46 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -62.37 174.42 0.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.887 . . . . 0.0 110.359 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 31.75 0.67 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.976 HD13 HG23 ' A' ' 68' ' ' ILE . 1.8 pp -85.88 177.9 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.059 -1.026 . . . . 0.0 110.611 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.822 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -49.1 -176.89 0.01 OUTLIER Glycine 0 N--CA 1.498 2.823 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.26 -177.17 5.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.253 -1.145 . . . . 0.0 110.001 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.936 HD12 ' OH ' ' A' ' 109' ' ' TYR . 0.2 OUTLIER -148.58 147.55 29.13 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.047 -1.033 . . . . 0.0 110.453 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 9.4 m-20 -86.82 -28.42 22.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.375 -0.828 . . . . 0.0 110.626 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HD3' ' HB3' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -152.54 156.83 40.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.909 . . . . 0.0 110.011 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' CE ' ' HA ' ' A' ' 34' ' ' GLU . 6.6 mmmm -120.65 43.8 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.054 -1.029 . . . . 0.0 109.781 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 1.5 ptmm? -157.94 109.75 2.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.379 -0.825 . . . . 0.0 109.74 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.629 ' CD1' HG21 ' A' ' 33' ' ' VAL . 28.1 m-85 -104.29 147.44 27.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 110.965 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 28' ' ' ARG . 0.4 OUTLIER -120.12 114.17 21.56 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.747 ' HB ' HD12 ' A' ' 55' ' ' LEU . 2.8 m -141.0 165.32 30.2 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.714 -1.241 . . . . 0.0 110.889 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 51' ' ' VAL . 43.7 Cg_endo -69.22 147.93 67.46 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 124.151 1.606 . . . . 0.0 110.46 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.534 ' HB3' ' CA ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -65.34 -12.72 54.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.461 -0.775 . . . . 0.0 111.336 -178.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -84.08 -5.48 59.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.084 -1.01 . . . . 0.0 110.913 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.851 HD22 ' CB ' ' A' ' 59' ' ' GLN . 3.8 mt -61.96 141.52 57.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.83 -1.169 . . . . 0.0 111.107 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.498 ' OG1' ' HG2' ' A' ' 59' ' ' GLN . 0.9 OUTLIER -92.07 159.57 15.63 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.589 -0.694 . . . . 0.0 109.698 178.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 88.3 t -58.44 -26.64 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.082 -1.011 . . . . 0.0 109.674 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.76 -31.51 67.44 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.851 ' CB ' HD22 ' A' ' 55' ' ' LEU . 15.7 mm100 -69.34 -51.1 40.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.162 ' CD1' HD11 ' A' ' 63' ' ' LEU . 6.9 t80 -59.97 -33.57 72.12 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.016 -1.074 . . . . 0.0 109.436 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.583 ' HA ' ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -55.58 -35.14 65.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 109.998 178.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -79.74 -50.01 11.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.74 . . . . 0.0 112.682 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.162 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -58.66 -39.85 81.81 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.434 -1.416 . . . . 0.0 111.927 -177.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.132 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -76.11 -42.95 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 119.877 -1.764 . . . . 0.0 108.432 178.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.882 ' HG2' HD11 ' A' ' 70' ' ' LEU . 3.4 mtt180 -35.92 -61.58 0.47 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.825 -0.547 . . . . 0.0 110.863 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.71 -33.07 75.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.029 . . . . 0.0 109.895 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.767 ' HB3' HD21 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -69.97 -10.3 58.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.258 -0.901 . . . . 0.0 109.624 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.976 HG23 HD13 ' A' ' 41' ' ' ILE . 5.5 mm -100.4 7.5 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.442 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.43 ' ND1' ' N ' ' A' ' 69' ' ' HIS . 3.0 m-70 54.84 31.47 15.74 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.415 -0.803 . . . . 0.0 110.416 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.882 HD11 ' HG2' ' A' ' 65' ' ' ARG . 4.2 pp -110.62 150.6 28.75 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.835 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 1.2 ptt180 -167.0 -167.19 0.9 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 111.017 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 71' ' ' ARG . . . 56.56 -86.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.562 -0.711 . . . . 0.0 110.96 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 71' ' ' ARG . 35.7 mt-10 -151.38 30.28 0.61 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 0.0 110.914 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -59.72 176.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.076 -1.015 . . . . 0.0 109.637 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -103.69 139.73 38.55 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.135 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.659 HD21 ' CZ ' ' A' ' 78' ' ' PHE . 19.3 tp -160.95 150.7 17.25 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.237 -0.915 . . . . 0.0 110.465 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 85.9 m-85 -160.32 120.57 2.89 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.865 -0.522 . . . . 0.0 109.641 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.696 ' CE1' HD12 ' A' ' 64' ' ' ILE . 81.4 m-85 -89.94 113.53 25.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.101 -0.999 . . . . 0.0 110.214 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 68.5 m-85 -104.97 136.61 44.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.342 -0.849 . . . . 0.0 109.876 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.768 HG22 HG12 ' A' ' 107' ' ' ILE . 4.9 t -120.18 125.92 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.474 ' HB2' ' CG ' ' A' ' 98' ' ' HIS . 0.8 OUTLIER 46.31 39.26 6.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 110.241 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 2.3 t30 67.53 38.45 3.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.886 . . . . 0.0 110.401 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.7 t -135.51 168.51 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.305 -0.872 . . . . 0.0 109.864 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.815 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.4 mp -154.44 69.5 5.99 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.505 -0.747 . . . . 0.0 109.718 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.28 170.49 19.75 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.068 1.562 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.22 179.55 5.35 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.101 1.579 . . . . 0.0 110.36 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.511 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.69 21.62 2.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.399 -0.813 . . . . 0.0 110.559 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.7 t -95.73 39.64 1.13 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.522 -0.736 . . . . 0.0 109.791 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.81 -176.7 5.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 110.338 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 45.3 p -139.61 148.32 42.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.569 -0.707 . . . . 0.0 110.255 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.026 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -52.96 -41.47 64.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.204 -0.935 . . . . 0.0 109.946 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.534 ' CA ' ' HB3' ' A' ' 53' ' ' SER . . . -49.56 -50.07 31.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 90' ' ' THR . 2.2 pt20 -64.72 -28.95 69.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -1.146 . . . . 0.0 109.671 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.051 HD21 HD22 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -68.31 -23.12 64.7 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.318 -0.864 . . . . 0.0 109.677 179.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.881 ' CE1' HG13 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -50.07 -55.9 12.98 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.094 -1.004 . . . . 0.0 109.909 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -17.51 63.93 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.545 -1.347 . . . . 0.0 110.623 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 3.5 mt-10 -88.57 -71.75 0.57 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.17 -0.956 . . . . 0.0 113.445 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.474 ' CG ' ' HB2' ' A' ' 81' ' ' ASN . 16.3 m-70 -100.74 38.35 1.55 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.653 -1.28 . . . . 0.0 113.112 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.604 ' CG ' ' O ' ' A' ' 95' ' ' TYR . 0.0 OUTLIER -89.58 -2.03 58.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.988 -1.07 . . . . 0.0 111.029 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 60.85 43.13 12.27 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 121.739 -0.601 . . . . 0.0 110.089 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 102' ' ' ASP . 12.7 tt0 44.18 76.11 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.225 -0.922 . . . . 0.0 110.407 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 101' ' ' GLU . 2.9 t0 177.09 -147.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.323 -0.861 . . . . 0.0 110.315 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.583 ' O ' ' CD1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -122.38 71.12 1.0 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.258 -0.901 . . . . 0.0 110.311 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 1.075 ' CE2' HD11 ' A' ' 32' ' ' ILE . 0.1 OUTLIER 168.38 134.08 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.243 -0.911 . . . . 0.0 109.658 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.051 HD22 HD21 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -98.52 154.22 18.05 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.67 -1.269 . . . . 0.0 110.057 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.648 ' N ' HD12 ' A' ' 105' ' ' LEU . 62.7 m-85 -119.09 122.07 41.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.115 -0.991 . . . . 0.0 111.218 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.768 HD12 HD11 ' A' ' 105' ' ' LEU . 25.3 mt -140.26 149.42 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.364 -0.835 . . . . 0.0 109.697 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -143.29 178.69 7.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 110.116 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.936 ' OH ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -143.71 164.07 31.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.156 -0.965 . . . . 0.0 110.641 179.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.5 OUTLIER -160.05 176.27 12.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.386 -179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 6.3 p-10 -112.53 31.99 5.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 110.127 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 16.8 pt-20 -178.58 142.55 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.378 -0.827 . . . . 0.0 110.112 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.01 -18.96 16.04 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 110.409 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -141.43 170.04 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.458 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -119.21 152.03 37.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 110.167 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 51.88 -154.76 4.65 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.505 ' CG ' ' O ' ' A' ' 117' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.222 -1.163 . . . . 0.0 110.147 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.13 -38.6 39.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.166 -1.196 . . . . 0.0 109.933 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 3.8 tptt -80.87 -37.61 29.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.268 -0.895 . . . . 0.0 110.394 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -63.24 -17.91 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.068 -1.02 . . . . 0.0 109.898 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.431 ' C ' ' HD3' ' A' ' 22' ' ' ARG . 11.6 tpp180 -85.71 -57.62 2.98 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.227 -0.921 . . . . 0.0 109.64 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -49.25 -37.33 23.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.196 -0.94 . . . . 0.0 109.881 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 5.2 mmtm -84.31 -47.66 10.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.261 -0.899 . . . . 0.0 109.676 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 29.0 m-85 -112.14 65.06 0.72 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 110.867 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 47.0 Cg_endo -72.24 -4.77 15.83 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.857 1.451 . . . . 0.0 110.347 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -94.55 -6.88 42.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.19 -0.944 . . . . 0.0 110.504 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -97.29 -162.15 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.974 . . . . 0.0 110.076 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.751 HG12 HG12 ' A' ' 31' ' ' VAL . 23.7 t -145.03 107.06 4.54 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.271 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.541 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -77.33 86.24 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 124.145 1.603 . . . . 0.0 109.938 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.751 HG12 HG12 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -81.45 136.1 23.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.305 -0.872 . . . . 0.0 111.113 -179.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 47.1 mm -91.88 139.38 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.735 HG13 ' HE1' ' A' ' 109' ' ' TYR . 3.0 t -126.06 139.97 49.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 120.889 -1.132 . . . . 0.0 111.332 -178.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 2.2 tt0 -156.51 174.24 15.72 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.635 ' CD ' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -102.46 159.77 15.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.924 -1.11 . . . . 0.0 110.419 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.965 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.04 -175.29 0.17 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.478 -0.764 . . . . 0.0 109.436 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.965 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.6 Cg_endo -71.98 107.25 2.18 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.564 1.297 . . . . 0.0 109.877 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 63.46 40.05 8.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.376 -0.827 . . . . 0.0 110.026 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.78 -174.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.117 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.04 31.49 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.0 110.797 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.826 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -90.28 176.31 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.96 -1.087 . . . . 0.0 110.493 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.826 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -51.42 -173.8 0.02 OUTLIER Glycine 0 N--CA 1.499 2.853 0 O-C-N 121.308 -0.87 . . . . 0.0 111.117 -178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -71.49 -175.93 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -1.162 . . . . 0.0 109.867 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.921 HD13 ' CD ' ' A' ' 47' ' ' LYS . 1.4 pp -134.99 133.13 39.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.146 -0.972 . . . . 0.0 110.651 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.493 ' HB2' ' HD3' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -86.68 -42.32 13.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 110.219 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HD3' ' HD2' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -152.79 151.71 30.78 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.32 -0.862 . . . . 0.0 110.279 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.921 ' CD ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -111.25 49.59 0.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 109.728 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -169.55 111.17 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.519 -0.738 . . . . 0.0 109.659 179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.87 ' CD2' HD13 ' A' ' 63' ' ' LEU . 10.2 m-85 -108.36 141.05 40.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.075 -1.015 . . . . 0.0 110.37 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 mp -104.37 92.14 4.2 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.5 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 34.4 m -114.25 147.57 38.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 110.486 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.714 ' HD2' HD12 ' A' ' 55' ' ' LEU . 45.1 Cg_endo -70.96 150.33 60.71 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.815 1.429 . . . . 0.0 109.772 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.55 ' HA ' ' CA ' ' A' ' 92' ' ' GLY . 0.7 OUTLIER -65.08 -13.49 58.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.302 -0.874 . . . . 0.0 111.594 -178.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -87.72 -14.23 40.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.888 -1.132 . . . . 0.0 111.189 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.722 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.2 mt -62.14 146.16 51.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.956 -1.09 . . . . 0.0 111.503 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.49 ' OG1' ' HG3' ' A' ' 59' ' ' GLN . 3.9 p -91.28 160.05 15.71 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.638 -0.664 . . . . 0.0 109.533 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.728 HG12 HG22 ' A' ' 87' ' ' THR . 63.5 t -60.01 -22.04 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.016 . . . . 0.0 110.043 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.83 -39.72 64.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.722 ' CB ' HD22 ' A' ' 55' ' ' LEU . 1.5 mm-40 -67.96 -48.64 65.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -1.173 . . . . 0.0 109.987 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.122 ' CE2' HD11 ' A' ' 64' ' ' ILE . 47.2 t80 -60.41 -44.21 95.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.211 -0.996 . . . . 0.0 109.569 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.683 ' CE2' ' CD2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -53.24 -26.53 18.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.934 -1.104 . . . . 0.0 109.706 179.356 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -73.97 -47.74 35.28 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.398 -0.814 . . . . 0.0 109.668 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.088 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.2 pp -66.43 -17.16 64.63 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 118.971 -1.091 . . . . 0.0 112.013 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.122 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.1 mt -89.33 -41.07 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 120.046 -1.659 . . . . 0.0 109.398 178.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.554 ' CG ' ' N ' ' A' ' 66' ' ' LYS . 2.2 ptm180 -39.64 -46.28 1.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.547 -0.721 . . . . 0.0 110.616 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.554 ' N ' ' CG ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -72.81 -36.9 67.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.984 -1.073 . . . . 0.0 109.814 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.519 ' CB ' ' OH ' ' A' ' 49' ' ' TYR . 5.8 mmp_? -69.41 -10.12 56.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.302 -0.874 . . . . 0.0 109.857 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.795 HG21 HD23 ' A' ' 70' ' ' LEU . 45.1 mt -104.03 7.77 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 110.006 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.534 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 50.07 31.29 4.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.363 -0.835 . . . . 0.0 110.308 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.906 HD12 ' O ' ' A' ' 70' ' ' LEU . 2.9 pp -103.56 156.28 17.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 0.0 109.607 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -165.37 -165.15 0.82 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.036 -1.04 . . . . 0.0 110.941 -179.001 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 51.04 -90.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.782 . . . . 0.0 110.601 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 71' ' ' ARG . 4.6 pt-20 -156.41 26.1 0.35 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 111.037 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.523 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -48.04 176.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.063 -1.023 . . . . 0.0 110.002 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.523 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -110.98 142.99 42.37 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.137 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.971 HD21 ' CE1' ' A' ' 78' ' ' PHE . 21.8 tp -156.16 155.49 32.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 0.0 110.545 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' O ' ' CE1' ' A' ' 79' ' ' PHE . 19.4 m-85 -152.83 123.28 7.2 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.548 -0.72 . . . . 0.0 109.818 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.971 ' CE1' HD21 ' A' ' 76' ' ' LEU . 21.3 m-30 -88.17 135.85 33.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.255 -0.903 . . . . 0.0 111.273 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.571 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 54.0 m-85 -120.33 119.0 31.85 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.852 HG22 HG23 ' A' ' 107' ' ' ILE . 2.0 t -121.25 112.43 35.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 O-C-N 121.357 -0.839 . . . . 0.0 110.304 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.645 ' O ' HG23 ' A' ' 83' ' ' VAL . 13.4 t-20 59.96 42.22 16.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 0.0 110.22 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.92 34.49 14.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.662 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -134.47 168.02 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 0.0 109.994 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.0 OUTLIER -155.02 67.5 5.23 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.599 -0.688 . . . . 0.0 109.581 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.86 160.04 46.93 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.922 1.485 . . . . 0.0 110.665 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.82 -178.91 3.38 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.038 1.547 . . . . 0.0 110.65 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.728 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -85.85 20.53 2.17 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.459 -0.776 . . . . 0.0 110.618 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.3 t -95.37 42.76 1.09 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.443 -0.786 . . . . 0.0 109.507 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.13 -169.69 3.25 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.663 0.744 . . . . 0.0 110.3 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 45.0 p -139.24 143.1 37.84 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.687 -0.633 . . . . 0.0 109.935 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.01 ' HA ' HD23 ' A' ' 94' ' ' LEU . 25.4 mmm -50.88 -45.15 59.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.912 . . . . 0.0 109.545 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.55 ' CA ' ' HA ' ' A' ' 53' ' ' SER . . . -49.55 -48.54 34.99 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 90' ' ' THR . 0.1 OUTLIER -64.59 -31.76 73.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -1.136 . . . . 0.0 110.106 -179.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.018 HD11 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -68.54 -23.17 64.49 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.115 -0.991 . . . . 0.0 110.133 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.541 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -48.64 -53.45 18.58 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.756 -1.178 . . . . 0.0 109.519 -179.435 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.12 -20.98 63.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.194 -0.941 . . . . 0.0 111.291 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 14.8 mt-10 -84.27 -63.99 1.24 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.014 -1.054 . . . . 0.0 112.06 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.58 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 7.5 m-70 -97.41 40.62 1.15 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.966 -1.084 . . . . 0.0 110.779 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.479 ' CD2' ' O ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER -68.24 -174.45 0.51 Allowed 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.08 -162.16 1.18 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.858 -1.151 . . . . 0.0 110.523 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.43 1.88 12.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.366 -0.834 . . . . 0.0 110.129 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 104' ' ' PHE . 0.3 OUTLIER -135.44 146.15 47.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 109.92 179.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.448 ' C ' ' O ' ' A' ' 102' ' ' ASP . 15.1 m-85 -39.42 -27.81 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.471 -0.768 . . . . 0.0 110.453 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' ASP . 4.4 m-85 -77.6 155.04 31.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.06 -1.025 . . . . 0.0 110.493 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.056 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.3 OUTLIER -103.04 171.09 7.58 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.717 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.2 m-85 -118.14 126.89 53.12 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.402 -1.436 . . . . 0.0 112.211 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.056 ' CG1' HD11 ' A' ' 105' ' ' LEU . 4.1 mt -141.58 144.63 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.366 -0.834 . . . . 0.0 110.225 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -146.62 163.05 37.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.192 -0.943 . . . . 0.0 109.372 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.735 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.4 p90 -134.09 165.73 24.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.646 -1.284 . . . . 0.0 111.278 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.463 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -159.22 177.25 11.25 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.483 -179.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.473 ' HB2' HG22 ' A' ' 41' ' ' ILE . 11.9 t0 -126.66 37.54 4.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.302 -0.874 . . . . 0.0 109.922 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 4.6 mt-10 62.06 132.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.871 . . . . 0.0 110.165 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.34 48.24 2.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 110.306 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 116' ' ' GLY . 9.6 p -47.2 168.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.944 . . . . 0.0 110.206 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -53.46 89.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 114' ' ' VAL . . . -156.4 167.7 33.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.26 -1.141 . . . . 0.0 110.226 -179.989 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -47.79 -33.22 6.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.339 -1.095 . . . . 0.0 110.08 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -78.44 -38.44 41.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.229 -0.92 . . . . 0.0 110.086 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.466 ' HA ' HD13 ' A' ' 21' ' ' ILE . 9.9 mm -60.15 -19.87 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.227 -0.921 . . . . 0.0 110.089 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.497 ' HD2' ' N ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -89.22 -44.22 10.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 110.16 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -53.6 -43.86 68.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.961 . . . . 0.0 109.142 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.465 ' C ' ' HD3' ' A' ' 26' ' ' PRO . 5.4 mtpt -85.62 -48.83 8.51 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.565 -0.71 . . . . 0.0 109.975 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.538 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 6.1 m-85 -115.43 62.49 1.75 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.256 -0.903 . . . . 0.0 110.147 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.487 ' CD ' ' O ' ' A' ' 22' ' ' ARG . 44.3 Cg_endo -70.12 -19.86 33.89 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.837 1.44 . . . . 0.0 110.543 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -111.65 24.84 12.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.214 -0.929 . . . . 0.0 110.021 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.538 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 5.4 mpt_? -118.86 179.82 4.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.14 -0.975 . . . . 0.0 110.777 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.754 HG12 HG12 ' A' ' 31' ' ' VAL . 17.3 t -148.02 116.97 4.15 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.383 -0.823 . . . . 0.0 110.203 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 50.3 Cg_endo -79.35 90.96 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 124.257 1.661 . . . . 0.0 110.005 179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.754 HG12 HG12 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -88.55 138.66 18.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.164 -0.96 . . . . 0.0 110.559 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.543 HG13 ' CE1' ' A' ' 104' ' ' PHE . 24.8 mm -95.95 152.82 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 108.901 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.782 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.6 t -133.6 141.83 43.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 120.965 -1.084 . . . . 0.0 111.109 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -157.27 -166.76 2.13 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' HD2' HG12 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -124.56 160.77 27.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.885 -1.135 . . . . 0.0 110.508 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.015 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -61.63 -167.81 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.015 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.1 Cg_endo -71.72 123.64 9.57 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.189 1.099 . . . . 0.0 109.673 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.669 ' HG2' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 40.55 49.54 2.7 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.599 0.714 . . . . 0.0 110.549 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.09 -179.11 0.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.603 -0.686 . . . . 0.0 110.126 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.33 36.18 0.66 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.699 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 111' ' ' ASP . 1.8 pp -85.18 177.87 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.025 -1.047 . . . . 0.0 110.378 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.822 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -47.9 -179.58 0.01 OUTLIER Glycine 0 N--CA 1.497 2.718 0 C-N-CA 120.488 -0.863 . . . . 0.0 110.997 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.963 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -75.85 -179.28 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -1.171 . . . . 0.0 110.071 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.963 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.6 mm? -136.17 134.8 38.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.164 -0.96 . . . . 0.0 110.579 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.462 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 29.7 t0 -86.49 -36.96 18.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.436 -0.79 . . . . 0.0 110.099 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -152.83 154.44 35.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.379 -0.826 . . . . 0.0 110.2 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.665 ' HG3' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -117.69 46.42 1.74 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.12 -0.987 . . . . 0.0 109.818 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -164.51 109.66 0.97 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.423 -0.798 . . . . 0.0 109.965 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.926 ' CD2' HD13 ' A' ' 63' ' ' LEU . 16.3 m-85 -108.14 139.6 42.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.04 -1.038 . . . . 0.0 110.12 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.85 99.63 8.51 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.93 ' HB ' HD12 ' A' ' 55' ' ' LEU . 5.1 m -126.14 160.03 59.3 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.046 -1.034 . . . . 0.0 110.861 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.481 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 42.3 Cg_endo -67.69 144.98 67.99 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.052 1.553 . . . . 0.0 110.434 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.572 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.4 OUTLIER -63.5 -14.0 46.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.446 -0.784 . . . . 0.0 111.441 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -83.73 -10.36 58.19 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.96 -1.088 . . . . 0.0 110.945 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.93 HD12 ' HB ' ' A' ' 51' ' ' VAL . 4.1 mt -62.22 141.32 58.27 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.003 -1.06 . . . . 0.0 111.027 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 1.4 p -91.44 169.15 11.02 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.703 -0.623 . . . . 0.0 109.827 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.829 ' CG1' HG22 ' A' ' 87' ' ' THR . 95.3 t -61.93 -26.63 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.307 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.88 -39.61 75.33 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.211 -1.155 . . . . 0.0 110.211 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.912 ' CB ' HD22 ' A' ' 55' ' ' LEU . 5.3 mm-40 -67.67 -48.56 66.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.1 -1.236 . . . . 0.0 110.101 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.176 ' CE2' HD11 ' A' ' 64' ' ' ILE . 24.0 t80 -60.45 -46.43 90.1 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.469 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -50.51 -23.62 2.62 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.888 -1.132 . . . . 0.0 109.928 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -78.79 -51.79 9.26 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.394 -0.816 . . . . 0.0 110.138 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.047 HD11 ' CE1' ' A' ' 60' ' ' PHE . 4.0 pp -63.54 -17.83 63.22 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.99 -1.084 . . . . 0.0 112.432 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.176 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.6 mt -91.82 -39.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 120.01 -1.681 . . . . 0.0 109.059 177.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.459 ' C ' ' O ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -35.43 -64.66 0.27 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.086 0.47 . . . . 0.0 110.961 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.02 -31.4 72.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.134 -0.979 . . . . 0.0 110.208 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.695 ' O ' HD13 ' A' ' 44' ' ' LEU . 28.6 mmt-85 -68.21 -16.79 64.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 110.066 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.909 ' CG2' HD23 ' A' ' 70' ' ' LEU . 1.2 mm -97.44 8.74 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.601 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.491 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER 57.04 30.17 17.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 110.317 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.909 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.3 pp -117.61 154.84 30.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.428 -0.795 . . . . 0.0 109.917 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.1 OUTLIER -166.25 -169.07 1.34 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.235 -0.916 . . . . 0.0 111.046 -179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 49.74 -92.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.523 -0.736 . . . . 0.0 111.015 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' O ' ' CG ' ' A' ' 73' ' ' GLU . 0.7 OUTLIER -142.5 45.9 1.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 111.039 -179.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.518 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -72.85 176.32 5.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.889 -1.132 . . . . 0.0 109.803 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.518 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.38 140.32 38.67 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.157 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.742 HD21 ' CE1' ' A' ' 78' ' ' PHE . 44.6 tp -164.3 153.27 13.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 110.591 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 74.4 m-85 -158.01 119.91 3.65 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.703 -0.623 . . . . 0.0 109.621 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.742 ' CE1' HD21 ' A' ' 76' ' ' LEU . 16.7 m-30 -83.5 134.7 34.83 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.155 -0.965 . . . . 0.0 111.977 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 77' ' ' PHE . 50.1 m-85 -121.17 123.35 42.06 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.551 ' CG1' ' CD2' ' A' ' 98' ' ' HIS . 2.1 t -120.49 119.85 60.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 O-C-N 121.201 -0.937 . . . . 0.0 110.077 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.571 ' O ' HG23 ' A' ' 83' ' ' VAL . 26.4 t30 50.91 39.05 21.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.1 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 64.95 35.2 8.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.26 -0.9 . . . . 0.0 110.239 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.68 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 t -135.41 168.41 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.306 -0.871 . . . . 0.0 109.931 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.808 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.3 mp -154.37 72.84 6.18 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.554 -0.716 . . . . 0.0 109.533 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.12 165.64 32.18 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.072 1.564 . . . . 0.0 110.662 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.47 ' HG2' ' OG ' ' A' ' 88' ' ' SER . 45.9 Cg_endo -72.85 178.31 6.56 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.044 1.55 . . . . 0.0 110.348 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.829 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -87.56 21.59 2.49 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.47 ' OG ' ' HG2' ' A' ' 86' ' ' PRO . 3.0 p -93.04 39.68 1.05 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.464 -0.772 . . . . 0.0 109.61 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.5 -172.91 3.98 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.684 0.754 . . . . 0.0 110.275 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.483 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 64.2 p -138.95 145.8 40.21 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.501 0.667 . . . . 0.0 110.016 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.017 ' HA ' HD23 ' A' ' 94' ' ' LEU . 4.3 mmm -51.42 -39.76 57.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.91 . . . . 0.0 110.232 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.572 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -51.83 -49.96 45.81 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -64.6 -26.48 68.42 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.35 -1.088 . . . . 0.0 109.628 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.017 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -69.02 -25.52 64.53 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.302 -0.874 . . . . 0.0 110.044 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.589 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -49.12 -56.0 10.5 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.824 -1.173 . . . . 0.0 109.652 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -70.14 -18.32 63.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.992 -1.067 . . . . 0.0 111.2 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 14.0 mt-10 -87.75 -67.05 0.85 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.983 -1.073 . . . . 0.0 112.789 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.551 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 12.9 m-70 -98.6 36.96 1.55 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.795 -1.19 . . . . 0.0 112.315 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.518 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -68.89 167.98 14.54 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.126 -0.984 . . . . 0.0 109.422 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 99' ' ' HIS . 0.1 OUTLIER -176.78 164.74 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.754 -1.216 . . . . 0.0 110.792 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 104' ' ' PHE . 0.9 OUTLIER 47.03 -124.94 1.55 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.419 -0.801 . . . . 0.0 110.349 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.529 ' HB2' ' CD2' ' A' ' 104' ' ' PHE . 6.0 m-20 -59.85 -134.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.95 -1.094 . . . . 0.0 110.403 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.48 ' CD1' ' NH1' ' A' ' 22' ' ' ARG . 18.0 p90 -106.59 13.35 28.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.007 -1.058 . . . . 0.0 110.523 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 101' ' ' GLU . 7.5 p90 -98.08 -176.23 3.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.111 -0.993 . . . . 0.0 109.874 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.071 HD11 ' CD1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.8 168.37 9.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.989 -1.07 . . . . 0.0 110.304 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.705 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -122.11 133.76 54.76 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.926 -1.109 . . . . 0.0 110.727 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.071 ' CD1' HD11 ' A' ' 105' ' ' LEU . 4.6 mt -138.86 137.16 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.316 -0.865 . . . . 0.0 110.289 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -139.16 145.01 38.84 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.236 -0.915 . . . . 0.0 108.778 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.782 ' HE1' HG13 ' A' ' 33' ' ' VAL . 2.9 p90 -130.2 170.96 13.4 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.54 -1.35 . . . . 0.0 111.924 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.91 179.78 8.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.845 -0.535 . . . . 0.0 110.063 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.93 ' HB3' HG22 ' A' ' 41' ' ' ILE . 8.8 p-10 -121.11 36.68 4.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.214 -0.928 . . . . 0.0 110.268 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.18 154.22 47.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -0.93 . . . . 0.0 110.257 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.46 31.97 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.286 -0.884 . . . . 0.0 110.136 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 115' ' ' TYR . 9.9 p -52.08 176.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.88 . . . . 0.0 110.291 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.568 ' H ' HG22 ' A' ' 114' ' ' VAL . 42.7 t80 -78.54 135.67 37.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 110.21 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.58 -155.06 7.73 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.248 -1.149 . . . . 0.0 110.222 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.439 ' O ' ' HB ' ' A' ' 21' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -49.66 -39.36 36.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.17 -1.194 . . . . 0.0 110.203 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 6.0 mtpt -76.2 -28.62 57.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.253 -0.904 . . . . 0.0 110.373 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 25' ' ' TYR . 1.2 mp -61.08 -17.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.0 109.813 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -88.4 -51.4 5.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.44 -42.5 43.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.438 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 24.6 mttm -85.44 -47.41 9.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.471 -0.768 . . . . 0.0 109.904 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.498 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 9.9 m-85 -113.77 61.8 0.97 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 0.0 110.345 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.477 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 43.7 Cg_endo -69.66 -25.33 29.14 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.816 1.43 . . . . 0.0 110.666 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.76 19.78 19.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 110.282 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.498 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -107.78 -163.14 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.964 . . . . 0.0 110.307 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.657 HG13 ' CD1' ' A' ' 95' ' ' TYR . 23.2 t -144.51 109.73 4.89 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 110.188 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.585 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 48.6 Cg_endo -76.02 96.14 1.05 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.162 1.611 . . . . 0.0 110.18 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.733 ' HB ' HD21 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -90.9 145.92 6.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.354 -0.841 . . . . 0.0 110.626 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 1.1 mp -100.25 156.03 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.812 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.3 t -133.19 136.36 55.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.034 -1.041 . . . . 0.0 110.972 -179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' O ' ' HB1' ' A' ' 108' ' ' ALA . 2.1 mt-10 -148.65 177.23 9.68 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.759 -0.588 . . . . 0.0 109.454 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.619 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -112.82 158.15 20.49 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.898 -1.126 . . . . 0.0 110.614 -179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -63.9 -169.31 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.556 -0.715 . . . . 0.0 109.24 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.0 Cg_endo -73.54 109.45 2.85 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.31 1.163 . . . . 0.0 110.197 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.23 41.49 6.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.365 -0.834 . . . . 0.0 110.433 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.554 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -61.44 174.47 0.73 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -0.945 . . . . 0.0 109.804 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.58 34.56 0.62 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.0 111.092 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -87.66 -175.84 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.848 -1.158 . . . . 0.0 110.033 179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.505 ' O ' HD13 ' A' ' 41' ' ' ILE . . . -49.07 178.25 0.01 OUTLIER Glycine 0 N--CA 1.495 2.602 0 C-N-CA 119.954 -1.117 . . . . 0.0 110.328 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.971 ' O ' HD22 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -82.5 -176.81 6.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -1.156 . . . . 0.0 109.777 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.971 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.5 mm? -137.18 131.8 33.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 110.782 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -86.84 -26.78 23.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -0.825 . . . . 0.0 109.429 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.475 ' O ' ' HD2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -152.67 154.31 35.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.457 -0.777 . . . . 0.0 109.798 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -120.05 44.73 2.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.032 -1.042 . . . . 0.0 109.945 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.525 ' O ' ' CG ' ' A' ' 48' ' ' LYS . 8.9 pttp -159.0 111.2 2.18 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.355 -0.841 . . . . 0.0 109.497 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.719 ' HD2' HD13 ' A' ' 63' ' ' LEU . 12.0 m-85 -103.86 140.09 38.16 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.992 -1.067 . . . . 0.0 110.335 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' A' ' 50' ' ' LEU . 3.6 mm? -102.05 92.3 4.71 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.943 HG21 ' HE3' ' A' ' 91' ' ' MET . 26.9 m -116.02 142.42 29.16 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.178 -0.951 . . . . 0.0 110.898 -178.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 28' ' ' ARG . 42.2 Cg_endo -67.49 148.87 79.72 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.103 1.58 . . . . 0.0 109.956 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.565 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 2.0 m -63.12 -13.94 42.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 0.0 111.614 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -83.37 -14.8 52.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.111 -0.993 . . . . 0.0 110.888 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.864 HD22 ' CB ' ' A' ' 59' ' ' GLN . 4.7 mt -62.65 142.67 57.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.021 -1.05 . . . . 0.0 111.424 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 89' ' ' ALA . 3.2 p -90.97 163.97 14.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.637 -0.665 . . . . 0.0 109.288 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.542 HG12 HG22 ' A' ' 87' ' ' THR . 39.2 t -61.52 -24.6 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.957 -1.089 . . . . 0.0 110.086 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.07 -31.98 66.23 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.864 ' CB ' HD22 ' A' ' 55' ' ' LEU . 5.2 mm100 -74.6 -47.82 30.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -1.214 . . . . 0.0 109.886 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.057 ' CD1' HD11 ' A' ' 63' ' ' LEU . 38.9 t80 -60.2 -32.59 71.24 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.287 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.545 ' HE1' HD23 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -60.72 -31.92 71.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 109.567 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 3.7 t80 -71.74 -52.87 15.52 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.54 -0.725 . . . . 0.0 110.993 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.057 HD11 ' CD1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -59.67 -35.09 73.75 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.834 -1.167 . . . . 0.0 112.57 -178.206 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.026 HD11 ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -77.7 -32.19 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 119.657 -1.902 . . . . 0.0 109.394 178.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.93 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -39.81 -64.08 0.52 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.512 -0.742 . . . . 0.0 110.624 -179.32 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.25 -30.31 71.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.164 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.47 ' C ' HD13 ' A' ' 68' ' ' ILE . 5.8 mmp_? -67.7 -17.42 64.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.011 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.806 HD12 HD21 ' A' ' 44' ' ' LEU . 2.7 mm -104.44 15.86 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.9 . . . . 0.0 109.793 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.475 ' HB2' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER 49.99 28.84 3.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.587 -0.695 . . . . 0.0 110.655 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.93 HD11 ' HG2' ' A' ' 65' ' ' ARG . 4.2 pp -111.0 155.06 23.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.357 -0.839 . . . . 0.0 109.783 179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.0 -173.41 2.63 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.923 -179.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 52.11 -91.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.469 -0.77 . . . . 0.0 110.784 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -146.31 36.61 1.0 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.995 . . . . 0.0 111.051 -179.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -60.05 176.65 0.3 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.078 -1.013 . . . . 0.0 109.825 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -94.23 138.25 32.46 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.175 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.553 ' O ' ' CG ' ' A' ' 77' ' ' PHE . 20.3 tp -164.78 152.05 11.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.399 -0.813 . . . . 0.0 110.596 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 79' ' ' PHE . 81.7 m-85 -158.35 119.9 3.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.578 -0.701 . . . . 0.0 109.757 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.906 ' CZ ' HD12 ' A' ' 64' ' ' ILE . 10.7 m-85 -90.44 124.08 34.68 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.178 -0.951 . . . . 0.0 110.862 -179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 77' ' ' PHE . 68.3 m-85 -115.5 127.29 55.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 109.307 178.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.77 HG22 HG12 ' A' ' 107' ' ' ILE . 2.8 t -121.25 121.93 66.11 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.503 -0.748 . . . . 0.0 109.959 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.802 ' O ' HG23 ' A' ' 83' ' ' VAL . 0.8 OUTLIER 47.7 47.26 18.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.067 -1.021 . . . . 0.0 110.119 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 81' ' ' ASN . 18.8 m120 57.22 36.84 27.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 110.491 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.802 HG23 ' O ' ' A' ' 81' ' ' ASN . 2.6 t -135.3 168.0 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.17 -0.956 . . . . 0.0 109.772 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.816 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -155.02 73.74 5.66 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.539 -0.725 . . . . 0.0 109.524 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.55 165.37 31.81 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.095 1.576 . . . . 0.0 110.767 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.51 -178.86 3.97 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.046 1.551 . . . . 0.0 110.435 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.542 HG22 HG12 ' A' ' 57' ' ' VAL . 0.8 OUTLIER -86.1 20.57 2.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.223 -0.923 . . . . 0.0 110.593 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.7 t -95.85 41.55 1.1 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.504 -0.748 . . . . 0.0 109.527 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 56' ' ' THR . . . -145.55 -175.1 4.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.496 -0.752 . . . . 0.0 110.287 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.525 ' O ' ' HG2' ' A' ' 93' ' ' GLN . 77.7 p -139.45 138.24 36.29 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.601 0.715 . . . . 0.0 110.229 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.05 ' HA ' HD23 ' A' ' 94' ' ' LEU . 2.7 mmm -45.72 -39.24 7.83 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.966 -1.084 . . . . 0.0 109.842 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.565 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -49.83 -53.03 23.62 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.972 -1.109 . . . . 0.0 110.439 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.529 ' HG3' ' N ' ' A' ' 94' ' ' LEU . 2.6 pt20 -64.13 -27.03 68.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.089 -1.242 . . . . 0.0 110.008 -179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.05 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.2 OUTLIER -68.36 -25.97 65.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.21 -0.931 . . . . 0.0 109.929 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.657 ' CD1' HG13 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -50.03 -55.5 14.52 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.855 -1.153 . . . . 0.0 109.698 -179.434 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.632 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 2.0 mt-30 -69.41 -18.44 63.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.951 -1.093 . . . . 0.0 110.974 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 10.5 mt-10 -88.38 -68.36 0.77 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.012 -1.055 . . . . 0.0 113.13 -177.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.49 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 11.4 m-70 -99.35 38.05 1.48 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 120.703 -1.248 . . . . 0.0 112.795 -176.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.632 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -82.53 165.98 19.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.995 -1.065 . . . . 0.0 109.856 178.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.478 ' CB ' ' O ' ' A' ' 99' ' ' HIS . 0.3 OUTLIER 169.54 154.02 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.882 -1.136 . . . . 0.0 110.332 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 100' ' ' GLU . 3.9 mt-10 57.98 117.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 110.223 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.551 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 73.3 m-20 56.12 -122.66 1.78 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.264 -0.898 . . . . 0.0 109.948 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -137.86 33.42 2.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.798 -1.189 . . . . 0.0 109.895 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 102' ' ' ASP . 8.8 m-85 -117.36 169.09 9.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.24 -0.912 . . . . 0.0 110.468 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.8 HD13 HD11 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -101.99 165.29 11.25 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.374 -0.829 . . . . 0.0 109.301 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.617 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -122.9 123.82 41.82 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.77 -1.206 . . . . 0.0 111.165 -179.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.77 HG12 HG22 ' A' ' 80' ' ' VAL . 10.9 mt -141.97 147.66 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.204 -0.935 . . . . 0.0 109.82 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 34' ' ' GLU . . . -147.18 -179.57 6.92 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.145 -0.972 . . . . 0.0 110.159 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.812 ' HE1' HG13 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -140.97 162.26 35.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.945 -1.097 . . . . 0.0 111.418 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' A' ' 36' ' ' ALA . 6.8 t -148.0 -177.81 5.94 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 3.0 p-10 -116.66 29.96 7.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.268 -0.895 . . . . 0.0 110.53 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 4.7 pt-20 -178.98 160.4 1.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.323 -0.861 . . . . 0.0 110.519 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.0 t -160.06 34.93 0.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.417 -0.802 . . . . 0.0 110.09 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.424 HG22 ' N ' ' A' ' 115' ' ' TYR . 10.0 p -48.34 169.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -0.947 . . . . 0.0 110.213 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.439 ' CD2' ' O ' ' A' ' 115' ' ' TYR . 67.9 t80 -56.99 92.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 110.139 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.2 -151.67 6.31 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.251 -1.146 . . . . 0.0 110.257 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -49.03 -38.39 23.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -1.171 . . . . 0.0 110.135 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -75.48 -34.12 60.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 110.363 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -59.97 -17.54 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.164 -0.96 . . . . 0.0 109.74 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -50.48 9.41 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.989 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -56.73 -42.9 80.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.31 -0.869 . . . . 0.0 110.032 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 2.0 mtpm? -76.78 -43.3 37.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.274 -0.891 . . . . 0.0 109.716 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 21' ' ' ILE . 44.9 m-85 -114.07 62.59 1.13 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.373 -0.829 . . . . 0.0 110.728 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.487 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 47.3 Cg_endo -72.37 -11.53 26.71 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.811 1.427 . . . . 0.0 110.441 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' C ' ' HD2' ' A' ' 28' ' ' ARG . 1.2 t0 -102.08 9.45 40.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.22 -0.925 . . . . 0.0 110.32 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.423 ' HD2' ' C ' ' A' ' 27' ' ' ASP . 6.0 mpt_? -106.9 -169.87 1.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.897 . . . . 0.0 110.152 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.783 HG12 HG12 ' A' ' 31' ' ' VAL . 21.8 t -147.24 107.78 3.89 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 110.39 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.501 ' O ' ' HB3' ' A' ' 104' ' ' PHE . 49.3 Cg_endo -77.78 90.85 1.22 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 124.253 1.66 . . . . 0.0 110.029 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.783 HG12 HG12 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -90.85 133.49 32.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 111.215 -179.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 44.0 mm -95.68 133.76 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.132 -0.98 . . . . 0.0 108.438 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -126.85 128.26 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.711 -1.243 . . . . 0.0 111.866 -178.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 3.1 tm-20 -132.62 159.5 39.37 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.7 ' CE ' HD11 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -87.55 163.38 16.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.867 -1.146 . . . . 0.0 110.863 -179.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.994 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -65.47 -174.82 0.16 Allowed Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.621 -0.674 . . . . 0.0 109.62 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.994 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 44.1 Cg_endo -72.85 116.61 4.78 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.638 1.336 . . . . 0.0 110.046 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER 63.88 42.25 6.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.341 -0.849 . . . . 0.0 110.463 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.589 ' CB ' ' CG ' ' A' ' 35' ' ' LYS . . . -65.49 175.09 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.0 110.075 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.28 33.17 0.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 110.669 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.832 HD12 ' O ' ' A' ' 42' ' ' GLY . 1.9 pp -95.35 177.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.023 -1.048 . . . . 0.0 110.247 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.832 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -42.41 169.52 0.01 OUTLIER Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.093 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 1.003 ' O ' HD22 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -78.75 -176.48 4.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -1.195 . . . . 0.0 110.066 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.003 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.2 mm? -139.4 135.84 34.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.898 . . . . 0.0 110.562 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -86.49 -29.7 22.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.369 -0.832 . . . . 0.0 109.534 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -153.68 150.17 28.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 179.778 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.512 ' HA ' HG12 ' A' ' 33' ' ' VAL . 0.3 OUTLIER -111.47 47.14 1.04 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.9 -1.125 . . . . 0.0 109.942 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -159.41 111.71 2.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.588 -0.695 . . . . 0.0 109.244 179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.765 ' CD2' HD13 ' A' ' 63' ' ' LEU . 19.6 m-85 -103.76 141.12 36.64 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.022 -1.049 . . . . 0.0 110.351 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tp -108.01 93.09 4.35 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.92 ' HB ' HD12 ' A' ' 55' ' ' LEU . 9.5 m -117.86 154.06 51.1 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.342 -0.849 . . . . 0.0 110.721 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.6 Cg_endo -70.34 147.01 58.22 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.085 1.571 . . . . 0.0 109.888 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.552 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.3 m -62.38 -14.8 44.09 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 0.0 111.488 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -84.12 -12.4 55.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.025 -1.047 . . . . 0.0 111.331 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.92 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.8 mt -62.12 142.0 57.84 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.898 -1.126 . . . . 0.0 111.257 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.42 ' HA ' HG22 ' A' ' 90' ' ' THR . 1.1 p -91.61 164.78 13.64 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.586 -0.696 . . . . 0.0 109.448 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.726 HG12 HG22 ' A' ' 87' ' ' THR . 93.4 t -60.87 -21.11 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.868 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.33 59.04 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.907 ' CB ' HD22 ' A' ' 55' ' ' LEU . 4.3 mm-40 -67.64 -47.98 68.04 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.164 -1.198 . . . . 0.0 109.845 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.191 ' CE2' HD11 ' A' ' 64' ' ' ILE . 34.8 t80 -60.82 -42.82 98.44 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.196 -1.001 . . . . 0.0 109.492 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -54.36 -22.56 12.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.752 -1.218 . . . . 0.0 109.838 179.27 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -79.39 -54.51 5.87 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.473 -0.767 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.925 HD11 ' CE1' ' A' ' 60' ' ' PHE . 1.2 pp -59.64 -25.94 65.1 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.833 -1.167 . . . . 0.0 112.102 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.191 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.7 mt -84.13 -42.45 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 119.997 -1.689 . . . . 0.0 108.844 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.475 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 1.8 mtp-105 -36.49 -60.58 0.58 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.017 0.436 . . . . 0.0 110.721 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -66.94 -32.7 74.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.831 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 64' ' ' ILE . 6.0 mmt-85 -69.34 -10.27 57.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.166 -0.959 . . . . 0.0 109.262 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.771 HG21 HD23 ' A' ' 70' ' ' LEU . 62.1 mt -103.97 13.21 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.474 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.56 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.6 OUTLIER 44.67 31.97 0.71 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.44 -0.787 . . . . 0.0 110.344 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.848 ' O ' HD12 ' A' ' 70' ' ' LEU . 3.8 pp -104.9 153.55 21.24 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.893 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' GLU . 14.3 ptt180 -166.06 -168.45 1.26 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -0.934 . . . . 0.0 111.033 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 49.85 -92.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.507 -0.746 . . . . 0.0 110.858 179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 8.4 pt-20 -143.37 40.49 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 110.834 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.519 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -64.69 176.62 1.1 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.083 -1.011 . . . . 0.0 109.799 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -115.1 140.17 49.29 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.268 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.758 HD21 ' CE1' ' A' ' 78' ' ' PHE . 43.3 tp -157.6 150.7 23.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 110.532 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 80.9 m-85 -158.82 121.36 3.62 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.762 -0.586 . . . . 0.0 109.943 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.758 ' CE1' HD21 ' A' ' 76' ' ' LEU . 18.3 m-30 -88.09 128.16 35.42 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.061 -1.024 . . . . 0.0 110.963 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 77' ' ' PHE . 60.7 m-85 -115.98 128.61 55.87 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 108.984 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.869 HG11 ' CD2' ' A' ' 98' ' ' HIS . 2.3 t -120.4 128.71 76.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.149 -0.97 . . . . 0.0 110.27 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.539 ' OD1' ' CG2' ' A' ' 83' ' ' VAL . 5.6 p30 43.11 35.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.342 -0.849 . . . . 0.0 110.151 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 1.4 m-20 73.69 39.45 0.55 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.598 -0.689 . . . . 0.0 111.311 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.688 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.8 t -136.33 168.36 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.0 110.047 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.814 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.96 68.71 5.54 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.58 -0.7 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.05 164.36 35.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.992 1.522 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.479 ' HG2' ' OG ' ' A' ' 88' ' ' SER . 44.2 Cg_endo -71.92 179.09 5.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.144 1.602 . . . . 0.0 110.583 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.726 HG22 HG12 ' A' ' 57' ' ' VAL . 1.1 p -87.03 20.35 2.71 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.322 -0.861 . . . . 0.0 110.842 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.479 ' OG ' ' HG2' ' A' ' 86' ' ' PRO . 2.2 p -90.53 39.9 0.99 Allowed 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.447 -0.783 . . . . 0.0 109.475 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.38 -174.39 4.37 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.589 0.709 . . . . 0.0 110.006 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.481 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 82.2 p -139.59 152.84 47.15 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.462 -0.773 . . . . 0.0 110.318 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.025 ' HA ' HD23 ' A' ' 94' ' ' LEU . 43.8 mmm -56.57 -41.73 77.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.388 -0.82 . . . . 0.0 109.926 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -52.04 -48.16 52.89 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -65.28 -27.13 68.41 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.407 -1.055 . . . . 0.0 109.657 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.06 HD11 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -69.02 -23.82 64.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.263 -0.898 . . . . 0.0 109.907 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.591 ' O ' ' CG ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER -49.26 -56.65 8.69 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.851 -1.156 . . . . 0.0 109.434 -179.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.597 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . 11.9 tt0 -70.94 -16.09 62.64 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.836 -1.165 . . . . 0.0 111.373 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER -87.97 -63.31 1.32 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.994 -1.066 . . . . 0.0 113.626 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.869 ' CD2' HG11 ' A' ' 80' ' ' VAL . 9.3 m-70 -98.03 35.89 1.66 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.757 -1.214 . . . . 0.0 112.624 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.597 ' CD2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -107.81 174.88 5.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 110.312 178.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 99' ' ' HIS . 0.1 OUTLIER 175.16 93.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.738 -1.226 . . . . 0.0 110.083 -179.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 103' ' ' PHE . 32.9 mt-10 43.84 -137.29 0.39 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.764 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 103' ' ' PHE . 10.1 t70 51.75 -89.15 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.06 -1.025 . . . . 0.0 110.275 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 101' ' ' GLU . 0.1 OUTLIER 174.29 -64.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.211 -0.931 . . . . 0.0 110.51 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' PRO . 5.6 m-85 -92.64 -174.85 3.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.377 -0.827 . . . . 0.0 110.582 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.06 HD22 HD11 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -99.02 166.08 11.44 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.291 -0.881 . . . . 0.0 109.12 179.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.797 ' N ' HD12 ' A' ' 105' ' ' LEU . 0.8 OUTLIER -118.72 121.75 40.85 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.696 -1.253 . . . . 0.0 111.896 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.735 ' CG1' HG13 ' A' ' 80' ' ' VAL . 7.5 mt -141.63 149.79 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.462 -0.774 . . . . 0.0 109.181 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -139.23 177.02 8.21 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.005 -1.06 . . . . 0.0 109.963 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.637 ' N ' ' CD1' ' A' ' 109' ' ' TYR . 0.9 OUTLIER -155.13 163.73 39.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.011 -1.056 . . . . 0.0 111.251 179.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.4 t -159.56 -178.31 7.02 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.234 0.54 . . . . 0.0 110.137 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.564 ' HB3' HG22 ' A' ' 41' ' ' ILE . 8.5 p-10 -117.1 29.19 8.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.199 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.47 ' OE1' ' CE2' ' A' ' 77' ' ' PHE . 2.0 mt-10 61.7 166.28 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.212 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.88 36.2 3.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 110.244 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.516 HG22 ' H ' ' A' ' 115' ' ' TYR . 9.9 p -99.67 175.34 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 110.235 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.516 ' H ' HG22 ' A' ' 114' ' ' VAL . 12.9 t80 -127.32 142.51 51.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.287 -0.883 . . . . 0.0 110.189 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.36 159.21 24.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.238 -1.154 . . . . 0.0 110.281 -179.987 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' ' 22' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -46.47 -28.14 1.3 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.262 -1.14 . . . . 0.0 110.194 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -76.83 -41.0 45.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.247 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 21' ' ' ILE . 11.7 mm -64.11 -14.47 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.206 -0.934 . . . . 0.0 110.248 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.562 ' N ' ' CD ' ' A' ' 22' ' ' ARG . 1.4 mpt_? -88.95 -52.01 5.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.94 . . . . 0.0 110.168 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -49.75 -42.09 45.51 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.285 -0.884 . . . . 0.0 109.396 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 20' ' ' LYS . 3.6 mtpp -85.45 -49.49 8.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 110.088 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.503 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 21.6 m-85 -117.03 64.85 3.54 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.24 -0.912 . . . . 0.0 110.455 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.452 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 46.4 Cg_endo -72.84 -8.22 22.0 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.841 1.443 . . . . 0.0 110.292 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -120.19 19.46 12.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.915 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 25' ' ' TYR . 7.1 mpt_? -102.78 -174.07 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.0 110.457 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.704 HG12 ' CG1' ' A' ' 31' ' ' VAL . 20.0 t -147.4 105.11 3.77 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.12 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.602 ' HD2' ' CE1' ' A' ' 95' ' ' TYR . 49.5 Cg_endo -76.37 83.41 2.03 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.289 1.678 . . . . 0.0 110.222 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.704 ' CG1' HG12 ' A' ' 29' ' ' VAL . 1.9 m -81.26 154.27 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.216 -0.928 . . . . 0.0 110.803 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 31.1 mm -111.33 161.92 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.346 -0.846 . . . . 0.0 108.761 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.856 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.8 t -134.9 144.67 33.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 120.947 -1.095 . . . . 0.0 111.168 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.36 178.02 10.79 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.593 ' HD2' ' CE2' ' A' ' 109' ' ' TYR . 0.0 OUTLIER -117.07 157.61 25.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.905 -1.122 . . . . 0.0 110.681 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -64.87 -173.74 0.12 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.516 -0.74 . . . . 0.0 109.253 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 43.1 Cg_endo -71.25 105.62 1.76 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.446 1.235 . . . . 0.0 109.762 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 37' ' ' PRO . 0.8 OUTLIER 63.43 40.74 8.1 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.41 -0.806 . . . . 0.0 110.326 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -54.84 -177.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.184 -0.947 . . . . 0.0 109.831 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.443 ' HD3' ' HB3' ' A' ' 111' ' ' ASP . 2.9 ptm180 -144.67 26.63 1.4 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 0.0 110.994 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.416 ' CD1' ' HD2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -85.48 -177.37 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.938 -1.101 . . . . 0.0 109.378 179.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 69' ' ' HIS . . . -62.4 171.05 11.08 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 1.0 ' O ' HD22 ' A' ' 44' ' ' LEU . 4.4 t70 -75.15 -177.29 3.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -1.1 . . . . 0.0 109.998 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.0 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.5 mm? -138.6 133.29 32.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.128 -0.982 . . . . 0.0 110.808 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.503 ' CB ' ' HE2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -86.8 -21.9 26.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.814 . . . . 0.0 109.136 178.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.503 ' HE2' ' CB ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -151.68 147.66 26.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.571 -0.706 . . . . 0.0 109.105 179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -123.61 48.84 1.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.921 -1.112 . . . . 0.0 110.184 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 48' ' ' LYS . 11.5 pttm -158.19 108.95 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 0.0 110.118 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.916 ' CD2' HD13 ' A' ' 63' ' ' LEU . 23.4 m-85 -103.83 144.17 31.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.134 -0.979 . . . . 0.0 110.412 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.8 103.68 11.2 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.004 ' HB ' HD12 ' A' ' 55' ' ' LEU . 3.3 m -128.8 159.37 68.66 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 110.931 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.488 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 44.9 Cg_endo -70.65 148.17 58.74 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.193 1.628 . . . . 0.0 110.513 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.558 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.1 OUTLIER -63.02 -17.08 61.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.494 -0.754 . . . . 0.0 111.305 -179.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -83.51 -9.65 58.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.097 -1.002 . . . . 0.0 111.322 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.004 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.9 mt -62.08 141.41 58.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.784 -1.198 . . . . 0.0 110.908 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.503 ' HA ' HG22 ' A' ' 90' ' ' THR . 6.0 p -91.21 156.67 17.67 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.504 -0.748 . . . . 0.0 109.575 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.731 ' CG1' HG22 ' A' ' 87' ' ' THR . 95.5 t -54.05 -24.55 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 110.068 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.81 -38.37 66.02 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.874 ' CB ' HD22 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -68.57 -49.28 60.66 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.142 -1.211 . . . . 0.0 110.017 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.19 ' CE2' HD11 ' A' ' 64' ' ' ILE . 31.3 t80 -60.49 -47.38 86.38 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.793 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.85 -21.8 1.87 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.68 -1.263 . . . . 0.0 109.776 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -78.68 -54.16 6.4 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.765 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.013 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.6 pp -60.72 -18.45 54.48 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.27 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.19 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -92.3 -41.36 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 O-C-N 120.115 -1.616 . . . . 0.0 109.145 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.935 ' HG2' HD11 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -37.26 -61.2 0.6 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.872 -0.518 . . . . 0.0 110.677 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -65.16 -32.87 74.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.098 -1.001 . . . . 0.0 109.618 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 29.3 mmt-85 -69.94 -12.11 61.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.837 . . . . 0.0 110.109 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.833 HD12 HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -99.09 4.48 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.123 -0.985 . . . . 0.0 109.295 179.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.527 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER 55.47 29.25 12.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.459 -0.776 . . . . 0.0 110.018 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.935 HD11 ' HG2' ' A' ' 65' ' ' ARG . 3.8 pp -101.0 151.81 21.33 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.038 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' GLU . 0.0 OUTLIER -166.82 -161.76 0.46 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.288 -0.883 . . . . 0.0 110.778 -179.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.525 ' O ' ' CG ' ' A' ' 73' ' ' GLU . . . 49.92 -87.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.0 110.917 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 72' ' ' ALA . 40.7 mt-10 -156.37 36.45 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.313 -0.867 . . . . 0.0 110.634 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.52 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -62.91 176.59 0.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.059 -1.026 . . . . 0.0 109.848 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.552 ' HB3' ' OD1' ' A' ' 111' ' ' ASP . . . -119.0 145.06 46.14 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.061 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.837 HD21 ' CE1' ' A' ' 78' ' ' PHE . 22.2 tp -158.84 153.56 24.66 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.288 -0.883 . . . . 0.0 110.351 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.537 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 56.2 m-85 -154.39 122.35 5.94 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.547 -0.72 . . . . 0.0 109.767 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.837 ' CE1' HD21 ' A' ' 76' ' ' LEU . 16.7 m-30 -84.2 131.15 34.78 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 121.337 -0.852 . . . . 0.0 111.869 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.492 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 64.6 m-85 -120.12 119.04 32.15 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 177.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.783 HG22 HG23 ' A' ' 107' ' ' ILE . 1.4 t -121.59 126.26 74.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.654 ' O ' HG23 ' A' ' 83' ' ' VAL . 8.7 t-20 55.25 35.28 24.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 110.079 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 2.0 t-20 64.58 32.16 11.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.335 -0.853 . . . . 0.0 110.106 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.695 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.4 t -135.12 168.55 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.277 -0.889 . . . . 0.0 110.067 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.822 HD12 ' N ' ' A' ' 84' ' ' ILE . 1.1 mp -154.86 73.43 5.8 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.58 -0.7 . . . . 0.0 109.297 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.19 165.14 33.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.099 1.579 . . . . 0.0 110.867 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.62 178.73 5.92 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.108 1.583 . . . . 0.0 110.339 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.731 HG22 ' CG1' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -88.22 21.91 2.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.361 -0.837 . . . . 0.0 110.657 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.7 p -90.5 37.36 0.91 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.46 -0.775 . . . . 0.0 109.795 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.08 -171.96 4.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.463 -0.773 . . . . 0.0 110.142 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.539 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 44.2 p -138.81 150.12 45.7 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.654 0.74 . . . . 0.0 110.267 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.1 ' HA ' HD23 ' A' ' 94' ' ' LEU . 3.1 mmt -47.53 -47.93 27.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.469 -0.77 . . . . 0.0 110.692 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.558 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -42.69 -43.58 5.17 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.539 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 0.7 OUTLIER -67.82 -42.49 81.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.342 -1.093 . . . . 0.0 109.23 179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.1 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -58.84 -23.24 60.35 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.662 -0.815 . . . . 0.0 110.363 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.602 ' CE1' ' HD2' ' A' ' 30' ' ' PRO . 0.6 OUTLIER -48.36 -54.06 15.27 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.675 -1.265 . . . . 0.0 109.716 -179.305 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.71 -22.7 63.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.251 -0.905 . . . . 0.0 111.375 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 2.1 mm-40 -81.54 -63.52 1.38 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.957 -1.089 . . . . 0.0 111.655 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.643 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.8 m-70 -97.63 41.58 1.12 Allowed 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.002 -1.061 . . . . 0.0 110.141 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 95' ' ' TYR . 6.1 t-80 -74.48 166.09 24.09 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 121.259 0.552 . . . . 0.0 109.691 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.549 ' CG ' ' O ' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -145.73 68.98 1.21 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -0.923 . . . . 0.0 109.882 179.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 103' ' ' PHE . 4.5 mt-10 41.31 -164.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.597 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.483 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 8.3 m-20 39.93 -93.0 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.509 -0.744 . . . . 0.0 110.53 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.571 ' O ' ' CD2' ' A' ' 104' ' ' PHE . 0.2 OUTLIER 179.26 64.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.976 . . . . 0.0 110.164 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.595 ' CE1' ' HB2' ' A' ' 30' ' ' PRO . 1.9 m-85 -161.36 150.51 16.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.386 -0.821 . . . . 0.0 109.979 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.066 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -114.87 161.77 17.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.046 -1.034 . . . . 0.0 109.488 179.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.75 ' N ' HD12 ' A' ' 105' ' ' LEU . 4.3 p90 -120.49 132.81 55.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.778 -1.201 . . . . 0.0 111.749 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.066 ' CG1' HD11 ' A' ' 105' ' ' LEU . 7.7 mt -141.25 124.54 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 0.0 109.98 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -122.36 160.3 25.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.993 -1.067 . . . . 0.0 109.671 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.856 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.4 p90 -135.42 162.2 33.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.694 -1.254 . . . . 0.0 111.258 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 36' ' ' ALA . 0.3 OUTLIER -147.33 178.76 8.16 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.135 179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.552 ' OD1' ' HB3' ' A' ' 75' ' ' ALA . 9.6 t0 -105.95 -3.21 21.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.21 -0.931 . . . . 0.0 110.325 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.533 ' HB2' ' CD2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER 47.59 -177.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.15 -0.969 . . . . 0.0 110.424 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 114' ' ' VAL . 9.1 t -118.94 29.76 7.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.31 -0.869 . . . . 0.0 109.883 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 113' ' ' SER . 8.2 p -42.55 166.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 110.407 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.36 126.82 15.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.228 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.68 -146.94 0.73 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 117' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.272 -1.134 . . . . 0.0 110.241 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.95 -20.23 5.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -1.149 . . . . 0.0 109.819 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 2.0 mttt -76.57 -36.99 57.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.359 -0.838 . . . . 0.0 110.361 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.443 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.2 mp -59.78 -19.42 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 0.0 109.67 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.467 ' CD ' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -88.2 -36.57 16.72 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.178 -0.952 . . . . 0.0 109.808 179.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HG2' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -65.76 -36.88 84.81 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.305 -0.872 . . . . 0.0 108.933 179.315 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.477 ' HG2' ' HG2' ' A' ' 23' ' ' LYS . 5.1 mttt -85.34 -44.04 13.16 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.463 -0.773 . . . . 0.0 109.675 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -114.61 61.51 1.21 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 110.77 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.47 ' HD3' ' C ' ' A' ' 24' ' ' LYS . 48.0 Cg_endo -72.81 -4.38 15.27 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.813 1.428 . . . . 0.0 110.381 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -116.39 13.57 15.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 110.453 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.62 -175.1 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.052 -1.03 . . . . 0.0 110.298 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.743 HG12 HG12 ' A' ' 31' ' ' VAL . 16.3 t -147.2 107.25 3.89 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 110.315 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.504 ' HD2' ' OH ' ' A' ' 95' ' ' TYR . 46.3 Cg_endo -75.41 86.48 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.181 1.621 . . . . 0.0 109.855 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.743 HG12 HG12 ' A' ' 29' ' ' VAL . 1.1 m -79.71 136.61 23.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.317 -0.865 . . . . 0.0 110.553 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.487 ' HB ' ' HA ' ' A' ' 106' ' ' TYR . 14.9 mm -91.86 157.25 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.791 HG13 ' HE1' ' A' ' 109' ' ' TYR . 2.5 t -134.05 140.41 46.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 120.898 -1.126 . . . . 0.0 111.336 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 0.0 OUTLIER -156.23 169.74 23.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HG3' ' CB ' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -109.5 162.62 14.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.857 -1.152 . . . . 0.0 110.522 -179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.983 ' HB1' ' HD2' ' A' ' 37' ' ' PRO . . . -62.42 -172.17 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.499 -0.751 . . . . 0.0 109.307 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.983 ' HD2' ' HB1' ' A' ' 36' ' ' ALA . 42.9 Cg_endo -71.55 110.41 2.87 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.433 1.228 . . . . 0.0 109.83 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.64 42.58 10.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.26 -0.9 . . . . 0.0 110.025 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.541 ' CB ' ' HG3' ' A' ' 35' ' ' LYS . . . -59.38 179.13 0.11 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.0 110.286 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.527 ' CG ' ' OD2' ' A' ' 111' ' ' ASP . 6.5 ptm180 -150.04 29.81 0.72 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.186 -0.946 . . . . 0.0 110.825 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.843 HG22 ' HB3' ' A' ' 111' ' ' ASP . 1.9 pp -85.41 178.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.064 . . . . 0.0 110.424 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.82 ' O ' HD12 ' A' ' 41' ' ' ILE . . . -48.02 -178.4 0.01 OUTLIER Glycine 0 N--CA 1.496 2.666 0 O-C-N 121.332 -0.855 . . . . 0.0 111.055 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.99 ' O ' HD22 ' A' ' 44' ' ' LEU . 7.7 t70 -84.95 -178.98 6.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -1.202 . . . . 0.0 109.858 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.99 HD22 ' O ' ' A' ' 43' ' ' ASP . 1.3 mm? -138.41 134.73 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.096 -1.002 . . . . 0.0 110.592 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -85.95 -24.02 26.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.456 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.08 154.46 29.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.556 -0.715 . . . . 0.0 109.591 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.523 ' HG2' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -118.73 43.18 2.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.945 -1.097 . . . . 0.0 110.017 179.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.523 ' HG3' ' HG2' ' A' ' 47' ' ' LYS . 18.9 mttt -158.23 109.53 2.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.619 -0.676 . . . . 0.0 109.566 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.905 ' CD2' HD13 ' A' ' 63' ' ' LEU . 15.3 m-85 -103.84 141.06 36.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.018 -1.051 . . . . 0.0 110.314 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 tp -103.87 94.57 5.49 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.952 ' HB ' HD12 ' A' ' 55' ' ' LEU . 14.7 m -117.57 149.65 45.3 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 110.851 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.457 ' HG2' ' HG ' ' A' ' 55' ' ' LEU . 47.0 Cg_endo -70.56 149.71 62.18 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.212 1.638 . . . . 0.0 110.074 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.557 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 1.5 m -62.27 -17.15 57.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.405 -0.809 . . . . 0.0 111.405 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -83.95 -11.57 56.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.072 -1.017 . . . . 0.0 111.385 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.952 HD12 ' HB ' ' A' ' 51' ' ' VAL . 3.3 mt -61.61 141.21 57.93 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.858 -1.151 . . . . 0.0 111.145 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.5 p -91.17 154.0 19.63 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.285 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 87' ' ' THR . 25.6 t -53.97 -20.98 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.057 -1.027 . . . . 0.0 109.785 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.73 -39.63 59.72 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.822 ' CB ' HD22 ' A' ' 55' ' ' LEU . 10.9 mm-40 -67.85 -47.38 69.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.046 -1.267 . . . . 0.0 109.599 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.172 ' CE2' HD11 ' A' ' 64' ' ' ILE . 21.3 t80 -60.38 -45.97 91.65 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.432 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -50.64 -22.86 2.23 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.953 -1.092 . . . . 0.0 109.911 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -80.15 -54.54 5.66 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.818 . . . . 0.0 110.357 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.043 HD11 ' CD1' ' A' ' 60' ' ' PHE . 3.6 pp -59.61 -21.64 60.69 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.012 -1.055 . . . . 0.0 112.306 -178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.172 HD11 ' CE2' ' A' ' 60' ' ' PHE . 1.8 mt -90.45 -38.56 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 120.09 -1.632 . . . . 0.0 108.816 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.839 ' HG3' HD11 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -36.65 -62.43 0.47 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.863 -0.523 . . . . 0.0 110.691 -179.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -30.63 71.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.133 -0.98 . . . . 0.0 109.845 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.484 ' CG ' ' O ' ' A' ' 63' ' ' LEU . 20.1 mmt180 -68.01 -13.85 62.51 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 109.481 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.013 ' CG2' HD23 ' A' ' 70' ' ' LEU . 70.6 mt -103.21 14.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.449 -0.782 . . . . 0.0 109.545 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.564 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 1.4 t60 47.8 28.76 1.41 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.552 -0.718 . . . . 0.0 110.493 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.013 HD23 ' CG2' ' A' ' 68' ' ' ILE . 4.0 pp -110.71 155.17 22.84 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 109.636 179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 73' ' ' GLU . 11.5 ptt180 -166.15 -171.67 2.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.114 -0.991 . . . . 0.0 111.054 -179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 54.47 -89.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.522 -0.736 . . . . 0.0 110.763 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -148.55 33.24 0.78 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.143 -0.973 . . . . 0.0 110.919 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' CG ' ' N ' ' A' ' 75' ' ' ALA . 0.0 OUTLIER -56.76 176.81 0.09 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.024 -1.048 . . . . 0.0 109.796 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' N ' ' CG ' ' A' ' 74' ' ' ASP . . . -105.29 138.77 40.96 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.128 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.745 HD21 ' CE1' ' A' ' 78' ' ' PHE . 17.5 tp -164.41 152.85 12.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 110.505 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 76' ' ' LEU . 94.1 m-85 -158.85 122.08 3.77 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.663 -0.648 . . . . 0.0 109.896 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.745 ' CE1' HD21 ' A' ' 76' ' ' LEU . 16.9 m-30 -85.62 132.33 34.19 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 121.136 -0.977 . . . . 0.0 111.346 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 77' ' ' PHE . 58.2 m-85 -119.45 121.46 39.52 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.49 -0.756 . . . . 0.0 109.227 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.827 HG22 HG23 ' A' ' 107' ' ' ILE . 2.5 t -120.63 123.48 70.45 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 O-C-N 121.358 -0.839 . . . . 0.0 110.074 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 83' ' ' VAL . 7.6 t30 50.39 34.54 9.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 81' ' ' ASN . 8.4 t-20 66.98 37.37 3.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.181 -0.95 . . . . 0.0 110.146 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.612 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.7 t -135.47 169.96 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 109.83 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.814 HD12 ' N ' ' A' ' 84' ' ' ILE . 0.6 OUTLIER -154.68 73.67 5.89 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.478 -0.764 . . . . 0.0 109.207 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.52 155.77 58.99 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.164 1.613 . . . . 0.0 110.925 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.71 -178.67 3.58 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.167 1.614 . . . . 0.0 110.273 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.538 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 1.2 p -86.03 18.46 3.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.906 . . . . 0.0 110.823 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.4 m -90.33 32.49 0.94 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.397 -0.814 . . . . 0.0 109.662 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -146.31 -174.18 4.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.525 -0.735 . . . . 0.0 110.096 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.53 ' OG1' ' HG3' ' A' ' 93' ' ' GLN . 67.3 p -139.4 149.91 44.66 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.561 -0.712 . . . . 0.0 110.19 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.019 ' HA ' HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -48.74 -43.81 37.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.317 -0.864 . . . . 0.0 110.175 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 53' ' ' SER . . . -46.1 -44.18 14.02 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.53 ' HG3' ' OG1' ' A' ' 90' ' ' THR . 2.4 mt-30 -65.58 -47.0 77.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.385 -1.067 . . . . 0.0 109.434 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.019 HD23 ' HA ' ' A' ' 91' ' ' MET . 0.3 OUTLIER -56.91 -23.43 44.94 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.617 -0.833 . . . . 0.0 110.385 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.53 ' CD1' HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -48.94 -56.18 9.61 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.812 -1.18 . . . . 0.0 109.848 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -16.78 62.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.027 -1.046 . . . . 0.0 111.532 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -87.15 -65.53 1.0 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.892 -1.13 . . . . 0.0 112.473 -178.043 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.555 ' CD2' ' CG1' ' A' ' 80' ' ' VAL . 8.7 m-70 -98.78 41.48 1.14 Allowed 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.953 -1.092 . . . . 0.0 111.388 -177.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 6.8 p80 -68.12 -19.98 64.88 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.492 -0.755 . . . . 0.0 109.758 179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.521 ' CB ' ' O ' ' A' ' 99' ' ' HIS . 0.4 OUTLIER 75.4 -75.95 0.06 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.918 -0.489 . . . . 0.0 110.778 179.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 102' ' ' ASP . 6.5 tt0 -166.61 45.53 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.089 -1.007 . . . . 0.0 110.096 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 101' ' ' GLU . 3.8 t0 177.58 -142.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.862 . . . . 0.0 110.105 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -94.01 -58.34 2.27 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.187 -0.946 . . . . 0.0 109.881 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.429 ' HA ' ' HG2' ' A' ' 30' ' ' PRO . 4.9 p90 -55.29 166.95 0.51 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 110.105 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.076 HD11 ' CG1' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -121.73 171.64 8.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.125 -0.985 . . . . 0.0 109.752 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.568 ' N ' HD12 ' A' ' 105' ' ' LEU . 1.3 m-85 -122.64 126.23 47.23 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.666 -1.271 . . . . 0.0 111.366 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 1.076 ' CG1' HD11 ' A' ' 105' ' ' LEU . 9.0 mt -138.75 136.16 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.179 -0.951 . . . . 0.0 110.358 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' GLU . . . -130.73 173.11 11.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -1.0 . . . . 0.0 109.731 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.791 ' HE1' HG13 ' A' ' 33' ' ' VAL . 1.4 p90 -150.69 165.33 33.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.87 -1.144 . . . . 0.0 111.364 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -150.54 -178.28 6.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.768 -0.583 . . . . 0.0 110.177 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.843 ' HB3' HG22 ' A' ' 41' ' ' ILE . 8.4 p-10 -128.5 29.98 5.22 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -148.53 147.42 29.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.33 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 80.2 p -132.17 19.34 4.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 0.0 110.168 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.443 HG22 ' N ' ' A' ' 115' ' ' TYR . 9.2 p -105.21 172.32 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.443 ' N ' HG22 ' A' ' 114' ' ' VAL . 2.0 t80 -82.52 177.09 8.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 110.159 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 45.52 -141.13 4.8 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.305 -1.115 . . . . 0.0 110.16 179.935 . . . . . . . . 0 0 . 1 stop_ save_